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Summary

From 1962 to 1971, the U.S. military sprayed herbicides over Vietnam to
strip the thick jungle canopy that could conceal opposition forces, to destroy
crops that those forces might depend on, and to clear tall grasses and bushes from
the perimeters of U.S. base camps and outlying fire-support bases. Mixtures of
2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,
5-T), picloram, and cacodylic acid (collectively, the “chemicals of interest” or
COIs) made up the bulk of the herbicides sprayed. The herbicide mixtures used
were named according to the colors of identification bands painted on the storage
drums. The most-used chemical mixture sprayed was Agent Orange,1 a 50:50 mixture of 2,4-D and 2,4,5-T. At the time of the spraying, 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD), the most toxic form of dioxin, was an unintended contaminant
generated during the production of 2,4,5-T and so was present in Agent Orange
as well as some of the other formulations sprayed in Vietnam.
Concerns from returning Vietnam veterans about their own health and that
of their children combined with emerging toxicologic evidence of the adverse
effects of phenoxy herbicides and TCDD exposure from animal studies and some
positive findings from epidemiologic studies led Congress to pass Public Law
(PL) 102-4, the Agent Orange Act of 1991. This legislation directed the Secretary
of Veterans Affairs to ask the National Academies of Sciences, Engineering, and
Medicine (the “National Academies”) to perform a comprehensive evaluation
1 Despite loose usage of “Agent Orange” as a collective term for all of the herbicides sprayed by
U.S. forces during the Vietnam War—including in the title of this publication—it was only one of
the formulations used. The text of the report uses “herbicides” or “COIs” to refer to the full range of
herbicide agents, while “Agent Orange” is reserved for that specific formulation.

1
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2

VETERANS AND AGENT ORANGE: UPDATE 2014

of scientific and medical information regarding the health effects of exposure to
Agent Orange, other herbicides used in Vietnam, and the various components of
those herbicides, including TCDD. The legislation also instructed the Secretary
to ask the National Academies to conduct updates every 2 years for 10 years from
the date of the first report in order to review newly available literature and draw
conclusions from the overall evidence.
In response to the first request, the Institute of Medicine convened a committee
whose conclusions were published in 1994 in Veterans and Agent Orange: Health
Effects of Herbicides Used in Vietnam (VAO). The work of later committees resulted in a series of biennial updates (Update 1996, Update 1998, Update 2000,
Update 2002, and Update 2004) and focused reports on the scientific evidence
regarding type 2 diabetes, acute myeloid leukemia in the children of veterans,
and the latent period for respiratory cancers.
Enacted in 2002, PL 107-103, the Veterans Education and Benefits Expansion Act of 2001, mandated a continuation of the VAO biennial updates. Update
2006, Update 2008, Update 2010, Update 2012, and Update 2014 were published
under that legislation and subsequent extensions to the Department of Veterans
Affairs’ (VA’s) authority to request reports. The current update presents this
committee’s review of peer-reviewed scientific reports concerning associations
between various health outcomes and exposure to TCDD and other chemicals in
the herbicides used in Vietnam that were published between September 30, 2014,
and December 31, 2017, and the committee’s integration of this information with
the previously established evidence database.
CHARGE TO THE COMMITTEE
The committee was asked to “determine (to the extent that available scientific data permit meaningful determinations)” the following regarding associations between specific health outcomes and exposure to TCDD and other
chemicals present in the herbicides used by the military in Vietnam:
A. whether a statistical association with herbicide exposure exists, taking
into account the strength of the scientific evidence and the appropriateness of the statistical and epidemiological methods used to detect the
association;
B. the increased risk of disease among those exposed to herbicides during
service in the Republic of Vietnam during the Vietnam era; and
C. whether there exists a plausible biological mechanism or other evidence
of a causal relationship between herbicide exposure and the disease. [PL
102-4, § 3(d)]
In addition, the committee was asked to address the current research available on
possible generational health effects that may be the result of exposures to these
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chemicals, including the biologic plausibility or potential for exposures to lead
to an increased risk of birth defects or other adverse conditions in the descendants of male veterans; on myeloproliferative neoplasms (MPN) as part of its
consideration of the literature concerning leukemias and related diseases; and on
glioblastoma multiforme in its review of brain cancers.
In conducting its work, the committee operated independently of VA and
other government agencies. It was not asked to make and did not make judgments
regarding specific cases in which individual Vietnam veterans have claimed injury
from herbicide exposure or such broader issues as the potential costs of compensation for veterans or policies regarding such compensation.
COMMITTEE’S APPROACH TO ITS CHARGE
Following the pattern established by previous VAO committees, the present
committee concentrated its review on epidemiologic studies so as to fulfill its charge
of assessing whether specific human health effects are associated with exposure to
at least one of the herbicides sprayed in Vietnam or to TCDD. The committee also
examined controlled laboratory investigations that provided information on whether
a scientifically relevant association between the COIs and a given effect is biologically plausible. Information on dioxins other than TCDD and dioxin-like chemicals
was considered because of the common mode of action underlying biologic effects.
The evidence evaluation process presumes neither the presence nor the absence of association for any particular health outcome. Over the sequence of reviews, evidence has accrued of various degrees of association, lack of association,
or persistent indeterminacy with respect to a wide array of disease states. For many
conditions, however, particularly ones that are very uncommon, any association
with the COIs has remained unaddressed in the medical research literature. The
committee does not offer a conclusion for these conditions unless the condition
is logically subsumed under a broader disease category that has been evaluated,
abiding by the maxim that “absence of evidence is not evidence of absence.”
In accord with Congress’s mandated presumption of herbicide exposure of all
Vietnam veterans, VAO committees have treated Vietnam-veteran status as a proxy
for herbicide exposure when no more specific exposure information is available.
To anticipate the health conditions associated with aging and to obtain additional
information potentially relevant to the evaluation of health effects in Vietnam veterans, the committees have reviewed studies of other groups potentially exposed
to the constituents present in the herbicide mixtures used in Vietnam.
The original legislation calling for the report series, PL 102-4, did not provide a list of specific diseases and conditions suspected of being associated with
herbicide exposure. Instead, a list was developed on the basis of diseases and conditions that had been mentioned in the scientific literature or in other documents
identified through the original VAO’s extensive literature searches. The VAO list
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has since been augmented in response to new scientific findings, requests by VA,
and concerns of Vietnam veterans.
The information that the present committee reviewed was identified through
a comprehensive search of relevant databases, including databases covering epidemiologic, biologic, medical, toxicologic, chemical, historical, and regulatory
information. To determine whether there is a scientifically relevant association
between exposure and a health outcome, epidemiologists estimate the magnitude of an appropriate measure (such as the relative risk or the odds ratio) that
describes the relationship between exposure and disease in a defined population
or group. In evaluating the strength of the evidence linking herbicide exposure
with a particular outcome, the committee considered whether such estimates of
risk might not be consistent with a causal association (because of confounding,
chance, or bias related to errors in selection and measurement) or might be an
indication of a true association. Although they are not required, data supporting biologic plausibility can increase the confidence that an association is not
spurious, and such data are presented in each of the sections. In this regard, it
is important to note that while the biologic plausibility for a particular effect
has been considered sufficient evidence of association by other bodies that have
reviewed the health effects of environmental exposures, PL 102-4 specifies that
the scientific determinations concerning the association between exposures and
outcomes be supported by epidemiologic evidence. It has been the practice of all
VAO committees to evaluate all studies according to the same criteria and then
to weight findings of similar strength and validity equivalently, whether or not
the study subjects are Vietnam veterans, when drawing conclusions. The committee recognizes that an absolute conclusion about the absence of association
might never be attained, because—as is generally the case in science—studies of
health outcomes after an exposure cannot demonstrate that a purported outcome
is impossible, only that it is statistically improbable.
Tables on individual health outcomes summarizing the salient results of
epidemiologic studies that have been evaluated over the entire series of VAO
reports have been compiled and are available in digital form from www.nap.edu/
catalog/25137. The results for a particular endpoint are grouped by study population to emphasize and clarify the relationship among successive publications
based on the repeated study of particular exposed populations.
EVIDENCE REVIEWED BY THE COMMITTEE
The sections below describe the epidemiologic information that was newly
evaluated for this update and illustrate the broad scope and nature of that information. The studies are divided, both here and in the report’s health-outcome chapters,
into four categories—Vietnam-veteran, occupational, environmental, and casecontrol—reflecting the committee’s judgement of their relative relevance to the
exposures of interest. Details of these publications are presented in Chapters 5–11.
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Vietnam-Veterans Studies
There has been an upswing of research interest in studies of the health of
veterans of the Vietnam War, with publications addressing both U.S. and other
populations. The committee considered analyses of the data and biospecimens
collected in the course of the Air Force Health Study—a 20-year study of personnel involved in wartime aerial herbicide spray missions and a matched comparison group—to be particularly valuable because of the large amount of health
and other information collected over an extended time period and because of the
availability of measured serum dioxin levels. Since Update 2014, investigators
have published studies of monoclonal gammopathy of undetermined significance
(MGUS) and testosterone levels (which influence type 2 diabetes risk) in the
cohort. A new study of hypertension in Army Chemical Corps personnel, who
managed ground spraying operations, was also reviewed. Researchers using data
from VA’s Agent Orange Registry, a database containing health information on
Vietnam veterans who voluntarily undergo examinations in a VA medical center,
produced papers on various health outcomes that relied on surrogates of herbicide
exposure such as self-reports. Studies of health outcomes for Australian, Korean,
and New Zealand Vietnam veterans were also released.
Occupational Studies
In contrast with Update 2014, which found few studies of health outcomes in
workers occupationally exposed to the COIs, there were several new publications
available for the current committee to consider. The subjects of these included
chemical manufacturing workers in the United States, New Zealand agrochemical
production personnel, waste incineration workers in Japan, and employees of an
electric arc furnace facility in Italy, a transformer and capacitor recycling plant in
Germany, and five factories in the United Kingdom manufacturing or formulating
phenoxy herbicides.
The Agricultural Health Study—a longstanding examination how agricultural, lifestyle, and genetic factors affect the health of U.S. farming populations
being conducted by the National Institutes of Health (NIH)—has yielded numerous papers reviewed in the VAO series of reports. New studies of asthma, body
mass index (a risk factor for type 2 diabetes), end-stage renal disease, lung cancer,
prostate cancer, and rheumatoid arthritis were reviewed by this committee.
Environmental Studies
The committee reviewed a considerable number of studies of the effects
of environmental exposures to the COIs. Most involved measurements of compounds with dioxin-like activity in blood samples and their association with
a diverse set of health outcomes. The U.S. efforts included analyses of data
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from Centers for Disease Control and Prevention’s (CDC’s) National Health and
Nutrition Examination Surveys and NIH’s Longitudinal Investigation of Fertility
and the Environment study cohorts. The large body of international work examined included the Danish Fetal Origins 1988–1989 Cohort, Duisburg (Germany)
Birth Cohort Study, Hokkaido Study on Environment and Children’s Health and
its Sapporo companion study, the (Chapaevsk) Russian Children’s Study, the
Seveso (Italy) Woman’s Health Study, and publications concerning populations
in Belgium, Brazil, Canada, China, Finland, France, Greece, Hong Kong, Italy,
Korea, Nicaragua, Norway, Spain, and Taiwan. Ten newly published studies of
birth and other health outcomes in the Vietnamese population were also identified and reviewed.
Case-Control Studies
Several new publications using case-control methodology from the CDC’s
National Birth Defects Prevention Study were identified for the current update.
These included studies of parental exposure to the COIs and spina bifida, congenital heart defects, gastroschisis, and a series of defects including anotia/
microtia, anorectal atresia/stenosis, transverse limb deficiency, craniosynostosis,
and diaphragmatic hernia in offspring.
A number of case-control studies in various other populations that examined
forms of cancer (including cutaneous melanoma, female breast cancer, hepatocellular carcinoma, infiltrating ductal carcinomas, non-Hodgkin lymphoma, pancreatic cancer, prostate cancer, soft tissue sarcoma, and testicular cancer) and other
health outcomes including Parkinson disease, amyotrophic lateral sclerosis, and
kidney and urinary disorders were also reviewed.
THE COMMITTEE’S CONCLUSIONS
General Observations Regarding Findings
VAO committees classify the evidence regarding exposure to the COIs and
health outcomes into four categories: sufficient, limited or suggestive, inadequate
or insufficient, and no association. Table S-1 sets forth the criteria for assigning
categorizations and summarizes the committee’s conclusions, with the changes in
classification made since the previous volume (Update 2014) indicated in boldface. The classifications are based on the committee’s evaluation of the epidemiologic literature and reflect the committee members’ judgement of the relative
certainty of the association between the outcome and exposure to the herbicides
that were used in Vietnam or to any of their components or contaminants (with
no intention of specifying particular chemicals).
The changes and the decisions not to modify other findings from earlier VAO
committees were made after the present committee weighed the strengths and
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TABLE S-1 Summary of the Eleventh Biennial Update Findings on
Vietnam-Veteran, Occupational, and Environmental Studies Regarding
Scientifically Relevant Associations Between Exposure to Herbicides and
Specific Health Outcomesа
Sufficient Evidence of an Association
Epidemiologic evidence is sufficient to conclude that there is a positive association. That is,
a positive association has been observed between exposure to herbicides and the outcome in
studies in which chance, bias, and confounding could be ruled out with reasonable confidence.b
For example, if several small studies that are free of bias and confounding show an association
that is consistent in magnitude and direction, there could be sufficient evidence of an association.
There is sufficient evidence of an association between exposure to the chemicals of interest and the
following health outcomes:
Soft-tissue sarcoma (including heart)
* Non-Hodgkin lymphoma
*	Chronic lymphocytic leukemia (including hairy cell leukemia and other chronic B-cell
  leukemias)
* Hodgkin lymphoma
Chloracne
Hypertension (category change from Limited or Suggestive in Update 2014)
	
Monoclonal gammopathy of undetermined significance (MGUS) (newly considered
  condition)
The committee did not reach consensus on whether the evidence regarding type 2 diabetes
(mellitus) was more properly classified as Sufficient or Limited or Suggestive.
Limited or Suggestive Evidence of an Association
Epidemiologic evidence suggests an association between exposure to herbicides and the
outcome, but a firm conclusion is limited because chance, bias, and confounding could not be
ruled out with confidence.b For example, a well-conducted study with strong findings in accord
with less compelling results from studies of populations with similar exposures could constitute
such evidence. There is limited or suggestive evidence of an association between exposure to the
chemicals of interest and the following health outcomes:
Laryngeal cancer
Cancer of the lung, bronchus, or trachea
Prostate cancer
Cancer of the urinary bladder
* Multiple myeloma
* AL amyloidosis
Early-onset peripheral neuropathy
Parkinson disease (including Parkinsonism and Parkinson-like syndromes)
Porphyria cutanea tarda
Ischemic heart disease
Stroke
Hypothyroidism
The committee did not reach consensus on whether the evidence regarding type 2 diabetes
(mellitus) was more properly classified as Sufficient or Limited or Suggestive.
continued
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TABLE S-1 Continued
Inadequate or Insufficient Evidence to Determine an Association
The available epidemiologic studies are of insufficient quality, consistency, or statistical power to
permit a conclusion regarding the presence or absence of an association. For example, studies fail
to control for confounding, have inadequate exposure assessment, or fail to address latency. There
is inadequate or insufficient evidence to determine association between exposure to the chemicals
of interest and the following health outcomes that were explicitly reviewed:
Cancers of the oral cavity (including lips and tongue), pharynx (including tonsils), or nasal
cavity (including ears and sinuses)
Cancers of the pleura, mediastinum, and other unspecified sites in the respiratory system
and intrathoracic organs
Esophageal cancer
Stomach cancer
Colorectal cancer (including small intestine and anus)
Hepatobiliary cancers (liver, gallbladder, and bile ducts)
Pancreatic cancer
Bone and joint cancers
Melanoma
Non-melanoma skin cancer (basal-cell and squamous-cell)
Breast cancer
Cancers of reproductive organs (cervix, uterus, ovary, testes, and penis; excluding prostate)
Renal cancer (kidney and renal pelvis)
Cancers of brain and nervous system (including eye)
Endocrine cancers (thyroid, thymus, and other endocrine organs)
Leukemia (other than chronic lymphocytic leukemia, including hairy-cell leukemia and
other chronic B-cell leukemias)
    Other myeloid diseases (including myeloproliferative neoplasms)
Cancers at other and unspecified sites
Infertility
Spontaneous abortion (other than after paternal exposure to TCDD, which appears not to be
associated)
Neonatal or infant death and stillbirth in offspring of exposed people
Low birth weight in offspring of exposed people
Birth defects in offspring of exposed people, including spina bifida
Childhood cancer (including acute myeloid leukemia) or other adverse health outcomes in
offspring of exposed people
Neurobehavioral disorders (cognitive and neuropsychiatric)
Neurodegenerative diseases, excluding Parkinson disease
Chronic peripheral nervous system disorders
Hearing loss
Respiratory disorders (wheeze or asthma, chronic obstructive pulmonary disease, and
farmer’s lung)
Gastrointestinal, metabolic, and digestive disorders (changes in hepatic enzymes, liver
disorders including cirrhosis, lipid abnormalities, and ulcers)
Immune system disorders (immune suppression, allergy, and autoimmunity)
Circulatory disorders (other than hypertension, ischemic heart disease, and stroke)
Endometriosis
continued
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TABLE S-1 Continued
Disruption of thyroid homeostasis (other than hypothyroidism)
Eye problems
Bone conditions
    Kidney and urinary disorders (including chronic kidney disorder, differences in kidney
    function, nephropathy, and end stage renal disorder)
    Chronic skin disorders (including skin infections and changes in skin pigmentation)
The committee used a classification that spans the full array of cancers. However, reviews for
non-malignant conditions were conducted only if they were found to have been the subjects of
epidemiologic investigation or at the request of the Department of Veterans Affairs. By default, any
health outcome on which no epidemiologic information has been found falls into this category.
Limited or Suggestive Evidence of No Association
Several adequate studies, which cover the full range of human exposure, are consistent in
not showing a positive association between any magnitude of exposure to a component of the
herbicides of interest and the outcome. A conclusion of “no association” is inevitably limited to the
conditions, exposures, and length of observation covered by the available studies. In addition, the
possibility of a very small increase in risk at the exposure studied can never be excluded. There is
limited or suggestive evidence of no association between exposure to the herbicide components of
interest and the following health outcome:
Spontaneous abortion after paternal exposure to TCDD
aHerbicides indicates the following chemicals of interest: 2,4-dichlorophenoxyacetic acid (2,4-D),
2,4,5-trichlorophenoxyacetic acid (2,4,5-T) and its contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD or dioxin), cacodylic acid, and picloram. The evidence regarding association was drawn
from veteran, occupational, and environmental cohort studies in which people were exposed to the
herbicides used in Vietnam, to their components, or to their contaminants.
bEvidence of an association is strengthened by experimental data supporting biologic plausibility,
but its absence would not detract from the epidemiologic evidence.
*The committee notes the consistency of these findings with the biologic understanding of the
clonal derivation of lymphohematopoietic cancers that is the basis of the World Health Organization classification system (Campo et al., 2011; see table here: www.ncbi.nlm.nih.gov/pmc/articles/
PMC3109529/table/T1, accessed May 17, 2018).

limitations of the epidemiologic evidence reviewed in this report and in previous
VAO reports. Although the studies published since Update 2014 are the subject
of detailed evaluation in this report, the committee drew its conclusions in the
context of the entire body of literature, and the committee did not weigh new
findings more heavily than past research.
As mandated by PL 102-4, the distinctions among categories are based on
statistical association and not on strict causality. The committee was directed to
review the scientific data, not to recommend VA policy; therefore, the conclusions
reported in Table S-1 are not intended to imply or suggest policy decisions. The
conclusions are related to the associations between exposure and outcomes in
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human populations, not to the likelihood that any individual’s health problem is
associated with or caused by the herbicides in question.
Hypertension
The committee concluded that the information now assembled constitutes
sufficient evidence of an association between exposure to at least one of the
COIs and hypertension. The decision to change the classification from limited or
suggestive evidence of an association was motivated in large part by the work
of Cypel and colleagues (2016). These investigators conducted a study on the
population of interest, U.S. Vietnam veterans (specifically, the Army Chemical Corps), that was characterized by a large sample size, appropriate controls,
and validated health endpoints. The statistical analyses conducted were robust,
used state-of-the-art methods, and adjusted for relevant confounders. The study
clearly showed that self-reported hypertension rates were the highest among
those military personnel with the greatest opportunity for exposure to the COIs.
Among Vietnam-deployed veterans, there was a statistically significantly elevated
association between the odds of hypertension for sprayers versus nonsprayers that
remained after an adjustment for potential confounders. Similarly, for those veterans who did not deploy to Vietnam, self-reported hypertension was significantly
elevated among sprayers compared with nonsprayers. Earlier studies reviewed
in previous updates consistently reported increased hypertension with increasing
levels of serum dioxin in Vietnam veterans as well as increased prevalence in
veterans with higher presumed exposure to the COIs. When considered in light
of other new research and earlier studies that demonstrated a consistency in the
direction and magnitude of this effect, the committee found that this body of
literature constitutes sufficient evidence of an association.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
The committee also concluded that there was sufficient evidence of an association between exposure to at least one of the COIs and MGUS. MGUS is a
precursor to multiple myeloma, although only an estimated 1% of MGUS cases
progress to multiple myeloma each year. It is a clinically silent condition defined
by the presence of a monoclonal antibody, antibody heavy chain, or antibody
light chain in the blood or urine of a person lacking symptoms or signs of a
more serious plasma cell dyscrasia. The foundation of this finding was a wellconducted study by Landgren and colleagues (2015) that examined data and biospecimens from a population of veterans that included participants with known
exposure to herbicides in Vietnam: the Air Force Health Study cohort. The study
used previously measured serum levels of TCDD and performed a new assay of
serum samples to detect MGUS. Known confounders including age, race, body
mass index, smoking and drinking history, and a history of radiation therapy or
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chemotherapy were considered. The investigators found a statistically significant
higher prevalence of MGUS in veterans involved in herbicide spray operations
than in comparison veterans. Although no previous study directly addressed
MGUS incidence, the direct relevance of the exposure and exposed population
and the high quality of the study and underlying database were persuasive in
finding sufficient evidence of an association.
Type 2 Diabetes
Finally, the committee—after extensive deliberations—could not come to
a consensus on whether the available evidence regarding exposure to the COIs
and type 2 diabetes continued to be limited or suggestive or merited elevation
to sufficient. Both newly reviewed and previously reviewed studies quite consistently show a relationship between well-characterized exposures to dioxin
and dioxin-like chemicals and measures of diabetes health outcomes in diverse
cohorts, including Vietnam veteran populations. However, the lack of exposure
specificity and the potential for uncontrolled confounding that characterized
many of these studies complicates any attribution of the outcome to the COIs.
Thus, a case can be made that the body of literature regarding the exposure to
the COIs and diabetes meets the criteria for sufficient evidence of an association,
but it was not clear to the committee as a whole whether a category change was
appropriate, given its limitations.
Findings on Health Outcomes Identified for Special Focus by VA
As noted, VA asked the committee to specifically address three health outcomes: possible generational health effects that may be the result of herbicide
exposure among male Vietnam veterans, myeloproliferative neoplasms, and glioblastoma multiforme.
Research on the effects of paternal chemical exposures on their descendants
is burgeoning. Few studies address Vietnam veterans, however, and almost all of
them that were conducted on other populations have weaknesses—prominently,
different exposures than those experienced by veterans and poor exposure characterization—that limit their usefulness when assessing the risks for veterans.
Some find associations between exposures and various outcomes, but there are
no circumstances where there is a consistent and compelling body of evidence
that would lead the committee to conclude that there might be limited or suggestive or sufficient evidence of an association between an exposure to a COI
and a particular outcome. Transgenerational effects—those that might occur in
descendants when gestational exposure did not take place—are of great interest
to veterans, but no literature exists to evaluate whether the COIs might have an
influence on outcomes. Given these gaps in the knowledge base, the committee
strongly believes that more work in this area is warranted. It concurs with the
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Update 2014 committee that there is a critical need for this research to include
animal studies in order to elucidate whether and which mechanisms for intergenerational and transgenerational effects might exist. It is in principle possible to
do studies on the health of children and grandchildren of veterans, but it must be
understood up front that such complex studies will need to be carefully planned
and conducted if they are to yield meaningful results. Voluntary participation
surveys and registries relying on self-reported information will not be helpful.
Myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes are
diseases of the blood cells and bone marrow. VA asked that MPNs be explicitly
examined as part of the consideration of the literature concerning leukemias
and related diseases. However, after conducting a targeted search of science and
medical databases, the committee was able to identify only one relevant paper,
which assessed cancer incidence among Korean veterans who had served in
Vietnam during 1964–1973 and was evaluated by the Update 2014 committee.
The paper’s authors reported non-significant and imprecise increased risks of
myeloproliferative disease and of myelodysplastic syndromes in internal comparisons of high- and low-exposure groups. The committee observes that, in
general, those studies that have looked at the correlation between exposure to the
COIs and hematological outcomes have generated much more compelling results for abnormalities of lymphoid development and immune function, such as
non-Hodgkin lymphoma, chronic lymphocytic leukemia, multiple myeloma, and
MGUS, than have those that examined myeloid neoplasms of granulocytic lineage
such as MPN. Given the absence of new studies, the paucity of epidemiologic
studies in general, and the lack of information on the biologic plausibility of a
connection between exposures to the COIs and abnormalities of hematopoietic
cells, the committee concluded there was inadequate or insufficient evidence of
an association between exposure to the COIs and MPN. Because the outcome
has not been subject to previous research attention and is of interest to veterans,
the committee recommends that investigators examine existing databases on
myeloid diseases to determine whether there are data available that would
allow for an evaluation of MPN in Vietnam veterans and others who have
been exposed to dioxin and the other COIs.
The scientific literature regarding exposure to the COIs and brain and other
nervous system cancers, including glioblastoma, has been examined since the
first VAO report. The body of evidence that has been developed has not found
statistically significant associations between exposure and any relevant outcome
in studies performed on Vietnam-veteran, occupational, or environmental cohorts. These studies have by and large been underpowered because of the relative rarity of these cancers. Given the limited epidemiologic data available on
glioblastoma, the committee heard invited presentations from two experts on the
disease. While their presentations to the committee were helpful and impressive,
demonstrating that the biological understanding of glioblastoma in particular
is rapidly advancing, they reinforced the absence of clear data suggesting that
the COIs are associated with the occurrence of brain cancers. Information on
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glioblastomas in Vietnam veterans submitted for the committee’s consideration
by the Sierra Valley Cancer Registry Services, Inc., was, in part, anecdotal and
without documented levels of exposure and was therefore of limited usefulness
for the purpose of drawing conclusions. Furthermore, the committee did not
identify any animal studies that have reported an association between exposure
to the COIs and any brain cancer. While some studies have put forward mechanisms that might explain why dioxin exposure would be associated with glioblastoma, the information reviewed by the committee along with the presentations
it received from experts in the field were not sufficient to alter the conclusion
of previous reports that the evidence is inadequate or insufficient to determine
whether there is an association between exposure to the COIs and brain or other
nervous system cancers. The committee believes it is appropriate for VA to be
mindful of the concerns raised about the possible association between Vietnam
service and glioblastoma, but it observes that the outcome is so rare and the
information concerning herbicide exposures so imprecise that it is doubtful that
any logistically and economically feasible epidemiologic study of veterans—no
matter how well designed or executed—would produce meaningful results. The
committee therefore recommends that epidemiologic studies of glioblastoma
in Vietnam veterans should not be pursued and that VA should instead focus
on fostering advancements in other areas that may be used to inform improved treatment options.
Risk in Vietnam Veterans
Part of the committee’s charge was to determine, to the extent permitted by
available scientiﬁc data, the increased risk of disease among veterans exposed to
herbicides or the contaminant TCDD during service in Vietnam. Estimating the
magnitude of risk of each particular health outcome among herbicide-exposed
Vietnam veterans requires quantitative information about the dose–time–response
relationship for the health outcome, information on the extent of herbicide exposure among Vietnam veterans, and estimates of individual exposure. Vietnam
veterans were exposed to other agents and stresses—such as tobacco smoke,
insecticides, therapeutics, drugs, diesel fumes, alcohol, hot and humid conditions,
and combat—that may have independent effects or increase or decrease the ability of chemicals in herbicides to produce a particular adverse health outcome.
Few, if any, studies either in humans or in experimental animals have examined
those interactions. The committees that produced the first VAO report and the
updates found that the body of evidence was sufﬁcient for reaching conclusions
about statistical associations between herbicide exposures and health outcomes
but that the lack of adequate data on Vietnam veterans themselves complicated
the consideration of this part of the charge. The committees responsible for the
VAO report series have therefore concluded that, in general, it is impossible to
quantify the risk posed to veterans by their exposure to herbicides in Vietnam.
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COMMITTEE RECOMMENDATIONS
As part of their charge, all VAO committees have been asked to offer recommendations concerning the need for additional scientific studies and research to
resolve areas of continuing scientific uncertainty concerning the health effects
of the COIs. The previous (tenth; Update 2014) update of the VAO series was
originally understood to be the last of the reports mandated by Congress. The
committee responsible for that update thus considered it appropriate to compile
the recommendations made by prior VAO committees and, in light of the lessons
learned in this process, to consider what would be the most important activities to undertake in the future. That committee produced a compendium of the
recommendations of prior committees condensed and sorted into topic areas,
with comments on what response these recommendations had received from VA,
Department of Defense (DoD), and other parties along with a summary of the
future activities that the committee considered most important for monitoring and
evaluating the health issues of Vietnam veterans and other veterans who might
experience service-related health problems long after discharge.
Generally speaking, the recommendations of previous VAO committees fell
into four primary areas: better management of veterans’ health information; additional epidemiologic studies; improvement of exposure estimation; and priority
areas for toxicologic research. Suggested future activities included these areas
plus initiatives related to the collection and analysis of additional information on
Vietnam veterans’ service, exposures, and health.
While there have been a few laudable exceptions—notably, the initiation
of additional epidemiologic studies on Vietnam veterans, the development of a
herbicide exposure assessment model for use in studies of Vietnam veterans, and
the fostering of additional research on the data and biospecimens collected in the
course of the Air Force Health Study2—there has been no known follow-up to
the vast majority of recommendations that have been offered. The current committee did not choose to revisit this issue in general, concluding that the Update
2014 committee had effectively covered it. It does observe, though, that the very
first VAO (1994) indicated that “carefully conducted epidemiologic studies—with
adequate sample size to detect elevated associations—of the reproductive history
of individuals with occupational or environmental exposure to herbicides and
dioxin are . . . needed” (p. 731). Several subsequent volumes have echoed and
expanded on this. The current committee is in agreement with these sentiments
and therefore recommends further specific study of the health of offspring of
male Vietnam veterans.
The Update 2014 committee also offered suggestions for research activities
that should follow the end of the VAO report series. Several of these addressed
2 The Institute of Medicine publications Disposition of the Air Force Health Study (2006) and The
Air Force Health Study Assets Research Program (2015) provide details of this work.
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reproductive outcomes. As that committee noted, although progress has been
made in understanding the health effects of exposure to the COIs and the mechanisms underlying these effects, significant gaps in our knowledge remain. Many
additional opportunities for progress via continuing and new toxicologic, mechanistic, and epidemiologic research exist. Such work should include efforts to gain
new knowledge through the integration of existing DoD and VA databases. While
they were mentioned in previous VAO updates, that committee restated them to
emphasize their conviction that more progress should be made in the fields noted.
This committee concurs in this assessment and endorses the recommendations
offered in Table 12-3, noting that research in the rapidly advancing field of epigenetics appears to hold particular promise.
FINAL OBSERVATIONS
In the course of carrying out its Statement of Task, the committee has offered
myriad criticisms of the conduct of studies of Vietnam veterans’ health, pointing
out specific weaknesses and shortcomings in particular papers and widespread
(although not universal) issues such as poor exposure characterization, failure
to fully control for confounding influences on outcomes, and sample sizes that
are inadequate to draw statistically meaningful results. It wishes to make clear,
though, that the difficulty in conducting research on Vietnam veteran health issues
should not act as a barrier to carrying out such work. There are many questions
regarding veterans’ health that cannot be adequately answered by examining
superficially analogous exposures and outcomes in other populations. It is only
through research on veterans themselves that the totality of the military service
experience can be properly accounted for.
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Introduction

The Agent Orange Act of 1991—Public Law (PL) 102-4, enacted February 6,
1991, and codiﬁed as Section 1116 of Title 38 of the United States Code—
directed the Secretary of Veterans Affairs to ask the National Academies of
Sciences, Engineering, and Medicine (“the National Academies”) to conduct
an independent comprehensive review and evaluation of scientiﬁc and medical
information regarding the health effects of exposure to herbicides used during
military operations in Vietnam. The act specified that the herbicides picloram and
cacodylic acid were to be addressed, as were chemicals in various formulations
that contain the herbicides 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5trichlorophenoxyacetic acid (2,4,5-T).
Agent Orange refers speciﬁcally to a 50:50 formulation of 2,4-D and 2,4,5-T,
which was stored in barrels identiﬁed by an orange band, but the term has
come to often be used more generically to refer to all the herbicides sprayed
by the U.S. military in Vietnam.1 2,4,5-T contained the contaminant 2,3,7,8tetrachlorodibenzo-p-dioxin, commonly referred to as “dioxin,” which is referred
to in this report as TCDD, to represent a single—and the most toxic—congener
of the tetrachlorodibenzo-p-dioxins. It should be noted that TCDD and Agent
Orange are not synonymous. The National Academies was also asked to recommend, as appropriate, additional studies needed to resolve continuing scientiﬁc
uncertainties related to health effects and herbicide exposures and to comment
1 Despite loose usage of “Agent Orange” by many people, in numerous publications, and even in
the title of this series, this committee uses “herbicides” to refer to the full range of herbicide exposures experienced in Vietnam, while “Agent Orange” is reserved for a speciﬁc one of the mixtures
sprayed in Vietnam.
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on particular programs mandated in the law. The original legislation called for
biennial reviews of newly available information for a period of 10 years, which
was subsequently extended to October 1, 2014, by the Veterans Education and
Beneﬁts Expansion Act of 2001 (PL 107-103). Subsequently, through the Department of Veterans Affairs Expiring Authorities Act, the Agent Orange Act of 1991
was extended annually for 4 years (PL 113-175, PL 114-58, PL 114-228, and PL
115-62), with a final termination date of September 30, 2018. Although the previous Veterans and Agent Orange (VAO) update was thought to be the ﬁnal update
in the series mandated by PL 107-103, the Department of Veterans Affairs (VA)
interpreted the extension act to require an additional study.
PREVIOUS VETERANS AND AGENT ORANGE REPORTS
In response to the request from VA, the Institute of Medicine (IOM)2 of the
National Academies convened the Committee to Review the Health Effects in
Vietnam Veterans of Exposure to Herbicides. The results of the original committee’s work were published in 1994 as Veterans and Agent Orange: Health Effects
of Herbicides Used in Vietnam, hereafter referred to as VAO (IOM, 1994). Successor committees formed to fulﬁl the requirement for updated reviews produced
Veterans and Agent Orange: Update 1996 (IOM, 1996), Update 1998 (IOM,
1999), Update 2000 (IOM, 2001), Update 2002 (IOM, 2003c), Update 2004
(IOM, 2005), Update 2006 (IOM, 2007), Update 2008 (IOM, 2009), Update 2010
(IOM, 2011a), Update 2012 (IOM, 2014), and Update 2014 (NASEM, 2016a).
Intermittently between biennial updates, VA has requested targeted reviews
of specific health outcomes to determine whether they are associated with exposure to any of the chemicals of interest (COIs). These separate and focused
topics have included type 2 diabetes (IOM, 2000b), childhood acute myelogenous
leukemia (now generally referred to as acute myeloid leukemia) associated with
parental exposure to any of the COIs (IOM, 2002), and respiratory cancers (IOM,
2004). The respiratory cancer review was included in PL 107-103, which was
passed by Congress in 2001 and which directed the Secretary of Veterans Affairs
to ask the National Academies to review “available scientiﬁc literature on the
effects of exposure to an herbicide agent containing dioxin on the development of
respiratory cancers in humans” and to address “whether it is possible to identify a
period of time after exposure to herbicides after which a presumption of serviceconnection” of the disease would not be warranted.
Each report in the VAO series contains detailed reviews of the scientiﬁc studies evaluated by the committees and their implications for cancers, reproductive
and developmental effects, neurologic disorders, and other health effects. VA
has specified particular areas of focus for each update, for example, the Update
2 Since March 2016, the Health and Medicine Division of the National Academies has continued the
consensus studies and convening activities previously undertaken by the Institute of Medicine (IOM).
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2014 committee was asked to specifically address whether all neurodegenerative
diseases with Parkinson-like symptoms should be considered service-related under the association identified between Parkinson disease and herbicide exposure
by the committee for Update 2006. Each committee used the compilation of
evidence presented in the previous reports as a starting point for updating the evidence base concerning the associations of health outcomes with exposure to any
of the COIs. As such, each committee operated independently of prior committees, chose how to present the new and existing information, and determined its
own conclusions regarding the strength of the evidence and each health outcome.
In conducting their work, the committees responsible for the updates and the
targeted reviews operated independently of VA and other government agencies.
They were not asked to and did not make judgments regarding speciﬁc cases
in which individual Vietnam veterans claimed injury from herbicide exposure.
The reports are intended to provide evidence-based assessments of the scientiﬁc
information available for the Secretary of Veterans Affairs to consider as VA exercises its responsibilities to Vietnam veterans. This report and all previous VAO
reports are freely accessible online at the National Academies Press’s website
(http://www.nap.edu).
CHARGE TO THE COMMITTEE
Box 1-1 shows the committee’s Statement of Task. A VA representative
delivered the charge to the committee during the open session of the committee’s ﬁrst meeting. In addition to the standard language of assessing associations
between health outcomes and exposures to chemicals present in the herbicides
used by the military in Vietnam that all VAO update committees are charged
with reviewing, the committee for this final update was asked to assess three
health outcomes in particular: possible generational effects on the descendants
of male Vietnam veterans that may be the result of exposure to any of the COIs,
myeloproliferative neoplasms, and glioblastoma multiforme. In addition, the
committee was asked to offer recommendations as appropriate, such as which
areas to prioritize for future research, a request that has been made of each of the
VAO committees.
Both the committee’s congressional mandate and the Statement of Task instruct that the evaluation be focused on the “association” between exposure and
health outcomes, although biologic mechanisms and causal relationships are also
mentioned as part of the evaluation in Article C. The criteria for causation do
not themselves constitute a set checklist, but they are more stringent than those
for association. The unique mandate of VAO committees to evaluate association
rather than causation means that the rigor of the evidence required to support a
ﬁnding of statistical association is weaker than what is required to support causality. Positive ﬁndings on any of the indicators for causality would strengthen a
conclusion that an observed statistical association is valid. In accordance with its
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BOX 1-1
Committee’s Statement of Task
In accordance with PL 102-4, the committee was asked to “determine (to
the extent that available scientiﬁc data permit meaningful determinations)” the
following regarding associations between speciﬁc health outcomes and exposure
to TCDD and other chemicals present in the herbicides used by the military in
Vietnam:
A)	whether a statistical association with herbicide exposure exists, taking into
account the strength of the scientiﬁc evidence and the appropriateness of the
statistical and epidemiological methods used to detect the association;
B)	the increased risk of the disease among those exposed to herbicides during
service in the Republic of Vietnam during the Vietnam era; and
C)	whether there exists a plausible biological mechanism or other evidence of a
causal relationship between herbicide exposure and the disease. [PL 102-4,
Section 3(d)]
It will also assess the current research available on possible generational
health effects that may be the result of exposures to these chemicals—including
the biologic plausibility or potential for an exposure to lead to an increased risk of
birth defects or other adverse conditions in the descendants of male veterans—
and will address myeloproliferative neoplasms (MPNs) as part of its consideration
of the literature concerning leukemias and related diseases. The review of brain
cancer will address, in particular, glioblastoma multiforme. The report will offer
findings, conclusions, and recommendations as appropriate.

charge, the committee examined a variety of indicators appropriate for the task,
including factors commonly used to evaluate statistical associations, such as the
adequacy of control for bias and confounding and the likelihood that an observed
association could be explained by chance, and it assessed evidence concerning
biologic plausibility derived from laboratory ﬁndings in cell culture or animal
model systems. As such, a full array of indicators was used to categorize the
strength of the evidence. In particular, associations supported by multiple indicators were interpreted as having stronger scientiﬁc support.
INFORMATION GATHERING
The committee convened by the National Academies included experts in
epidemiology, biostatistics, environmental health, exposure assessment, military
and veteran’s health, genetics and epigenetics, toxicology, oncology, and reproductive health. It comprised 12 members who met in person 7 times over 14
months. Between in-person meetings, small groups of committee members would
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hold conference calls related to reviewing the specific studies or to discuss the
evidence base on a particular topic.
Several activities were undertaken to develop the scientific foundation for
the report’s findings, conclusions, and recommendations. As has been the practice of previous VAO committees, the committee held three open sessions not
only to gather additional information from people who have particular expertise
on topics and subjects that arise during deliberations (such as VA researchers,
experts in glioblastoma multiforme, and specialists in environmental exposures
and heritable health effects), but also especially to listen to individual Vietnam
veterans and others, such as spouses and other family members and veterans
service organization advocates, who are concerned about aspects of health that
may be service-related. Open sessions were held during meetings 1, 3, and 4,
the agendas and presentation topics of which are presented in Appendix A. The
comments and information provided by the public at the open meetings and over
the course of the study were used to identify information gaps in the literature
regarding speciﬁc health outcomes of concern to Vietnam veterans.
In addition to information provided from invited speakers and public attendees at open sessions, the committee made information requests to VA to follow up
on issues raised during presentations and on sources of data on Vietnam veterans
who use VA health care. All presentations, responses to information requests, and
written comments are available in the public access file for the project.
The principal source of information on health effects from potential exposure
to the COIs for the committee to consider and deliberate on came from detailed
searches of the peer-reviewed literature published since VAO: Update 2014
(NASEM, 2016a). The literature search strategy and process for reviewing all
results is discussed in detail in Chapter 3: Evaluating the Evidence Base. This
was supplemented by examining other pertinent published literature, government documents and reports, and testimony presented to Congress; attending
professional meetings and educational events; and consulting relevant National
Academies reports. The committee also received data from VA, veterans’ advocacy organizations, and other sources including the Sierra Valley Cancer Registry.
ORGANIZATION OF THE REPORT
The remainder of this report is organized into 11 chapters, 2 appendixes,
and an online supplement of studies reviewed in the course of the VAO series
for each health outcome that has an associated conclusion. Chapter 2 presents
background information about the population of Vietnam veterans and the military herbicides used in the conflict and addresses exposure-assessment issues.
Chapter 3 briefly describes the considerations that guided the committee’s review
and evaluation of the scientiﬁc evidence. Chapter 4 summarizes the toxicology
data on the effects of 2,4-D, 2,4,5-T and its contaminant TCDD, cacodylic
acid, and picloram; these data contribute to the committee’s consideration of the
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biologic plausibility of health effects in human populations. Chapter 5 offers a
selected overview of the study populations that have generated ﬁndings (in some
instances presented in dozens of separate publications) reviewed in the VAO report series as well as those studies that have presented multiple health outcomes,
which are presented and discussed in several chapters. In addition to showing
where the new literature ﬁts into the compendium of previous publications on
Vietnam veterans, occupational cohorts, environmentally exposed groups, and
case-control study populations, that chapter includes a description and critical
appraisal of the approaches used in the design, exposure assessment, and analysis
in these studies.
The committee’s evaluation of the epidemiologic literature and its conclusions regarding the associations between exposures and the particular health
outcomes that might be manifested long after exposure to the COIs are presented
in Chapters 6–11. Because many individual outcomes are included in each chapter, a summary of the ﬁndings for each health outcome reviewed in a particular
chapter is presented at the beginning of the chapter.
Chapter 6, the ﬁrst of the chapters evaluating epidemiologic evidence concerning particular health outcomes, addresses immunologic effects and discusses
the reasons for what might be perceived as a discrepancy between a clear demonstration of immunotoxicity in animal studies and a paucity of human epidemiologic studies with similar ﬁndings. Its placement in the report reflects the
committee’s belief that immunologic changes may constitute an intermediate
step in the generation of distinct clinical conditions, as discussed in subsequent
chapters.
Chapter 7 discusses issues related to the possible overall carcinogenic potential of the COIs, particularly TCDD, and then assesses, in order of their codes
in the International Classification of Diseases, the available epidemiologic
evidence on speciﬁc types of cancer, which are regarded as individual disease
states that might be found to be service-related. Two of the conditions specified in the committee’s charge—glioblastoma multiforme and myeloproliferative
neoplasms—are covered in this chapter.
Chapter 8 addresses reproductive outcomes that may have been manifested
in the veterans themselves, such as reduced fertility and pregnancy loss. It then
covers gestational issues, including low birth weight and preterm delivery. This
is followed by problems that might be manifested in veterans’ children at birth
(traditionally deﬁned as birth defects) or later in their lives (childhood cancers,
plus a broad spectrum of conditions for which impacts from parental exposures
have been posited) or even in later generations.
Chapter 9 addresses neurologic disorders and diseases of the nervous system.
Chapter 10 covers conditions related to cardiovascular and metabolic effects
(including diabetes) on the basis of their apparent interrelationship in the emerging medical phenomenon known as “metabolic syndrome.” Chapter 11 contains
information covering the residual “other chronic health outcomes” about which
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epidemiologic results related to the COIs have been encountered in the course
of this series of VAO reports and in the current literature search: respiratory disorders, gastrointestinal problems and liver toxicity, kidney and urinary bladder
disease, thyroid homeostasis and other endocrine disorders, chronic skin conditions (new to this report), eye problems, and bone conditions.
A summary of the committee’s ﬁndings and its research recommendations are
presented in Chapter 12. In the previous report, which was intended to be the final
report of the series as mandated by PL 102-4 and PL 107-103 (and extended by
PL 113-175, PL 114-58, PL 114-228, and PL 115-62), the committee reported on
the status of recommendations made throughout the VAO series.
In the interest of minimizing unnecessary repetition, the citations for all chapters have been merged into a single reference list that follows all of the chapters.
Appendix A provides a list of open meeting agendas and invited presentation topics. Committee and staff biographies can be found in Appendix B. Compendium
tables summarizing new results identified for this current update as well as those
reviewed by prior committees are available in digital form only and can be accessed from www.nap.edu/catalog/25137.
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2
Background

This chapter provides background information on the current population of
Vietnam veterans, the military use of herbicides during the Vietnam War, how different groups of veterans were exposed to the herbicides and how that exposure
can be characterized, and the determination of risks due to that exposure. It condenses and updates some of the information presented in chapters 2 (Evaluating
the Evidence) and 3 (Exposure to the Herbicides Used in Vietnam) of Veterans
and Agent Orange: Update 2014 (NASEM, 2016a), which contain more detailed
descriptions of the topics under discussion.
THE CURRENT POPULATION OF VIETNAM VETERANS
Although the conflict ended more than 40 years ago, there are a substantial
number of Vietnam veterans who are still living and who, because of herbicide
exposure in Vietnam, may have a higher risk than the general public for various
negative health effects. The exact number of U.S. military personnel who served
in Vietnam is unknown because deployment to the theater was not specifically
recorded in military records. Estimates range from 2.6 million to 4.3 million
(see Table 2-1), depending on which dates are used to deﬁne the Vietnam era
and which areas are included in the Vietnam theater of operations (that is, Laos,
Cambodia, Vietnam, and the surrounding waters). Approximately 7,500 American women are thought to have served in Vietnam (VA, 2017a). The lack of a
comprehensive or ofﬁcial roster of U.S. Vietnam veterans has made it much
more difficult to conduct epidemiology studies of health trends in this group of
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TABLE 2-1 Estimates (in millions) of the Vietnam Veteran Population
(adapted from IOM, 1994)
Reference

Definition of Service

Time Period

N (millions)

DoD (1976)
Fischer et al. (1980)
VA (1985)
Kulka et al. (1988)
DoD (1976)
BLS (1990)
Fischer et al. (1980)
BLS (1990)
VA (1985)
DoD (1976)

Vietnam
Vietnam
Vietnam theater
Vietnam theater
Vietnam theater
Vietnam theater
Vietnam theater
Vietnam era
Vietnam era
Vietnam era

1/1/65 – 3/31/73
8/64 – 6/75
8/4/64 – 5/7/75
8/64 – 5/75
1/1/65 – 3/31/73
8/64 – 5/75 (males)
8/64 – 6/75
8/64 – 5/75 (males)
8/4/64 – 5/7/75
8/4/64 – 1/27/73

2.6
3.8
2.7
3.1
3.4
3.7
4.3
7.9
8.3
8.7

NOTE: BLS, Bureau of Labor Statistics; DoD, Department of Defense; VA, Department of Veterans
Affairs.

military personnel or to track their survival. However, Australian, New Zealand,
and South Korean militaries did keep registries of personnel who were deployed
to Vietnam.
Beginning in 1990, the Bureau of Labor Statistics used its Current Population Surveys to generate several estimates of the number and age distributions
of deployed and non-deployed male Vietnam-era veterans in the civilian population. The 1990 Survey estimated that the number of surviving deployed Vietnam
veterans was 29.0% of living male Vietnam-era veterans and 32.7% of surviving
non-deployed veterans (Cohany, 1992; NASEM, 2016a).
In 2018, VA estimated that approximately 5,978,000 Vietnam-era veterans
(deployed and non-deployed, defined as dates of service from August 1964 to
April 1975) were living (VA, 2018c). The committee notes that current information on overall mortality in U.S. Vietnam veterans themselves has been elusive.
The most recent reliable information was obtained in the 30-year update of
mortality (through 2000) based on the Vietnam Experience Study (Boehmer et
al., 2004). The study reported that mortality among the deployed veterans was
approximately 9% higher than among the non-deployed veterans. A follow-up
study of a random sample of 1,000 Australian Vietnam veterans selected from
Australia’s comprehensive roster of 57,643 service members deployed to Vietnam
found that mortality among Vietnam veterans was 11.7% through 2004 (O’Toole
et al., 2010). This estimate of mortality among Australian veterans is slightly
higher than but comparable with what was reported among Americans in the
Vietnam Experience Study. The most recent update on mortality among female
U.S. Vietnam veterans stated that at the end of 2010, 20.2% of the deployed
women in the cohort had died compared with 24.6% of those who remained in the
United States (Kang et al., 2014a). However, there are considerable differences
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in mortality profiles between men and women, and the information provided by
Kang and colleagues may not necessarily apply to the majority of American Vietnam veterans who are male. VA informed the committee that an updated mortality
study was underway as of 2017 (Davey, 2017), but no results were available at
the time the committee completed its work.
MILITARY USE OF HERBICIDES IN VIETNAM
Military use of herbicides in Vietnam took place from 1962 through 1971.
Specific herbicides were selected based on tests conducted in the United States
and elsewhere that were designed to evaluate defoliation efficacy (IOM, 1994;
Young and Newton, 2004). Four compounds were used in the herbicide formulations in Vietnam: 2,4-dichlorophenoxyacetic acid (2,4-D); 2,4,5-trichlorophenoxyacetic acid (2,4,5-T); 4-amino-3,5,6-trichloropicolinic acid (picloram); and
dimethylarsinic acid (DMA, or cacodylic acid). These herbicides were used to
defoliate inland hardwood forests, coastal mangrove forests, cultivated lands, and
zones around military bases. Whereas the chlorinated phenoxy acids 2,4-D and
2,4,5-T persist in soil for only a few weeks, picloram is much more stable and can
persist in soil for years, and cacodylic acid is nonvolatile and stable in sunlight
(NRC, 1974). More details on the herbicides used are presented in Chapter 4.
However, other toxic compounds were also present in these herbicide formulations. Specifically, polychlorinated dibenzo-p-dioxins (PCDDs), which includes
75 different congeners that vary by the number and placement of the chlorine
atoms, can be formed during the manufacture of 2,4,5-T and the half-lives of
these in subsurface soil may exceed 100 years (Sinkkonen and Paasivirta, 2000).
One contaminant of particular concern is 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD). This compound is an unintentional byproduct of the production of 2,4,5trichlorophenol (NRC,1974). The structures of the chemicals of interest (COIs)
identified above are shown in Figure 2-1.
Herbicides were identified by the color of a band on 55-gallon shipping containers and were called Agent Pink, Agent Green, Agent Purple, Agent Orange,
Agent White, and Agent Blue. Table 2-2 shows the herbicides used in Vietnam
by color code name and summarizes the chemical constituents, concentration of
active ingredients, years used, and estimated amount sprayed, based on original
and revised estimates. Two different formulations of Agent Orange were used
in the course of military operations in Vietnam. All agents were liquid except
Agent Blue, which was used in powder form in 1962–1964 and as a liquid in
1964–1971. Agent Pink, Agent Green, Agent Purple, Agent Orange, and Agent
Orange II all contained 2,4,5-T and were contaminated to some extent with
TCDD. Agent White contained 2,4-D and picloram. Agent Blue (powder and
liquid) contained cacodylic acid.
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Phenoxy Herbicides
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FIGURE 2-1 Chemical structures and Chemical Abstracts Service (CAS) numbers for
the specific chemicals of interest.
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TABLE 2-2 Military Use of Herbicides in Vietnam (1961–1971)

Code Name Chemical Constituentsa

Concentration
of Active
Ingredienta

Amount Sprayed
Years VAO
Useda Estimateb

Revised
Estimatea

Pink

60% n-butyl ester,
961–1,081 g/L 1961, 464,817 L
40% isobutyl ester of 2,4,5-T acid equivalent 1965 (122,792 gal)

50,312 L
sprayed;
413,852 L
additional on
procurement
records

Green

n-butyl ester of 2,4,5-T

31,026 L on
procurement
records

50% n-butyl ester of 2,4-D,
1,033 g/L acid 1962– 548,883 L
30% n-butyl ester of 2,4,5-T, equivalent
1965 (145,000 gal)
20% isobutyl ester of 2,4,5-T

1,892,733 L

Purple

50% n-butyl ester of 2,4-D,
50% n-butyl ester of 2,4,5-T

1,033 g/L acid 1965– 42,629,013 L
equivalent
1970 (11,261,429
gal)

45,677,937
L (could
include
Agent
Orange II)

Orange II

50% n-butyl ester of 2,4-D,
50% isooctyl ester of 2,4,5-T

910 g/L acid
equivalent

After —
1968

Unknown;
at least
3,591,000 L
shipped

White

Acid weight basis: 21.2%
triisopropanolamine
salts of 2,4-D,
5.7% picloram

By acid
weight, 240
g/L 2,4-D, 65
g/L picloram

1966– 19,860,108 L 20,556,525 L
1971 (5,246,502 gal)

Blue,
powder

Cacodylic acid
(dimethylarsinic acid)
sodium cacodylate

Acid, 65%
1962– —
active
1964
ingredient; salt,
70% active
ingredient

Blue,
aqueous
solution

21% sodium cacodylate
+ cacodylic acid to yield
at least 26% total acid
equivalent by weight

Acid weight,
360 g/L

1964– 4,255,952 L
4,715,731 L
1971 (1,124,307 gal)

—

—

Orange

Total, all
—
formulations
a
b

—

1961, 31,071 L
1965 (8,208 gal)

67,789,844 L
(17,908,238
gal)

25,650 L

76,954,766
L (including
procured)

Based on Stellman et al., 2003a.
IOM, 1994, based on data from MRI, 1967; NRC, 1974; Young and Reggiani, 1988.
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Estimates of TCDD Concentrations and Amounts of Herbicides Sprayed
TCDD concentrations in individual herbicide shipments were known to vary
between batches and between manufacturers, but the concentrations were not recorded (FAO/UNEP, 2009; Young et al., 1976). In 1974, domestic manufacturing
standards for 2,4,5-T required that TCDD not be present at more than 0.05 parts
per million (ppm) (NRC, 1974). Tests of TCDD concentrations were conducted in
stocks of Agent Orange that remained after the conflict that had been returned from
South Vietnam or had been procured but not shipped. The concentration of TCDD
in these samples ranged from less than 0.05 ppm to almost 50 ppm, and averaged
2–3 ppm in two sets of samples (NRC, 1974; Young et al., 1978). Later work by
Stellman et al. (2003a) resulted in substantial revisions of the earlier estimates of
TCDD contamination in the herbicide formulations. The researchers concluded that
the mean TCDD concentration in Agent Orange was closer to 13 ppm than to the
earlier estimate of 3 ppm. Using their revised estimate, the researchers proposed that
366 kilograms of TCDD was likely applied in Vietnam between 1961 and 1971.
Several studies have attempted to estimate the amount of herbicides sprayed
in Vietnam. Through the National Academies of Sciences, Engineering, and
Medicine (“the National Academies”), one committee used records gathered from
August 1965 through February 1971 and calculated that about 18 million gallons
(about 69 million liters) of herbicides were sprayed from helicopters and other
aircraft over an area of about 3.6 million acres in Vietnam over that time period
(NRC, 1974). This estimate does not include the amount of herbicides sprayed on
the ground to defoliate the perimeters of base camps and fire bases or the amount
sprayed by Navy boats along river banks.
A revised analysis of spray activities and of the exposure potential of troops
emerged from a study overseen by a committee of the Institute of Medicine (IOM,
1997, 2003a,b). That work yielded new estimates of the amounts of military herbicides used in Vietnam from 1961 through 1971 (J. M. Stellman et al., 2003a).
The investigators reanalyzed the original data sources used to develop herbicideuse estimates in the 1970s and identified errors that had inappropriately removed
spraying missions from the dataset. They also added new data on spraying missions that took place from 1961 to 1965. Finally, a comparison of procurement
records with spraying records found errors that suggested that additional spraying
had taken place but had gone unrecorded at the time. The new analyses led to
a revision of the estimates of the amounts of the agents applied, as indicated in
Table 2-2, as well as of the concentration of TCDD-containing herbicides. The
new research effort estimated that about 77 million liters were applied, which is
about 9 million liters more than the previous estimate.
EXPOSURE OF DIFFERENT GROUPS OF VIETNAM VETERANS
The lack of accurate estimates of chemical exposures experienced by
U.S. military personnel who served in Vietnam has significantly hindered
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the epidemiological study of the health effects associated with herbicides
and TCDD. For example, some military personnel stationed in cities or on
large bases may have received little or no herbicide exposure, whereas troops
who moved through defoliated areas soon after treatment may have been
exposed through many pathways, including skin contact (directly or indirectly through clothing), direct (through contaminated foodstuffs) or indirect
(through hand-to-mouth contact) ingestion, or via contaminated water (drinking, bathing, or immersion during operations). The lack of records regarding
individual behaviors and locations combined with the lack of contemporaneous chemical measurements and the lack of a full understanding of the
movement and behavior of the defoliants in the environment greatly reduces
the ability to conduct the exposure assessments that are necessary for ascertaining the association between the COIs and health effects among Vietnam
veterans.
Consequently, most studies have focused on populations that had welldefined tasks that brought them into contact with the agents. These populations
primarily include Air Force personnel involved in fixed-wing aircraft spraying
activities (often referred to as Operation Ranch Hand) and members of the U.S.
Army Chemical Corps. The exposures of ground troops are difficult to define,
so this group has not been studied as intensively. In accordance with Congress’s
mandated presumption of herbicide exposure of all Vietnam veterans, Veterans
and Agent Orange (VAO) committees have treated Vietnam-veteran status as a
proxy for herbicide exposure when more specific exposure information is not
available.
Herbicide Handlers
Military personnel who came into direct contact with the herbicidal chemicals through mixing, loading, spraying, and clean-up activities had relatively high
chemical exposures. The precise number of U.S. military personnel who handled
herbicides directly is not known. However, two groups have been identified
as high-risk subpopulations among veterans: Air Force personnel involved in
Operation Ranch Hand and members of the Army Chemical Corps. Additional
units and individuals handled or sprayed herbicides around bases or communication lines. For example, Navy river patrols were reported to have used herbicides
to clear inland waterways, and engineering personnel used herbicides to remove
underbrush and dense growth when constructing fire-support bases. At the time,
the herbicides used in Vietnam were not thought to present an important human
health hazard, so few precautions were taken to prevent the exposure of personnel (GAO, 1978, 1979). Thus, military personnel did not typically use chemicalprotective gloves, coveralls, or protective aprons, and dermal exposure almost
certainly occurred in these populations in addition to exposure by inhalation and
other routes.
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Operation Ranch Hand
Air Force personnel who participated in Operation Ranch Hand were the
first Vietnam-veteran population to receive special attention with regard to
herbicide exposure. The Air Force Health Study (AFHS) was a longitudinal,
prospective epidemiologic study initiated by the Air Force in 1979. Its purpose
was to determine whether Air Force personnel who had participated in Operation
Ranch Hand had experienced adverse health outcomes as a result of their service.
The study protocol had three components: a retrospective mortality study, a retrospective morbidity study, and a 20-year prospective follow-up study.
The 20-year prospective follow-up study identified 1,242 Ranch Hands who
were individually matched on age, race, and military occupation to comparison
subjects who served in the Air Force between 1962 and 1971 and who were
stationed in and flew cargo operations elsewhere in Southeast Asia during the
Vietnam conflict but had not been exposed to tactical herbicides. The comparison group was assumed to be similar to the Ranch Hands regarding lifestyle,
training profiles, and socioeconomic factors. The study itself consisted of six
comprehensive exams that began with a baseline exam in 1982 and occurred
thereafter in years 3, 5, 10, 15, and 20 of the study. A comprehensive set of
clinical measurements and observations were made, and biological specimens
(serum, whole blood, urine, semen, and adipose tissue) were obtained and preserved during the exams. In all, 2,758 individuals participated in at least one
exam cycle. Data collection and analysis for the formal study was completed in
2006 (IOM, 2015).
Exposure among Ranch Hands and the comparison group was evaluated by
objective measurements of TCDD in serum samples drawn in 1987 or later, and
serum TCDD concentrations were often used as the primary exposure metric
for epidemiologic classification in the AFHS (AFHS, 1991a; Kern et al., 2004;
Michalek et al., 2001a, 2003; Pavuk et al., 2003). Pavuk et al. (2014) examined
the serum concentrations of several dioxins and dioxin-like chemicals in serum
samples gathered in 2002 from 777 Ranch Hands and 1,173 AFHS comparison
subjects. While the median serum TCDD levels were more than twice as high in
the Ranch Hands as in the comparison veterans (5.0 and 2.2 pg/g, respectively),
no substantial differences were found between these groups for the other COIs.
Additionally, the authors compared serum dioxin levels in AFHS participants
with data collected by the National Health and Nutrition Examination Survey
(NHANES) during 2001–2002 in U.S. civilian men of the same age range. The
Ranch Hands had serum concentrations of dioxins that were similar to those
found in the civilians except for TCDD, where the Ranch Hand mean level of
9.5 pg/g lipid was more than three times the NHANES mean level of 2.5 pg/g
lipid. This demonstrates the specificity of the dioxin exposure experienced from
contact in Vietnam with military herbicides.
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Additionally, several methods for estimating the herbicide exposure of members of the cohort were developed based on questionnaires that focused on such
factors as the number of days of skin exposure, the percentage of skin area exposed, and the concentration of TCDD in the different herbicidal formulations
(Michalek et al., 1995). Overall, serum TCDD was generally elevated among
airmen whose jobs involved more frequent handling of herbicides, but there was
no clear demarcation between the distributions of serum TCDD concentrations
in the Ranch Hands and those in the comparison group (AFHS, 1991a). A more
detailed discussion of the study design and exposure measurement methods used
in the AFHS can be found in Chapter 5.
As illustrated by Figure 2-2, the median TCDD levels in veterans who had
worked in Operation Ranch Hand were higher than those measured in their own
comparison group or in ground troops. The TCDD concentrations found in the
controls were of the magnitude of a few parts per trillion (ppt), which are in the
range of contemporaneous background levels. Herbicide production workers, by
contrast, have serum TCDD levels that are about an order of magnitude higher,
and individuals who resided near the site of the industrial explosion in Seveso,
Italy, had serum TCDD levels that are about two orders of magnitude higher
(Pirkle et al., 1995).

Ground troop veterans in AOVS
Controls
Low
Medium
High
Ranch hand veterans
Controls
Officers, nonflying
Officers, flying (navigators)
Officers, flying (pilots)
Enlisted men, flying
Enlisted men, nonflying
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quintile 4
quintile 5
German plant workers
New Zealand sprayers
Seveso, Italy population
Without chloracne
With chloracne

157

355

4540
0

20

40

60

80

100

1000

16,600

10,000

Serum dioxin, (ppt)

FIGURE 2-2 Median serum TCDD levels in various study populations.
NOTE: AOVS = Centers for Disease Control and Prevention’s Agent Orange Validation
Study (CDC, 1989a); NIOSH = National Institute for Occupational Safety and Health.
SOURCE: Pirkle et al., 1995.
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Army Chemical Corps
Members of the Army Chemical Corps used hand-operated equipment and
helicopters to conduct smaller-scale operations, including defoliation around
special-forces camps; clearing of the perimeters of airfields, depots, and other
bases; and small-scale crop destruction (NRC, 1980; Thomas and Kang, 1990;
Warren, 1968). Studies of health effects related to herbicide exposure in this
population were first conducted in the late 1980s (Thomas and Kang, 1990). A
small feasibility study of deployed and non-deployed Vietnam-era veterans from
within the Army Chemical Corps found an association between veterans reporting
having sprayed herbicides and higher serum TCDD concentrations (Kang et al.,
2001); this finding was confirmed in a follow-up study of a larger fraction of the
cohort (Kang et al., 2006). Modeling efforts (Ross et al., 2015a,b) have also found
that higher exposures were probably experienced by those involved with mixer,
loader, and applicator activities than by bystanders because the former were generally in closer proximity to and had more frequent contact with the herbicides.
Other Groups of Herbicide Handlers
Other veteran populations also handled herbicides during their service in
Vietnam, although probably to a small degree. For example, as part of Operation
PACER IVY, Air Force personnel who were separate from, but who were also
assisted by, the Ranch Hands and Army Chemical Corps were responsible for
removing stocks of Agent Orange from Vietnam to Johnston Island in the central
Pacific Ocean (Young, 2009). As part of the operation, procedures included the
identification of unused herbicides, the transport of the identified herbicides to
a central location in Vietnam for relabeling, and re-drumming for about half of
the barrels before shipment. Most of the relabeling, repackaging, and handling
of Agent Orange during PACER IVY was overseen and conducted by contractors from China, local residents, and the Vietnam military, so exposure to U.S.
military personnel was likely low. However, there were spills of Agent Orange
in the re-drumming and storage areas, which contaminated surrounding soils
and asphalt (Young, 2009), and these have been suggested as possible sources
of exposure.
Other possible points of contamination for Vietnam-era veterans include
defoliation tests conducted in South Vietnam as part of Project AGILE; ports in
the United States that served as embarkation points for shipping of Agent Orange
to Vietnam; storage locations on Johnston Island, where contamination could
have occurred from the re-drumming and maintenance of drums that contained
Agent Orange; and at-sea incineration of Agent Orange as part of Operation
PACER HO (Young, 2009). Because the Army of the Republic of Vietnam was
responsible for the handling, transport, and storage of herbicides from the time
it was delivered to Vietnam until it was loaded onto Ranch Hand aircraft, Young
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asserts that the herbicide exposures of Allied troops during these procedures may
have been negligible.
Ground Troops
Given the widespread, long-term use of herbicides in Vietnam, it is reasonable to assume that many military personnel were inadvertently exposed to
the COIs. In contrast with government reports and veterans’ testimony about
exposure (CDC, 1989b; GAO, 1979), Young et al. (2004a,b) used data from unpublished military records and environmental-fate studies to argue that ground
troops had little direct contact with herbicide sprays and that TCDD residues in
Vietnam had low bioavailability. They also argued that direct exposures of ground
troops were relatively low because herbicide-spraying missions were carefully
planned and because spraying occurred only when friendly forces were not in
the target area.
To resolve the issue, numerous attempts were made in the 1980s to characterize the herbicide exposures of ground troops in Vietnam (CDC, 1988a; Erickson
et al., 1984a; NRC, 1982; S. D. Stellman and J. M. Stellman, 1986; S. D. Stellman
et al., 1988a). Those efforts combined self-reports of contact with herbicides or
military service records with aerial-spray data to produce a measure of the opportunity for exposure (discussed in greater detail later in this chapter). The search
for a way to validate this method led to the development of exposure biomarkers
in veterans. Initial studies measured concentrations of dioxin in the adipose tissue of veterans (Gross et al., 1984; Schecter et al., 1987), and dioxin concentrations in adipose tissue were then linked to dioxin concentrations in blood (Kahn
et al., 1988). The Centers for Disease Control and Prevention’s (CDC’s) Agent
Orange Validation Study measured TCDD concentrations in blood serum from
a relatively large sample of Vietnam veterans and other Vietnam-era veterans
(CDC, 1989a) but did not find a statistically significant difference in mean serum
TCDD concentrations between the groups. The mean values in each group were
about 4 ppt (CDC, 1988a). However, the long lag time between exposure and the
serum measurements (about 20 years) leads to questions regarding the accuracy
of exposure classification based on serum concentrations. The first VAO committee cautioned that serum TCDD measurements that are collected years after the
potential exposure occurred should not be regarded as a “gold standard” or as a
fully accurate measure of herbicide exposure because each COI has a different
biological half-life. More details on the metabolism of the COIs are presented
later in this chapter.
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Brown Water Navy
Navy riverine units (or the “Brown Water Navy”) are known to have used
herbicides while patrolling inland waterways (IOM, 1994).1 It is generally acknowledged that estuarine waters became contaminated with herbicides and
dioxin as a result of shoreline spraying and runoff from spraying on land, particularly in heavily sprayed areas that experienced frequent flooding. Thus, military
personnel who did not serve on land could have been among those exposed to
the chemicals during their service in Vietnam.
Blue Water Navy
Dioxin exposure among personnel who served offshore but within the territorial limits of the Republic of Vietnam has also been of concern. It has been
hypothesized that in addition to possibly experiencing drift from herbicide-spray
missions, personnel on ships that converted seawater by distillation may have
been exposed via drinking water. Those concerns were heightened by the findings
of an Australian study that showed that TCDD could be enriched in a simulation
of the potable-water distillation process that was used on U.S. Navy and Royal
Australian Navy ships during the Vietnam War era (Muller et al., 2002). The
National Academies convened the Blue Water Navy Vietnam Veterans and Agent
Orange Exposure Committee to address that specific issue; its report found that
there was inadequate information to determine the extent of exposure experienced
by Blue Water Navy personnel, but that there were possible routes of exposure
(IOM, 2011b).
Vietnam Military and Civilians
Although studies of the residents of Vietnam are not directly relevant to
the committee’s task, a summary is provided because these studies may inform
possible routes of exposure in U.S. military forces, future epidemiologic studies, and the development of risk-mitigation policies. Researchers have attempted
to characterize the herbicide exposure of residents of Vietnam in the process of
trying to assess adverse reproductive and other outcomes (Constable and Hatch,
1985). Some researchers compared residents of South Vietnam with residents of
unsprayed North Vietnam, others compared South Vietnam residents who lived in
sprayed and unsprayed villages as determined by observed defoliation, and other
researchers compared women from North Vietnam married to veterans who had
served in South Vietnam with women whose husbands had not in order to evaluate reproductive and pregnancy outcomes. Few studies have provided information
1 E. R. Zumwalt, Jr. 1993. Letter to the Institute of Medicine Committee to Review the Health Effects
in Vietnam Veterans of Exposure to Herbicides regarding draft version of the IOM chapter on the
U.S. military and the herbicide program in Vietnam, May 20.
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on TCDD concentrations in Vietnamese civilians who were exposed to the COIs
during the conflict (Schecter et al., 1986, 2002, 2006).
Armitage et al. (2015) indirectly estimated dermal exposure from direct overspray and long-term dietary exposures in South Vietnam using an aerial dispersion
model coupled with a chemical fate and transport model and additional models.
The investigators concluded that people in the upland forests of South Vietnam did
not commonly experience highly elevated exposures. Dwernychuk et al. (2002)
evaluated dioxin contamination around former air bases in Vietnam. The researchers collected environmental and food samples, human blood, and breast
milk from residents of the Aluoi Valley of central Vietnam and identified locations where relatively high dioxin concentrations existed in soil and water
systems. Soil dioxin concentrations were particularly high in areas (termed “hot
spots”) around former airfields and military bases where herbicides were handled.
Other hot spots included depots of chemical defoliants, air bases used for defoliant spray missions, and areas where chemical defoliants were used extensively.
People have since inhabited the areas in and around many former air bases and
depots, which have become the focus of studies of environmental contamination
and bioaccumulation. For example, studies of poultry raised by Vietnam residents
currently living in hot spots have found that dioxin total toxic equivalent (TEQ)
levels in poultry eggs are more than twice the adult exposure guideline set by the
World Health Organization (WHO) and more than five times the child guideline
(Hoang et al., 2014) and that the dioxin content per unit of fat mass in the muscle
and liver of the poultry also exceeded the WHO guidelines (Banout et al., 2014).
Publications reviewed in earlier updates have reported environmental concentrations and human body burdens of dioxins in various areas throughout
Vietnam (Brodsky et al., 2009; Feshin et al., 2008; Hatfield Consultants, 2009a,b;
Nhu et al., 2009; Saito et al., 2010; Tai et al., 2011) and have found pervasive
exposure to dioxins more than 50 years after the Vietnam War. Dioxin concentrations in breast milk reflect the residence location of the mothers, with levels and
TEQs being elevated in areas where herbicides were sprayed or stored during
the war.2 Another study compared men who had lived in and around the Phu Cat
airbase for 50 years or more with men who lived in the unsprayed Kim Bang
district of Ha Nam Province in North Vietnam (Manh et al., 2014). Men currently
living in the vicinity of the Phu Cat air base have a greater body burden of dioxin
than those who spent time in areas that had been the target of herbicide spraying
(a geometric mean TEQ of 41.7 pg/g lipid in men who spent time closest to the
air base, versus ~29 pg/g lipid for those in two nearby sprayed areas).
2 For example, Tai et al. (2011, pp. 6629–6630) reported that “[t]he total toxic equivalents of
2,3,7,8-substituted PCDDs/PCDFs in breast milk of mothers living in the hot spots, and the sprayed
and unsprayed areas were 14.10 pg/g lipid, 10.89 pg/g lipid, and 4.09 pg/g lipid for primiparae and
11.48 pg/g lipid, 7.56 pg/g lipid, and 2.84 pg/g lipid for multiparae, respectively, with significant
differences in the values among the three areas.”

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

38

VETERANS AND AGENT ORANGE: UPDATE 11

International Forces
Military personnel of the Republic of Korea served in Vietnam during 1964–
1973. The Korean Veterans Health Study is a large epidemiological study of more
than 114,000 South Korean veterans who served in Vietnam. Several publications
from it, including one on how exposure metrics were derived, have been reviewed
by prior VAO committees. A more detailed discussion of exposure measurement
methods used with this cohort is found in Chapter 5.
Other nations also sent military personnel to assist the South Vietnam military. Reports on the morbidity and mortality of Australian Vietnam veterans have
been published on different groups of service members who deployed to Vietnam.
These groups include military and some nonmilitary personnel of both sexes who
served on land or in the waters of Vietnam from May 23, 1962, to July 1, 1973.
However, the comprehensive studies are limited to male members of the military,
and most of the analyses focus on men who served in the defense forces—the
Army (41,084), the Navy (13,538), and the Air Force (4,570). Objective measures
of exposure were not collected, and deployment to Vietnam is generally considered a surrogate of exposure.
A total of 3,394 men and women from New Zealand served in Vietnam
between 1962 and 1971, 36 of whom were killed in action or died of wounds
or accidents. A cohort of 2,783 living male veterans has been followed prospectively using the New Zealand Veterans Affairs and National Health Index. The 23
women who served in Vietnam were excluded because analyses by sex would not
have sufficient statistical power to rule out chance findings. As with the Australian cohort, objective measures of exposure were not collected, and deployment
to Vietnam is considered a surrogate of exposure.
Previous volumes of the VAO series and later chapters of this report provide
citations to research on these populations as appropriate.
CHARACTERIZING EXPOSURE
The development of a means of characterizing the exposure of individual Vietnam veterans has long been a prime objective of researchers who are interested in
refining epidemiologic investigations of health outcomes in this population. Serum
TCDD levels might have been a very useful proxy for harmful exposures to all
the components of the herbicides used by the U.S. military in Vietnam had they
been measured both before and after deployment; however, these data were not
collected. Since over time metabolic processes would have reduced the initial
chemical concentrations by many half-lives, collecting new samples would not
provide valuable information about exposures that occurred during the Vietnam
War even among individuals who were likely highly exposed, such as some of the
Ranch Hands. For example, serum TCDD measurements taken in 2002 from the
Ranch Hands were still sufficiently elevated to distinguish exposed and unexposed
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veterans at the group level. However, TCDD has a half-life of about 7.6 years, and
the half-lives of the other COIs are considerably less. With the passage of several
decades, serum concentrations decrease exponentially, and newly drawn serum
samples are thus unlikely to be useful metrics for assessing health outcomes in
surviving Vietnam veterans, occupational cohorts, or Seveso residents. The factors
influencing TCDD’s half-life are discussed in Chapter 4.
The consideration of records detailing the herbicide spray missions has
provided another approach to deriving individual-specific exposure estimates.
Two models—a proximity-based Exposure Opportunity Index (EOI) model and
an aerial spray distribution model (explained and contrasted below)—have been
proposed for estimating the exposure of Vietnam veterans. However, to date only
a few studies (which are addressed in detail later in the chapter) have used these
exposure assessment methodologies to study the health of Vietnam veterans.
Other National Academies reports have addressed the issue of exposure assessment in military environments, pointing out both the challenges of gathering good
contemporaneous information and the desirability of such data for assessing service
members’ and veterans’ health and well-being (IOM, 2000a; NRC, 2000a,b).
Methodologic Issues and Considerations in Exposure Assessment
The focus of this section is on three key methodological issues that complicate the development of accurate exposure estimates in the Vietnam-veteran
population and the other study populations discussed in this report: the latent
period between exposure and disease, exposure misclassification, and exposure
specificity.
Latency
The temporal relationship between exposure and disease is complex and
often difficult to define in studies of human populations. Many diseases do not
appear immediately after exposure. Cancers, for example, might not appear for
many years after exposure. The latency period refers to the amount of time between an initiative event, such as a toxic exposure, and the manifestation of the
clinical disease. For many disease processes the latency period is not known.
If the latency period is underestimated, the effect of the exposure of interest on
health outcomes will not be captured by epidemiological methods. Exposures can
be brief (acute) or occur over a longer period of time (chronic). At one extreme,
an exposure can be the result of a single event, as in an accidental poisoning. At
the other extreme, a person exposed to a chemical that is stored in the body may
continue to experience “internal exposure” for years even if exposure from the
environment has ceased.
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Exposure Misclassification
Exposure misclassification in epidemiologic studies can affect estimates of
risk. In a case-control study, this would be a situation in which the reported measurement of exposure in either the cases or the controls (or sometimes in both cases
and controls) is incorrect (classifying a person who was not exposed as having been
exposed, for example). Non-differential exposure misclassification occurs if the
probability of exposure misclassification is the same in both cases and controls. If
this happens, then the estimated association between disease and exposure is biased
toward the null value. In other words, one would expect the true association, if it
exists, to be stronger than the observed association. Differential exposure misclassification occurs if the probability of misclassification is different between cases
and controls. If this occurs, then the estimated association can be biased in either
direction, either toward the null value or away from the null value. Then the true
association, if it exists, might be stronger or weaker than the observed association.
When exposure is classified into more than two levels, the slope of a dose–
response trend is not necessarily attenuated toward the null value even if the
probability of misclassification is the same in the two groups of subjects being
compared. Therefore, the observed trend in disease risk among the several levels
of exposure may be either an overestimate or an underestimate of the true trend
(Dosemeci et al., 1990). Greenland and Gustafson (2006) discussed the effects
of exposure misclassification on the statistical significance of the result and demonstrated that if one adjusts for exposure misclassification when the exposure is
represented as a binary variable, the resulting association is not necessarily more
significant than in the unadjusted estimate. That result remains true even though
the observed magnitude of the association might be increased.
The Update 2014 committee was concerned about the strong degree of misclassification associated with publications concerning various health outcomes authored by researchers who categorized exposure based on a variable in a patient’s
electronic medical record indicating whether the individual was “exposed to Agent
Orange” (Ansbaugh et al., 2013; Q. Li et al., 2013). Likewise, several studies of
VA health care–user populations have been identified that continue to define exposure on the basis of that indicator in the medical record. That variable conveys
a degree of authenticity that this and the prior committee strongly suspected is
unmerited because there is little documentation about the source of information
used to make this classification—deployment status, entry on the Agent Orange
Registry, the veteran’s self-report, a physician’s observation that the patient has a
condition presumed to be service-related, results of serum TCDD measurements
performed on some patients, or perhaps some other criterion. Regardless, none of
these approaches offers a reliable method of determining whether an individual
was truly exposed to herbicides (above some unspecified level) or yields a method
that can be applied uniformly to all veterans using the VA medical system, who
themselves are a self-selected subset of veterans. The current committee concurs
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with the Update 2014 committee’s concern that these publications do not adequately discuss the reliability of their exposure metric.
Specificity
The evaluation of the findings of studies of persons exposed to components
of the herbicides sprayed in Vietnam requires some decisions about their relative
contributions to the VAO project’s evidentiary database. Only a few herbicidal
chemicals were used as defoliants during the Vietnam conflict: esters and salts of
2,4-D and 2,4,5-T, cacodylic acid, and picloram in various formulations. TCDD
as a contaminant of 2,4,5-T is also of import. The committee recognizes that
in real-world conditions, exposure to TCDD virtually never occurs in isolation
and that there are hundreds of similar compounds to which humans might be
exposed, including other PCDDS, polychlorinated dibenzofurans (PCDFs), and
polychlorinated biphenyls (PCBs). Human exposure to TCDD is almost always
accompanied by an exposure to one or more of the other compounds, but the
exposure of Vietnam veterans to substantial amounts of the other chemicals relative to the exposure to TCDD has not been documented. Studies that analyzed
for dioxin-like PCDF and PCB congeners and expressed the results in terms of
TEQs have also been considered since Update 1998.
Among the various chemical classes of herbicides that have been identified
in published studies reviewed by the committee, phenoxy herbicides, particularly 2,4-D and 2,4,5-T, are directly relevant to the exposures experienced by
U.S. military forces in Vietnam. On the basis of the assumption that compounds
with similar chemical structure may have analogous biologic activity, information on the effects of other chemicals in the phenoxy herbicide class—such
as 2-(2,4,5-trichlorophenoxy) propionic acid (fenoprop or Silvex), 2-methyl4-chlorophenoxyacetic acid (MCPA), 2-(2-methyl-4-chlorophenoxy) propionic
acid (mecoprop, MCPP), and 3,6-dichloro-2-methoxybenzoic acid (dicamba)—
has been factored into the committee’s deliberations with somewhat less weight
(see Figure 2-1).
Many scientific studies reviewed by the current and prior committees report exposures to broad categories of chemicals rather than to those specific
chemicals. Many studies have examined the relationship between exposure to
“pesticides” and adverse health outcomes, while others have used the category
of “herbicides” without identifying specific chemicals. A careful reading of a
publication often reveals that none of the COIs contributed to the exposures of the
study population, so such studies could be excluded from consideration. Chapter
3, Evaluation of the Evidence Base, contains a detailed discussion of inclusion
and exclusion criteria for the studies reviewed in the current update.
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Modeling Herbicide Exposure in Vietnam
Two models have been used to estimate exposure to herbicides experienced
by ground personnel in Vietnam: the EOI and AgDRIFT®. The models have different purposes; the EOI model was specifically developed to estimate herbicide
exposure potential to persons on the ground on the basis of data on aerial spray
history and troop locations, whereas AgDRIFT® is a modification of a model
developed by the U.S. Forest Service that predicts agricultural pesticide ground
concentrations based on variables related to dispersal, drift, and deposition. The
AgDRIFT® model thus does not consider troop-location data, nor is it specific to
exposures in Vietnam.
Exposure Opportunity Index Model
Following from recommendations contained in the first VAO report (IOM,
1994), VA asked the National Academies to issue a request for proposals seeking individuals and organizations to develop historical exposure-reconstruction
approaches suitable for epidemiologic studies of the herbicide exposure of U.S.
veterans during the Vietnam War (IOM, 1997). A team of researchers in Columbia University’s Mailman School of Public Health was awarded the contract for
the Characterizing Exposure of Veterans to Agent Orange and Other Herbicides
in Vietnam project. Several sources of information concerning spraying activities and information on the locations of military units assigned to Vietnam were
integrated into a database. The resulting EOI model (J. M. Stellman and S. D.
Stellman, 2003) generates individualized estimates (EOI scores) of the exposure
potential of troops who served in Vietnam.
Mobility factor analysis, a technique used for studying troop movement,
was developed for use in reconstructing herbicide-exposure histories. The
analysis is a three-part classification system for characterizing the location and
movement of military units in Vietnam. It comprises a mobility designation
(stable or mobile), a distance designation (usually in kilometers) to indicate
how far a unit might travel in a day, and a notation of the modes of travel available to the unit (by air, by water, or on the ground by truck, tank, or armored
personnel carrier). A mobility factor was assigned to every unit that served in
Vietnam.
The data were combined into a geographic information system (GIS) for
Vietnam. Herbicide-spraying records were integrated into the GIS and linked with
data on military-unit locations to derive individual EOI scores. The results are the
subject of reports by the contractor (J. M. Stellman and S. D. Stellman, 2003) and
the Committee on the Assessment of Wartime Exposure to Herbicides in Vietnam
(IOM, 2003a,b). A summary of the findings on the extent and pattern of herbicide
spraying (Stellman et al., 2003a), a description of the GIS for characterizing
exposure to Agent Orange and other herbicides in Vietnam (Stellman et al.,
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2003b), and an explanation of the EOI model based on that work (S. D. Stellman
and J. M. Stellman, 2004) have been published in peer-reviewed journals. In
those publications the researchers argued that it is feasible to conduct epidemiologic investigations of veterans who served as ground troops during the Vietnam
War. The National Academies later issued a report that examined the feasibility of
using the EOI model (IOM, 2008). The report concluded that “despite the shortcomings of the exposure assessment model in its current form and the inherent
limitations in the approach, the committee agreed that the model holds promise for supporting informative epidemiologic studies of herbicides and health
among Vietnam veterans and that it should be used to conduct studies” (p. 2).
This model has since been used in analyses of the Korean Veterans Health Study
(Yi and Ohrr, 2014; Yi et al., 2014b).
AgDRIFT®-Based Model
Ginevan et al. (2009a,b, 2014, 2015) proposed the use of the AgDRIFT® Tier
III forestry model for estimating the deposition of herbicides via aerial spraying
as alternative to the EOI model. They suggested that dermal exposure through
both direct deposition and post-application transfer from foliage could be derived
from application information such as aircraft speed and altitude, from nozzle
characteristics, and from droplet evaporation and environmental parameters such
as canopy density, canopy roughness, and crosswind speed. The authors did not
consider exposures resulting from contact with soil and dust or through inhalation because they considered these routes to be negligible (Ginevan et al., 2009a;
citing Driver et al., 1989; Gunther et al., 1977; Nadal et al., 2004). However,
subsequent reviews of the methodology underlying the authors’ analyses (S. D.
Stellman and J. M. Stellman, 2014, 2015) found several weaknesses that call the
results by Ginevan et al. into serious question.
DETERMINING INCREASED RISK IN VIETNAM VETERANS
Part of the committee’s charge—derived from the text of Public Law 102-4—
was to determine, to the extent permitted by the available scientiﬁc data, the
increased risk of disease among veterans exposed to herbicides or the contaminant TCDD during service in Vietnam. Estimating the magnitude of risk
of each particular health outcome among herbicide-exposed Vietnam veterans
requires quantitative information about the dose–time response relationship for
the health outcome in humans, information on the extent of herbicide exposure
among Vietnam veterans, and estimates of individual exposure. Vietnam veterans
were exposed to other agents and stressors—such as tobacco smoke, insecticides, therapeutics, drugs, diesel fumes, alcohol, hot and humid conditions, and
combat—that may increase or decrease the ability of chemicals in herbicides to
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produce a particular adverse health outcome. Few, if any, studies either in humans
or in experimental animals have examined those interactions.
As mentioned earlier in this chapter, most health studies of Vietnam veterans
were hampered by relatively poor measures of exposure to herbicides or TCDD
and by other methodological problems. Most of the evidence on which the
ﬁndings regarding associations are based, therefore, comes from studies of people
exposed to TCDD or herbicides in occupational and environmental settings rather
than from studies of Vietnam veterans. The committees that produced the first
VAO report and the updates found that the body of evidence was sufﬁcient for
reaching conclusions about statistical associations between herbicide exposures
and health outcomes but that the lack of adequate data on Vietnam veterans themselves complicated the consideration of this part of the charge.
Although some groups had well-documented high exposures of herbicides
(such as participants in Operation Ranch Hand and Army Chemical Corps personnel),
most Vietnam veterans had lower exposures to herbicides and TCDD than did the
subjects of many occupational and environmental studies (see Figure 2-2 from
Pirkle et al., 1995). The committees responsible for the first VAO report and the
updates have concluded that in general it is impossible to quantify the risk posed
to veterans by their exposure to herbicides in Vietnam.
After decades of research, the challenge of estimating the magnitude of
potential risk posed by exposure to the COIs remains intractable. The requisite
information is still not available despite concerted efforts to use modeling to reconstruct likely exposure from records of troop movements and spraying missions
(J. M. Stellman and S. D. Stellman, 2003; S. D. Stellman and J. M. Stellman,
2004; J. M. Stellman et al., 2003a,b), to extrapolate from agricultural models
of drift associated with spraying (Ginevan et al., 2009a; Teske et al., 2002), to
measure serum TCDD in individual veterans (Kang et al., 2006; Michalek et al.,
1995), and to model the pharmacokinetics of TCDD clearance (Aylward et al.,
2005a,b; H. L. Chen et al., 2006; Emond et al., 2004, 2005, 2006). Additionally, there is still uncertainty about the toxicity and health effects of the speciﬁc
COIs. Prior committees have thought it unlikely that additional information or
more sophisticated methods would permit any sort of quantitative assessment of
Vietnam veterans’ increased risks of particular adverse health outcomes that are
attributable to exposure to the chemicals associated with herbicide spraying in
Vietnam. Even if one accepts an individual veteran’s serum TCDD concentration
as the best available surrogate for overall exposure to Agent Orange and the other
herbicide mixtures sprayed in Vietnam, not only is it nontrivial to make this measurement, but the hurdle of accounting for biologic clearance and extrapolating
to the proper timeframe remains. Accordingly, the lack of exposure estimations
for Vietnam veterans will likely remain a hurdle to epidemiologic studies, and
unless this issue is resolved, the potential for additional epidemiologic studies to
yield improved information regarding the specific question of whether an association exists between herbicide exposure and health outcomes will remain limited.
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Evaluation of the Evidence Base

This chapter describes the approach and methods that the committee used to
identify and evaluate the scientific and medical literature on exposures to herbicides that occurred in U.S. military personnel during the Vietnam War as well as
the process that the committee used to reach conclusions on the association between exposures to the chemicals of interest (COIs)—2,4-dichlorophenoxyacetic
acid (2,4-D); 2,4,5-trichlorophenoxyacetic acid (2,4,5-T); picloram; dimethylarsinic acid (DMA or cacodylic acid); and 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD)—and a given health outcome. The committee’s process entailed the
following steps: a literature search, screening of abstracts, a full text review of
studies flagged in the abstract screening, and the evaluation of a final set of studies identified as relevant after the full text review. The first part of this chapter
details the methodology used to identify and screen the literature. The second part
of the chapter details the evaluation criteria used to review the relevant studies,
including the types of studies considered, the health outcomes considered, and the
categories of association used to draw conclusions about the strength of the evidence of possible health effects resulting from herbicide exposure. The committee
also describes some of the issues it encountered when reviewing the literature on
Vietnam War exposures and health outcomes, such as multiple exposures and individual variability. Because the current committee closely followed the approach
used by prior Veterans and Agent Orange (VAO) and Update committees, much
of the following information was previously described in those volumes as well,
particularly Update 2014 (NASEM, 2016a).
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IDENTIFICATION AND SCREENING OF THE LITERATURE
Literature Identification
Much as was the case with previous VAO committees, this committee was
tasked with comprehensively reviewing, evaluating, and summarizing the scientific literature that has appeared since the previous biennial update regarding
associations between TCDD and other chemicals present in the herbicides used
by the U.S. military in Vietnam and health outcomes and then adding this new
information to the existing compendium of evidence to draw conclusions on the
strength of associations between exposure and health outcomes. To begin, the
committee oversaw extensive searches of the scientific literature using a strategy
adapted from prior committees’ literature search methodology (see Box 3-1).
This committee’s search included additional terms to evaluate specific conditions
called out in the Statement of Task: possible generational health effects, myeloproliferative neoplasms, and brain cancer, in particular, glioblastoma multiforme
(see Chapter 1 for the full Statement of Task).
For this update, electronic searches of the medical and scientific literature
were carried out on four databases: Web of Science, Scopus, Medline, and Embase. In the previous VAO updates, only Medline and Embase were used. The
four searchable databases index biological, chemical, medical, and toxicological
publications. The full texts of the articles were searched so that if any of the
search terms was included in the title or abstract or indexed in the key words or
text of the article (excluding the cited references section), the article would be
included in the results of the search. Search terms included full and abbreviated
chemical names, common and manufacturer trade names, the Chemical Abstracts
Service numbers, and MeSH1 descriptors for each of the COIs and other similar
chemicals on an assumption that compounds with similar chemical structure
may have analogous biologic activity. The aryl hydrocarbon receptor (AHR) and
related MeSH descriptors were also included as primary search terms since this
protein appears to mediate essentially all of the toxicity of TCDD.
Using the search terms in Box 3-1, the databases were searched in two
phases, with the searches spanning over timeframes that were extended from
those used in prior updates. In the spring of 2017, the databases were searched
for articles published between January 1, 2014, and March 31, 2017. Then in
early February 2018 the databases were again searched for any articles with
the relevant search terms published between March 1, 2017, and December 31,
2017. The timeframes for those searches overlapped each other and also overlapped with the Update 2014 committee’s search (October 1, 2012–September
30, 2014). The overlapping dates made possible the capture of articles that might
1MeSH descriptors are sets of terms naming descriptors in a hierarchical structure that permits
searching at various levels of specificity. For example, MeSH terms for 2,3,7,8-tetrachlorodibenzop-dioxin include “TCDD” and “dioxin,” without those terms having to be specified individually.
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BOX 3-1
Search Terms
TERMS INCLUDED IN PREVIOUS VAO SEARCHES
Herbicide Formulations2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), 4-amino-3,5,6-trichloropicolinic acid (picloram), and
dimethylarsinic acid (DMA or cacodylic acid) and the contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Other Similar Chemicals
2-(2,4,5-trichlorophenoxy) propionic acid (Silvex), 2-methyl-4-chlorophenoxyacetic acid, 2-(2-methyl-4-chlorophenoxy) propionic acid (Mecoprop), 3,6dichloro-2-methoxybenzoic acid (dicamba), and polycholorinated biphenyls (PCBs).
Full and abbreviated chemical names, common and manufacturer trade names,
the Chemical Abstracts Service (CAS) numbers (that serve as a unique identifier
for every chemical), and MeSH descriptors for each of the chemicals of interest.
TCDD Toxicity Mediator
Aryl hydrocarbon receptor (AHR) and related MeSH descriptors
Generic Terms
Vietnam, veteran, Vietnam veteran, Agent Orange, dioxin, herbicide, and
phenoxy

SEARCH TERMS FOR CONDITIONS SPECIFIED IN THE
STATEMENT OF TASK
Generational Health Effects
Reproductive OR Reproduction OR Gonads OR Fertility OR Infertility OR
Fertilization OR Sperm* OR Testes OR Testicular OR Pregnancy OR Birth OR
Embryo OR Fetus OR Fetal OR Spermatozoon (MeSH) OR Infertility, male
(MeSH) OR Infertility, female (MeSH) OR Testis (MeSH) OR Testicle OR Sperm–
ovum interactions (MeSH) OR Semen OR Semen quality OR Ova OR Ovum OR
Oocyte OR Egg OR Parturition (MeSH) OR Embryonic structures (MeSH) OR
Fetal development OR Embryonic and fetal development (MeSH) OR Pregnancy
complications (MeSH C13.703) OR Abortion, spontaneous (MeSH) OR Miscarriage OR Premature birth OR Fetal death OR Pregnancy loss OR Preconception
injuries (MeSH C21.676) OR Germline OR Microbiome OR DNA methylation OR
Histone modification OR Histone* OR SNP* OR Polymorphism* OR Non-coding
RNAs OR ncRNA* OR Small RNA* OR MicroRNA* OR miRNA OR Imprinted
gene* OR Gene–environment OR Gene OR Epigenetic processes OR Epigenetic
OR Epigenomic OR Transgeneration* OR Trans-generation* OR Multigeneration*
OR Multi-generation* OR Intergeneration* OR Inter-generation* OR Generation*
OR Multigenerational effect* OR Multi-generational effect* OR Multigenerational
inheritance OR Multi-generational inheritance OR Multigenerational epigenetic
inheritance OR Multi-generational epigenetic inheritance OR F1 OR “F 1” OR
continued
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BOX 3-1 Continued
“F(1)” OR F2 OR “F 2” OR “F(2)” OR F3 OR “F 3” OR “F(3)” OR F4 OR “F 4”
OR “F(4)” OR Offspring OR Progeny OR One generation OR Two generation*
OR Second generation* OR Three generation* OR Third generation* OR Four
generation* OR Fourth generation* OR Child* OR Parent* OR Father* OR Son*
OR Daughter* OR Grandparent* OR Grand parent* OR Grandfather* OR Grand
father OR Grandmother OR Grand mother OR Grandchild* OR Grandson* OR
Grand son* OR Granddaughter* OR Grand daughter* OR Greatgrandparent* OR
Great-grandparent* OR Greatgrandmother* OR Great-grandmother* OR Greatgrandchild* OR Great-grandchild* OR Greatgrandson* OR Great-grandson* OR
Greatgranddaughter* OR Great-granddaughter*
Myeloproliferative Neoplasms
Myeloproliferative disorder* OR Myeloproliferative neoplasm* OR Aryl hydrocarbon receptor OR Myeloproliferative syndromes OR Myeloproliferative disorders OR “P vera” OR Polycythemia vera OR “ET” essential thrombocytosis
OR Essential thrombocythemia OR Myeloid metasplasia OR Agnogenic myeloid
metaplasia OR Myelofibrosis OR Primary myelofibrosis OR Chronic idiopathic
myelofibrosis OR “CML” OR Chronic myelogenous leukemia OR Jak2 mutation
OR Janus kinase 2 OR bcr-abl OR Philadelphia chromosome OR “CALR” mutation OR Calreticulin mutation OR MPL mutation OR Thombopoietin mutations OR
“XPD polymorphism” OR LNK (Src homology 2B3) OR CBL (Casitas B lineage
lymphoma)
Glioblastomas
“TET” OR ASXL2 OR IDH OR IKZF1 OR EZH2 OR DNMT3A OR Glioblastoma OR Glioblastoma cell line OR Brain neoplasm OR Glioblastoma multiforme
OR Astrocytoma grade IV OR Multifocal glioblastoma OR Glioma OR Neuroepithelial neoplasm OR Optic glioblastoma OR T98G glioblastoma multiforme cell
line OR brain tumor (MeSH)

have been published but not indexed at the time of the first search. Other than
dates, no limitations (such as language, populations, or species) were put on the
search. In addition, potentially relevant articles were also identified by searching
the reference lists of relevant review and research articles, books, and reports.
Exact duplicate articles and those that had been summarized and referenced in
Update 2014 were deleted. The committee became aware of a few studies that
reported updated findings on relevant exposed populations (such as the Seveso,
Italy, cohort and New Zealand phenoxy herbicide producers) published following
the December 31, 2017, search cutoff and reviewed these studies as well.
Literature Screening
The search strategy was devised to ensure that abstracts of all potentially
relevant articles were subjected to closer screening, but it also resulted in the
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identification of a large number of non-relevant studies. The first search produced
in excess of 12,000 “hits,” and the second search identified more than 1,600
articles of potential relevance. The articles were generally in English, but VAO
committees have traditionally obtained translations for crucial ones that were not
in English. Article titles and abstracts were screened for relevance by committee
members and the Health and Medicine Division staff to determine which studies
should be considered for full-text retrieval using the criteria in Box 3-2.
In the VAO series, neurologic deficits associated with Vietnam service are
distinguished from psychiatric/psychologic conditions—such as posttraumatic
stress disorder (PTSD), depression, and anxiety—and their sequelae. While, as
past VAO committees have noted, the increased risks of these types of mental
health conditions among veterans of all U.S. conflicts are of scientific and public
health concern, military service alone, including deployment and service in Vietnam, is known to confer a range of exposures to potentially traumatic events that
may be expected to increase the risk of developing PTSD and related psychologic
conditions. For example, compelling evidence has established that the prevalence
of PTSD is more than twice as high for operational infantry units exposed to
direct combat than it is in the general population (Kok et al., 2012). Previous
committees further drew the conclusion that it would be infeasible to disentangle
potential adverse effects from exposure to the COIs on mental health outcomes
that may occur independently of psychological effects accrued through military
service. The current committee expands upon that perspective by placing it in a
framework that underscores the relevance of the concepts of multifactorial causation, the literature on which has recently begun to mature and offer new insights.
Both independent and interacting risk factors may play a role. An example of
multiple independent effects can be seen in a recent study of Vietnam veterans in
Australia, which found that both sons and daughters of veteran fathers diagnosed
with PTSD had an increased risk for PTSD even after controlling for PTSD in the
mother and for other diagnoses (O’Toole et al., 2017). The statistical interactions
of risk factors, which can have synergist or antagonistic effects, can result in effects of combined exposures that would not have been predicted based on their
independent impacts. An example of a synergistic interaction is the association
with lung cancer from combined exposures to workplace arsenic and smoking:
in this case, the risks from arsenic are much higher among smokers than among
non-smokers (Hertz-Picciotto et al., 1992).
Disentangling the separate effects of combined exposures or risk factors in
relation to a particular outcome does raise serious challenges, however, and it
may indeed be infeasible when the correlations among those exposures are exceedingly high, to the point of inseparability, or when sufficiently large studies
cannot be conducted. For example, service-related emotional trauma, such as
occurs in combat, and exposures to the COIs in Vietnam are associated (J. M.
Stellman et al., 1988), but whether they are separable depends on the extent to
which those experiencing service-related trauma also had high exposures to the
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BOX 3-2
Criteria for Excluding Scientific Articles
from Further Consideration
•

•
•
•
•
•
•
•
•
•
•
•
•

•

Study does not include the chemicals used as tactical herbicides in military
operations in Vietnam. Examples include exposure to herbicides containing
organophosphates (not otherwise specified), atrazine, paraquat, glyphosate,
metamifop, rotenone, clarityon, and diuron; and exposure to pesticides and
insecticides (e.g., chlorpyrifos, imidacloprid, thiacloprid, DDT, DDE, etc.), fungicides, rodenticides, and non-dioxin-like PCBs.
Descriptions of ecosystem or environmental monitoring or exposure
surveillance.
Evaluations of chemical toxicities in environmental samples (e.g., plants,
water, soils).
Therapeutic or treatment studies following intentional or unintentional exposure to one of the chemicals of interest (COIs).
Descriptions of intentional acute chemical exposure or poisoning (including
suicide).
Case studies or case series (while such reports may be interesting and provide
unusual information, it is not appropriate to extrapolate findings from a single
case to an entire population).
Conference abstracts or proceedings, commentaries, or letters to the editor.
Stated narrative or historical accounts of the Vietnam era.
Studies that did not relate exposure to a COI and a health outcome.
Exposures experienced as children or adolescents (if the study subjects were
exposed prenatally and followed, the article was further considered).
Studies of lactation or ingestion of breast milk as the sole outcome of interest
without associated outcomes.
Studies about occupational exposure in greenhouse workers (consistent with
previous updates).
Described mental health or psychological conditions as a result of herbicide or
pesticide exposure, because it would be impossible to disentangle the potential
adverse effects on mental health outcomes caused by exposure to the COIs that
may occur independently of psychological effects accrued through military service.
Epidemiologic literature on the health effects of inorganic arsenic. Inorganic arsenic and benzene were not considered as relevant service-related exposures
among Vietnam veterans and were not evaluated in relation to their potential risk
of adverse health outcomes. VAO committees have considered and reviewed
toxicologic studies in which animals were directly exposed to dimethylarsinic acid
(DMA), but the extensive literature on the health effects of exposure to inorganic
arsenic (including the epidemiologic research, animal experiments, and mechanistic studies) has been regarded as not primarily pertinent to DMA exposure and
has not been considered.

COIs and, conversely, the extent to which those with high exposures to the COIs
invariably had a high degree of service-related trauma.
Current epidemiologic thinking recognizes that multiple risk factors may
operate not only independently, but also synergistically, and that sometimes the
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combined impacts may have both an independent and synergistic or antagonistic
component. Thus, a nuanced and comprehensive approach to combined exposures
is critical to understanding causation. Underlying susceptibility is not always genetic, but can instead be a prior or concomitant exposure, and thus the possibility
of multifactorial causation requires paying attention to confounding as well as to
interactions. Few studies have rigorously addressed the combination of combat
duty and the COIs through an assessment of interactions. In addition, a review of
the vast toxicology literature that relates to the COIs reveals that there is a dearth
of reports that address the potential associations and mechanistic explanations
relating to how exposure to the COIs may influence the risk of developing mental
health conditions. This applies specifically to an overall absence of published evidence as to how TCDD exposure could be etiologically implicated in the development of PTSD and related psychological comorbidities. Animal models will not
be informative for studying potential associations between exposure to the COIs
and development of PTSD. Because the literature appears to be quite limited, it
does not provide the opportunity to address effects on PTSD or other mental health
conditions that may occur as a result of the combined effect of military service/
combat duty and the COIs. Thus, at this time the committee was not able to determine whether the COIs might magnify the impact of traumatic events.
Although exposure to 2,4-D, 2,4,5-T, TCDD, cacodylic acid, and picloram are most germane to the committee’s charge and given the most weight
in the review of the evidence on a particular health outcome, chemicals that
are structurally similar to the herbicides and contaminants found in the tactical herbicides used in Vietnam are assumed to have similar biologic activity
and thus were also included in the committee’s review of the literature, consistent with prior VAO Update committees. These related chemicals include other
phenoxy herbicides—such as 2-(2,4,5-trichlorophenoxy) propionic acid (Silvex),
2-methyl-4-chlorophenoxyacetic acid (MCPA), 2-(2-methyl-4-chlorophenoxy)
propionic acid (Mecoprop or MCPP), and 3,6-dichloro-2-methoxybenzoic acid
(dicamba)—as well as dioxin-like chemicals such as those found in mono-ortho
and non-ortho-substituted polychlorinated biphenyls (PCBs) and also metabolites of organic arsenic (DMAV). Very few epidemiologic studies on exposure to
picloram or cacodylic acid have been published, which is another reason for the
committee to consider metabolites of these compounds.
Examining the structural representation of the COIs shown in Figure 2-1,
one can readily see the basis of an assertion heard repeatedly from individual
Vietnam veterans that “benzene is contained in TCDD.” Indeed, the two rings
at the ends of the three-ring structure constituting the basic structure of dioxin
compounds, to which chlorine molecules or other chemical radicals can be attached, do have the molecular structure of a single benzene molecule, and the
“dibenzo-dioxin” in TCDD’s chemical name does mean that the molecule is a
benzene-substituted dioxane. The benzene ring structure is a basic building block
of a vast number of organic compounds, both industrial (such as polyaromatic
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hydrocarbons, the phenoxy herbicides, picloram, and PCBs) and natural (such
as estradiol, a hormone present in both men and women). However, the biologically active compound benzene does not emerge from dioxin, whose three-ring
structure is extremely stable and resistant to metabolism.
An interaction or synergism among the COIs or in conjunction with other agents
is another theoretical concern. The committee was not charged with attributing
effects to specific COIs, and joint effects among them should be adequately identified by the committee’s approach. The combinations of the chemicals with other
agents that might lead to problems are virtually infinite, and hence, not feasible
for systematic and comprehensive evaluation. Real-life experience, as investigated
with epidemiologic studies, effectively integrates any results of exposure to a target
substance in combination with other substances that may be etiologically relevant.
Thus, in aggregate, the primary COIs evaluated by the committee with
respect to potential associations with adverse health outcomes among Vietnam
veterans are 2,4-D, 2,4,5-T, picloram, cacodylic acid, and TCDD. As explained,
inorganic arsenic and benzene were not considered as relevant service-related
exposures among Vietnam veterans and thus were not evaluated in terms of their
risk for adverse health outcomes.
The committee recognizes that in real-world conditions, human exposure to
TCDD virtually never occurs in isolation and that there are hundreds of similar
compounds to which humans might be exposed, including other polychlorinated
dibenzo-p-dioxins, polychlorinated dibenzofurans (PCDFs), and PCBs which
have dioxin-like biologic activity. The literature on the other compounds, particularly PCBs, has not been reviewed systematically by the committee except for
those reports in which TCDD was identified as an important component of the
exposure or when the risks of health effects were evaluated in relation to exposures
to dioxin-like chemicals. In many cases, when dioxin-like chemicals are present
the exposure is expressed in terms of toxic equivalencies (TEQs), which are the
sums of toxicity equivalence factors (TEFs) for individual dioxin-like chemicals
as measured by activity with AHR. Studies that report TEQs based only on monoortho PCBs (which are PCBs 105, 114, 118, 123, 156, 157, 167, and 189) are considered even though their TEQs are several orders of magnitude lower than those
of the non-ortho PCBs (77, 81, 126, and 169), based on the revised World Health
Organization (WHO) 2005 TEF values (La Rocca et al., 2008; van den Berg et al.,
2006). This is because the lower TEQs of the mono-ortho PCBs may be counterbalanced by their abundance, which is generally many orders of magnitude higher
than the non-ortho PCBs (H.-Y. Park et al., 2010). For example, PCB congeners
118 and 156 are present in numerous human populations (United States, Europe,
and Japan), at levels that are 4 to 5 orders of magnitude greater than the levels of
TCDD itself (Bake et al., 2007; Becher et al., 1995; Lorber et al., 2009, Tsuchiya
et al., 2003), with the levels of mono-ortho TEQs closely approximating those of
TCDD or in some cases exceeding them (H.-Y. Park et al., 2010).
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Exposure to non-dioxin-like PCBs only has not been considered by VAO
committees for two reasons. First, Vietnam veterans may have been exposed to
substantial amounts of the other chemicals, and the amount of exposure to those
chemicals relative to TCDD has not been documented. Second, the most important mechanism for TCDD toxicity involves its ability to bind to and activate the
AHR. Many of the other chemicals act by different or multiple mechanisms, so
it is difficult to attribute toxic effects after such exposures specifically to TCDD.
Furthermore, an individual’s exposures to dioxin-like chemicals and their nondioxin-like counterparts tend to be correlated, which means that it is difficult
for epidemiologic studies to attribute any observed association to a particular
chemical configuration (Longnecker and Michalek, 2000); carrying out analyses
in terms of TEQs somewhat circumvents this problem. The interaction or synergism among the COIs or in combination with other agents is a concern, but the
combinations of the COIs with other toxicants, or physical, biological stressors
is outside of the committee’s charge.
In cases when the title or abstract mentioned only broad chemical categories
or used non-specific terms such as “herbicide” or “pesticide,” the full text was reviewed for mention of the specific COIs. It was evident from most of the abstracts
that the article did not address health effects in association with exposure to the
specific COIs. The committee only deleted studies from further consideration if
it verified that exposure information specifically did not include at least one of
the COIs or if the study was not at all relevant, such as studies that evaluated the
efficacy of the COIs in killing specific plants or that measured concentrations of
the COIs in environmental samples, studies that merely provided a description
of manufacturing processes, or studies that did not include a health outcome. All
studies that discussed health effects or changes in pathophysiology or cell signaling were considered if the text indicated that any of the herbicides of interest
(or any of their components) may have been investigated. The committee only
included literature that had undergone peer review or government reports and
invited presentations that were provided to the committee, under the assumption
that they have been carefully reviewed. The process of peer review by fellow
professionals increases the likelihood that high-quality studies will appear in
the literature, but it does not guarantee the validity of any particular study or the
ability to generalize its findings.
Because the use of the general search terms “pesticides” or “pesticide,”
“defoliants,” “defoliant agent,” and “herbicide” or “herbicides” resulted in more
than 57,000 “hits,” the committee focused its search on the specific COIs as
well as related chemical classes. Even using the more targeted terms for the COI
identified many studies that examined the relationship between exposure to “pesticides” or “herbicides” and adverse health outcomes without identifying specific
chemicals. After carefully reading the full text of an identified article, if none of
the COIs were specified as contributing to the exposures of the study population,
the committee generally excluded such a study from further consideration and
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did not summarize it. An exception to this practice was made for studies that
indicated exposure to herbicides but did not characterize exposure with sufficient
specificity for their results to meet the committee’s criteria for inclusion in the
evidentiary database. For example, numerous case-control studies characterized
exposure to pesticides or herbicides on the basis of job titles, farm residence, or
longest-worked industry. Consistent with prior VAO reports, such studies were
not given full evidentiary weight because their results are not regarded as fully
relevant for the purpose of this review, but they are presented more briefly under
the heading of “Other Identified Studies.” However, given that the exposure
was not adequately described for these studies, their results are not included in
supplementary summary tables.
Articles using the generic term “herbicide” were kept if a published report
specified that the COIs were among the pesticides or herbicides used by the study
population or the COIs are used commonly for the crops identified in the study
or the COIs are used commonly for a specific purpose, such as the removal of
weeds and shrubs along highways. For instance, this rubric would apply to any
published articles from the Agricultural Health Study because 2,4-D was one of
the most frequently used pesticides in this large prospective cohort, but some
results have lumped all herbicide exposure together. In general, if the COIs were
not presented separately in the results of a study, the study was considered to be
of limited relevance and acknowledged as an “other identified study.” Exposures
to dioxin-like chemicals, such as mono-ortho and non-ortho substituted PCBs,
PCDFs, and dioxins other than 2,3,7,8-TCDD, were also considered relevant to
the committee’s charge and were included as long as the results were expressed
in terms of total or individual congener toxic equivalents. The most weight was
given to studies that used quantitative measures (such as TEQs) and specified
exposure.
Studies with original data collection and analyses were preferred over studies that were re-analyses of a population (without the incorporation of additional
information), pooled analyses or meta-analyses, reviews, and so on, and the
former are the type of evidence that the committee preferentially considered
when assessing the strength of association between herbicide exposure and a
health outcome when drawing its conclusions. While studies of the latter type
may be informative and may be discussed in conjunction with primary results or
in synthesis sections on a given health outcome, they are not themselves part of
the evidence dataset and therefore were not considered in the final count of new
literature considered in this volume.
EVALUATION PROCESS
This section details the methods used by the committee for evaluating and
synthesizing the relevant studies identified by the literature search and screening
and for making its conclusions on the relationships between the COIs and health
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outcomes among Vietnam veterans. The quantitative and qualitative procedures
underlying the committee’s literature evaluation have been made as explicit as
possible, but ultimately the conclusions about associations expressed in this
report are based on the committee’s collective judgment. The committee has
endeavored to express its judgments as clearly and precisely as the data allow.
A total of 14,750 abstracts were retrieved from the two literature searches.
Full text was then obtained for any articles that were considered potentially relevant based on their titles and abstracts and after applying the inclusion and exclusion criteria. Full-text articles were distributed among the committee members
based on their areas of expertise, with at least two committee members reviewing
each paper. As with all VAO committees, the committee began its assessment of
the literature by assuming neither the presence nor the absence of an association
between exposure and any particular health outcome. Because of the variability in
the descriptions and diagnoses of the health conditions considered in this report,
the committee made no a priori assumptions about the usefulness of any article or
report for a health outcome. Each study was reviewed and objectively evaluated
for each health outcome it presented. If a study examined more than one health
outcome, it was considered separately for each of those outcomes. After reading,
if the full text revealed that the study met one of the exclusion criteria (see Box
3-2), it was excluded from further consideration.
After review of the full text of the identified articles, studies that were considered relevant (165 epidemiologic studies and nearly 100 toxicologic studies)
were discussed and evaluated thoroughly, and are included in this report. New
evidence on each health outcome was reviewed in detail, but the committee’s
conclusions are based on the accumulated evidence of all VAO reports, not just
on recently published studies.
The responsible committee members then presented the information from
each new relevant study—including the methods used for selecting the study
populations and conducting the research (i.e., design, measures of exposure and
health outcomes, statistical analyses used, adjustment factors, etc.), the results,
and an assessment of the strengths, limitations, and potential biases—to the full
committee for discussion. Based on the details of exposure and the description of
how exposure was measured, an epidemiologic study was classified either as a
primary article, in which case it was given full evidentiary weight, or as a secondary article, in which case it was reviewed and more briefly described under the
heading of “Other Identified Studies.” In a secondary study, the exposure was
either not adequately described or considered not to be specific enough for its
findings to contribute evidentiary weight. An epidemiologic study was also classified as secondary if the outcome was a biologic marker of effect as opposed to
a recognized condition or disease. Studies that measured well-defined functional
outcomes indicative of mild impairments and likely of worsening function that
have not yet progressed to frank clinical diagnoses, such as cognitive function
and loss of grip strength, as evaluated in Chapter 9: Neurologic Disorders, were
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considered primary evidence. Mechanistic and toxicologic studies contributed to
the evidence for biologic plausibility but were not considered primary studies, so
that based on those studies alone, their weight would not be enough to change the
level of evidence of an association.
Following the discussion of each individual study for a specific health outcome, the lead committee member for an outcome then reviewed and summarized
for the full committee the epidemiologic evidence reported in prior VAO updates
and the most recent conclusion from Update 2014 on that health outcome. The
toxicologists on the committee provided a summary of previous and new mechanistic or toxicologic studies for that health outcome. Although both primary and
secondary studies contributed to the committee’s conclusion regarding the evidence of the COIs to be associated with a particular health condition or outcome,
primary studies were given more weight. Using all of the available information,
the full committee then came to a consensus regarding the conclusion and assigned a category of association (discussed later in this chapter) on the strength of
the evidence of exposure to at least one of the COIs and the health outcome under
scrutiny. When drafting language for a conclusion, the committee considered the
nature of the exposures, the nature of the specific health outcome, the populations
exposed, and the quality of the evidence examined.
The draft text was reviewed and discussed in further plenary sessions until
all committee members reached a consensus on the description of the studies and
the conclusion for each health outcome. The committee did not use a formulaic
approach to determining the number of primary or supporting studies that would
be necessary to assign a specific category of association. Rather the committee’s
review required a thoughtful and nuanced consideration of all the studies as well
as expert judgment, and this could not be accomplished by adherence to a narrowly prescribed formula of what data would be required for each category of
association or for a particular health outcome.
The supplementary tables to this report (available online at www.nap.edu/
catalog/25137) were revised to include only the new primary epidemiologic studies; secondary studies, including mechanistic and toxicologic studies, were not
included in the compendium evidence tables for each outcome. If no new primary
studies for a health outcome were identified, the evidence table from Update
2014 was included. Effect estimates, data, and units of measure are presented as
reported in the cited studies, except where otherwise noted. The committee did
not collect original data, nor did it perform any secondary data analyses, such as
meta-analyses.
Types of Studies Considered
The committee focused on epidemiologic studies because epidemiology
deals with the determinants, frequency, and distribution of disease in human
populations rather than in individuals and animal models, which have several

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

EVALUATION OF THE EVIDENCE BASE

57

limitations as discussed below. Epidemiologic studies effectively integrate any
results of exposure to a target substance in combination with other substances
that may be etiologically relevant. Several types of epidemiologic studies were
evaluated, including cohort, case-control, and cross-sectional designs. Other reports of health outcomes among veteran populations have described these major
types of epidemiologic studies and chronicled the limitations inherent in conducting them and in using them to make conclusions based on associations between
deployment-related factors and health conditions (IOM, 1994; NASEM, 2016a).
The committee weighed the importance of the epidemiologic studies in the
following order: Vietnam veterans, occupationally exposed workers, and people
who were exposed environmentally. Exposures gleaned from case-control designs
were considered separately. Vietnam veterans (U.S. veterans and those from allied countries) are presumed to have been exposed to all the COIs; the limitations
of such an assumption are discussed in Chapter 2. Although Vietnam veterans
constitute the source population of interest, the committee has taken into account
the potential for more precise quantification and evaluation of the risks of adverse
health outcomes associated with the COIs in better characterized cohorts (for
example, occupational and environmental cohorts). Including these more highly
exposed populations had the additional advantage that epidemiologic studies of
them were likely to have greater statistical power to detect any adverse effects
that might occur with exposure. Within the occupational-study populations, due
to the substantial differences in the nature and intensity of their exposures, workers in the production of herbicides and other industrial products contaminated
with TCDD were prioritized, followed by those involved in occupational use of
the herbicides of interest (such as agricultural workers). The committee for VAO
and the first several updates gave more weight to results that were based on job
title (for example, “farmer” with no additional information) than have the committees since Update 2006 (where such studies are now considered secondary
and given less weight). Those first committees also entirely excluded findings
from the Yusho and Yucheng PCDF and PCB poisonings, whereas recent committees have considered these and other environmental studies that analyzed for
dioxin-like PCDF and PCB congeners and expressed the results in terms of TEQs.
Toxicologic studies, particularly in animal models, are included to inform the
understanding of biologic plausibility through the toxicology of the chemicals
and their exposure pathways.
Vietnam Veterans
Because Vietnam veterans are the target population of the charge to the
VAO committees, studies of these veterans (whether American or otherwise)
have always been accorded considerable weight in the committees’ deliberations
and are presented first in the literature for each health outcome. The committee reviewed all identified studies of U.S. and international Vietnam veterans
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published since Update 2014. In general, few studies include objective measures
of TCDD or other chemical concentrations; those that are available were performed in small subsets of Vietnam veterans, such as those from the Air Force
Health Study and Army Chemical Corps. Instead, having served in Vietnam or
participating in the Agent Orange Registry is often considered a proxy of herbicide exposure. Therefore, it is difficult to quantify the risk of specific health
outcomes when the exposures of the total at-risk population have not been measured or estimated. In the absence of actual measures of exposure, comparisons
between deployed and non-deployed Vietnam-era veterans are considered the
next most relevant comparison. Moreover, in many studies of Vietnam veterans,
not all health outcomes of interest were reported (in some cases there were too
few cases to report, only specific health outcomes were of interest, or the veteran
population was too young for a particular manifestation). Consequently, several
other groups known or thought to have potentially higher and better-characterized
exposure to TCDD or phenoxy herbicides than the Vietnam veterans themselves
were considered.
Human Studies Among Non-Veterans
Whereas exposure estimation and characterization of the COIs has been
lacking in many (especially early) studies of Vietnam veterans, studies of occupational exposure (for example, among chemical-production, paper and pulp,
railroad, agricultural, and forestry workers) and of environmental exposure (for
example, residents of dioxin-contaminated sites such as Seveso, Italy, and the areas around some former U.S. military installations in Vietnam) to TCDD and the
other COIs provide evidence of exposure and health outcomes to supplement the
studies of Vietnam veterans. Some occupational and environmental cohorts that
received exceptionally high exposures have produced many informative results
and provide stronger evidence about health outcomes than studies of Vietnam
veterans because the exposures were better characterized and measured sooner
relative to the exposure. Moreover, in several studies of chemical-production
plant workers, the magnitude and duration of exposure to the chemicals were
measured and generally greater than among Vietnam veterans, so the likelihood
that any possible health consequences would be manifested was greater. Some
of the populations used in these types of studies were large enough to examine
dose–response relationships. Other populations, such as the Agricultural Health
Study, a prospective cohort study of U.S. agricultural workers with specific information on the COIs, continue to contribute new evidence of association with
health outcomes.
As the information on populations that had established exposure to the COIs
has grown, VAO committees have become less dependent on data from studies
that had non-specific exposure information (e.g., exposure to non-specified herbicides) and have been able to focus more on the findings of studies that had refined
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exposure specificity. For each health outcome, occupational and environmental
studies are presented after the studies of Vietnam veterans.
Animal and Mechanistic Studies
The committee used studies of toxicology data to determine whether there
is a plausible biologic mechanism or other evidence of a causal relationship
between herbicide exposure and a health effect. A positive statistical association
between an exposure and an outcome does not necessarily mean that the exposure
is the cause of that outcome. Data from toxicology studies may support or conflict
with a hypothesis that a specific chemical can contribute to the occurrence of a
particular disease. Insights about biologic processes inform whether an observed
pattern of statistical association might be interpreted as the product of more
than error, bias, confounding, or chance. Discussions on biologic plausibility are
presented after new epidemiologic evidence and before the synthesis of all the evidence. The degree of biologic plausibility itself influences whether the committee
perceives positive ﬁndings to be indicative of a pattern or the product of statistical
fluctuations. Ultimately, the results of the toxicology studies should be consistent
with what is known about the human disease process if they are to support a
conclusion that the development of the disease was influenced by an exposure.
Aryl Hydrocarbon Receptor Many of the available toxicologic and mechanistic studies involve the AHR because it has been found that essentially all of the
toxic effects of TCDD involve interaction with this protein (receptor). The AHR
can modulate transcription by binding TCDD and other aromatic hydrocarbons
with high affinity. The formation of an active complex that involves the intracellular receptor, the ligand (the TCDD molecule), and other proteins is followed
by an interaction of the activated complex with specific sites on DNA, which
can alter the expression of specific genes involved in the regulation of cellular
processes. The affinity of TCDD for the AHR is species- and strain-specific, and
responses to the binding of the receptor vary among cell types and developmental
stages.
Although studying AHR biology in transformed human cell lines minimizes
the inherent error associated with species extrapolations, it is still not clear to
what extent toxicity is affected by the transformation itself or by the conditions
under which cell lines are cultured in vitro. Genetically based differences in the
properties of the AHR are known to exist in human populations (Zhou et al.,
2010), as they are in laboratory animals, so there are genetically based differences in people’s responses to TCDD, which leads to some people having an
intrinsically greater risk of toxic effects from the same TCDD exposure, while
others have less risk. Therefore, as humans have AHR with differing affinities
for dioxin, a single transformed human cell line will not accurately reflect the
spectrum of responses observed in the entire human population. As a result, the
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TEQ approach should be seen as qualitatively generalizable, but cannot be definitively quantitative when discussing differences between tissues or individual
humans.
Limitations of Animal Models Animal models are the basis for many of the
toxicologic and mechanistic studies, although cell lines and in vitro cell cultures
(human or animal) are also used. Studies that use isolated cells in culture also can
elucidate how a chemical alters cellular processes. The objectives of those toxicology studies are to determine what toxic effects are observed at different exposure levels and to identify the mechanisms by which the effects are produced.
To be considered an acceptable surrogate for the study of a human disease,
an animal model must reproduce, with some degree of fidelity, the manifestations of the disease in humans. However, a given effect of an exposure in an
animal species does not necessarily establish its occurrence in humans, nor does
the apparent absence of a particular effect in animals mean that the effect could
not occur in humans. In addition to possible species differences, many factors
affect the ability to extrapolate results from animal studies to health effects
in humans. For example, animals used in experimental studies are most often
exposed to purified chemicals, not to mixtures. Even if herbicide formulations
or mixtures are used, the conditions of exposure might not realistically reproduce the human exposures that occur in the field. Other variables, including
the amount and duration of exposure, can be controlled precisely in laboratory
settings.
TCDD is thought to be responsible for many of the toxic effects of the herbicides used in Vietnam. Attempts to establish correlations between the effects
of TCDD on experimental systems and their effects on humans are particularly
difficult because there are well-known species-, sex-, and outcome-specific differences in susceptibility to TCDD toxicity. Even in humans, the data on TCDD’s
toxic effects are not consistent (DeVito and Birnbaum, 1995; Ema et al., 1994;
Moriguchi et al., 2003). Differences in vulnerability may also be affected by
variations in metabolism and by the rate at which TCDD is eliminated from
the body. Although the degree of susceptibility is generally thought to be an
inherent biological response, it can be influenced by life stage, past history, and
co-exposures.
Many factors may contribute to differences between the results of controlled
animal studies and the effects observed in humans. The following, which are
elaborated on in Chapter 4, are among the most important:
• Physiologic differences. Laboratory animals are not miniature humans.
Depending on the biologic process under investigation, a particular test
species may match the human system more closely and so be a better
experimental model than others.
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• Magnitude of exposure. As is often the case for toxicologic studies of
any chemical, the TCDD exposure used for animal studies has been many
orders of magnitude higher than Vietnam veterans are likely to have received during military service, although the ultimate body burdens may
not be as different.
• Duration of exposure. Although TCDD is a persistent organic pollutant,
animal studies seldom examine the chronic low-level exposure that occurs
over a period of years or even many months.
• Timing of exposure. It is well known that many organ systems are highly
susceptible to xenobiotic exposure during critical stages of development,
such as gestation; the response of some systems (such as the immune system) may also depend on the timing of the exposure to antigens relative
to the timing of the exposure to xenobiotics such as TCDD.
• The route of exposure. The route of exposure by which an exogenous agent
enters an organism may influence the nature of any toxic response elicited.
The outcomes of animal studies may be perturbed by the delivery of treatment doses by “unnatural” routes of exposure, such as a bolus by gavage
or intraperitoneal injection, but the route of exposure does not seem to be
a major reason that the results of epidemiology studies may not agree with
the findings of controlled studies for the COIs considered in the VAO series.
• Genetic constitution and expression. The etiologies of most diseases
in humans and in animals are likely to be influenced by numerous genes
and to involve complex gene–environment interactions, and preliminary
evidence suggests that TCDD can induce epigenetic modifications of an
organism’s DNA and alter expression of its genes.
• Sex differences. There are well-known differences between male and
female animals (including humans) in susceptibility to xenobiotic exposures, some of which are modified by sex steroids.
• Prior and recurring exposures to multiple sources. Humans are
exposed to xenobiotics from multiple sources throughout their lifetimes.
• Complex mixtures. Most xenobiotic exposures occur in complex mixtures; the makeup of these mixtures can heavily influence the ultimate
toxic effects. In addition to the dietary modulation of responses to other
exposures of both humans and animals, including dietary supplements
in humans, prescription and over-the-counter pharmaceuticals, and other
factors (such as cigarette smoking and ambient pollution) may have effects.
• Stress. Stress—of known or unknown origin—is a well-known modifier
of human disease responses (such as immune responses); stress is an everpresent variable that is difficult to assess or control for in epidemiologic
studies because there is substantial individual variation in response to it.
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Selection of Health Outcomes
The committee was charged with summarizing the strength of the scientific
evidence concerning associations between exposure to various herbicides and
contaminants during service in the Vietnam War and individual diseases or other
health outcomes. The list of outcomes was developed on the basis of diseases
and conditions identified from searches of the scientific literature, as first done
by the original VAO committee and amended and expanded as needed by VAO
Update committees. For example, the current committee included chronic skin
conditions, which had not specifically been addressed by prior committees. Some
health outcomes in the series have been added in response to requests from the
Department of Veterans Affairs (VA) and various Veterans Service Organizations
and in response to concerns of Vietnam veterans and their families. Comments
received at public hearings and in written submissions from veterans and other
interested persons have been valuable in identifying issues to be pursued to
greater depth in the scientific literature. The current committee defined a health
outcome as any recognized diagnosis (based on ICD-9 or ICD-102). Studies of
exposure to the COIs that examined changes in pathophysiology, cell signaling,
or other biologic markers of effect, such as hormone levels and blood counts,
are more briefly mentioned as “Other Identified Studies” in applicable chapters,
but because of the uncertainty of their relevance on the actual health outcome of
interest, they are not considered further.
In aggregate, the health outcomes that the committee has focused on include
cancers of all types, cardiovascular and metabolic outcomes such as diabetes,
immune system disorders, and neurologic disorders. Other chronic health outcomes have also been considered, including respiratory disorders, gastrointestinal
disorders, endocrine disorders, and bone conditions. Generational effects were
specifically included in the committee’s charge and are addressed along with reproductive outcomes in a combined chapter. Although for most health outcomes
the primary focus of the evaluation was on adverse outcomes in the veterans
themselves, to examine potential effects, the children of Vietnam veterans and also
later generations were included in the evaluation of the literature.
After reviewing the updated literature, the committee agreed that some reorganization of the health conditions was warranted for this volume. For example,
it was more appropriate to group monoclonal gammopathy of undetermined
significance, multiple myeloma, and amyloid lightchain amyloidosis under the
heading “Plasma Cell Dyscrasias.” Whereas reproductive outcomes and effects
on descendants were presented in a single chapter from VAO through Update
2010, the committees for Update 2012 and Update 2014 divided these outcomes
into two chapters. The current committee believed that it made more sense to
2 ICD refers to the International Classification of Diseases, which is maintained by the World
Health Organization. Its current version, ICD-10, is the 10th revision.
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present the reproductive outcomes and effects on descendants as a continuum in
a single chapter.
Because any effect of the herbicides or contaminants in individuals or groups
of veterans is evaluated in terms of disease or medical outcome, the committee
paid particular attention to disease diagnosis and classification as it assembled
pertinent data from various investigations related to a particular outcome in preparation for integrating the information. Pathologists, clinicians, and epidemiologists
use several classification systems, including the International Classification of
Diseases (ICD), which has been updated over time and with regard to topic. ICD
codes are a hierarchic system for indicating the type of disease and site. For example, whereas many medical insurance and research investigators preferentially
use the ninth revision of ICD (ICD-9) or its clinical modification (ICD-9-CM)
to classify diagnoses or clinical outcomes, the tenth revision (ICD-10) is used to
classify mortality information. Although outcome misclassification is still a possibility when recording a diagnosis with a specific ICD code into a record, the
ICD system has been refined over many decades and is virtually universally used
and understood, in addition to being exhaustive and explicit. Therefore, this and
previous VAO committees have opted to use the ICD system as an organizing tool.
Many of the epidemiologic studies reviewed by VAO committees have not
used the ICD approach to classification of disease and have relied instead on
clinical impression alone. Self-reported diagnoses obtained from survey questionnaires often have inaccuracies due to recall bias and misinterpretations of the
questions being asked. For example, a patient may report having been treated for
stomach cancer when the correct diagnosis was gastric adenocarcinoma, gastric
lymphoma, or peritoneal cancer. Furthermore, many epidemiologic studies report
disease outcome by organ system. Sometimes this is done because there are few
cases of a specific outcome and the study is lacking the necessary statistical
power to make valid statistical associations using such specific diagnoses. However, such grouping into broader outcome categories can be problematic (and
the same is true when categorizing potential exposure). For instance, the term
“digestive system” may be used for conditions that are benign or malignant and
that affect the esophagus, stomach, liver, pancreas, small intestine, large intestine,
or rectum. Therefore, if a report indicated that a cohort has an increased incidence
of digestive system cancers, then it would be unclear whether the association
was attributable to excess cases of any single organ or type or to some combination thereof. Additionally, such generalization is complicated by the fact that the
cause of cancer may differ among anatomic sites. For instance, there are strong
associations between smoking and squamous cell carcinoma of the esophagus and
between chronic hepatitis B infection and hepatic cancer. Furthermore, a single
site may experience a carcinogenic response to multiple agents, while the same
agent may cause cancer at multiple sites.
Several of the identified studies examined the association of exposure to
at least one of the COIs (or a mixture containing it) with an individual health
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outcome. However, some of the primary studies (for example, Collins et al.,
2016; Cox et al., 2015) reported multiple health outcomes, and individuals might
have been counted in more than one category. This can also be an issue in mortality studies when more than the primary cause of death is used. Designing studies
to analyze concurrent health outcomes is much more difficult, and valid methods
that can be applied with confidence to identify patterns among multiple health
outcomes associated with a single exposure have not yet been developed. If such
methods were developed, studies of multiple health outcomes could potentially
provide more insight into whether the COIs cause multiple health effects, into
competing risks among various health outcomes, and into the interactive effects
of health outcomes.
Defining Statistical Association
Box 3-3 provides brief definitions of some of the most common terms used
in the epidemiologic studies considered by this committee. The strength of an association between exposure and a condition is generally estimated quantitatively
by using relative risks, odds ratios, correlation coefficients, or hazard ratios,
depending on the epidemiologic design used. A ratio greater than 1.0 indicates
that the outcome variable has occurred more frequently in the exposed group,
and a ratio less than 1.0 indicates that it has occurred less frequently. Ratios
are typically reported with a confidence interval (CI) to quantify random error.
Statistical significance may be represented by a CI or a p-value. If the 95% CI
for a risk estimate (such as a risk ratio or odds ratio) includes 1.0, the association is not considered to be statistically significant; however, if the interval does
not include 1.0, the association is said to be statistically significant with a type I
alpha error (likelihood that the association is due to chance) of less than 5% (that
is, p < 0.05).
Determining whether an estimated association between an exposure and an
outcome represents a real relationship requires careful scrutiny because there can
be more than one explanation for an estimate. Bias is a general term for a distortion of the measure of association. There are several types of biases, and each
type may affect the estimate differently. For example, misclassification bias may
result in exaggerated or underestimated estimates, whereas self-selection bias affects the representativeness of the study population and can limit the applicability
of the results to the larger population of interest. Another type of bias that may
potentially affect studies of Vietnam veterans is detection bias, in which veterans
who are encouraged to and who choose to participate in screening programs or
registries, such as the Agent Orange Registry (discussed in Chapter 5) may have
additional tests or follow-up exams that could potentially detect disease or a condition earlier or because more thorough assessments were conducted. This type
of bias may occur disproportionately for Vietnam veterans with known or who
report herbicide-exposure compared with Vietnam-era veterans who were not
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BOX 3 -3
Statistical Terms Used in This Report
Confidence interval (CI) is a range of values for the estimate within which the
true value is thought to lie, with a (usually specified) 95% level of confidence.
Hazard ratio (HR) is a ratio of the chance of an event occurring in one group
compared with the chance in another group.
Incidence is the number of new cases of illness during a given period of time
in a specified population divided by the total population.
Odds ratio (OR) represents the odds that an outcome will occur, given a particular exposure, compared with the odds of the outcome occurring in the absence
of exposure. The measure approximates the relative risk when a disease is rare.
Prevalence is the number of existing cases of an illness or disease in a given
population at a specific time or within a specified time period.
Relative risk (RR) denotes the risk of a disease or outcome in a population with a
given exposure compared to a population without the exposure. Relative risk may
be described by a risk ratio, rate ratio, or odds ratio.
Standardized hospitalization ratio (SHR) is the ratio of hospitalizations among
a population for a specific condition by person-years of follow-up divided by the
national age- and sex-specific hospitalization rates for a health outcome using the
annual hospitalization numbers and annual mean resident population estimates.
Standardized incidence ratio (SIR) is the ratio of observed new cases of an outcome in the exposed cohort to the expected number of new cases in the general
population. The term “standardized” refers to adjustments made for age and sex
differences between the study population and the general population.
Standardized mortality ratio (SMR) is the ratio of the number of deaths observed
in a study population to the number of deaths expected if the study population had
the same mortality rate as the general population. The term “standardized” refers
to adjustments made for age and sex differences between the study population
and the general population.

known to be exposed to herbicides or who were deployed elsewhere. Detection
bias may lead to an overestimate or underestimate of the true effect size.
Confounding is a common type of bias in epidemiologic studies that occurs
when a risk factor for the disease is also related to the exposure and creates a
spurious exposure–disease association. Potentially, if a confounder is known,
there are methods that can be used to adjust for its effects; however, not all confounders are always known or identified, and unknown confounders may affect
the estimate of association. Effect modifiers differ from confounders in that the
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former are associated with the outcome but not the exposure. Effect modification occurs when an exposure has a different effect among different subgroups
or strata. Chance is the degree to which an estimated association might vary
randomly among different samples of the population studied.
Integrating New Information into the Evidence Base
Because relatively few studies of exposure to herbicides or TCDD (especially with objective measures) and health effects have been conducted among
cohorts of Vietnam veterans, much of the evidence that VAO committees have
considered has been from studies of well-documented populations that received
occupational or environmental exposures to TCDD or specific herbicides. In
many other studies, TCDD exposure was combined with exposures to an array of
“dioxin-like” chemicals, and the herbicides were often analyzed as members of a
functional class. Such studies are less informative for the committee’s purposes
than individual results on a specific chemical but are still considered as part of the
evidence base. In the case of epidemiologic studies, exposure to multiple, possibly toxic, chemicals is common in some industries, such as agriculture, and those
exposures cannot be controlled for in the same way that laboratory experiments
can. In its examination of these epidemiologic studies, the committee looked for
evidence of health effects that are associated with the specific compounds in the
herbicides used in Vietnam and sought consideration of and adjustment for other
possibly confounding exposures. When all the available epidemiologic evidence
has been evaluated, Vietnam veterans are presumed to be at increased risk for a
specific health outcome if there is evidence of a positive association between one
or more of the COIs and the outcome.
The quality of exposure information in the scientific literature reviewed
by this and previous VAO committees varies widely. Some studies relied on
interviews or questionnaires to determine the extent and frequency of exposure.
Such self-reported information, which has the potential for recall bias, generally
carries less weight than do more objective measures of exposure, such as levels
of a contaminant as measured in serum or other biospecimens. The strength of
questionnaire-based information as evidence of exposure is enhanced to the
extent that the information can be corroborated or validated by other sources.
Similarly, greater weight is given for studies that use more objective measures of
health outcome assessments (such as clinical diagnosis).
In drawing conclusions, the committee examined the most thoroughly adjusted quantitative estimates of association, judged whether an adjustment for any
crucial confounders was lacking, and evaluated the potential influences of bias and
chance. In integrating the findings of various studies, the committee considered the
degree of statistical significance associated with every estimated risk (a reflection
of the magnitude of the observed effect and the power of the study designs) and
took note of whether dose–response relationships were evident with increasing
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exposure rather than simply tallying the “significant” and “non-significant” outcomes as dichotomous items of evidence. The committee also considered whether
controlled laboratory investigations provide information consistent with the COIs
being associated with a given effect and perhaps causally linked to it.
Categories of Association
As was done in previous volumes, the current committee used four categories
of association to rate health outcomes based on the strength of the scientific evidence. The criteria for each category express a degree of confidence based on the
extent to which bias and other sources of error could be reduced. The coherence
of the full body of epidemiologic information, including biologic plausibility, is
considered when the committee reaches a judgment about association for a given
outcome. As was the case with the past three update committees, this committee
did not use the Bradford Hill criteria for causality (Hill, 1965) as a checklist for
its strength-of-association assessments. The committee discussed the evidence
and reached consensus on the categorization of the evidence for each health
outcome, which appears in the Conclusion section for each health outcome.
Those categories of association have gained wide acceptance by Congress, VA,
researchers, and veterans groups.
Sufﬁcient Evidence of an Association
For effects in this category, a positive association between herbicides and
the outcome must be observed in studies in which chance, bias, and confounding
can be ruled out with reasonable confidence. For example, the committee might
regard evidence from several small studies that are free of bias and confounding and that show an association that is consistent in magnitude and direction to
be sufficient evidence of an association. Experimental data supporting biologic
plausibility strengthen the evidence of an association but are not a prerequisite
and are not enough to establish an association without corresponding epidemiologic ﬁndings.
Limited or Suggestive Evidence of an Association
In the category of “limited or suggestive evidence of an association,” the evidence must suggest an association between exposure to herbicide compounds or
COIs and the outcome in studies of humans, but the evidence can be limited by an
inability to confidently rule out chance, bias, or confounding. Typically, at least
one high-quality study indicates a positive association, but the results of other
studies could be inconsistent. Because the VAO series has a number of agents
of concern whose toxicity proﬁles are not expected to be uniform—speciﬁcally,
four herbicides and TCDD—apparent inconsistencies can be expected among
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study populations that have experienced different exposures. Even for a single
exposure, a spectrum of results would be expected, depending on the power of
the studies, inherent biological relationships, and other study design factors.
Inadequate or Insufﬁcient Evidence to Determine an Association
By default, any health outcome is placed in the category of “inadequate
or insufﬁcient evidence to determine an association” before enough reliable
scientiﬁc data have accumulated to promote it to the category of sufﬁcient evidence or limited or suggestive evidence of an association or to move it to the
category of limited or suggestive evidence of no association. In this category,
the available human studies may have inconsistent ﬁndings or be of insufﬁcient
quality, validity, consistency, or statistical power to support a conclusion regarding the presence of an association. Such studies might have failed to control for
confounding factors or might have had inadequate assessment of exposure. Several health effects have been moved into or out of this category since the original
VAO committee reviewed the evidence then available.
For nonmalignant conditions, the diversity of disease processes involved
makes the use of broad ICD ranges less useful, but because VAO committees
could not possibly address every rare nonmalignant disease, they do not draw
explicit conclusions about diseases that are not discussed, and thus, this category
is the default or starting point for any health outcome. If a condition or outcome
is not addressed specifically, then it will be in this category.
Limited or Suggestive Evidence of No Association
The original VAO committee deﬁned the category “limited or suggestive
evidence of no association” for health outcomes for which several adequate
studies covering the “full range of human exposure” were consistent in showing
no association with exposure to herbicides at any concentration and had relatively
narrow conﬁdence intervals. A conclusion of “no association” is inevitably limited to the conditions, exposures, and observation periods covered by the available studies, and the possibility of a small increase in risk related to the magnitude
of exposure studied can never be excluded. However, a change in classiﬁcation
from inadequate or insufﬁcient evidence of an association to limited or suggestive evidence of no association would require new studies that correct for the
methodologic problems of previous studies and that have samples large enough
to limit the possible study results attributable to chance.
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The committee reviewed all the relevant experimental studies of 2,4dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T),
4-amino-3,5,6-trichloropicolinic acid (picloram), dimethylarsinic acid (DMA,
also called cacodylic acid), and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
that have been published since Update 2014 (NASEM, 2016a). The findings
have been incorporated into this chapter when it is appropriate and into the
biologic-plausibility sections of Chapters 6–11 when they are of consequence for
particular health outcomes. For each substance, this chapter includes a review of
its toxicokinetic properties, a brief summary of the toxic outcomes investigated
in animal experiments, and a discussion of underlying mechanisms of action as
illuminated by in vitro studies. The final section of this chapter discusses factors
that complicate the extrapolation of findings from laboratory experimentation
to humans. Additionally, information about three emerging subjects in molecular and biologic science—epigenetics, developmental immunotoxicology, and
oxidative stress—are discussed because they provide insights into the potential
mechanisms that could explain biologic responses associated with exposure to
the herbicides sprayed in Vietnam.
The establishment of biologic plausibility through laboratory studies
strengthens the case for a cause–effect relationship between herbicide exposure
and health effects that has been reported in epidemiologic studies. Such information supports the existence of the less stringent relationship of association, which
is the target of this committee’s work. Experimental studies of laboratory animals
or cultured cells make it possible to observe the effects of herbicide exposure
under controlled conditions, which is difficult or impossible to do in epidemiologic studies. The conditions that can be controlled in a laboratory animal study
69
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include genetic differences, the frequency and magnitude of exposure, exposure
to other chemicals, dietary intake, preexisting and confounding health conditions, stressors, and the tissues or cells under examination. The limitations of
extrapolating results of laboratory studies to human responses is discussed later
in this chapter.
Once a chemical contacts the body, it becomes subject to the processes of
absorption, distribution, metabolism, and excretion. The combination of those
four biologic processes determines the concentration of the chemical in the various tissues and organs in the body and how long each organ or tissue is exposed
to the chemical and thus influences its pharmacologic and possibly toxic activity
(Lehman-McKeeman, 2013).
The absorption of a substance in an organism can occur through different
routes. If ingested, it normally is taken up into the bloodstream from mucous surfaces, such as the intestinal walls of the digestive tract. If inhaled, the substance
enters the bloodstream through the alveoli in the lungs. Some compounds can
also be absorbed across the skin (dermal adsorption). Animal studies may involve
additional routes of exposure that are not ordinarily encountered by humans,
such as intravenous or intraperitoneal injection, when a chemical is injected into,
respectively, the bloodstream or the abdominal cavity. The route of exposure and
other factors influence how much of a chemical dose is absorbed by the organism.
For example, the hydrophobicity of a chemical and its solubility in fat influence
how much of that chemical is absorbed. Thus, absorption is a critical determinant
of a chemical’s bioavailability—that is, the fraction of the chemical that reaches
systemic circulation.
Once a chemical is absorbed, it is affected by distribution. This refers to the
movement of a substance from the site of entry to the different tissues and organs
in the organism. Distribution takes place most commonly via the bloodstream.
As the chemical is moved through the body, it may enter a target tissue where
it may have its ultimate toxic effect, or it may enter into tissues that sequester
it. As a chemical is distributed in the organism, it will also begin to undergo
metabolism.
Biotransformation or metabolism is the process by which a foreign substance
is chemically modified when it enters an organism. For many environmental
toxicants, this process takes place largely in the liver via the action of enzymes,
including cytochromes P450, which catalyze the oxidative metabolism of many
chemicals. As metabolism occurs, the parent chemical is converted into new
chemicals called metabolites, which are often more water-soluble (polar) and
thus more readily excreted. When the resulting metabolites are pharmacologically or toxicologically inert, metabolism has deactivated the administered dose
of the parent chemical and thus reduced its effects on the body. Metabolism may,
however, generate a chemical that is more potent or more toxic than the parent
compound. This process is often referred to as bioactivation. A chemical’s structure influences the organism’s ability to metabolize (structurally transform) the
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chemical, and this ability ultimately determines whether it persists in the body
or is excreted.
Excretion is the removal of substances or their metabolites from the body,
most commonly in urine or feces. This is different from elimination, which refers
to the disappearance of the parent molecule from the bloodstream. The rate of
excretion of a chemical from the body is often limited by the rate of metabolism
of the parent chemical into more water-soluble, readily excreted metabolites.
Excretion is often incomplete, especially in the case of chemicals that resist
biotransformation. Incomplete excretion results in the accumulation of foreign
substances that can adversely affect biologic functions.
Elimination is referred to as “first-order” when its rate is directly proportional to the amount of chemical in the body, in which case the chemical’s
half-life is independent of dose. A half-life is defined as the time required for
the plasma concentration or the amount of a chemical in the body to be reduced
by half. The half-life of TCDD in humans is estimated to vary from 0.4 to more
than 10 years, based on measurements of TCDD in serum samples; the half-life
depends on a number of factors, including a person’s body mass index (BMI),
age, sex, and exposure (Aylward et al., 2005a; Emond et al., 2005; Flesch-Janys
et al., 1996; Geusau et al., 2002; Kumagai and Koda, 2005; Leung et al., 2006;
Michalek et al., 2002; Milbrath et al., 2009; Needham et al., 1994; Pirkle et al.,
1989; Sorg et al., 2009). Shorter half-lives were observed in humans during the
first months after exposure or in severely contaminated persons, which is consistent with the nonlinear elimination predicted by physiologically based pharmaco
kinetic models. Several studies of the half-life of TCDD have been conducted in
monkeys, mice, and rats, but the estimates are generally shorter than those found
in humans, ranging from 8 to 74 days, and are generally proportional to body
weight (DeVito and Birnbaum, 1995; Emond et al., 2006; Gasiewicz et al., 1983;
Hurst et al., 1998; Koshakji et al., 1984; Minero et al., 2001; Neubert et al., 1990;
Viluksela et al., 1996).
Collectively, the routes and rates of absorption, distribution, biotransformation or metabolism, and excretion of a toxic substance make up the toxicokinetics
(or the pharmacokinetics for chemicals used as pharmaceutical agents) of the
substance. Those processes determine the amount of a particular substance or
metabolite that will reach specific organs or cells and the amount of a particular
substance that persists in the body. Understanding the toxicokinetics of a chemical is useful for assembling a valid reconstruction of a human exposure. It is also
important in assessing the concentration of the active chemical in target tissues,
which influences the risk of disease. The basic principles involved in toxicokinetics are similar from chemical to chemical, but the precise way in which
principles are applied will depend on the structure and other inherent properties
of the particular chemical under consideration. For example, the lipophilicity or
hydrophobicity of a chemical influences how long that chemical will persist in the
body because those factors influence how much of the chemical is absorbed into
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fat cells, metabolized, and excreted. The degree to which different toxicokinetic
processes influence the toxic potential of a chemical depends on the metabolic
pathways, which often differ among species. Animal and cell culture studies are
often conducted at higher exposures and for shorter durations than are typical
in human exposures, which can influence biotransformation. For that reason, attempts to extrapolate from experimental animal studies to human exposures must
be done extremely carefully.
Many chemicals were used by the U.S. armed forces in Vietnam. The nature
of the substances themselves was discussed in detail in Chapter 4 of the original
Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam (VAO)
report (IOM, 1994). Four herbicides documented in military records were of particular concern in that report and are examined here: 2,4-D; 2,4,5-T; picloram;
and cacodylic acid. This chapter also examines TCDD, the most toxic congener
of the tetrachlorodibenzo-p-dioxins, also commonly referred to as dioxin, which
is a contaminant of 2,4,5-T. Considerably more information is available on
TCDD than on the herbicides themselves. Other contaminants present in 2,4-D
and 2,4,5-T are of less concern. Except as noted, the laboratory studies of the
chemicals of concern used pure compounds or formulations; the epidemiologic
studies discussed in later chapters often tracked exposures to mixtures.
PICLORAM
Chemistry
Picloram (Chemical Abstracts Service Number [CAS No.] 1918-02-1; see
chemical structure in Figure 4-1) was used with 2,4-D in the herbicide formulation Agent White, which was sprayed in Vietnam. It is also used commonly in
Australia in a formulation that has the trade name Tordon 75D®. Tordon 75D
contains several chemicals, including 2,4-D; picloram; a surfactant, diethylene
glycolmonoethyl ether; and a silicone defoamer. A number of studies of picloram
used such mixtures as Tordon formulations or other mixtures of 2,4-D and picloram that are similar to Agent White.
CI

NH2

HO
CI
O

N
CI

4-amino-3,5,6-trichloropicolinic acid

FIGURE 4-1 Chemical structure of picloram.
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Toxicokinetics
The original VAO committee reviewed studies of the toxicokinetics of picloram
(IOM, 1994). Studies of animals showed a rapid absorption through the gastro
intestinal tract and a rapid elimination of picloram in unaltered form in urine. In
humans, Nolan et al. (1984) examined the toxicokinetics of picloram in six healthy
male volunteers who were given a single oral dose of either 0.5 or 5.0 mg/kg or
a dermal dose of 2.0 mg/kg. In the oral study picloram was rapidly absorbed and
rapidly excreted unchanged in urine. More than 75% of the dose was excreted
within 6 hours, and the remainder with an average half-life of 27 hours. On the
basis of the quantity of picloram excreted in urine in the dermal study, the authors
concluded that only 0.2% of the picloram applied to the skin was absorbed. Because
of its rapid excretion, picloram has low potential to accumulate in humans.
In general, the literature on picloram toxicity continues to be sparse. Studies
of humans and animals indicate that picloram is rapidly eliminated as the parent
chemical. Studies of animals indicate that picloram has low toxicity even at high
doses (IARC, 1991).
Toxicity Profile
The original VAO committee reviewed studies of the carcinogenicity, genotoxicity, acute toxicity, chronic systemic toxicity, reproductive and developmental
toxicity, and immunotoxicity of picloram (IOM, 1994). In general, there is some
evidence of benign liver carcinogenicity in female Osborne-Mendel rats but
picloram was not found to be carcinogenic for either male or female OsborneMendel rats or B6C3F1 mice (NCI, 1978). Because of some concern that contaminants in picloram (in particular, hexachlorobenzene) might be responsible
for the carcinogenicity, picloram itself has not been established as a chemical
carcinogen. Furthermore, studies conducted by the Environmental Protection
Agency (EPA, 1988) yielded no evidence that picloram is a genotoxic agent.
Acute Toxicity
Picloram is considered a mild irritant. At high doses, it has produced erythema in rabbits. Some neurologic effects—including hyperactivity, ataxia, and
tremors—were reported in pregnant rats exposed to picloram at 750 or 1,000
mg/kg (Thompson et al., 1972). However, the available information on the acute
toxicity of picloram is very limited.
Chronic Systemic Toxicity
There is some evidence from chronic experimental animal studies that ingesting high doses of picloram affects the liver. Several studies have reported various
effects of technical-grade picloram on the livers of rats. In the carcinogenicity

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

74

VETERANS AND AGENT ORANGE: UPDATE 11

bioassay conducted by Stott et al. (1990), treatment-related hepatomegaly, hepatocellular swelling, and altered tinctorial properties were noted in the central
regions of the liver lobules in groups of rats exposed at 60 and 200 mg/kg per
day. Gorzinski et al. (1987) reported a dose-related increase in hepatocellular
hypertrophy and changes in centrilobular tinctorial properties in male and female
F344 rats exposed for 13 weeks to picloram at 150 mg/kg per day and higher
in the diet. In a 90-day study, cloudy swelling in the liver cells and bile duct
epithelium occurred in male and female F344 rats given 0.3% or 1.0% technical
picloram in the diet (EPA, 1988). No other toxic effects of chronic exposure to
picloram have been reported.
Reproductive and Developmental Toxicity
The reproductive toxicity of picloram was evaluated in a two-generation study.
No toxicity was detected at the highest dose tested, which was 150 mg/kg per day;
however, only a few animals were evaluated (EPA, 1988). Some developmental
toxicity was produced in the offspring of pregnant rabbits exposed to picloram
by gavage at 400 mg/kg per day on gestation days 6–18. Fetal abnormalities were
forelimb flexure, fused ribs, hypoplastic tail, and o mphalocele, each occurring in
a single litter (John-Greene et al., 1985). Some maternal toxicity was observed at
that dose, however, and EPA concluded on the basis of the sporadic nature of the
findings that the malformations were not treatment related (EPA, 1988). No terato
genic effects were produced in the offspring of rats given picloram by gavage at
up to 1,000 mg/kg per day on gestation days 6–15, but the occurrence of bilateral
accessory ribs was significantly increased (Thompson et al., 1972).
Immunotoxicity
Studies of the potential immunotoxicity of picloram have included dermal
sensitization in humans and rodent immunoassays. In one study, 53 volunteers
received nine 24-hour applications of 0.5 mL of a 2% potassium picloram solution on the skin of both upper arms. Each volunteer received challenge doses
17–24 days later. The particular formulation of picloram (its potassium salt) was
not a skin sensitizer or an irritant (EPA, 1988). In a similar study, a 5% solution
of picloram (M-2439, Tordon 101 formulation) produced a slight dermal irritation and a sensitization response in 6 of the 69 volunteers exposed. When the
individual components of M-2439—picloram, triisopropanolamine (TIPA) salt,
and 2,4-D TIPA salt—were tested separately, no sensitization reaction occurred
(EPA, 1988). Tordon K+, but not technical-grade picloram, was also found to be
a skin sensitizer in guinea pigs (EPA, 1988). CD1 mice exposed to Tordon 202C
(94% 2,4-D and 6% picloram) had no consistent adverse effects on antibody responses (Blakley, 1997), but the lack of a consistent response may be due to the
fact that CD1 mice are outbred.
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Mechanisms
No well-characterized mechanisms of toxicity for picloram are known.
CACODYLIC ACID
Chemistry
Arsenic (As) is a naturally occurring element. It exists in inorganic forms
that can be trivalent (As+3 or AsIII) or pentavalent (As+5 or AsV). It can also exist
in organic forms that are often methylated. See Figure 4-2 for the chemical structures of selected arsenic-containing compounds. Sodium arsenite, which contains
AsIII, is generally considered to be the most toxic of these arsenic compounds.
Inorganic arsenic is commonly present in drinking-water sources that are associated with volcanic soils and can reach high concentrations (more than 50 parts
per billion). Numerous human health effects have been attributed to drinking
water contaminated with inorganic arsenic, particularly bladder, skin, kidney,
and lung cancers; developmental effects on learning and memory; reproductive
endpoints; skin lesions; and diabetes and vascular diseases (NRC, 2001; WHO,
2018). Inorganic arsenic is readily metabolized in humans and other species into
organic forms of arsenic. Although organic forms of arsenic can be converted into
inorganic forms by microorganisms in the soil, there is no evidence that this can
occur in humans or other vertebrate species (Cohen et al., 2006).
The arsenic in cacodylic acid (CAS No. 75-60-5) is an organic form of arsenic and has a valence of +5. Cacodylic acid (also known by its more standard
chemical name, dimethylarsinic acid [DMAV]) was the form of arsenic used in
Agent Blue, one of the mixtures used for defoliation in Vietnam. DMAV made
up about 30% of Agent Blue. Agent Blue was chemically and toxicologically
unrelated to Agent Orange, which consisted of phenoxy herbicides contaminated with dioxin-like compounds. Potential cacodylic acid exposure of Vietnam
veterans would have involved direct exposure to exogenous DMAV, rather than
exposure to inorganic arsenic, which would have led to the endogenous formation of MMAV and MMAIII and then DMAV. The old hypothesis that methylation
of inorganic arsenic was a detoxifying mechanism has been dispelled by newer
studies. The direct treatment of laboratory animals with these metabolic products
has demonstrated the products to be linked to an increased incidence of cancers
and non-cancer health outcomes. However, it is still the trivalent species (AsIII
and MMAIII) that appear to be the most toxic. No studies of health effects in
humans following direct exposure to DMA have been identified by the VAO
committees. If there were, such studies could provide epidemiologic evidence
of an association between DMA and health effects. However, most studies have
focused on exposure to inorganic arsenic, which human metabolism turns into
DMA. Consequently, VAO committees have excluded studies where the source
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Inorganic Arsenic
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FIGURE 4-2 Chemical structures of selected arsenic-containing compounds.
NOTES: Inorganic arsenic (AsV and AsIII) is commonly found in the environment and is
metabolized by humans to form methylated organic arsenic species (MMA and DMA).
The methylation process is incomplete in humans, and both inorganic and organic arsenic
species are excreted in urine when approximately 10% is in inorganic forms (AsV and
AsIII), 10–20% is MMA, and 70–80% is DMA. Cacodylic acid, which is the type of arsenic found in Agent Blue, is the same as DMAV and is excreted in urine as DMA.

of exposure was inorganic arsenic and have only considered and reviewed toxicologic studies in which the animals were directly exposed to DMA. Information about effects of inorganic arsenic exposure may be found in reviews by the
International Agency for Research on Cancer (IARC, 2012a) and the National
Research Council (NRC, 2013).
Toxicokinetics
In humans, metabolism studies have generally found DMAV to be rapidly excreted and mostly unchanged in the urine after an exposure has occurred (Cohen
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et al., 2006; S. Suzuki et al., 2010). However, rats differ from most other mammals (including humans) in that a larger percentage of DMAV binds to hemoglobin in their red blood cells, which leads to a considerably longer half-life in blood
(Cui et al., 2004; K. T. Suzuki et al., 2004). The binding of DMAV to hemoglobin
is 10 times higher in rats than in humans (M. Lu et al., 2004). Chronic exposure
of normal rat hepatocytes to DMAV results in decreased uptake and increased
excretion, so that over time the rats developed resistance to the cytotoxic effects
of DMAV (Kojima et al., 2006). This tolerance is mediated by the induction of
glutathioneS-transferase activity and of multiple-drug-resistant protein expression.
Recent work by Banerjee et al. (2014, 2016) found that multiple-drug-resistant
protein 4 on renal proximal tubules transports DMAV, which facilitates urinary
excretion, and that polymorphic variants of this protein can alter the transport
activity and change local cellular responses. Rats also appear to biotransform
DMAV to DMAIII. Adair et al. (2007) examined the tissue distribution of DMA
in F344 rats after they were exposed to DMA for 14 days through drinking water.
They found that DMAV was extensively metabolized to trimethylated forms that
may play a role in toxicity. In a study of DMA treatment of Wistar rats for 10
weeks, the metabolism to trimethylated forms was far less apparent, and the tissue distribution of DMAV and trimethylated metabolites was strikingly different
(S. Liu et al., 2015). Thus, DMA distribution and metabolism may differ according to exposure duration or the strain of rat, or both.
A physiologically based pharmacokinetic model of intravenous and ingested
DMAV has been developed on the basis of mouse data (Evans et al., 2008). Similar models have been developed for humans on the basis of exposure to inorganic
arsenic (El-Masri and Kenyon, 2008), but these models have limited relevance
for assessing potential harm to Vietnam veterans, who are presumed to have been
directly exposed to DMAV.
Although epidemiologic studies of direct exposure to DMAV are not available, investigations into the relationship between health outcomes and the metabolic profiles of humans exposed to inorganic arsenic provide some insight
into the roles of the individual metabolites in producing adverse outcomes. An
increased incidence of urothelial cancer (cancer of the bladder, kidney, renal
pelvis, ureter, and urethra) among people exposed to high levels of inorganic
arsenic in drinking water was found in those who generate more MMA and less
DMA endogenously (S. K. Huang et al., 2008). Also, a lower risk of arsenical
skin lesions was associated with evidence of higher arsenic methylation capacity
in people in areas of high arsenic exposure via the drinking water (Q. Zhang et
al., 2014a,b) as well as in smelter workers (Wen et al., 2012). These results could
suggest that elevated cumulative levels of urinary MMA may be causally associated with an increased risk of inorganic arsenic-induced adverse health outcomes,
but they could also imply that complete methylation of inorganic arsenic to DMA
and resulting enhanced excretion are relatively protective.
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Toxicity Profile
This section discusses the toxicity associated with organic forms of arsenic,
most notably DMAV because it is the active ingredient in Agent Blue. The toxicity
of inorganic arsenic is not considered to be relevant to veteran exposures to
Agent Blue.
Neurotoxicity
Kruger et al. (2006) found that both DMAIII and DMAV significantly attenuated neuronal ion currents through N-methyl-D–aspartate receptor ion channels,
whereas only DMAV inhibited ion currents through α-amino-3-hydroxy-5methylisoxazole-4-propionic acid receptors. The data suggest that DMA may
have neurotoxic potential.
Immunotoxicity
Previous studies have shown that a low concentration of DMAV (10–7 M)
could increase the proliferation of human peripheral blood monocytes after
their stimulation with phytohemagglutinin, whereas it took a high concentration
(10–4 M) to inhibit the release of interferon-γ. This suggested that different
concentrations of DMAV may produce various immunomodulatory effects (Di
Giampaolo et al., 2004).
Skin Toxicity
In an evaluation of the effects of topical exposure of pregnant mice to DMA
(valence not stated) on the skin of the dams and offspring (E. Kim et al., 2012), no
effects were observed in offspring, but the exposure did increase skin thickness
in the area of application and alter the expression of multiple apoptosis-related
genes (Bcl-2, Bad, Casp-12). The results suggested that transient DMA exposure
can be a skin irritant and produce dermatitis.
Genotoxicity and Carcinogenicity
DMAIII and DMAV are genotoxic and increase oxidative stress and cause
DNA damage, particularly aneuploidy, but they are poor mutagens (Rossman
and Klein, 2011). Gómez et al. (2005) demonstrated that DMAIII induces a doserelated increase in DNA damage and oxidative stress in Jurkat cells. DMAIII
was considerably more potent than DMAV in inducing DNA damage in Chinese
hamster ovary cells (Dopp et al., 2004), which was associated with a greater
uptake of DMAIII into the cells. Similarly, an analysis of arsenical dimethylated
metabolites in human bladder cancer cells found dimethylmonothioarsinic acid
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(DMMTAV) and DMAIII to be more toxic and DMAV to be less toxic in terms of
DNA damage (Naranmandura et al., 2011). DNA damage from DMMTAV was
shown to be related to the accumulation of reactive oxygen species and to the
down-regulation of p53 and p21 (DNA repair proteins); these processes were
mediated in part through the intracellular conversion of DMMTAV to DMAV
and DMAIII (Naranmandura et al., 2011). Thus, although extracellular DMAV
has little toxic effect in cells because of its low uptake, intracellular DMAV can
be highly toxic. Gene-expression profiling of bladder urothelium after chronic
exposure to DMAV in drinking water showed significant increases in genes that
regulate oxidative stress (Sen et al., 2005). Additionally, hepatic gene-expression
profiling showed that DMAV exposure induced changes consistent with oxidative
stress (Xie et al., 2004). In vivo, DMAV-induced proliferation of the urinary bladder epithelium could be attenuated with the antioxidant N-acetylcysteine (M. Wei
et al., 2005). Arsenicals, including DMA, also interfere with certain DNA repair
mechanisms (both base- and nucleotide-excision repair) and may thereby act as
co-carcinogens enhancing the effect of other genotoxic carcinogens (Rossman
and Klein, 2011). In fact, MMAIII is a stronger inhibitor of nucleotide-excision
repair than inorganic arsenic (Shen et al., 2008).
Toxicological data suggest DMAIII and DMAV are carcinogenic. Cancers
have been induced in the urinary bladder, kidneys, liver, thyroid glands, and
lungs of laboratory animals exposed to high concentrations of DMA. In a 2-year
bioassay of F344/Crl rats fed a diet containing 40 or 100 parts per million (ppm)
DMAV, the females consuming the highest dose (100 ppm) developed urothelial
carcinomas and papillomas in the bladder, and males and females at both dose
levels (40 and 100 ppm) developed hyperplastic non-neoplastic changes in the
bladder (Arnold et al., 2006). M. Wei et al. (2002) exposed male F344/DuCrj
rats to DMA (valence not stated) via their drinking water and found statistically
significant incidences of bladder hyperplasia and transitional cell papillomas and
carcinomas at doses of 50 and 100 ppm. Similarly, A. Wang et al. (2009) found
that exposure of F344 rats to DMAV in drinking water at 1, 4, 40, or 100 ppm
resulted in a change in the urinary bladder epithelium, but there were no changes
in DNA repair capacity. In another study, Cohen et al. (2007b) exposed F344 rats
to DMAV in the diet for 2 years and found an increase in bladder tumors in those
receiving 100 ppm. As noted above, at least some strains of rats can reduce DMAV
to DMAIII, and thus these researchers proposed that that trimethylated forms of
arsenic (MMAIII and DMAIII) may be responsible for bladder cancer in rats.
Direct intravesical administration of 90 mg/kg DMAV to female adult rats resulted
in increased bromodeoxyuridine labeling in urothelial cells, indicating DNA damage; weak neutrophil infiltration; and the proliferation of urothelial epithelium
mediated through modest increases in oxidative-stress indexes (Takahashi et al.,
2011). Increased urothelial cell proliferation was also found following DMA
(valence not stated) exposure via the drinking water (M. Wei et al., 2002). It is
noteworthy that co-treatment with an antioxidant, N-acetylcysteine, worsened
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the DMAV-induced bladder injury rather than ameliorating it as expected. This
suggests that the carcinogenic mechanism of DMAV is more complicated than a
simple production of oxidative stress. In the mouse lung, DMAV acts as a tumor
initiator (Yamanaka et al., 2009) and as a tumor promoter (Mizoi et al., 2005).
DMAV can also act as a complete carcinogen, inducing lung tumors in susceptible
strains of mice, including those with deficient DNA-repair activity (Hayashi et
al., 1998; Kinoshita et al., 2007). In F344/DuCrj rats treated with a mixture of
carcinogens for 4 weeks, subsequent exposure to DMA (no indication of whether
this was DMAIII or DMAV) via their drinking water for 24 weeks caused tumor
promotion in the urinary bladder, kidney, liver, and thyroid gland but inhibited
the induction of tumors of the nasal passages (S. Yamamoto et al., 1995). In a
similarly designed experiment, DMA (valence not stated) was found to be a
bladder tumor promotor after treatment with the bladder carcinogen N′-butyl-N′(4-hydroxybutyl) nitrosamine (Wanibuchi et al., 1996). Yamanaka et al. (2009)
suggested that DMAIII can act as a tumor promoter through the formation of a
DMAIII radical after the reduction of DMAV. Studies have also found that an oral
exposure of adult mice to 200 ppm DMAV in addition to fetal inorganic arsenic
exposure can act as a promoter of renal and hepatocellular carcinoma, markedly
increasing tumor incidence beyond that produced by the fetal arsenic exposure
alone (Tokar et al., 2012). These findings emphasize how multiple life events can
contribute to an adverse health outcome in which adult DMAV exposure triggered
an otherwise dormant disease.
Mechanisms
It is believed that arsenic exerts its toxicity through several different mechanisms. Anwar-Mohamed et al. (2014) found that DMAV and other pentavalent
arsenic metabolites induce the carcinogen-activating enzyme CYP1A1. There
is also considerable evidence that arsenic induces oxidative stress, which can
induce cancers in animals. Ebert et al. (2016) found that thio-DMAV exposure
upregulated DNA repair and damage response proteins in human urothelial cells,
and studies have shown that mice that are deficient in enzymes associated with
the repair of oxidative DNA damage are highly susceptible to the induction of
tumors, particularly lung tumors, by DMAV (Kinoshita et al., 2007). Some studies
have also suggested that methylated arsenicals (MMAIII and DMAIII) can induce
aneuploidy in mammalian cells at concentrations below those required to produce
oxidative stress after in vitro exposure (Kligerman and Tennant, 2007; Rossman
and Klein, 2011). The chemical reaction of arsenicals with thiol groups in sensitive target tissues, such as red blood cells and kidneys, may also be a mechanism
by which organic arsenicals act (Naranmandura and Suzuki, 2008).
Cohen et al. (2007b) postulated that regenerative cell proliferation in response to cytotoxicity in the urothelium is a major factor in the carcinogenicity
of DMA to the rat bladder, and, indeed, urothelial cell proliferation has been
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shown to increase following DMA exposure (Takahashi et al., 2011; M. Wei et
al., 2002). There may also be epigenetic effects involved in DMA carcinogenicity,
as suggested by a study in humans in which there was a significant association
between global DNA methylation and urinary DMA levels (Tellez-Plaza et al.,
2014). Unterberg et al. (2014) observed DNA hypomethylation in urothelial cells
that had been incubated for 21-days with inorganic AsIII or thio-DMAV.
The variation in the susceptibility of various animal species to tumor formation caused by inorganic and organic arsenic is thought to arise in large part
from differences in metabolism and distribution. Thus, genetic differences may
play an important role. Numerous investigators have examined potential human
susceptibility factors and gene polymorphisms that may increase a person’s risk
of cancer and other diseases induced by arsenicals (Aposhian and Aposhian,
2006; Hernandez et al., 2008; S. K. Huang et al., 2008; Y. K. Huang et al., 2008;
McCarty et al., 2007; Meza et al., 2007; Steinmaus et al., 2007, 2010), but no
polymorphisms that may contribute to a person’s susceptibility to DMA-induced
cancers or tissue injury have yet been identified.
Summary
DMA is genotoxic and carcinogenic in certain animal models and in vitro
assays, including studies in human cells. It is believed to exert a direct toxic effect by generating oxidative stress, inducing epigenetic dysregulation, binding to
thiols, and interfering with DNA repair mechanisms. These mechanisms of action
may be involved in gene damage and carcinogenesis. However, it is not clear
whether these effects would also occur in humans directly exposed to DMAV.
PHENOXY HERBICIDES: 2,4-DICHLOROPHENOXY ACID AND
2,4,5,-TRICHLOROPHENOXYACETIC ACID
Chemistry
2,4-D (CAS No. 94-75-7) is an odorless crystalline powder that, when pure,
is white in color (see Figure 4-3); it may appear yellow when phenolic impurities
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FIGURE 4-3 Chemical structures of 2,4-D and 2,4,5-T.

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

82

VETERANS AND AGENT ORANGE: UPDATE 11

are present. The melting point of 2,4-D is 138° C, and the free acid is corrosive to
metals. It is soluble in water and in a variety of organic solvents (such as acetone,
alcohols, ketones, ether, and toluene). 2,4,5-T (CAS No. 93-76-5) is an odorless,
white to light-tan solid with a melting point of 158° C. 2,4,5-T is noncorrosive
and is soluble in alcohol and water. It reacts with organic and inorganic bases to
form salts and with alcohols to form esters.
Uses of 2,4-D and 2,4,5-T
2,4-D has been used commercially in the United States since World War II
to control the growth of broadleaf plants and weeds on range lands, lawns, golf
courses, forests, roadways, parks, and agricultural land; it remains a widely used
herbicide that is approved for use by both the European Union and EPA. Formulations include 2,4-D amine and alkali salts and esters, which are mobile in soil
and readily absorbed through the leaves and roots of many plants. Like 2,4-D,
2,4,5-T was developed and marketed as a herbicide during World War II. However, the registration for 2,4,5-T was canceled by EPA in 1978 when it became
clear that it was contaminated with TCDD during the manufacturing process. It
is recognized that the production of 2,4-D also involves the generation of some
contaminants with dioxin-like activity, but the fraction of TCDD represented in
the toxic equivalent (TEQ) is comparatively very small.
The herbicidal properties of 2,4-D and 2,4,5-T are related to the chemical’s
ability to mimic the plant growth hormone indole acetic acid. They are selective
herbicides in that they affect the growth of only broadleaf dicots (which include
most weeds) and do not affect monocots, such as wheat, corn, and rice.
Toxicokinetics
Several studies have examined the absorption, distribution, metabolism,
and excretion of 2,4-D and 2,4,5-T in animals and humans. Data on both compounds are consistent among species and support the conclusion that the absorption of oral or inhaled doses is rapid and complete. One study indicates that
2,4-D can bind to innate intestinal, intracellular lipid-binding proteins, which
may be how these compounds move through columnar absorptive epithelial
cells from the intestines to systemic distribution (Carbone and Velkov, 2013).
Absorption through the skin is much lower but may be increased with the use
of sunscreens or alcohol (Brand et al., 2002; Pont et al., 2004). After absorption, 2,4-D and 2,4,5-T are distributed widely in the body but are eliminated
quickly, predominantly in an unmetabolized form in urine (Sauerhoff et al.,
1977), but 2,4,5-trichlorophenol and 2,4-dichlorophenol have been identified
as trace metabolites in urine. The half-life of single doses of 2,4-D or 2,4,5-T
in humans has been estimated to be about 18–23 hours and is highly dependent
on urinary pH (Gehring et al., 1973; Kohli et al., 1974; Sauerhoff et al., 1977;
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WHO, 1984). Hines et al. (2003) found that concentrations of 2,4-D and its
metabolites in the urine of herbicide applicators—that is, those who apply the
herbicides—were consistent with 2,4-D urinary half-life estimates of 13–40 hours
in humans.
Toxicity Profile
The toxicity database on 2,4-D is extensive, whereas the available data on
the toxicity of purified 2,4,5-T, independent of its contamination by TCDD, are
sparse. TCDD is much more toxic than 2,4,5-T, and much of the toxicity that had
been attributed to 2,4,5-T in early studies was later shown to be caused by the
TCDD contaminant. The following summary therefore focuses on 2,4-D toxicity,
and information on pure 2,4,5-T is added when it is available.
A 2018 monograph from the IARC classified 2,4-D as possibly carcinogenic
to humans. This statement originated from limited evidence available on the
carcinogenic effects in animals and inadequate evidence in humans (IARC, 2018).
When reviewing animal literature, studies show that after a single oral dose, 2,4-D
is considered to produce moderate acute toxicity with a dose lethal to 50% of
exposed animals (LD50) of 375 mg/kg in rats, 370 mg/kg in mice, and from less
than 320 to 1,000 mg/kg in guinea pigs. Rats and rabbits have dermal LD50s of
1,500 mg/kg and 1,400 mg/kg, respectively. 2,4,5-T itself also produces moderate acute toxicity, with oral LD50s of 389 mg/kg in mice and 500 mg/kg in rats.
Death from acute poisoning with 2,4-D or 2,4,5-T has been attributed to the ability
of the chemicals to uncouple oxidative phosphorylation, a vital process used by
almost all cells in the body as the primary means of generating energy. After an
animal is exposed to a high dose, death due to multiple organ failure can occur
rapidly. Studies in rats, cats, and dogs indicate that the central nervous system is
the principal target organ for acute 2,4-D toxicity in mammals and suggest that the
primary site of action is the cerebral cortex or the reticular formation (Arnold et
al., 1991; Dési et al., 1962a,b). Based on case reports, in humans the predominant
effect of acute inhalation and oral exposure to 2,4-D is neurotoxicity; symptoms
include stiffness of the arms and legs, lack of coordination, lethargy, anorexia,
stupor, and coma. 2,4-D is also an irritant of the gastrointestinal tract that causes
nausea, vomiting, and diarrhea.
Chronic exposure to 2,4-D at relatively high concentrations has been shown to
produce a variety of toxic effects, including hepatic and renal toxicity, neurotoxicity,
and hematologic changes. A no-observed-effect level of 2,4-D of 1 mg/kg was identified for renal toxicity in rats (Hazleton Laboratories America, 1986). Exposure to
2,4-D was associated with reduced survival and decreased growth rates in offspring
of mothers fed high doses during pregnancy; these doses were also associated with
maternal toxicity (Munro et al., 1992). Charles et al. (2001) found that 2,4-D did
not affect fertility or produce teratogenic effects in the offspring of rats or rabbits
given doses lower than 90 mg/kg/day by gavage, which did, however, cause overt
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maternal toxicity. A one-generation study in which rats were fed diets containing
2,4-D (females: up to 40 mg/kg/day; males: up to 45 mg/kg/day) from 4 weeks before breeding through 3 weeks of lactation confirmed these results and furthermore
found that even at the highest exposure there is no evidence of interaction with the
androgen, estrogen, or steroidogenesis pathways in the pups (Marty et al., 2013).
Other studies, however, suggest that exposure to 2,4-D does have an impact on the
male reproductive system (Alves et al., 2013; Joshi et al., 2012). Alves et al. (2013)
found that the exposure of rat Serotoli cells in culture at 10 μM 2,4-D resulted in
alterations in cellular metabolism linked to effective spermatogenesis, which could
be a mechanism that would reduce sperm density. Mazhar et al. (2014) treated pregnant rats by gavage on gestation days 1–19 with 100 mg/kg/day of 2,4-D alone or
administered with 100 mg/kg/day of the antioxidant vitamin E. Morphological and
skeletal defects and low birth weight were observed in the fetuses of dams treated
with only 2,4-D, but not in those whose mothers were also treated with vitamin E,
thereby suggesting that 2,4-D exposure elicits fetotoxicity through inducing oxidative stress. In vitro exposure of human erythrocytes to 2,4-D caused changes
in antioxidant enzyme activity as well as increased protein carbonyls, indicating
induction of oxidative stress (Bukowska, 2003). Similar changes were observed in
the liver of exposed rats (Tayeb et al., 2010, 2013). The immunotoxicity of 2,4-D
has been reported in a small number of studies, including a few studies of 2,4-D
applicators showing both immunosuppression (Faustini et al., 1996) and immunostimulation (Figgs et al., 2000; Holland et al., 2002). At high doses that produced
clinical toxicity in experimental animals, a suppression of the antibody response
was observed, whereas other measures of immune function were normal. The immunotoxicity of 2,4,5-T has not been evaluated in laboratory animals.
The carcinogenicity of 2,4-D and 2,4,5-T has been studied in rats, mice, and
dogs after exposure in their food, direct placement in their stomachs, or exposure
on their skin. Early studies in mice (NTIS, 1968) and rats (W. H. Hansen et al.,
1971) found little to suggest tumor induction when animals were treated with
2,4-D by gavage or subcutaneously. Hazelton Laboratories of America (1986,
1987) conducted a series of studies in rats and mice, which all had negative
results except one that found an increased incidence of brain tumors in male
rats—but not female rats—that received the highest dose of 45 mg/kg/day 2,4-D
in their feed. The occurrence of malignant lymphomas in dogs kept as pets was
reported to be higher when owners reported that they used 2,4-D on their lawns
than when they did not (Hayes et al., 1991, 1995), but a detailed reanalysis did
not confirm this finding (Kaneene and Miller, 1999). A controlled study that used
dogs exposed to 2,4-D in the laboratory had negative results. Timchalk (2004)
suggested that dogs are not relevant for comparative evaluation of human health
risk attributable to 2,4-D exposure because they excrete 2,4-D less efficiently than
rats or humans. Given the degree of variability observed in humans (Hines et al.,
2003), however, the canine information might be applicable for some people.
2,4-D is not metabolized to reactive intermediates capable of interacting with
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DNA, and the evidence supports the conclusion that 2,4-D is not a genotoxic
carcinogen. However, Sandal and Yilmaz (2011) found that lymphocytes from
smokers show genotoxic damage after exposure to 2,4-D, whereas lymphocytes
from non-smokers do not. In the Agricultural Health Study (AHS), Andreotti et
al. (2015) found that a cumulative metric of 2,4-D exposure in pesticide applicators was associated with shorter relative telomere length in leukocytes. Although
2,4-D may not be a carcinogen, it may have some role influencing the activity of
known carcinogens or potentially carcinogenic changes within a cell.
Genetic Studies
In recent years, a number of investigators have used telomere length as a sensitive marker of exposure to a variety of chemical pollutants. Telomere length generally decreases with age and the assumption is that the activation of many different
biochemical pathways affects telomere maintenance and repair. The alterations in
these pathways can in turn either reduce or increase telomere length, depending on
which factors they affect. Since Update 2014, two large studies of telomere length
have examined the effects of exposure to the chemicals of interest (COIs).
Andreotti et al. (2015) studied 568 cancer-free male subjects from the AHS
who were between 31 and 94 years, taking blood samples from them between
2006 and 2008. Relative telomere length in DNA from blood was examined for
associations with self-reported cumulative pesticide use of 57 types, with exposure data collected at enrollment (1993–1997) and in two follow-up telephone
questionnaires (1998–2003, 2005–2008). The researchers used three metrics of
pesticide use (ever use, lifetime days, and intensity-weighted lifetime days),
divided into tertiles and applied multivariable linear regression analysis to examine associations, adjusting for age at blood-draw and the use of other pesticides. Further adjustments were made for potential confounding from the use of
other pesticides. The analysis showed an association between blood telomere
shortening, independent of age, and the cumulative use of 2,4-D in lifetime days
(p < 0.01) for ever versus never used, but is borderline significant when using
lifetime intensity-weighted days (p < 0.05). Similar effects had previously been
observed for buccal relative telomere length in a subset of 40 AHS subjects, but
their sample buccal and blood relative telomere length values were uncorrelated.
A significant trend (p < 0.001) was shown for categorical 2,4-D lifetime use (low,
medium, high) (Andreotti et al., 2015); however, the 2,4-D never used category
had substantially longer telomeres than any other group in the study and some
of the other chemicals were shown to lead to longer telomeres and this could
confound analysis. Thus, relative telomere length might show an effect with
cumulative 2,4-D exposure in blood leukocytes, but the mechanisms of action
and consequences for disease are unknown.
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2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN
Chemistry
TCDDs are polychlorinated dibenzo-p-dioxins that have a triple-ring structure consisting of two benzene rings connected by an oxygenated ring with four
attached chlorine atoms; in the case of the dioxin congener of greatest concern,
2,3,7,8-TCDD (commonly called simply TCDD), the chlorine atoms are attached
at the 2, 3, 7, and 8 positions of the benzene rings (see Figure 4-4). The chemical properties of TCDD include a molecular weight of 322, a melting point of
305–306°C, a boiling point of 445.5°C, and a log octanol–water partition coefficient of 6.8 (National Toxicology Program substance profile). It is very lipophilic,
or fat soluble; is virtually insoluble in water (19.3 ng/L); and is soluble in organic
solvents, such as benzene and acetone. It has been suggested that the volatilization of dioxin from water may be an important mechanism of transfer from the
aqueous to the atmospheric phase (EPA, 2004); however, because of its very low
water solubility, most TCDD is bound to sediments and particulate matter.
Toxicokinetics
The disposition of TCDD (which includes its absorption, distribution, biotransformation, and excretion) has been extensively studied in humans and a
number of other animal models over the past 30 years. Given the plethora of data,
this section highlights and summarizes only key findings. TCDD is absorbed into
the body rapidly but is eliminated slowly. Because it is very lipophilic, resistant
to biotransformation, and slowly eliminated, the concentration of TCDD in the
lipid fraction of blood serum is thought to be in dynamic equilibrium with that
in the lipid fraction in other tissue compartments. Thus, the lipid-adjusted blood
serum concentration of TCDD is used to estimate total body burdens; however,
at high TCDD concentrations, the liver sequesters some of the dioxin, so a lipid
adjustment that ignores the hepatic fraction would underestimate the total body
burden. The exposure of humans to TCDD is thought to occur primarily via the
mouth, skin, and lungs. In laboratory animals, oral administration of TCDD has
been shown to result in absorption of 50–93% of the administered dose (Nolan
et al., 1979; Rose et al., 1976). Similarly, a study performed in a 42-year-old
man found that 87% of the oral dose was absorbed (Poiger and Schlatter, 1986).
Dermal absorption appears to be dose-dependent: lower absorption occurs at
CI
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FIGURE 4-4 Chemical structure of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
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higher doses (Banks and Birnbaum, 1991). In vitro studies of tissues isolated
from humans indicate that intact human skin may not be readily penetrable
(Weber et al., 1991). The varied and complex environmental matrices make environmental exposures difficult to quantify. Animal studies have demonstrated that
the presence of soil or lipophilic agents dramatically reduces dermal absorption
of TCDD: application in an activated carbon–water paste essentially eliminates
absorption in contrast with the absorption of the pure compound dissolved in
solvents. The oral bioavailability of TCDD and related compounds also depends
on the matrix: contaminated breast milk and food products have much higher
bioavailability than soil-bound or sediment-bound TCDD, and activated carbon
essentially blocks oral bioavailability (Olson, 2012).
After ingestion and gastrointestinal absorption, TCDD associates primarily
with the lipoprotein fraction of the blood and later partitions into the cellular
membranes and tissues (Henderson and Patterson, 1988). TCDD is distributed to
all compartments of the body; the amounts differ from organ to organ, but most
studies indicate that the primary distribution of TCDD is in the liver and adipose
tissues. For example, in a human volunteer it was found that 135 days after ingestion, 90% of TCDD was in fat (Poiger and Schlatter, 1986), and TCDD persists in
adipose tissue in the rhesus monkey (Bowman et al., 1989). The specific details of
the distribution and elimination of TCDD depend on the tissue examined, the time
that has elapsed since exposure, total exposure, and other factors. For example,
the concentration of cytochrome P450 1A2 (CYP1A2) in the liver is increased by
TCDD (Poland et al., 1989). Direct binding of TCDD to CYP1A2 is thought to
result in the sequestration of TCDD in the liver and to inhibit its distribution to
other tissues. The importance of CYP1A2 concentrations for the toxic actions of
TCDD has also been demonstrated in several laboratory situations; for instance,
CYP1A2-knockout mice were more susceptible than wild-type mice to TCDD
immunotoxicity (Smialowicz et al., 2008), and maternal hepatic CYP1A2 was
found to sequester TCDD and protect mouse fetuses against TCDD-induced
teratogenesis (Dragin et al., 2006). In addition, the distribution of TCDD is age
dependent, as shown by studies in which young animals displayed the highest
concentration of TCDD in the liver and aged animals the highest concentrations
in kidneys, skin, and muscle (Pegram et al., 1995). Finally, the rate of elimination
of TCDD, particularly after low exposures, depends heavily on the amount of
adipose tissue mass (Aylward et al., 2005a; Emond et al., 2005, 2006).
In laboratory animals, TCDD is metabolized slowly. It is eliminated primarily in feces as both the parent chemical and its more polar metabolites. However,
elimination appears to be dose dependent; at low doses, about 35% of the administered dose of TCDD was detected in the feces, while at higher doses, about
46% was observed (Diliberto et al., 2001). The dose-dependent occurrence of
TCDD metabolites in the feces is thought to be due to the increased expression
of metabolizing enzymes at higher doses and to hepatic sequestration, which
makes dioxins more available for metabolism. Milbrath et al. (2009) conducted
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a comprehensive review of studies that reported the congener-specific elimination
rates of TCDD and related compounds and analyzed the relationships between
the apparent half-lives of the compounds as a function of age, body fat, smoking status, and breastfeeding. In infants (less than 2 years old), the compounds
have a reported half-life of 0.4 year (Leung et al., 2006), and in adults a half-life
of 7.2 years, based on the regression method used by Flesch-Janys et al. (1996)
(Milbrath et al., 2009). Aging results in an increase in and redistribution of body
fat and lipophilic chemicals that alters their rate of elimination (Van der Molen
et al., 1996). Human studies of the Ranch Hand cohort have consistently found a
similar relationship between an increasing half-life of TCDD and an increasing
BMI (Michalek and Tripathi, 1999; Michalek et al., 1992, 1996). Smoking and
breastfeeding are associated with promoting the elimination of TCDD and, in the
case of breastfeeding, exposing infants through breast milk. Polycyclic aromatic
hydrocarbons (PAHs) in cigarette smoke are capable of inducing CYP1A1, 1A2,
and 1B1, which in turn may increase the rate of metabolism and subsequent
elimination of TCDD. Smoking has been associated with a 30% decrease in
TCDD plasma half-life (Flesch-Janys et al., 1996). Update 2014 (NASEM,
2016a) includes a table (4-1; pp. 95–96) summarizing the results of studies of
TCDD half-life in humans and animals.
Special Case of the Poisoning of Victor Yushchenko
In 2004 Victor Yushchenko, a candidate for the presidency of the Ukraine,
was poisoned with TCDD. It led to severe chloracne and a blood serum TCDD
concentration of 108,000 ppt (pg/g lipid), which was about 50,000 times as great
as that in the general population. The incident provided an unfortunate opportunity to assess the toxicokinetics of TCDD after a single large exposure. Serum
and fat analysis of TCDD supports the first-order elimination half-life of 15.4
months in Yushchenko, and the similarity in the decay curves of serum lipids
and subcutaneous fat confirmed that TCDD was in equilibrium between the two
(Sorg et al., 2009). The elimination half-life of 15.4 months is much shorter than
the 7.2-year reference half-life reported by Milbrath et al. (2009) and supports a
dose-dependent elimination of TCDD, which is associated with the induction of
potential TCDD-metabolizing enzymes (CYP1A1, 1A2, and 1B1) in very high
TCDD exposures. Two metabolites of TCDD (2,3,7-trichloro-8-hydroxydibenzop-dioxin and 1,3,7,8-tetrachloro-2-hydroxydibenzo-p-dioxin) were detected in
Yushchenko’s feces, serum, and urine but not in his fat or skin. Over a 12-month
period, about 38% of the TCDD-derived material was eliminated as metabolites
(95% in feces, 5% in urine) and 62% as parent chemical. The metabolite-toTCDD ratio in the blood serum was about one-fiftieth of that in the feces; this
supports the conclusion that the metabolites were not originally ingested with
TCDD (Sorg et al., 2009). The very slow metabolism of TCDD has been previously reported in laboratory animal models (Gasiewicz et al., 1983; Olson, 1986;
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Olson et al., 1980; Poiger and Schlatter, 1979) and in humans (Wendling et al.,
1990). It is also noteworthy that the structures of the human metabolites are the
same as previously reported in the rat and dog (Poiger et al., 1982; Sawahata et
al., 1982). A continued analysis of Yushchenko’s condition has revealed putative
metabolomic and transcriptomic biomarkers that may prove useful for predicting
health effects in populations with significant TCDD exposures (Jeanneret et al.,
2014; Saurat et al., 2012).
In light of the variables discussed above and the effect of differences in
physiologic states and metabolic processes, which can affect the mobilization of
lipids and possibly of the compounds stored in them, complex physiologically
based pharmacokinetic models have been developed to integrate exposure dose
with organ mass, blood flow, metabolism, and lipid content in order to predict
the movement of toxicants into and out of each organ. A number of modeling
studies have been performed in an effort to understand the relevance of animal
experimental studies to the exposures that occur in human populations (Aylward
et al., 2005a,b; Beaudouin et al., 2010; Emond et al., 2005).
Toxicity Profile
Effects on Tissues and Organs of Laboratory Animals
The effects of TCDD in laboratory animals have been observed in several
species (rats, mice, guinea pigs, hamsters, monkeys, cows, and rabbits) after the
administration of a variety of doses and after periods that represent acute exposures (less than 24 hours), sub-chronic exposures (1 day–3 months), and chronic
exposure (more than 3 months). Some differences have been observed between
species, particularly with respect to the degree of sensitivity, but in general the
effects observed are qualitatively similar. Some differences in sensitivity have
been observed within rodent species, and has been found to be related to speciesspecific aryl hydrocarbon receptor (Ahr)1 AHR polymorphisms (Ema et al., 1994;
Pohjanvirta et al., 1998). Relatively high exposures of TCDD affect a variety of
organs and result in organ dysfunction and death. The lethal toxicity of TCDD
varies widely among animal species; the oral LD50 of the chemical varies from
1 μg/kg in guinea pigs to 5,000 μg/kg in hamsters. The developing fetus, however,
is especially vulnerable to TCDD exposure, and there is only about a 10-fold variability in fetal lethal potency among these species (Kransler et al., 2007; Peterson
et al., 1993; Poland and Knutson, 1982). One characteristic of TCDD exposure
is a wasting syndrome that includes the loss of adipose and muscle tissue and
severe weight loss, but the specific mechanisms of lethality remain unknown.
Hwang et al. (2016) suggested that mitochondrial dysfunction caused by Ahrmediated, TCDD-induced toxicity contributes to wasting syndrome and metabolic
1 The

aryl hydrocarbon receptor is denoted as AHR when in human cells and Ahr in rodent models.

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

90

VETERANS AND AGENT ORANGE: UPDATE 11

dysfunction. In most rodents, exposure to TCDD leads to hepatic enlargement,
the presence of hepatic lesions, and impaired hepatic function (Harrill et al.,
2016); work by X. Cheng et al. (2014) suggest a role for TCDD-AHR acting on
fibroblast growth factor 21 as a contributor to liver effects. The thymus is also
sensitive. Recent work by Diani-Moore et al. (2017) in a chick-embryo model
found poly(ADP-ribose) polymerase activation and resulting NAD+ loss offers a
possible unifying mechanism for the effects of TCDD exposure such as wasting,
hepatosteatosis, and thymus atrophy. Finally, in both humans and nonhuman primates, TCDD exposure results in chloracne and associated dermatologic changes.
As will be discussed in more detail in Chapters 6–11, studies performed in animal models have indicated that exposure to TCDD adversely affects the heart,
the skin, and the immune, endocrine, and reproductive systems and increases
the incidence of cancers of the liver, skin, thyroid, adrenal cortex, hard palate,
nasal turbinates, tongue, and respiratory and lymphatic systems (ATSDR, 1998;
Barouki et al., 2012; Birnbaum, 1994; Huff et al., 1994; Knerr and Schrenk, 2006;
Tian et al., 2015). When TCDD has been administered to pregnant animals, birth
defects—such as cleft palate, malformations of the reproductive organs of male
and female progeny, and abnormalities in the cardiovascular, pulmonary, endocrine, skeletal, and nervous systems—have been observed. Of course, effects arising from perinatal exposure are not in question for Vietnam veterans themselves,
but this activity is of concern with respect to their offspring. The developmental
origins of health and disease are discussed in more detail in Chapter 8.
Effects on Enzymes, Hormones, and Receptors in
Laboratory Animals and Cultured Cells
In addition to adversely affecting the ability of specific organs to fulfill
their normal physiologic roles, TCDD has been found to alter the function and
expression of essential proteins, particularly a number of enzymes. The enzymes
that are most affected by TCDD are ones that act on or metabolize xenobiotics
and hormones, often by changing the chemicals’ polarity (water solubility) and
thus promoting the elimination of the metabolites. Among the enzymes affected
by TCDD, the best studied is CYP1A1, which metabolizes some xenobiotics.
In laboratory animals, exposure to TCDD commonly results in an increase in
CYP1A1 in most tissues; CYP1A1 therefore is often used as a marker of TCDD
exposure. Related enzymes whose levels are also increased with TCDD exposure
include CYP1B1 and CYP1A2, which together with CYP1A1 are capable of
biotransforming some procarcinogens to potentially mutagenic and carcinogenic
metabolites.
In addition to CYP1A1 and CYP1A2, TCDD can affect other enzymes that
metabolize hormones, such as thyroid hormones, retinoic acid, testosterone,
estrogens, and adrenal steroids (reviewed in Kung et al., 2009, and Safe et al.,
2000). Those hormones transmit their signals by interacting with specific proteins

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

BIOLOGIC MECHANISMS

91

called receptors and in this manner initiate a chain of events in many tissues of the
body. For example, the binding of the primary female sex hormone, estrogen, to
the estrogen receptor promotes the formation of breasts and the thickening of the
endometrium, regulates the menstrual cycle, and influences brain development.
Exposure to TCDD can increase the metabolism of estrogen and thus lead to a
decrease in the amount of estrogen available for binding and activating the estrogen receptor. The ultimate effect of TCDD is an interference with all the bodily
functions that are regulated by estrogens. Similarly, the actions of TCDD on the
adrenal steroids can adversely affect their ability to regulate glucose tolerance,
insulin sensitivity, lipid metabolism, body weight, vascular function, and cardiac
remodeling. In addition to changing the amount of hormone present, TCDD has
been found to interfere with the ability of receptors to fulfill their role in transmitting hormone signals. Those actions of TCDD on enzymes and hormone receptors
are thought to underlie, in part, the observed developmental and reproductive
effects and cancers that are hormone responsive.
Effects on Paths of Cellular Differentiation
The broad spectrum of TCDD effects on hormone and growth factor systems, cytokines, and other signal-transducer pathways indicates that TCDD is an
extremely powerful growth dysregulator (Birnbaum, 1994). Research performed
primarily in cultured cells has shown that TCDD can affect the ability of cells to
undergo such processes as proliferation, differentiation, and apoptosis (Duan et
al., 2014; Marlowe and Puga, 2005). During the proliferation process, cells grow
and divide. When cells are differentiating, they are undergoing a change from less
specialized to more specialized. Cellular differentiation is essential for an organism to mature from a fetal to an adult state. In the adult, proper differentiation
is required for the normal functioning of the body—for example, in maintaining
a normally responsive immune system. The processes of controlled cell death,
such as apoptosis, are similarly important during the development of the fetus
and are necessary for normal physiologic functions in the adult. Apoptosis is a
way for the body to eliminate damaged or unnecessary cells. The ability of a cell
to undergo proliferation, differentiation, and apoptosis is tightly controlled by
an intricate network of signaling molecules that allows the body to maintain the
appropriate size and number of all the specialized cells that form the fabric of
complex tissues and organs. Any disruption of the network that alters the delicate
balance of cell fate can have severe consequences, including impairment of the
function of the organ because of the absence of specialized cells. Alternatively,
the presence of an excess of some kinds of cells can result in the formation and
development of tumors. Thus, the ability of TCDD to disrupt the normal course
of a specific cell to proliferate, differentiate, or undergo apoptosis is thought
to underlie (at least in part) its adverse effects on the immune system and the
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developing fetus and its ability to promote the formation of some cancers (Kolluri
et al., 2017).
Mechanisms
TCDD binds and activates AHR in the cells of virtually every tissue in the
body. The ability of TCDD to bind to AHR with high affinity is necessary—but
not sufficient—to produce most of the adverse effects associated with TCDD
exposure, including those from direct TCDD binding to and activation of the
AHR and later alterations in the expression of TCDD-regulated genes as well
as changes to those signaling pathways altered through interactions with the
canonical AHR pathway (Poland and Knutson, 1982; Safe, 1990; Schmidt and
Bradfield, 1996; Whitlock, 1990).
In the canonical pathway, AHR functions as a ligand-activated nuclear
transcription factor. Upon binding of agonists (ligands), such as TCDD, AHR
forms a heterodimer with a structurally related protein called AHR nuclear translocator (ARNT). The dimeric complex (structural model proposed by Corrada et
al., 2017) binds to core DNA sequences called xenobiotic-responsive elements or
dioxin-responsive elements in the promoter region of responsive genes and enhances the transcription of those genes. Many of the AHR-regulated genes encode
drug-metabolizing enzymes, such as CYP1A1, CYP1A2, CYP1B1, and a variety
of Phase II conjugating enzymes. Although the up-regulation of these enzymes is
a sensitive biomarker of exposure to TCDD and may contribute mechanistically
to some of the adverse effects of TCDD, the tissue-, species-, time-, and dosespecific modulation (increase or decrease) of many genes is thought to contribute to the wide array of toxic responses to TCDD exposure (Black et al., 2012;
Boverhof et al., 2006; Y. Chen et al., 2017; Ovando et al., 2006, 2010; Perdew,
2008; Puga et al., 2009; Schneider et al., 2014). Many of these effects may be
the result of activation of non-canonical cytoplasmic AHR pathways that lead to
SRC activation, calcium release, and binding to other transcription factors, and
their downstream effects as reviewed in Larigot et al. (2018).
AHR Signaling Pathways
The primary and most intensely studied pathway by which TCDD elicits
biologic responses is depicted in Figure 4-5. In the absence of a bound ligand,
the inactive AHR is retained in the cytoplasm of the cell in a complex consisting of two molecules of the heat-shock protein HSP90, one molecule of prosta
glandin E synthase 3 (p23) (Kazlauskas et al., 1999), and one molecule of
the immunophilin-like protein hepatitis B virus X-associated protein 2 (XAP2)
(Petrulis et al., 2003), previously identified as either AHR-interacting protein (Ma
and Whitlock, 1997) or AHR-associated protein 9 (Carver and Bradfield, 1997).
The HSP90 dimer–p23 complex plays multiple roles in the protection of the AHR
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FIGURE 4-5 Mechanisms of gene regulation by the AHR following activation by TCDD.
NOTES: In the canonical pathway, activation of the AHR though binding TCDD or other
ligands, the AHR undergoes conformational changes that result in the dissociation of the
AHR/HSP90 complex and its translocation to the nucleus. Once in the nucleus, the AHR
establishes protein–protein interactions with the AHR nuclear translocator (ARNT) and
additional coactivators and transcription factors. These complexes bind to AHRE (aryl
hydrocarbon response elements) to control the transcriptional activity of target genes (e.g.,
CYP1A1, AHR repressor [AHRR]). In the non-canonical pathway, activation of the AHR
through binding TCDD, or other ligands, results in cytoplasmic interactions leading to
rapid changes in intracellular calcium, activation of signaling pathways, and direct binding
to other transcription factors.

from proteolysis, maintaining it in a conformation that makes it accessible to
ligand binding at the same time that it prevents the premature binding of ARNT
(Carver et al., 1994; Pongratz et al., 1992; Whitelaw et al., 1993). XAP2 interacts
with the carboxyl terminus of HSP90 and with the AHR nuclear-localization
signal, a short amino acid domain that targets the receptor for interaction with
nuclear-transport proteins. The binding of XAP2 blocks such an interaction,
preventing the inappropriate trafficking of the receptor into the nucleus (Petrulis
et al., 2003).
The binding of ligands (such as TCDD) induces the release of XAP2 and the
exposure of the nuclear localization signal and leads to the binding of nuclearimport proteins and the translocation of the cytosolic complex into the nucleus
(Davarinos and Pollenz, 1999; Song and Pollenz, 2002). Once the cytosolic
complex is in the nucleus, HSP90, p23, and XAP2 dissociate from the AHR,
which allows the binding of ARNT (Hoffman et al., 1991; Probst et al., 1993).
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The activated AHR–ARNT heterodimeric complex is then capable of directly
or indirectly interacting with DNA by binding to recognition sequences in the
regulatory region of responsive genes (Dolwick et al., 1993; Probst et al., 1993).
DeGroot and Denison (2014) found that the nucleotide specificity of DNA binding by the activated AHR-ARNT is not affected by structurally different ligands.
The canonical DNA recognition motif of the AHR–ARNT complex is referred to as the AHR-responsive element (AHRE, also referred to as the d ioxin- or
xenobiotic-response element, respectively). This element is found in the promoter
region of AHR-responsive genes and contains the core sequence 5′-GCGTG-3′
(Shen and Whitlock, 1992), which is part of a more extensive consensus-binding
sequence, 5′-T/GNGCGTGA/CG/CA-3′ (Lusska et al., 1993; Yao and Denison,
1992). The AHR–ARNT complex binds to the AHRE core sequence in such a
manner that ARNT binds to 5′-GTG-3′ and AHR binds to 5′-TC/TGC-3′ (Bacsi
et al., 1995; Swanson et al., 1995). A second type of element, termed AHRE-II,
5′-CATG(N6)C[T/A]TG-3′, has been shown to be capable of acting indirectly with
the AHR–ARNT complex (Boutros et al., 2004; Sogawa et al., 2004). The end
result of the process is the recruitment of the transcriptional machinery associated
with RNA polymerase II and the initiation of differential changes in the expression of the genes bearing the AHR–ARNT recognition motif. Many of the genes
code for proteins responsible for detoxification reactions directed at the elimination of the ligand. Research suggests that posttranslational modifications in histone
proteins may modify the response (Hestermann and Brown, 2003; J. B. Kim et
al., 2017; Schnekenburger et al., 2007).
In the canonical pathway, the actions of TCDD are mediated by the binding
of the activated AHR–ARNT dimer to AHREs on DNA, which results in altered
gene expression (see Figure 4-5). More recently, studies suggest that a noncanonical pathway within the cytoplasm also contributes to the toxic effects of
TCDD, as first reviewed by Matsumura (2009). The TCDD-mediated activation
of AHR within the cytoplasm does not involve binding to ARNT or DNA and
appears to contribute to the rapid inflammatory responses associated with TCDD
(Sciullo et al., 2008). In several cell lines, the activation of protein kinase C and
the later activation of the serine phosphorylated form of cytosolic phospholipase A2 (cPLA2) takes place within 15 minutes of TCDD exposure (Dong and
Matsumura, 2008; S. Park et al., 2007). It is proposed that within the cytoplasm,
the TCDD-mediated activation of AHR leads to a rapid increase in intracellular
Ca2+, plus activation of cPLA2, protein kinases, and pro-inflammatory proteins,
such as cyclooxygenase (COX-2) (Matsumura, 2009). This pathway and other
alternative mechanisms of TCDD-mediated AHR activation have also been reviewed by Denison et al. (2011), Larigot et al. (2018), Perdew (2008), and Wright
et al. (2017).
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AHR Physiology
The vertebrate AHR is presumed to have evolved from its counterpart in
invertebrates, in which it serves a ligand-independent role in normal development processes. The ancestral function of the AHR appears to be the regulation
of specific aspects of embryonic development, it having acquired the ability to
bind xenobiotic compounds only during vertebrate evolution (Hahn, 2001; Hahn
et al., 2017). The invertebrate AHR also functions as a transcription factor and
binds to the same dimerization partner (ARNT) and DNA-response elements as
the vertebrate protein, but it does not respond to any of the environmental ligands
recognized by the vertebrate receptor. Instead, it regulates diverse developmental
processes that are independent of exogenous ligand exposure, such as neuronal
differentiation during worm development in Caenorhabditis elegans (X. Huang
et al., 2004; Qin and Powell-Coffman, 2004) or the normal morphogenesis of
legs, antennae, and bristles in Drosophila melanogaster (Adachi-Yamada et al.,
2005; Céspedes et al., 2010). In developing vertebrates, AHR seems to play a
role in cellular proliferation and differentiation and, in keeping with this role in
invertebrates, also has a developmental role in craniofacial, muscle, pulmonary,
renal, cardiovascular, and reproductive tract morphogenesis and blood cell differentiation (Birnbaum et al., 1989; C. Chiu et al., 2014; Fernandez-Salguero et
al., 1997; Lahvis et al., 2005). Other potential functional roles of AHR include
reproduction, innate immunity, tumor suppression, and blood-pressure regulation (Fujii-Kuriyama and Kawajiri, 2010). Dietrich (2016) reviewed antioxidant
functions of the AHR.
The clearest adaptive physiologic response to AHR activation is the induction of xenobiotic-metabolizing enzymes involved in the detoxification of
toxic ligands. Evidence of that response, which was described above, was first
observed in conjunction with the induction of CYP1A1, which resulted from
exposure to PAHs or TCDD and was directly related to the activation of the
AHR signaling pathway (Israel and Whitlock, 1983, 1984). Because of the presence of the AHRE motif in their gene promoters, other metabolizing genes were
tested and found to be induced by AHR ligands, which led to the identification
of a so-called AHR gene battery of phase I and phase II detoxification genes that
code for the drug-metabolizing enzymes CYP1A1, CYP1A2, CYP1B1, NQO1,
ALHD3A1, UGT1A2, and GSTA1 (Nebert et al., 2000). Presumably, vertebrates
have evolved those enzymes to detect a wide array of foreign, potentially toxic
chemicals, represented in the wide variety of substrates that the AHR is able to
bind to and whose biotransformation and elimination it is able to facilitate.
A potential complication of the adaptive responses elicited by AHR activation is the induction of a toxic response. Toxicity may result from the adaptive
response itself if the induction of metabolizing enzymes results in the production
of toxic metabolites. For example, the PAH benzo[a]pyrene, an AHR ligand,
induces its own metabolism and detoxification by the AHR-dependent signaling
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mechanism described earlier, but paradoxically it becomes bioactivated to a toxic
metabolite in several tissues by a metabolism that depends on CYP1A1 and
CYP1B1 activity (Harrigan et al., 2004). A second potential source of AHR-mediated toxicity may be aberrant changes in global gene expression beyond those
observed in the AHR gene battery. The global changes in gene expression may
lead to deleterious changes in cellular processes and physiology. Microarray and
other transcriptomic analyses have proved invaluable in understanding and characterizing that response (Boverhof et al., 2006; Martinez et al., 2002; Ovando et
al., 2006, 2010; Puga et al., 2000, 2004; Takeda et al., 2012; Vezina et al., 2004).
Endogenous AHR functions likely involve interaction with endogenous
ligands that activate specific physiological processes. Several chemicals and
chemical classes have been identified as putative endogenous ligands, including equilenin, indigoids, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic
acid methyl ester, leukotrienes, heme metabolites, arachidonic acid metabolites, tryptophan metabolites, and ultraviolet (UV) photoproducts of tryptophan
(Guyot et al., 2013; Nguyen and Bradfield, 2008). The tryptophan catabolite and
AHR ligand kynurenine has been identified as a tumor promoter that suppresses
anti-tumor immune responses and promotes tumor-cell survival and motility
(Opitz et al., 2011). The tryptophan UV photoproduct 6-formylindolo[3,2-b]
carbazole (FICZ) is a high-affinity AHR ligand, an inducer of CYP1A1 (Y.-D.
Wei et al., 1998), and a substrate for CYP1A1 (Wincent et al., 2012). This
autoregulatory loop maintains endogenous low levels of FICZ, which influence
circadian rhythms, responses to UV light, homeostasis associated with pro- and
anti-inflammatory processes, and genomic stability (Wincent et al., 2012). FICZ
has been shown to reduce the inflammatory response in skin inflammation models
(Di Meglio et al., 2014) and to enhance natural killer cell control of tumors (Shin
et al., 2013).
It is clear that AHR is an essential component of the toxicity of dioxin and
of dioxin-like chemicals. Studies of certain genetic polymorphisms in AHR in
human cells suggest an association with differential susceptibility to dioxins
(Kovalova et al., 2016; G. Liu et al., 2015), and experimental alteration of human
AHR can suppress ARNT function (J. H. Xie et al., 2014). The homozygous
deletion of Ahr in mice leads to a phenotype that is resistant to the toxic effects
of TCDD and to the carcinogenic effects of benzo[a]pyrene (Fernandez-Salguero
et al., 1996; Lahvis and Bradfield, 1998; Schmidt and Bradfield, 1996). The Ahr
knockout mice, however, have other phenotypic effects, including reduced liver
size, hepatic fibrosis, and cardiovascular abnormalities. Ahr knockout rats also
demonstrate resistance to the toxic effects of TCDD and, in contrast to mice,
display pathological alterations to the urinary tract in the absence of TCDD
(Harrill et al., 2013). Hence, it is likely that dioxin has effects that are due to the
disruption of endogenous AHR functions and that are unrelated to the intrinsic
toxicity of some of its ligands.
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Definition of Dioxin-Like Compounds, Toxic
Equivalence Factor, and Toxic Equivalents
TCDD has the highest affinity for the AHR, but many other chemicals
have dioxin-like properties: they have similar chemical structures, have similar
physiochemical properties, and cause a common battery of toxic responses because of their relatively high affinity for the AHR. Because of their hydrophobic
nature and resistance to metabolism, these chemicals persist and bioaccumulate
in the fatty tissues of animals and humans. Although there are several hundred
polychlorinated, polybrominated, and mixed polychlorinated–polybrominated
dibenzo-p-dioxins, dibenzofurans, and biphenyls, only a relatively small number of congeners of these chemical classes display dioxin-like activity. Only 17
polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans
(PCDFs) with chlorine at the 2, 3, 7, and 8 positions and a few of the coplanar
polychlorinated biphenyls (PCBs) that are often measured in environmental
samples are recognized as being dioxin-like chemicals.
In the context of risk assessment, these polychlorinated–polybrominated
dibenzo-p-dioxin, polychlorinated dibenzofuran, and biphenyl dioxin-like chemicals are commonly found as complex mixtures when detected in environmental media and biologic tissues or when measured as environmental releases from specific
sources. That complicates the human health risk assessment that may be associated
with exposures to varied mixtures of dioxin-like chemicals. To address the problem, the concept of toxic equivalence has been elaborated by the scientific community, and the toxic equivalence factor (TEF) has been developed and introduced
to facilitate the risk assessment of exposures to those chemical mixtures (reviewed
in Tavakoly Sany et al., 2015; van den Berg et al., 2006). On the most basic level,
TEFs compare the potential toxicity of each dioxin-like chemical found in a mixture with the toxicity of TCDD, the most toxic member of the group. The procedure
involves assigning individual TEFs to the dioxin-like chemicals on the basis of in
vivo and in vitro potency relative to TCDD, which is assigned a TEF of 1.0. The
dioxin-like chemicals have been assigned TEFs ranging from 0.00001 to 1.0 by
the World Health Organization (WHO) (van den Berg et al., 2006, as summarized
in Table 4-1). This approach has significant limitations due to the lack of in vivo
human data and the difficulty of extrapolating cell line and rodent data to humans.
Larsson et al. (2015) used 17 in vitro assays from multiple species and in
silico models to develop consensus toxicity factors that were then compared to
internationally recognized WHO TEF values. The vast majority of the consensus
toxicity factors for PCDDs and PCDFs were generally lower than the WHO TEFs
but within an order of magnitude. The greatest differences between the human
(but not rodent) consensus toxicity factor and TEQ values were in the effects of
PCBs, which were inactive in the human cell line assays. The computational tools
used by Larsson et al. (2015) could be quite useful in future discussion of TEF
values, however, in vivo data must have more weight.
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TABLE 4-1 World Health Organization Toxicity Equivalence Factors (TEFs)
for Dioxin-Like Chemicals (values revised in 2005)
Chemical
Chlorinated dibenzo-p-dioxins
2,3,7,8-TCDD
1,2,3,7,8-PeCDD
1,2,3,4,7,8-HxCDD
1,2,3,6,7,8-HxCDD
1,2,3,7,8,9-HxCDD
1,2,3,4,6,7,8-HpCDD
OctoCDD
Chlorinated dibenzofurans
2,3,7,8-TCDF
1,2,3,7,8-PeCDF
2,3,4,7,8-PeCDF
1,2,3,4,7,8-HxCDF
1,2,3,6,7,8-HxCDF
1,2,3,7,8,9-HxCDF
2,3,4,7,8,9-HxCDF
1,2,3,4,6,7,8-HpCDF
1,2,3,4,7,8,9-HpCDF
OctoCDF
Non-ortho-substituted PCBs
PCB 77—3,3′,4,4′-tetraCB
PCB 81—3,4,4′,5-tetraCB
PCB 126—3,3′,4,4′,5-pentaCB
PCB 169—3,3′,4,4′,5,5′-hexaCB
Mono-ortho-substituted PCBs
PCB 105—2,3,3′,4,4′-pentaCB
PCB 114—2,3,4,4′,5-pentaCB
PCB 118—2,3′,4,4′,5-pentaCB
PCB 123—2′,3,4,4′,5-pentaCB
PCB 156—2,3,3′,4,4′,5-hexaCB
PCB 157—2,3,3′,4,4′,5′-hexaCB
PCB 167—2,3′,4,4′,5,5′-hexaCB
PCB 189—2,3,3′,4,4′,5,5′-heptaCB

TEF
1.0
1.0
0.1
0.1
0.1
0.01
0.0003
0.1
0.03
0.3
0.1
0.1
0.1
0.1
0.01
0.01
0.0003
0.0001
0.0003
0.1
0.03
0.00003
0.00003
0.00003
0.00003
0.00003
0.00003
0.00003
0.00003

NOTE: CB, chlorinated biphenyl; CDD, chlorinated dibenzo-p-dioxin; CDF, chlorinated dibenzofuran; PCB, polychlorinated biphenyl; TEF, toxicity equivalence factor.
SOURCE: Adapted from van den Berg et al., 2006.

Interim TEF values have been established for brominated congeners by the
2011 joint WHO–UN Environment Programme meeting to evaluate the WHO
TEF scheme. The recommendation is to use the TEF of the corresponding chlorinated congener as an interim TEF value for brominated congeners for human
risk assessment (van den Berg et al., 2013).
When several chemicals are present in a mixture, the toxicity of the mixture
is estimated by multiplying the TEF of each dioxin-like chemical in the mixture
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by its mass concentration and summing the products to yield the TCDD TEQs
of the mixture. In that approach to assessing the dioxin-like activity of a complex real-world mixture of dioxin-like chemicals, an environmental or biologic
specimen with a 100-ppt (100-pg/g) TEQ is toxicologically equivalent to 100-ppt
TCDD. There are two accepted specialized methods for assessing the dioxin-like
chemicals in a complex biologic or environmental specimen: one involves analytic chemistry that quantifies specific dioxin-like chemicals (high-resolution gas
chromatography–mass spectroscopy), and the other is a reporter-gene biologic
screen that assesses dioxin-like activity due to binding to AHR in a transformed
cell line (CALUX, EPA method 4435). Epidemiologic studies discussed in this
and other updates assess exposure by reporting the specific concentration of
TCDD in a specimen or by expressing dioxin-like activity in a complex mixture
in units of TEQs.
Carcinogenic Classification
EPA and IARC have developed criteria to classify the potential carcinogenicity of chemicals on the basis of the weight of scientific evidence from animal,
human, epidemiologic, mechanistic, and mode-of-action studies. EPA classified TCDD as a “probable human carcinogen” in 1985 and as “carcinogenic to
humans” in a 2003 reassessment. In 1998 an IARC panel of experts concluded
that the weight of scientific evidence supported the classification of dioxin as a
class I carcinogen, that is, as “carcinogenic to humans.” Four years later the U.S.
National Toxicology Program upgraded its classification to “known to be a human carcinogen.” In 2006 a panel of experts convened by the National Research
Council to evaluate the EPA reassessment concluded that TCDD was “likely to
be carcinogenic to humans”; this designation reflected the revised EPA Guidelines
for Carcinogen Risk Assessment made public in 2005.
Genotoxicity
Genotoxicity refers to a deleterious action that affects the integrity of a cell’s
DNA. Genotoxic substances are known to be potentially mutagenic or carcinogenic. Although TCDD is carcinogenic in humans and laboratory animals, it is
generally classified as nongenotoxic and nonmutagenic (Wassom et al., 1977).
There is no evidence of covalent binding of TCDD or its m
 etabolites to DNA
(Poland and Glover, 1979). TCDD does interact with DNA through a receptormediated pathway that involves the initial binding of TCDD to AHR, binding of
the activated receptor complex to dioxin responsive elements on DNA and later
alterations in the expression of TCDD-regulated genes, and altered signaling of
the biologic pathways that interact with the AHR signal-transduction mechanism
(Poland and Knutson, 1982; Safe, 1990; Schmidt and Bradfield, 1996; Whitlock,
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1990). TCDD, 2,4,5-T, and 2,4-D were not mutagenic in Salmonella typhimurium
with or without the addition of liver metabolic-activation enzymes (Blevins,
1991; Mortelmans et al., 1984). TCDD-induced cytogenetic damage in laboratory
mice showed no increase in the frequencies of sister-chromatid exchanges, chromosomal aberrations, or micronuclei in the bone marrow cells of either C57Bl/6J
or DBA/2J mice after the administration of a single high dose of TCDD—up to
150 μg/kg (Meyne et al., 1985). TCDD did not alter the frequency or the spectrum
of mutations in male and female Big Blue transgenic rats (Thornton et al., 2001).
There is one report of a positive result with TCDD in a test that measured the
induction of chromosomal deletions resulting from intrachromosomal recombination in mouse embryos in vivo (Schiestl et al., 1997). More recently, Scinicariello
and Buser (2015) found associations of dioxin-like PCBs and dioxins (other than
TCDD) with longer leukocyte telomere length. In that study, leukocyte telomere
length asays were used to assess the effects of exposure to dioxin-like PCBs (126,
169), PCDDs, and 1,2,3,4,6,7,8-heptachlorodibenzofuran. The study sample consisted of 2,413 adults from the 1999–2002 cycle of National Health and Nutrition
Examination Survey (NHANES). Lipid-adjusted PCBs, PCDDs, and PCDFs
were measured for a randomly selected one-third of all NHANES subjects. Both
individual values and TEQs were estimated. Multivariate linear regression was
used to study associations between natural log-transformed leukocyte telomere
length and persistent organic pollutant quartiles. Individuals in the 3rd and 4th
quartiles of the sum of PCBs were associated with, respectively, 8.33% (95%
confidence interval [CI] 4.08–13.88) and 11.63% (95% CI 6.18–17.35) longer
leukocyte telomere length, compared with the lowest quartile, with an evidence of
a dose–response relationship (p-trend < 0.01). Most of these effects were stronger
in the non-dioxin-like congeners than in the dioxin-like congeners, which brings
into question the direct relevance to the committee’s charge. No significant associations were observed between leukocyte telomere length and the sum of PCDD;
however, the congener 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin was associated
with a longer leukocyte telomere length. By TEQs, the highest quartiles of dioxinlike and the TEQ PCBs were associated with 11.63% (95% CI 4.08–18.53) and
6.18 (95% CI 1.01–11.63) longer leukocyte telomere length; both demonstrated a
dose–response relationship (p < 0.01). This study suggests that telomere length
may be influenced by exposure to dioxin and dioxin-like chemicals, however, the
association between telomere length and disease is not well understood.
In summary, although TCDD does have some genotoxic activity, the vast
majority of studies did not detect mutagenic activity of TCDD in a variety of in
vitro and in vivo short-term tests.
Epigenetic Activity
Chromosomes contain the genetic material of an organism and are composed of both DNA and proteins called histones. Interactions between DNA
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and histones regulate the accessibility of DNA to binding factors that activate or
suppress gene transcription. This interaction is controlled by chemical modifications of the DNA (generally methylation of cytosine bases in cytosine–guanine
dinucleotides or CpG sites) and histones (such as methylation, acetylation, sulfation, and ubiquitination), which are maintained by enzymatic processes. These
modifications are considered “epigenetic” because they control the function of
genes without changing the coding sequence. TCDD has been associated with
epigenetic marks on the chromosomes, indicating that it could potentially be
altering the function of numerous genes. Below is a brief summary of the epigenetic effects of TCDD. More detailed information about epigenetic mechanisms
in general can be found later in this chapter, particularly concerning somatic
modifications in an individual, and again in Chapter 8 with respect to effects that
may affect offspring of an exposed organism.
The exposure of rodents to TCDD has been shown to result in the methylation of DNA in the adult rodents’ tissues—sperm, mammary tissue, liver, and a
number of other solid tissues (Amenya et al., 2016; Papoutsis et al., 2013; Somm
et al., 2013). The effects on DNA methylation were found to persist in rats for
three generations following maternal exposure to 100 ng/kg TCDD and so could
essentially be considered permanent and heritable (Manikkam et al., 2012a). As
Ahr activation is generally considered necessary, but not sufficient, to induce adverse biological responses, and the dose–response relationship for Ahr activation
is generally quite steep, the relevance of high-dose rodent studies such as these to
human “low-dose exposures” is not always clear. When Olsvik et al. (2014) fed
female zebrafish TCDD in their diet prior to breeding, they found no change in
the level of DNA methylation throughout the genomes of fish or their embryos,
but altered methylation was identified by probes for the promoter regions of a
number of specific genes, with corresponding marked elevations in the expression
of CYP1A1 and CYP1B1 in the mothers and embryos (Olsvik et al., 2014). To
date, however, there have not been publications reporting on the persistence of
methylation or other epigenetic modifications in the offspring of males exposed
to TCDD as adults. In vitro studies in cell lines have identified altered DNA
methylation and expression in genes related to adipocyte differentiation following
TCDD exposure (van den Dungen et al., 2017) and in CYP1A1 following PCB
126 exposure (Vorrink et al., 2014).
Other Toxic Outcomes
Chloracne is a signature effect of high exposure to TCDD and dioxin-like
chemicals in some species and in humans who are sensitive. There is an extensive body of evidence from experimental studies in animal model systems
that TCDD, other dioxins, and several dioxin-like chemicals are immunotoxic
(Kerkvliet, 2009, 2012; K
 reitinger et al., 2016). Although the available evidence
on dioxin immunotoxicity in humans is scant, mechanistic considerations support
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the suggestion that chemical alterations of immune function would cause adverse
health outcomes because of the critical role that the immune system plays in general protection—fighting off infection and eliminating cancer cells at early stages.
Because of those considerations, the chemicals are potential immunotoxicants.
Similarly, reproduction and embryonic development clearly are targets of
TCDD (Chen and Chan, 2016), other dioxins, and dioxin-like chemicals; it
is a consistent finding that the adverse effects are more prevalent during fetal
development than in the adult. Data on the developmental effects of dioxin-like
chemicals in humans have begun to emerge over the past 10 years (Mocarelli et
al., 2008). Human and animal studies have revealed other potential health outcomes, including cardiovascular disease, hepatic disease, thyroid dysfunction,
lipid disorders, neurotoxicity, and metabolic disorders such as diabetes.
A number of effects of TCDD exposure in vitro appear to be independent
of AHR-mediated transcription and, in at least one instance, perhaps independent of AHR itself. Guo et al. (2004) showed that TCDD induced expression of
transforming growth factor α and other genes involved in extracellular matrix
deposition in cells from mice that had homozygous ablation of the Ahr gene.
Studies have shown that TCDD can mobilize calcium from intracellular sources
and increase calcium imported from the culture medium (Puga et al., 1995).
Mitochondrial oxidative stress has been shown to be induced when calcium is mobilized (Senft et al., 2002). Calcium mobilization by TCDD may have an important
effect on signal-transduction mechanisms that control gene expression, inasmuch
as several proto-oncogenes, such as c-fos, are activated by calcium changes.
Earlier VAO Update reports address the other toxic effects of TCDD in
greater detail, including the relationship between human and animal-model sensitivity to exposure.
Summary of Biologic Plausibility That TCDD
Induces Adverse Effects in Humans
Mechanistic studies in vitro and in laboratory animals have characterized
the biochemical pathways and types of biologic events that contribute to the
adverse effects of exposure to TCDD. For example, much evidence indicates
that TCDD, acting via AHR in partnership with ARNT, alters gene expression.
Receptor binding may result in the release of other cytoplasmic proteins that
alter the expression or activity of other cell-regulatory proteins. Mechanistic
studies also indicate that many other cellular-component proteins contribute to
the gene-regulatory effect and that the response to TCDD exposure involves a
complex interplay between genetic and environmental factors. Comparative data
from animal and human cells in vitro and from tissues suggest a strong qualitative
similarity among species in their response to TCDD, and this further supports the
applicability to humans of the generalized model of initial events in response to
dioxin exposure.
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Biochemical and biologic responses to TCDD exposure are considered adaptive or simply reflective of exposure and not adverse in themselves if they take
place within the normal homeostatic ranges of an organism; the exception to this
is during development. However, they may exceed normal physiologic boundaries or constitute early events in a pathway that leads to damage in sensitive
members of the population. In the latter case, the response is toxic and would
be expected to cause an adverse health effect. Those qualitative generalizations
about dose–response and individual variability are central to establishing biologic
plausibility, which in the case of TCDD largely relies on extrapolation from animal studies to human risks. However, there are significant quantitative differences
between responses in humans and rodents. Evidence from highly exposed human
populations is an important means for corroborating biological plausibility.
OVERARCHING TOXICOLOGIC ISSUES
RELATED TO THE CHEMICALS OF INTEREST
Limitations of Extrapolating Results of Laboratory
Studies to Human Responses
In some instances, the toxic responses identified in laboratory-animal and
cell-culture studies are not detected in epidemiologic studies with human exposure to the same chemicals. Although animal and cell-culture studies provide
important links to understanding the biochemical and molecular mechanisms associated with toxicity induced by xenobiotics, many factors must be considered
in extrapolating their results to human disease and disease progression. The following are key factors that might limit the ability of laboratory studies to predict
human responses completely and accurately.
• Magnitude and duration of exposure In many instances, animal and cellculture studies are conducted at higher exposures and for shorter durations
than are typical in human exposures. For example, the concentrations of
TCDD used in animal studies can be many times higher than was typical in
the TCDD exposures of Vietnam veterans during their military service. In
addition, TCDD is a persistent organic pollutant, and this results in human
exposure that occurs over a lifetime, whereas animal studies seldom examine chronic low-level exposures that occur over a p eriod of many months
or years, except those that evaluate chronic toxicity or carcinogenicity.
Animal studies that establish a measurement of body burden over a specific
period provide the best potential for extrapolation to humans.
• Toxicokinetics The toxicokinetics—absorption, distribution, metabolism,
and excretion—of xenobiotics can differ sharply between laboratory animals and humans. As described previously, the biologic half-life of TCDD
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varies from 8 to 29 days in rats and mice, while it is about 7 years in humans
even though the drug-metabolizing enzymes—including cytochrome P450
1A1, 1A2, and 1B1—are up-regulated or induced via TCDD-mediated
activation of the AHR in both rat and human liver (Black et al., 2012).
Timing of exposure Many organ systems are more susceptible to xenobiotic exposure during critical stages of development, differentiation,
or function—such as during gestation or in the face of another external
challenge (for example, antigens, smoking, dietary salt, and fat)—than at
other times. Therefore, the response of some systems (such as the immune
or cardiovascular systems) may depend on the timing of exposure relative
to the other challenges.
Exposure composition Most animal and cell-culture studies involve exposure to single chemicals or to a well-defined mixture, but most human
exposures are to complex mixtures from multiple sources, so it is difficult
to definitively attribute any observed effects to a particular component of
the environment.
Difference in AHR affinity The binding affinity of AHR for TCDD
differs between species (discussed in Okey et al., 2005). Many of the
strains of mice used for toxicologic studies harbor a high-affinity Ahr
allele (Ahrb), and these mice exhibit greater sensitivity to hepatic CYP1A
induction, immunosuppression, birth defects, and other responses than
do strains that carry the low-affinity allele (Ahrd). Such a simple allelic
difference in AHR affinity has not been observed in humans, and the
TCDD-binding affinity of the AHR found in most humans more closely
resembles the low-affinity mouse Ahrd allele. Nonetheless, Nebert et al.
(2004) reported that some people have TCDD-binding affinity that is 12
times higher than that found in others. Thus, although humans are generally considered to be less sensitive on the basis of an AHR that has low
TCDD-binding affinity, this assumption may not apply to everyone.
Complex disease etiology and environment The etiology of human diseases is highly influenced by genetics, environmental factors, and gene–
environment interactions; these factors can be protective as well as deleterious.
In addition to the COIs, the environmental factors that commonly influence
human responses include diet, prescription and over-the-counter pharmaceuticals, cigarette smoking, alcohol consumption, physical activity, the microbiome, and stress. Stress (not to be confused with oxidative stress) produced
via known or unknown sources is a well-known modifier of human disease
responses (for example, immune and cardiovascular responses). Furthermore,
stress is an ever-present factor that is difficult to assess or control for in epidemiologic studies because there is substantial individual variation in response
to it (Cohen et al., 2007a). In contrast, laboratory studies are often conducted
with inbred strains of animals and under tightly controlled experimental
conditions, thus possibly underestimating or overestimating the potential
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contribution of a single chemical exposure to disease development. On the
other hand, direct cause-and-effect relationships are more easily established
in animal studies because of their standardization.
• Sex differences There are well-known differences in susceptibility to xenobiotic exposures between male and female animals, some of which are
modified by sex steroids. For example, female Sprague Dawley rats are significantly more responsive to the hepatotoxic (neoplastic and non-neoplastic)
effects of TCDD than are males of the same strain (Kociba et al., 1978).

Epigenetics
Epigenetics, as previously noted, is the term used to describe the mechanisms
that regulate gene expression and genomic stability but that involve no changes
in DNA sequence. The epigenetic marks on DNA and bound histones are mitotically stable because they are maintained every time a cell divides. The totality of
epigenetics marks in each cell, termed the epigenome, creates and maintains the
identity and function of the cell type (Christensen and Marsit, 2011; Cortessis et
al., 2012; Skinner et al., 2010).
Conrad Waddington used the term “epigenetics” in the 1940s to describe
environment–gene interactions that alter biologic traits (Waddington, 1940, 1953,
1956). It was not until the 1970s, however, that the first molecular epigenetic
factor was described: DNA methylation, the chemical addition of a methyl group
to DNA (Holliday and Pugh, 1975). In the 1980s, the role of DNA methylation in modifying gene expression—turning genes on and off—was established
(Chen and Riggs, 2005). In the 1990s, the chemical modification of histone
proteins associated with DNA was shown to also modify gene expression, thus
establishing a second molecular epigenetic mechanism (Turner, 1998). In the
early 2000s, various small noncoding RNA molecules were shown to regulate
DNA activity (Sato et al., 2011). Around 2005, the first mapping of the yeast
epigenome was conducted (Pokholok et al., 2005). Since that time, the mapping
of cell-specific human epigenomes has accelerated under the National Institutes
of Health’s E
 pigenomics Roadmap and ENCODE Project, and more than 100
human cell lines and tissues have been epigenetically characterized (Kundaje et
al., 2015). The studies show that epigenetic marks act together in an exquisitely
choreographed fashion to control cellular differentiation and the cellular ability
to interact with, process, and initiate events and to respond to the signals and
needs of the individual and local tissue environment. New National Institutes of
Health efforts are under way within the Toxicant Exposures and Responses by
Genomic and Epigenomic Regulators of Transcription Program to use mouse
models of human relevant exposures to address the role of the environment in
disease susceptibility as a function of changes to the epigenome, including TCDD
and arsenic (T. Wang et al., 2018).
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Today, the processes recognized as epigenetic mechanisms are DNA methylation (Chen and Riggs, 2005; Holliday and Pugh, 1975), histone modification
(Turner, 1998), alterations in chromatin structure (Murr, 2010), and modulation
of expression by some small and long non-coding RNA molecules (Valeri et al.,
2009). DNA methylation is the addition of a methyl group onto specific nucleotides. In mammals it occurs mostly at cytosine nucleotides that are adjacent to
guanine nucleotides (CpG sites), but it can also occur at cytosine nucleotides
followed by other bases in embryonic cells and brain cells (Lister et al., 2013).
Methylation of DNA in the promoter region of the gene can reduce the expression
of the adjacent gene. Other modulations of DNA include hydroxymethylation
(which is prominent in stem cells and brain cells), formylcytosine, and carboxylcytosine (X. Cheng et al., 2014; Song et al., 2013). Histones are the proteins
that bind and form complex structures with DNA called nucleosomes in which
DNA is wrapped around the histone core. The combination of DNA and histones
is called chromatin. Chemical modifications of histones, such as methylation
and acetylation, can alter the histone structure and modify gene expression by
attracting protein complexes that can stimulate or repress transcription, in part by
changing nucleosome spacing (Reid et al., 2009; Zhang and Pradhan, 2014). The
influence of regulatory non-coding RNA including small interfering RNA and
piwi-interacting RNA, as well as long non-coding RNA, on gene transcription is
another field of epigenetic gene regulation that is now emerging. For example,
recent findings suggest that micro-RNAs may be important regulators of cytokines involved in T-cell polarization and the allergic response (Tay et al., 2014).
Small RNAs can elicit both epigenetic and non-epigenetic responses depending on whether they are inhibiting transcription via the RNA-induced initiation
of transcriptional silencing (RITS) pathway (epigenetic) or degrading mRNA
through RNA-induced silencing complex (RISC) complex (not epigenetic). For
example, short antisense RNA transcripts are produced within the nucleus by the
action of the enzyme Dicer, which cleaves double-stranded RNA precursors into
21–26 nucleotide long RNA species (Matzke and Birchler, 2005; Verdel et al.,
2005). These then associate with silencing–effector complexes, such as RISC,
which directs cleavage of cognate mRNA or causes translational repression and
RITS, which mediates heterochromatin formation at target loci and abrogates
gene expression (Verdel et al., 2005). Thus, regulation mediated by small noncoding RNAs occurs both at the posttranscriptional and transcriptional levels.
The latter transcriptional regulation is referred to as “epigenetic silencing,” and is
mediated either by covalent modifications of chromatin (such as H3 methylation
at Lys9) or by DNA methylation (Verdel and Moazed, 2005).
The interaction of all those epigenetic processes creates the epigenome,
which has a critical role in regulating gene expression (Christensen and Marsit,
2011; Cortessis et al., 2012; Skinner et al., 2010). The variation that is possible
in the epigenome is remarkable: The histone proteins that control chromatin
configurations have dozens of possible modifications, and there are upwards of
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50 million nucleotides in the DNA where methylation can occur and participate
in regulating the cellular state. That implies that trillions of configurations of the
epigenome are possible, although typically only about half of all genes are expressed in any given cell. Epigenetic marks are erased and re-established at two
times during the life cycle—shortly after fertilization and during gametogenesis—
to allow gamete-specific epigenomes to be converted to cell-specific epigenomes
and vice versa (Dean, 2014).
Environmental epigenetics is the study of how environmental factors such
as nutrition, toxicants, and stress alter epigenetic programming. In particular,
epigenetics provides a molecular mechanism—other than mutations in the DNA
itself—by which environmental factors can influence disease etiology (Jirtle
and Skinner, 2007; Szyf, 2007). Epigenetics has been shown to have a role in
the disease etiology of cancers and a number of other diseases (Christensen and
Marsit, 2011; Cortessis et al., 2012; Skinner et al., 2010). In addition, exposure
to environmental factors at critical times of development when epigenomes are
shifting has the ability to alter epigenetic programming and cause changes in
gene expression because these are times when epigenomes are evolving rapidly
as stems cells differentiate into more mature cell types (Skinner et al., 2010).
Hence, immune responses, fetal development, and gamete formation are important examples of physiological processes whose functioning can be affected by
environmentally induced epigenetic changes.
New investigative tools and a more refined understanding of the epigenetic
process have given rise to active research on the nature of the relationship between environmental exposure to epigenetically active agents and the occurrence
of diverse disease states, including cancers, reproductive-developmental problems, immune dysregulation, diabetes, obesity, and psychiatric illnesses (Brookes
and Shi, 2014). The committee sought to review data on the potential relationship
of the exposures of interest with adverse epigenetic effects in directly exposed
veterans in an attempt to find evidence linking the exposures to disease processes
that might have been mediated epigenetically. The committee also sought to review relevant data on female veterans and male veterans separately inasmuch as
the epigenetic consequences of exposures could be different, particularly in the
case of adverse reproductive outcomes. Of note, possibly the greatest limitation
to environmental epigenetic studies in human cohorts is access to the target tissue of interest. Researchers rely on more accessible proxy tissues such as blood
leukocytes, saliva, buccal cells, or placenta. A second consideration is that DNA
methylation levels change as a function of age in both humans and animal models
and that these age-related changes in methylation are gene- and tissue-specific,
can be either random or predictable, and are thought to play a role in chronic
disease development.
A relevant example within the COIs is that the in vitro exposure of preimplantation embryos to TCDD alters the DNA methylation of imprinted genes (Q.
Wu et al., 2004). Imprinted genes are a unique category of genes in which only
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one copy is expressed in a parent-of-origin specific manner, and imprinted genes
are important for growth and development. Similar results to those of Q. Wu et
al. were obtained more recently when several solid tissues and sperm DNA were
analyzed in adult male mice exposed to TCDD in utero (Somm et al., 2013). In
utero exposure to TCDD was also associated with altered DNA methylation and
reduced expression of the BRCA1 (breast cancer) gene in mammary tissue in
adult female offspring (Papoutsis et al., 2013). More generally, studies of the developmental origins of health and disease have shown that early-life exposures or
environmental influences can be associated with the onset of disease much later in
life (Barker et al., 2010). These early developmental alterations in the epigenome
provide a molecular mechanism by which environmental exposures of female
veterans can have effects on their children into adulthood. In humans, using data
from the AHS, Rusiecki et al. (2017) evaluated high pesticide exposure events
and altered DNA methylation in the blood of male pesticide applicators (n = 695).
A candidate gene approach was used to investigate three gene promoters as well
as the repetitive element LINE-1. Ever having had a high pesticide exposure
event was associated with increased DNA methylation at the GSTp1 promoter,
an effect that was more pronounced among applicators older than 59 years. High
pesticide exposure events were also associated with decreased DNA methylation
at the MGMT promoter among applicators older than 59 and in applicators with
less than 16.6 ng/mL plasma folate.
Of note, there are almost no toxicological studies with animal models that
have evaluated more than a single, and at times very high dose, of the COIs. The
potential for epigenetic changes induced via TCDD in Vietnam veterans and their
descendants remains uncertain until more dose–response studies are completed to
determine if epigenetic effects are secondary to AHR activation or separate from
AHR activation. If epigenetic responses are the result of downstream events following extensive and prolonged AHR activation, they may be irrelevant to exposure scenarios that are inadequate to extensively induce AHR. On the other hand,
if evidence demonstrates that TCDD can induce epigenetic changes at doses
that cause no or minimal induction of AHR, it could well be the most important
toxicological outcome to potentially occur in humans. There is precedent within
the endocrine disrupting chemical literature for epigenetic alterations to have
low-dose and non-monotonic effects, which are not necessarily linked to blocking
or mimicking hormones, but may occur through other mechanisms such as oxidative stress or direct interactions with any of the many epigenetic enzymes and
co-factors necessary for epigenetic gene regulation (Tapia-Orozco et al., 2017).
Most epigenetic modifications occur in somatic cells and are heritable only
within the altered cell line, thereby having the potential to generate effects in
the exposed individual but not in that individual’s offspring. Other studies have
found direct effects of exposures on the germline (e.g., sperm or oocytes), which
can be multi-generationally transmitted to the next generation. The possibility
exists, however, of epigenetic transgenerational inheritance, which involves the
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environment promoting a stable alteration in the germline that is transmitted to
later unexposed generations (Schmidt, 2013; Skinner, 2014; Skinner et al., 2010;
Y. Wei et al., 2015). Manikkam et al. (2012b) showed that the exposure of pregnant female rats to TCDD at critical times of development of the germline (when
epigenetic programming is being established) can lead to abnormalities in the
third-generation offspring, including kidney disease and changes in the ovaries
and sperm of the offspring. There are few data on possible male-mediated heritable effects of TCDD or other environmental compounds. The sparse data include
the results of studies of lead, a known developmental and neurologic toxicant.
Lead exposure can alter semen quality in males (Alexander et al., 1996) and has
been shown to induce paternally mediated developmental toxicity in rats (Anjum
et al., 2011); this demonstrates that male-mediated effects on reproduction can
be induced by reproductive toxicants. It has been suggested that environmental
exposures can result in reduced fertility (Guerrero-Bosagna and Skinner, 2014;
Paoloni-Giacobino, 2014). However, a serious need exists for additional study of
the question, particularly of the effects of the COIs to this committee.
In summary, the ability of epigenetic mechanisms to regulate gene expression coupled with the interaction of the epigenome and the environment, including multi- and trans-generational effects, might underlie the ability of xenobiotic
exposure to contribute to disease development and the potential for offspring to
inherit the effects of the disrupted epigenetic processes.
Developmental Immunotoxicity
A second emerging field in the biologic sciences that may provide insight
into the mechanism of xenobiotic-induced disease is developmental immunotoxicity, the study of the disruption of the developing immune system by xenobiotic
exposure. The developing immune system is among the most sensitive physiologic targets of prenatal and childhood environmental insult. The sensitivity is
due, in part, to the novel processes of gene rearrangement, somatic-cell selection,
and immune-cell distribution that are required to produce a security system that
can effectively protect not only the child but also the aging adult from disease.
To produce that security system, the immune system, as it matures, must coordinate steps that result in highly specialized immune cells that are capable of
self-versus-non-self recognition and that are tailored to the specialized functional
environments of different tissues and organs (such as brain, lungs, skin, liver, gastrointestinal tract, and reproductive tract). A disruption of immune development
can place the integrity of the organism at risk.
Among the known risk factors for developmental immunotoxicity are
various chemicals including heavy metals, some pesticides, TCDD, industrial
solvents such as trichloroethylene, and PCBs. The adverse outcomes of developmental immunotoxicity may become apparent soon after exposure or can emerge
much later in life (Gascon et al., 2013). Often, childhood or adult infections can
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trigger the appearance of developmental immunotoxicity-associated immune
problems that were established earlier in life (Dietert, 2009). Developmental
immunotoxicity-induced alterations can also contribute to myriad health problems related to dysfunction or pathologic conditions in virtually any tissue or
organ. Chemicals, drugs, infectious agents, and physical and emotional stressors
can act synergistically and increase the risk of developmental immunotoxicity.
Not everyone is at identical risk for developmental immunotoxicity. People
who have particular genotypes may be at increased risk for specific chemicalinduced developmental immunotoxicity on the basis of heritable factors that
affect metabolism or immune vulnerability.
The heightened sensitivity of the developing immune system is due to the
existence of critical developmental windows of vulnerability during which environmental interference with key steps of immune maturation can change the
entire course of immune development and result in later-life immune dysfunction and an increased risk of disease. The events programmed for these critical
developmental windows have several basic features:
• They are necessary, usually one-time events of early development, with
no equivalents in adults.
• They lock in building blocks on which additional maturational events rely.
• If they do not occur both on time and efficiently, the ramifications are
usually profound, prolonged, and irreversible.
Examples of critical windows of immune vulnerability and the chemicals
that can cause disruptions have been described in several reviews (R. Dietert and
J. Dietert, 2008; R. Dietert and Piepenbrink, 2006; R. Dietert et al., 2000; Hessel
et al., 2015; Holsapple et al., 2003; Landreth, 2002) and include
• The process of the seeding of immune cells in tissues where they grow
into resident populations.
• The selection process of thymocytes in the thymus to distinguish nonself
from self during the development of acquired immunity.
• The maturation of macrophage populations in the lung, in the brain, and
elsewhere.
• The maturation of dendritic cells to provide balanced immune responses.
• The initial development, expansion, and seeding to the periphery of regulatory cell populations.
• Comparison with current tolerable daily intakes and their underlying
overall no observed adverse effect levels showed that for some of the
compounds, the tolerable daily intakes may need reconsideration based
on developmental immune parameters.
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The increased sensitivity of the fetal, neonatal, and juvenile immune systems
compared with the immune system of an adult can manifest itself as a sensitivity
to lower doses of chemical exposure than the doses that affect the adult, a greater
persistence of the immune problems that follow exposure than are seen in adults,
a broader array of immune problems than are experienced by adults, and a greater
likelihood that a second later-life chemical exposure or environmental stressor
will trigger an unexpected immune problem (Rooney et al., 2008). It is also important to note, similar to epigenetic mechanisms discussed above, the relevance
of single or high-dose animal model studies remains uncertain until more dose–
response studies are completed to determine if developmental immunotoxicity
effects are secondary to AHR activation or separate from AHR activation.
Disruption of immune maturation is not the only route for developmental
immunotoxicity. Early-life chemical exposure may affect the status of genes (the
epigenome) in such a way that their pattern of expression in later life is affected
and thereby alters immune functional capacity (J. Xu et al., 2016a). Such changes
in gene status that affect immune status could occur in the exposed generation
(for people exposed in utero or during childhood), or they could carry through
one or more additional generations as a result of epigenetic alterations.
MEDIATORS OF HEALTH OUTCOMES
Identifying and assessing the mediators of health outcomes, which are effectors in the pathway of exposure to disease and may contribute to disease
progression, is essential for characterizing the impact of toxicant exposures on
health outcomes. Such mediators include oxidative stress, the cytogenetic status of cells, and factors that affect normal function and the development of the
blood–brain barrier.
Recently, the study of oxidative stress has emerged as a mechanism for
investigating toxicity. Oxidative stress is classically defined as an imbalance in
oxidant and antioxidant species within a system in which oxidant species are predominant (Lushchak et al., 2014). Although oxidative stress and exposure to toxicants have been associated with many of the same health effects, they are rarely
studied in parallel. For example, both oxidative stress and toxicant exposures
have been associated with metabolic syndrome, insulin resistance, diabetes, obesity, and cardiovascular complications (Bonomini et al., 2015; Lang et al., 2008).
Using a longitudinal study of non-smoking Iowa corn farmers (n = 30) and
non-farming controls (n = 10), Lerro et al. (2017) evaluated the effects of atrazine
and 2,4-D exposures on three markers of oxidative stress in 225 samples collected during five agricultural periods (pre-planting, planting, growing, harvest,
and off-season). Farmers exhibited higher urinary levels of atrazine and 2,4-D
than controls. 2,4-D exposure (but not atrazine exposure) was associated with
elevated levels of 8-OHdG (a marker of oxidative damage) and 8-isoPGF (a
marker of lipoprotein peroxidation). No effects on the oxidative stress biomarker

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

112

VETERANS AND AGENT ORANGE: UPDATE 11

malondialdehyde were observed in either atrazine or 2,4-D. Thus, 2,4-D may
induce oxidative stress and contribute to the pathogenesis of cancer and other
chronic diseases.
Using the Prospective Investigation of the Vasculature in Uppsala Seniors
(PIVUS) cohort, Kumar et al. (2014a) evaluated serum persistent organic pollutants levels and several biomarkers of oxidative stress in 992 male and female
subjects 70 years and older. Measurements included PCBs, organochlorine pesticides, octachlorinated dibenzo-p-dioxin, and polybrominated diphenyl ethers,
and TEQ values were calculated for dioxin and dioxin-like mono-ortho PCBs via
the van den Berg method. Oxidative stress markers consisted of protein stress
markers (e.g., homocysteine, GSH, GSSG), lipid stress (e.g., conjugated dienes),
and total antioxidant capacity. Several PCBs showed a significant positive association with oxidized low density lipoproteins (PCB 99, 138, 153, 156, 170,
180, 194, 206, and 209). In multivariable-adjusted analyses, the sum of PCBs
was positively associated with oxidized low density lipoproteins and negatively
associated with glutathione-related markers. Other summary measures did not
show any significant associations with oxidative stress markers.
Sycheva et al. (2016) studied the cytogenetic status of cells isolated from
the buccal and nasal epithelium from a sample of cases (n = 26) and controls
(n = 35) from a rural population in Vietnam. The cases were individuals living in
dioxin-contaminated areas (TCDD in soil 2.6 ng/kg), and the controls were villagers living in an area with negligible contamination (TCDD in soil 0.18 ng/kg).
A variety of cellular damage parameters were examined, and a small increase in
cell death was found for both types of epithelial cells in males from the contaminated area, indicating that dioxins had a more pronounced effect and that years of
residence and aging affected the results inversely. Thus, the increase in apoptosis
could suggest a dioxin effect and serve as a marker for cellular damage generally.
However, the small sample size and the lack of a dioxin association with oral
or nasopharyngeal cancers limits the confidence with which conclusions can be
drawn from this study.
There is increasing investigation into the mechanics of the interactions between TCDD (and dioxin-like chemicals) and the normal function and development of the blood–brain barrier. Filbrandt et al. (2004) first demonstrated that
TCDD was active in regulating gene expression in isolated murine cerebral
vascular endothelial cells and astrocytes. X. Wang et al. (2011) demonstrated that
TCDD exposure results in an increased expression and activity of several xenobiotic efflux transporters at the blood–brain barrier in rats and isolated capillaries in
vitro. This has the potential to alter the delivery of drugs or endogenous chemicals to the brain. Miyazaki et al. (2016) reported that exposure to TCDD during
blood–brain barrier formation disrupts and impairs blood–brain barrier function
in part by the suppression of glial cell derived neurotrophic factor action, which
may contribute to the adverse effects of TCDD on the fetal central nervous system. In a human cerebral microvascular endothelial cell line, Jacob et al. (2015)

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

BIOLOGIC MECHANISMS

113

did not observe a change in the expression or activity of two of the major efflux
transporters in the human cerebral endothelium (ABCB1 and ABCG2) after exposure to TCDD. In a second study using the same cell line, Jacob et al. (2017)
demonstrated that TCDD exposure increased the levels of the pro-inflammatory
cytokines IL-1β and IL-6, which could induce blood–brain barrier breakdown and
contribute to the pathogenesis of a variety of neurologic disorders.
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5
Background on Selected Epidemiologic
Studies and Populations

The process of updating the evidence base of possible health effects of the
chemicals of interest (COIs)—2,4-dichlorophenoxyacetic acid (2,4-D); 2,4,5trichlorophenoxyacetic acid (2,4,5-T) and its contaminant 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD); 4-amino-3,5,6-trichloropicolinic acid (picloram); and dimethyl
arsenic acid (DMA or cacodylic acid)—has involved the evaluation and integration
of thousands of epidemiologic publications over successive reports. The search
strategy used to identify these publications, along with refinements that have been
made since the initial volume of the series was prepared, are described in Chapter 3.
In addition to reviewing studies involving exposures to the specific COIs,
the current and previous Veterans and Agent Orange (VAO) committees have
considered studies that examined compounds chemically related to the herbicides used in Vietnam, such as 2-(2-methyl-4-chlorophenoxy) propionic acid,
hexachlorophene, and chlorophenols, particularly 2,4,5-trichlorophenol. If a publication did not specify the herbicides or polychlorinated biphenyls (PCBs) with
dioxin-like actions to which study participants were exposed or the magnitude
of exposure, those limitations were considered when weighing the evidence of
each publication. The committee considers studies of exposure to PCBs and other
dioxin-like chemicals informative if their results were reported in terms of TCDD
toxic equivalents (TEQs) or concentrations of specific congeners of dioxin-like
chemicals. The details of the exposure assessments conducted within individual
studies are presented in this chapter, whereas generic issues of exposure assessment are discussed in Chapter 3 along with the special challenges involved in
characterizing and reconstructing the herbicide exposures of Vietnam veterans.
This chapter presents study design and other important methodologic information on populations of Vietnam veterans, occupational cohorts, and
115
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environmentally exposed groups that have been reported on repeatedly, often
for many health outcomes, as well as on case-control studies that have generated
multiple epidemiologic publications relevant to the VAO series. This integrative
approach has been taken to avoid repeating design information in multiple healthoutcomes chapters and to make evident to the reader the extensive degree of
interrelationship among many of the published analyses that have been reviewed
in the course of the VAO series. If new results are based on updating information
from or adding subjects to previously studied populations or use a subset of the
original study population, then this synthesis considers the redundancy among
studies while recognizing that separately reported information can impart new
relevance to other data on a study population. Such clusters of studies are useful
in describing the course of a population’s response to an exposure, and joint consideration of an entire body of research on a population may yield insights into
relationships with potential confounding factors. The various study designs have
strengths and weaknesses that influence the evidentiary weight that they contribute, and these factors are addressed in the health-outcomes chapters. One-time
reports on a study population that addressed only a single health outcome are not
described in this chapter, but instead are described and critiqued in the sections
of the report that discuss the results related to that particular health outcome.
Many of the cohorts that have contributed to the cumulative findings of the
VAO committees, occupational cohorts in particular, are no longer being followed.
For completeness, these cohorts are mentioned briefly in this chapter and, where
relevant, in the body of this report. Additional detailed background information on
them is available in the earlier volumes of the series. This chapter is intended to
give a brief overview of those major cohorts and studies that have contributed to
the evidence base of potential health outcomes that stem from exposure to the COIs
and for which new information has become available on the incidence or prevalence of disease and other health outcomes since Update 2014. It is not intended
to be a compendium of every study or population ever reviewed in the VAO series.
Many groups potentially exposed to the COIs have been monitored periodically, including the cohorts of the International Agency for Research on Cancer
(IARC) and the National Institute for Occupational Safety and Health (NIOSH);
residents of Seveso, Italy; and Ranch Hand and Army Chemical Corps (ACC)
personnel who served in Vietnam. Discussions of the specific cohorts in this
chapter include references both to publications discussed in previous VAO reports
and to new publications. In drawing its conclusions, the committee combined the
evidence in new publications and the evidence synthesized from Update 2014,
taking into account the interdependence of related publications.
Individual researchers who belong to the research consortia that are evaluating cohorts in large multicenter studies (such as the IARC and NIOSH cohort
studies) sometimes publish reports based on subsets of study participants who
they themselves are monitoring. VAO committees consider all published reports, including those based on entire cohorts and those based on subcohorts.
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In drawing its conclusions, the committee factored in both types of studies, taking
into consideration the interdependence among related studies. In particular, some
subcohort studies have access to information not available for the entire cohort,
such as data on individual serum TCDD concentrations and personal information
that can be used to adjust for additional confounders. Furthermore, in the case
of analyses based on an entire cohort that include data from a subcohort as a
subset, using the reports on the subcohort as part of the evaluation might provide
additional information on the consistency of the relationships among subcohorts,
such as whether there are important subcohort-by-exposure interaction effects
that were not considered in the full-cohort analysis. As long as the design and
analysis methods of the study populations are recognized, VAO committees have
been less concerned about over-weighting unstable positive findings based on
small subgroups or giving “repeated consideration” to duplicative results than
they would have been if a quantitative meta-analysis were being undertaken.
The chapter is organized to present the study populations in the order that
roughly reflects the importance attributed to the data generated (Vietnam veterans,
occupationally exposed workers, and people who have been environmentally exposed). It begins with Vietnam veterans and first covers studies conducted in the
United States by the Air Force, the Centers for Disease Control and Prevention
(CDC), the Department of Veterans Affairs (VA), and other groups, before describing studies of veterans from other countries (particularly Australia, New Zealand,
and South Korea) who served in Vietnam. The section “Occupational Studies”
covers studies of workers who, through employment or other work (other than
military service), were exposed to the COIs and dioxin-like chemicals, including
production workers, agriculture and forestry workers (including herbicide and pesticide applicators), and other groups (e.g., sawmill and paper and pulp w
 orkers).
Again, studies of U.S. workers are presented before those of international cohorts.
The section “Environmental Studies” covers studies of populations exposed to
the COIs and dioxin-like chemicals from non-occupational sources and includes
assessments of the general population, such as the National Health and Nutrition
Examination Survey (NHANES), and also assessments of people who had unusually high exposures because of war-related or industrial sources in their residential
neighborhoods (such as the residents of southern Vietnam; suburban Taichung,
Taiwan; and Chapaevsk, Russia) or accidents (such as Seveso, Italy, and the Yusho
poisoning in Western Japan). The chapter ends with a section that addresses the
publications that are based on repeatedly mentioned case-control study populations; the case-control studies that assessed Vietnam-veteran status, however, are
included in the section on veteran studies, and nested case-control studies are
presented along with the cohorts from which they were derived.
Because of the breadth of literature reviewed in this chapter, Figure 5-1 provides the reader with a comprehensive overview of the individual study populations that have been reviewed in the course of the VAO series, although not all of
these populations are discussed in this chapter or even in this volume.
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Vietnam Veterans

U.S. Air Force Health Study
U.S. Department of Veterans Affairs
U.S. Centers for Disease Control and
Prevention
Other U.S. Vietnam-Veteran Studies
Australian Vietnam-Veteran Studies
New Zealand VietnamVeteran Studies
Korean Vietnam-Veteran Studies

Occupational Studies

IARC Cancer Phenoxy
Herbicide Cohort
IARC Subcohort of Workers

Herbicide
Production
Workers

U.S. National Institute for
Occupational Safety and Health
Studies (NIOSH)
Other International (non-IARC)
Subcohorts of Workers
Studies of Other Industrial Cohorts

Herbicide-Using
Workers

Environmental Studies

Studies of Herbicide-Using Workers

U.S. National Health and
Examination Nutrition Survey
Other U.S. Environmental
Studies
Seveso, Italy, Industrial Accident
International Environmental
Studies
Birth Cohort Studies

Case-Control Studies

Canadian Studies
U.S. Studies

FIGURE 5-1 Overview of the individual study populations reviewed in the VAO series.
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*National Vietnam Veterans Readjustment Study
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*American Legion Study

*Proportionate Mortality
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*VE-HEROeS *Other VA Studies

*Vietnam Experience Study

*Selected Cancers Study

*State-specific studies

*Australian Vietnam Veterans
*Australian Vietnam Veterans Family Study
*Sample of 1,000 Veterans
*Australian Conscripted Army National Service
*Birth Defects in Australian Infants

*TCDD Concentrations in Korean Vietnam Veterans
*Other Studies of Korean Vietnam Veterans

*Korean Vietnam Veterans Health Study

*Austria *Denmark *Germany *Great Britain *Netherlands *New Zealand
*NIOSH PCP Cohort
*NIOSH Cross-Sectional Medical Study
*NIOSH TCDD Mortality Cohort:
*Monsanto Mortality Study
*BASF Ludwigshafen Plant (Germany)

*Dow Herbicide Production Workers

*Czechoslovakia

*Waste Incineration (Japan, Korea)
*Paper and Pulp Cohorts (United States, Finland, Denmark, IARC)
*Sawmill Workers (Canada, New Zealand)
*Automobile Foundry Workers (China)
*Other Chemical Plants (Croatia, Germany, Italy, Russia, United Kingdom, United States)
*US: Agricultural Health Study, California United Farm Workers of America Study
*International Herbicide Users:
*Argentina *Australia *Canada *Denmark *Finland *Germany *Iceland
*India *Italy *Mexico *Netherlands *New Zealand *Norway *Sweden

*Times Beach and Quail Run Cohort
*Iowa Women’s Health Study
*Anniston, AL Community Health Survey
*Salinas Mothers and Children Cohort
*Longitudinal Investigation of Fertility and the Environment Study
*Seveso Full Cohort

*Seveso Women’s Health Study

Country-specific Environmental Studies: *Belgium *Brazil *Canada *China *Denmark *Finland *France
*Germany *Greece *Hong Kong *Italy (other than Seveso) *Japan *Korea *Netherlands *Nicaragua
*Norway *Russia *Spain *Sweden *Taiwan *Vietnam
*Danish Fetal Origins 1988–1989 Cohort *Norwegian Mother and Child Cohort Study
*Duisburg (Germany) Birth Cohort *Hokkaido (Japan) Study on Environment and Children’s Health
*Other birth cohorts and mother-child pair studies in Belgium, Denmark, Netherlands, Taiwan, and Vietnam
*Cross-Canada Study of Pesticides and Health
*National Birth Defects Prevention Study *Upper Midwest Health Study

FIGURE 5-1 Continued
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VIETNAM-VETERAN STUDIES
Studies of Vietnam veterans who might have been exposed to herbicides,
including Agent Orange, have been conducted in the United States at the national
and state levels and in Australia, South Korea, and New Zealand. Exposures have
been defined in various ways, and health outcomes have been evaluated with
reference to various comparison or control groups. This section is organized
primarily by research organization or sponsor because it is more conducive to a
methodical presentation of the studies. The means by which herbicide or dioxin
exposures were characterized varies from the individually specified exposures of
Ranch Hand and ACC personnel, as reflected in serum TCDD measurements, to
the use of service in Vietnam as a surrogate for TCDD exposure in some studies.
Several comparison groups have been used for veteran cohort studies: Vietnam
veterans who were stationed in areas where herbicide-spraying missions were
unlikely to have taken place; Vietnam-era veterans who were in the military at
the time of the conflict but did not serve in Vietnam; veterans who served in other
wars or conflicts, such as the Korean War and World War II; and various state and
national populations. In all of the studies of Vietnam veterans, whether or not the
study participants were American, the study participants were the target population of the committee’s charge, and they were assumed to have had a higher
probability of exposure to the COIs than people who did not serve in Vietnam,
regardless of whether there was any information on individual exposures beyond
the mere fact that they were deployed to Vietnam.
The studies in the publication period considered in the present update examined a range of health outcomes among Vietnam veterans with service history
from the United States as well as those from New Zealand. These included new
analyses of the Air Force Health Study cohort (AFHS) (Landgren et al., 2015;
Mazur et al., 2013, 2014), ACC personnel (Cypel et al., 2016), several publications from VA Medical Centers (Krishnamurthy et al., 2016; Nosrati et al., 2014;
Ovadia et al., 2015), and a 20-year hospitalization study of New Zealand Vietnam
veterans (Cox et al., 2015).
Air Force Health Study
Reports and findings from the AFHS have provided important information
that has been incorporated throughout the VAO series, including the current volume, and it continues to be considered an important cohort in the committee’s
assessment of the overall evidence of exposure to the COIs and health outcomes.
Active data collection from this cohort was completed in 2002, but VAO committees have remained interested in reviewing additional publications that provide
longitudinal analysis of the vast amount of information assembled or that make
use of the collection of preserved biologic samples. As yet, the few new published
findings have been disease specific and not always focused on the effects of
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exposure to the herbicides, but have grouped all participants to examine outcomes
related to aging (IOM, 2015).
Major defoliation activities in Vietnam were conducted by Air Force personnel as part of Operation Ranch Hand. Veterans who took part in the defoliation
activities became the ﬁrst subpopulation of Vietnam veterans to receive special
attention with regard to herbicide exposure and have become known as the Ranch
Hand cohort within the AFHS. To determine whether exposure to herbicides,
including Agent Orange, had adverse health effects on these veterans, the Air
Force made a commitment to Congress and the White House in 1979 to conduct
an epidemiologic study of Ranch Hand personnel (AFHS, 1982). The study
protocol had three components: a retrospective mortality study, a retrospective
morbidity study, and a 20-year prospective follow-up study with longitudinal data
and biospecimens collection. Details on the mortality and retrospective morbidity
arms can be found in prior reports (IOM, 2006b, 2015). The prospective study
arm has been the focus of multiple reports on a variety of health outcomes in the
cohort as well as new research using these assets.
Prospective Study Design and Data Collection
Records from the National Personnel Records Center and the Air Force
 uman Resources Laboratory were searched and cross-referenced to identify all
H
Ranch Hand personnel (AFHS, 1982; Michalek et al., 1990). The exact number
of Ranch Hands varies among published reports, depending on the time frame
of identification, but the most widely used estimate is 1,242, which reflects the
number who served in Vietnam and who were not killed in action. Ultimately,
however, not all of those who have been identified actually participated in the
AFHS (some were deceased before the study began, others were unlocatable, and
a small number refused to participate) (IOM, 2015). A comparison population of
24,971 C-130 crew members and support personnel who served in the U.S. Air
Force between 1962 and 1971 and were assigned to duty in Southeast Asia but
who were not occupationally exposed to tactical herbicides (AFHS, 1983, 1984a)
was selected from the same data sources. Each Ranch Hand was matched to a pool
of 8 to 10 comparisons, who were selected based on the first living and compliant
person randomly selected from the individual-level pool. Individual comparison
participants remained associated with their matched Ranch Hand for the duration
of the study, but those who died, dropped out, or were lost to follow-up were
replaced with the next best comparable control who was living and agreed to
participate (AFHS, 1982). Comparison participants were individually matched for
age, type of job (differentiated into five categories: officer/pilot, officer/navigator,
officer/other, enlisted/flight engineer, and enlisted/other), and race (white or not
white) to control for possible differences in the development of chronic disease
that may relate to age, race, or educational and socioeconomic status (AFHS,
1984a). To control for the many potential confounders related to the physical and
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psycho-physiologic effects of combat stress and the Southeast Asia environment,
Ranch Hands were matched to control participants who performed similar combat
or combat-related jobs (AFHS, 1982). Comparisons were assumed to be similar to
the Ranch Hands regarding lifestyle, training profiles, and socioeconomic factors.
Although not representative of the U.S. population, the sample was diverse in
terms of socioeconomic status and educational background (IOM, 2015).
The prospective follow-up consisted of six comprehensive exams that began
with the baseline exam in 1982 and occurred thereafter in years 3, 5, 10, 15, and
20 of the study (the final physical exam was conducted in 2002 and final analysis
for the formal AFHS study was completed in 2006). Morbidity was ascertained
through comprehensive questionnaires and accompanying physical examination,
which included more than 200 laboratory and clinical tests (although the number
and type of laboratory tests performed at each physical examination changed
over time, reflecting changes in science and technology). Questionnaire data
included information relating to demographics; employment; child and family
health; health habits; recreation, leisure, and physical activities; toxic exposures;
military experience; and wartime herbicide exposure. Data collected during the
physical examinations included indices of health status that encompassed general
health and endpoints by major organ system. Additional sources of data collected in the course of the AFHS included medical records from the participants’
physicians, dentists, and other health providers; vital status records, such as
birth and death certificates; information on the participants’ families, including
spouses and children who were under 18 years old at the time of the exam; and
military administrative records that contained duty station orders, flight records,
performance reports, awards and decorations, and discharge documents (IOM,
2015). The number of Ranch Hand and comparison participants who completed
the questionnaire and physical exam differed at each follow-up. In all, 2,758
individuals participated in at least one exam cycle.
Over the course of the AFHS, more than 91,000 unaliquoted biospecimens
were collected as part of the physical exam component. The number of samples
varied by type of specimen, participant, and cycle. Although some samples were
collected as part of the laboratory testing and work-ups, additional biospecimens
samples were collected from study participants at each exam cycle and preserved
to be used for future analyses. Serum and urine were collected longitudinally
across multiple cycles, while semen and whole blood were collected at a single
exam cycle. Adipose tissue was collected from a subset of individuals at one
exam cycle. To obtain samples for a TCDD assay carried out by the CDC on 777
Ranch Hand and 1,174 matched comparisons, a separate blood draw was performed during cycles 3–6 (see discussion on estimating exposure in the cohort,
below). Multiple blood samples were drawn for a subset of the population for use
in dioxin biological half-life and other studies.
Results have been published for baseline morbidity (AFHS, 1984a) and
baseline mortality (AFHS, 1983) and for reproductive outcomes (AFHS, 1992;

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

BACKGROUND ON SELECTED EPIDEMIOLOGIC STUDIES AND POPULATIONS

123

Michalek et al., 1998a,c; Wolfe et al., 1995). Mortality updates have been published for 1984–1986, 1989, and 1991 (AFHS, 1984b, 1985, 1986, 1989, 1991b).
An interim technical report updated cause-specific mortality in Ranch Hands
through 1993 (AFHS, 1996). Michalek et al. (1998b) and Ketchum and Michalek
(2005), respectively, reported on 15-year and 20-year follow-ups of post-service
mortality in the Ranch Hand veterans, updating an earlier cause-specific mortality
study by Michalek et al. (1990). Many analyses presented in the voluminous reports on the follow-up examinations of 1984, 1987, 1992, 1997, and 2002, which
are cited as AFHS (1987, 1990, 1995, 2000, 2005), have been deemed not useful
for the purposes of the VAO reviews because they were limited to comparisons
of data on those in the cohort who were still alive and participated in a particular
examination.
Exposure Estimation
As described in Chapter 2, the results of biologic-marker studies of Ranch
Hand personnel have been consistent with their being exposed, as a group, to
TCDD. When the Ranch Hand cohort was classiﬁed by military occupation, a
higher level of serum TCDD was detected in people whose jobs involved more
frequent handling of herbicides (AFHS, 1991a). The exposure index initially
proposed in the AFHS relied on military records that documented spraying missions of TCDD-containing herbicides (Agent Orange, Agent Purple, Agent Pink,
and Agent Green) as reported in the Herbicide Reporting System tapes for the
period starting in July 1965. For exposure before July 1965, exposure information
would be based on military procurement records and dissemination information.
In 1991 the record-based exposure index was compared with the results of the
Ranch Hand serum-TCDD sampling conducted on personnel at least 10 years
after their service in Vietnam. The exposure index and the TCDD serum levels,
which the authors referred to as body burden, correlated weakly.
Blood samples for use in determining serum TCDD concentrations were
drawn at the periodic examinations conducted in 1982 (cycle 1) from 36 Ranch
Hands (Pirkle et al., 1989), in 1987 (cycle 3) from 866 Ranch Hands (AFHS,
1991a), in 1992 (cycle 4) from 455 Ranch Hands (AFHS, 1995), and in 1997
(cycle 5) from 443 Ranch Hands (AFHS, 2000). For veterans whose TCDD
was not measured in 1987 but was measured later, the later measurement was
extrapolated to 1987 by using a first-order kinetics model with a constant halflife of 7.6 years.
Michalek et al. (1995) developed several indexes of herbicide exposure of
members of the Ranch Hand cohort and tried to relate them to the measurements
of serum TCDD from 1987 to 1992. Self-administered questionnaires completed
by the Ranch Hand veterans were used to develop several indexes of herbicide or
TCDD exposure: the number of days of skin exposure, the percentage of skin area
exposed, and the product of the number of days of skin exposure, the percentage
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of skin exposed, and a factor for the concentration of TCDD in the herbicide. A
fourth index, which used no information gathered from individual study participants, was calculated by multiplying the volume of herbicide sprayed during a
person’s tour of duty by the concentration of TCDD in herbicides sprayed in that
period and then dividing the product by the number of crew members in each
job specialty at the time.
Each of the four indexes tested was signiﬁcantly related to serum TCDD concentrations, although the models explained only 19% to 27% of the variability in
serum TCDD concentrations. Days of skin exposure had the highest correlation.
Military job classiﬁcation (for example, Ranch Hand combat troops, Ranch Hand
administrators, Ranch Hand ﬂight engineers, and Ranch Hand ground crew),
which is not included in any of the four indexes, explained 60% of the variability
in serum TCDD. When the questionnaire-derived indexes were applied within
each job classiﬁcation, days of skin exposure added statistical signiﬁcance, but
not substantially, to the variability explained by job alone.
Ranch Hands were divided into three categories on the basis of their potential
exposure:
• Low potential. Pilots, copilots, and navigators. Exposure was primarily
through preflight checks and spraying missions.
• Moderate potential. Crew chiefs, aircraft mechanics, and support personnel. Exposure could occur by contact during de-drumming and aircraft
loading operations, onsite repair of aircraft, and repair of spray equipment.
• High potential. Spray-console operators and flight engineers. Exposure
could occur during operation of spray equipment and through contact with
herbicides in the aircraft.
At times, other metrics of exposure were also applied. For example, rank was
used as a surrogate of exposure because officers (pilots, copilots, and navigators)
were unlikely to handle the herbicides.
Pavuk et al. (2014) analyzed serum concentrations of TCDD and dioxin-like
chemicals (i.e., polychlorinated dibenzo-p-dioxins [PCDDs], polychlorinated
dibenzofurans [PCDFs], and PCBs) from samples collected in 2002 from 777
Ranch Hand and 1,173 comparison subjects. In addition, the results were compared with serum samples from 436 age- and gender-matched adults from the
NHANES research initiative. The main findings showed that median serum
TCDD levels were more than two times higher in the Ranch Hand veterans than
in either the AFHS comparison veterans or the NHANES comparison group.
However, the absolute values of serum TCDD levels, as well as the group differences in median serum TCDD levels, were substantially lower than results from
prior serum samples collected in 1987. For the other dioxin-like chemicals, the
concentrations in 2002 were similar in all three groups. These data demonstrate
the unique TCDD signature experienced from herbicide exposure in Vietnam and
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indicate that, over time, the elimination rate is higher than the ongoing intake rate
from background exposure to TCDD in both groups of AFHS veterans.
Analyses of the serum TCDD readings were included in the 1987 examination report (AFHS, 1991a). Other Ranch Hand publications have addressed the
relationship between serum TCDD and reproductive hormones (Henriksen et al.,
1996); diabetes mellitus, glucose, and insulin (Henriksen et al., 1997); skin disorders (Burton et al., 1998); preterm birth and infant death (Michalek et al., 1998a);
sex ratios (Michalek et al., 1998c); skin cancers (Ketchum et al., 1999); insulin,
fasting glucose, and sex-hormone-binding globulin (Michalek et al., 1999a); immunologic responses (Michalek et al., 1999b); diabetes mellitus (Longnecker and
Michalek, 2000; Steenland et al., 2001); cognitive function (Barrett et al., 2001);
hepatic abnormalities (Michalek et al., 2001b); peripheral neuropathy (Michalek
et al., 2001c); hematologic results (Michalek et al., 2001a); psychologic functioning (Barrett et al., 2003); correlations between diabetes and TCDD elimination
(Michalek et al., 2003); thyroid function (Pavuk et al., 2003); cancer incidence
(Akhtar et al., 2004; Pavuk et al., 2005); insulin sensitivity (Kern et al., 2004);
prostate cancer (Pavuk et al., 2006); serum testosterone and the risk of benign prostate hyperplasia (Gupta et al., 2006); and diabetes and cancer incidence (Michalek
and Pavuk, 2008).
The tendency of the AFHS researchers to use different cutpoints and population definitions for analogous analyses suggests that they used an a posteriori
selection that may have influenced the results. For example, Michalek and Pavuk
(2008) allude to the commonly held assumption that Agent Orange was more
heavily contaminated earlier in the war as the motivation for making various
temporal partitions in their analyses, but the choices were not consistent among
studies. With respect to the development of cancer, service in 1968 or earlier was
considered to have been in the critical exposure period, whereas for diabetes,
the critical exposure period was considered to be 1969 or earlier. Additionally,
the construction of low- and high-exposure variables based on “days of spraying” was done differently for cancer than it was diabetes. Days of spraying were
grouped into 30-day blocks for cancer, and into blocks of 90 or more days for
diabetes.
Impact of the AFHS on VAO Reviews
Ostensibly, the AFHS was designed to answer exactly the question that the
VAO series is asking: Is exposure to the herbicides used during the Vietnam
War associated with long-term health outcomes or outcomes in the offspring of
exposed veterans? The AFHS is perceived by many to be the central piece of research for decision making by the VAO committees because it used longitudinally
collected data and objective, quantifiable measures of TCDD exposure through
serum samples, on a population that was directly exposed to the COIs in the
Vietnam theater. Unlike many other studies of Vietnam veterans, data on alcohol
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use and smoking status were collected and included in the analysis when they
were known risk factors for the outcome of interest. However, the AFHS also has
important limitations that all VAO committees have had to consider.
Although the study was carefully designed to match Ranch Hand and comparison subjects to minimize bias to the extent possible, the AFHS population
is likely not representative of the entire population of Vietnam veterans, so its
findings might not be generalizable to all Vietnam veterans. The 1987 TCDD
serum assay found the comparison subjects to also have elevated levels of TCDD,
although the exposure was significantly higher in the Ranch Hand group than
in the comparison group. Therefore, the comparison is not an ideal exposedversus-unexposed comparison but rather a high-exposure-versus-low-exposure
comparison (IOM, 2006b, 2015). The exposure in the comparison group might
also make the study findings vulnerable to bias toward the null if the difference
in exposures between the AFHS group and the comparison group was not large
enough to allow an association between exposure and outcome to be detected.
That problem does not affect the validity of positive findings, however. Similarly,
for AFHS analyses that used non-AFHS Vietnam veterans as the comparison
group, those individuals might also have been exposed to the COIs, which would
likewise influence results toward the null.
The AFHS might be underpowered for detecting small effects, especially
rare outcomes, because of its relatively small sample size. Therefore, its findings
are vulnerable to false negatives (failure to detect an important association). This
also raises questions about the stability of positive findings; this is somewhat less
of a problem if the findings are repeated over examination cycles, although the
results of the examination cycles themselves are not fully independent repetitions.
Three new studies have been published using AFHS data since Update
2014. In the first study, Landgren et al. (2015) used data and serum samples
from 479 Ranch Hands and 479 comparison veterans to examine the association between s erum TCDD levels and the presence of monoclonal gammopathy
of undetermined significance (MGUS). After the model had been adjusted for
several demographic and clinical factors, Ranch Hands were found to have a
2.4-fold increased risk for MGUS. This study is the first to correlate an objective measurement of levels of TCDD exposure with MGUS and additional detail
of it is found in Chapter 7. The second study used AFHS data from 991 AFHS
participants to examine the relationship between testosterone levels and the
levels of fasting glucose and, therefore, a diagnosis of type 2 diabetes (Mazur et
al., 2014). The authors found that low testosterone levels in men were an independent risk factor (comparable to aging and obesity) for high fasting glucose
and, therefore, that testosterone was a weak predictor of a diagnosis of type 2
diabetes. In a second publication based on AFHS data, Mazur et al. (2013) used
data from the same 991 AFHS subjects to examine the relationship of obesity to
individual and population-level declines in testosterone. Over 20 years of followup, mean testosterone levels declined at least twice as much as would have been
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expected from cross-sectional estimates of the decline usually associated with
aging. However, because neither of the Mazur studies considered exposure status
or TCDD levels in the analysis, these studies were not considered to be relevant
to the committee’s charge even though they were conducted using AFHS data.
Department of Veterans Affairs
Army Chemical Corps Cohort
Analyses of members of the ACC were conducted by VA, whose other research efforts on Vietnam veterans are discussed together below. Like the Ranch
Hand personnel, ACC personnel performed chemical operations involving the
direct handling and distribution of herbicides, but instead of using planes, they
performed these tasks on the ground and by helicopter in Vietnam. Nearly 1,000
men serving in ACC units were deployed to Vietnam between 1966 and 1971.
ACC members were responsible for the storage, preparation (handling and mixing), and application of herbicides, tear gas, and napalm among other chemicals.
ACC units were also tasked with cleaning and maintenance of the equipment used
to prepare and apply the chemicals (Thomas and Kang, 1990). Because the ACC
personnel were expected to have been highly exposed to herbicides, VAO committees recommended studying this important group of Vietnam veterans (IOM,
1994) and later encouraged the publication of the study’s findings (IOM, 2005).
The availability of serum TCDD concentrations in a subset of this cohort of
Vietnam veterans has made its findings particularly useful in appraising possible
associations with various health outcomes. The primary strengths and limitations
of the ACC studies are similar to those of the AFHS.
ACC service members were belatedly identified using morning reports for
all ACC units known to have been assigned to Vietnam between 1966 and 1971
for a study of health effects and mortality related to herbicide exposure (Thomas
and Kang, 1990). However, the findings of increased risk of certain outcomes,
such as digestive diseases, were based on small numbers of cases and cannot
be associated with particular exposures since serum samples or other objective
measures of exposure were not collected. In an extension of that study, Dalager
and Kang (1997) compared the mortality of ACC veterans who deployed to
Vietnam with the mortality of those who did not. For that study, ACC veterans
were identified using a combination of the same morning reports for ACC units
stationed in Vietnam as used by Thomas and Kang (1990), Defense Manpower
Data Center tapes of Vietnam-era Army personnel with a military occupational
specialty code indicating a chemical operations position between 1971 and 1974,
and class rosters for chemical courses conducted at the Army Chemical School at
Fort McClellan, Alabama, from 1965 to 1972. Analyses compared cause-specific
mortality among Vietnam-deployed ACC men (n = 2,872) and those who never
deployed to Southeast Asia (n = 2,737), and also compared each group to the
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standardized U.S. population. Because all men who served in ACC units were
stationed at Fort McClellan for at least some time, and Fort McClellan is in close
proximity to Anniston, Alabama, where Monsanto operated a plant that produced
PCBs, all ACC veterans were likely exposed to at least low levels of these and
other chemicals. Therefore, comparisons using deployed and non-deployed ACC
men are likely to be biased toward the null due to this baseline of increased exposure, but this bias is not the case for analyses that used the standardized U.S.
population as the comparison group.
The results of an initial feasibility study that measured serum dioxin levels
in a subset of Vietnam-deployed and nondeployed ACC veterans were reported
by Kang et al. (2001). The researchers recruited 565 veterans: 284 Vietnam veterans and 281 non-Vietnam veterans as controls. Blood samples were collected
in 1996 from 50 Vietnam veterans and 50 control veterans, and 95 of the samples
met CDC standards of quality assurance. A comparison of both groups showed
that the geometric mean TCDD concentrations did not differ between groups
(p = 0.6). The 50 Vietnam-deployed veterans were then stratified into those who
sprayed herbicides and those who did not, based on self-reported information.
The sprayers had higher TCDD concentrations than those who reported no spraying activities. The authors concluded that Agent Orange exposure was a likely
contributor to TCDD concentrations in Vietnam veterans who had a history of
spraying herbicides.
Following the 2001 feasibility study Kang et al. (2006) reported the findings
from the larger study of this population of ACC veterans. A health survey was
administered by telephone to 1,499 Vietnam-deployed veterans and 1,428 nonVietnam-deployed veterans. Exposure to herbicides was assessed by analyzing
serum specimens from a sample of 897 veterans for dioxin. Consistent with the
findings from the feasibility study, veterans who reported spraying herbicides
had significantly higher TCDD serum concentrations than veterans who did not
report herbicide spraying.
Having determined the vital status—that is, whether an individual was alive
or had died—of the ACC personnel through 2005, Cypel and Kang (2010) presented results on mortality from the following causes: cancers (oral and pharyngeal, digestive, respiratory, prostate, testicular, skin, brain, and lymphopoietic
[leukemia]), diabetes, circulatory conditions (hypertension and cerebrovascular),
respiratory conditions (pneumonia, influenza, and chronic obstructive pulmonary
disease), and cirrhosis of the liver. The study compared 2,872 ACC personnel
who served in Vietnam with 2,737 ACC personnel who did not serve in Vietnam,
using survival analysis that controlled for race, age at entry into follow-up,
rank, and duration of military service. It also compared 662 ACC personnel who
served in Vietnam and reported spraying herbicides with 811 who did not serve in
Vietnam and did not report spraying herbicides, controlling for additional covariates of body mass index (BMI) and smoking status obtained in the telephone
survey. Mortality in both cohorts was also compared with the expected mortality
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in U.S. males. Concerns were raised over the lack of adjustment for smoking
status in the analysis of respiratory diseases in Vietnam-deployed veterans and
non-Vietnam-deployed veterans. (The subcohort analyses that compared sprayers
with nonsprayers were adjusted for smoking status.)
In a new study of ACC veterans, Cypel et al. (2016) analyzed the results of
a 2013 survey of 3,086 ACC veterans that compared prevalence of self-reported,
physician-diagnosed hypertension in both Vietnam-deployed and non-Vietnamdeployed herbicide sprayers and non-sprayers. This study, which is reviewed in
Chapter 10, reports that the mean serum TCDD level in ACC Vietnam-service
sprayers was 4.3 parts per trillion (ppt) (lipid based) as compared with a mean
level of 9.5 ppt in AFHS participants.
U.S. Female Vietnam Veterans Cohort
Although estimates have varied, the most recent estimates from VA are
that 7,500 U.S. women served in Vietnam between August 1964 and May 1975
(VA, 2017a). The vast majority of them served as combat nurses—mostly in the
Army Nurse Corps—but some also served in the Women’s Army Corps and the
Air Force, Navy, and Marine Corps (Spoonster-Schwartz, 1987; Thomas et al.,
1991; VA, 2017a).
In 1986, Public Law (PL) 99-972 was enacted. It required that an epidemiologic study be conducted to examine the long-term adverse health effects
on female Vietnam veterans who had exposure to traumatic events, exposure
to herbicides such as Agent Orange or other chemicals or medications, or any
other related experience or exposure during such service. The first study that VA
conducted to assess mortality in female Vietnam veterans was by Thomas et al.
(1991). No comprehensive record of female personnel who served in Vietnam
in 1964–1972 existed, so the researchers gathered military service data from
each branch of the armed forces through December 31, 1987. Female Army and
Navy personnel were identified from morning reports and muster rolls of hospitals and administrative support units where women were likely to have served.
Military personnel were identified as female by their names, leaving open the
possibility that some women may have been inadvertently excluded from the
analysis. Women who served in the Air Force and Marine Corps were identified
through military records. The combined roster of all female personnel from the
military branches was considered by the researchers to be generally complete.
A comparison group of female veterans was identified through the same process
as the women who served in Vietnam but the comparison group had not served
in Vietnam during their military service. Demographic information and information on overseas tours of duty, unit assignments, jobs, and principal duties
were abstracted from military records. Mortality information was obtained from
VA’s Beneficiary Identification Records Locator Subsystem, the Social Security
Administration, the Internal Revenue Service, the National Death Index (NDI),
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and military personnel records. Women whose service in the military fell outside
the period of interest, whose records were missing data, or who served in Southeast Asia but not in Vietnam were excluded. The analysis included 132 deaths
among 4,582 female Vietnam veterans and 232 deaths among 5,324 comparison
veterans who served in the military from July 4, 1965, to March 28, 1973, which
was when combat operations occurred. Cause-specific mortality was derived for
both groups of veterans and compared with mortality in U.S. women with adjustments for race, age, and calendar period. Dalager et al. (1995a) updated mortality
in the original cohort through December 31, 1991, using the same study protocol
as Thomas et al. (1991). After updating the mortality figures and adjusting the
existing cohort on the basis of new information about the study groups based on
the inclusion criteria, an additional 4 Vietnam-deployed veterans and 1 comparison veteran were included in the final study population (Dalager et al., 1995a).
Updates of mortality among women Vietnam veterans have been published
periodically. Cypel and Kang (2008) conducted a mortality study of female veterans who deployed to Vietnam, comparing them with a control group of women
veterans matched on rank and military occupation who were in the military at
the same time period but who were not deployed to Vietnam. Kang and colleagues (2014a) updated total and cause-specific mortality analyses of female
U.S. Vietnam-era veterans through December 31, 2010, using the same sources
to determine vital status as were used by Thomas et al. (1991) and Dalager et
al. (1995a). For deaths that occurred before 1992, the cause of death was ascertained from official death certificates. For deaths occurring on or after January
1, 1992, cause-of-death information was obtained from NDI Plus, which codes
the cause of death by the International Classification of Diseases (ICD) system.
The underlying causes of death were formally assigned by a qualified nosologist.
This mortality update was structured as a retrospective cohort study consisting
of three study groups of female veterans who served during the Vietnam era using the same dates as Thomas et al. (1991) and Dalager et al. (1995a). The first
group included 4,734 female veterans who served in Vietnam, the second group
consisted of 2,062 female veterans who served near Vietnam, and the third group
included 5,313 female veterans who did not deploy outside of the United States.
Mortality comparisons were made using either the non-deployed U.S. cohort or
women of the U.S. general population, adjusted for age, race, and calendar year,
as the reference group. Of the total sample of 12,109 female veterans, 2,743
(23%) were deceased by the study end date of December 31, 2010, and the cause
of death was available for 96.2% of the deaths. The adjusted total mortality and
heart-disease-specific rates were lower in the female Vietnam veterans than in the
U.S. Vietnam-era female veterans or in the U.S. general population. The cancer
mortality rate was approximately equal between the female Vietnam veterans
group and both the U.S. cohort of female veterans and the U.S. general population. When the analysis was constrained to nurses only (approximately two-thirds
of the study cohort), higher adjusted mortality rates for pancreatic, brain, and

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

BACKGROUND ON SELECTED EPIDEMIOLOGIC STUDIES AND POPULATIONS

131

other nervous system cancers were reported for the female Vietnam veterans.
Whereas all reports from the female U.S. Vietnam-veteran cohort provide direct
information on the health and mortality status of female military personnel who
served in Vietnam, the limitations of the results must be kept in mind. Specifically, female veterans likely experienced low herbicide exposure because they
were not involved in applying herbicides or engaged in direct combat, and their
in-country tours of duty were generally limited to 1 year and at fixed locations
that were not in proximity to known defoliated areas. In summary, this analysis
does not provide evidence of a higher risk of total or cause-specific mortality in
female Vietnam-deployed veterans compared with non-deployed female Vietnam
veterans and the U.S. general population. The suggestion of higher rates of mortality from pancreatic, brain, and other nervous system cancers among Vietnam
nurse veterans should be cautiously interpreted, given the study’s limitations and
the large number of causes of mortality examined.
VA also published studies of pregnancy outcomes and gynecologic cancers—
namely, neoplasms of the cervix, uterus, and ovary—in U.S. female Vietnam veterans (Kang et al., 2000a,b). Army veterans were identified from a list obtained
by the Army and Joint Services Environmental Support Group; computerized
lists were also provided by the Air Force, Navy, and Marine Corps. Militaryservice data were abstracted from personnel records. Of 5,230 eligible veterans,
4,390 with a documented tour of duty in Vietnam were alive on January 1, 1992.
From a pool of 6,657 women whose military units did not serve in Vietnam,
4,390 veterans who were alive on January 1, 1992, were randomly selected as
controls. After the research group excluded 250 veterans and 250 nonveterans
who participated in a pilot study as well as those who could not be located
(n = 370), who were deceased (n = 339), or who declined to participate (n = 775,
13% of Vietnam veterans and 17% of non-Vietnam veterans), 6,430 women
completed a full telephone interview, and another 366 women completed only
a short, written questionnaire. The information collected included demographic
background, general health, lifestyle, menstrual history, pregnancy history, pregnancy outcomes, and military experience, including nursing occupation and
combat exposure. Information on pregnancy risks and complications—including
smoking, infections, medications, exposure to X-rays, occupational history, and
exposure to anesthetic gases, ethylene oxide, herbicides, and pesticides—was
collected for each pregnancy. In Kang et al. (2000a), for each woman veteran,
the first pregnancy following the beginning of Vietnam service was designated as
the index pregnancy. For the comparison group, the first pregnancy after July 4,
1965, was designated as the index pregnancy. The study analyzed data on 3,392
Vietnam and 3,038 non-Vietnam veterans and on 1,665 Vietnam and 1,912 nonVietnam veteran index pregnancies. In Kang et al. (2000b), a self-reported history
of g ynecologic cancers (defined by the authors as cancers of the breast, ovary,
uterus, and cervix) was collected. The authors attempted to “retrieve hospital
records on all reported cancers as far back as 30 years.” Of records successfully
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found, 99% of the breast cancer and 90% of all cancer diagnoses were confirmed.
The authors did not provide specific data on diagnosis confirmation for the three
sites other than the breast, but they stated that Vietnam status was not associated
with a greater likelihood of finding confirmatory medical records.
After the publications by Kang et al. (2000a,b), Congress passed PL 106-419,
which provides compensation for the children of female Vietnam veterans who
are born with birth defects unrelated to an existing familial disorder, to a birthrelated injury, or to a fetal or neonatal infirmity with a well-established cause. The
legislation covers 18 birth defects, including cleft lip or palate, congenital heart
disease, hypospadias, neural-tube defects, and Williams syndrome. A complete
list of covered birth defects can be found in 38 CFR 3.815.
Proportionate-Mortality Cohort
Among the earliest reports on health outcomes in Vietnam veterans was
a proportionate-mortality study by Breslin et al. (1988). The participants were
Army and Marine Corps ground troops (all men) who served at any time from
July 4, 1965, through March 1, 1973. A list of 186,000 Vietnam-era Army and
Marine Corps veterans who were reported deceased as of July 1, 1982, was assembled from VA’s Beneficiary Identification Records Locator Subsystem. From
this list, 75,617 individuals were randomly selected for inclusion in the study. The
information extracted from the selected military records included duty stations,
dates of tours, branch of military service, date of birth, sex, race, military occupation specialty codes, education level, type of discharge, and confirmation of
service in Vietnam. Additional information was extracted on veterans who served
in Southeast Asia, including the first and last dates of service in Southeast Asia,
the military unit, and the country where the veteran served. For the final sample
of Army and Marine Corps veterans, the cause of death was ascertained from
death certificates or Department of Defense (DoD) Report of Casualty forms for
24,235 men who served in Vietnam and 26,685 men who did not serve in Southeast Asia. Each veteran’s cause of death was coded by a nosologist who used
ICD-8. Exposue to herbicides or other environmental factors was not considered
in the analysis. Deaths from external causes (accidents, poisonings, and violence)
were slightly eleveated among Vietnam veterans who served in the Army but
not among marines who served in Vietnam. Death from any cancer was elevated
among marines who served in Vietnam but not Army veterans. When examined
by type of cancer, proportionate mortality ratios were not elevated for Army
veterans, but proportionate mortality ratios for lung and non-Hodgkin lymphoma
(NHL) were elevated among the Marine Corps veterans.
Using the proportionate-mortality cohort assembled by Breslin et al. (1988),
Burt et al. (1987) conducted a nested case-control study of NHL with controls
selected from among the cardiovascular-disease deaths. Although unrecognized
at the time of that publication, using cardiovascular deaths as the control group
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biased estimates of NHL toward the null because some cardiovascular diseases,
such as hypertension, are associated with exposure to herbicides, see Chapter 10.
When all Army and Marine Corps veterans who were deployed to Vietnam were
compared with veterans who did not serve in Vietnam, no excess of mortality
from NHL was found. When stratified by service branch and age, only marines
with combat roles or who served in Vietnam from 1967 to 1969 (when herbicide
spraying was greatest) had statistically significant increased odds of death from
NHL. In a follow-up of the Breslin et al. (1988) study, Bullman et al. (1990)
compared cause-specific proportionate mortality of 6,668 Army I Corps Vietnam
veterans, who served in the northernmost part of South Vietnam in a combat zone
designated as Military Region I by the U.S. military, with 27,917 Army Vietnamera veterans who had not served in Vietnam. The subjects studied by Bullman
et al. included the study population identified by Breslin et al. and an additional
9,555 Army Vietnam-era veterans whose deaths were identified after VA’s Beneficiary Identification Records Locator Subsystem database was searched for
mortality data through December 31, 1984. Deaths from external causes (accidents, poisonings, and violence) were found to be slightly eleveated among
Army I Corps Vietnam veterans, particularly deaths attributed to motor vehicle
accidents and accidental poisonings. Similarly, Watanabe et al. (1991) updated
the Vietnam-veteran mortality experience reported by Breslin et al. (1988) by extending the follow-up from January 1, 1982, to December 31, 1984. An additional
11,325 deceased Army and Marine Corps Vietnam-era veterans were identified
from the period and included in the study. The study population for Watanabe
et al. consisted of 62,068 military veterans, of whom 29,646 served in Vietnam
and 32,422 never served in Southeast Asia. Proportionate-mortality ratios were
calculated for three referent groups: branch-specific (Army and Marine Corps)
non-Vietnam veterans, all non-Vietnam veterans combined, and the U.S. male
population. Deaths from external causes were again statistically significantly
elevated among Vietnam-deployed marines compared with non-Vietnam veterans
and Army veterans who served in Vietnam compared with Army veterans who
did not serve in Vietnam and all non-Vietnam veterans. Cancer of the larynx was
statistically significantly higher among Vietnam-deployed Army veterans than
either non-Vietnam Army veterans or all non-Vietnam veterans but lung cancer
was only significantly different for Army Vietnam veterans compared with all
non-Vietanm veterans. Deaths from lung cancer, NHL, and Hodgkin disease were
all statistically significantly elevated for Marine Corps veterans who had served
in Vietnam compared with marines who had not served in Vietnam only. A third
follow-up proportionate-mortality study (Watanabe and Kang, 1996) used the veterans from Breslin et al. (1988) and Watanabe et al. (1991) and included an additional 9,040 randomly selected Vietnam-era veterans who died from July 1, 1984,
through June 30, 1988. The final study included 70,630 veterans—33,833 who
had served in Vietnam and 36,797 who had never served in Southeast Asia. The
analyses were performed using the same referent groups described in Watanabe
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et al. (1991). Just as in the previous analyses of mortality, Army and Marine
Corps Vietnam veterans had statistically significant excesses of deaths from
external causes. Army Vietnam veterans had statistically significant excesses
of deaths for laryngeal cancer and lung cancer when compared to both Army
non-Vietnam veterans and all non-Vietnam veterans. Results showing statistical
significance for Marine Corps Vietnam veterans varied according to the referent
population used (non-Vietnam marine veterans or all non-Vietnam veterans).
When compared with non-Vietnam marine veterans, marine Vietnam veterans
had significantly elevated proportionate mortality ratios for deaths from NHL,
Hodgkin disease, and cancers of the pancreas, lung, and skin. Deaths from
circulatory diseases were statistically significantly lower among Marine Corps
Vietnam veterans than marines who did not serve in Vietnam and all non-Vietnam
veterans. Marine Corps Vietnam veterans also had significant excesses for lung
cancer and skin cancer compared with all non-Vietnam veterans. Proportionate
mortality ratios for deaths due to respiratory and digestive diseases were statistically significantly lower among marine Vietnam veterans than all non-Vietnam
veterans. Compared with the standardized U.S. population, deaths from many
of the major categories of organ systems were statistically significantly lower
among both the Vietnam-deployed and non-deployed veterans. However, cancers overall were higher among the Vietnam-deployed and non-deployed Army
veteran groups and the Marine Corps non-Vietnam veteran group. Lung cancer
deaths were significantly higher among both Army veteran groups and the Marine
Corps Vietnam-deployed group compared with the U.S. population. Using the
U.S. population for comparison, proportionate mortality ratios were statistically
significantly higher for prostate cancer in Army non-deployed veterans and skin
cancer for Marine Corps veterans that served in Vietnam.
National Vietnam Veterans Readjustment and Longitudinal Studies
In response to concerns about the health and well-being of Vietnam veterans, in 1983 Congress passed PL 98-60, which directed VA to contract for an
independent national study looking at the frequency and effects of posttraumatic
stress disorder (PTSD) and related postwar psychological issues. In 1984 the contract for the National Vietnam Veterans Readjustment Study was awarded to the
Research Triangle Institute (RTI). Several publications resulted from that work
(Currier and Holland, 2012; Schlenger et al., 2015a; Yager et al., 2016) but given
the focus on mental health, most are not relevant to the VAO series.
In 2000 Congress passed PL 106-419, which directed VA to contract for a
follow-up study, the National Vietnam Veterans Longitudinal Study, to determine
the effects of PTSD over a 25-year period and postservice adjustment. The study
was awarded to Abt Associates (VA, 2018b). A total of 1,450 veterans participated in at least one of the study phases of the National Vietnam Veterans Longi
tudinal Study, which included a self-administered paper health questionnaire,
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a computer-assisted telephone health interview, and a telephone mental health
interview conducted by a professional clinical interviewer (Marmar et al., 2015).
Results from this second effort have been recently published (Marmar et al.,
2015; Schlenger et al., 2015b, 2016; Steenkamp et al., 2017). But because the
focus of this research is mental health outcomes, the results are not considered
by VAO update committees. The data collected from veterans who participated in
both the National Vietnam Veterans Readjustment Study and the National Vietnam Veterans Longitudinal Study are now part of the National Vietnam Veterans
Longitudinal Study Registry, which was acquired in 2015 and is housed at VA’s
Seattle Epidemiologic Research Information Center in Seattle, Washington (VA,
2018a). However, as noted previously, VAO committees do not consider mental
health conditions in their review of health outcomes of Vietnam veterans.
Most recently, VA has undertaken a new research initiative to assess the
current health of Vietnam veterans who served on the ground, Blue Water Navy
veterans, and veterans who served elsewhere during the Vietnam Era (1961–1975).
The Vietnam Era Health Retrospective Observational Study (VE-HEROeS) is
designed to compare the overall health, lifestyle characteristics, and aging-related
conditions of these veterans with similarly aged U.S. residents who never served
in the military. The committee invited the lead investigator, Dr. Victoria Davey, to
discuss the project. The study was designed to compare a retrospective cohort of
Vietnam veterans, with all service branches represented, with Vietnam-era veterans who were deployed to countries other than Vietnam, Cambodia, or Laos and
with members of the U.S. general population who never served in the military.
Recruitment was based on a sampling frame that was constructed to be a randomly
selected sample of persons from VA’s database of all veterans (both users of VA
health care or benefits and those not using VA services). The questionnaire collected information on the following topics: military service (combat experience,
chemical and other exposures, re-entry into civilian life, or no military service),
general health (neurologic conditions, infections, presumptive conditions, cancer,
hypertension, and mental health conditions), experience with aging, lifestyle factors (tobacco use, health care use, living arrangements), and health experiences of
descendants (nine questions on birth defects and other conditions of children and
grandchildren). A medical records review is being conducted of a small subset of
participants (n = 4,000) to validate the questionnaire information (Davey, 2017).
The data are being analyzed, and although some abstracts and posters containing
a few findings have been submitted to VA research and outside conferences, no
results had been published in the peer-reviewed literature as of January 31, 2018.
Other VA Studies
VA also conducted studies that focused on specific health outcomes, using
data from VA’s Agent Orange Registry, a computer database containing health
information on Vietnam veterans who voluntarily undergo examinations in a
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VA hospital. This registry was established in 1978 to monitor health complaints
or problems of Vietnam veterans that potentially could be related to herbicide
exposure during their military service in Vietnam, but it was not intended to be
a research program (Dick, 2015). The registry was established also as a means
to facilitate increased access of Vietnam veterans to the VA health care system.
Veterans are eligible to participate if they had any active military service in the
Republic of Vietnam between 1962 and 1975 and express a health concern related to herbicide exposure. Beginning in 2011, eligibility has been expanded to
include veterans who served along the Korean Demilitarized Zone between 1968
and 1971, veterans who served in certain units in Thailand, and veterans who
were involved in the testing, transporting, or spraying of herbicides for military
purposes (Dick, 2015). The examinations that these veterans undergo consist of
an exposure history (based on self-reports that are not verified by DoD records),
a medical history, laboratory tests if indicated, and an examination of the organ
systems most commonly affected by toxic chemicals. The quality, consistency,
and usability of data from this registry—and indeed from all registries with
voluntary participation that rely on self-reported information—are limited. As of
July 6, 2017, this registry contained information on 676,774 veterans who had undergone an initial examination and there had been 79,846 follow-up evaluations,
for a total of 756,620 examinations (VA, 2017b). Some VA investigators have
used participation in the registry as a surrogate of herbicide exposure (Clemens
et al., 2014; Nosrati et al., 2014; Ovadia et al., 2015).
Other VA analyses have relied on self-reported exposure to herbicides (Beard
et al., 2016, 2017; Krishnamurthy et al., 2016; Le et al., 2016; Q. Li et al., 2013).
Two other VA studies (Baumann Kreuziger et al., 2014; Mescher et al., 2018) determined exposure to Agent Orange (or presumably other herbicides) by reviewing claims of exposure submitted by veterans that were reviewed by VA benefits
and compensation officers who used service records to confirm that locations and
timeframes of deployment corresponded to sprayed areas.
VA has evaluated specific health outcomes, including carrying out case-control
studies of soft-tissue sarcoma (STS) (Kang et al., 1986, 1987), NHL (Dalager
et al., 1991), Hodgkin lymphoma (HL) (Dalager et al., 1995b), testicular cancer
(Bullman et al., 1994), and lung cancer (Mahan et al., 1997). Each study created
and applied a different measure of surrogate herbicide exposure because objective
measures, such as serum TCDD analyses, were not available. Other VA studies
included a post-service mortality analysis (separate from the proportionate mortality cohort) of marines that compared those who served in Vietnam (n = 10,716)
with Vietnam-era marines (n = 9,346) (Watanabe and Kang, 1995), and a small
case-control study that compared dioxin and dibenzofuran concentrations in the
adipose tissue of 36 Vietnam veterans and 79 non-Vietnam veterans and a sample
of U.S. men born in 1936–1954 (Kang et al., 1991). All tissue samples were
archived specimens from the EPA’s National Human Adipose Tissue Survey and
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had been collected by hospitals and medical examiners from men who died from
external (non-combat) causes or surgical procedures.
VA has examined other outcomes in Vietnam veterans: PTSD (Bullman et al.,
1991; Goldberg et al., 1990; True et al., 1988), suicide and motor-vehicle crashes
(Bullman and Kang, 1996; Farberow et al., 1990), tobacco use (McKinney et al.,
1997), and self-reported physical health (Eisen et al., 1991). The studies have
been included for completeness, but the outcomes that they address are outside
the purview of this committee. VAO and Update 1998 discussed them in detail;
most did not deal with exposure to herbicides specifically, and the exposure to
“combat” was evaluated as the risk factor of interest. As noted VA has also initiated a study to update the mortality experience of Vietnam veterans. This update
is expected to update the rates, causes, and patterns of overall and cause-specific
mortality from 1979 through 2014 of all Vietnam veterans compared with all
Vietnam-era veterans and the general U.S. population (Davey, 2017).
Centers for Disease Control and Prevention Studies
Surveys of U.S. Vietnam veterans who were not part of the Ranch Hand or
ACC groups indicated that 25% to 55% believed they were exposed to herbicides
(CDC, 1989b; Erickson et al., 1984a,b; S. D. Stellman and J. M. Stellman, 1986).
Several attempts have been made to estimate the exposures of Vietnam veterans
who were not part of the Ranch Hand or ACC groups. CDC has undertaken a
series of studies to examine various health outcomes in Vietnam veterans as
directed by Congress in the Veterans Health Programs Extension and Improvement Act of 1979 (PL 96-151) and the Veterans’ Health Care, Training, and Small
Business Loan Act of 1981 (PL 97-72). The first of these CDC studies was a
case-control interview study of birth defects in the offspring of men who served
in Vietnam, which included developing an exposure opportunity index to score
herbicide exposure (Erickson et al., 1984a,b).
Agent Orange Validation Study
The CDC Agent Orange study (CDC, 1985) was initiated in response to a
1983 request by the U.S. government to conduct a study of possible long-term
health effects in Vietnam veterans exposed to herbicides. The study attempted
to classify veterans’ service-related exposures to herbicides by determining the
proximity of troops to herbicide spraying through the use of military records
to track troop movement and the use of the HERBS tapes1 to locate herbicidespraying patterns.

1 The HERBS tapes were a digital record of herbicide spray missions compiled by the Department of
Defense in the early 1970s. Information on them is presented in the original VAO report (IOM, 1994).
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In 1987, CDC conducted the CDC Agent Orange Validation Study to test
the validity of the various indirect methods used to estimate the exposure of
ground troops to herbicides in Vietnam. The study measured serum TCDD in a
non-random sample of Vietnam veterans and in Vietnam-era veterans who did not
serve in Vietnam (CDC, 1988b). Vietnam veterans were selected for the study on
the basis of the number of herbicide exposure events that they were thought to
have experienced, based on the number of days their unit was within 2 kilometers
and 6 days of a recorded herbicide-spraying event. Blood samples were obtained
from 66% of 646 Vietnam veterans and from 49% of the eligible comparison
group of 97 veterans. More than 94% of those whose serum was obtained had
served in one of five battalions.
The median serum TCDD concentration in Vietnam veterans in 1987 was
4 ppt (range: < 1 to 45 ppt, but only two veterans had concentrations above
20 ppt). The “low” exposure group consisted of 298 Vietnam veterans, the
“medium” exposure group 157 veterans, and the “high” exposure group 191
veterans. The distribution of TCDD measurements was nearly identical to that
in the control group of 97 non-Vietnam veterans. The CDC validation study
concluded that study participants could not be distinguished from controls on the
basis of serum TCDD. In addition, neither record-derived estimates of exposure
nor self-reported exposure to herbicides could predict which Vietnam veterans
would have high serum TCDD at the time of the study (CDC, 1988b, 1989a). The
report concluded that it was unlikely that military records alone could be used
to identify a large number of veterans who might have been heavily exposed to
TCDD in Vietnam. The serum TCDD measurements in Vietnam veterans also
suggested that the exposure to TCDD in Vietnam was substantially lower, on
average, than that of persons exposed as a result of the industrial explosion in
Seveso, Italy, or that of the heavily exposed occupational workers who have been
the focus of many of the studies evaluated by VAO committees. The assessment
of average exposure does not eliminate the possibility that some Vietnam veterans
had heavy exposures.
Vietnam Experience Study
Using exposure estimates from the Agent Orange Validation Study, CDC
conducted the CDC Vietnam Experience Study, a historical cohort study of the
health experience of Vietnam veterans (CDC, 1989b). The study was divided into
three parts: physical health, reproductive outcomes and child health, and psychosocial characteristics (CDC, 1988a,c,d). CDC examined post-service mortality
(through 1983) in a cohort of 9,324 U.S. Army veterans who served in Vietnam
and in 8,989 Vietnam-era Army veterans who served in Germany, Korea, or
the United States (Boyle et al., 1987; CDC, 1987). In other studies using the
data collected from the Agent Orange Validation Study, O’Brien et al. (1991)
combined the mortality and interview data to identify veterans who developed
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NHL. Decoufle et al. (1992) evaluated the influence of self-reported exposure to
herbicides on self-reported adverse health outcomes. Finally, in a follow-up of
CDC’s Vietnam Experience Study cohort, Boehmer et al. (2004) reported findings
on mortality from 1965 through 2000.
Selected Cancers Study
The CDC Selected Cancers Study (CDC, 1990a) was designed to investigate
the effects of military service in Vietnam and of exposure to herbicides on the
health of American veterans, with a specific focus on the risk of developing NHL
(CDC, 1990b), STS and other sarcomas (CDC, 1990c), HL (CDC, 1990d), and
nasal, nasopharyngeal, and primary liver cancers (CDC, 1990d).
Other U.S. Vietnam-Veteran Studies
American Legion Study
The American Legion, a voluntary service organization for veterans, conducted a cohort study of the health and well-being of Vietnam veterans who were
members. The studies examined physical health and reproductive outcomes, socialbehavioral consequences, and PTSD in veterans who had served in Southeast
Asia and elsewhere (Snow et al., 1988; J. M. Stellman et al., 1988; S. D. Stellman et al., 1988a,b). No additional studies have been published on the cohort.
State Studies
Several states have conducted studies of Vietnam veterans, most of which
have not been published in the scientific literature. The VAO and Update 1996
committees reviewed studies of veterans of Hawaii (Rellahan, 1985), Iowa
(Wendt, 1985), Maine (Deprez et al., 1991), Massachusetts (Clapp, 1997; Clapp
et al., 1991; Kogan and Clapp, 1985, 1988; Levy, 1988), Michigan (Visintainer et
al., 1995), New Jersey (Fiedler and Gochfeld, 1992; Kahn et al., 1988, 1992a,b,c),
New Mexico (Pollei et al., 1986), New York (Greenwald et al., 1984; Lawrence
et al., 1985), Pennsylvania (Goun and Kuller, 1986), Texas (Newell, 1984), West
Virginia (Holmes et al., 1986), and Wisconsin (Anderson et al., 1986a,b). Chamie
et al. (2008) examined the association between herbicide exposure and prostate
cancer in Vietnam-era veterans using the VA health system in northern California;
the reliability of this study of about 13,000 men is limited by its reliance on selfreported exposure status and by the exclusion of prostate cases diagnosed before
1998, before computerized records became available. No additional single-state
studies have been identified.
Grufferman et al. (2014) evaluated the role of parental military service in
Vietnam and service-related exposures and the risk of rhabdomyosarcoma in
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offspring using data from the Intergroup Rhabdomyosarcoma Study Group clinical trial, which included hospitals in 46 U.S. states and the District of Columbia
from 1982 to 1988.
Australian Vietnam-Veteran Studies
The Australian government has commissioned a number of studies to follow
the health outcomes of Australian veterans who served in Vietnam. Although the
Australians did not participate in herbicide spraying, there is a possibility that
they may have been exposed to the herbicides if stationed or passing through
areas that were sprayed.
Australian Vietnam Veterans
The Australian Vietnam veterans study population corresponds to the cohort
defined by the Nominal Roll of Vietnam Veterans, which lists Australians who
served on land or in Vietnamese waters from May 23, 1962, to July 1, 1973,
including military and some non-military personnel of both sexes. People who
served in any branch of service in the defense forces and citizen military forces
(such as diplomatic, medical, and entertainment personnel) were considered. The
comprehensive studies, however, are limited to male members of the military, and
most of the analyses focus on men in the defense forces—the Army (41,084),
the Navy (13,538), and the Air Force (4,570). One investigation examined the
possibility of an association between Vietnam service and cancer incidence by
comparing diagnoses from 1982 to 2000 among male Vietnam veterans with
those in the general population of Australia (ADVA, 2005a). The results in that
report supersede those reported by the Australian Department of Veterans’ Affairs
(CDVA 1998a). Morbidity in female Vietnam veterans had also been studied
(CDVA, 1998b). Additional case-control studies of the incidence of adrenal gland
cancers, leukemias, and NHL were conducted in this population (AIHW, 1999,
2000, 2001).
There have been several studies of mortality among Australian Vietnam
veterans (CDVA, 1997; CIH, 1984a,b,c; Crane et al., 1997a,b; Evatt, 1985;
Fett et al., 1987a,b; Forcier et al., 1987). The latest one (ADVA, 2005b), which
considered the causes of death of men in all branches of service through 2001
compared with that of the general Australian population and reported by branch
of service, supersedes the others.
Australian Vietnam Veterans Family Study
The Australian Department of Veterans’ Affairs has published four large
volumes that summarize the results of studies conducted among family members
of Vietnam-era veterans (ADVA, 2014a,b,c,d). The purpose of this study was to
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better understand the long-term impacts of service on the health and welfare of
the families of Australian Vietnam veterans. The first volume (2014a) provided
an overview of the entire effort. The second (2014b) assessed the health of the
family members with more emphasis placed on the details of psychological
and social well-being, rather than adverse impacts on physical health. The third
(2014c) investigated mortality among members of the veterans’ families, while
the final volume (2014d) discussed qualitative information gathered in the course
of the entire study. Although responses were collected on spouses and partners of
the veterans, the analyses focused on outcomes reported by the children of the
veterans. The wide range of outcomes examined for the family members themselves included mental health outcomes, pregnancy and birth defect outcomes,
physical health, social functioning, and mortality. Because many of the health
outcomes reported for these family members are not central to the charge of the
committee (e.g., mental health and social functioning), minimal consideration
was given to these publications.
From the roster of Australian Vietnam veterans, more than 10,000 Australians who had served in the Vietnam War were randomly selected and contacted,
along with their family members, for potential participation in the study. The
Vietnam veterans who were identified and ultimately selected included 3,940
who were randomly selected and 2,569 who self-selected into the study based on
media publications announcing that the study would be conducted.
The primary comparison group consisted of family members of nondeployed Vietnam-era personnel. These personnel comprised 3,967 randomly
selected non-deployed era veterans and 418 who self-selected into the study.
Thus, there were far more Australian Vietnam veterans who self-selected into
the study than non-deployed Australian Vietnam-era veterans who self-selected,
and the percentage of the Vietnam veterans who self-selected was much higher
than the percentage of non-deployed Vietnam-era veterans who self-selected. In
total, the family members of Vietnam veterans included 2,199 sons and daughters,
of whom 1,385 were examined for pregnancy and birth defect–related outcomes.
When there is no specific exposure information provided, the VAO series has
considered these comparisons of deployed versus non-deployed groups to cover
potential exposure to all the COIs and thus the most relevant measures for their
task. Such contrasts, however, also cover all aspects of the deployment experience, and in this set of Australian studies there was considerably more concern
about the psychological effects on the veterans (especially PTSD) and their secondary impact on the veterans’ family members, which would not be expected to
be an effect of herbicide exposure. Some analyses have been conducted among
all study participants, and some analyses were stratified by the type of enrollment (random versus self-selected). The committee fully recognized the potential
reporting biases that may have emanated from the self-selected cohort, and thus it
placed considerably more weight on the results derived for the randomly selected
cohort, as did the researchers themselves.
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Australian Conscripted Army National Service
The Australian Conscripted Army National Service study population is a
subset of the veterans considered in the overall Australian Vietnam Veterans
study group. The 19,240 conscripted male Army veterans deployed to Vietnam
(“National Service” veterans) were compared with 24,729 non-deployed counterparts (“National Service non-veterans”). The results on death and cancers
in the Australian conscripted Army National Service veterans (ADVA, 2005c)
supersede those of earlier internal comparisons of deployed and non-deployed
Vietnam War–era National Service veterans (CIH, 1984a,b,c; Crane et al., 1997b;
Fett et al., 1987a,b). Those government-sponsored studies of Australian Vietnam
veterans did not characterize the veterans’ exposure to the herbicides sprayed in
Vietnam beyond the fact that they had served on land or in Vietnamese waters
from May 23, 1962, through July 1, 1973. It is the convention of VAO committees to regard Vietnam veterans in general as being more likely to have received
higher exposures to the COIs than the general public, but ideally that assumption
should have been validated by more objective measurements of exposure, such
as serum measurements, in a sample of Australian Vietnam veterans.
Sample of 1,000 Australian Vietnam Veterans
O’Toole et al. (1996a,b,c) studied a broad spectrum of health issues in a
random sample of 1,000 Australian Vietnam veterans (both regular enlisted and
conscripted Army National Service members) selected from Australia’s comprehensive roster of 57,643 service members who were deployed to Vietnam. In
wave 1, conducted in 1990–1993, 641 members of the sample were located and
interviewed. In wave 2, conducted in 2005–2006, O’Toole et al. (2009) obtained
responses from 450 (51.4% of those not known to have died). A total of 391
veterans responded to both waves. The Australian Bureau of Statistics’ National
Health Survey was administered in both waves, and additional data were collected on combat experience, PTSD, and general psychiatric status. The veterans’
self-reported health status was compared with that of the general male Australian
population gathered during the government’s administration of the same survey in
1989–1990 and 2004–2005; it is not clear that this instrument was administered
to the two groups under comparable conditions. The low response rates make the
findings vulnerable to nonresponse bias, and the self-report measures of health
conditions might be of low validity and subject to recall bias. The committee for
Update 2010 was skeptical about the reliability of the nearly uniform findings of
statistically increased prevalence of nearly 50 health conditions.
O’Toole et al. (2010) reported on mortality in the sample through 2004 as
related to previously gathered information on psychosocial factors that are not
within the scope of VAO reviews. It is of interest, however, that they found that
11.7% of the veterans in the sample had died by the end of 2004. Additional
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publications using the survey results from waves 1 and 2 have been published on
the course of combat-related PTSD (O’Toole and Catts, 2017) and the intergenerational transmission of PTSD in the offspring of these veterans (O’Toole et al.,
2017). However, as mental health outcomes related to combat cannot easily be
teased apart from any potential effects of herbicide exposure, such publications
are not reviewed in depth.
Birth Defects in Australian Infants
The Australian government sponsored a case-control study of 8,517 infants
with congenital anomalies born in 1966–1979 at 34 hospitals in New South
Wales, Victoria, and in the Australian Capital Territory; the infants were matched
by period of birth, mother’s age, hospital, and means of hospital payment to liveborn infants without diagnosed birth defects (Donovan et al., 1983, 1984; Evatt,
1985). The fathers of infants in both groups were identified and their names
compared with those on the roster of men who had served in the Australian Army
in 1962–1972; additional means of verification were used to determine whether
a child’s father was in the Army during this interval (329 cases and 338 controls)
and also whether the father was deployed to Vietnam (127 cases and 123 controls). After adjustments were made for maternal age, infant sex, multiple births,
and father’s place of birth, conditional logistic regression was used to compare
the Vietnam veterans (National Service or regular Army) to other era veterans
and to all other fathers for all birth anomalies and for seven diagnostic groups.
Korean Vietnam-Veteran Studies
Military personnel of the Republic of Korea served in Vietnam from 1964
through 1973. Studies of the health of these personnel have been pursued by
several researchers.
Study of TCDD Concentrations in Korean Vietnam Veterans
J. S. Kim et al. (2001) attempted to use serum dioxin concentrations to validate an index for estimating group exposure. The study involved 720 veterans
who served in Vietnam and 25 veterans who did not. The exposure index was
based on herbicide-spraying patterns in military regions where Korean personnel
served, time and location data on the military units stationed in Vietnam, and an
exposure score derived from self-reported activities during service. A total of 13
pooled samples were submitted to CDC for serum dioxin analyses. One analytic
sample was prepared from the pooled blood of the 25 veterans who did not serve
in Vietnam. The remaining 12 samples were intended to correspond to 12 exposure categories; each was created by pooling blood samples from 60 veterans. The
12 exposure categories ultimately were reduced to four exposure groups, each
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representing a quartile of 180 Vietnam veterans but characterized by only three
serum TCDD measurements.
The paper by J. S. Kim et al. (2001) reported highly significant Pearson
correlation coefficients and results of multiple logistic-regression analysis. The
statistical analyses apparently were based on the assignment of the pooled serum
dioxin value to each individual in the exposure group. The multiple regression
analysis evaluated such variables as age, BMI, and consumption of tobacco or
alcohol. In a later report on the same exposure groups and serum dioxin data,
the authors corrected their analysis (J. S. Kim et al., 2003). A correlation was
observed between serum dioxin concentrations and ordinal exposure categories,
but the correlation was not statistically significant. The authors attributed the lack
of statistical significance to the small sample size, and they noted that the data
exhibited a distinct monotonic upward trend; the average serum dioxin concentrations were 0.3, 0.6, 0.62, 0.78, and 0.87 pg/g (lipid-adjusted) for, respectively,
exposure categories 0 through 4. The decision to pool blood samples from a
large number of persons in each exposure set (J. S. Kim et al., 2001) greatly
reduced the power of the validation study. Instead of 180 samples in each of the
final exposure categories, the pooled analysis produced only three samples in
each category. The lipid-adjusted serum TCDD concentrations in the 12 pooled
samples from Vietnam veterans ranged from 0.25–1.2 pg/g, whereas the single
sample from the non-Vietnam veterans contained 0.3 pg/g. The narrow range of
results makes the biologic relevance of any differences questionable.
Thus, it appears that there was not a clear separation in terms of TCDD levels
between Korean Vietnam veterans and non-Vietnam veterans. Furthermore, the
range of mean values in the four Vietnam veteran exposure categories was narrow, and all concentrations were relatively low (less than 1 pg/g). The relatively
low serum dioxin concentrations observed in the 1990s in those people are the
residuals of substantially higher initial concentrations, as has been seen in other
Vietnam veteran groups. However, the concentrations reported in the Korean
veterans study are significantly lower than those reported in American Vietnam
veterans in the 1988 CDC Agent Orange Validation Study, which was nonetheless
unable to distinguish Vietnam veterans from non-Vietnam veterans on the basis of
serum dioxin (CDC, 1988b). The Korean authors were able to construct plausible
exposure categories based on military records and self-reporting, but they were
unable to validate the categories with serum dioxin measurements.
Korean (Vietnam) Veterans Health Study
Six publications have been reviewed from an exceptionally large epidemiological study of more than 180,000 Korean Vietnam veterans, denoted herein
as the “Korean study.” It is much larger in scope than all of the other published
epidemiological studies conducted among Vietnam veterans. The Korean study
provides results for a very large set of health outcomes, including rare conditions,
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as well as non-fatal outcomes and cause-specific mortality. The research methodology used in the Korean study was very carefully evaluated by the Update 2014
committee (the first committee to examine these publications) because the study
used multiple methods of exposure ascertainment and health outcome ascertainment. The careful evaluation was done so that across all health outcomes, committee members would weigh the results from the Korean study in a consistent
manner and take into account the strengths and limitations from this large body
of data.
For the Assessment of the Potential Exposure to Herbicides Publications on
the Korean study have relied on multiple methods for the exposure assessment
(referred to imprecisely in the Yi articles as Agent Orange). First, a self-report
perceived exposure index was used to query Korean veterans as to how they
might have been exposed to herbicides in Vietnam (Yi et al., 2013a,b). Responses
to six questions on a postal survey were used to derive a four-tiered categorization of self-perceived herbicide exposure (Yi et al., 2013a); see Table 5-1. The
initial four-tier scale (high, moderate, low, and none) was further compressed into
simply “high” or “low” for many analyses. The perceived herbicide exposure
estimates were highly correlated with the health outcomes, indicating the possibility of recall bias.
In the second method, an objective exposure opportunity index (EOI) score
of exposure potential was calculated for each veteran based on the proximity of
the veteran’s military unit to herbicide-sprayed areas (Yi et al., 2014a,b). The
Korean investigators obtained locations and calendar date histories for the military units represented in their cohort and used this information as input to obtain
EOI scores from its model (J. M. Stellman et al., 2003b), which consolidates
all the temporal and spatial information gathered from the original military records on the herbicide spray missions conducted in Vietnam. The investigators
classified the resulting EOI scores using two- and four-group categorizations

TABLE 5-1 Distribution of Perceived Herbicide Exposure Among 114,562
Korean Vietnam Veteransa
2 Groups

Exposure Questions

4 Groups

Prevalence

High

1. Sprayed herbicides
2. Handled herbicide spray equipment
3. Present during herbicide spraying
4. Got herbicide on skin or clothing
5. Walked through sprayed area
6. Exposed in other ways (not listed above)
Answered “no” to all six questions

High

16.1%

Moderate

35.7%

Low

13.2%

None

34.9%

Low

aExposure

assigned based on their self-reported responses to a postal survey.
SOURCE: Adapted from Yi et al., 2013a.
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and multiple aggregations of military units. The initial four-tier scale (high,
moderate, low, and none) was further compressed into simply “high” or “low”
for many analyses, the details of which are presented in Tables 5-2 and 5-3. The
self-reported perceived exposures are not directly comparable to the objective
EOI scores, which were designed to assess the exposure opportunity that would
result from unintended proximity to herbicide spraying and not the direct result
of duties that required handling or applying herbicides (IOM, 2008).

TABLE 5-2 Distribution of EOI Scores on Two-Level Scale in Epidemiology
Studies Among Korean Vietnam Veteransa
Exposure Category
(log10 EOI Score)

Yi et al. (2014a)b
Division/Brigade or Battalion/Company
(n = 111,726)d

Yi et al. (2014b)c
Division/Brigade
(n = 180,251)e

Low (< 4.0)

62.0%

52.4%

High (≥ 4.0)

38.0%

47.6%

aDetails of the two-level exposure classification is described in the Ohrr et al. (2006, publication
in Korean).
bBattalion/company level EOI score assigned for combat units only.
cThe overall range of log EOI scores in Yi et al. (2014b) is 0.0–5.8.
dYi et al. (2014a), 111,726 veterans analyzed for disease prevalence.
eYi et al. (2014b), 180,251 veterans analyzed for cancer outcomes.
SOURCES: Adapted from VAO Update 2014 (NASEM, 2016a).

TABLE 5-3 Distribution of EOI Scores on Four-Level Scalea
Source

Yi et al. (2013a)

Exposure Category
(log10 EOI score)

Division/
Brigade
(n = 96,126)b

Battalion/
Company
(n = 96,126)

Division/Brigade
or Battalion/
Companyc
(n = 111,726)d

Division/
Brigade
(n = 180,251)e

20.1%
28.2%
31.1%

26.1%
33.1%
21.5%

30.9%
31.2%
20.1%

25.2%
27.2%
28.3%

20.6%

19.3%

17.9%

19.3%

None (< 0.1)
Low (0.1 ≤ EOI < 4.0)
Medium (4.0 ≤ EOI
< 5.0)
High (≥ 5.0)

Yi et al. (2014a)

aDetails

of the four-level exposure classification is described in Ohrr et al. (2006, publication in
Korean).
bYi et al. (2013a), 96,126 veterans analyzed for self-reported disease prevalence. Log (EOI score)
mean and range not reported.
cBattalion/company level EOI score assigned for combat units only.
dYi et al. (2014a), 111,726 veterans analyzed for disease prevalence. Log (EOI score) mean 2.6
± 2.2 (range 0.0–6.2).
eYi et al. (2014b), 180,251 veterans analyzed for cancer outcomes. Log (EOI score) range 0.0–5.8.
SOURCE: Adapted from VAO Update 2014 (NASEM, 2016a).
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In developing the EOI scores, military units were aggregated at two levels:
the larger brigade/division level and the smaller battalion/company level. The
distributions of EOI scores are similar across the Korean study publications,
regardless of military unit aggregation. The Update 2014 committee noted that
the proportion of veterans in the “high” exposure category may be too large and
the individuals too similar to the lower categories to detect the true strength of
associations between exposure and adverse health conditions. The committee
proposed that an exposure classification that put only the top 10% or 15% of
individuals in the “high” category would have been better for the purpose of
identifying adverse health effects due to exposure.
The Korean study overcame significant logistical challenges in applying the
EOI model to a large-scale epidemiologic study of a broad spectrum of health
effects. The Update 2014 committee found that although there were likely sources
of error in the EOI method for modeling herbicide exposures of Vietnam veterans,
there was no indication of systematic bias in the rank ordering of exposure scores
developed by this method. Furthermore, since nondifferential misclassification
of exposure would bias measures of association toward the null, the observed
statistically significant relationships found between EOI scores and health effects
are likely to be real.
For the Assessment of the Health Outcomes of Interest As with exposure
assessment, multiple methods were used to ascertain health outcomes in the
Korean study. First, veterans self-reported all current and physician-diagnosed
diseases. The diseases were classified into seven groups of diseases: cancers,
circulatory diseases, respiratory diseases, digestive diseases, neuromuscular diseases, endocrine diseases, and other diseases. Within the major disease groups,
self-reporting was further provided for 17 cancers (including stomach cancer,
liver cancer, and lung cancer), 13 circulatory diseases (including hypertension,
myocardial infarction, and angina), 5 respiratory diseases (including chronic
bronchitis and emphysema), 6 digestive diseases (including gastritis and peptic
ulcer), 4 neuromuscular diseases (including central nervous system disorders and
peripheral neuropathy), 2 endocrine diseases (diabetes and hypothyroidism), and
4 other diseases (including renal failure and skin disease).
Second, incidence data for the specific types of cancer reported in the cohort
were obtained from the Korean Cancer Incidence Database (1992–2003) and
classified according to ICD-10.
Third, prevalent cases of individual disease conditions were identified by
extracting claims data from the Korea National Health Insurance service during
the period January 1, 2000, to September 30, 2005. Data on health outcomes
were also obtained through a review of medical care covered directly by the
Korean government through the Veterans Health Service during the same period.
The health outcomes that were examined included the prevalence of endocrine
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diseases (ICD-10 E00–E90), neurologic diseases (G00–G99), circulatory diseases
(I00–I99), respiratory diseases (J00–J99), and digestive diseases (K00–K93).
Fourth, vital status of Korean Vietnam veterans and the underlying causes of
deaths were ascertained by use of the 1992–2005 death records of the National
Statistical Office. Categories included all causes of death, 23 specific cancers, and
36 specific causes other than cancer.
Using these multiple methods for exposure classification and health outcome ascertainment, associations between metrics of herbicide exposure potential and health
outcomes were derived. First, in some analyses, the health experiences of Korean
Vietnam veterans, as a function of their exposure status, was compared to the health
status of age-matched adults in the Korean general population. This method is known
as an “external” control group. Second, some analyses were performed among Korean Vietnam veterans with the lowest herbicide exposure classification serving as
the comparison group. This method is known as an “internal” control group.
The above variations in exposure assessment, health outcome ascertainment, and the use of internal and external comparison groups have significant
implications for the appropriate interpretation of results from the Korean study.
In considering these variations, the committee kept in mind the following methodological principles and empirical observations:
1. Whereas self-reported exposure may be reliable and valid in some research circumstances, it is generally considered less reliable and valid
than objectively obtained estimates of exposure (Zajacova and Dowd,
2011). The potential for recall bias is of particular concern, and the likelihood of this bias occurring increases with the length of time from the
potential exposure to the incidence of disease.
2. In acquiring health outcome data, objective sources (e.g., a cancer registry or
health claims system) are generally preferred over self-report outcome data,
assuming that the objective source of outcome data is largely comprehensive.
3. For morbidity and mortality analyses, the estimation and validity of relative risk may be more prone to bias when an external control group is used
(e.g., the general population) than when an internal control group is used
(Monson, 1990). This may be due to the “healthy warrior” effect. That
is, in order to be accepted to military service and deploy, members must
meet a high standard of general and physical fitness, whereas the general
population includes some individuals of poor health. Using an internal
control group, so long as the veteran groups are similar or adjusted for
potential confounding variables, alleviates concerns of bias due to the
healthy warrior effect.
4. Relative risk estimates that are only slightly above (e.g., 1.1) or below
(e.g., 0.9) the null value of 1.0 may achieve statistical significance because of the large number of subjects in the study population, but may
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still reflect bias (e.g., selection or confounding bias) and be of less clinical
significance than relative risk estimates of larger magnitude.
Therefore, when reviewing results within and across publications from the
Korean study, the Update 2014 committee gave very limited overall weight to
self-reported exposure data and self-reported health-outcomes data compared
to objective measurements of the chemicals and health outcomes of interest.
Also, more weight was given to the relative risk estimates of mortality and cancers derived from the use of an internal control group than from the use of the
general population in order to minimize concern about a healthy warrior effect.
Finally, less weight was afforded to statistically significant associations close to
the null value (e.g., ranging from 0.9 to 1.1) than to those further from the null
in order to account for differences of questionable clinical significance arising
from this large study’s statistical power and to account for modest selection bias
and confounding.
Brief Reviews of Individual Publications on
the Korean Veterans Health Study
No new publications on the Korean study were identified for the current
update. Relevant results from these publications are presented in each of the
applicable health outcome sections under the heading of Conclusions from VAO
and Previous Updates. However, to avoid redundancy, each of the publications
is reviewed here, with a focus on the methods used.
In Yi (2013), a total of 185,265 Korean men, who had served in Vietnam
from 1964 to 1973 and who were alive in 1992 were followed for cancer incidence from 1992 to 2003. Cancer diagnoses were ascertained via linkage with
the Korean National Cancer Incidence Database, whereas cancer deaths were
identified using National Statistical Office records. Cancer incidence and cancer
mortality were not examined in terms of the veterans’ herbicide exposure during
military service in Vietnam. Age-adjusted incidence and standardized incidence
ratios were calculated using the Korean male population during 1992 to 2003 as
the reference population (Yi, 2013). The overall cancer incidence among Vietnam
veterans was not higher than in the general male population. However, when the
incidence was analyzed by cancer type, Vietnam veterans and subgroups of the
study population classified by military rank (enlisted; non-commissioned officer;
officer) experienced a higher incidence of several cancers, including prostate
cancer, T-cell lymphoma, lung cancer, bladder cancer, kidney cancer, and colon
cancer, than the general Korean population. In Yi et al. (2013a), exposure of
114,562 Korean Vietnam veterans was assessed using two methods, as previously
described in the section For the Assessment of the Potential Exposure to Herbicides. The first method was perceived self-report herbicide exposure in which
veterans were categorized as having either “low” or “high” perceived exposure.
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The second method used to estimate herbicide exposure was more objective and
based on the proximity of each veterans’ military unit to herbicide-sprayed areas
using the EOI model developed by J. M. Stellman et al. (2003b) and veterans
were again classified using “high” and “low” group exposure categorizations.
Associations were reported between self-reported diseases and high versus low
exposures. All disease outcomes were based on self-report and classified into
seven groups of diseases: cancers, circulatory diseases, respiratory diseases,
digestive diseases, neuromuscular diseases, endocrine diseases, and other diseases. Subtypes of disease were reported for each disease condition. The Update
2014 committee was concerned about the reliability of self-reported exposure and
health data because the use of such data in Yi et al. (2013a) uniformly yielded
highly significant statistical associations across an exhaustive spectrum of disease
conditions, while the use of the objective EOI method of exposure classification
and documented reports of adverse health outcomes in the later publication on
this population produced more variable results. The observation of inconsistencies when theoretically more reliable measures of health and exposure were
analyzed reinforced the concern about the findings based on self-report in the
Korean study.
Yi et al. (2013b) examined the serum levels of TCDD in 102 of these Korean
Vietnam veterans for three purposes:
1. to assess their use as a potential objective tool for herbicide exposure;
2. to determine their correlation to self-reported exposure (six-item questionnaire); and
3. to evaluate how they related to age, BMI, and smoking.
In 2002 serum samples were collected, and a health examination was performed.
For an objective assessment of herbicide exposure, EOI scores were again derived using the model by J. M. Stellman et al. (2003b), and veterans were classified as low versus high exposure or in four categories consisting of none, low,
moderate, or high exposure. The serum TCDD concentrations among the Korean
Vietnam veterans were lower than those reported in other studies of Korean and
U.S. Vietnam veterans, and concentrations were not associated with herbicide
exposure indices or with age, BMI, or smoking. The net value of this study is the
observation that the assessment of serum levels of TCDD among veterans long
after service in Vietnam (e.g., 40 years or more) may be of very limited value
as a metric for herbicide exposure unless individuals were exposed to very high
levels during military service.
Yi and Ohrr (2014) examined the incidence of cancer among 180,251 Korean
Vietnam veterans from 1992 through 2003 using EOI scores for exposure assessment. The incidence of cancer was determined through a review of records from
the Korea National Cancer Incidence Database. Overall, the veterans classified
with high exposure had a small yet statistically significant higher risk of cancer

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

BACKGROUND ON SELECTED EPIDEMIOLOGIC STUDIES AND POPULATIONS

151

than the veterans classified with low exposure. Compared with low exposure,
high herbicide exposure appeared to be most related to an elevated risk of cancers of the mouth, salivary glands, stomach, and small intestine. The objective
classification of both herbicide exposure and cancer incidence is considered a
strength of this study over other publications from this cohort that used self-report
data for analyses.
Again, using EOI scores to estimate herbicide exposure, Yi et al. (2014a)
examined the prevalences of a wide range of disease conditions, specifically,
those pertaining to the endocrine, nervous, circulatory, respiratory, and digestive
systems. Health information was derived through a review of claims data from
the Health Insurance Review and Assessment Service of Korea from January 1,
2000, to September 30, 2005. Overall, and compared with low exposure, high
herbicide exposure was associated with a statistically significantly higher prevalence of hypothyroidism, autoimmune thyroiditis, other endocrine gland disorders
including pituitary gland disorders, as well as amyloidosis and Alzheimer disease.
As with Yi and Ohrr (2014), the objective classification of both herbicide exposure and disease prevalence is considered a strength of this study.
Finally, Yi et al. (2014b) used objective classifications of both herbicide exposure and cause-specific mortality to analyze cause-specific mortality in 180,639
Korean Vietnam veterans. The EOIs were used as the basis for two characterizations of herbicide exposure: as “low” versus “high” and as per unit increase based
on a log-transformed scale. The incidence of mortality and cause of death were
ascertained by the use of death records from the National Statistical Office for
the period 1992–2005. Veterans with high herbicide exposure were found to have
10% increased long-term risk of mortality and 13% increased cancer mortality.
The observed cause-specific cancer mortality estimates were very imprecise, but
were highest for thyroid cancer, chronic myeloid leukemia, small intestine cancer,
and bladder cancer.
Other Studies of Korean Vietnam Veterans
Epidemiologic studies have also looked at immunotoxicologic outcomes (H.
A. Kim et al., 2003) and skin and general disease patterns (Mo et al., 2002) in
Korean Vietnam veterans who were exposed to herbicides during the Vietnam
War. One case-control study of the association between exposure to TCDD and
recovery outcomes (hypertension, hyperlipidemia, and the rate and severity of
major adverse coronary events) in male veterans who presented with acute coronary syndrome was also examined, but the study findings are not informative
about associations between TCDD and acute coronary syndrome itself. Two new
studies of Korean veterans who served in Vietnam were identified for the current update. Y. S. Yang et al. (2016) used a case-control design to examine the
association between exposure to Agent Orange and Parkinson disease. Han et al.
(2016) conducted a small hospital-based case-control study of acute ischemic
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stroke to compare vascular features among those presumed to have been exposed
to Agent Orange (based on deployment in Vietnam) and those veterans who did
not serve in Vietnam.
New Zealand Vietnam-Veteran Studies
McBride et al. (2013) followed 2,783 male veterans from New Zealand who
served in Vietnam between 1964 and 1972. Their status with respect to cancer
incidence and mortality was determined from 1988 through 2008. This cohort
included 84% of all 3,322 Vietnam veterans from New Zealand who had survived
service in Vietnam. Standardized incidence and mortality ratios were generated
by comparing the observed incident cases and deaths in this cohort with the corresponding expected numbers of new cases and deaths rates from the general
male population of New Zealand. For all-cause mortality, the Vietnam veterans
had significantly lower rates than the New Zealand general population. Cancer
mortality and overall incidence were similar between Vietnam veterans and the
New Zealand general population, as was heart disease mortality. In contrast,
New Zealand Vietnam veterans appeared to be at higher risk of cancers of the
head and neck and oral cavity, pharynx, and larynx as well as of incident chronic
lymphoid leukemia (also known as chronic lymphocytic leukemia) than was the
New Zealand general population. Although the follow-up of this cohort was long
(20 years), the study did not have information on cancer incidence and mortality
in the time period immediately after the service (i.e., between 1972 and 1988).
It also lacked an internal comparison group, and information on potential confounding factors including smoking, drinking habits, and human papilloma virus
status was not available, which limits the interpretation of the data, particularly
regarding incident cancers. Moreover, it was assumed that any veteran who had
been deployed had been exposed to the herbicides, and the presumed exposure
was not validated through more objective measures such as serum concentrations
or even more targeted self-reported questions of exposure.
For the current report, one new follow-up publication of the New Zealand
Vietnam veteran cohort was identified. Cox et al. (2015) used hospital discharge
records from 1988 to 2009 to report the prevalent health conditions among the
same cohort of 2,783 New Zealand Vietnam veterans used by McBride et al.
(2013). For participants 30 years of age or older, person-years of follow-up were
calculated by 5-year age categories. Age-specific hospitalization rates were calculated using the total number of annual hospitalizations published by the Ministry
of Health and the average annual resident population. The comparison group was
the standardized general population of New Zealand. Standardized hospitalization ratios and 99% confidence limits were calculated and reported as a means to
control for the multiple tests performed for various outcomes. Overall, this study
found that hospital admissions due to all causes combined was slightly higher for
Vietnam veterans than for the standardized population of New Zealand. Multiple
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outcomes by system and specific conditions were reported; however, several of
the outcomes are not generally conditions for which an individual would be hospitalized (e.g., diabetes, cataract, anxiety disorder), thereby limiting the utility of
some of the findings reported. This study is also subject to the same limitations
discussed for McBride et al. (2013).
OCCUPATIONAL STUDIES
Several occupational groups in the United States and elsewhere have been
exposed to the COIs. Exposure characterization in studies of these groups varies widely in the metric used, the extent of detail, confounding exposures, and
whether individual, surrogate, or group (ecologic) measures are used. Some
studies reviewed in earlier VAO reports used job titles as broad surrogates of
exposure; others rely on disease-registry data.
The VAO committees have reviewed many epidemiologic studies of occupationally exposed groups for evidence of an association between exposure to
TCDD or to the herbicides used in Vietnam and health risks. In reviewing the
studies, the committee considered two types of exposure separately: exposure
to 2,4-D or 2,4,5-T and exposure to TCDD from 2,4,5-T or other sources. That
separation is necessary because some health effects could be associated with
an exposure to 2,4-D or 2,4,5-T in the absence of substantial TCDD exposure.
After the dioxin contamination of phenoxy herbicides was recognized, production conditions were modified to minimize that contamination, and the use of the
products most likely to contain TCDD (2,4,5-T and Silvex) was banned. As a
result, workers who were exposed to phenoxy herbicides only after the late 1970s
are not assumed to have been at risk for exposure to TCDD. The distinction is
particularly important for workers in agriculture and forestry, including farmers
and herbicide appliers, whose exposure is primarily the result of mixing, loading,
and applying herbicides.
The committee also considered studies of occupational exposure to dioxins,
focusing on workers in chemical plants that produced phenoxy herbicides or
chlorophenols, which tend to be contaminated with PCDDs. Waste-incineration
workers were also included in the occupation category because they can come
into contact with dioxin-like chemicals while handling the byproducts of incineration. Other occupationally exposed groups included were pulp-and-paper
workers exposed to dioxins through bleaching processes that use chlorinated
compounds and sawmill workers exposed to chlorinated dioxins, which can be
contaminants of the chlorophenates used as wood preservatives.
Because no new information has been published on several of these cohorts
for years or decades and detailed information on them is available in previous
volumes of the series, this section offers only a brief overview of those major
occupational cohorts and studies that have contributed to the evidence base on
potential health outcomes stemming from exposure to the COIs but for which no
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new information for the current volume is available. Instead, the focus here is on
the design and methodology of studies for those occupational cohorts for which
new information is available in this report.
Studies of Herbicide Production Workers
International Agency for Research on Cancer (IARC)
A multisite study by IARC involved 18,390 production workers and p henoxy
herbicide sprayers working in 10 countries (Saracci et al., 1991). The full cohort
was established by using the International Register of Workers Exposed to
Phenoxy Herbicides and Their Contaminants. Twenty cohorts were combined
for the analysis: one each in Australia, Austria, Canada, Finland, and Sweden;
two each in Denmark, Italy, the Netherlands, and New Zealand; and seven in
the United Kingdom. There were 12,492 production workers and 5,898 sprayers
in the full cohort. Several studies published using data from this cohort were
reviewed by the first few VAO committees and contributed to conclusions on
some cancers (Kogevinas et al., 1992, 1993, 1995, 1997), but no new studies of
the IARC cohort have been published since Update 1998.
Several of the subcohorts that make up the IARC cohort have generated independent reports that have been evaluated separately by VAO committees to garner
additional insights, such as the results associated with TCDD concentrations
measured in various subjects: Austrian production workers (Jäger et al., 1998;
Neuberger et al., 1998, 1999), British production workers (Coggon et al., 1986,
1991, 2015), Danish production workers (Lynge, 1985, 1993), Dutch production
workers (Boers et al., 2010, 2012; Bueno de Mesquita et al., 1993; Hooiveld et
al., 1998), German production workers (Becher et al., 1992, 1996; Flesch-Janys,
1997; Flesch-Janys et al., 1995, 1996; Manz et al., 1991), and New Zealand production workers (Burns et al., 2010; Collins et al., 2009a; McBride et al. 2009a,b;
't Mannetje et al., 2005, 2017, 2018). Several of the component cohorts have
not been the subject of any separate publications: Australian herbicide sprayers,
Canadian herbicide sprayers, Finnish production workers, two cohorts of Italian
production workers, and Swedish production workers. The U.S. NIOSH cohort
was added to the IARC cohort as of the 1997 publication by Kogevinas et al. and
is discussed after the international production-worker cohorts.
Previous committees have examined studies of several international productionworker or herbicide-using worker cohorts, including many that were subcohorts
of IARC. No new studies were identified by the committee for inclusion in the
current report on many of these groups, including
• BASF Ludwigshafen Plant workers, Germany, who were involved in an
accident in 1953 when some of the workers experienced extremely high
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exposures to TCDD during the manufacture of trichlorophenol (TCP), or
as a result of the accident, or following the accident during reactor cleanup,
maintenance, or demolition (Ott and Zober, 1996; Thiess et al., 1982;
Zober et al., 1990, 1994, 1997). (This group was not in the IARC cohort.)
• Two Dutch subcohorts of the IARC cohort consisting of 2,106 male
workers employed in two manufacturing factories producing and formulating chlorophenoxy herbicides: 2,4,5-T in factory A from 1955 through
1985, and 2-methyl-4-chlorophenoxyacetic acid (MCPA), 2-(2-methyl-4chlorophenoxy) propionic acid (Mecoprop, MCPP), and 2,4-D in factory
B from 1965 through 1986. Accordingly, members of both subcohorts
had potential exposure to phenoxy herbicides, but only those in factory
A would have been exposed to TCDD. Several analyses have been made
using the entire cohort population or subsets of workers from chemical
production factory A and factory B—these have examined different endpoints and applied different methods and measures to estimate exposure
to TCDD (Boers et al., 2010, 2012; Bueno de Mesquita et al., 1993;
Hooiveld et al., 1998; Saberi Hosnijeh et al., 2011, 2012a,b,c, 2013a,b).
• German production workers consisting of four German cohorts added to
the IARC cohort as of 1997: the Boehringer–Ingelheim cohort, which
had a high potential for TCDD exposure from the production of TCP and
2,4,5-T from 1951 to 1954 and from 1957 to 1984 (Flesch-Janys, 1997;
Flesch-Janys et al., 1995; Manuwald et al., 2012; Manz et al., 1991), a cohort in the BASF Ludwigshafen plant that did not include those involved
in the 1953 accident, and cohorts in two Bayer plants (Becher et al.,
1992, 1996). All the plants were involved in the production of phenoxy
herbicides or chlorophenols.
• Workers in Czechoslovakia (n > 80) who were exposed to TCDD during
the production of 2,4,5-T (Pazderova-Vejlupková et al., 1981; Pelclová et
al., 2001, 2002, 2007, 2009, 2011; Urban et al., 2007).
New Zealand Production Workers Two new studies on this cohort were identified ('t Mannetje et al., 2017, 2018). The Dow AgroSciences plant in New Plymouth, New Zealand, produced phenoxy herbicides from the late 1950s through
the mid-1980s. This plant also produced picloram, one of the COIs about which
very little information is available. The New Zealand cohort was incorporated
into the original IARC cohort.
Complete employment records for 1969–1984 (referred to as the 1984 cohort)
were available and 't Mannetje et al. (2005) used them to report on the mortality experience through 2000 of the 713 men and 100 women who had worked at
least 1 month in that period. McBride et al. (2009a) conducted expanded analyses
and updated previous analyses of cause-specific mortality from both cancers and
other conditions. The cohort was increased to 1,599 participants (the 1988 cohort),
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including a substantial number of people who had minimal opportunity for exposure, by extending the employment period for eligibility to November 1, 1988, and
removing the requirement that employment lasted at least 1 month. A subsample
of the 1988 cohort participated in a serum-dioxin analysis that found that 70%
had been exposed. McBride et al. (2009b) further expanded the cohort to 1,754
participants (the 2003 cohort) by further extending eligibility to anyone who had
worked at the site at any time until October 1, 2003. Both enlarged cohorts were
followed through 2004. The New Zealand Health Information Service Mortality
Collection was used to identify deaths, and exposure status was classified according to work experience. Collins et al. (2009a) described the group’s serum TCDD
concentrations overall, and Burns et al. (2010) performed analyses to determine
what factors might predict serum TCDD: age, BMI, and employment history were
found to be significant determinants. Both Collins et al. (2009a) and C. J. Burns et
al. (2010) reported standardized mortality ratios adjusted for age, sex, and calendar
age and used the New Zealand general population as the reference population. For
the 1988 cohort, effect estimates were stratified by exposure status (ever exposed
and never exposed) and by predicted cumulative exposure categories. For the
2003 cohort, standardized mortality ratios were reported for the entire cohort and
stratified by employment duration (less than 3 months and at least 3 months) and
by latency (15 years of latency and less than 15 years of latency). For the 1988
cohort, proportional-hazards survival analysis was also used to test the association
between mortality and predicted cumulative exposure categories.
The New Zealand studies have several important limitations. The sample loss
was substantial: 13% were lost to follow-up in both cohorts, and 8% of the 1988
cohort and 9% of the 2003 cohort emigrated. If subject loss was nonrandom, then
the study findings might be vulnerable to sample selection bias. In addition, the
inclusion in the 2003 cohort of the employees hired as recently as 2003 is questionable. It appears that no deaths were observed in the increment between the
1988 cohort and the 2003 cohort (those hired since 1988), presumably because
these participants were relatively young. The inclusion of the incremental participants might dilute the power of the study to detect the effects of TCDD exposure
on health outcomes that require a long latent period; participants who have not yet
“matured” through the latent period might be contributing noise rather than signal
to the analyses. The Update 2010 committee, therefore, did not give substantial
weight to the dose–response findings of McBride et al. (2009b). The serum concentrations of dioxins and furans observed in a subset of the workers in the Dow
phenoxy-herbicide plant in New Zealand have been used in estimating individual
exposure (Aylward et al., 2010; Collins et al., 2009a).
National Institute for Occupational Safety and Health (NIOSH) Studies
NIOSH has collected data on and followed several groups of U.S.
workers exposed to the committee’s COIs, including the dioxin registry; the

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

BACKGROUND ON SELECTED EPIDEMIOLOGIC STUDIES AND POPULATIONS

157

pentachlorophenol (PCP) cohort (Ruder and Yiin, 2011); the cross-sectional medical study of workers in plants producing 2,4,5-TCP and 2,4,5-T or 2,4,5-TCP,
2,4,5-T, and hexachlorophene (Alderfer et al., 1992; Calvert et al., 1991, 1992,
1994, 1998, 1999; Egeland et al., 1994; Halperin et al., 1995, 1998; Kayajanian,
2002; Lawson et al., 2004; Sweeney et al., 1993, 1996, 1997–1998); and the
TCDD mortality cohort. The NIOSH cohort was added to the IARC cohort as of
the 1997 publication by Kogevinas et al. No new studies on the entire NIOSH
cohort have been published since those reviewed in Update 2006.
NIOSH TCDD Mortality Cohort Since 1978, NIOSH has compiled an extensive set of data on chemical production workers potentially contaminated with
TCDD in 1942–1984. More than 5,000 workers who were involved in production or maintenance in any of 12 companies were identified from personnel and
payroll records; 172 additional workers identified previously by their employers
as being exposed to TCDD were also included in the study cohort (Suskind and
Hertzberg, 1984). The employees’ possible exposure resulted from working with
various substances of which TCDD was a contaminant: 2,4,5-TCP, 2-(2,4,5trichlorophenoxy) propionic acid (Silvex, 2,4,5-TP), 2-(2,4,5-trichlorophenoxy)
ethyl 2,2-dichloropropionate (Erbon), O,O-dimethyl O-(2,4,5-trichlorophenyl)
phosphorothioate (Ronnel®), and hexachlorophene. The 12 plants involved were
large manufacturing sites of major chemical companies, so many of the participants were potentially exposed to many other compounds, some of which could
be toxic and carcinogenic.
Exposure status was determined initially through a review of process operating conditions, employee duties, and analytic records of TCDD in industrial
hygiene samples, process streams, products, and waste (Fingerhut et al., 1991).
Occupational exposure to TCDD-contaminated processes was confirmed by measuring serum TCDD in 253 cohort members. The duration of exposure, defined
as the number of years an employee had worked in processes contaminated with
TCDD, was used as the primary exposure metric in the study. The use of duration
of exposure as a surrogate for cumulative exposure was based on a correlation
(Pearson correlation efficient, 0.72) between log-transformed serum TCDD levels
and the number of years worked in TCDD-contaminated processes. The duration of exposure of individual workers was calculated from work records, and
exposure-duration categories were created: < 1 year, 1–<5 years, 5–<15 years,
and ≥15 years. In some cases, information on the duration of exposure was not
available, so a separate metric, duration of employment, was defined as the total
time that each worker was employed at the study plant. Fingerhut et al. (1991)
used the exposure measures in assessing mortality through 1987.
A follow-up study (Steenland et al., 1999) examined the association between
TCDD exposure and cause of death through 1993; it examined specific health
outcomes, including cancers (all and site-specific), respiratory disease, cardiovascular disease, and diabetes. The researchers used a more refined exposure
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assessment than had previous analyses. It excluded workers whose records were
inadequate to determine the duration of exposure, and this reduced the number
of study participants to a subcohort of 3,538 workers (69% of the overall cohort).
The exposure assessment for that subcohort was based on a job–exposure matrix
that assigned each remaining worker a quantitative exposure score for each year
of work (Piacitelli and Marlow, 1997).
Subcohorts of the NIOSH TCDD Mortality Cohort
Monsanto The NIOSH study cohort (Fingerhut et al., 1991) included employees of the Monsanto facility in Nitro, West Virginia, which produced 2,4,5-T in
1948–1969. Zack and Suskind (1980) examined the mortality experience of the
121 men who had chloracne associated with an unintentional release that occurred on March 8, 1949. Other studies considered mortality and other health
outcomes in additional workers involved in numerous aspects of 2,4,5-T production at the Monsanto plant (Collins et al., 1993; Moses et al., 1984; Suskind
and Hertzberg, 1984; Zack and Gaffey, 1983). No additional studies on those
participants alone have been published; they have since been followed as part of
the NIOSH and IARC cohorts.
Dow Production Workers At the Dow plant in Midland, Michigan, 2,4-D,
TCP, and PCP were manufactured over different, overlapping time periods and
exposed different populations of workers. The cohort of TCP workers who were
potentially exposed specifically to TCDD is one of the eight cohorts in the
NIOSH cohort of dioxin-exposed U.S. workers that were entered into the IARC
phenoxy herbicides cohort. Dow PCP workers who were not exposed to TCDD
are not in the IARC or NIOSH cohorts for TCDD, but this group is one of four
cohorts included in NIOSH’s PCP cohort (Fingerhut et al., 1984; Ruder and Yiin,
2011). Dow assembled a large cohort at the Midland, Michigan, plant (Bond et
al., 1989a; Cook et al., 1986, 1987). TCDD exposure in the cohort was defined
by chloracne diagnosis (Bond et al., 1989b). Within the cohort, a subcohort study
of women (Ott et al., 1987) and a case-control study of STS (Sobel et al., 1987)
were conducted. The Dow cohorts have been followed as part of the NIOSH and
IARC cohorts since 1991 and 1997, respectively.
C. J. Burns et al. (2011) reported on cancer incidence in 2,4-D production
workers in the Dow Midland plant. The exposed cohort consisted of 1,316 men
who worked in 2,4-D operations from 1945 through 1994 and who were alive
on January 1, 1985, when the Michigan statewide cancer registry was initiated.
Exposure was considered both as a discrete category (exposed cohort members
versus a non-exposed reference population) and as a cumulative variable estimated as (job-specific exposure estimate) × (duration on the job) summed over
all jobs held since 1945. Workers were stratified into three categories according
to their estimated cumulative exposure. The cohort was followed from 1985
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through 2007. Cancer incidence was ascertained from the Michigan statewide
cancer registry, and data were linked to two other states where cohort members
might reside. Three nested cohorts were used for statistical analyses in order to
address potential problems with missing data due to migration outside the three
states, with data linkage. Cohort 1 consisted of the entire exposed cohort regardless of residency (1,316 people who had 25,267 person-years of follow-up).
Cohort 2 required Michigan residency: follow-up was terminated when a person
was no longer a Michigan resident because company records showed a permanent
non-Michigan address (those who died were classified as residents if Michigan
was listed as the state of residency on their death certificates) (1,256 who had
23,354 person-years). Cohort 3 was the most restrictive and required Michigan
residency; follow-up was terminated as soon as a person was no longer known to
be a Michigan resident (1,108 who had 18,897 person-years). People of unknown
residency status were assumed to remain Michigan residents and were included
in the follow-up for Cohort 2 but were excluded from Cohort 3. Standardized
incidence ratios were derived for all three cohorts, with Michigan white males as
the reference population; Fisher’s exact confidence intervals were used to characterize the uncertainty. For Cohort 2, additional analyses were conducted by using the National Cancer Institute’s Surveillance, Epidemiology, and End Results
registry population and a regional population as the reference populations. The
cohort was stratified according to cumulative duration and cumulative exposure
categories. There were several concerns that the study findings might be biased.
First, the study cohort might be healthier than the general population being used
as the reference population. Second, the lack of a latency period in the study
design might lead to an attenuation effect on the risk estimates. Third, Cohort 2,
which was the researchers’ focus in the study, might be vulnerable to an attenuation effect because of the uncertainty in residency status. The results on Cohort 3
are considered the least subject to bias and therefore the most reliable. Although
Cohort 3 was the smallest group and as such is also subject to the most variability, consistency in results among the three cohorts was considered confirmatory.
All Dow TCP-Exposed Workers TCP was produced in Dow’s Midland facil
ity from 1942 to 1979, and 2,4,5-T was produced there from 1948 to 1982.
Collins et al. (2009b) reported on the vital status through 2003 of 1,615 people
who worked with TCP or 2,4,5-T from 1942 through 1982; 58,743 person-years
were accumulated, and 662 deaths were observed. Standardized mortality ratios
for cause-specific mortality in the cohort—with and without the overlap of
196 people who were also part of the PCP cohort (reviewed in Collins et al.,
2009c)—were calculated by using the U.S. population as the reference population and using the Occupational Mortality Analysis Program. Work history
records were used to determine length of exposure. Serum samples used for
measuring the levels of six types of dioxins were collected for 431 TCP and
PCP workers. Historic concentrations for each dioxin congener were calculated
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from the median concentrations from the serum samples and the known halflives associated with each congener. A job exposure matrix was created for both
the TCP and PCP production facilities based on measured concentrations for
workers in different jobs. A pharmacokinetic model was applied to job-specific
concentrations to the work history of each member of the study group to estimate their time-dependent serum concentration profiles for each dioxin congener
(i.e., TCDD, as well as Hexa-CDD, Hepta-CDD, and Octa-CDD). Collins et al.
(2016) reported the results of an additional follow-up of vital status to TCP and
PCP production workers. Vital status was determined for the cohort through
December 2011; a total of 1,198 deaths since 1979 were found.
Dow PCP Production Workers These workers were engaged in the manufacture of PCP from 1937 to 1980 in the same plant where the TCP cohort
worked. Unlike TCP, PCP did not contain TCDD, but it did contain other highly
chlorinated dioxin congeners, and 20% of the PCP workers had suffered from
chloracne. Dow performed an exposure risk assessment on the subset of its manufacturing workers who were exposed to PCP (Ramlow et al., 1996). The exposure
assessment evaluated the available industrial-hygiene and process data, including
recollections from employees about their job, processes, and changes in processes
as well as data from engineering controls, measurements from surface wipes, and
exposure-monitoring data from area sampling and personal breathing zones. Jobs
in the “flaking/prilling/packaging area” were determined to have a higher potential exposure because of dermal exposure to airborne PCP; the industrial-hygiene
data suggested a difference of about a factor of 3 between the areas of highest
and lowest potential exposure. An estimated exposure-intensity score of between
1 and 3 (from lowest to highest potential exposure intensity) was assigned to
each job. Information concerning the use of personal protective equipment was
deemed to be unreliable. For each participant, cumulative PCP and TCDD exposure indexes were calculated by multiplying the duration of each exposed job
by its estimated exposure intensity and then summing across all exposed jobs.
Collins et al. (2009c) conducted a mortality study of the Dow PCP production workers with the accrual of years at risk starting at the beginning of 1940
and followed through 2003; the TCP workers were followed over the same years
(Collins et al., 2009b). The cohort consisted of 773 PCP workers; 27,035 personyears were accumulated, and 370 deaths were observed. Standardized mortality
ratios for the PCP cohort (with and without the overlap of 196 people in the TCP
cohort) were reported for cause-specific mortality, with the U.S. population as
the referent population. Proportional-hazards survival analysis was also used to
assess the association between mortality and predicted cumulative exposure as
a function of the total TCDD TEQ. An updated mortality analysis that follows
the cohort of PCP and TCP workers though 2011 and reports cause-specific
mortality on several cancers and other diseases (Collins et al., 2016) is reviewed
in the current update.
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Dow TCDD-Exposed Production Workers Dow conducted a study of 204
workers engaged in the production of 2,4,5-T (Ott et al., 1980) and another
study of 61 TCP manufacturing workers who had chloracne (Cook et al., 1980).
Industrial hygienists developed a job-exposure matrix that ranked employee exposures as low, moderate, or high on the basis of available air-monitoring data
and professional judgment. The matrix was merged with employee work histories
to assign an estimate of exposure to each job. A cumulative dose was then developed for each of the 878 employees by multiplying the representative 8-hour
time-weighted average exposure value for each job by the number of years in
the job and then adding the products for all jobs. A 2,4-D time-weighted average
of 0.05 mg/m3 was used for low, 0.5 mg/m3 for moderate, and 5 mg/m3 for high
exposure. The exposure estimates do not appear to have taken into account the
role of dermal exposure in the facilities. It is not clear to what extent the use of
air measurements alone can provide accurate classification of workers into low-,
moderate-, and high-exposure groups. The study apparently did not include biologic monitoring of 2,4-D.
Bond et al. (1983) investigated potential exposure to TCDD and morbidity
in the sets of workers reported on by Cook et al. (1980) and Ott et al. (1980). Potential TCDD exposure and reproductive outcomes were studied in the offspring
of 930 men who worked with chlorophenol from 1939 through 1975 (Townsend
et al., 1982). Dow employees who had a diagnosis of chloracne or who were
classified as having chloracne on the basis of a clinical description were followed prospectively for mortality (Bond et al., 1987). There was a succession of
mortality studies of workers involved in 2,4-D production in several of the plants
(Bloemen et al., 1993; Bond et al., 1988; C. J. Burns et al., 2001). These studies
also used the same exposure-assessment procedures.
Bodner et al. (2003) published a 10-year follow-up of the work of Cook et al.
(1986), comparing the mortality experience of 2,187 male workers at Dow who
were potentially heavily exposed to dioxin before 1983 with that of the NIOSH
and IARC cohorts. Dow researchers have published a study of serum dioxin
concentrations measured in 2002 in former chlorophenol workers (Collins et al.,
2006). Most of the workers in the study were included in the NIOSH and IARC
cohorts. The authors used their data to estimate worker exposure at the time of
exposure termination by using several pharmacokinetic models. They concluded
that their findings were consistent with those of other studies that reported high
serum dioxin concentrations in chlorophenol workers after occupational exposure.
Aylward et al. (2013) examined the elimination rates of dioxin congeners in
former chlorophenol workers from the Midland plant. Blood samples from 56
former chlorophenol workers were taken and examined in 2004–2005 and then
resampled in 2010. The purpose of this analysis was to estimate half-life reductions for TCDD TEQs, which, in aggregate, were 9.3 years for the dioxin congeners analyzed. This analysis is informative with respect to estimating elimination
rates over time for the COIs as the Vietnam-veteran cohort continues to age.
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Studies of Other Industrial Cohorts
VAO committees have reviewed several other occupational cohorts and studies
of industrial workers over the series. The countries and industries have included
• Chinese automobile foundry workers (L. Wang et al., 2013);
• pulp and paper workers exposed to TCDD and other dioxins that can be
generated by the bleaching process during the production and treatment of
paper and paper products in the United States (Henneberger et al., 1989;
Robinson et al., 1986; Solet et al., 1989), Finland (Jäppinen and Pukkala,
1991), Denmark (Rix et al., 1998), and an IARC cohort of paper and pulp
workers in 11 countries (McLean et al., 2006);
• sawmill workers with dermal and inhalation exposure through the use
of pentachlorophenates (which are contaminated with higher-chlorinated
PCDDs [Cl6–Cl8]) in British Columbia, Canada (Dimich-Ward et al.,
1996; Heacock et al., 1998; Hertzman et al., 1997), and New Zealand
(McLean et al., 2009), or to tetrachlorophenates (which are less contaminated with higher-chlorinated PCDDs) (McLean et al., 2009) in New
Zealand; and
• waste incineration workers in Japan (Yamamoto et al., 2015; Yoshida et
al., 2006) and Korea (Oh et al., 2005).
Studies of U.S. workers in other chemical plants have also included studies
of 2,4-D and 2,4,5-T production workers (Poland et al., 1971), white men employed at a chemical plant that manufactured flavors and fragrances (Thomas,
1987), and workers producing PCP, lower-chlorinated phenols, and esters of
chlorophenoxy acids (Hryhorczuk et al., 1998).
International cohorts of chemical workers exposed to the COIs have included
UK chemical workers exposed to TCDD as a result of an industrial accident in
1968 (Jennings et al., 1988; May, 1973, 1982, 1983), 2,4-D production workers
in the former Soviet Union (Bashirov, 1969), and Croatian workers exposed to
a complex mixture of pesticides (atrazine, alachlor, cyanazine, 2,4-D, and malathion) during the production process (Garaj-Vrhovac and Zeljezić, 2002). Some of
these worker populations, such as the Chinese automobile foundry workers, were
reported on only once, and others were prospectively or retrospectively followed
for years, such as waste incineration workers in Japan (Yamamoto et al., 2015;
Yoshida et al., 2006). Summaries of these studies are included in the update in
which they were first identified. For the current volume, morbidity and mortality
outcomes of worker cohorts at an electric arc furnace in Italy (Cappelletti et al.,
2016) and at a transformer and capacitor recycling plant in Germany (Fimm et
al., 2017; Haase et al., 2016; Putschogl et al., 2015) are reviewed.
Inadequate occupational hygiene at a recycling plant for capacitors and
transformers in Dortmund, Germany, led to a significant body burden of PCBs
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in workers, their family members, and people working or living in the immediate vicinity of the plant. A medical surveillance program, Health Effects in
High-Level Exposure to PCB, was initiated to provide biomonitoring to identify
potential health risks related to PCB exposure for the affected population (Kraus
et al., 2012). Workers of and residents around this plant were exposed to both
dioxin-like (PCBs 105, 114, 123, 156, 157, 167, and 189) and non-dioxin-like
PCBs as a result of contamination of the area. Participation in the surveillance
program was voluntary, and data and blood samples were collected at three time
points: immediately (beginning in 2010), 1 year, and 2 years after exposure.
PCB congeners were measured in serum using blood samples collected from the
participants, and urine samples were also collected at the three time points. Of
the eligible 294 adults, 148 participated at all three time points. Three studies
using these data were published and are reviewed in this update. Putschogl et al.
(2015) studied associations with neurotransmitter metabolites of dopamine and
norepinephrine in urine as markers of targeted effects on these specific neurotransmission pathways, and Haase et al. (2016) confirmed that PCB exposure can
modify lymphocyte profiles. However, neither of these analyses of metabolites or
immune cells is diagnostic of a specific health outcome, and they are therefore
only of tangential relevance to the committee’s charge. Fimm et al. (2017) examined a broad range of cognitive functions covering attention, executive processing, reasoning, memory, and motor performance in this cohort.
Studies of Herbicide-Using Workers
The original VAO committee and committees up through Update 2006 were
more inclusive of identified studies from the literature searches. Several of the
early studies reviewed and included in the updates had nonspecific, inferred
exposure characterizations based on “usual occupation” from death certificates,
self-reported “current occupation,” or census tract or area of residence (e.g., rural
or farming areas). The studies focused primarily on farmers and people employed
in the agricultural industry, but workers in forestry and other outdoor occupations,
such as highway-maintenance workers, are also likely to have been exposed to
herbicides and other chemicals. The problem with using such nonspecific surrogates of exposure is that it will influence and change the effect estimates (either
toward or away from the null depending on the types of bias present) making it
impossible to know the true effect of the COIs. Occupation or job titles do not
provide information on the duration or the intensity of the exposure, and they
cannot be used to determine whether a worker was exposed to a specific agent.
Even those studies that collected more details on the number of years of employment in the agriculture industry, broad categories of the chemicals used (e.g.,
herbicides, insecticides, fungicides, etc.), specific classes of chemicals or names,
the frequency of application, the use of personal protective equipment, and the
method of application may be limited by recall or information bias (depending on
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whether other records are available) and do not provide much evidentiary weight
if the specific agents and chemicals used are not collected.
Since the first VAO report, exposure assessments in epidemiology studies
have been increasingly exact in both specificity and amount, enabling the committees of the more recent updates to establish stricter criteria for accepting exposure as sufficiently specific for results to be added to the evidentiary database.
The current committee now seeks results expressed in terms of the five COIs for
this project or their analogues, and it regards classification based only on job title
as inadequate. Data derived from studies in which exposure is described nonspecifically as “herbicide” can at most be used as supportive evidence. According
to the policy established by the Agent Orange Act of 1991, studies of Vietnam
veterans are presumed to involve relevant exposure, as are studies of workers
at a particular plant during a period when it is known to have been producing
phenoxy herbicides or other chemicals recognized as having been contaminated
with TCDD.
The most reliable information on health effects among American herbicide
applicators and users exposed to the COIs has come from prospective investigations of the Agricultural Health Study (AHS). More than 200 publications have
reported on outcomes from this cohort, although not all have focused on the use
of 2,4-D or other COIs. Several new publications from the AHS were reviewed
in the current update. VAO and update committees have also reviewed studies
of other populations of farmers and agricultural workers conducted among state
populations and as part of larger cohorts such as the CropLife America Farm
Family Exposure Study (Mandel et al., 2005) and the California United Farm
Workers of America Study (Mills and Yang, 2005, 2007; Mills et al. 2005). In
addition to studies of herbicide users in the United States, several international
publications have been reviewed by VAO committees.
Agricultural Health Study
The AHS is a prospective investigation of cohorts of private pesticide applicators (farmers), their spouses, and commercial pesticide applicators in Iowa and
North Carolina, with a total of 89,658 participants, including 57,311 applicators
(82% of those seeking licensing) and 32,347 spouses (75% of all spouses). The
applicators are predominantly male, and the spouses are predominantly female.
The AHS is sponsored by the National Cancer Institute, the Environmental Protection Agency, and the National Institute of Environmental Health Sciences.
Enrollment in the study was offered to applicants for applicator certification in
Iowa and North Carolina. The project’s website (www.aghealth.nih.gov) provides
many details about the study, including a specification of which pesticides were
the subject of information gathered from the enrollment forms and mailed questionnaires (Alavanja et al., 1994).
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In phase I (1993–1997), the enrollment form for both commercial (8.6%) and
private (largely farmers) applicators asked for details on the use of 22 pesticides
(10 herbicides, including 2,4-D; 9 insecticides; 2 fungicides; and 1 fumigant)
and yes–no responses as to whether 28 other pesticides (8 herbicides, including
2,4,5-T and Silvex; 13 insecticides; 4 fungicides; and 3 fumigants) had ever been
used. A subset of 24,034 applicators also completed and mailed back a take-home
questionnaire (response rate 42%). The questionnaire asked for details about use
of the 28 pesticides with yes–no information on the enrollment form and for yes–
no responses as to whether 108 other pesticides (34 herbicides, including organic
arsenic, which would cover cacodylic acid; 36 insecticides; 29 fungicides; and 9
fumigants) had ever been “frequently” used. Although no pronounced differences
in demographics, medical histories, or farming practices were found between
those who completed the questionnaire and those who did not (Tarone et al.,
1997), it is still possible that selection bias might have compromised the validity
of any studies based on the questionnaire because of differences that might not
have been captured in the enrollment form. Dosemeci et al. (2002) published
an algorithm designed to characterize the personal exposures of that population. Weighting factors for the key exposure variables were developed from the
literature on pesticide exposure. This quantitative approach has the potential to
improve the accuracy of exposure classification for the cohort, but the published
epidemiologic studies reviewed as part of the VAO series do not appear to have
used that method.
Phase II was a 5-year follow-up conducted in 1999–2003. Computer-assisted
telephone interviews were completed by 60,138 participants. The interviews
specified “pesticides” in general to include herbicides. They asked about specific
pesticides on individual crops; for several crops, only if atrazine or 2,4-D was
specified was a participant asked whether it had been used alone or as part of
the manufacturer’s mixture. A full pesticide list was not posted on the website
with the follow-up questionnaire. In addition, dietary histories were completed
by 35,164 respondents, and buccal-cell samples were gathered from 34,810
participants. The rate of response to the phase II survey—67% overall and 63%
of the original cohort of 55,748 male applicators—was modest and leaves some
room for selection bias to compromise the validity of studies based on the survey.
In phase III (2005–2010), responses to an updated computer-assisted telephone
interview were provided by 43,426 participants.
Numerous reports on the AHS cohort have been considered in the VAO series, and several new published studies have been reviewed in the current update
(Bonner et al., 2017; Christensen et al., 2016; Henneberger et al., 2014; Koutros
et al., 2016; LaVerda et al., 2015; Lebov et al., 2015, 2016; Parks et al., 2016). All
have developed pesticide-exposure estimates or exposure categories from selfadministered questionnaires, but only those studies that have considered exposure
to the COIs are considered most relevant to VAO committees. The results on the
relative rates of individual conditions seem comparable in exposure specificity

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

166

VETERANS AND AGENT ORANGE: UPDATE 11

with findings in production cohorts in which not all of the workers included were
necessarily exposed to the COIs and may have had additional toxic exposures.
The AHS questionnaire collected detailed information regarding herbicide use;
2,4-D was the most commonly reported herbicide. Because all relevant studies
have been reviewed in detail in the VAO report that corresponded to their publication date, only an overview is presented here. Details of the studies reviewed
for the first time in the current volume are presented in the section corresponding
to the health outcome of interest. Using various subsets of the study population,
they have addressed a variety of health outcomes associated with one or more of
the COIs, including
• all-cause and cause-specific mortality (Blair et al., 2005a; Waggoner et al.,
2011) and morbidity (Alavanja et al., 2005; Blair et al., 2005b);
• incidence of prostate cancer (Alavanja et al., 2003, 2005), lung cancer
(Alavanja et al., 2004), breast cancer (Engel et al., 2005), colorectal cancer (W. J. Lee et al., 2007), cutaneous melanoma (Dennis et al., 2010),
all cancers (Alavanja et al., 2005; Koutros et al., 2010a, Samanic et al.,
2006), and risk factors for pancreatic cancer (Andreotti et al., 2009);
• neurotoxicity of chronic exposure to modest amounts of pesticides (Kamel
et al., 2005), neurologic symptoms including memory and concentration
problems (Kamel et al., 2007a), Parkinson disease (Kamel et al., 2007b,
2014; Tanner et al., 2011), and amyotrophic lateral sclerosis (Kamel et
al., 2012);
• reproductive effects (Farr et al., 2004, 2006) and cancer risk in the 21,375
children of pesticide appliers born in 1975 or later (Flower et al., 2004);
• diabetes in applicators and their wives (Montgomery et al., 2008; Starling
et al., 2014) and history of gestational diabetes (Saldana et al., 2007);
• incidence of and mortality from myocardial infarction (Mills et al., 2009)
and mortality from stroke (Rinsky et al., 2013);
• respiratory symptoms and disorders: chemical predictors of wheeze
(Hoppin et al., 2002, 2006b), hypersensitivity pneumonitis (Hoppin et
al., 2007b), chronic bronchitis (Hoppin et al., 2007a; Valcin et al., 2007),
atopic and nonatopic asthma in women (Hoppin et al., 2008), and allergic
and nonallergic adult-onset asthma (Hoppin et al., 2009);
• thyroid disease among AHS female spouses (Goldner et al., 2010) and
male pesticide applicators (Goldner et al., 2013); and
• genetic markers (single nucleotide polymorphisms and candidate genes)
and outcomes of prostate cancer risk (Andreotti et al., 2012; Barry et al.,
2011, 2012; Karami et al., 2013; Koutros et al., 2010b, 2011), and telomere length (Hou et al., 2013).
Health outcomes examined by a single study that have accounted for and presented results on relevant COI exposures include doctor visits resulting from

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

BACKGROUND ON SELECTED EPIDEMIOLOGIC STUDIES AND POPULATIONS

167

pesticide exposure (Alavanja et al., 1998), rheumatoid arthritis (De Roos et al.,
2005b), hearing loss (Crawford et al., 2008), and rhinitis in the past 12 months
(Slager et al., 2009).
Several additional publications have discussed pesticide-use patterns in the
population (Hoppin, 2005; Hoppin et al., 2006a; Kirrane et al., 2004; Samanic et
al., 2005), estimated amounts of absorption of 2,4-D and chlorpyrifos exposures
(Thomas et al., 2010), and have developed (Dosemeci et al., 2002) or refined
(Coble et al., 2011) an algorithm for estimating pesticide exposure intensity.
Other studies have focused on examining a variety of exposure issues, including
the effect of exposure misclassification in the AHS (Blair et al., 2011) and using
multiple imputation methods to assign pesticide use values for nonresponders and
other missing data (Heltshe et al., 2012).
International Studies of Herbicide Users
Several studies have been reviewed in the VAO series that have published
results of health effects on herbicide users in many different countries. In some
countries, large studies were designed and large cohorts were followed, producing
several publications that have been reviewed in the VAO series; those cohorts are
described in brief by country of origin.
The Canadian Ontario Farm Family Health Study examined exposure to
phenoxyacetic acid herbicides, including 2,4-D, and several fertility, reproductive, and pregnancy outcomes (Arbuckle et al., 1999a,b, 2001; Curtis et al.,
1999; Savitz et al., 1997) and birth defects (Weselak et al., 2008). Biomonitoring
was conducted in a subset of participants to evaluate the validity of the selfreported predictors of exposure (Arbuckle and Ritter, 2005; Arbuckle et al., 2002,
2005) and to examine other potential indirect sources of exposure to herbicides
(Arbuckle et al., 2006). A second large cohort of 156,242 Canadian male farmers from three provinces, known as the Canadian Farm Operator Study, was assembled, and information on herbicide use in the cohort was used to determine
the risk of specific causes of death in that population: NHL (Morrison et al.,
1994; Wigle et al., 1990), prostate cancer (Morrison et al., 1993), brain cancer
(Morrison et al., 1992), multiple myeloma (Semenciw et al., 1993), and leukemia
(Semenciw et al., 1994). Other Canadian studies of agricultural workers have
evaluated immune, neurobehavioral, and lung function of farmers who mixed
and applied commercial formulations that contained chlorophenoxy herbicides
and of residents in an agricultural area of Saskatchewan, Canada (Faustini et al.,
1996), as well as asthma and pesticide use among male farmers in Saskatchewan
(Senthilselvan et al., 1992). Mortality in men employed by a Canadian public
utility, who were likely exposed to herbicides similar to those used in Vietnam,
has also been reviewed (Green, 1987, 1991).
In Denmark, three studies reported on a cohort of Danish gardeners who
had been exposed to herbicides (E. S. Hansen et al., 1992, 2007; Kenborg et
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al., 2012), and one study examined cancer incidence among Danish farmers
(Ronco et al., 1992). Danish gardeners were identified from union worker records
on May 1, 1975. Most of the women (n = 859) worked in greenhouses, where
herbicides are not routinely used; the men (n = 3,156), however, were known
to be highly exposed to pesticides and herbicides, which included the phenoxy
herbicides 2,4-D, 2,4,5-T, and MCPA. Vital status of the entire cohort through
1984 was achieved. Person-years at risk were calculated and reported for a latent
period of 10–15 years. E. S. Hansen et al. (1992) determined the incidence of
cancer in this cohort from 1975 to 1984 and compared those numbers with expected numbers calculated from incidence rates in the general Danish population.
E. S. Hansen et al. (2007) used analogous methods to extend the follow-up period
for the men through 2001 but used year of birth as a surrogate for intensity of
exposure, with high exposures assumed for those who had been born before 1915,
low exposures for those born in 1934 or later, and intermediate exposure for those
born in between. Using this same cohort of Danish gardeners but restricted to
men alive and living in Denmark at the beginning of 1977 (n = 3,124), Kenborg et
al. (2012) reported on the incidence of Parkinson disease as a primary diagnosis
from 1977 through 2008 and compared the results with the observed incidence of
Parkinson disease in all Danish men by calendar period and age group. Kenborg
et al. (2012) also reported on the incidence of lung, larynx, and bladder cancers
in the cohort compared with the incidence in the general male Danish population.
For the current update, a study of parental employment in farming and agriculture and cryptorchidism in offspring using the Danish National Patient Registry
(Jorgensen et al., 2014) was identified and reviewed.
Three studies reporting on or updating mortality or cancer morbidity in Finnish men who had applied 2,4-D and 2,4,5-T for at least 2 weeks in 1955–1971
through work removing brush have been reviewed in the VAO series (Asp et al.,
1994; Riihimaki et al., 1982, 1983).
Studies of Italian herbicide users have primarily been conducted among
farmers in particular regions. Gambini et al. (1997) examined cancer mortality
in a cohort of rice growers in northern Italy. Two studies reported on a cohort of
male farmers in Italy’s southern Piedmont region who were licensed to use agricultural pesticides in 1970–1974, and the use of phenoxy herbicides in the area
was reported to be twice the national average. Corrao et al. (1989) evaluated cancer incidence in the 25,945 men in the cohort on the basis of new diagnoses from
hospital admissions in 1976–1983. In a continuation of that study, Torchio et al.
(1994) reported on mortality through 1986 in the 23,401 men who were residents
of the Piedmont area at the time of registration, stratified by the location of their
residences (lived near arable land, near woodlands, and near mixed-use land).
The original VAO committee reviewed several studies that used data from the
Swedish Cancer-Environment Register, which contained data from the Swedish
Cancer Registry and individual responses from the 1960 and 1970 n ational censuses, including data on current occupation. Publications that used the Swedish
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Cancer-Environment Register included a study of cancer incidence and farm work
(Wiklund, 1983); studies of STS and malignant lymphoma in agricultural and forestry workers (Wiklund and Holm, 1986; Wiklund et al., 1988a); and a study of the
risk of multiple myeloma in relation to various occupational activities (Eriksson
and Karlsson, 1992). Two studies of cancer mortality in Swedish railroad workers
who were exposed to 2,4-D, 2,4,5-T, and other herbicides were also examined
(Axelson and Sundell, 1974; Axelson et al., 1980). Other studies reviewed by
the committee addressed mortality and cancer incidence in a cohort of Swedish
lumberjacks (Thörn et al., 2000) and cancers in Swedish pesticide and herbicide
applicators (Dich and Wiklund, 1998; Wiklund et al., 1987, 1988b, 1989a,b).
For some countries, only one or two studies have been published on exposure
to the COIs and health outcomes (mortality, prevalence, or incidence) among
herbicide handlers. Many of these studies were small and, especially the earlier
studies, lacked adequate or specific exposure information. These have included:
Argentinian farmers (Butinof et al., 2015; Lerda and Rizzi, 1991); Australians
exposed to phenoxy herbicides (Fritschi et al., 2005); Dutch forestry workers
exposed to 2,4,5-T (van Houdt et al., 1983) and Dutch male herbicide applicators (Swaen et al., 1992, 2004); German male agricultural plant-protection
workers in the former German Democratic Republic who spent at least 5 years
during 1948–1972 applying pesticides, some of which were phenoxy herbicides
(Barthel, 1981); Icelanders whose occupation may have exposed them to 2,4-D
(Zhong and Rafnsson, 1996); Indian herbicide sprayers and warehouse employees (Linga Reddy et al., 2015); Mexican agricultural workers (Carbajal-López
et al., 2016); New Zealand forestry workers (Reif et al., 1989); and offspring of
Norwegian farmers (Kristensen et al., 1997).
ENVIRONMENTAL STUDIES
Industrial accidents have led to the evaluation of long-term health effects in
non-worker populations that live near areas with fairly high environmental concentrations of the COIs. Effects on residents around normally operating industrial
operations, such as waste incinerators, and even on people exposed only to “background” concentrations have also been studied. The systematic follow-up studies
that have been conducted on the Seveso population and the numerous analyses of
the population-level data collection effort of NHANES have contributed prominently to the evidence base considered by VAO committees.
Environmental exposures to the COIs almost never occur in isolation. Exposures to dioxin-like chemicals generally occur as part of mixtures that also
include non–dioxin-like chemicals that tend to correlate with the dioxin-like
chemicals, so it is not surprising that specific chemicals measured in a person’s
serum also tend to correlate with one another; this collinearity means that it is
difficult for epidemiologic studies to attribute any observed association to a particular chemical configuration (Longnecker and Michalek, 2000).
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Environmental studies are presented below, beginning with the United States,
then summarizing major international cohorts.
U.S. Environmental Studies
Several populations with environmental exposures to the COIs have been
reviewed in the course of the VAO series. Descriptions of those populations and
cohorts for which no new information has been identified since the last VAO update report (e.g., Anniston, Alabama, Community Health Survey; the Great Lakes
Fish Consumption Study; the Iowa Women’s Health Study; and Times Beach
and Quail Run, Missouri) can be found in Chapter 6 of Update 2014 (NASEM,
2016a) and the volume that first reviewed the study following its publication.
Studies of U.S. populations that the committee identified and that have not been
the focus of multiple ongoing follow-up or publications are summarized in the
chapters related to the health outcome of interest.
National Health and Nutrition Examination Survey
In the early 1960s the CDC National Center for Health Statistics began the
NHANES program as a means of monitoring and assessing the health and nutritional status of people of all ages living in the United States. In 1999 the survey
became a continuous program that has a changing focus on a variety of health and
nutrition measurements in order to meet emerging needs. A rich variety of data—
demographic and socioeconomic data; dietary information; medical, dental, and
physiologic assessments; and the serum concentrations of persistent organic pollutants (POPs), including specific congeners of dioxins, furans, and PCBs—are
collected through in-person interviews, health examinations, and blood samples
obtained from a nationally representative sample of adults and children in the
noninstitutionalized U.S. population. Information obtained from NHANES data
is used to determine the prevalences of diseases, to assess nutritional status, and
to establish national standards of height, weight, and blood pressure. Researchers
also conduct analyses of the NHANES data for epidemiologic studies and medical research on various health outcomes using serum concentrations of various
compounds to determine associations.
Starting with the preparation of Update 2008, VAO committees began seeing
a stream of publications addressing the possible association of some pesticides
and various individual and grouped dioxin-like chemicals with the occurrence of
a v ariety of health outcomes as assessed by the surveys for particular temporal
spans. NHANES data from 1999 to 2002 were used to evaluate the relationships
of the COIs with cardiovascular disease (Ha et al., 2007); diabetes, metabolic
syndrome, insulin resistance, and arthritis (D. H. Lee et al., 2006, 2007a,b,c);
peripheral neuropathy and poor glycemic control (A1C ≥ 7.0%) (D. H. Lee et
al., 2008); obesity via BMI and waist circumference (Elobeid et al., 2010); and
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thyroid-hormone concentrations (Turyk et al., 2007). Hypertension over this time
period was examined by Ha et al. (2009) and Everett et al. (2008a), but Everett et
al. also provided additional information for the years 2003–2004 in a subsequent
commentary (Everett et al., 2008b). Peters et al. (2014) added NHANES data
for 2005–2008 to the sets for 1999–2002 and 2003–2004 previously analyzed
by Everett et al. (2008a,b) for the association of blood pressure with blood
concentrations of dioxin-like PCBs 126 and 169 and mono-ortho PCBs 118 and
156. Using this expanded data set, they developed a model to predict blood PCB
concentrations using generally available variables (age, sex, ethnicity, and blood
lipid levels). However, because only a single mono-ortho dioxin-like PCB was
used in combination with PBCs having no dioxin-like activity, this work does
not augment the results previously published by Everett et al. (2008a,b) for VAO
purposes.
As additional cycles of NHANES were conducted and became available for
research, new analyses used data collected over multiple cycles. For example,
serum samples collected from NHANES participants between 1999–2004 were
analyzed for organochlorine pesticides, POP residues, and dioxin-like chemicals,
including PCDDs, PCDFs, and PCBs. M. R. Cho et al. (2011) reported on the
associations between bone mineral density and exposures to POPs and organochlorine pesticides. Y. S. Lin et al. (2012) examined samples for levels of dioxinlike chemicals (PCDDs, PCDFs, and PCBs based on TEQs) and their associations
with total and cause-specific (cardiovascular and cancer) mortality, through 2006,
based on ICD-10 codes. Everett and Thompson (2014) examined the relationship
between dioxins (including TCDD) and dioxin-like PCBs (TEQs were calculated
for six different dioxins and eight dioxin-like PCBs) and the prevalence of diabetic
nephropathy. Using 2003–2004 NHANES data, Y. M. Lee et al. (2013) evaluated
the associations between toxic equivalency factors (TEFs) for organochlorine
pesticides as well as PCDDs, PCDFs, and PCBs and the risk of hyperuricemia
in subjects 20 years of age and older. Jones et al. (2011) examined the association between urinary arsenic and hypertension and blood pressure in NHANES
2003–2008 participants. Each of the relevant NHANES studies and their results
have been summarized in detail previously. For the current update, 1999–2004
NHANES data were used to examine the relationship of serum concentrations of
dioxin-like PCBs and other relevant chemicals with cancer (S. A. Kim et al., 2015;
Morgan et al., 2017), diabetes and nephropathy (Everett and Thompson, 2016),
cardiovascular outcomes (S. A. Kim et al., 2015), and possible indicators of immune dysfunction (Serdar et al., 2014). NHANES data from cycles 1999–2000
and 2001–2002 were used to examine the correlation between serum concentrations of dioxin-like PCBs and cognitive impairment in adults (Przybyla et al.,
2017), and NHANES data from the 2011–2012 cycle were used to study whether
different sets of urinary environmental chemical concentrations are risk factors of
high blood pressure (Shiue et al., 2014).
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Priority Toxicant Reference Range Study The study population for the Priority Toxicant Reference Range Study was a subgroup of participants aged 20–59
years in NHANES III (1988–1994), which was established to characterize the
levels of 44 environmental toxicants (including 2,4-D and its metabolite 2,4dichlorophenol) in urine and blood (regarded as indicators of internal dose). Unlike overall NHANES samples, which were established by rigorous statistical
sampling procedures to be representative samples of the U.S. population, this
study sample is regarded as a convenience sample because its 1,338 members had
voluntarily provided an additional 20 ml of blood and had responded to an extra
questionnaire during their regular NHANES medical examination (Needham
et al., 1995).
Schreinemachers (2010) examined the association in 727 healthy adults between exposure to 2,4-D, as indicated by its presence in urine, and biomarkers that
are linked to the pathogenesis of acute myocardial infarction and type 2 diabetes,
namely, serum high density lipoprotein, triglycerides, total cholesterol minus high
density lipoprotein, insulin, C-peptide, plasma glucose, and thyroid-stimulating
hormone. Urinary 2,4-D was detectable in 102 (14%) samples, with concentrations
of 1–28 mg/dL. The outcome variables were compared between participants with
and without detectable urinary 2,4-D by using Wilcoxon’s rank-sum test.
Krieg (2013) performed a limited assessment of cognition in 700 adults.
Twelve pesticide metabolites were measured in the urine, including two
chemicals found in the urine after 2,4-D exposure: unmetabolized 2,4-D and
2,4-dichlorophenol. The analysis investigated the association of urine pesticide
metabolite concentrations with the results of three neurobehavioral tests (simple
reaction time, symbol-digit substitution, and serial digit learning).
Longitudinal Investigation of Fertility and the Environment Study
The Longitudinal Investigation of Fertility and the Environment (LIFE) Study
examined environmental influences on human fecundity and fertility. Participants
were 501 male partners of couples discontinuing contraception for the purposes of
becoming pregnant who were recruited in Michigan and Texas during 2005–2009.
Upon enrollment, in-person interviews were conducted with each male partner
to ascertain health, demographic, and reproductive histories. All data and biospecimens were collected in the home, and baseline interviews were followed by a
standardized anthropometric assessment for the determination of BMI conducted
by research nurses who also obtained non-fasting blood (10 mL) for quantification of serum chemicals and lipids. The quantification of POPs in serum included
polybrominated biphenyl 153, 9 organochlorine pesticides, and 10 polybrominated
diphenyl ethers. PCBs with TEFs included 105, 114, 118, 156, 157, 167, and
189. A baseline semen sample was obtained followed by a second sample approximately 1 month later irrespective of couples’ pregnancy status. A total of 35
semen p arameters were measured including 5 that reflected general characteristics

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

BACKGROUND ON SELECTED EPIDEMIOLOGIC STUDIES AND POPULATIONS

173

(volume, straw distance, sperm concentration, total sperm count, hypo-osmotic
swollen), 8 motility measures, 12 morphometry measures, 8 morphology measures,
and 2 sperm chromatin stability assay measures. Two publications from this study
were identified and are reviewed in detail in Chapter 8: Mumford et al. (2015)
examined the relationship between exposure to a number of persistent organic
pollutants and semen quality, and Robledo et al. (2015) used blood samples from
adult couples to characterize the relationship between the concentrations of a
number of persistent organic pollutants and birth outcomes.
International Environmental Studies
Several studies of international populations that were environmentally exposed to the COIs have been reviewed by VAO committees. As this chapter
is not intended to be a compendium of every study ever reviewed in the VAO
series, only those cohorts and groups with environmental exposures that have
contributed more than one study for review by VAO committees and for which
new information is available are considered here. A number of reviewed studies have used data analyzed from birth cohorts. For example, results from the
Norwegian Mother and Child Cohort Study on prenatal exposure to dioxin-like
PCBs and health outcomes have been previously reviewed (Papadopoulou et
al., 2013; Stølevik et al., 2011). The Norwegian Mother and Child Cohort Study
is a prospective, population-based pregnancy cohort that recruited more than
100,000 pregnant women (resulting in about 114,000 children) and more than
75,000 fathers from 1998 to 2008 to study the causes, variability, and trajectories
of diseases over the life course. The participation rate was relatively low (41%),
perhaps due, in part, to the requirement to be able to fluently read Norwegian.
Questionnaires were administered to collect health data, demographic factors,
lifestyle exposures, and developmental progress (Magnus et al., 2016). Blood
samples were collected twice from the mothers (first at the ultrasound appointment at 17–18 weeks of gestation and later after delivery) and were processed
and stored. A single blood sample was collected from fathers at the ultrasound
appointment. A sample from the cord blood was drawn at delivery (Paltiel et
al., 2014). New results from Caspersen et al. (2016) are presented in Chapter 8.
A second birth cohort for which several published studies have been reviewed in the VAO series is the Duisburg Birth Cohort Study (Nowack et al.,
2015; Rennert et al., 2012; Winneke et al., 2014). This cohort consists of 232
healthy mother–infant pairs, in which the mothers were recruited between 2000
and 2002 in Duisburg, Germany; had no serious complications or illnesses during
pregnancy or parturition; and gave birth to children who were born at term (weeks
38–42 of pregnancy). Maternal blood samples were taken during weeks 28–43
of gestation, and samples of maternal milk were collected from nursing mothers
during the first 3 weeks after parturition. Both samples were tested for dioxins,
dioxin-like PCBs, and six indicator PCBs (Wilhelm et al., 2008).
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Other prenatal exposures studies have examined exposure to endocrinedisrupting chemicals (including dioxins) in Belgian children (Delvaux et al.,
2014) and birth weight and development (Halldorsson et al., 2009; Olsen et al.,
2001) and childhood growth (Wohlfahrt-Veje et al., 2014) in Danish children
who were exposed prenatally to dioxins and dioxin-like chemicals. Two publications that used data from the Danish Fetal Origins 1988–1989 Cohort, in
which offspring were followed for 20 years, were identified for the current
update. The first study examined prenatal levels of maternal POPs in serum
and the risk of asthma in offspring (S. Hansen et al., 2014), and the second
examined allergic sensitization and lung function in offspring (S. Hansen et
al., 2016). The effects of prenatal and lactational dioxin and PCB exposure on
several neurodevelopment and functioning parameters have been examined in a
longitudinal assessment of Dutch children (Berghuis et al., 2014; ten Tusscher
et al., 2014). However, these Belgian, Danish, and Dutch studies have potential relevance only to female Vietnam veterans with pregnancy subsequent to
military service.
In addition to the many studies that used birth cohorts to examine point-intime or longitudinal health effects of prenatal exposure to dioxins and dioxinlike chemicals, several cohorts of people who were exposed as adults to the
COIs from their residential environments have been established and followed.
These have included studies from the Dutch LifeLines cohort study, a multidisciplinary prospective population-based cohort study examining health and healthrelated behaviors of persons living in the northern region of the Netherlands
(de Jong et al., 2014); Finnish fishermen and their wives who were exposed to
higher amounts of dioxins and PCBs through consumption of contaminated fish
(Turunen et al., 2008, 2012); and French residents in the vicinity of municipal solidwaste incinerators that had high levels of TCDD emissions, who were examined
for cancer (Floret et al., 2003; Viel et al., 2000, 2008a,b, 2011) or birth defects
(Cordier et al., 2004, 2010). For the current update, the subjects of studies of the
effects of environmental exposures have included populations in Belgium (Den
Hond et al., 2015; Van Larebeke et al., 2015), Brazil (Cremonese et al., 2017;
Ueker et al., 2016), Canada (Singh and Chan, 2017; Thomas et al., 2015), China
(J. Z. Yang et al. 2015; X. L. Yang et al., 2015; J. Zhang et al., 2014), France
(Danjou et al., 2015; Kalfa et al., 2015; Mayhoub et al., 2014; Nicolle-Mir, 2014;
Ploteau et al., 2017), Germany (Fimm et al., 2017; Haase et al., 2016; Putschogl
et al., 2015), Greece (Vafeiadi et al., 2017), Hong Kong (Hui et al., 2016), Italy
(Cappelletti et al., 2016), Korea (Lim et al., 2017), Nicaragua (Raines et al.,
2014), Norway (Koutros et al., 2015), Russia (Galimova et al., 2015), and Spain
(Martínez-Zamora et al., 2015; Paul et al., 2017).
Some environmental exposures, such as the large accidental release of TCDD
in Seveso, Italy, have been the subject of multiple studies and long-term followup. For many of these populations new studies continue to be published, and
those that have adequate exposure specificity and assessment are reviewed by
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VAO committees. Additional background on those groups is summarized in more
detail below.
Seveso, Italy
On July 10, 1976, a large industrial accident caused by an uncontrolled reaction during TCP production in Seveso, Italy, resulted in chemical release to the
surrounding area that created an environmental exposure to TCDD. The degree
of TCDD contamination in the soil has been used extensively as a means of
imputing exposures of members of the population. Three areas were defined on
the basis of soil sampling: Zone A (556 people), the most heavily contaminated,
from which all residents were permanently evacuated within 20 days; Zone B
(3,920), an area of lower contamination that all children and women in the first
trimester of pregnancy were urged to avoid during daytime; and Zone R (26,227),
a region with some contamination in which the consumption of local crops was
prohibited (Bertazzi et al., 1989a,b). The sample sizes differ among follow-up
studies, presumably because of migration; the sample sizes given above were
reported in Bertazzi et al. (1989b).
Cohort of Entire Exposed Population
Data on serum TCDD concentrations in Zone A residents have been presented by Mocarelli et al. (1990, 1991) and by CDC (1988e). In the 10 residents
who had severe chloracne, TCDD concentrations were 828–56,000 ppt of lipid
weight (median 16,600 ppt). In 9 residents without chloracne (one sample was
lost), TCDD concentrations were 1,770–10,400 ppt (median 4,540 ppt). TCDD
was undetectable in all control participants but one. The highest of the concentrations exceeded any that had been estimated at the time for TCDD-exposed
workers on the basis of backward extrapolation and a half-life of 7 years. Data
on nearby soil concentrations, the number of days that a person stayed in Zone
A, and whether local food was consumed were considered in evaluating TCDD,
but none of those data correlated with serum TCDD, which suggested strongly
that the important exposure was from fallout on the day of the accident. The presence and degree of chloracne correlated with TCDD. Adults seemed much less
likely than children to develop chloracne after acute exposure, but surveillance
bias could have affected that finding. More recent updates (Bertazzi et al., 1998,
2001) have not changed the exposure-assessment approach.
A number of studies of the Seveso population have used lipid-adjusted serum
TCDD concentrations as the primary exposure metric (Baccarelli et al., 2002;
Eskenazi et al., 2002a,b, 2003, 2004, 2005, 2007, 2010, 2014; Landi et al., 2003).
Fattore et al. (2003) measured the current air concentrations of PCDDs in Zones
A and B and compared them with measurements in a control area near Milan.

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

176

VETERANS AND AGENT ORANGE: UPDATE 11

The authors concluded that a release from PCDD-contaminated soil did not add
appreciably to air concentrations in the Seveso study area. Finally, Weiss et al.
(2003) collected breast milk from 12 mothers in Seveso and compared TCDD
concentrations in the milk with concentrations in a control population near Milan,
and they found that the TCDD concentrations in milk from mothers in Seveso
were twice as high as in controls. The authors concluded that breastfed children in
the Seveso area were likely to have higher body burdens of TCDD than children
in other areas.
Several cohort studies have been conducted using the Zone A, Zone B, and
Zone R exposure categories. There have been multiple long-term follow-up investigations of the health outcomes, especially cancers, of Seveso residents. Bertazzi
and colleagues, for example, conducted 10-year mortality follow-up studies of
adults (Bertazzi et al., 1989a) and children who were 1–19 years old at the time
of the accident (Bertazzi et al., 1989b, 1992), 15-year follow-up studies (Bertazzi
et al., 1997, 1998), and a 20-year follow-up study (Bertazzi et al., 2001). Pesatori
et al. also conducted a 15-year follow-up study to update non-cancer mortality (1998), and a 20-year follow-up of incident cancers (2009). Consonni et al.
(2008) reported on the 25-year follow-up (through 2001) vital status of residents
(“present”) in the Seveso area and reference territory at the time of the Seveso
accident and of immigrants and newborns (“non-present”) in the 10 years thereafter. Cause-specific mortality was determined for each zone, compared with that
in the comparison cohort, and adjusted for presence at the accident, sex, age, and
time since the Seveso accident. Most recently, Eskenazi et al. (2018) published a
review summarizing the results of research studies conducted in this population
over the 40 years since the explosion as well as areas of continuing investigation,
including effects in children and grandchildren of both men and women exposed
to dioxin in the three zones of exposure.
In addition to a 2-year prospective controlled study of workers potentially
exposed to TCDD during the cleanup of the most highly contaminated areas
after the accident (Assennato et al., 1989a), other studies have examined specific
health effects associated with TCDD exposure in Seveso residents—chloracne,
birth defects, and spontaneous abortion—as well as crude birth and death rates
(Bisanti et al., 1980); the distribution of chloracne in Seveso children (Caramaschi
et al., 1981); chemicals in the blood and urine of children who had chloracne
(Mocarelli et al., 1986); chloracne and peripheral nervous system conditions
(Barbieri et al., 1988); dermatologic and laboratory tests in a group of the children
who had chloracne and in a group of controls (Assennato et al., 1989b); health
status and TCDD concentrations in chloracne cases and non-cases (Baccarelli
et al., 2005a) that had been recruited previously by Landi et al. (1997, 1998);
hepatic enzyme–associated conditions (Ideo et al., 1982, 1985); abnormal pregnancy outcomes (Mastroiacovo et al., 1988); cytogenetic abnormalities in maternal and fetal tissues (Tenchini et al., 1983); neurologic disorders (Boeri et al.,
1978; Filippini et al., 1981); cancers (Bertazzi et al., 1993; Pesatori et al., 1992,
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1993, 2008, 2009); the sex ratio of offspring who were born in Zone A (Mocarelli
et al., 1996); birth weight and neonatal thyroid function (Baccarelli et al., 2008);
immunologic effects (Baccarelli et al., 2002); effects on reproductive hormones
and sperm quality (Mocarelli et al., 2008, 2011); aryl hydrocarbon receptor
(AHR)-dependent pathway and toxic effects of TCDD in humans (Baccarelli et
al., 2004); effects of TCDD-mediated alterations in the AHR-dependent pathway
in people who lived in Zones A and B (Landi et al., 2003); and NHL-related
(14;18) translocation prevalence and frequency in dioxin-exposed healthy people
in Seveso (Baccarelli et al., 2006). Baccarelli et al. (2005b) reviewed statistical
strategies for handling non-detectable readings or readings near the detection
limit in dioxin-measurement datasets. They recommended that a distributionbased multiple-imputation method be used to analyze environmental data when
substantial proportions of observations have non-detectable readings.
Seveso Women’s Health Study
The Seveso Women’s Health Study (SWHS) was undertaken to evaluate the
association between individual serum TCDD concentrations and reproductive
effects in women who resided in Seveso at the time of the 1976 accident. From a
pool of 1,271 eligible women who were between infancy and 40 years old at the
time of the accident, who had resided in Zone A or B at that time, and for whom
adequate serum remained from the samples collected shortly after the explosion,
981 were enrolled in the study group in 1996–1998 (80% participation rate). All
the women were interviewed by a nurse blinded to their exposure status, and each
subset received gynecologic examinations. Medical records of those who reported
ever having received a diagnosis of cancer were obtained and subjected to blind
review by a pathologist. The stored samples were used for new TCDD analyses
with improved analytic techniques that had become available.
As an initial step in the SWHS, Eskenazi et al. (2001) tested the validity of
exposure classification by zone. Investigators measured serum TCDD in samples
collected in 1976–1980 from 601 residents (97 in Zone A and 504 in Zone B). A
questionnaire that the women completed in 1996–1998 included age, chloracne
history, animal mortality in the vicinity, consumption of homegrown food, and
the woman’s location at the time of the explosion. Participants did not know their
TCDD concentrations at the time of the interview, but most knew their zones
of residence. Interviewers and TCDD analysts were blinded to the participants’
zones of residence. The zone of residence explained 24% of the variability in
serum TCDD. Adding the questionnaire data improved the regression model to
the point that it explained 42% of the variability. Those findings demonstrate a
significant association between zone of residence and serum TCDD, but much of
the variability in TCDD concentration is still unexplained by the models. Warner
et al. (2005) used a chemical-activated luciferase-gene expression bioassay and
a high-resolution isotope-dilution gas-chromatography mass-spectrometry assay
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to measure PCDDs, PCDFs, and PCBs in the serum of 78 women who resided
near Seveso in order to determine average total dioxin-like chemical TEQs; the
two methods produced similar results. Warner et al. (2014) compared the concentrations of TCDD in serum samples taken in 1976 and in 1996 to examine
characteristics that could be used to predict 1996 TCDD concentrations. They
also presented an updated estimate of the TCDD elimination half-life over the
20-year period since the uncontrolled release took place.
In one study, the women enrolled in the SWHS were assessed for cancer
incidence in the 20 years following the accident (Warner et al., 2002). Warner et
al. (2011) later added more than 10 years of observations on cancer incidence in
the women in the SWHS, covering the period from the 1976 explosion through
2009. Of the 981 women who had participated in the first study, 833 were located,
alive, and willing to participate in the second. Each was re-interviewed, provided
clinical measurements, and consented to a medical record review to confirm her
cancer diagnosis. A subset underwent bone-density testing. The average age was
50.8 years. An additional 45 cancers had been diagnosed, for a total of 66 cases,
of which 33 were breast cancers. Thyroid cancer was the next most prevalent,
with 7 cases, and the 15 other types of cancer observed had at most 3 cases. After
adjusting for the women’s age at the time of the accident and for marital status,
the researchers found that the association between the risk of any cancers and
the lipid-adjusted, log-transformed serum TCDD concentrations at the time of the
accident was significantly higher in the subjects than in controls. The availability
of serum TCDD concentrations measured from blood samples gathered fairly
soon after the single-substance accident (which minimizes uncertainty about
what exposure had been experienced and reduces the need for back-extrapolation)
contributes substantially to the value of the results.
A series of studies have examined the associations between serum TCDD and
a variety of endpoints related to female reproductive functioning: menstrual cycle
(Eskenazi et al., 2002a), endometriosis (Eskenazi et al., 2002b), pregnancy outcome (Eskenazi et al., 2003a), age at menarche and age at menopause (Eskenazi
et al., 2005), and age at menarche in women who were premenarcheal at the time
of the explosion (Warner et al., 2004). Eskenazi et al. (2007) and Warner et al.
(2007) examined the incidence of fibroids and ovarian function, respectively, in
SWHS participants.
Eskenazi et al. (2010) examined the relationship between serum TCDD
around the time of the accident and time to pregnancy in 463 SWHS participants
who had attempted pregnancy since the accident and who were no more than 40
years old at the time of the accident. The main analysis was restricted to the 278
women who had delivered live births that were not the results of contraceptive
failure. Effect estimates for the associations between TCDD and fecundity and
between TCDD and infertility were adjusted for several factors including maternal age, maternal smoking in the year before conception, parity, menstrual-cycle
irregularity, oral-contraceptive use in the year before attempt, paternal age near
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the time of conception, and the history of reproductive and endocrine conditions.
Wesselink et al. (2014) examined the risk of adverse pregnancy outcomes in
relation to TCDD concentrations (measured in 1996) in the SWHS among 1,211
post-chemical-explosion pregnancies through the 2008–2009 follow-up assessment. The birth outcomes that were examined included gestational age, pre-term
delivery, and birth weight. Of note, only 35% of women in the analysis were age
21 or older at the time of explosion, thereby limiting the inference of this work
to female veterans who served in Vietnam.
Several publications from the SWHS have been reviewed by the committee
that examined health outcomes in addition to reproductive and pregnancy outcomes. These have included risk for the development of diabetes and metabolic
syndrome 30 years after the accident (Warner et al., 2013), thyroid hormone
levels (and disruption) in relation to TCDD concentrations measured over time
(Chevrier et al., 2014), and TCDD concentrations measured in 1996 versus the
bone mineral density of the spine and hip measured in 2008 (Eskenazi et al.,
2014). A study of neurocognitive and physical functioning among the SWHS
participants is reviewed in the current volume (Ames et al., 2018).
Japanese Environmental Studies
Several population-based studies of relevant exposures in Japan have been
considered by VAO committees, including investigations of serum concentrations
of PCDDs, PCDFs, and dioxin-like PCBs relative to the prevalence of diabetes
(Uemura et al., 2008a), distributions with respect to various demographic characteristics (Uemura et al., 2008b), and the prevalence of metabolic syndrome
(Uemura et al., 2009). In a separate analysis representative of the Japanese
population, Nakamoto et al. (2013) gathered fasting blood samples from a crosssectional sample of 1,063 men and 1,201 women (aged 15–76 years) who were
living in 125 areas of 45 prefectures throughout Japan and who were not occupationally exposed to dioxins (including TCDD). The full WHO 2005 set of dioxinlike PCDDs, PCDFs, and PCBs were measured in the samples and assessed in
relation to a range of self-reported history of diseases, including allergic diseases,
hypertension, diabetes, hyperlipidemia, gout, thyroid disease, kidney disease,
gastric ulcer, and gynecological disease. Fukuda et al. (2003) examined mortality
and incinerator dioxin emissions in municipalities in Japan. The associations of
adverse pregnancy outcomes and proximity of maternal residence (10 kilometers
or fewer) with municipal solid waste incinerators with high dioxin emission levels
at the time of birth have also been examined (Tango et al., 2004).
The emphasis of environmental studies in Japan has been on the long-term
follow-up of the 1968 Yusho rice oil poisoning accident. The accident occurred in
western Japan, where the rice oil intended for cooking was contaminated during
processing with PCBs and PCDFs, exposing more than 1,900 people (Kuratsune
et al., 1972). Based on unusual symptoms following exposure, a total of 1,961
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cases of “Yusho Disease” were registered and subsequently followed for more
than 40 years. Because of changes in the symptoms and advances in analytic
techniques, the diagnostic criteria have changed several times since they were
first published in 1968 (Akahane et al., 2017). Several studies have considered
exposure status based on designation as a Yusho case, but VAO committees have
generally not reviewed such studies unless the concentrations of dioxins and
dioxin-like chemicals were presented, such as in Tsukimori et al. (2012, 2013)
(reviewed in Update 2012), and M. C. Li et al. (2015) and Mitoma et al. (2015),
which are both reviewed in the current update.
Hokkaido Study on Environment and Children’s Health
The Hokkaido Study on Environment and Children’s Health is a prospective birth cohort study that began in 2002 and includes two cohorts (Kishi et al.,
2017). The first is the Sapporo (Toho Hospital) cohort with one obstetric hospital,
and the second cohort is the much larger Hokkaido cohort, which has 37 hospitals and clinics. The primary study goals are to examine the effects of low-level
environmental chemical exposures on birth outcomes; to follow the development
of allergies, infectious diseases, and neurobehavioral developmental disorders
and perform a longitudinal observation of child development; to identify highrisk groups based on genetic susceptibility to environmental chemicals; and to
identify the additive effects of various chemicals, including tobacco smoking
(Kishi et al., 2017).
The Sapporo cohort consists of 514 women who enrolled at 23–35 weeks
of gestation and who had planned to deliver at Toho Hospital in Sapporo city
between July 2002 and October 2005 (participation rate of 26.6%). A selfadministered questionnaire was completed at the time of enrollment to obtain
parental baseline information. Various specimens, including maternal and cord
blood, maternal hair, and breast milk, were collected for the assessment of exposures to 29 dioxin and dioxin-like PCB congeners, 58 other PCB congeners, and
5 hydroxylated PCB congeners. Maternal medical and infant birth records were
obtained from the hospital. Follow-ups and the administration of neurobehavioral
developmental tests were conducted at ages 6 and 18 months and 3.5 and 7 years.
The focus of investigations using the Sapporo cohort are on child neurobehavioral
development, but the development of asthma, allergies, and infectious diseases
is also examined.
The Hokkaido cohort enrolled 20,926 pregnant women before 13 weeks of
gestational age who visited one of the associated hospitals or clinics in the Hokkaido prefecture between February 2003 and March 2012 (participation rate of
55%). A simultaneous analysis of 11 perfluorinated alkyl substances in maternal
plasma collected during the third trimester of pregnancy was conducted. The
Hokkaido cohort focuses on rare diseases such as birth defects and developmental disorders as well as on the prevalence of complicated pregnancies and birth
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outcomes, such as miscarriage, stillbirth, low birth weight, preterm birth, and
small for gestational age. Follow-ups of the children were conducted at 18 months
and 3 years of age and began in October 2013 and January 2015, respectively.
The follow-ups of 5- and 6-year-old participants started in October 2014 (Kishi
et al., 2017).
Previous VAO volumes have reviewed publications from the Sapporo and
Hokkaido cohorts. Four publications using subsets of the cohort data were identified and reviewed in this volume. Kobayashi et al. (2017) obtained maternal
blood samples during the third trimester or within a week of delivery. The
samples were tested for total dioxin levels (as the sum of 29 congeners) and
genotyping for genes coding three enzymes involved in dioxin metabolism.
The genotype status was previously shown to be related to birth weight in 484
children in the H
 okkaido cohort. Miyashita et al. (2015a,b) investigated 70 PCB
congeners, including dioxin-like PCBs, in the blood of 367 mother–child pairs
from the Hokkaido Study cohort and the relationship with newborn anthropometric measurements of birth weight (small for gestational age), length, chest
circumference, and head circumference. Finally, Nakajima et al. (2017) examined
sex-specific differences in the effect of prenatal exposure to dioxin-like chemicals
on neurodevelopment in children who were participants in the Sapporo cohort;
190 mother–infant pairs in the 6-month-old group and 122 mother–child pairs in
the 18-month-old group were studied.
Russian Environmental Studies
Chapaevsk
Several studies in the Samara region of Russia have identified the Middle
Volga Chemical Plant (also known as SZVH or Khimprom) in Chapaevsk, about
950 kilometers southeast of Moscow, as a major source of TCDD pollution
(Revazova et al., 2001; Revich et al., 2001). From 1967 to 1987 the plant produced γ-hexachlorocyclohexane (lindane) and its derivatives, and many of the
workers experienced chloracne. Since then, it has produced various chlorinated
products. Dioxins were detected in the small number of air, soil, drinking-water,
and cow’s-milk samples gathered in the region, but no description of how these
media were sampled was given. When Revich et al. (2001) compared the samples
with measurements from four other Russian cities that had industrial facilities, the
TCDD concentrations observed in Chapaevsk exceeded all reported maximums.
Revich et al. (2001) presented rudimentary comparisons of cancer incidence and
mortality and reproductive outcomes with regional and national rates; residence
in the city of Chapaevsk was used as a surrogate for exposure, and no attempt
was made to create exposure categories based on factors that might have influenced the degree of TCDD exposure. The analyses of chromosomal aberrations
and other cytologic indicators of genetic damage partitioned the women studied
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into three groups on the basis of worker status or distance of residence from the
factory (Revazova et al., 2001).
Chapaevsk Children’s Study Later research efforts on Chapaevsk residents
have focused on quantifying the serum concentrations of dioxins and TEQs
associated with furans and PCBs. Akhmedkhanov et al. (2002) reported on a
convenience sample of 24 volunteers. The Russian Children’s Study was designed to assess the effect of in utero and childhood exposure on development.
Although 516 peripubertal boys (identified through health insurance and clinic
records) were enrolled, the final cohort consisted of 499 boys and 449 mothers.
This prospective longitudinal study enrolled boys at age 8–9 years (in 2003–2005)
who then underwent a physical exam and blood sampling and who, together with
the mother or guardian, completed a questionnaire. Annual follow-up examinations
were also conducted (9-year retention rate of 73%), blood is collected biennially,
urine is collected annually, and semen collection began in 2012. Serum samples
were used to measure 7 PCDDs, 10 PCDFs, 4 non-ortho-substituted PCBs, 6
mono-ortho-substituted PCBs, and 31 other non-dioxin-like PCBs.2 Although the
design does not allow researchers to isolate possible in utero exposure and postnatal
exposure and its utility is further limited by the fact that subjects were exposed to
dioxins in a different period of their lives (infancy, childhood, and adolescence)
than Vietnam veterans, the exposures are well characterized. The information
generated by this cohort will be relevant to VAO reports only in conjunction with
effects in offspring after maternal exposure to the extent that the consequences
of gestational and childhood exposure can be distinguished. The published findings have detailed the characterizations of serum concentrations in the boys (J. S.
Burns et al., 2009) and their mothers (Humblet et al., 2010), and the first papers
that examine semen parameters are detailed in Chapter 8 (Mínguez-Alarcón et al.,
2017). The committee also heard an invited presentation from the lead researcher,
Dr. Russ Hauser, and is able to offer a bit more detail regarding initial findings
based on his presentation.
Swedish Environmental Studies
Most Swedish environmental studies have focused on results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
Participants were recruited within 2 months after their 70th birthdays randomly
from the registry of residents of the community of Uppsala, Sweden, between
April 2001 and June 2004. The primary aim was to investigate cardiovascular
disease (CVD) in an elderly population. Of the 2,025 subjects who were invited
to participate, 1,016 were included, for a participation rate of about 50%; half
2 Dr. Russ Hauser, Harvard T.H. Chan School of Public Health, presentation to the committee
November 30, 2017.
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of the participants were female. All participants answered a questionnaire about
their medical history, medications, diet, and smoking habits. The burden of POPs,
including several dioxin-like PCBs, was assessed from blood serum or plasma.
However, the results are limited by the fact that participants were recruited in the
2-month period after their 70th birthday. This potentially imparts a survival bias,
meaning that persons from the catchment area with very high levels of POPs may
have been disproportionately excluded from the study sample. In addition, results
are limited by the relative non-specificity of the POPs examined, although the
battery of congeners did include octachlorodibenzo-p-dioxin, which is relevant
to Vietnam veterans.
VAO committees have reviewed several studies from the PIVUS data or
subsets of it. The subjects of these studies have included sex differences in the
concentrations of 17 of 21 POPs (Salihovic et al., 2012a); a new method for
extracting POPs from human blood (Salihovic et al., 2012b); and associations
between POPs and type 2 diabetes (D. H. Lee et al., 2011), fat mass and abdominal obesity (D. H. Lee et al., 2012a; Rönn et al. 2011), stroke (D. H. Lee et al.,
2012b), and carotid atherosclerosis (Lind et al., 2012). Many other studies from
the PIVUS cohort have examined relationships between POPs and surrogate
health outcomes, including CVD measures and risk factors; examples include
left ventricular systolic and diastolic dysfunction (Sjöberg Lind et al., 2013b),
left ventricular hypertrophy (Sjöberg Lind et al., 2013a), and carotid atherosclerosis (Lind et al., 2012). In addition to these health outcomes, changes in weight
(Lind et al., 2013), inflammatory markers, complement system, and oxidative
stress (Kumar et al., 2014a,b,c) have also been studied. These studies augment
previous publications from PIVUS that examined a range of indicators related to
CVD and cardiovascular health. The topics of new publications from the PIVUS
cohort reviewed in this volume include outcomes of hypertension (Lind et al.,
2016), circulating lipid levels (Penell et al., 2014), and cognitive impairment (D.
H. Lee et al., 2014).
Other studies of Swedish cohorts have also been included in the VAO series
when the exposures have been relevant.
Taiwanese Environmental Studies
Two populations with environmental exposures in Taiwan have been examined by VAO committees: residents of contaminated areas and mother–child
studies. The first type of studies primarily examined people who resided near a
closed factory in the An-nan District of Tainan City in southwestern Taiwan that
had manufactured PCP, which left the area highly contaminated with dioxin.
Na-PCP, a widely used pesticide, had been used in the production process at the
abandoned factory, and after the factory shut down, a large quantity was improperly stored and later released into the environment. A cross-sectional study was
conducted in 2005–2007 using subjects recruited from a health center near the
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factory, and the final sample consisted of about 80% of the invited residents of the
community. A series of publications using these data have been reviewed by prior
VAO committees, an overview of which is provided here. The general limitations
for all those studies include an unknown age at first exposure to PCDDs and
PCDFs; an unknown duration of exposure; the cross-sectional design; an adjustment for obesity as one element of metabolic syndrome, rather than BMI; and
some arbitrary choices inherent in factor analysis. J. W. Chang et al. (2010) used
these data to report on the relationship between exposure to PCDDs and PCDFs
and hypertension in metabolic syndrome in 1,490 non-diabetic people residing in
this area. In addition, an analysis of the association between each congener and
the prevalence of metabolic syndrome was conducted. J. W. Chang et al. (2011a)
then reported on the same cross-sectional study, restricted to 1,449 non-diabetic
residents, to investigate the joint effects of exposure to dioxins (from the factory)
and mercury (from eating contaminated seafood from the reservoir near the factory) on pancreatic endocrine function; the committee noted several limitations
with the study’s analysis and methods for assessing insulin-resistance. Using
the same cross-sectional study with enrollment extended to December 2009,
J. W. Chang et al. (2011b) investigated the association between PCDD and PCDF
exposure and continuous measures of CVD within 10 years as measured by the
Framingham Risk Score, a formula for combining established risk factors into a
single number, using a sample of 914 residents who did not have CVD and who
were 30–45 years old. One limitation is the use of the Framingham score; other
factors are associated with risk but were not included in the score, such as socioeconomic position, genetics, and imaging biomarkers. A fourth publication using
this cross-sectionally collected data involved 1,167 residents who were more than
50 years old and had fasting blood samples available to investigate the biochemical profiles of those exposed to PCDDs and PCDFs (J. W. Chang et al., 2012). For
this analysis, there were three exposure groups of retired Na-PCP workers: those
who still lived locally, those who lived locally but did not knowingly eat polluted
fish, and those who had moved away. Three control groups did not include any
Na-PCP workers and consisted of local residents who had eaten polluted fish,
local residents who had not eaten polluted fish, and “background participants”
in Taiwan’s general population. The first two of the control groups made up the
1,167 in the study population. The limitations of the study include the unknown
PCDD and PCDF concentrations in retired workers who moved away and knowledge about when the exposure ceased. There may also be important unmeasured
confounders related to which workers moved away and which ones did not.
Three new studies among the residential population near this factory were
identified and reviewed in the current volume. The outcomes examined are type
2 diabetes (C. Y. Huang et al., 2015), chronic kidney disease (C. Y. Huang et al.,
2016), and hyperuricemia (J. W. Chang et al., 2013).
The second type of relevant environmental exposure studies conducted in the
Taiwanese population are mother-and-child studies, which have been reviewed
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in Chapter 8. These have included findings from a prospective study of healthy
Taiwanese mothers and their children recruited during the mothers’ pregnancy
to study the associations between exposures to PCDDs, PCDFs, and PCBs and
health outcomes (Chao et al., 2004, 2007; P. H. Su et al., 2010, 2012; S. L. Wang
et al., 2004, 2005). The study enrolled pregnant women who had no clinical
complications, were 25–35 years old, and delivered in the period December 1,
2000, to November 30, 2001, in a medical center in central Taiwan, the location
of a solid-waste incinerator. Participants completed a questionnaire concerning
maternal age, occupation, disease history, cigarette smoking, alcohol consumption, dietary habits, and the baby’s stature. Biologic samples (including placenta,
umbilical cord blood, mother’s venous blood, and breast milk) were collected
for analysis of PCDDs, PCDFs, and PCBs. A total of 610 women were enrolled
(80% of those invited). The placenta was collected from and the questionnaire
completed by 430 participants. Of those, 250 provided sufficient venous blood for
the chemical analyses. Of the 250, 175 provided adequate breast-milk samples.
S. L. Wang et al. (2004) reported on PCDDs, PCDFs, and PCBs in the biologic
samples and on correlations among specimens. Chao et al. (2004) reported on
PCDDs, PCDFs, and PCBs in breast milk and the cumulative dose derived for
infants exclusively breastfed versus those formula-fed. In a follow-up analysis,
S. L. Wang et al. (2005) examined the association between high and low in utero
exposures to PCDDs, PCDFs, and PCBs and the thyroid and growth hormones in
the newborns overall and by sex. S. L. Wang et al. (2006) examined the association between PCDDs, PCDFs, and PCBs measured in the placenta and estrogens
and metabolites measured in mothers’ blood. P. H. Su et al. (2010) reported on
the 2-year and 5-year follow-ups of the mother–child pairs of S. L. Wang et al.
(2005). Children’s anthropomorphic measures were obtained, including height,
weight, BMI, head circumference, chest girth, bone age, and the ratio between
bone age and chronologic age. Thyroid, sex-hormone, and growth-factor concentrations were measured in venous blood samples obtained from those children
whose mothers’ serum PCDD and PCDF TEQs were available. The anthropomorphic measures and the thyroid, sex-hormone, and growth-factor concentrations were compared in children with high (≥15 pg-TEQ/g of lipid) versus low
(< 15 pg-TEQ/g of lipid) in utero PCDD and PCDF concentrations. Comparisons
were made by sex and by pooling all children. P. H. Su et al. (2012) reported
on the 8-year follow-up of the same cohort in a subset of 23 boys and 33 girls.
In addition to anthropomorphic measures used in previous waves, reproductive
development (breast, genital, and armpit stages) was assessed. P. H. Su et al.
(2015) conducted a study of 56 children from the cohort stratified into high- and
low-exposure groups based on maternal PCB and PCDD/F concentrations to
examine hormone levels and other measures of blood chemistry.
Other studies of health effects in offspring prenatally exposed to the COIs in
Taiwan have been reviewed, but they have been from different population samples.
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Vietnamese Environmental Studies
Various epidemiologic studies have been conducted in subsets of the Vietnamese population who were exposed to the herbicide spraying that occurred during
the Vietnam War. In a review paper, Constable and Hatch (1985) summarized the
unpublished results of studies conducted by researchers in Vietnam. They also
examined nine reports that focused primarily on reproductive outcomes (Can et al.,
1983a,b; Huong and Phuong, 1983; Khoa, 1983; Lang et al., 1983a,b; Nguyen,
1983; Phuong and Huong, 1983; Trung and Chien, 1983). Vietnamese researchers
later published the results of four additional studies: two on reproductive abnormalities (Phuong et al., 1989a,b), one on mortality (Dai et al., 1990), and one on
hepatocellular carcinoma (Cordier et al., 1993). Ngo et al. (2006) published a metaanalysis that addressed an association between exposure to herbicides in Vietnam
and birth defects and that covered some reports reviewed previously by Constable
and Hatch (1985), some new Vietnam studies, and studies on U.S. and Australian
veterans who served in Vietnam.
In general, three types of environmental studies have been conducted in
Vietnam and reviewed by VAO committees: those that have measured environmental concentrations of contaminants in soil or animals (food) in “hot spot”
areas such as Bien Hoa City (Schecter et al., 2003), studies of mother–child pairs
and concentrations of dioxins in breast milk, and surrogate measures of health
outcomes in adults in contaminated areas. In total, 10 new studies of outcomes in
the Vietnamese population were identified and reviewed for the current volume.
C. H. Nguyen et al. (2017) examined serum TCDD levels and the expression
of AHR and a variety of pro-inflammatory cytokines in people living in areas that
were sprayed with herbicides and in areas that were not. Two studies (S. Hansen
et al., 2009; Nhu et al., 2009) examined maternal concentrations of organochlorine
chemicals and dioxins in communities known to have been sprayed with herbicides
during the war compared with communities that were not sprayed. However, no
results were reported on associations between the concentrations of these chemicals
in mothers and health status in mothers or infants. Two new studies of mothers and
their children in different herbicide-contaminated and non-contaminated areas in
Vietnam were reviewed in the current volume (Anh et al., 2017; Van Tung et al.,
2016).
Several studies have examined mother–infant pairs who were living near
the Da Nang airbase, the site of a former U.S. airbase, which is an area of documented high exposures to TCDD and other PCDD/Fs. The Da Nang Birth Cohort
consists of 216 mother–infant pairs recruited in 2008–2009. The recruitment and
residence area includes two districts in a surrounding area of 10 kilometers from
the former air base. This is because the residents outside the immediate area of the
airbase have also been shown to have high dioxin levels suspected to have been
caused by the ingestion of contaminated food and water originating from the airbase. Breast-milk samples were collected from each nursing mother 1 month after
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she gave birth in order to quantify the levels of 17 different 2,3,7,8-substituted
PCDD and PCDF congeners, and TEQs were calculated.
Tai et al. (2013) examined 216 mother–infant pairs and relationships between the dioxin levels in breast milk and infant neurodevelopment parameters
(based on the Bayley Scales of Infant and Toddler Development) at 4 months of
age. Tai et al. (2016) followed the birth cohort longitudinally for neurodevelopment and physical growth during the first 3 years of life. In Pham et al. (2015),
the Bayley Scales of Infant Development, 3rd edition, was administered at age
12 months to examine differences in overall cognition, language composite,
receptive language and expressive language, and motor skills. Nishijo et al.
(2014) examined 153 mother–infant pairs in the Da Nang birth cohort to evaluate potential associations between perinatal dioxin exposure and autism spectrum
disorders in the children. Nishijo et al. (2015) focused on urinary metabolite
levels in 26 children who were part of the study cohort and examined associations
with dioxin-exposure-induced neurodevelopmental deficits. Using this same birth
cohort, Tran et al. (2016) investigated effects of early life exposure to dioxins in
176 children. Dioxins were measured at birth and 5 years of age and compared
with outcomes of the Movement Assessment Battery for Children-2 test and other
tests of pattern reasoning, planning ability, and neurodevelopmental skills.
Although they are not a primary health outcome of interest per se, X. Sun
et al. (2013) compared prostate-specific antigen levels (which may be indicative
of a risk for prostate cancer, but is not a surrogate of prostate cancer) in a crosssectional study of men over the age of 50 years residing in the Phu Cat district
(a presumed contamination hot spot, n = 101) with those residing in the Kim
Bang district (presumed non-sprayed, n = 97). Analyses were adjusted for age
and included stratification by occupation, including farmers and other non-farm
occupations. Results of this study are limited by its cross-sectional design and, in
particular, the relatively crude measurement of exposure assessment many years
after the time when herbicide spraying would have occurred. In a second study
by X. L. Sun et al. (2014) that used similar methodology and surrogate indicators
of health (and thus has similar limitations), serum dioxin and steroid hormone
levels were compared between 48 men in the presumed hot spot area (Phu Cat
district) and 36 men in the non-sprayed area (Kim Bang district). Five dioxin
congeners expressed as TEQs were calculated along with the levels of nine serum
steroid hormones, including testosterone, cortisol, estradiol, and others. Multiple
linear-regression analyses were conducted with statistical adjustments made for
age, BMI, employment status, and tobacco use.
Using the same study population as in prior studies (X. L. Sun et al., 2013,
2014), two new publications compared steroid hormone levels and other blood
chemistry between men residing in the presumed hot spot area and men residing
in the non-sprayed area (X. L. Sun et al., 2016, 2017). However, these studies are
somewhat limited in that these measures do not serve as indicators or even surrogates of health conditions or diseases of primary concern to Vietnam veterans.
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CASE-CONTROL STUDIES
Numerous case-control studies have been reviewed in previous updates,
some of which have produced multiple publications on the same population
or dataset. For example, several case-control studies of specific cancers, such
as STS, HL, and NHL, in Sweden were carried out to investigate exposure to
phenoxyacetic acids and other relevant COIs (Eriksson et al., 1979, 1981, 1990;
Hardell, 1977, 1979, 1981; Hardell and Bengtsson, 1983; Hardell and Eriksson,
1988, 1999; Hardell and Sandström, 1979; Hardell et al., 1980, 1981, 2002; Olsson
and Brandt, 1988; Persson et al., 1989, 1993; Wingren et al., 1990). Similarly,
overlapping case-control studies have been conducted among New Zealanders
exposed to phenoxy herbicide and chlorophenols examining incidence and mortality from specific cancers (Pearce et al., 1985, 1986a,b, 1987; Smith and Pearce,
1986; A. H. Smith et al., 1983, 1984). Other case-control studies conducted internationally have addressed the connection between the COIs and various cancers
in England (Balarajan and Acheson, 1984; Magnani et al., 1987), France (Aras
et al., 2014; Orsi et al., 2009), Italy (Amadori et al., 1995; Donna et al., 1984;
LaVecchia et al., 1989; Musicco et al., 1988; Nanni et al., 1996; Vineis et al.,
1986), Canada (McDuffie et al., 1990; Ng et al., 2010; Spinelli et al., 2007), Australia (Smith and Christophers, 1992), and Denmark (Mellemgaard et al., 1994).
Case-control studies have been conducted in various U.S. populations looking for associations of herbicides with cancers. Studies have included leukemia
mortality among white farmers in Nebraska (Blair and Thomas, 1979; Blair and
White, 1985), Iowa (Burmeister, 1981; Burmeister et al., 1982), and in Iowa and
Minnesota (L. M. Brown et al., 1990). Another study investigated associations
of leukemia and NHL with 2,4-D in eastern Nebraska (Zahm et al., 1990). Other
lymphohematopoietic cancer outcomes investigated as case-control studies in
U.S. populations include NHL (Cantor, 1982; Cantor et al., 1992; Czarnota et
al., 2015; Hartge et al., 2005; Tatham et al., 1997; Zahm et al., 1993), multiple
myeloma (Boffetta et al., 1989; L. M. Brown et al., 1993; Morris et al., 1986), and
NHL and HL (Dubrow et al., 1988). Other studies have assessed, generally using
occupation or residence as surrogates for exposure, multiple cancer outcomes,
such as gastric cancer, prostate cancer, NHL, and multiple myeloma (Burmeister
et al., 1983); STS, HL, and NHL (Hoar et al., 1986); and STS and NHL (Woods
and Polissar, 1989; Woods et al., 1987). In a subset of participants in the Hartge et
al. (2005) study, De Roos et al. (2005a) studied associations between the overall
TEQs of PCBs, furans, and dioxins but not TCDD alone.
Non-cancer health outcomes have also been investigated in case-control
studies: birth defects and congenital anomalies (Blatter et al., 1997; García et al.,
1998; Nurminen et al., 1994), spontaneous abortion (Carmelli et al., 1981), mortality from neurodegenerative diseases associated with occupational risk factors
(R. M. Park et al., 2005; Schulte et al., 1996), and Parkinson disease (Firestone
et al., 2005, 2010; Liou et al., 1997; Seidler et al., 1996; Semchuk et al., 1993).
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Again, as this chapter is not intended to be a compendium of every study ever
reviewed in the VAO series, only those cohorts and groups that have contributed
more than one study for review by VAO committees and for which new information is available are considered here. A full account of every study ever reviewed
in the VAO series that has provided evidentiary weight for an association between
exposure to the COIs and a health outcome can be found in the supplementary
tables (available at www.nap.edu/catalog/25137), and details of the studies can
be found in the corresponding report for which they were first identified and reviewed by a VAO committee. Some additional information may be found in the
subsections of “Conclusions from VAO and Previous Updates” for an outcome
throughout the chapters.
National Birth Defects Prevention Study
The National Birth Defects Prevention Study (NBDPS) is a population-based
case-control study conducted cooperatively by CDC and eight monitoring centers
throughout the United States (in Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, and Texas) using a standardized study methodology
(Yoon et al., 2001). Starting in October 1, 1997, the individual centers began
monitoring births in their respective areas for the occurrence of more than 30
types of birth defects (excluding cases attributable to single-gene conditions
or chromosomal abnormalities) for comparison with randomly selected sets of
live-born babies without malformations. Information about demographics and
possible exposures is abstracted from an extensive telephone interview that the
mothers complete within 24 months of delivery. On the basis of the work histories, job classifications are assigned by an industrial hygienist and processed
using a job-exposure matrix and expert opinion used to derive occupational exposures. Buccal epithelial samples are gathered for DNA testing from the infant
and its parents. Major limitations of the study are the lack of exposure specificity
(e.g., using general categories of insecticides, herbicides, and fungicides), crude
exposure histories (ever/never), lack of exposure concentrations or durations, and
the use of self-report, which may introduce recall bias especially among mothers
whose child has been diagnosed with a birth defect. Despite those limitations
and the fact that the results are only potentially relevant to child-bearing female
Vietnam veterans, several publications using data from all of the NBDPS or just
subsets of the NBDPS have been reviewed by VAO committees.
Rocheleau et al. (2011) reported on the association between maternal occupational pesticide exposure and the risk of hypospadias in the NBDPS using a
sample of 647 cases of hypospadias and 1,496 controls with estimated delivery
dates of October 1997–December 2002. Most exposure was to insecticides only
or to three types of pesticides (insecticides, herbicides, and fungicides), but there
was generally a low level of occupational pesticide exposure in the study population. The lack of exposure specificity made it difficult to make an association
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between the birth defects and any pesticide exposure or an individual pesticide
exposure, and other exposures of the population could have contributed to the
outcome in question. In a separate analysis of NBDPS data, Kielb et al. (2014)
analyzed the occurrence of isolated craniosynostosis, gastroschisis, diaphragmatic hernia, or transverse limb deficiencies in children born to employed women
with due dates between October 1, 1997, and December 31, 2002. Cases included
871 live-born, stillborn, or electively terminated fetuses, which were compared
to 2,857 live-born control infants. The odds of the appearance of these musculoskeletal malformations were examined in relation to periconceptional maternal
occupational exposure to insecticides, herbicides, or fungicides (classified as
yes/no) for each job held during the period of 1 month pre-conception through
3 months post-conception.
Several papers from the California Center (in the San Joaquin Valley) of the
NBDPS have been published, although many of the same limitations apply as for
analyses with the full NBDPS. The center has monitored deliveries from 1997
to 2006 and has invested considerable effort toward developing time-specific
estimates of exposure to individual pesticides by women residing in the area at
the time of delivery. Carmichael et al. (2014) evaluated 569 medically confirmed
congenital heart defect cases (8 different types) and 785 non-malformed controls
born during 1997–2006. Maternal pesticide exposure was crudely classified as
“any” versus “no exposure” based on the commercial application of pesticides
within a 500-meter radius of the mother’s address during a 3-month periconception window (determined by data obtained from the California Pesticide Use
Report record system). Exposure to individual pesticides was examined, including the dimethylamine salt of 2,4-D. Analogous investigations were conducted on
neural tube defects and orofacial clefts (W. Yang et al., 2014) and on gastroschisis
(Shaw et al., 2014).
Several new publications from the NBDPS were identified for the current
update. Makelarski et al. (2014) and Pettigrew et al. (2016) both examined associations of spina bifida with parental non-specific herbicide exposure. Rocheleau
et al. (2015) examined the association between maternal occupational exposure
to fungicides, insecticides, and herbicides and the risk of congenital heart defects
among offspring. Specific publications from the California Center of the NBDPS
included studies of gastroschisis (Shaw et al., 2014) and anotia/microtia, anorectal atresia/stenosis, transverse limb deficiency, craniosynostosis, and diaphragmatic hernia (Carmichael et al., 2016).
Upper Midwest Health Study
The Upper Midwest Health Study (UMHS) was initiated by NIOSH as a
population-based case-control study of cancer risk in a non-metropolitan Midwestern U.S. population. Several reports from the study were reviewed in previous updates. Chiu et al. (2004) and W. J. Lee et al. (2004a) conducted pooled
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analyses of two earlier case-control studies of NHL carried out by the UMHS in
Iowa and Minnesota (Cantor et al., 1992) and in Nebraska (Zahm et al., 1990).
Chiu et al. (2004) examined the association of NHL with agricultural pesticide
use and familial cancers, and W. J. Lee et al. (2004a, 2006) looked at NHL in
asthmatic people who reported pesticide exposure. Data from Nebraska (B. C.
Chiu et al., 2006, based on Zahm et al., 1990, 1993) were used to determine if the
risk of NHL was driven by any specific subtypes. Tissue samples were analyzed
from 172 of 385 cases for the presence of a specific chromosomal translocation
(t(14;18)(q32;q21)). Two studies focused on pesticide use and the risk of adenocarcinomas of the stomach and esophagus (W. J. Lee et al., 2004b) and the risk
of gliomas (W. J. Lee et al., 2005) in white Nebraska residents over 21 years old
who were identified from the Nebraska Cancer Registry and matched to controls
drawn from an earlier study by Zahm et al. (1990). Other publications evaluated
farm pesticide exposure in men (Ruder et al., 2004) and women (Carreon et al.,
2005) in Iowa, Michigan, Minnesota, and Wisconsin in relation to gliomas as part
of the UMHS. Ruder et al. (2006) reported a follow-up of Ruder et al. (2004)
that evaluated gliomas in UMHS participants, but the new analyses provided
no evidence of a greater use of pesticides in cases than in controls, and agents
were not specified. Ruder et al. (2009) reported another follow-up in the same
group, which had similar findings and, again, provided no specificity of agents.
Finally, Yiin et al. (2012) has reported findings from new analyses of the UMHS
sample that incorporated more detailed exposure information that was not used
in previous analyses, including years of use and estimated cumulative exposures
to categories of pesticides, including phenoxy herbicides, and the use of specific
agents, including 2,4-D and dicamba.
Cross-Canada Study of Pesticides and Health (Rare Tumors Study)
The Cross-Canada Study of Pesticides and Health (Rare Tumors Study) was
designed as a full population-based case-control study of men in six Canadian
provinces to address the relation of four relatively uncommon malignancies—HL,
NHL, multiple myeloma, and STS—with occupational and domestic exposure
to pesticides (McDuffie et al., 2001). A target number of cases of each cancer
type was preset for each province. Researchers gathered incident cases that were
diagnosed starting on September 1, 1991, from the provincial cancer registries
(or hospital records) in Québec until the end of 1994 or until the target number
was reached. People who had Kaposi sarcoma or who were HIV positive were
excluded. Physician consent was obtained, and diagnoses were confirmed with
pathology reports and a review of preserved tissues. Consent forms and questionnaires were sent to the cases. The controls were men at least 19 years old identified
in the health-insurance records of Alberta, Manitoba, Saskatchewan, and Québec;
from telephone listings for Ontario; and from voter lists in British Columbia. The
controls were selected randomly to obtain a stratified age distribution matching
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that of the cases, and they were sent consent forms and questionnaires. All 1,506
controls who responded were used in comparisons for each of four cancer groups:
316 HL cases, 517 NHL cases, 342 multiple myeloma cases, and 357 STS cases.
The postal questionnaire gathered standard demographic information, personal and family medical histories, employment history, smoking behavior, and
basic data on pesticide exposure. The pilot study tested the reliability of selfreported pesticide use by comparison with purchase records. Any subject who
reported at least 10 hours of pesticide exposure per year was asked to complete
a telephone questionnaire on the details of the pesticide exposure; in addition,
15% of the remaining subjects were randomly selected to answer the telephone
survey. A conditional logistic regression stratified on age and province and adjusted for all covariates found to be associated with the outcome at the 0.05 level
of significance was used to estimate odds ratios for specific active ingredients,
including dicamba and the phenoxy herbicides 2,4-D, Mecoprop, MCPA, and
diclofop-methyl. Dose–response relationships were investigated for the cumulative time spent in mixing or applying particular products.
A series of publications have addressed the relationship between each of the
cancers and various risk factors. Those pertaining to herbicides overall or to the
particular ones of interest are as follows:
•
•
•
•

HL: Karunanayake et al. (2012); P. Pahwa et al. (2003)
NHL: Hohenadel et al. (2011); McDuffie et al. (2001)
Multiple myeloma: P. Pahwa et al., (2003, 2012)
STS: P. Pahwa et al., (2003, 2011)

A number of other publications arising from that dataset have addressed topics somewhat more tangential to the interests of the VAO reports. For instance,
McDuffie et al. (2005) and P. Pahwa et al. (2006) considered the possible role
of exposure to insect repellents, particularly DEET and phenoxy herbicides, in
the genesis of the malignancies in question. McDuffie et al. (2009) examined
family histories of cancers in first-degree relatives of the study participants to
assess the interaction between family history and pesticide exposure. Hohenadel
et al. (2011) investigated how various combinations of pesticide exposures influenced the occurrence of NHL. Ghosh et al. (2011) investigated the association
of occupational exposures other than pesticides with the occurrence of multiple
myeloma. M. Pahwa et al. (2012) examined the interactions between self-reported
pesticide exposures and self-reported measures of immune suppression (asthma,
allergies, hay fever) and the risk of NHL, but this analysis is limited by the use
of self-reported measurements of immunologic conditions and the non-specific
and crude self-report classification of pesticide use, which did not characterize
exposure use by duration, intensity, or frequency. Similarly, Navaranjan et al.
(2013) examined HL relative to the number of pesticides to which an individual
reported exposure and to estimates of work-related exposure and home-related
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exposure, grouped by class (herbicides, insecticides, and fungicides). This study
is also limited by the relatively nonspecific and crude self-report classification of
pesticide use, which significantly limits direct inference to the effects of herbicide
exposure during military service in Vietnam.

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

6
Immune System Disorders

Chapter Overview
Based on new evidence and a review of prior studies, the current committee
did not find any new associations between the relevant exposures and immune
outcomes that warranted a change in level of evidence of association. Current
evidence supports the findings of earlier studies that there is inadequate or insufficient evidence to determine whether there is an association between exposure
to the chemicals of interest (COIs) and any specific diseases involving immune
suppression, allergy, autoimmunity, or inflammation.
Immune-system disorders affect more than 23.5 million Americans (NIEHS,
2012), with some sources estimating that as many as 50 million Americans are
currently affected by immune-system disorders (AARDA, 2018). The causal
factors for immune-system disorders are mainly unknown; however, it has been
hypothesized that they most likely reflect both genetic and environmental factors.
The immune system plays three important roles in the body:
• It defends the body against infectious pathogens, including viruses, bacteria, and other disease-producing microorganisms.
• It helps defend against cancer by destroying mutated cells that may otherwise develop into tumors and providing immunity against tumors.
• It provides resident immune cells that are specially adapted for different
tissues and organs (such as microglia in the central nervous system and
Kupffer cells in the liver) to help regulate the functional activity and
integrity of those tissues.
195
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This chapter begins with an overview of the various types of health problems
that can arise as a result of a malfunction of the human immune system, such as
immune suppression, allergic diseases, autoimmune diseases, and inflammatory
diseases. Outcomes related to infectious agents would be included in this chapter,
but no studies had specific enough information on exposure to warrant inclusion.
Following the brief description of the types of immune dysfunction, the findings
from previously reviewed literature and the conclusions from prior updates are
summarized regarding the epidemiologic evidence concerning an association
between exposure to any one of the COIs, that is, 2,4-dichlorophenoxyacetic
acid (2,4-D); 2,4,5-trichlorophenoxyacetic acid (2,4,5-T); picloram; dimethylarsinic acid (DMA or cacodylic acid); and 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD). As described in Chapter 3, studies of exposure to polychlorinated biphenyls (PCBs) and other dioxin-like chemicals were also considered informative
if their results were reported in terms of TCDD toxic equivalents (TEQs) or as
concentrations of specific congeners of dioxin-like chemicals. Studies that report
TEQs based only on mono-ortho PCBs (which are PCBs 105, 114, 118, 123, 156,
157, 167, and 189) are considered even though their TEQs are several orders of
magnitude lower than those of the non-ortho PCBs (77, 81, 126, and 169), based
on the revised World Health Organization (WHO) toxicity equivalency factor
(TEF) scheme of 2005 (La Rocca et al., 2008; van den Berg et al., 2006). Epidemiologic findings from five newly identified studies are reviewed. Biologic plausibility data on the effects of the COIs on the immune system are summarized.
The chapter ends with a synthesis of the studies and what they contribute to the
evidence base and then the committee’s conclusion regarding the association of
exposure to the COIs and effects on the immune system. The studies reviewed
in this chapter are limited to those investigating effects on the immune system
from exposures that occurred to adults. Immune effects stemming from perinatal
exposures are discussed in Chapter 8. Table 1, which can be found at www.nap.
edu/catalog/25137, summarizes the results of studies reviewed in the VAO series
related to immune disorders.

CATEGORIES OF IMMUNE DYSFUNCTION
There are four major categories of immune dysfunction, which are not
mutually exclusive: immune suppression, allergy, autoimmunity, and inflammatory dysfunction (inappropriate or misdirected inflammation). Most times,
immune suppression manifests itself as an increased incidence of infections or
an increased risk of neoplasia. Allergic, autoimmune, and inflammatory disorders
can be manifested as diseases that affect virtually any tissue. It is often difficult
to diagnose such diseases, so they may not always be medically categorized as
immune disorders.
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Immune Suppression
The suppression of immune responses can reduce resistance to infectious disease and increase the risk of cancer. Infection with the human immunodeficiency
virus (HIV) is a well-recognized example of an acquired immune deficiency
in which a specific type of lymphocyte (CD4+ T cell) is the target of the virus
(Okoye and Picker, 2013). The decline in the number of CD4+ T cells after HIV
infection correlates with an increased incidence of infectious diseases, including
fatal opportunistic infections, and with an increased incidence of several types of
cancer (Davis, 1998). The treatment of the cancer with toxic chemotherapeutic
drugs suppresses the immune system by inhibiting the generation of new white
blood cells by the bone marrow and blocking proliferation of lymphocytes during
an immune response. Both of those examples represent severe immune suppression in which the adverse outcome is easily detected with clinical measurements.
Immune suppression can also result from exposure to chemicals in the
workplace or in the environment and can manifest as recurrent infections, opportunistic infections, a higher incidence of a specific category of infections, or a
higher incidence of many forms of cancer (Saberi Hosnijeh et al., 2013; Warren
et al., 2000). However, unless the immune suppression is severe (as occurs in
rare cases of genetic disorders of immunity), it is often difficult to obtain clinical
evidence that directly links chemically induced changes in immune function to
increases in infectious diseases or cancers because many confounding factors and
effect modifiers can influence a person’s ability to combat infection. These factors
include age, vaccination status, the virulence of the pathogen, the presence of
other diseases (such as diabetes), stress, smoking, and the use of drugs or alcohol.
Therefore, immunotoxicology studies are often conducted in laboratory animals
to understand the scope and mechanism of chemical-induced immune suppression. The results of such studies can be used to develop biomarkers to assess the
effects in human populations. Infectious disease models in animals can also be
used to determine whether the pattern of disease changes with chemical exposure.
Allergic Diseases
The immune system sometimes responds to a foreign substance that is
not pathogenic; such immunogenic substances are called allergens. Like most
immune-based diseases, allergic diseases have both environmental and genetic
risk factors. Their prevalence has increased in many countries in recent decades
(Linneberg et al., 2000; Simpson et al., 2008; Sly, 1999). The major forms of
allergic diseases are asthma, allergic rhinitis, atopic dermatitis, and gastrointestinal responses. In immediate hypersensitivity, the response to some allergens,
such as pollen and bee venom, results in the production of immunoglobulin E
(IgE) antibodies. Once produced, IgE antibodies bind to mast cells, which are
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specialized cells that are found in tissues throughout the body, including the
lungs, the intestinal wall, and blood-vessel walls. When a person is exposed once
again to the allergen, it binds to the antibodies on the mast cells and causes them
to release histamine and leukotrienes, which produce the symptoms associated
with an allergic response. In delayed-type hypersensitivity reactions, also known
as cell-mediated immunity, other allergens, such as poison ivy and nickel, activate
allergen-specific lymphocytes (memory T cells) at the site of contact (usually the
skin) that release substances that cause inflammation and tissue damage. Some
allergic responses, such as those to food allergens, may involve a combination
of allergen-specific lymphocyte-driven and IgE-driven inflammation. Allergic
responses may manifest in specific tissues (such as the skin, eyes, airways, and
gastrointestinal tract) or may result in a system-wide response called anaphylaxis.
Autoimmune Diseases
The National Institutes of Health’s Autoimmune Diseases Coordinating Committee recognizes 80 different autoimmune diseases and conditions that affect the
cardiovascular, respiratory, nervous, endocrine, skin, gastrointestinal, hepatic, and
excretory systems (NIH Autoimmune Diseases Coordinating Committee, 2005).
These diseases affect both men and women, but most of them affect more women
than men (Fairweather et al., 2008). Genetic predisposition, age, hormone status,
and environmental factors, such as the presence of infectious diseases and stress,
are known to affect the risk of developing autoimmune diseases. Different autoimmune diseases can occur in the same person and tend to cluster in families. The development of one autoimmune condition is also a risk factor for the development of
other immune-related diseases and for some types of cancer (Landgren et al., 2010).
Autoimmunity occurs when an individual’s immune system fails to recognize self and attacks tissues as though they were foreign. Inappropriate immune responses that cause autoimmunity originate with either cell-mediated or
humoral-mediated immune systems and can be directed against a wide variety
of tissues or organs. For example, the autoimmune reaction in multiple sclerosis
targets the myelin sheath of nerve axons; in Crohn’s disease, the intestinal epithelium; in type 1 diabetes mellitus, the insulin-producing islet cells of the pancreas;
and in rheumatoid arthritis, the joint synovium and other proteins associated with
connective tissue.
Other systemic autoimmune diseases also occur. Systemic lupus erythematosus is an autoimmune disease in which multiple organs are targeted by a variety
of autoantibodies. Patients display a variety of non-specific signs and symptoms
such as joint pain or fatigue that makes timely diagnosis challenging. A characteristic rash across the cheeks and nose and a sensitivity to sunlight are common
symptoms, but oral ulcers, arthritis, pleurisy, proteinuria, and neurologic signs
may also be present. Almost all of those affected with systemic lupus erythematosus test positive for antinuclear antibodies, specifically antibodies directed at
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double-stranded DNA. The cause of systemic lupus erythematosus is unknown, but
environmental and genetic factors have been implicated. The environmental factors
that are thought to trigger it include infections, antibiotics (especially those in the
sulfa and penicillin groups) and some other drugs, ultraviolet radiation, extreme
stress, and hormones (Kamen, 2014). Occupational exposures to such chemicals as
crystalline silica, solvents, and pesticides have also been associated with systemic
lupus erythematosus (Cooper and Parks, 2004; Parks and Cooper, 2005).
Inflammatory Diseases
Inflammatory diseases (also referred to as auto-inflammatory diseases) make
up a more recently identified category of immune-related disorders and are characterized by exaggerated, excessively prolonged, or misdirected dysfunctional inflammatory responses (usually involving immune cells). Tissue disease can result from
this inappropriate inflammation, which can affect virtually any organ. Examples
of the diseases and other conditions that are most often included in other disease
categories but that are also considered to be inflammatory diseases are: coronary
artery disease, asthma, eczema, chronic sinusitis, hepatic steatosis, psoriasis, celiac
disease, and prostatitis. Inflammatory diseases often co-occur with one another,
which has resulted in the categorizing of different but linked inflammatory diseases
together as a single chronic inflammatory disorder (Borensztajn et al., 2011). Ordinarily, inflammation is advantageous in fighting infection. It is one component of
the normal host response to infection and is mediated by innate and adaptive immunity. Innate inflammatory responses involve the rapid mobilization of macrophages,
granulocytes, and natural killer cells to the area of infection, where they produce
toxic metabolites that kill pathogens. The adaptive immune response follows with
specific antibodies and cell-mediated immunity that add to the inflammatory process. Interactions among innate immune cells and epithelial and endothelial cells are
important in regulating the magnitude of inflammation, and improperly regulated
inflammation can contribute to diseases that arise in non-lymphoid tissues, such as
the lungs, skin, nervous system, endocrine system, and reproductive system.
Inappropriate inflammation also appears to play a role in promoting the
growth of neoplasms (Bornschein et al., 2010; Hillegass et al., 2010; Landgren
et al., 2010; Porta et al., 2011; Winans et al., 2010); examples can be seen in the
higher prevalence of specific cancers in patients who have such inflammatory
diseases as inflammatory bowel disease (Lucas et al., 2010; Viennot et al., 2009;
Westbrook et al., 2010), prostatitis (Sandhu, 2008; W. Wang et al., 2009), and
psoriasis (Ji et al., 2009).
CONCLUSIONS FROM VAO AND PREVIOUS UPDATES
The studies reviewed in this section are limited to effects on the immune
system due to exposures that occurred to adults. Immune effects stemming from
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perinatal exposures are discussed in Chapter 8: Reproductive Health Effects and
Effects on Descendants.
Two studies of Vietnam veterans reported a statistically significant difference of single immune measures of veterans exposed to Agent Orange compared
with veterans without diseases and with age-matched healthy controls. Among
Air Force Health Study (AFHS) veterans, Ranch Hands with the highest TCDD
levels had statistically significantly elevated absolute counts of CD20 cells, the
sum of natural killer (NK) cell antigens (CD16 and CD56) and total CD3+ cells
compared with the AFHS controls (Michalek et al., 1999b). H. A. Kim et al.
(2003) conducted an immunotoxicologic study of Korean Vietnam veterans who
had been deployed to areas that were known to be sprayed with Agent Orange and
found elevated levels of IgE and IgG1 among exposed veterans compared with
age-matched healthy controls. Other studies of Vietnam veterans and populations
exposed to the COIs did not find similar elevations for these immune markers.
Thus, there were no consistent findings indicative of immunosuppression, an
increased risk of autoimmunity (usually as measured with autoantibodies), or
biomarkers of atopy or allergy (such as increased IgE concentrations). Much of
the focus of the studies was on measuring CD4+:CD8+ T-cell ratios (T4:T8). The
T4:T8 ratio is an effective biomarker of the progression of HIV-induced AIDS
(acquired immune deficiency syndrome), but the TCDD-exposure animal data
indicate that it is not an immunologic index that is expected to be altered. The
results of a survey of Australian Vietnam veterans (O’Toole et al., 2009) showed
purportedly significant increases in the prevalence of a number of conditions in
which immune function may play a prominent role, but the study’s methods were
deemed unreliable.
The occupational exposure studies evaluated by VAO committees have examined the concentrations of lymphoid populations in circulation, such as CD4+
T cells, CD8+ T cells (and their ratio), and NK cells; cell-mediated immunity
(the delayed-hypersensitivity response); serum concentrations of immunoglobulins, such as IgM, IgG, and IgA; concentrations of complement, such as C3
and C4; and concentrations of cytokines, such as IL-1, IL-2, interferon-γ, IL-4,
IL-6, and tumor necrosis factor (TNF)-α. A few studies also included disease or
condition endpoints, such as rheumatoid arthritis, systemic lupus erythematosus, immune suppression, and sensitivity to fungal infection. Ex vivo analyses
included measures of NK activity, lymphoid mitogen-induced proliferation, and
the mixed lymphocyte response against allogeneic cells. Some studies identified one or more dioxin-related shifts in immune measures, but many reported
no significant differences in the same measures. Saberi Hosnijeh et al. (2012a)
reported a positive correlation between plasma TCDD concentrations and decreased levels of cytokines, chemokines, and growth factors in Dutch workers
who produced and formulated chlorophenoxy herbicides. In additional studies,
Saberi Hosnijeh et al. (2012b, 2013a) assessed TCDD levels with respect to several other immunological parameters and found no differences in hematologic

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

IMMUNE SYSTEM DISORDERS

201

measurements other than an increase in the T4:T8 ratio (p = 0.05) when high- and
low-exposure groups were compared. In the third study, Saberi Hosnijeh et al.
(2013a) reported on the levels of interleukin 1 receptor antagonist (IL-1RA) as
well as of the soluble forms of CD27 and CD30, immunomodulatory members
of the TNF receptor superfamily. In this case they found no association of TCDD
level with CD27 or CD30; however, IL-1RA was significantly decreased in
those with higher TCDD levels after adjusting for concurrent chronic disease.
This result is also consistent with a degree of immune system impairment being
associated with high exposure to TCDD. Similarly, the occupational exposure
studies that examined NK concentrations reported the full spectrum of results:
no alterations (Halperin et al., 1998), a decrease (Faustini et al., 1996), and even
an increase in NK numbers (Jennings et al., 1988) in different populations of
people exposed to dioxin.
Several environmental exposure studies have been published, with inconsistent findings. Some studies reported alterations in immune measures associated
with dioxin exposure. For example, Van den Heuvel et al. (2002) reported a
negative correlation between increased serum TEQ levels and eosinophil counts,
NK-cell counts, and levels of cat dander, house dust mite, and grass pollen IgEs
(measured by radioallergosorbent tests); but a positive correlation with IgA levels. These alterations, however, were not seen consistently in other studies. Baccarelli et al. (2002) found no changes in IgA levels but saw changes in IgG levels
in the Seveso population. Svensson et al. (1994) found that NK-cell numbers
were reduced with increasing concentrations of persistent organic chemicals, but
Lovik et al. (1996) found no difference in NK numbers or activity.
Some early studies of the Quail Run Mobile Home Park population who
were exposed to TCDD-contaminated soil reported that dioxin exposure was associated with a reduction in a specific type of cell-mediated immune response,
the delayed type hypersensitivity response (Andrews et al., 1986; Hoffman et
al., 1986; Knutsen et al., 1987; Stehr-Green et al., 1987). However, several studies of
the Times Beach population, another dioxin-exposed population, did not find any
alteration of the delayed type hypersensitivity response (Knutsen, 1984; Stehr et
al., 1986; Webb et al., 1987). An analysis of National Health and Nutrition Examination Survey (NHANES) data found that exposure to dioxin-like PCBs was
associated with an increase in self-reported arthritis (D. H. Lee et al., 2007a), but
De Roos et al. (2005b) did not find this association. Spector et al. (2014) assessed
immune function in 109 postmenopausal women who participated in a year-long
study of exercise and health in Seattle. At baseline, the concentrations of monoortho PCBs 105, 118, and 156 were not associated with changes in lymphocyte
proliferation assays; after 1 year, however, a decrease in lymphocyte proliferation
was associated with increased levels of this group of PCBs (p = 0.039).
Nakamoto et al. (2013) gathered fasting blood samples to assess environmental exposure to dioxin-like polychlorinated dibenzo-p-dioxins (PCDDs),
polychlorinated dibenzofurans (PCDFs), and PCBs and found an association of
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exposure to dioxins with differential leukocytes and a significantly decreased
incidence of reported atopic dermatitis. Gallagher et al. (2013) examined the
link between environmental exposures to the COIs and autoimmunity in women.
Among women, after adjustments for mercury blood level, race, menopausal status, diet, and body mass index (BMI), the total TEQs for PCBs were significantly
associated with antinuclear antibody positivity (intensity ≥ 3) for each higher
quartile compared with the lowest and as an overall trend (p < 0.001). After
adjusting for mercury blood level, race, menopausal status, diet, and BMI, total
TEQs for PCBs were significantly associated with antinuclear antibody positivity for each quartile compared with the referent group, and the overall trend was
significant (p < 0.001). Turunen et al. (2012) derived the total toxic equivalence
for 17 PCDD/F and 37 PCB congeners in blood samples from 123 men and 132
women from a population with high fish consumption and analyzed their relationship with C-reactive protein, an indicator of inflammation. No evidence of
a trend across the tertiles of overall TEQ concentration was seen for either the
men or the women.
Based on these mixed results, the variety of endpoints assessed, and the
poor methods used in some studies, VAO committee have concluded that epidemiologic data were either insufficient or inadequate to determine an association between exposure to the COIs and immunosuppression, allergic disease, or
autoimmune disease.
UPDATE OF THE EPIDEMIOLOGIC LITERATURE
Since Update 2014, five new published studies have been identified: one
focused on New Zealand Vietnam veterans, three among occupational cohorts,
and one on environmental exposures in Vietnam.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to
identify prevalent health conditions in 2,783 male New Zealand veterans who
served in Vietnam during 1964 to 1972. Age-specific hospitalization rates were
calculated using the total number of annual hospitalizations published by the
Ministry of Health and the average annual resident population. Standardized
hospitalization rates and 99% confidence intervals (CIs) were calculated for the
veteran cohort and the general population for several noncancerous conditions
and a standardized hospitalization ratio (SHR) was calculated using the two rates.
Results were presented for three categories of arthritis: rheumatoid arthritis, infective arthritis, and osteoarthrosis. A statistically significant increased risk was
observed for rheumatoid arthritis (n = 25; SHR = 1.70, 99% CI 1.03–2.36) and
osteoarthrosis (n = 179; SHR = 1.32, 99% CI 1.12–1.51) but not for infective arthritis (n = 26; SHR = 1.39, 99% CI 0.85–1.92). However, arthritis is not usually
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a condition that requires hospitalization, so this study likely underestimates
the prevalence or detects only persons with an unusually complicated disease
process. In addition, hospitalization for systemic lupus erythematosus was not
statistically significantly increased among veterans (n = 5; SHR = 1.82, 99%
CI 0.22–3.41). Exposure to the COIs was not validated through serum measurements, and the study did not control for smoking or ethnicity or other potentially
important risk factors.
Occupational Studies
Parks et al. (2016) used data collected from the prospective, longitudinal
Agricultural Health Study (AHS) to examine the associations between rheumatoid arthritis and pesticide exposures among the spouses of licensed pesticide
applicators from Iowa and North Carolina who were part of the AHS. Specific
pesticide exposures included exposure to herbicides 2,4-D and dicamba and to
several insecticides and fungicides; only 2,4-D and dicamba are considered relevant to committee’s charge. Details of the AHS study design and data collections
are found in Chapter 5. Cases of rheumatoid arthritis were identified based on
self-report. Cases in which disease-modifying antirheumatic drugs or other medications for rheumatoid arthritis were identified were considered to be probable
instances of rheumatoid arthritis, and those individuals for whom a medical record review allowed confirmation of the diagnosis were considered to be definite
cases of rheumatoid arthritis. Surveys collected information on age, tobacco use,
menopausal status, childhood farm exposure, non-specific household and specific
farm pesticide exposure, farm activities related to pesticides and other activities
such as sun exposure, exposure to solvents and exposure to pesticides through
mixing or application. A total of 275 cases of rheumatoid arthritis were identified
among the 24,018 women participants, of which 132 were incident cases (that is,
they developed after the start of the study, having been reported in phase II or III
surveys but not phase I). Cases reported in phase I were considered prevalent, that
is, as having developed before the start of the study. After adjusting for age, state
of residence, and smoking history, the researchers found a statistically significant
association between all-cases rheumatoid arthritis (incident and prevalent) and
any specific pesticide exposure (odds ratio [OR] = 1.4; 95% CI 1.0–1.8; p < 0.05).
Incident cases of rheumatoid arthritis were not associated with any exposure
(OR = 1.4; 95% CI 0.93–2.1). A decreased association was observed for rheumatoid arthritis and exposure to 2,4-D with all cases (OR = 0.75; 95% CI 0.51–1.1)
and incident cases (OR = 0.69; 95% CI 0.39–1.2). Likewise, a decreased association was observed for rheumatoid arthritis and exposure to dicamba based on
7 cases (OR = 0.68; 95% CI 0.32–1.5). The effect estimate was not presented for
incident cases of rheumatoid arthritis and dicamba exposure because there were
fewer than 5 cases. The only individual pesticide to demonstrate a statistically
significant association with rheumatoid arthritis was glyphosate (OR = 1.4; 95%
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CI 1.0–2.1; p < 0.05). Thus, this study does not support an association of 2,4-D in
the development of rheumatoid arthritis. The strengths of the study are the sample
size, duration of follow-up, and specific pesticide data. The self-reported nature
of the exposure without quantification could lead to under- or over-estimation as
well as a misclassification of the agents of exposure. Para-occupational exposure
and agricultural drift were not considered. Though the statistical methods for
handling missing data were sound, there was a variety of missing data.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of
workers who were employed at the New Plymouth, New Zealand, phenoxy herbicide production plant for at least 1 month between 1969 and 1984. The plant
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, intermediates
of trichlorophenol and other chlorophenols, and TCDD. Workers had previously
been recruited and examined as part of the international cohort of producers of
phenoxy herbicides led by the International Agency for Research on Cancer
(IARC; Kogevinas et al., 1997); see Chapter 5 for more details on the IARC cohort and the New Zealand phenoxy producers. The 't Mannetje et al. (2018) study
extended the follow-up period of these workers to approximately 30 years from
their last 2,4,5-T production exposure. From the original cohort of 1,025 workers,
631 were living, had a current address in New Zealand, and were below 80 years
of age on January 1, 2006. For the current follow-up, 430 of the 631 workers were
randomly selected and invited to participate in the morbidity survey, of which
245 (57%) participated. The survey, which was administered in 2007–2008 by
face-to-face interview, collected information on demographic factors and health
information, including doctor-diagnosed conditions and year of diagnosis. A
blood sample was also collected at that time to be analyzed for TCDD, lipids,
thyroid hormones, and other parameters. For 111 of the participants, a neurological examination was also conducted. Associations between exposure and health
outcomes were assessed using logistic regression models that controlled for age,
gender, smoking, BMI, and ethnicity using two methods: (1) working in a TCDDexposed job (based on occupational records), and (2) serum TCDD concentration
≥10 pg/g lipid (18%). Mean TCDD concentrations were 19 pg/g lipid in the 60
men directly involved in phenoxy or trichlorophenol production and 6 pg/g lipid
in 141 men and 43 women who worked in other parts of the plant. Compared
with the 124 people in the non-highly exposed jobs, the 121 people who had ever
worked in a highly exposed job were no more likely to have doctor-diagnosed
nasal allergies, including hay fever (n = 21; OR = 1.00; 95% CI 0.48–2.08). When
compared by serum TCDD concentration ≥10 pg/g lipid, no difference in nasal
allergies was found (n = 7; OR = 0.80; 95% CI 0.27–2.37).
Cappelletti et al. (2016) performed a retrospective study of 331 male electric
arc foundry workers at a single plant in Trentino, Italy, to determine if they had
experienced excess mortality from all causes or were at an increased risk for several other diseases, including rheumatoid arthritis, due to occupational exposures
to foundry dust. An analysis of the dust found that it contained metals (including
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iron, aluminum, zinc, manganese, lead, chromium, nickel, cadmium, mercury,
and arsenic), polycyclic aromatic hydrocarbons (PAHs), PCBs, and PCDD/Fs (reported as TEQs). Therefore, the authors could not determine which of the agents
were associated with a specific outcome or to what extent. Each of the men had
worked at the factory for at least 1 year, and, for the rheumatoid arthritis analysis,
they were compared with 32 presumed non-exposed workers (clerks, managers,
and watchmen) or the standardized general population of Region Trentino-Alto
Adige (where the factory was located) because there were few non-exposed
foundry workers and high attrition rates. Company and medical records were
used to determine vital status; cause of death was determined from death certificates or other registries. Requests for exemption health care fees were used as a
surrogate measure to identify the most prevalent morbid conditions in the general
population, which were then applied to the cohort to compute relative risks for
each of the conditions. The workers were followed from March 19, 1979 (or their
first day of employment), through December 31, 2009, or their date of death. The
analysis for rheumatoid arthritis was limited to 235 workers, and effect estimates
were calculated using Mantel-Haenszel tests. Although a statistically significant
increase of rheumatoid arthritis was found among the workers compared with the
age-adjusted provincial population, it was based on three cases, which resulted in
an imprecise effect estimate (RR = 6.18, 95% CI 2.00–19.02). This study is most
limited by the fact that foundry dust is a complex mixture, which results in an
inability to discern the impact of the specific contaminants of the foundry dust on
the health outcomes of those exposed workers. Estimates were only adjusted for
age group and were not adjusted for other risk factors such as tobacco use, BMI,
or other jobs or activities that could also influence health outcomes. The exposure
to foundry dust by the general population that was used for comparison was not
discussed, although the foundry appears to be in the local vicinity, and emissions
from it were reported to be present within a 2-kilometer radius of the foundry.
Environmental Studies
C. H. Nguyen et al. (2017), studied serum TCDD levels, the expression of
AHR, and a variety of pro-inflammatory cytokines in Vietnamese who were either exposed or not exposed to TCDD-like chemicals. The exposed individuals
(36 women and 24 men) had lived near the Da Nang Air Base for more than 10
years. The controls were healthy men and women recruited from unsprayed areas
in northern Vietnam. Serum levels of TCDD and “other” types of dioxins were
measured using a chemical-activated luciferase gene-expression bioassay. RNA
was isolated from whole blood for quantitative real-time polymerase chain reaction
assays that were used to examine gene expression for AHR, IL-1β, TNFα, IL-6,
IL-22, and β-actin. Dioxin levels, presented as bioanalytic equivalents (BEQ)/g
fat (1.5 interquartile range), were significantly higher in the TCDD-exposed participants than in the controls—62.03 (40.74–89.42) versus 17.45 (12.05–35.57),
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respectively. AHR expression was 16.39 times higher in the exposed versus unexposed controls, which was statistically significant. To determine if there was an
association between AHR expression and rheumatoid arthritis in the dioxin-exposed subjects, AHR expression was measured and the 6 people with rheumatoid
arthritis were compared to the 54 people without rheumatoid arthritis. While the
dioxin-exposed group had higher levels of AHR expression than controls, there
were no differences in AHR expression levels between the exposed subjects with
and without rheumatoid arthritis. Because of the role they play in the pathogenesis of autoimmune conditions, IL-1β, TNFα, IL-6, and IL-22 were expression levels measured in TCDD-exposed and unexposed populations. The median increase
and 1.5-interquartile range for IL-1β was 11.18-fold (6.76–20.72, p < 0.05); for
TNFα, 6.64-fold (3.43–13.67, p < 0.05); and for IL-6, 2.93-fold (1.80–5.18,
p < 0.05). IL-22 was decreased 0.05-fold (0.01–0.11, p < 0.01). There was, however, no association between cytokine levels and dioxin levels. There was a weak
positive correlation between AHR expression and IL-6 and IL-22 expression.
Next the investigators looked at the range of conditions reported in the
exposed subjects. Cardiac disease was the most common, affecting 18%. Rheumatologic conditions affected 16.7%, and rheumatoid arthritis affected 10%. The
rate for rheumatoid arthritis in the general Vietnamese population was 0.05%.
The main strength of this study of Vietnamese individuals living near the Da
Nang Air Base is the availability of serum dioxin levels. While the levels of proinflammatory cytokines were significantly elevated in the exposed population,
they did not correlate with serum dioxin levels. While there were more cases of
rheumatoid arthritis in the exposed population than in the general population,
neither the dioxin levels nor pro-inflammatory cytokines were compared between
exposed people with and without rheumatoid arthritis. The study demonstrates
an increased expression of pro-inflammatory cytokines in persons exposed to
dioxins, but there is no information on lifestyle habits, tobacco, obesity, or other
rheumatologic disorders or family history that may confound the findings.
Other Identified Studies
Several other studies were identified by the committee but either lacked sufficient exposure specificity or examined biologic markers of effect on the immune
system that do not relate to a diagnosable health outcome; these studies were not
considered further. Akahane et al. (2017) examined the prevalence of a variety of
self-reported conditions, including several connective tissue disorders, in people
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the
ingestion of contaminated rice bran oil following the Yusho accident. Because
neither TEQs nor any other quantification of relevant exposures was presented,
this study was not considered further.
A study of people who either worked at a transformer and capacitor recycling plant in Dortmund, Germany, or lived in the immediate area and might
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have been exposed to dioxin-like (PCBs 105, 114, 118, 156, 157, 167, and 189)
and non-dioxin-like PCBs as a result of contamination of the area by the facility
confirmed that exposure can modify lymphocyte profiles, but this was not linked
with specific health outcomes (Haase et al., 2016). The results are consistent
with the literature suggesting that PCB exposure may alter the immune profile,
but these data do not provide any evidence of any consistent abnormality. This
study did not detect any functional immunodeficiency, and the problems with its
design and analysis (detailed in Chapter 5) seriously limit its contribution to the
scientific evidence on the effects of exposure to the COIs.
Serdar et al. (2014) used data from the 2003–2004 cycle of NHANES to
examine the association of serum, lipid-adjusted PCB levels, and organochlorine
pesticide levels (including PCDDs, PCDFs, and dioxin-like PCBs) with hematology and blood chemistry profiles that measured electrolytes, liver and renal
function, globulin, total protein, and other factors. Although some statistically
significant differences were found between counts and levels in the highest- and
lowest-exposed quartiles, all were within the normal ranges and limits for those
markers. These measures are indicators, not health outcomes, thus limiting their
interpretability concerning immune system conditions.
BIOLOGIC PLAUSIBILITY
Given the growing recent understanding of the role of AHR in immune functions (Abe et al., 2014; Biljes et al., 2017; Bock et al., 2017a; Chinen et al., 2015;
Huai et al., 2014; Kado et al., 2016; Kimura et al., 2014; Y. H. Lee et al., 2015;
Liao et al., 2017; Murray and Perdew, 2016; Stockinger et al., 2014), it is not
surprising that there is an extensive body of evidence from experimental studies
in cultured cells and animal models indicating that TCDD and other dioxin-like
chemicals are immunotoxic to a variety of leukocytes (Kerkvliet, 2009, 2012;
Kreitinger et al. 2016). Given that most of the cell types involved in the immune
system express the AHR, there are many potential pathways to immunotoxicity.
TCDD-induced immunotoxicity is due primarily to changes in adaptive immune
responses resulting in the suppression of both antibody-mediated and cell-mediated
immunity. Dioxin and other AHR agonists may also reduce the clearance of infections and promote tumor growth through alterations in immune function. TCDD
exposure alters macrophages and neutrophils so as to exacerbate some types
of inflammation during infections, and it may contribute to the development of
chronic inflammatory lung disease (Teske et al., 2005; P. S. Wong et al., 2010).
Although there are many examples of dioxin and dioxin-like chemicals having
immunosuppressive effects, these chemicals also appear to influence autoimmune
diseases, which are viewed as an inappropriate increase in immune function.
Therefore, these chemicals may be best described as immunomodulatory.
TCDD has been shown to be a potent immunosuppressive chemical in
laboratory animals and cell culture models. Data show that the relative potencies

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

208

VETERANS AND AGENT ORANGE: UPDATE 11

of TCDD and dioxin-like chemicals on leukocytes are predicted by their TEFs
(Frawley et al., 2014; Smialowicz et al., 2008). The exposure of animals to dioxin
not only suppresses some adaptive immune responses, but also has been shown
to increase the incidence, progression, and severity of various infectious diseases
and to increase the development of cancers (Choi et al., 2003; Elizondo et al.,
2011; Fiorito et al., 2010, 2011, 2014; Head and Lawrence, 2009; Jin et al., 2010;
Sanchez et al., 2010). Also, developmental exposure to TCDD (in utero and via
suckling) in mice reduces immune response capacity to the influenza virus in
adulthood (Boule et al., 2014). Consistent with its immunosuppressive effects,
TCDD exposure suppresses the allergic immune response of rodents; this in
turn results in decreased allergen-associated pathologic lung conditions and has
been shown to suppress the development of experimental autoimmune disease
(Quintana et al., 2008), to induce the suppression of autoimmune uveoretinitis
(L. Zhang et al., 2010), and to affect colitis (Ji et al., 2015; Takamura et al.,
2011), arthritis (Nakahama et al., 2011), and inflammatory lung diseases, such as
silicosis (Beamer et al., 2012).
Experimental studies indicate that the AHR pathway plays an integral role
in B-cell maturation, and that exposure to TCDD and other dioxin-like chemicals
may alter B-cells and result in critical changes in the immune response (Baba et
al., 2012; Sibilano et al., 2012; Simones and Shephard, 2011; Singh et al., 2011).
Feng et al. (2016) found that chronic TCDD exposure impaired both B- and Tcell differentiation in a mouse model. Working with human B cells in vitro, Allan and Sherr (2010) demonstrated a new AHR-dependent mechanism by which
exposure to environmental PAHs suppressed humoral immunity by blocking the
differentiation of B cells into plasma cells. This finding was confirmed by data
from human hematopoietic stem cells and knockout Ahr mouse models showing
that the Ahr is critical in the maturation and differentiation of hematopoietic stem
cells (Bock, 2017b; Fracchiolla et al., 2011; J. Li et al., 2017; Singh et al., 2011;
Vaidyanathan et al., 2017). Furthermore, data from a B-cell specific Ahr knockout
showed that the receptor pathway is required for efficient B-cell proliferation
(Villa et al., 2017). Using a novel pluripotent stem cell–based culture system,
B. W. Smith et al. (2013) demonstrated that AHR expression and activity can direct human hematopoietic progenitor cell proliferation and differentiation. These
data show that pluripotent hematopoietic human cells express AHR and that AHR
agonists enhance erythroid differentiation, whereas the antagonism of AHR favors the expansion of megakaryocyte cells. This finding supports previous work
indicating that B-cell activation results in increased AHR expression and that an
exposure of B-cells to benzo[a]pyrene, a PAH, suppresses B-cell differentiation
(Allan and Sherr, 2010). H. Lu et al. (2010) demonstrated that although human
B cells appeared less responsive to TCDD in increasing the expression of AHR
battery genes, TCDD’s ability to decrease IgM production was similar in both
mouse and human B cells. Data from Q. Zhang et al. (2013) suggest that this
decrease in IgM production is the result of a TCDD-mediated decrease in B-cell

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

IMMUNE SYSTEM DISORDERS

209

terminal differentiation, which results in fewer IgM-producing cells. Recent
data from Kovalova et al. (2017) identify other species-specific gene expression
in TCDD-exposed mouse, rat, and human B cells. In addition, Kovalova et al.
(2016) found that certain AHR polymorphisms altered the sensitivity of human
B cells to TCDD-mediated suppression of IgM secretion, consistent with AHR
levels mediating this suppression.
TCDD not only alters hematopoietic stem cell maturation but also alters
activation, proliferation, and migration in vivo and in vitro (Casado et al., 2011;
Fader et al. 2015; Phadnis-Moghe et al., 2016), which indicates that exposure to
it may have multiple effects on immune-cell function. Recent data have linked
TCDD activation of the AHR with altered regulation of BCL-6 in human B-cells,
which in turn is linked to non-Hodgkin lymphoma and diffuse large B-cell lymphomas (Phadnis-Moghe et al., 2015, 2016), providing a suggestive mechanistic
link between TCDD exposure and some lymphomas.
Cellular immunity, which is mediated by the thymus and T cells, is also a
target of TCDD and dioxin exposure and the AHR pathway (Baricza et al., 2016;
Feng et al., 2016; Kuwatsuka et al., 2014). Early evidence indicated that dioxin
and dioxin-like chemicals alter cellular immunity because it was observed that
exposure to these chemicals resulted in thymic involution and suppressed cytotoxic T-lymphocyte activity (Hanieh, 2014). Recently attention has focused on
the ability of the AHR to induce regulatory T cells, or Tregs (Bruhs et al., 2015;
Kerkvliet, 2012; Marshall and Kerkvliet, 2010; Mohinta et al., 2015). A recent
paper elucidates one potential molecular mechanism of AHR activation of Tregs,
using real-time imaging to show the migration of AHR-Tr1 Tregs in the small intestine and the colon (Ehrlich et al., 2017). Tregs have potent suppressive activity
in the immune system, and their inappropriate induction by TCDD could account
for much of the immune suppression (Funatake et al., 2008; Kerkvliet, 2012;
Marshall et al., 2008; Quintana et al., 2008; Stockinger et al., 2011; Yamamoto
and Shlomchik, 2010). AHR activation in dendritic cells has also been shown to
promote the development of Tregs by inducing tryptophan metabolism. Furthermore, a recent study shows a role for the AHR pathway in promoting gut Tregs
(Ye et al., 2017).
One ultimate effect of the dysregulation of the immune system is an alteration in autoimmunity. Data from animal models and cell cultures indicate
that exposure to dioxin and dioxin-like chemicals alters the development of
autoimmune disorders. Boule et al. (2015) found that developmental exposure
to TCDD exacerbated the severity of autoimmune disease in a genetically susceptible mouse model. In another example, antagonism of the AHR repressed the
expression of cytokines and chemokines in primary human synovial fibroblasts
(Lahoti et al., 2013), indicating a potential contribution to the inflammatory
process of rheumatoid arthritis. N. T. Nguyen et al. (2013) hypothesized that the
inflammatory process may occur when AHR stimulation of IL-17 production in
Th17 cells overwhelms the immune suppressive effects of the inhibition of Treg
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differentiation. TCDD has also been shown to induce apoptosis in rabbit chondrocytes, which supports a potential role of TCDD in contributing in a novel way
to arthritis (Yang and Lee, 2010). A recent study indicates that sub-chronic lowdose TCDD exposure can show immunomodulatory effects in a mouse model of
experimental autoimmune encephalitis (E. J. Yang et al., 2016). Recent work by
L. Cheng et al. (2017) in a hospital-based study of Han Chinese patients suggests
that a polymorphism in the AHR repressor gene may increase an individual’s
susceptibility to rheumatoid arthritis. Exposure to TCDD was also shown to
induce the reactivation of the latent form of the Epstein Barr virus in 19 patients
with Sjögren syndrome, an autoimmune disease, when compared with 19 healthy
patients (Inoue et al., 2012). AHR activation by ultraviolet light may play a role
in the exacerbation of systemic lupus erythematosus symptoms by reducing DNA
methylation in CD4+ T cells (Z. Wu et al., 2017). Taken together these studies
suggest mechanisms by which TCDD may alter the incidence and progression of
autoimmune disorders.
Allergies and allergic-induced asthma are also linked to TCDD exposure.
A study of 18 people who had allergic asthma, 17 people whose asthma was
controlled, and 12 controls showed that the plasma concentrations of IL-22 and
the expression of the AHR in peripheral blood mononuclear cells were associated with the severity of allergic asthma; this finding strengthened the possibility
that the AHR is involved in allergic asthma, thereby implying a role for dioxin
exposure in this condition (Zhu et al., 2011). X. M. Li et al. (2016) studied a
mouse model of non-allergic asthma and found that TCDD exposure reduced the
airway infiltration of neutrophils and airway hyperresponsiveness and inhibited
Th17 differentiation. Thus, depending on the disease, TCDD exposure could
exacerbate or ameliorate symptoms.
SYNTHESIS
Previous VAO committees have concluded that the data were inadequate
or insufficient to support an increased risk of immune suppression, allergy, or
autoimmune disease. The studies reviewed by these committees were at times
poorly designed and often inconsistent and used a variety of biomarkers, making
comparisons difficult. Most of the studies used biomarkers rather than health
outcomes as endpoints.
The new studies reviewed here do not change this conclusion, as the results
continue to be inconsistent and inconclusive. Cox et al. (2015) used hospital discharge records from New Zealand Vietnam veterans to examine the prevalence
of inflammatory and autoimmune conditions. Although there was an increase in
the standard hospitalization rate for rheumatoid arthritis but not systemic lupus
erythematosus among veterans, no serum or tissue levels of dioxin-like chemicals
were provided to confirm exposure. Rheumatoid arthritis incidence and prevalence were examined by Parks et al. (2016) in the female spouses of licensed
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pesticide applicators in the AHS and found to be associated only with glyphosate,
not 2,4-D or dicamba. Again, exposure was not confirmed with blood or tissue
levels. Cappelletti et al. (2016) studied electric arc foundry workers exposed
to the COIs. Results showed a statistically significant increase in rheumatoid
arthritis among workers exposed to foundry dust. In a comparison of high- and
low-exposure areas in Vietnam, C. H. Nguyen et al. (2017) showed that persons
living in the high-exposure area had higher levels of AHR expression and some
pro-inflammatory cytokines. They also had a higher prevalence of rheumatoid
arthritis, but no data were provided linking the higher levels of pro-inflammatory
cytokines in persons with rheumatoid arthritis. Among New Zealand workers in
a plant that produced 2,4,5-T, comparisons of high- versus low-exposed workers
by job and by serum measurements showed no difference in doctor-diagnosed
nasal allergies, including hay fever.
It is biologically plausible for dioxins to influence immune dysfunction, but
because of the variety of methods and endpoints used in studies to date, it is hard
to confirm specific mechanisms by which the COIs induce immune suppression
and auto-immunity. TCDD has been shown to suppress both limbs of the adaptive
immune response, reduce the clearance of infection, and promote tumor growth
(Bruhs et al., 2015; Kerkvliet, 2009, 2012; Kreitinger et al., 2016; Marshall and
Kerkvliet, 2010). Exposure to dioxin-like chemicals has been shown to induce
immune suppression via T regulatory cells (Bruhs et al., 2015; Kerkvliet, 2012;
Marshall and Kerkvliet, 2010; Mohinta et al., 2015) in animal models. Animal
models also support the development of inflammatory conditions, especially rheumatoid arthritis, following exposure to dioxin, through the AHR and downstream
increased production of IL-17 (N. T. Nguyen et al., 2013). AHR polymorphisms
have been associated with an increased susceptibility to rheumatoid arthritis in
exposed persons (L. Cheng et al., 2017) and AHR activation by ultraviolet light
may exacerbate systemic lupus erythematosus via reduced methylation in CD4+
T cells (Z. Wu et al., 2017). The data are inconsistent for allergic asthma.
CONCLUSION
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
any specific diseases involving immune suppression, allergy, autoimmunity, or
inflammation.
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Cancer

Chapter Overview
Based on new evidence and a review of prior studies, the current committee deter
mined that epidemiologic results concerning an association between exposure
to any one of the chemicals of interest (COIs; 2,4-dichlorophenoxyacetic acid
(2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), picloram, dimethylarsinic
acid [DMA or cacodylic acid], and 2,3,7,8-tetrachlorodibenzo-p-dioxin [TCDD])
and monoclonal gammopathy of undetermined significance (MGUS) met the criteria for sufficient evidence of an association. No other changes in association
level between the relevant exposures and other cancer types were made as either
there were no published studies or the new evidence supported the findings of earlier updates. Thus, the current findings on cancer can be summarized as follows:
• There is sufficient evidence of an association between the COIs and soft tissue sarcomas, B-cell lymphomas (Hodgkin lymphoma, non-Hodgkin lymphomas, chronic lymphocytic leukemia, hairy-cell leukemia), and MGUS.
• There is limited or suggestive evidence of an association between
the COIs and bladder cancer; laryngeal cancer; cancers of the lung,
bronchus, or trachea; prostate cancer; multiple myeloma; and AL
amyloidosis.
• There is inadequate or insufficient evidence to determine whether there
is an association between the COIs and any other specific type of cancer.
Cancers are the second-leading cause of death in the United States (CDC,
2017a), with heart disease being the leading cause of death. However, among
213
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men 55–79 years old, the group that includes most Vietnam veterans, the risk of
dying from cancer exceeds the risk of dying from heart disease (CDC, 2017b).
According to estimates from the National Cancer Institute (NCI), 1,735,350 new
cases of cancer were expected to be diagnosed and 609,640 people of all ages
were expected to die from cancer in the United States in 2018 (NCI, 2018a).
The objective of this chapter is to provide an assessment of whether the
occurrence of cancers in Vietnam veterans may be associated with exposures
to herbicides that they may have experienced during their military service. This
chapter summarizes and presents conclusions about the strength of the evidence
from epidemiologic studies regarding associations between exposure to the COIs
and various cancer types. As described in Chapter 3, studies of exposure to polychlorinated biphenyls (PCBs) and other dioxin-like chemicals were also considered informative if their results were reported in terms of TCDD toxic equivalents
(TEQs) or concentrations of specific congeners of dioxin-like chemicals. Studies
that report TEQs based only on mono-ortho PCBs (which are PCBs 105, 114,
118, 123, 156, 157, 167, and 189) are considered even though their TEQs are
several orders of magnitude lower than those of the non-ortho PCBs (77, 81,
126, and 169), based on the revised World Health Organization (WHO) toxicity
equivalency factor (TEF) scheme of 2005 (La Rocca et al., 2008; van den Berg
et al., 2006). The lower TEQs of the mono-ortho PCBs, however, may be counterbalanced by their abundance, which is generally many orders of magnitude
higher than the non-ortho PCBs (H.-Y. Park et al., 2010).
A compendium of all of the studies reviewed by the various Veterans and
Agent Orange (VAO) and VAO Update committees can be found at www.nap.
edu/catalog/25137. In this update, if a new study reported on only a single type
of cancer and did not revisit a previously studied population, then its design
information is summarized here with its results; design information on studies
that are updates of or new analyses on populations or cohorts that have been
previously studied can be found in Chapter 5. Studies of childhood cancers in
relation to parental exposure to the COIs are discussed in Chapter 8, which addresses possible adverse effects in the veterans’ offspring. Studies that consider
only childhood exposure are not considered relevant to the committee’s charge.
In evaluating possible connections between herbicide exposure and the risk
of cancer, the approach used to assess the exposure of study subjects is of critical
importance in determining the overall relevance and usefulness of findings. There
is great variation in the detail and the accuracy of exposure assessments among
studies, which can distort the true relationship between exposure and disease. A
few studies used biologic markers of exposure, such as the presence of a chemical
in serum or tissues; others developed an index of exposure from employment or
activity records; and still others used other surrogate measures of exposure, such
as an individual’s presence in a locale when herbicides were used.
Each section on a specific cancer type opens with background information,
including data on its incidence in the general U.S. population and its known
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or suspected risk factors. Cancer incidence in the general U.S. population is
included in the background material to provide a context for consideration of the
cancer risk in Vietnam veterans; the numbers presented are estimates of incidence
in the entire U.S. population, not predictions for the Vietnam veteran cohort. The
data on the expected numbers of new cases and deaths for specific types of cancerin 2017 are based on estimates from NCI’s Surveillance, Epidemiology, and
End Results (SEER) program or, if estimates for a particular cancer type were
not available from NCI, on estimates by the American Cancer Society. Using the
most recent SEER data available when this was written (SEER-18; 2000–2014),
incidence data were derived for all races combined and separately for blacks and
whites using age groups likely to include most Vietnam-era veterans. Incidence
data are presented by sex, age, and race, all of which can have profound effects
on risk (NCI, n.d.a). For example, the incidence of prostate cancer is about 2.6
times higher in men who are 70–74 years old as in men 60–64 years old and about
75% higher in blacks 60–64 years old than in whites in the same age group (NCI,
2015). Many other factors can influence cancer incidence, including screening methods, tobacco and alcohol use, diet, obesity, genetic predisposition, and
medical history. Those factors can modify the risk of developing a given kind of
cancer; they also need to be taken into account in epidemiologic studies of the
possible contributions of the COIs.
Each section of this chapter pertaining to a specific type of cancer includes a
summary of the findings described in the previous 10 VAO reports. That is followed
by a discussion of the most recent scientific literature, and, when appropriate, the
literature is discussed by exposure type (service in Vietnam, occupational exposure,
or environmental exposure). A summary of biologic plausibility, which corresponds to the third element of the committee’s congressionally mandated Statement
of Task, follows the description of newly identified epidemiologic studies. In fact,
the degree of biologic plausibility itself influences whether the committee perceives positive findings to be indicative of an association or the product of statistical fluctuations (chance) or bias. Following a synthesis of the material reviewed,
each section ends with the committee’s conclusion regarding the strength of the
evidence from epidemiologic studies. The categories of association and the committee’s approach to categorizing the health outcomes are discussed in Chapter 3.
Chapter 4 contains information on the general biologic mechanisms by
which exposure to TCDD and the other COIs contribute to malignant transformation. Toxicology studies use a variety of methods and animal or cellular models to
derive results on the interactions of the COIs with the cellular machinery known
to be important in the development of cancer at any site. When biologic plausibility is discussed in each section, this generic information is implicit, and only
experimental data specific to carcinogenesis at the site in question are presented.
There is increasing evidence that TCDD and the COIs may disturb cellular processes through epigenetic mechanisms, and reference to this evidence as it applies
to specific cancers is included where it exists.
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Considerable uncertainty remains about the magnitude of the risk posed by
exposure to the COIs. Many of the veteran, occupational, and environmental
studies reviewed by the committee did not fully control for important confounders. There is not enough information about the exposure experience of individual
Vietnam veterans to permit combining exposure estimates for them with any
potency estimates that might be derived from scientific research studies to quantify risk. The committee therefore cannot accurately estimate the risk to Vietnam
veterans that is attributable to exposure to the COIs. The significant challenges
in deriving useful quantitative estimates of the risks of various health outcomes
in Vietnam veterans are explained in Chapter 2 of this report.
ORGANIZATION OF CANCER GROUPS
Consistent with the previous report in this series, the organization of cancer
groups follows the major and minor categories of cause of death related to cancer
sites established by the National Institute for Occupational Safety and Health
(NIOSH; Robinson et al., 2006). For the present update, the committee gave
more attention to the WHO’s classification of lymphohematopoietic neoplasms
(WHO, 2008), which stresses partitioning of the disorders first by the lymphoid
or myeloid lineage of the transformed cells, rather than categorizing into lymphomas and leukemias.
The system of organization used by the committee simplifies the process for
locating a particular cancer type for readers. For any cancer type for which no
epidemiologic research findings have been identified, the default category has
always been “inadequate or insufficient evidence” of association with exposure
to the COIs. A failure to review a specific cancer or other condition separately
reflects the paucity of information concerning that cancer, so there is indeed
inadequate or insufficient information to categorize an association with such a
disease outcome.
BIOLOGIC PLAUSIBILITY
The studies considered by the committee that speak to the biologic plausibility of associations between human cancers and exposure to 2,4-D, 2,4,5-T,
picloram, cacodylic acid, and TCDD have been performed primarily in laboratory
animals (rats, mice, hamsters, and monkeys) or in cultured cells.
The animal studies examining the carcinogenicity of 2,4-D, 2,4,5-T, and
picloram have, in general, produced negative results, although some bioassays
used in those studies would not meet current standards. For example, there is
a question of whether the highest doses (generally 30–50 mg/kg) used in some
of the experiments reached a maximum tolerated dose or represented the doses
that are capable of inducing carcinogenesis. Therefore, it is not possible to have
absolute confidence that these chemicals have no carcinogenic potential at higher
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doses. Additional evidence of a lack of carcinogenic potential comes from negative findings on the genotoxic effects of assays conducted primarily in vitro that
indicate that 2,4-D and 2,4,5-T are genotoxic only at very high concentrations.
There is evidence in laboratory animals that cacodylic acid is carcinogenic,
based on studies that have shown that it can induce neoplasms of the kidney
(Yamamoto et al., 1995), bladder (Arnold et al., 2006; Cohen et al., 2007b; A.
Wang et al., 2009; Wei et al., 2002; Yamamoto et al., 1995), liver, and thyroid
gland (Yamamoto et al., 1995). Treatment with cacodylic acid induced the formation of neoplasms of the lung when administered to mouse strains that are genetically susceptible to developing those tumors (Hayashi et al., 1998; Yamanaka
et al., 2009). Other studies have used the two-stage model of carcinogenesis in
which animals are exposed first to a known genotoxic agent and then to a suspected tumor-promoting agent; with this model, cacodylic acid has been shown
to act as a tumor promoter with respect to lung cancer (Yamanaka et al., 1996).
These studies are further discussed in Chapter 4.
Collectively, the evidence obtained from studies of TCDD supports a connection between human exposure and cancers. The effects of TCDD on cellular
function make carcinogenesis biologically plausible, and evidence from model
systems indicate that TCDD can enhance carcinogenesis. This will be discussed
in a generic sense below and more specifically in the biologic plausibility sections
on individual cancers. Several reviews have affirmed the well-established mechanistic roles of the aryl hydrocarbon receptor (AHR) in TCDD-induced cancers
(S. Ahmed et al., 2014; Androutsopoulos et al., 2009; Barouki and Coumoul,
2010; Dietrich and Kaina, 2010; Ide et al., 2017; Murray et al., 2014; Ray and
Swanson, 2009; Rysavy et al., 2013; Tsay et al., 2013). The effect can be both
cancer promoting—by activating oncogenes (Gardella et al., 2016) or blocking
apoptosis (Bekki et al., 2015)—or protective, depending on the tissue type and
timing of the exposure (Y. Li et al., 2014; Moore et al., 2016). The role of the
AHR is further established by:
• its activation of several proteins of the P450 system of enzymes that play
crucial roles in detoxification and drug metabolism (Al-Dhfyan et al.,
2017a,b);
• activation of the paraoxanase antioxidant enzymes (Shen et al., 2016); and
• activation of the transforming growth factor (TGF)-β pathway (Silginer
et al., 2016);
all of which are important in oncogenesis. TCDD can disrupt circadian rhythms
via the AHR, and chronic disruption of circadian rhythms is associated with an
increased incidence of cancer, suggesting a potential additional pathway by which
TCDD increases cancer risk (C. Wang et al., 2014; C. X. Xu et al., 2013). TCDD
increases the incidence or progression of human cancers through a variety of cellular mechanisms, and the biologic plausibility of an association between TCDD
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exposure and cancer has been firmly established in a mechanistic sense. Data also
indicate that AHR can play a protective role in cancer (reviewed in Kolluri et al.,
2017; Murray et al., 2014), and its role as a therapeutic target for cancer therapy is
being investigated. However, cancer therapies were considered beyond the scope
of the committee’s charge, and not included in this report.
TCDD is considered a non-genotoxic carcinogen, as reviewed by Hernández
et al. (2009), because it does not produce changes is DNA sequences. However,
because of the oxidative stress it produces, TCDD does have some genotoxic
potential. In vitro work with mouse hepatoma cells has shown that activation
of the Ahr results in increased concentrations of 8-hydroxy-2-deoxyguanosine
(8-OHdG), a product of DNA-base oxidation and a marker of DNA damage. The
induction of cytochrome P4501A1 (CYP1A1) in these cells by TCDD or indolo
(3,2-b) carbazole is associated with oxidative DNA damage (Park et al., 1996).
In vivo experiments in mice corroborated those findings by showing that TCDD
caused a sustained oxidative stress, as determined by measurements of urinary
8-OHdG (Shertzer et al., 2002), and that it involves AHR-dependent uncoupling of mitochondrial respiration (Senft et al., 2002). Mitochondrial reactiveoxygen production depends on the AHR. Electronics-dismantling workers who
experienced complex exposures, including exposure to polychlorinated dibenzop-dioxins and dibenzofurans (PCDD/Fs), were shown to have increased concentrations of urinary 8-OHdG, indicative of oxidative stress and genotoxicity;
however, this finding cannot be ascribed confidently to these compounds (Wen
et al., 2008). Other than these observations of 8-OHdG formation and oxidative
stress, there is little evidence that TCDD is genotoxic, and it appears likely that
some of its mechanisms of action may involve epigenetic modifications of the
DNA or chromatin (described in Chapter 4).
The ability to induce oxidative stress contributes to TCDD’s recognized
activity as a potent tumor promoter and as a weak initiator in two-stage initiation–
promotion models for ovarian cancer (Davis et al., 2000), liver cancer (Beebe et
al., 1995), and skin cancers (Wyde et al., 2004). Work with a mouse lung cancer
model suggests that in addition to increasing cell division, the tumor-promoting
activities of TCDD include blocking apoptosis (R. J. Chen et al., 2014a). Early
studies demonstrated that TCDD is two orders of magnitude more potent than the
“classic” promoter tetradecanoyl phorbol acetate and that its skin-tumor promotion depends on AHR (Poland et al., 1982).
Laboratory animals exposed to TCDD show an increase in the incidence
of several neoplasms, most notably of the liver, lungs, thyroid, and oral mucosa
(Kociba et al., 1978; NTP, 2006). In long-term bioassays in both sexes of several
strains of rats, mice, hamsters, and fish, TCDD increases the incidence of tumors,
including those at sites distant from the site of treatment, at doses well below the
maximum tolerated dose (Rysavy et al., 2013). TCDD exposure has also been
shown to cause hyperplasia or metaplasia of epithelial tissues. In both laboratory
animals and cultured cells, TCDD has been shown to exhibit a wide array of effects
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on growth regulation, hormone systems, and other factors associated with the
regulation of cellular processes that involve growth, maturation, and differentiation, in most cases via its interaction with AHR (Murray et al., 2014; Rysavy et
al., 2013). In rat liver, TCDD downregulates reduced folate carrier (Rfc1) mRNA
and protein, whose normal levels are essential in maintaining folate homeostasis
(Halwachs et al., 2010). Reduced Rfc1 activity and a functional folate deficiency
may contribute to the risk of carcinogenesis posed by TCDD exposure, perhaps
via an epigenetic effect of interfering with DNA methylation levels (Davis and
Uthus, 2004; Williams, 2012).
Tissue-specific protective cellular mechanisms may also be important to the
response to TCDD and may complicate our understanding of its site-specific carcinogenic effects. For example, studies reviewed by this committee (and further
described in specific cancer outcome sections below) include investigations of
TCDD and other AHR ligands that found anti-proliferative and anti-metastatic
activity in cell lines of different cancers, including breast, ovarian, and prostate
(Hanieh, 2015; Hanieh et al., 2016; Ide et al., 2017; Y. Li et al., 2014).
In humans, the cancer-causing effects of TCDD (and the other COIs) have to
be evaluated with respect to inherent genetic susceptibility or resistance, which
can vary considerably across human beings. Several polymorphisms in the AHR
gene have been identified in humans, although the functional significance remains
uncertain. One genome-wide association study found a weak association with
between the AHR locus and cutaneous squamous cell carcinoma (Chahal et al.,
2016), and another study (Spink et al., 2015) found that the (GGGGC)n repeat
polymorphism in the human AHR was overrepresented in a small sample size
of lung cancers, compared to a neonatal population in New York thought to
represent a the incidence in the general population. Variants of the DNA repair
gene XRCC1 have been associated with urothelial cancer risk and this risk was
increased with arsenic exposure (Chiang et al., 2014). Some of these genes exert
their effect by modulating the cellular exposure to COIs, such as the effects of the
CYP1A1, GSTM1, and p53 on polycyclic aromatic hydrocarbon (PAH) exposure
(Gao et al., 2014). Genetic variants can also be associated with non-neoplastic
health effects; for example, common polymorphisms in some cytochrome P450
genes (CYP1A1, CYP1B1, CYP17) are associated with benign prostatic hyperplasia related to organochlorine pesticide exposure (V. Kumar et al., 2014) and
may have an impact on chronic kidney disease and dioxin levels in an endemic
area of exposure (C. Y. Huang et al., 2016). Thus, identical exposures can have
non-identical effects in different individuals, making it challenging to perform
genotype/phenotype assessments of TCDD effects for specific cancers.
Several potential pathways for TCDD carcinogenesis have been proposed.
TCDD may contribute to tumor progression via the inhibition of p53 tumor
suppressor activity induced by genotoxic agents (Gardella et al., 2016). This
inhibition may occur through AGR2 (Ambolet-Camoit et al., 2010) or through
interaction with the AHR and FHL2 (four and a half LIM protein domains 2)
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(Kollara and Brown, 2009). A study in fish by Calò et al. (2018) suggests that
dioxin-like PCB 126 may promote the degradation of tumor suppressor p53
through the proteasome ubiquitin system. (In related work, Luecke-Johansson et
al. [2017] explored the mechanism of activating AHR function as E3 ubiquitin
ligase.) Borlak and Jenke (2008) demonstrated that AHR is a major regulator
of c-Raf and proposed that there is cross-talk between AHR and the mitogenactivated protein kinase signaling pathway in chemically induced hepatocarcinogenesis. TCDD inhibits ultraviolet-C radiation-induced apoptosis in primary rat
hepatocytes and in Huh-7 human hepatoma cells, supporting the hypothesis that
TCDD acts as a tumor promoter by preventing exposed cells from undergoing
apoptosis (Bekki et al., 2015; R. J. Chen et al., 2014b; Chopra et al., 2009). AHR
activation by TCDD in human breast and endocervical carcinogenic cell lines
induces sustained high concentrations of the cytokine interleukin (IL)-6. IL-6
has tumor-promoting effects in numerous tissues—including breast, prostate,
and ovary—which opens the possibility that TCDD may promote carcinogenesis
in these and possibly other tissues (Hollingshead et al., 2008). However, recent
work in normal mammary cells indicates that AHR may function as inhibitors
of mammary tumors (Hall et al., 2010; Hanieh, 2015; Hanieh et al., 2016; S.
Zhang et al., 2009, 2012), supporting work indicating that TCDD’s effect is
cell-type specific. More recent work has shown an interaction between the AHR
and ADM (adrenomedullin) oncogene in cell lines and lung tissue (Portal-Nunez
et al., 2012), and AHR repression experiments in gastric and head and neck
cancers suggest that AHR expression leads to increased cancer cell growth and
invasion (DiNatale et al., 2012; X. F. Yin et al., 2013). In cell culture studies of
mechanisms of cancer progression and metastasis, TCDD exposure increased the
epithelial-to-mesenchymal transition and the loosening of cell–cell contacts (Diry
et al, 2006; Gao et al., 2016).
Genetic disturbances arising from confirmed exposure to herbicides were
evaluated by analyzing sister-chromatid exchanges in lymphocytes from a group
of 24 New Zealand Vietnam War veterans and 23 matched control volunteers
(Rowland et al., 2007). The results showed a highly significant difference (p <
0.001) between the veterans and the control group in the mean frequency of
sister-chromatid exchanges, which is thought to be an indicator of genetic damage. The distribution was skewed left, and the Vietnam veterans also had a much
higher proportion of cells with sister-chromatid exchanges frequencies above the
95th percentile (≥17 sister chromatid exchanges per cell) than the controls (11.0%
versus 0.07%). A study of sister-chromatid exchanges frequencies in blood samples taken from Vietnamese women from high- and moderate-TCDD-sprayed
areas also showed increased sister-chromatid exchanges of 2.40 per cell and 2.19
per cell, respectively, compared with Vietnamese women from unexposed areas
(1.48 per cell, p < 0.001) (Suzuki et al., 2014).
The weight of evidence that TCDD and dioxin-like PCBs make up a group of
chemicals with carcinogenic potential includes unequivocal animal carcinogenesis
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and biologic plausibility based on mechanistic mode-of-action data. Although the
specific biological and genetic mechanisms by which dioxin causes cancer remain
to be elaborated, the intracellular factors and mechanistic pathways involved in
dioxin’s cancer-promoting activity all have parallels in animal and human studies.
Nevertheless, the extrapolation of animal studies to humans should be viewed
with caution since there are many biological differences among these species.
The International Agency for Research on Cancer (IARC) has classified TCDD
in group 1 as carcinogenic to humans. The strongest evidence for carcinogenicity
was observed when all cancers sites were aggregated, but a positive association
between TCDD exposure and soft-tissue sarcomas, non-Hodgkin lymphomas,
and lung cancer has also been found (IARC, 2012b), which likely contributes
to the strong association of all cancers combined. Risks for specific cancers
in reports of TCDD-exposed workers and in the TCDD-exposed population in
Seveso have been sporadic and inconsistent (J. Xu et al., 2016b), diluting the
strength of the evidence for anything more than an aggregation of all cancers.
Thus, the toxicologic evidence indicates that a connection of TCDD and perhaps cacodylic acid with cancer in humans is, in general, biologically plausible.
However, as discussed in the next section, whether such carcinogenic potential
contributes to an individual type of cancer must be evaluated on a case-by-case
basis. Experiments with 2,4-D, 2,4,5-T, and picloram in animals and cells have
not provided a strong biologic basis for the presence or absence of carcinogenic
effects for those COIs.
CURRENT VIEWS OF CANCER MECHANISMS
To address its charge, the committee weighed the scientific evidence linking the COIs to specific individual cancer sites. Before considering each site
individually, it is important to address the concept that cancers share some
characteristics among organ sites. All cancers share phenotypic characteristics:
unregulated cell proliferation, increased cell survival, invasion outside normal
tissue boundaries, and eventual metastasis. The current understanding of cancer
development holds that a cell must acquire a series of specific genetic mutations
that release it and its progeny from regulated growth in order to establish growth
independence. These mutations can occur in a variety of genes that positively
(oncogenes) or negatively (tumor suppressor genes) control cell growth, cell
death (apoptosis), or the repair of genes when mutations do occur (Hanahan and
Weinberg, 2000). Hanahan and Weinberg further add that for a tumor to survive,
four other changes are necessary: changes in metabolism that give cells a selective growth advantage, evasion of the immune system, genetic instability leading
to additional mutations, and local inflammation. In addition to mutational events,
non-mutational or epigenetic events contribute to malignant transformation by altering the expression of genes that contribute to malignant transformation. However, some researchers have hypothesized that whatever the triggers, the earliest
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cancer cells have recognizable somatic mutations and establish clonality (Burgio
and Migliore, 2015). Also, angiogenesis, or the formation of new blood vessels,
allows a developing malignancy to obtain nutrients and enable the cells of that
malignancy to invade the local normal tissue. Recent work has drawn attention
to the interaction of cancer cells and the tumor microenvironment. Derbal (2017)
has described how dysregulation of cellular metabolism locks cancer cells into a
“state of mutual dependence with the tumor microenvironment and deepens the
tumor’s inflammation and immune-suppressive state,” therefore making it more
difficult to treat.
Both genetic (mutational) and epigenetic (non-mutational) effects of carcinogenic agents can further contribute to and stimulate oncogenesis. Genotoxic
damage by environmental exposures, such as the committee’s COIs, can affect
tumor establishment through many non-carcinogenic processes, such as those
that take place in the the metabolic and immune systems. As discussed above
and in Chapter 4, 2,4-D, 2,4,5-T, and picloram have shown little evidence of
genotoxicity in laboratory studies, except at very high doses, and little ability
to induce carcinogenesis in laboratory animals. However, cacodylic acid and
TCDD—acting more like promoters than genotoxic initiators—have been shown
to induce tumors in laboratory animals. Extrapolating organ-specific results from
animal experiments to humans is problematic because of important differences
among species in the overall susceptibility of various organs to cancer development and in organ-specific responses to putative carcinogens. While experiments
using animal models can be carefully designed to control for confounding risk
factors, this is often not possible in human studies. Therefore, conclusions about
the potential carcinogenicity of a chemical in humans rely heavily on the results
of epidemiologic studies that examine evidence of an excess cancer risk for individual or multiple organ sites. As the evaluations of specific types of cancer in the
remainder of this chapter indicate, the committee finds that TCDD appears to be
a multisite carcinogen. That finding is in agreement with IARC, which has placed
TCDD as a category 1 “known human carcinogen” (Baan et al., 2009; IARC,
2012b); with the U.S. Environmental Protection Agency (EPA), which has concluded that TCDD is “likely to be carcinogenic to humans” (EPA, 2004); and with
the National Toxicology Program (NTP), which regards TCDD as “known to be a
human carcinogen” (NTP, 2011). It is important to emphasize that the goals and
methods of IARC and EPA in making their determinations were different from
those of the present committee: Those organizations focus on anticipating hazards
to minimize future exposure, whereas this committee focuses on risk after exposure. Furthermore, the recognition that TCDD and cacodylic acid are multisite
carcinogens does not imply that they cause human cancer at every organ site.
The distinction between a general carcinogen and a site-specific carcinogen
is more difficult to make because of the common practice of beginning analyses
of epidemiologic cohorts with a category of “all malignant neoplasms,” a routine first screen for increased cancer activity in a study population without any
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test of a biologically based hypothesis. When the distribution of cancers among
anatomic sites is not provided in the report of a cohort study, a statistical test for
an increase in all cancers is not meaningless, but it is usually less scientifically
supportable than analyses based on specific sites for which more substantial
biologically based hypotheses can often be developed. The size of a cohort and
the length of the observation period often constrain the number of cancer cases
that are observed and which specific cancers have enough observed cases to permit analysis. For instance, an analysis of the cumulative results on diabetes and
cancers in the prospective Air Force Health Study (AFHS; Michalek and Pavuk,
2008) produced important information summarizing previous findings on diabetes, a fairly common condition, but the cancer analysis does not go beyond “all
cancers.” The committee does not interpret the cancer findings as an indication
that exposure to herbicides increases the risk of every variety of cancer, but rather
as an indication that the agent is carcinogenic to humans. For example, the committee acknowledges that the results of the highly stratified analyses conducted in
the AFHS found an increased incidence of certain cancers as well as all cancers
combined in the Ranch Hand subjects. It views the result of all cancers combined
as a conglomeration of information on individual malignancies. However, it also
recognizes that melanoma and prostate cancer are two malignancies for which
increased risk has been published (Akhtar et al., 2004; Pavuk et al., 2006), and
therefore, that these conditions merit continued individual longitudinal analysis
to resolve outstanding questions and to confirm the association with TCDD.
OVERVIEW OF STUDIES THAT REPORT
MULTIPLE CANCER OUTCOMES
To avoid needless redundancy, the current committee made the decision to
summarize those studies that reported separate results on five or more individual
cancer outcomes here, at the beginning of the chapter. Two studies met this
criterion: Collins et al. (2016) and Coggon et al. (2015). The discussion of the
relevant study in each individual cancer section only includes the study population and specific effect estimates as well as any nuances of which the reader
should be aware.
Collins et al. (2016) provides additional follow-up to a retrospective analysis
of a cohort of 2,192 workers (only 5 of whom were female) exposed to dioxins
during trichlorophenol (TCP) and pentachlorophenol (PCP) production at a Dow
chemical manufacturing plant in Midland, Michigan (see Chapter 5). The U.S.
population was used as the comparator for standardized mortality ratio (SMRs).
Work history records were used to determine the length of exposure. Serum samples to measure levels of six types of dioxins were collected for 431 TCP and PCP
workers. Historic concentrations for each dioxin congener were calculated from
the median concentrations from the serum samples and the known half-lives associated with each congener. A job exposure matrix was created for both the TCP
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and PCP production facilities based on the measured concentrations for workers
in different jobs. A pharmacokinetic model was applied to job-specific concentrations based on the work history of each member of the study group to estimate
their time-dependent serum concentration profiles for each dioxin congener (i.e.,
TCDD as well as Hexa-CDD, Hepta-CDD, and Octa-CDD). Complete vital status
follow-up through December 2011 was achieved for the cohort, and there were
1,198 decedents through the entire study period (1979–2011); 1,615 TCP workers and 773 PCP workers (196 workers were exposed to both TCP and PCP and
were included in both groups). SMRs were reported for more than 20 types of
cancer and other health outcomes. Estimates were reported for all workers, TCP
workers (196 of whom were also exposed to PCP), and PCP workers (196 who
also had TCP exposure). This study is referred to throughout the chapter as the
Dow Midland, Michigan, plant workers.
Coggon et al. (2015) extended the follow-up period of a large IARC-sponsored
study and examined the carcinogenicity of phenoxy herbicides and their associations with, primarily, Hodgkin lymphoma (HL), STS, and chronic lymphocytic
leukemia, but other types of cancers were also included as outcomes. The original IARC study, a nested case-control study within a large international cohort
study included 36 subcohorts, 6 of which were made up of men who worked at
5 factories in the United Kingdom manufacturing or formulating a variety of
phenoxy herbicides or else were contract workers spraying the compounds. The
IARC study followed workers from 1947 through 1990/1991, and Coggon et al.
(2015) extended the follow-up of the six UK cohorts to December 2012. Data
were derived from individual employment and health care system records as well
as from cancer registries and death records to detect additional cases. SMRs were
reported, and the effect estimates were reported for all workers, workers exposed
to herbicide levels above background, and workers exposed for more than 1 year
at levels above background. The many results on specific cancer mortality in this
group are referenced as the UK phenoxy herbicide manufacturers and sprayers.
STUDIES OF OVERALL CANCER MORTALITY OR INCIDENCE
The literature search for this update identified a number of publications on
populations with relevant exposures that included risk estimates for overall mortality from any cancer (Cappelletti et al., 2016; Coggon et al., 2015; Collins et al.,
2016; Kashima et al., 2015; S. A. Kim et al., 2015) or overall cancer incidence or
prevalence (Ljunggren et al., 2014; Van Larebeke et al., 2015). However, grouping all cancer incidences or deaths is not informative for determining specific
health effects that may be due to an exposure to the COIs versus those attributable to many other factors. This method also imposes the assumption of homogeneity of association across the combined deaths or cancer types. For example,
Van Larebeke and colleagues (2015) assessed the prevalence of all cancer based
on a self-reported affirmative response to the question, “Do you suffer or have
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you suffered from one or another form of cancer?” The committee believed that
this was not specific enough to be useful for the assessment of cancer and the
potential effects from the COIs and excluded it from further review in the cancer
chapter. Likewise, Ljunggren et al. (2014) assessed the distribution of dioxin-like
chemicals in the lipoprotein fractions of cancer patients and controls but did not
distinguish the specific types of cancer diagnoses.
The committee identified four studies that examined the association between the COIs and cancer mortality. Among the Dow Midland, Michigan, plant
workers exposed to TCP or PCP or both, Collins et al. (2016) found that there
was no difference in mortality for all cancer when the 1,615 TCP workers were
compared with the standardized U.S. population (SMR = 0.98, 95% confidence
interval [CI] 0.86–1.11). Similarly, there was no difference found for mortality
from all cancer sites for the 773 PCP workers (SMR = 1.04, 95% CI 0.86–1.24).
Additional results for site-specific cancer mortality are covered in each applicable
section.
S. A. Kim et al. (2015) used serum concentrations of persistent organic pollutants, including dioxin-like and non-dioxin-like PCBs (n = 633) and organochlorine pesticides (n = 675) collected within the 1999–2004 National Health
and Nutrition Examination Survey (NHANES) and adjusted for fat mass to make
associations with overall mortality, mortality from all cancers combined, and
mortality from cardiovascular diseases in people aged 70 years and older. Models
were adjusted for age, sex, race, cigarette smoking, and physical activity. When
fat mass was not included in the analysis, no association was found between
any of the persistent organic pollutants and total mortality. When fat mass was
included in the analysis, PCBs were inversely associated with total mortality in
persons with high fat mass, but not in those with low fat mass. Organochlorine
pesticides were found to be positively associated with total mortality for low fat
mass, but the association was weaker with higher fat mass. Cancer mortality was
highest among persons with fat mass less than the 25th percentile and who had
the highest tertile concentration of PCB and organochlorine pesticides. None of
the hazard ratios for cancer mortality were statistically significant. The analysis
is limited by the low numbers of deaths in the follow-up period, which reduces
the power to calculate cause-specific mortality. One possible explanation for the
observed association may be that persistent organochlorine pesticides influence
disease pathogenesis but not mortality, which may be influenced by a number of
other factors.
The extended follow-up study of UK phenoxy herbicide manufacturers and
sprayers found that of the total 4,093 deaths reported among this cohort of workers, 1,205 deaths were attributable to cancer (Coggon et al., 2015). However,
neither overall mortality nor cancer-specific mortality were elevated among all
workers (SMR = 1.0, 95% CI 0.97–1.03 and SMR = 0.99, 95% CI 0.94–1.05,
respectively) or among workers potentially exposed to phenoxy herbicide levels
above background (SMR = 1.02, 95% CI 0.99–1.06 and SMR = 1.02, 95% CI
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0.96–1.09, respectively). Additional results for site-specific cancer mortality are
covered in each applicable section.
Cappelletti et al. (2016) performed a retrospective study of 331 male electric
arc foundry workers at a single plant in Trentino, Italy, to determine if they experienced excess mortality from all causes, all cancers, and specifically respiratory
cancers, or if they experienced increased risk for other morbidities. An analysis
of the dust emissions found that the dust contained metals (including iron, aluminum, zinc, manganese, lead, chromium, nickel, cadmium, mercury, and arsenic),
PAHs, PCBs, and PCDD/Fs (reported as TEQs). Therefore, the authors could
not determine which of the agents were associated with a specific outcome or to
what extent. The men had worked at the factory for at least 1 year and, for the
mortality analysis, were compared with the standardized general population of
Region Trentino-Alto Adige (where the factory was located) because there were
few non-exposed foundry workers and high attrition rates. Company and medical
records were used to determine vital status; the cause of death was determined
from death certificates or other registries. The workers were followed from March
19, 1979 (or their first day of employment), through December 31, 2009, or the
date of death. No difference between exposed workers and the general population
was found for all causes of mortality (SMR = 1.13, 95% CI 0.76–1.62, p = 0.53)
or for all deaths from cancer (SMR = 1.36, 95% CI 0.75–2.29, p = 0.238). No
differences in the mortality rates of all causes or all cancers were found when the
cause of death was stratified by years of employment or time since first exposure.
This study is most limited by the fact that foundry dust is a complex mixture,
which makes it difficult to discern the impact of the specific contaminants of the
foundry dust on the health outcomes of those exposed workers. Estimates were
adjusted only for age group and not for other risk factors such as tobacco use,
body mass index (BMI), or other jobs or activities that could result in similar
exposures. Exposure to foundry dust by the general population, which was used
for comparison, is not discussed, although the foundry appears to be in the local
vicinity and emissions were reported to be present within a 2-kilometer radius.
The remainder of this chapter deals with the committee’s review of the evidence on each individual cancer site in accordance with its charge to evaluate
the statistical association between exposure and cancer occurrence, the biologic
plausibility and potential causal nature of the association, and the relevance to
U.S. veterans of the Vietnam War. For each outcome, the relevant studies are
presented for populations of Vietnam veterans and then for other exposed, nonveteran subjects (occupational cohort studies, environmental studies, and casecontrol studies).
A number of studies of populations that received potentially relevant exposures were identified in the literature search for this review but did not characterize exposure with sufficient specificity for their results to meet the committee’s
criteria for inclusion in the evidentiary database (see Chapter 3). For instance,
this rubric would apply to the occupational study conducted by Ruder et al.
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(2014) in which 24,865 eligible workers from capacitor manufacturing, repair,
and maintenance sites in the United States were exposed to arochlor 1254, 1242,
and 1016, among others (mixed PCBs), and the authors sought to examine the
relationship between PCB exposure and different causes of mortality. However,
specific dioxin-like PCBs were not named, and no TEQs or other quantification
of relevant exposures was presented. Similarly, the hospital-based case-control
study by Niu et al. (2016) that examined hepatocellular carcinoma and risk
factors including environmental exposures such as exposure to pesticides (not
further defined) did not measure the levels of dioxins in serum samples and, as a
result, lacked the necessary specificity to contribute to the weight of the evidence
of an association between the COIs and hepatobiliary cancer; it was therefore
excluded from further consideration. In previous updates as well as in the current update, numerous cancer studies have been identified that used case-control
design and had exposure characterizations that were no more specific than job
titles, farm residence, or herbicide exposure. The committee acknowledges that
those studies were identified and presents briefly the reasons that they were not
further considered and did not contribute to the evidentiary weight for an outcome
under the heading of “Other Identified Studies.”
ORAL, NASAL, AND PHARYNGEAL CANCERS
Oral, nasal, and pharyngeal cancers develop in anatomical sites of the head
and neck: the structures of the oral cavity (inside lining of the lips, cheeks, gums,
tongue, and hard and soft palate: International Classification of Diseases, 9th
Revision (ICD-9) codes 140–145; ICD-10 codes C00–C08), oropharynx (ICD-9
146; ICD-10 C09–C10), nasopharynx (ICD-9 147; ICD-10 C11), hypopharynx
(ICD-9 148; ICD-10 C13), other buccal cavity and pharynx (ICD-9 149; ICD-10
C14), and nasal cavity and paranasal sinuses (ICD-9 160; ICD-10 C30–C31).
The salivary glands may or may not be included. The oropharynx includes the
soft palate, the tonsils, the side walls, and the posterior tongue. The nasopharynx
is made up of the structures from the part of the throat that is behind the nose,
whereas the hypopharynx consists of the area from the hyoid bone to the cricoid
cartilage. The larynx refers to only the laryngeal structures and is covered separately. Although the above cancers are classified together in the same category,
the epidemiological risk factors for cancers that occur in the oral cavity and oropharynx are different from the risk factors for cancer of the nasopharynx.
Tobacco and alcohol use are well-established risk factors that contribute
synergistically to the incidence of oral cavity and oropharyngeal cancers and, to
a certain degree, nasopharyngeal cancers. Infection with human papilloma virus
(HPV), particularly HPV16, is a relatively newly recognized major risk factor for
oropharygeal cancers (Gillison and Shah, 2001; Gillison et al., 2012; Hashibe et
al., 2007, 2009; Kreimer et al., 2013; Marur et al., 2010; Michaud et al., 2014;
Oliveira et al., 2012; Szentirmay et al., 2005). Some evidence has also been found
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linking HPV to tonsillar and base-of-tongue cancers (Ramqvist et al., 2015). The
risk factors for nasal cavity cancer include occupational exposure to nickel and
chromium compounds (d’Errico et al., 2009; Feron et al., 2001; Grimsrud and
Peto, 2006), wood dust (d’Errico et al., 2009), leather dust (Bonneterre et al.,
2007), and high doses of formaldehyde (Nielsen and Wolkoff, 2010). Nasopharyngeal cancer is a very specific malignancy, and although alcohol, tobacco, and
other environmental pollutants are risk factors, infection with the Epstein–Barr
virus in combination with certain genetic predispositions and the consumption of
poorly preserved food (Chang and Adami, 2006) constitutes the biggest attributable risk factor, especially in Africa, China, and other Asian countries.
Ecological studies in the United States have shown that between 2001 and
2010 the incidence of cancers of the oral cavity decreased (possibly because of
the decreasing prevalence of smoking), whereas the incidence rates for oropharyngeal cancers increased annually by 2.9%, which has been attributed to HPV
infection (Chaturvedi et al., 2011). In the United States in 2018 there were an
estimated 51,540 new cases of and 10,030 deaths from oral cavity and pharyngeal cancers (NCI, n.d.b). Nasopharyngeal cancers occur very rarely in the
United States (less than 1 case per 100,000 individuals); an estimated 3,200 cases
were reported in 2015 (ACS, 2016). Most oral, nasal, and pharyngeal cancers
are squamous-cell carcinomas. Nasopharyngeal carcinoma is the most common
malignant epithelial tumor of the nasopharynx and can be further classified into
one of three types: keratinizing squamous-cell carcinoma, nonkeratinizing carcinoma, and undifferentiated carcinoma.
The median age of diagnosis of oral cavity and pharynx cancers is 63 years,
and 30.8% of new cases are diagnosed among people 55–64 years old, and 24.5%
of cases are diagnosed among people 65–74 years old. Men of all races and ethnicities are at greater risk than women. Age-adjusted incidence rates were highest
among white males and females and lowest among Hispanic men and women.
Conclusions from VAO and Previous Updates
The committee responsible for the original VAO report concluded that there
was inadequate or insufficient information to determine whether there is an association between exposure to any of the COIs and oral cavity, nasal, and pharyngeal cancers. Additional information available to the committees responsible for
Update 1996 through Update 2014 did not change that conclusion.
In Update 2006, a separate evaluation of tonsil cancer cases was performed.
In the United States an estimated 70% of oral cavity and oropharyngeal cancers
are caused by HPV infection. Therefore, if herbicide exposure had inhibitory
or suppressive effects on cell-mediated or humoral-mediated immunity, then
Vietnam veterans with HPV16 infection might be at increased risk for the development of these cancers through the persistence of a high-risk oncogenic virus.
The Update 2006 committee concluded that, based on the three identified studies
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that provided the number of tonsil cancer cases in their populations, there was not
sufficient evidence to determine whether an association existed between exposure
to the COIs and tonsil cancer. No new published studies have offered any important additional insight into this specific question. The present committee strongly
reiterates the recommendation repeatedly made in Updates 2006, 2008, 2010,
2012, and 2014 that the Department of Veterans Affairs (VA) develop a strategy
that uses existing databases to evaluate tonsil cancer in Vietnam-era veterans.
Subsequent committees reviewed studies of U.S. and international cohorts of
Vietnam veterans. No statistically significant increase in oral cavity and pharyngeal cancers was found between deployed and nondeployed Vietnam-era Army
Chemical Corps veterans (Cypel and Kang, 2010); such findings were consistent
with a prior report on mortality through 1991 (Dalager and Kang, 1997). Among
the cohort of 2,783 New Zealand veterans who served in Vietnam and were followed prospectively beginning in 1988 for cancer incidence and mortality, no
statistically significant increased risk of head and neck cancers overall and specifically cancers of the oral cavity, pharynx, and larynx was observed compared
with the general population of New Zealand. Based on 11 cases each, statistically
significant increased risks of death from head and neck cancers and from cancers
of the oral cavity, pharynx, and larynx were observed among the New Zealand
Vietnam veteran cohort compared with the general New Zealand population
(McBride et al., 2013). However, that study had several limitations, including
the lack of observation until 15 years post-conflict and missing information on
(and therefore the inability to adjust for) known confounding factors, including
smoking, drinking habits, and HPV status, which limits the interpretation of the
data. The Update 2014 committee concluded that the greater than two-fold excess
risks of mortality from head and neck cancers as well as from cancers of the oral
cavity, pharynx, and larynx cannot be completely attributed to confounding by
smoking because excess risks were not found in this cohort for deaths from other
smoking-related diseases such as lung cancer, chronic obstructive pulmonary
disease, or coronary artery disease.
The Korean Veterans Health Study followed 185,265 male Vietnam veterans
who were alive in 1992 for cancer incidence through 2003 (Yi, 2013; Yi and
Ohrr, 2014) and for mortality through 2005 (Yi et al., 2014b) from cancers of
the oral cavity, nasal cavity, and pharynx. For the internal comparison analysis
of high- versus low-exposure categories derived from the exposure opportunity
index (EOI) scores generated by the EOI model, Yi and Ohrr (2014) found a 2.54
increase in hazard ratio for cancers of the mouth and a relative risk of nearly 7.0
for salivary glands (though the estimate was very imprecise) as well as a nonstatistically significant increase in the risk of oropharyngeal cancer. No difference
between the high- and low-exposure groups was found for tonsil cancer, and no
differences in incidence were observed for the other head and neck cancers analyzed separately: lip, tongue, nasopharynx, hypopharynx, and nose and sinuses.
Yi et al. (2014b) reported only on head and neck cancers as a group defined by
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ICD-10 codes C00–C14 and found no association when comparing the high- versus low-exposure categories, nor in the analysis based on the logarithms of the
individual EOI scores.
Several studies of occupational cohorts that reported on cancers of the oral
cavity or pharynx were examined by previous committees, but the evidence was
inconsistent. Specifically, studies of workers at Dow’s plant in Midland, Michigan, and in the NIOSH PCP cohort reported no increases in incidence (C. J. Burns
et al., 2011) or mortality (Ruder and Yiin, 2011) from oral cavity and pharyngeal
cancers. Likewise, McBride et al. (2009a) reported on mortality through 2004 in
the New Zealand cohort of 1,599 workers who had been employed in manufacturing phenoxy herbicides from TCP; picloram was also produced in the plant.
The researchers reported a non-significant excess in mortality from buccal cavity
and pharyngeal cancers, but there were no deaths from nasopharyngeal cancers in
either group. By contrast, Manuwald et al. (2012) reported a more than two-fold
increase in mortality from cancers of the lip, oral cavity, or pharynx in a cohort
of male and female chemical plant workers versus Hamburg’s general population.
Squamous cell oral cancer risk was also found to be elevated, but the estimate
was imprecise, in Sweedish workers who worked for the pulp industry and with
wood or wood products and workers who were exposed to phenoxyacetic acids
(Schildt et al., 1999).
Update of the Epidemiologic Literature
No new studies of Vietnam veterans or published environmental or casecontrol studies of exposure to the COIs and oral, nasal, or pharyngeal cancers
were identified for the current update. Reviews of the relevant studies are presented in the earlier reports. Table 2, which can be found at www.nap.edu/catalog/25137, summarizes the results of studies related to oral, nasal, and pharyngeal
cancer.
Occupational Studies
Cancers of the lip, tongue, and mouth were addressed by Coggon et al.
(2015) in an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers. No deaths were due to cancer of the lip. Tongue cancer mortality
was not statistically significant, and effect estimates were imprecise (wide CIs)
for all workers (n = 8; SMR = 1.93, 95% CI 0.83–3.80), for workers exposed
to herbicide levels above background (n = 5; SMR = 1.63, 95% CI 0.53–3.80),
or for persons exposed for more than 1 year at levels above background (n = 3;
SMR = 2.16, 95% CI 0.45–6.32). The estimates for mouth cancer showed a
decreased risk that was likewise not statistically significant, with even more
imprecise estimates for each of the groups: all workers (n = 2; SMR = 0.53, 95%
CI 0.06–1.90), workers exposed to herbicide levels above background (n = 1; SMR
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= 0.36, 95% CI 0.01–1.99), and workers exposed for more than 1 year at levels
above background (n = 0; SMR = 0.00, 95% CI 0.00–2.89). A decreased risk of
pharynx cancer was found, but the estimates were imprecise and not statistically
significant across the three groups of workers: all workers (n = 4; SMR = 0.49,
95% CI 0.13–1.25), workers exposed to herbicide levels above background (n = 4;
SMR = 0.66, 95% CI 0.18–1.68), and workers exposed for more than 1 year at
levels above background (n = 0; SMR = 0.00, 95% CI 0.00–1.34). These data do
not support an association between exposure to phenoxy herbicides and cancer
of the lip, tongue, or mouth.
Other Identified Studies
Although Ruder et al. (2014) examined U.S. workers exposed to mixed
PCBs and reported SMRs from all buccal cavity and pharynx neoplasms overall
as well as those specifically for the tongue, pharynx, and other parts of buccal
cavity, the authors did not state the specific dioxin-like PCBs at issue, and no
TEQs or other quantification of relevant exposures were presented. Akahane
et al. (2017) examined the prevalence of many long-term health effects, including tongue cancer, of people exposed to PCBs, dioxins (e.g., PCDD/Fs),
and dioxin-like chemicals through the ingestion of contaminated rice bran oil
(Yusho accident) compared with a group of age-, sex- and residential-areamatched individuals. Because TEQs or other quantification of relevant exposures
were not presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effects of exposure to the
COIs on tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker et al.,
2006; Wanibuchi et al., 2004). The National Institute of Environmental Health
Sciences conducted a 2-year study of female Harlan Sprage Dawley rats treated
with TCDD and other dioxin-like PCBs (Nyska et al., 2005; Yoshizawa et al.,
2005a). Yoshizawa et al. (2005a) reported an increase in the incidence of gingival
squamous-cell carcinoma in the rats treated orally (by gavage) with TCDD only
at doses as low as 3 ng/kg and average severities increased with higher dosing
levels. In the groups receiving 46 ng/kg or greater of TCDD, the incidence of
oral squamous-cell carcinoma increased, and a statistically significant difference
occurred in the highest dosed group (incidence rate: 19%) compared to the control group (2%). In the 100 ng/kg for 5 days/week for 104 weeks stop group, the
incidence of oral gingival squamous hyperplasia was also increased significantly,
and increased occurrence of squamous-cell carcinoma was observed (incidence
rate 10% versus 2% among controls). When a mixture of TCDD, PCB 126, and
2,3,4,7,8-pentachlorodibenzofuran was administered, all doses (ranging from
6 ng/kg to 200 ng/kg) induced gingival squamous hyperplasia significantly with
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no differences in severities, but the incidence of oral squamous-cell carcinoma,
however, did not increase. A second publication from this study examined olfactory epithelial metaplasia and hyperplasia outcomes (Nyska et al., 2005).
Squamous-cell carcinoma of the oral mucosa of the palate was increased. This
study did not, however, find any pathologic effect of TCDD on nasal tissues
(Nyska et al., 2005). Increased neoplasms of the oral mucosa had previously been
observed and described as carcinomas of the hard palate and nasal turbinates
(Kociba et al., 1978). Kociba et al. (1978) also reported a small increase in the
incidence of tongue squamous-cell carcinoma.
DiNatale et al. (2012) used head and neck squamous-cell carcinoma cell
lines to investigate mechanisms for tumor progression associated with AHR
activation. This tumor type typically produces large amounts of cytokines, and
its IL6 expression levels correlate with disease aggressiveness. In this model,
AHR activation by TCDD enhances IL-6 production induced by another cytokine
(IL-1β), so TCDD may play a role in head and neck squamous-cell oncogenesis.
The potential impact of AHR activation on oral squamous cell carcinoma was
recently described in a study by Stanford et al. (2016), which demonstrated that
exposure to AHR ligands resulted in enhanced stem-cell-like properties of the
human oral cells in culture and which used a novel orthotypic xenograft model to
demonstrate the ability of AHR inhibitors to inhibit oral squamous-cell carcinoma
progression.
Synthesis
Tonsil cancers, or more generally squamous-cell carcinomas of the oropharynx, remain of interest to Vietnam veterans and the committee, but no new
information on them with respect to possible herbicide exposure was available
for this update. Previous studies on Vietnam veterans from the Korean Veterans
Health Study did not find an association between herbicide exposure and the risk
of tonsillar cancers. Several previous studies have reported on oropharyngeal
cancers broadly, but few have examined tonsil cancer as a distinct outcome.
The existing evidence from all published studies conducted among Vietnam
veterans or various occupational cohorts reporting on the incidence of or mortality from cancers of the nose, oral cavity, or pharynx is largely inconclusive.
Most of these studies have reported no association or else non-significant modest
excesses in risk, while not characterizing exposure as specifically as needed for
the committee’s decision making. The one new study that extended the follow-up
period of men who worked at five factories in the United Kingdom manufacturing or formulating a variety of phenoxy herbicides or who were contract workers
spraying the compounds also found no association with exposure to phenoxy
herbicides and mortality from cancer of the lip, tongue, or mouth (Coggon et
al., 2015).
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The small numbers of oral, nasal, or pharyngeal cancer cases reported, in
combination with a general lack of information on the smoking and drinking
habits or HPV status of the tumors, limit the interpretation of the data. The other
issue affecting the interpretation of the data is that this group of cancers is often
grouped with respiratory cancers, most of which are cancers of the trachea, lung
parenchyma, or bronchus. Because of the relatively small numbers of head and
neck cancers, no meaningful conclusions can be drawn. Thus, in combination
with the previously reviewed literature, the new information does not support an
association between the cancers of oral cavity, nose, or pharynx with the herbicides sprayed in Vietnam.
Conclusion
Given the lack of new evidence, the committee concurs with the conclusion
in Update 2014 and concludes that there is inadequate or insufficient evidence
to determine whether there is an association between exposure to the COIs and
oral, oropharyngeal, or nasopharynx cancers.
CANCERS OF THE DIGESTIVE ORGANS
Esophageal cancer (ICD-9 150; ICD-10 C15), stomach cancer (ICD-9 151;
ICD-10 C16), colon cancer (ICD-9 153; ICD-10 C15), rectal cancer (ICD-9
154; ICD-10 C19–C21), hepatobiliary cancers (ICD-9 155; ICD-10 C22), and
pancreatic cancer (ICD-9 157; ICD-10 C25) are the major cancers arising in the
digestive organs. NCI estimated that 17,290 people would receive diagnoses of
esophageal cancers in the United States in 2018 and that 15,850 people would die
from esophageal cancers (NCI, n.d.c). The corresponding 2018 estimates of U.S.
diagnoses and deaths for the other digestive organ cancers are: stomach cancer
(incident diagnoses, 26,240; deaths, 10,800) (NCI, n.d.d), colon and rectal cancer
(incident diagnoses, 140,250; deaths, 50,630) (NCI, n.d.e), pancreatic cancer (incident diagnoses, 55,440; deaths, 44,330) (NCI, n.d.f), and hepatobiliary cancers
(incident diagnoses, 42,220; deaths, 30,200) (NCI, n.d.g), with other digestive
cancers—for example, small intestine and anal cancers—adding an estimated
19,050 new diagnoses and 2,610 deaths (NCI, n.d.h, n.d.i). Collectively, tumors
of the digestive organs were expected to account for 17.4% of new cancer diagnoses and 25% of cancer deaths in 2017.
The incidences of esophageal, stomach, colon, rectal, and pancreatic cancers
increase with age. In general, the incidences are higher in men than in women and
higher in blacks than in whites (NCI, 2018a). Risk factors for the cancers vary
but always include a family history of the same form of cancer, some diseases of
the affected organ, and diet. Tobacco use is a risk factor for pancreatic cancer and
possibly for stomach cancer (Maisonneuve and Lowenfels, 2015; Stewart et al.,
2008). An infection with the bacterium Helicobacter pylori increases the risk of
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stomach and pancreatic cancers. Type 2 diabetes is associated with an increased
risk of colorectal and pancreatic cancers (Berster and Göke, 2008).
Some studies of digestive cancers combine and report statistics on all digestive organ cancers rather than separating the data by types. For example, in a
study of disease-related mortality through 2005 in Army Chemical Corps (ACC),
veterans who handled or sprayed herbicides in Vietnam were compared with their
non-Vietnam veteran peers or with U.S. men in general, with all gastrointestinal
cancers reported collectively (Cypel and Kang, 2010). Adjusted estimates did
not show any statistically significant excess in mortality from all cancers of the
digestive tract in ACC Vietnam veterans compared with non-Vietnam veterans.
Several other studies identified in Update 2014 also combined several digestive cancers for their analyses, making the results not particularly informative
for individual cancers in the group (Boers et al., 2012; C. J. Burns et al., 2011;
Manuwald et al., 2012).
Esophageal Cancer
Epithelial tumors of the esophagus (squamous-cell carcinomas and adenocarcinomas) are responsible for more than 95% of all esophageal cancers; 17,290
newly diagnosed cases and 15,850 deaths were estimated for 2018 in the United
States (NCI, n.d.c). In the United States, adenocarcinoma of the esophagus has
slowly replaced squamous-cell carcinoma as the most common type of esophageal malignancy; although squamous-cell carcinoma continues to be the most
common form of esophageal cancer worldwide (Rubenstein and Shaheen, 2015).
The incidence of esophageal cancer is higher among men than women, higher in
black women than white women for all age groups from 60 to 74 years, but higher
for white men than black men for all age groups from 65 to 74 years.1
Smoking and heavy alcohol ingestion are associated with the development
of squamous-cell carcinoma (Dong and Thrift, 2017; Matejcic et al., 2017). For
esophageal adenocarcinoma, smoking is an established risk factor, but alcohol
consumption does not appear to be strongly associated (Dong and Thrift, 2017).
Some data suggest that gastroesophageal reflux disease and Barrett esophagus
are associated with an increased risk of esophageal adenocarcinoma. The rapid
increase in obesity in the United States has been linked to increasing rates of gastroesophageal reflux disease, and the resulting rise in chronic inflammation has
been hypothesized as explaining the link between gastroesophageal reflux disease
and esophageal adenocarcinoma (Rubenstein and Shaheen, 2015).

1 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing
SEER 18 dataset, age-adjusted rates, esophageal cancer, and age ≥ 50 years. Data were displayed by
choosing race and sex then separately by age.
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Conclusions from VAO and Previous Updates
The committee responsible for VAO explicitly excluded esophageal cancer
from the group of gastrointestinal tract tumors, and it was not separately evaluated
or categorized with this group until Update 2004, when it was formally placed
into the inadequate or insufficient category. No additional studies of esophageal
cancer were reviewed until Update 2010.
Most evidence on the potential effects of the COIs and esophageal cancer had
come from occupational cohorts until Update 2014, when three studies of international Vietnam veteran cohorts were published. The strongest evidence of an
association between the COIs and esophageal cancer came from an occupational
cohort of workers at a chemical plant in Hamburg, Germany, which reported a
statistically significant increase in esophageal cancer mortality relative to men in
the general population of Hamburg (SMR = 2.56, 95% CI 1.27–4.57) (Manuwald
et al., 2012). Several papers on mortality in TCP and PCP workers employed by
Dow Chemical Company in Midland, Michigan, from 1937 to 1980 have been
reviewed. Collins et al. (2009b) followed 1,615 workers who worked at least 1 day
in a department that had potential TCDD exposure; 5 esophageal cancer deaths
were observed but no statistically significant associations were found. Among the
773 PCP workers who were exposed to chlorinated dioxins that did not include
TCDD, there were two observed deaths from esophageal cancer (Collins et al.
2009c). In the Agricultural Health Study (AHS), Koutros et al. (2010a), found a
statistically significant decrease in the incidence of esophageal cancer among the
private applicators (52 cases, standardized incidence ratio [SIR] = 0.64, 95% CI
0.48–0.85) compared with the general population, which could indicate a healthy
worker effect.
Other than the study of chemical plant workers in Hamburg (Manuwald
et al., 2012), studies conducted outside the United States found no statistically significant associations between the COIs and esophageal cancer. McBride
et al. (2009a) reported on a mortality follow-up of the workers in the Dow
AgroSciences plant in New Plymouth, New Zealand, who were potentially exposed to TCDD; neither the SMR for esophageal cancer deaths in exposed workers nor the never-exposed group was statistically significant compared with the
general New Zealand population. A follow-up analysis on cancer incidence in the
men and women exposed to dioxin in the Seveso accident found no esophageal
cancers in the high-exposure zone and no exposure-related pattern in the occurrence of esophageal cancer in the medium- and low-exposure areas (Pesatori et
al., 2009).
Among studies of esophageal cancer in Vietnam veterans, two were related
to incidence (Yi, 2013; Yi and Ohrr, 2014), and one examined cancer-specific
mortality (Yi et al., 2014b) in the Korean Veterans Health Study, a large prospective cohort of 185,265 male Vietnam veterans alive in 1992, who were followed
for cancer incidence through 2003 and for mortality through 2005. Comparing the
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Vietnam veterans to the general Korean population, Yi (2013) reported a statistically significant decrease in the incidence of esophageal cancer (SIR = 0.70, 95%
CI 0.64–0.85). However, in the internal comparison of those with high versus
low EOI scores, Yi and Ohrr (2014) reported a statistically significant increased
risk for esophageal cancer (hazards ratio [HR] = 1.36, 95% CI 1.00–1.85). This
result was based on 184 incident esophageal cancers observed during followup, of which 113 cases were among veterans in the high-exposure category. Yi
et al. (2014b) reported a non-statistically significant increase in mortality from
esophageal cancer when comparing those in the higher exposure category (n
= 98) with those with lower estimated exposure (n = 64). Similarly, mortality
from esophageal cancer was not found to be associated with the individual, logtransformed EOI scores (Yi et al., 2014b). Information on smoking and alcohol
consumption was not available, leading to concerns that some of the association
could be due to confounding.
Update of the Epidemiologic Literature
No studies of Vietnam veterans or published environmental or case-control
studies of exposure to the COIs and esophageal cancer were identified for the
current update. Reviews of the relevant studies are presented in the earlier reports.
Table 3, which can be found at www.nap.edu/catalog/25137, summarizes the
results of studies related to esophageal cancer.
Occupational Studies Among the Dow Midland, Michigan, worker cohort that
was compared with the standardized U.S. population, Collins et al. (2016) found
no differences in mortality for esophageal cancer for the TCP workers (n = 8;
SMR = 1.09, 95% CI 0.47–2.14) or the PCP workers (n = 5; SMR = 1.52, 95%
CI 0.49–3.54).
Cancers of the digestive organs were addressed by Coggon et al. (2015) in
an extension of the follow-up of UK phenoxy herbicide manufacturers and sprayers. No statistically significant associations between exposure to phenoxy acids
and esophageal cancer were found for all groups of workers: all workers (n =
55; SMR = 0.99, 95% CI 0.74–1.28), workers exposed to herbicide levels above
background (n = 46; SMR = 1.11, 95% CI 0.81–1.48), and workers exposed
for more than 1 year at levels above background (n = 17; SMR = 0.89, 95% CI
0.52–1.43). These data do not support an association with phenoxy herbicides
and cancer of the esophagus.
Other Identified Studies Two other studies of esophageal cancer were identified but were limited by a lack of exposure specificity (Ruder et al., 2014; Yildirim
et al., 2014). A third study (Akahane et al., 2017) examined the prevalence of
self-reported long-term health effects (including esophageal cancer) in people
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the
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ingestion of contaminated rice bran oil (Yusho accident) compared with an age-,
sex- and residential-area-matched group. Because no TEQs or other quantification
of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effect of exposure to the COIs
on tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker et al., 2006;
Wanibuchi et al., 2004), and no increase in the incidence of esophageal cancer
has been reported in laboratory animals after exposure. A previous biomarker
study analyzed esophageal-cell samples from patients who had been exposed to
indoor air pollution of different magnitudes and who did or did not have highgrade squamous-cell dysplasia or a family history of upper gastrointestinal-tract
cancer (Roth et al., 2009). AHR expression was higher in patients who had a
family history of upper gastrointestinal-tract cancer, but it was not associated
with indoor air pollution, esophageal squamous-cell dysplasia category, age, sex,
or smoking. These results might be interpreted to suggest that an enhanced expression of AHR in patients who had a family history of upper gastrointestinaltract cancer may contribute to upper gastrointestinal-tract cancer risk associated
with AHR ligands—such as PAHs, which are found in cigarette smoke—and
with TCDD.
In a small series of studies, AHR expression was found to be higher in
esophageal tumors than in corresponding normal mucosa and, somewhat surprisingly, played a role in the suppression of metastatic potential, in contrast to many
other cancers (Safe et al., 2013). The significance of these observations and the
mechanism underlying increased AHR expression was not determined (J. Zhang
et al., 2012). No new mechanistic or biologic plausibility studies on esophageal
cancer have been published since Update 2014.
Synthesis
In this update, two studies were reviewed that increased the follow-up period
of workers exposed to dioxins (Collins et al., 2016) and phenoxy herbicides
(Coggon et al., 2015) and examined the relationship of a variety of cancers,
including esophageal, with mortality. Neither study provided additional evidence
for a potential association between esophageal cancer overall and exposure to
the COIs. Because the risk factors and etiologies for adenocarcinomas and squamous-cell carcinomas differ to some extent, it would have been more informative
if the analyses were stratified by type. In combination with the studies reviewed
previously, findings from the additional follow-up times do not provide adequate
new evidence of the relationship between exposure to the COIs and esophageal
cancer. No toxicologic studies provide evidence of the biologic plausibility of an
association between the COIs and tumors of the esophagus.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
esophageal cancer.
Stomach Cancer
The incidence of stomach cancer increases with age. NCI estimated that
26,240 people would receive a diagnosis of stomach cancer in the United States
in 2018 and that 10,800 people would die from it. The incidence is almost twice
as high in men than in women and is higher among all other race and ethnicity
groups than in whites (NCI, n.d.d). Other risk factors include a family history of
this cancer, some diseases of the stomach, and diet. Infection with Helicobacter
pylori increases the risk of stomach cancer. Tobacco or alcohol use and the consumption of nitrite- and salt-preserved food may also increase the risk (Ang and
Fock, 2014; Brenner et al., 2009; Key et al., 2004). The incidence rate of stomach cancer has been decreasing since 1975 when SEER began tracking it, and is
estimated to be 7.2 per 100,000 men and women per year (NCI, n.d.d). Among
men over age 65 years (the age group of Vietnam veterans), the age-adjusted
modeled incidence rate of stomach cancer for all races combined was 36.7 per
100,000 for 2000–2014.2
Conclusions from VAO and Previous Updates
Stomach cancer was first considered independently in Update 2006, and that
committee concluded that there was inadequate or insufficient evidence to determine whether there is an association between exposure to the COIs and stomach
cancer. That conclusion has been maintained by the committees responsible for
subsequent updates.
Case-control studies reviewed in previous updates examined agricultural
exposures and stomach cancer. Both Ekström et al. (1999) and Mills and Yang
(2007) found an association with herbicides and with phenoxy herbicides in
particular. A study that compared mortality from stomach cancer among Iowa
farmers versus other occupations found that the proportional mortality ratio of
farmers was significantly higher (Burmeister et al., 1981, 1983). Occupational
cohort studies reported little evidence of an exposure-related increase in stomach
cancer. Updated mortality findings from Seveso concerning TCDD exposure

2 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing
SEER 18 dataset, age-adjusted rates, stomach cancer, all races, male, and over age 65.
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(Consonni et al., 2008; Pesatori et al., 2009) found no evidence of an increase
in stomach cancer.
Update 2014 reviewed cohort studies of Vietnam veterans from New Zealand
and Korea that reported on stomach cancer. Stomach cancer mortality (Yi et al.,
2014b) and incidence (Yi and Ohrr, 2014) were assessed among Korean veterans
who had served in Vietnam between 1964 and 1973. Yi and Ohrr (2014) reported
a modestly increased risk of incident stomach cancer in the internal comparison
of the high- and low-exposure groups based on the EOI scores. Similarly, for
stomach cancer mortality, Yi et al. (2014b) reported a similar modestly increased
risk for the high- versus low-exposure groups and a positive association with
the individual log-transformed EOI scores. Among 2,783 New Zealand Vietnam
veterans who served in Vietnam between 1964 and 1975, McBride et al. (2013)
reported that stomach cancer mortality was slightly elevated in the cohort, while
stomach cancer incidence was slightly less than expected; however, neither estimate was statistically significant.
Update of the Epidemiologic Literature
No studies of Vietnam veterans or published environmental or case-control
studies of exposure to the COIs and stomach cancer were identified for the current
update. Reviews of the relevant studies are presented in the earlier reports. Table
4, which can be found at www.nap.edu/catalog/25137, summarizes the results of
studies related to stomach cancer.
Occupational Studies Among the Dow Midland, Michigan, worker cohort
that was compared with the standardized U.S. population, Collins et al. (2016)
found no differences in mortality from stomach cancer for the TCP workers
(n = 11; SMR = 1.58, 95% CI 0.79–2.83) or the PCP workers (n = 5; SMR = 1.30,
95% CI 0.42–3.04).
Cancers of the digestive organs were addressed by Coggon et al. (2015) in
an extension of the follow-up of UK phenoxy herbicide manufacturers and sprayers. Mortality from stomach cancer was lower than expected for all groups of
workers: all workers (n = 66; SMR = 0.78, 95% CI 0.61–1.00), workers exposed
to herbicide levels above background (n = 43; SMR = 0.73, 95% CI 0.53–0.99),
and workers exposed for more than 1 year at levels above background (n = 21;
SMR = 0.75, 95% CI 0.46–1.15).
Other Identified Studies Two other studies of stomach and gastric cancer
were identified but lacked sufficient exposure specificity to be included as contributing to the evidence base of the potential effects of the COIs (Ruder et al.,
2014; Yildirim et al., 2014). A third study (Akahane et al., 2017) examined the
prevalence of self-reported long-term health effects (including stomach cancer)
in people exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals
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through the ingestion of contaminated rice bran oil (Yusho accident) compared
with an age-, sex- and residential-area-matched group. Because no TEQs or other
quantification of relevant exposures was presented, the study was not considered
further.
Biologic Plausibility
Long-term animal studies have examined the effect of exposure to 2,4-D
and TCDD on tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker
et al., 2006; Wanibuchi et al., 2004). No increase in the incidence of gastro
intestinal cancers has been reported in laboratory animals. However, studies of
laboratory animals have observed dose-dependent increases in the incidence
of squamous-cell hyperplasia of the forestomach or fundus of the stomach after
an administration of TCDD (Hebert et al., 1990; Walker et al., 2006). Similarly,
in a long-term TCDD-treatment study in monkeys, hypertrophy, hyperplasia,
and metaplasia were observed in the gastric epithelium (Allen et al., 1977). A
transgenic mouse bearing a constitutively active form of the Ahr has been shown
to develop stomach tumors (Andersson et al., 2002); the tumors are neither dysplastic nor metaplastic, but are indicative of both squamous-cell and intestinalcell metaplasia (Andersson et al., 2005). The validity of the transgenic-animal
model is indicated by the similarities in the phenotype of the transgenic animal
(increased relative weight of the liver and heart, decreased weight of the thymus,
and increased expression of Ahr target gene CYP1A1) and of animals treated
with TCDD (Brunnberg et al., 2006). Recent cell culture work consistent with
the in vivo studies showed that decreased AHR expression in two human gastric
cancer cell lines was associated with decreased cell growth, migration, and invasion, all of which are hallmarks of malignant potential (X. F. Yin et al., 2013). In
a biomarker study of cancer patients, AHR expression and nuclear translocation
were significantly higher in stomach-cancer tissue than in precancerous tissue
(Peng et al., 2009a). The results suggest that AHR plays an important role in
stomach carcinogenesis. AHR activation in a stomach-cancer cell line has also
been shown to enhance stomach-cancer cell invasiveness, potentially through a
c-Jun-dependent induction of matrix metalloproteinase-9 (Peng et al., 2009b). No
new mechanistic or biologic plausibility studies on gastrointestinal cancers have
been published since Update 2014.
Synthesis
Studies that examined the association between the COIs and stomach cancer
that were reviewed in previous VAO Updates reported mixed findings. Among the
studies of Vietnam veterans, analyses from the AFHS did not report a statistically
significant association of increasing serum levels of TCDD and stomach cancer
(Pavuk et al., 2005). Other mortality studies of U.S. Vietnam veterans also did
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not report an increased risk of death from stomach cancer. A modestly increased
risk of stomach cancer was reported in Korean veterans, but there was inconsistent evidence in New Zealand Vietnam veterans. Whereas case-control studies of
agricultural exposures reported evidence of an association with stomach cancer,
studies of occupational cohorts—including the two reviewed above—found little
evidence of an exposure-related increase in stomach cancer. Moreover, Collins et
al. (2016) reported an increased but not statistically significant risk of stomach
cancer among the U.S. TCP and PCP manufacturing workers, but Coggon et al.
(2015) reported a statistically significant decreased risk of stomach cancer among
the entire cohort and short-term UK phenoxy herbicide workers or sprayers.
There is some evidence of biologic plausibility in animal models, but overall
the epidemiologic studies do not support an association between exposure to the
COIs and stomach cancer.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the committee concludes that there is inadequate or insufficient evidence to determine
whether there is an association between exposure to the COIs and stomach cancer.
Colorectal Cancers
Colorectal cancers include malignancies of the colon (ICD-9 153; ICD-10
C18) and of the rectum and anus (ICD-9 154; ICD-10 C19–C21); less prevalent tumors of the small intestine (ICD-9 152; ICD-10 C17) are often included.
Colorectal cancers account for 8% of all incident cancers; NCI estimated that
140,250 people would receive diagnoses of colorectal cancer in the United States
in 2018 and that 50,630 would die from it. Colon and rectum cancer is the second
leading cause of cancer death in the United States (NCI, n.d.e).
The incidence of colorectal cancers increases with age; the median age of
diagnosis is 67 years. Incidence is higher in men than in women, and highest in
blacks and lowest in Hispanics and Asians/Pacific Islanders. Between 2000 and
2013, incidence rates in adults aged 50 years and older declined by 32%, with the
drop largest for distal tumors in people aged 65 years and older. Over this same
period, colorectal cancer incidence rates increased by 22% among adults aged
less than 50 years, driven solely by tumors in the distal colon and rectum (Siegel
et al., 2015). (Screening can affect the incidence, and screening is recommended
for all persons over 50 years old.) Among men over age 65 years (the age group of
Vietnam veterans), the age-adjusted modeled incidence rate of colorectal cancer
for all races combined was 203.6 per 100,000 for 2000–2014.3 Other risk factors
3 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing
SEER 18 dataset, age-adjusted rates, colorectal cancer, all races, age ≥ 65 years, and male sex.
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include a family history of this form of cancer, obesity, a lack of physical exercise, and diet (Johnson et al., 2013; Kamangar et al., 2006). Type 2 diabetes is
associated with an increased risk of colorectal cancers (Berster and Göke, 2008).
Additional risk factors that have been studied include having a personal history
of chronic ulcerative colitis or Crohn disease for 8 years or longer, smoking cigarettes, and having three or more alcoholic drinks per day (NCI, 2018c).
Conclusions from VAO and Previous Updates
Until Update 2006, colorectal cancers were considered as a group with
gastrointestinal-tract cancers. Beginning with Update 2006, colorectal cancers
were considered independently, but each update committee has concluded that
the available evidence has not been sufficient to reassign the association between exposure to the COIs and colorectal cancers from inadequate or insufficient
evidence.
Studies of veterans from New Zealand and Korea who served in Vietnam
and reported colorectal cancer outcomes, in general, found no statistically significant associations. McBride et al. (2013) reported on mortality among 2,783
male New Zealand veterans who had served in Vietnam between 1964 and 1975,
were alive in 1988, and were followed through 2008. Based on 20 deaths from
colorectal cancer, the effect estimate (SMR) was not statistically significantly
elevated compared with the general New Zealand population, and the all-cause
mortality estimate was statistically significantly lower in the cohort. Colorectal
cancer incidence, based on 63 cases, was not statistically significantly different
than the general population.
Among Korean veterans who served in Vietnam, Yi and Ohrr (2014) found a
lower incidence of colon cancer among the more highly exposed compared with
the less exposed as well as a small excess of rectal cancer, but neither was statistically significant. Regarding mortality from colorectal cancers, Yi et al. (2014b)
reported no evidence of an increase in mortality from these cancers combined
for high- versus low-exposure opportunity groups or in association with the
individual log-transformed EOI scores.
Update of the Epidemiologic Literature
No studies of Vietnam veterans or published environmental or case-control
studies of exposure to the COIs and colorectal cancer were identified for the current update. Reviews of the relevant studies are presented in the earlier reports.
Table 5, which can be found at www.nap.edu/catalog/25137, summarizes the
results of studies related to colon cancer.
Occupational Studies Among the Dow Midland, Michigan, worker cohort
that was compared with the standardized U.S. population, Collins et al. (2016)
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reported SMRs for colon and rectal cancers separately. Only 4 total deaths from
rectum cancer were reported (3 among the TCP workers and 1 among the PCP
workers), making the risk estimates unreliable. Compared with the standardized
U.S. population, no statistically significant difference in mortality for colon cancer was found for the TCP workers (n = 22; SMR = 1.11, 95% CI 0.69–1.67) or
the PCP workers (n = 12; SMR = 1.23, 95% CI 0.64–2.15).
Coggon et al. (2015) extended the follow-up of a cohort of UK phenoxy
herbicide manufacturers and sprayers to examine the carcinogenicity of phenoxy
herbicides. Mortality from colon and rectal cancers was reported separately. No
difference in colon cancer mortality was found for all workers (n = 77; SMR =
0.97, 95% CI 0.77–1.22), for workers exposed to herbicide levels above background (n = 50; SMR = 0.87, 95% CI 0.65–1.15), or for persons exposed for more
than 1 year at levels above background (n = 23; SMR = 0.86, 95% CI 0.54–1.29),
although the all effect estimates indicated decreased risk. The estimates for rectal
cancer were similarly not statistically significant and lower than expected for
each of the groups: all workers (n = 39; SMR = 0.76, 95% CI 0.54–1.04), workers exposed to herbicide levels above background (n = 31; SMR = 0.84, 95% CI
0.57–1.19), and workers exposed for more than 1 year at levels above background
(n = 14; SMR = 0.81, 95% CI 0.44–1.36).
Other Identified Studies Three other studies of colon and rectal cancers were
identified. One lacked sufficient exposure specificity to be included as contributing
to the evidence base of the potential effect of the COIs (Ruder et al., 2014). The
second study examined disparities in colorectal cancer incidence in communities
around Ontario, Canada, but did not collect information on the COIs (Sitharan
et al., 2014). A third study (Akahane et al., 2017) examined the prevalence of
self-reported long-term health effects (including bowel cancer) in people exposed
to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through ingestion
of contaminated rice bran oil (Yusho accident) compared with an age-, sex- and
residential-area-matched group. Because no TEQs or other quantification of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies examining the effect of exposure to the COIs on
tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker et al., 2006;
Wanibuchi et al., 2004) have reported no increase in the incidence of c olorectal
cancers. Xie et al. (2012) reported that AHR activation by TCDD induces r obust
proliferation in two human colon-cancer cell lines through Src-mediated epidermal growth factor receptor activation. That novel finding suggests that TCDD
and other AHR ligands may contribute to an increased proliferation of colonic
cells, but more studies are needed to understand the relation of increased proliferation of these cells to colorectal cancers, if any, and the potential role of AHR
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activation in colorectal and intestinal carcinogenesis. Yin et al. (2016a) found
keratinocyte growth factor (KGF), AHR, and CYP1A1 are overexpressed in
colorectal cancer tissues. KGF promoted colon cancer cell growth in vitro and
also upregulated and activated AHR. Furthermore, KGF promoted cell proliferation through the AHR–cyclin D1 pathway in colon cancer cells.
In another study, Yin et al. (2016b) found that an endogenous AHR agonist
(6-formylindolo [3, 2-b] carbazole, or FICZ) inhibited LoVo colon cancer cell
proliferation by inducing cell cycle arrest. Ahr activation by TCDD was antiinflammatory in a mouse model of colon cancer by inducing acetylcholinesterasetargeting micro RNA-132, which suppressed production of TNF-α, IL-1β and
IL-6 (Alzahrani et al., 2017). These studies support a plausible mechanism by
which TCDD may influence colorectal cancers.
Synthesis
Epidemiologic findings for colorectal cancers have not been particularly
suggestive of an association with exposure to the COIs. None of the studies of
U.S. Vietnam veterans found an elevated risk of colorectal cancer, and similar
results have been reported for Vietnam veterans from Australia, Korea, and New
Zealand. In line with previous follow-up studies of the U.S. Dow chemical plant
workers, Collins et al. (2016) found few deaths from rectal cancer, and colon
cancer was not found to be elevated in either TCP or PCP workers compared
with the standardized U.S. population. Coggon et al. (2015) reported decreased,
but not statistically significant risks among the UK factory workers or sprayers of
phenoxy herbicides. Limited evidence is available on the biologic plausibility of
an association between exposure to any of the COIs and tumors of the colon or
rectum. Overall, the available evidence does not support an association between
the COIs and colorectal cancers.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the committee concludes that there is inadequate or insufficient evidence to determine whether
there is an association between exposure to the COIs and colorectal cancers.
Hepatobiliary Cancers
Hepatobiliary cancers include cancers of the liver (ICD-9 155.0, 155.2;
ICD-10 C22) and the intrahepatic bile duct (ICD-9 155.1; ICD-10 C22.1). NCI
estimated that 42,220 men and women would receive diagnoses of liver cancer or
intrahepatic bile duct cancer in the United States in 2018 and that 30,200 people
would die from these cancers (NCI, n.d.g). Gallbladder cancer and extrahepatic
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bile duct cancer (ICD-9 156; ICD-10 C23–C24) are uncommon and, when they
are addressed, are often grouped with liver cancer.
In the United States, liver cancers account for 2.4% of new cancer cases
and 4% of cancer deaths. Misclassification of metastatic cancers as primary liver
cancer can lead to an overestimation of the number of deaths attributable to liver
cancer (Chuang et al., 2009). Liver cancer is the second most common cause
of death from cancer worldwide and it is estimated that it will be responsible
for nearly 782,000 deaths in 2018 (Globocan, 2018). Liver cancers are most
common and are among the leading causes of death in less developed countries
and regions, especially those in Northern Africa, Micronesia, and Eastern and
Southeastern Asia (Globocan, 2018). Known risk factors for liver cancer include
chronic infection with the hepatitis B or hepatitis C virus and exposure to the
carcinogens aflatoxin and vinyl chloride. Alcohol cirrhosis and obesity-associated
metabolic syndrome may also contribute to the risk of liver cancer (Chuang et
al., 2009; Farazi et al., 2006). In the general population, the incidence of liver
and intrahepatic bile duct cancers is higher in men than in women and higher in
blacks than in whites but highest among Asian/Pacific Islanders and American
Indians/Alaska Natives (NCI, n.d.g). Among males of all races aged 65 years and
older, the age-adjusted modeled incidence rate of hepatobiliary cancers was 53.3
per 100,000 for 2000–2014.4
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate
or insufficient information to determine whether there is an association between
exposure to the COIs and hepatobiliary cancers. Additional information available to the committees responsible for subsequent updates did not change that
conclusion.
The committee for Update 2014 reviewed two studies of Korean veterans
who served in Vietnam and were part of the Korean Veterans Health Study. When
compared to the general Korean population, there was no evidence of increased
liver cancer risk (Yi, 2013). In the internal comparison of the high- versus
low-exposure-opportunity group, Yi and Ohrr (2014) reported a nonstatistically
significant elevation in liver cancer for the high-exposure group. The risk of
liver cancer mortality was slightly increased in the internal comparison and
from the analysis of the individual EOI scores (Yi et al., 2014b). The committee
for Update 2014 also reviewed an occupational study of 3,529 employees of a
Chinese automobile foundry that reported a statistically significantly elevated
risk of liver cancer mortality, based on 32 cancer deaths (L. Wang et al., 2013).
However, these studies did not change the committee’s conclusion that there is
4 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing
SEER 18 dataset, age-adjusted rates, hepatobiliary cancer, all races, age ≥ 65 years, and male sex.
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inadequate or insufficient evidence to determine whether there is an association
between exposure to the COIs and hepatobiliary cancers.
Update of the Epidemiologic Literature
No environmental or case-control studies of the COIs and hepatobiliary
cancers have been identified since Update 2014. Reviews of the relevant studies
are presented in the earlier reports. Table 6, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to hepatobiliary cancer.
Vietnam-Veteran Studies Krishnamurthy et al. (2016) conducted a retrospective study in the Dayton, Ohio, Veterans Administration Medical Center to investigate all patients carrying dual diagnoses of both cirrhosis and hepatitis C virus
(verified by viral genotype) at this facility from January 2000 to December 2013.
Of the 509 patients with both diagnoses, 119 did not have genotype results and
were excluded from the analysis. A total of 390 patients confirmed to have both
cirrhosis and hepatitis C virus were identified, and 311 had follow-up information; there were 79 confirmed hepatocellular carcinomas among the 390 patients
with dual diagnoses. Exposure to Agent Orange was determined by self-report.
Effect estimates were adjusted for smoking, alcohol “addiction” (ill defined), and
race. Alcohol addiction and African American race were associated with hepatocellular carcinoma among the patient sample (OR = 2.17, 95% CI 1.07–4.43
and OR = 2.07, 95% CI 1.22–3.51, respectively). The association between selfreported exposure to Agent Orange and hepatocellular carcinoma was not statistically significant (OR = 1.76, 95% CI 0.85–3.64).
Occupational Studies Among the Dow Midland, Michigan, worker cohort
that was compared with the standardized U.S. population, only four deaths from
hepatobiliary cancers were reported during the entire follow-up period (Collins
et al., 2016). All four deaths occurred in the TCP workers, and although the
estimate showed decreased risk, it was not statistically significantly different from
the comparison population (SMR = 0.62, 95% CI 0.17–1.58).
Cancers of the digestive organs were addressed by Coggon et al. (2015) in
an extension of the follow-up of UK phenoxy herbicide manufacturers and sprayers. Mortality from liver and gall bladder cancers was reported separately, but
the effect estimates from gall bladder cancer (two deaths among all workers) are
unreliable because of the small number of cases. The risk for liver cancer mortality was not different for any of the groups of workers: all workers (n = 20; SMR =
1.24, 95% CI 0.76–1.91), workers exposed to herbicide levels above background
(n = 14; SMR = 1.14, 95% CI 0.62–1.91), or for workers exposed for more than
1 year at levels above background (n = 4; SMR = 0.72, 95% CI 0.20–1.85).
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Other Identified Studies Four other studies of hepatobiliary cancers were identified but lacked sufficient exposure specificity (Niu et al., 2016; Ruder et al.,
2014; VoPham et al., 2015) and either did not collect serum samples to measure
levels of dioxins (Ruder et al., 2014; VoPham et al., 2015) or did not measure
the dioxin levels in collected samples (Niu et al., 2016). Therefore, these studies
were not considered as contributing to the evidence base of the potential effect of
the COIs. A fourth study (Akahane et al., 2017) examined the prevalence of self-
reported long-term health effects (including liver and gallbladder cancers) in people
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the
ingestion of contaminated rice bran oil (Yusho accident), compared with an age-,
sex- and residential-area-matched group. Because no TEQs or other quantification
of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effect of exposure to the COIs
on tumor incidence (J. F. Brown et al., 2007; Charles et al., 1996; Stott et al.,
1990; Walker et al., 2006; Wanibuchi et al., 2004). Studies performed in laboratory animals have consistently demonstrated that long-term exposure to TCDD
results in the formation of liver adenomas and carcinomas (Knerr and Schrenk,
2006; Walker et al., 2006). Furthermore, TCDD increases the growth of hepatic
tumors that are initiated by treatment with a complete carcinogen. Pathologic
liver changes have been observed after exposure to TCDD, including nodular
hyperplasia and massive inflammatory cell infiltration (Kociba et al., 1978; NTP,
2006; Walker et al., 2006; Yoshizawa et al., 2007); inflammation can be important
for the development and progression of many cancers, including liver cancers
(Mantovani et al., 2008). In monkeys treated with TCDD, hyperplasia and an
increase in cells that stain for alpha-smooth muscle actin have been observed
(Korenaga et al., 2007). Positive staining for alpha-smooth muscle actin is thought
to indicate a process (the epithelial–mesenchymal transition) that is associated
with the progression of malignant tumors (Weinberg, 2008). Zucchini-Pascal et
al. (2012) showed that TCDD exposure induced an epithelial-to-mesenchymal
transition in primary cultured human hepatocytes.
Bile duct hyperplasia (but not tumors) has been reported in rodents following chronic treatment with TCDD (Knerr and Schrenk, 2006; Walker et al.,
2006; Yoshizawa et al., 2007). Similarly, monkeys treated with TCDD developed
metaplasia, hyperplasia, and hypertrophy of the bile duct (Allen et al., 1977).
Hollingshead et al. (2008) showed that TCDD-activated AHR in human breast
and endocervical cell lines induces sustained high concentrations of the IL-6
cytokine, which has tumor-promoting effects in numerous tissues, including
cholangiocytes; thus, TCDD might promote carcinogenesis in biliary tissue.
TCDD may contribute to tumor progression by inhibiting p53 regulation
(phosphorylation and acetylation) triggered by genotoxicants through the increased
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expression of the metastasis marker AGR2 (Ambolet-Camoit et al., 2010) and a
functional interaction between the AHR and FHL2 (Kollara and Brown, 2009).
AHR has also been shown to be a regulator of c-Raf and proposed cross-talk
between AHR and the mitogen-activated protein kinase signaling pathway in
chemically induced hepatocarcinogenesis (Borlak and Jenke, 2008). TCDD inhibits ultraviolet-C radiation-induced apoptosis in primary rat hepatocytes and
Huh-7 human hepatoma cells, which supports the hypothesis that TCDD acts
as a tumor promoter by preventing damaged cells from undergoing apoptosis
(Chopra et al., 2009). TCDD inhibited the proliferation of isolated mouse oval
cells, which are liver precursor cells, via an Ahr-dependent pathway, suggesting
that these cells are not the precursor for TCDD-induced tumors in the mouse
(Faust et al., 2013a).
Elyakim et al. (2010) found that human microRNA miR-191 was upregulated in hepatocellular carcinoma and that miR-191 was also upregulated after
TCDD treatment, which may contribute to the mechanism of the carcinogenic
activity of TCDD. Ovando et al. (2010) used toxicogenomics to identify genomic
responses that may contribute to the development of hepatotoxicity in rats treated
chronically with the AHR ligands, TCDD, or PCB 126. The researchers identified, respectively, 24, 17, and 7 genes that were differentially expressed in the
livers of rats exposed to those Ahr ligands and in human cholangiocarcinoma,
human hepatocellular adenoma, and rat hepatocellular adenoma. These findings
may help elucidate the mechanisms by which dioxin-like chemicals induce their
hepatotoxic and carcinogenic effects.
In rodents, TCDD may promote hepatocarcinogenesis through cytotoxicity, chronic inflammation, and liver regeneration and through hyperplastic and
hypertrophic growth due to the sustained activation of Ahr (Köhle and Bock,
2007; Köhle et al., 2008). For example, TCDD exposure has been reported to
increase liver fibrosis in mice via an Ahr-dependent pathway (Andreola et al.,
2004). Kennedy et al. (2014) used transgenic mouse strains to measure dioxininduced liver cancers in a model in which TCDD was used as a tumor promoter.
One set of experiments showed that the number of TCDD-induced liver tumors
was significantly higher in mice that expressed Ahr with high-binding affinity
to TCDD than in an isogenic strain that expressed a low-binding-affinity Ahr.
A second set of experiments showed that the genetic ablation of inflammatory cytokines significantly reduced TCDD-induced liver tumors. Likewise, the
genetic ablation of AHR reduced TCDD-induction of the inflammatory cytokines (Pierre et al., 2014). Species differences governing AHR activation are
demonstrated by the divergence in the transcriptomic responses to TCDD in
mouse, rat, and human liver (Boutros et al., 2008, 2009; Carlson et al., 2009;
S. E. Kim et al., 2009), but it should be noted that the in vitro human hepatocyte
studies may not reflect the in vivo response of human liver to TCDD. In vitro
studies with transformed cell lines and primary hepatocytes cannot replicate the
complexity of a tissue response that is important in eliciting the toxic responses
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observed in vivo (Dere et al., 2006). Finally, AHR expression was shown to be
significantly elevated in human liver cancers, although the absolute level of increase is only about 30% to 40%, but the biological significance of this observation is not known (Z. Liu et al., 2013).
In a study of gene-expression changes in adult female primary human and
rat hepatocytes exposed to TCDD in vitro, Black et al. (2012) used wholegenome microarrays to show that TCDD produced different gene-expression
profiles in rat and human hepatocytes, both on an ortholog basis (conserved
genes in different species) and on a pathway basis. For commonly affected
orthologs or signaling pathways, the human hepatocytes were about one-fifteenth
as sensitive as rat hepatocytes. Such findings are consistent with epidemiologic
studies that show humans to be less sensitive to TCDD-induced hepatotoxicity.
A study of gene-expression changes in cultured rat liver cells (the WB-F344
cell line) showed that AHR agonist PCB 126 identified hundreds of dysregulated genes that increased in number as a function of time after exposure from
6 to 72 hours; these included the Wnt and TGF-β signaling pathways, which
are involved in tumorogenesis (Faust et al., 2013b). Peyre et al. (2014) studied
TCDD activity in human HepG2 hepatocarcinoma cells and demonstrated procarcinogenic activity (anti-apoptosis and induction of epithelial to mesenchymal
transition) via dysregulation of the TGF-β pathway. Reyes-Reyes et al. (2016)
described another mechanism of cancer progression in HepG2 cells involving
TGF-β; the long interspersed nuclear element-1 (L1) damages DNA and was
activated in HepG2 cells via TGF-β signaling in a study of AHR activation
by benzo[a]pyrene. L. T. Wang et al. (2017) found a high correlation between
histone deacetylase 8 (HDAC8) and AHR expression as mRNA and protein
levels. Expression of both HDAC8 and AHR was significantly upregulated in
hepatocellular carcinoma cell lines and tumor tissues compared with normal
hepatocytes; inhibition of HDAC8 inhibited hepatoma cell proliferation and
transformation.
The chronic exposure of rats to TCDD was associated with fatty liver degen
eration and necrosis (X. Chen et al., 2012). Another group reported that the hepatotoxic effects of TCDD were exacerbated in mice that had glutathione deficiency
(Y. J. Chen et al., 2012). The combined exposure to PCBs and TCDD induced
significant hepatotoxicity in rats (C. Lu et al., 2010). Brown et al. (2007) carefully evaluated the mechanisms by which dioxin-like PCBs caused liver cancer
in rats suggesting a process involving the net activity of multiple mixed-function
oxidases, redox cycling quinones, and reactive oxygen species.
Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown to
induce renal cancer. In F344/DuCrj rats treated with a mixture of carcinogens for
4 weeks, a subsequent exposure to DMA (not indicated whether this was DMAIII
or DMAV) via their drinking water for 24 weeks caused tumor promotion in the
liver, kidney, urinary bladder, and thyroid gland but inhibited induction of tumors
of the nasal passages (S. Yamamoto et al., 1995). More recent studies have also
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found that oral exposure of adult mice to 200 ppm DMAV in addition to fetal
arsenic exposure can act as a promoter of renal and hepatocellular carcinoma,
markedly increasing tumor incidence beyond that produced by fetal arsenic expo
sure alone (Tokar et al., 2012).
Synthesis
Epidemiologic findings for hepatobiliary cancers have not suggested an asso
ciation with exposure to the COIs. Since the previous update, one new study of
U.S. Vietnam veterans who attended a VA Medical Center examined hepatocellular carcinoma comorbid with dual diagnoses of cirrhosis and hepatitis C virus
and exposure to Agent Orange (determined by self-report) (Krishnamurthy et
al., 2016). Although the risk estimate was elevated, no statistically significant
association was found between exposure to Agent Orange and hepatocellular
carcinoma. Such null findings are consistent with studies of other cohorts of U.S.
Vietnam veterans as well as those from Australia and Korea. Two occupational
cohort studies that extended the long-term follow-up period of their cohorts were
reviewed. Similar to findings from previous follow-ups, few deaths from hepatobiliary cancers were reported among the U.S. Dow chemical plant workers, and
the risk estimate was lower for the workers than in the general U.S. population
(Collins et al., 2016). Among the UK factory workers or sprayers of phenoxy
herbicides that was followed since 1947, Coggon et al. (2015) also reported a
decreased, but not statistically significant risk of hepatobiliary cancer.
Although one new study (Krishnamurthy et al., 2016) reported modest evidence of excess liver cancer among Vietnam veterans using VA medical center services, the weak design, nonspecific exposure, and confounding remain a concern
for interpreting its results. The lack of evidence of association between exposure
and hepatobiliary cancers in the well-designed and exposure-characterized occupational studies does not support an association. Despite the evidence of TCDD’s
activity as a hepatocarcinogen in animals, the evidence from epidemiologic studies remains inadequate to link the COIs with hepatobiliary cancers, which has a
relatively low incidence in Western populations. Overall, the available evidence
does not support an association between the COIs and hepatobiliary cancers.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
hepatobiliary cancers.
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Pancreatic Cancer
The incidence of pancreatic cancer (ICD-9 157; ICD-10 C25) increases with
age, and the median age of diagnosis is 70 years. NCI estimated that there would
be 55,440 new diagnoses of pancreatic cancer in the United States in 2018, and
that 44,330 people would die from it (NCI, n.d.f). The incidence is higher in men
than in women. The age-adjusted modeled incidence rate of pancreatic cancer for
men 50–64 years old of all races combined was 23.1 per 100,000 in 2014 and
increased to 62.5 for 65- to 74-year-olds and 100.2 for men over 75 years.5 Blacks
have the highest incidence rates for both men and women, and American Indians/
Alaska Natives and Asians/Pacific Islanders have the lowest incidence rates. Risk
factors include chronic pancreatitis (Yadav and Lowenfels, 2013), family history,
diet, tobacco use, obesity, and type 2 diabetes (Huxley et al., 2005).
Conclusions from VAO and Previous Updates
Like other digestive organ cancers, pancreatic cancer was considered independently for the first time in Update 2006. In reviewing the existing evidence
concerning an association between herbicide exposure and pancreatic cancer, the
committee for Update 2006 noted a report of increased rates of pancreatic cancer
in U.S. female Vietnam nurse veterans (Dalager et al., 1995a) but concluded that
it alone did not constitute limited or suggestive evidence of an association. That
increase persisted in the follow-up study of the American female veterans cohort
(Cypel and Kang, 2008), but committees for subsequent updates have concurred
with the decision of the committee for Update 2006, which concluded that there
is inadequate or insufficient evidence of an association of exposure to any of the
COIs and pancreatic cancer.
Four studies of Vietnam veterans were reviewed in Update 2014: a follow-up
study of U.S. women veterans (H. K. Kang et al., 2014a), the cohort from New
Zealand (McBride et al., 2013), and two studies of Korean veterans (Yi, 2013; Yi
and Ohrr, 2014). Pancreatic cancer incidence was lower among the New Zealand
and Korean veterans than in their respective general populations, but the difference was not statistically significant. Among the mortality analyses, deaths from
pancreatic cancer were lower, but not statistically significantly so, among the
New Zealand cohort veterans compared with the standardized general population
of New Zealand. The risk of death from pancreatic cancer was higher among the
other Vietnam veteran cohorts that were followed, but again the differences were
not statistically significant. Among the U.S. women veterans, deployed women
were compared with Vietnam-era women who remained in the United States,
and no statistically significant differences in pancreatic cancer mortality were
5 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the
SEER 18 dataset and choosing age-adjusted rates, pancreatic cancer, all races, age ≥ 65 years, and
stratifying the results by sex.
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observed overall or when the analyses were limited to deployed and nondeployed
nurses. Among Korean veterans, neither pancreatic cancer incidence nor risk of
mortality from pancreatic cancers in association with herbicide exposure from
either the internal comparison of the high- and low-exposure-opportunity groups
or the analysis of the individual EOI scores was statistically significant. However,
none of the veteran studies controlled for smoking status, a known risk factor of
pancreatic cancer.
Update of the Epidemiologic Literature
No studies of Vietnam veterans or environmental studies of the COIs and
pancreatic cancer have been identified since Update 2014. Reviews of the relevant
studies are presented in the earlier reports. Table 7, which can be found at www.nap.
edu/catalog/25137, summarizes the results of studies related to pancreatic cancer.
Occupational Studies Two occupational cohort studies were identified since
Update 2014 that examined the relationship between phenoxy herbicides and
pancreatic cancer. Among the Dow Midland, Michigan, worker cohort that was
compared with the standardized U.S. population, no differences in mortality for
pancreatic cancer were found for the TCP workers (n = 7; SMR = 0.55, 95% CI
0.22–1.14) or the PCP workers (n = 6; SMR = 1.00, 95% CI 0.37–2.18) (Collins
et al., 2016).
Mortality from pancreatic cancers was one of the outcomes addressed by
Coggon et al. (2015) in an extension of the follow-up of UK phenoxy herbicide
manufacturers and sprayers. No difference in risk of mortality from pancreatic
cancer was found for any of the groups of workers: all workers (n = 54; SMR =
1.04, 95% CI 0.78–1.35), workers exposed to herbicide levels above background
(n = 39; SMR = 1.03, 95% CI 0.73–1.40), or workers exposed for more than 1
year at levels above background (n = 13; SMR = 0.74, 95% CI 0.39–1.26).
Case-Control Studies One population-based case-control study of occupational exposure to pesticides, including phenoxy herbicides, and pancreatic cancer has been published since Update 2014. Fritschi et al. (2015) recruited 504
confirmed pancreatic cancer cases and 643 controls between January 2007 and
June 2011 as part of the Queensland [Australia] Pancreatic Cancer Study. All
participants were Queensland residents and at least 18 years old. Controls were
randomly selected from the Australian electoral roll and frequency matched to
cases by sex and 5-year age group at diagnosis. Participants completed face-toface or telephone interviews that collected information about sociodemographic
and lifestyle factors (including detailed smoking behaviors and history), medical history, history of cancer in first-degree relatives, and detailed lifetime job
histories (including job title, industry, location, main tasks, and ages at start and
finish). Additional questions were asked for people who reported ever working in

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

CANCER

253

industries that are associated with nitrosamine exposure and the occupational or
direct use of pesticides on animals or crops. An occupational hygienist, who was
blinded to case status, reviewed the job history information to assess the likelihood of exposure to N-nitrosamines and pesticides and estimated level and frequency of such exposures. Pesticide assessments were made for organochlorine
insecticides, organophosphate insecticides, phenoxy herbicides, other herbicides,
fumigants, fungicides, and other pesticides. Risk estimates were adjusted for age
and sex. No statistically significant associations were found with exposure to
any of the individual pesticide groups. Specifically examining ever versus never
exposure to phenoxy herbicides (19 cases and 24 controls reported ever exposure),
no statistically significant association with pancreatic cancer was found (OR =
0.93, 95% CI 0.50–1.74). Among non-smokers the odds of pancreatic cancer with
exposure to pesticides was 1.00 (95% CI 0.48–2.06), and among ever smokers it
was 0.82 (95% CI 0.51–1.32).
Other Identified Studies Two other studies of pancreatic cancer were identified. The first lacked sufficient exposure specificity to be included as contributing
to the evidence base of the potential effect of the COIs (Ruder et al., 2014). The
second study (Akahane et al., 2017) examined the prevalence of self-reported
long-term health effects (including pancreatic cancer) in people exposed to PCBs,
dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion of
contaminated rice bran oil (Yusho accident) compared with an age-, sex- and
residential-area-matched group. Because no TEQs or other quantification of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effect on tumor incidence of
exposure to each of the COIs: 2,4-D and 2,4,5-T (Charles et al., 1996), TCDD
(Walker et al., 2006), picloram (Stott et al., 1990), and DMA (Wanibuchi et al.,
1996, 2004). No increase in the incidence of pancreatic cancer in laboratory
animals after the administration of cacodylic acid, 2,4-D, or picloram has been
reported. A 2-year study of female rats reported increased incidences of pancreatic adenomas and carcinomas after treatment at the highest dose of TCDD (100
ng/kg per day) (Nyska et al., 2004). Other studies have observed chronic active
inflammation, acinar-cell vacuolation, and an increase in the proliferation of the
acinar cells surrounding the vacuolated cells (Yoshizawa et al., 2005b). As previously discussed, chronic inflammation and hyperproliferation are closely linked
to the formation and progression of cancers, including cancers of the pancreas
(Hahn and Weinberg, 2002; Mantovani et al., 2008). Also, metaplastic changes in
the pancreatic ducts were observed in female monkeys treated with TCDD (Allen
et al., 1977). No new mechanistic or biologic plausibility studies on pancreatic
cancer have been published since Update 2014.
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Synthesis
Although prior studies of Vietnam veterans from the United States and Australia had reported an excess of pancreatic cancer, studies of New Zealand and
Korean veterans who served in Vietnam did not report an association between
service and pancreatic cancer, although none of them controlled for smoking. In
the current update, two studies of occupational cohorts that produced phenoxy
herbicides or were exposed to TCDD did not find elevated risks of pancreatic
cancer mortality and often did not report consistent directions of any effect. The
population-based case-control study of Fritschi et al. (2015) explored exposure
to organochlorine insecticides and herbicides and also found no evidence for an
association of exposure to these compounds with pancreatic cancer. Limited evidence is available on the biologic plausibility of an association between exposure
to any of the COIs and tumors of the pancreas; long-term animal studies of exposure to each of the COIs have not found increased incidence of pancreatic cancer.
Overall, the existing evidence does not support a conclusion that exposures to the
COIs are associated with the occurrence of pancreatic cancer.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
pancreatic cancer.
Other Digestive Cancers
Findings on cancers of the small intestine (ICD-9 152; ICD-10 C17), ill-
defined intestine, rectosigmoid junction, gallbladder (ICD-9 156; ICD-10 C23),
retroperitoneum (ICD-9 158; ICD-10 C48), and other unspecified digestive organs
(ICD-9 159; ICD-10 C26.8, C26.9, C48.8) are considered in this category.
Some studies have reported the risk of small intestine cancer separately, and
others have grouped it under “other digestive cancers.” Epidemiologic findings
for cancer of the small intestine and the COIs have not been encountered in any
of the VAO updates except in analyses of the Korean Veterans Health Study, reviewed by the Update 2014 committee. In a mortality analysis, Yi et al. (2014b)
found a statistically significant elevated risk for the internal comparison but not
for the analysis of the individual EOI scores of mortality from cancer of the small
intestine. Yi and Ohrr (2014) found a statistically significant increase in incidence
of cancers of the small intestine when comparing the high- versus low-exposure
opportunity groups, but the estimate was imprecise.
Since Update 2014, the committee has identified three studies, one that
reported on mortality from small intestine cancer specifically, one that reported
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mortality from “other digestive sites” that would include the small intestine and
others as defined above, and a third that presented “malignant neoplasms of the
peritoneum and other and unspecified of digestive organs” as a single group.
Among the Dow Midland, Michigan, worker cohort that used the standardized U.S. population for comparison, only four deaths were reported from other
digestive cancers during the follow-up period (Collins et al., 2016). The small
number of deaths resulted in a slightly elevated but imprecise risk estimate for
all reported categories of workers: all TCP/PCP workers (SMR = 1.37, 95% CI
0.37–3.51), TCP workers (n = 3; SMR = 1.91, 95% CI 0.52–4.89), and PCP workers (n = 1; SMR = 0.94, 95% CI 0.02–5.25).
In an extension of the follow-up of UK phenoxy herbicide manufacturers and
sprayers examining the carcinogenicity of phenoxy herbicides, Coggon et al. (2015)
reported that there were four deaths due to cancers of the small intestine over the
entire follow-up period. The risk estimates were not statistically significant and were
imprecise for all three groups of workers presented: all workers (SMR = 1.67, 95%
CI 0.65–4.28), workers exposed to phenoxy herbicides above background (n = 4;
SMR = 2.26, 95% CI 0.62–5.80), and workers exposed to phenoxy herbicides above
background levels for 1 year or longer (n = 2; SMR = 2.48, 95% CI 0.30–8.96).
A third identified occupational study (Ruder et al., 2014) reported SMRs
from many types of malignant neoplasms in the digestive organs using a category
of “malignant neoplasms of the peritoneum and other and unspecified of digestive
organs” but lacked the necessary exposure specificity to be considered further.
Given the small number of studies and, in some cases, non-specific categorization of the outcomes, these data do not allow the committee to reach any
definitive conclusions regarding the association of exposure to the COIs and other
digestive cancers, including cancers of the small intestine.
LARYNGEAL CANCER
The larynx is a part of the throat between the base of the tongue and the
trachea, and it contains the vocal cords, epiglottis, supraglottis, glottis, and subglottis. NCI estimated that in the United States in 2018, 13,150 people would
receive a new diagnosis of and 3,710 men and women would die from laryngeal
cancer (ICD-9 161; ICD-10 C32) (NCI, n.d.j). It is the 20th most common cancer
diagnosis. The incidence of laryngeal cancer increases with age; the age-adjusted
modeled incidence rate of laryngeal cancer for men 65 years and older (the age of
Vietnam veterans) for all races combined was 25.1 per 100,000 for 2000–2014.6
It is more common in men than in women and in blacks than in whites. Exposure
to tobacco smoke, paint fumes, metalworking fluids, and asbestos have been
associated with laryngeal cancer, as has alcohol and occupational exposures
6 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using SEER
18 dataset, choosing age-adjusted rates, laryngeal cancer, all races, male sex, and age ≥ 65 years.

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

256

VETERANS AND AGENT ORANGE: UPDATE 11

to wood dust and employment in the petroleum, plastics, and textile industries
(ACS, 2012a; IOM, 2006a).
Conclusions from VAO and Previous Updates
The original VAO committee reviewed five studies that presented data on
laryngeal cancers separately and concluded that “although the numbers are too
small to draw strong conclusions, the consistency of a mild increase in relative
risk is suggestive of an association for laryngeal cancer.” The weight of evidence
regarding laryngeal cancer has increased since the original VAO committee
review, particularly with the addition of epidemiological studies of workers
employed in manufacturing herbicides potentially contaminated with TCDD.
An elevated rate of laryngeal cancer deaths in workers who were exposed to any
phenoxyacetic acid herbicide or chlorophenol was found (SMR = 1.6, 95% CI
1.0–2.5, based on 21 deaths), especially in workers who were exposed to TCDD
or higher-chlorinated dioxins (SMR = 1.7, 95% CI 1.0–2.8, based on 15 deaths)
(Kogevinas et al., 1997). Ongoing updates have continued to indicate an increase
in laryngeal cancer in the occupational cohorts making up this IARC cohort. An
environmental study of residents of Chapaevsk, Russia, which was heavily contaminated by many industrial pollutants, including dioxin, showed an association
with laryngeal cancer in men (relative risk [RR] = 2.3, 95% CI 1.2–3.8) (Revich
et al., 2001).
Among the studies of Vietnam veterans, a positive association was found in
the study of veterans in Australia that compared mortality from laryngeal cancer with that in the general population (ADVA, 2005a) but not in the study that
compared Australian veterans who served in Vietnam with non-deployed soldiers
(ADVA, 2005c). In contrast, Watanabe and Kang (1996) found a statistically
significant 40% excess of mortality from laryngeal cancer in U.S. Army personnel deployed to the Vietnam theater. The AFHS did not have sufficient power to
detect whether an association existed. The New Zealand cohort of 2,783 Vietnam
veterans reported a total of five incident cases and two deaths from larynx cancers, but the study was insufficiently powered to provide reliable estimates (McBride et al., 2013). The Korean Veterans Health Study identified a large number
of incident cases (n = 157) and deaths (n = 82) from larynx cancer during a 20year follow-up (Yi, 2013; Yi and Ohrr, 2014; Yi et al., 2014a,b). Despite the large
sample size, the modestly increased risks of both incidence and mortality from
larynx cancer were not statistically significant. Although additional studies of
laryngeal cancers and exposure to the COIs have been reviewed, the update committees have continued to conclude that there is limited or suggestive evidence of
an association between exposure to at least one COI and laryngeal cancer.
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Update of the Epidemiologic Literature
No studies of Vietnam veterans and laryngeal cancer have been published
since Update 2014. Furthermore, no environmental or case-control studies of the
COIs and laryngeal cancer have been identified since Update 2012. Reviews of
the relevant studies are presented in the earlier reports. Table 8, which can be
found at www.nap.edu/catalog/25137, summarizes the results of studies related
to larangeal cancer.
Occupational Studies
Coggon et al. (2015) reported on mortality from laryngeal cancer as part of
their follow-up study that examined the carcinogenicity of phenoxy herbicides
among UK phenoxy herbicide manufacturers and sprayers. Fewer deaths than
expected from laryngeal cancer were found for all groups of workers, but none
of the estimates were statistically significantly different from the comparison
population: all workers (n = 7; SMR = 0.66, 95% CI 0.26–1.35), workers exposed
to herbicide levels above background (n = 7; SMR = 0.91, 95% CI 0.36–1.87),
and workers exposed for more than 1 year at levels above background (n = 3;
SMR = 0.84, 95% CI 0.17–2.44). These data do not support an association with
phenoxy herbicides and cancer of the larynx.
Other Identified Studies
One other study of laryngeal cancer was identified. However, it lacked sufficient exposure specificity to be included as contributing to the evidence base of
the potential effect of the COIs (Ruder et al., 2014).
Biologic Plausibility
Long-term animal studies have examined the effect of exposure to the COIs
on tumor incidence (Charles et al., 1996; Stott et al., 1990; Walker et al., 2006;
Wanibuchi et al., 2004). No increase in the incidence of laryngeal cancer in
laboratory animals after the administration of any of the COIs has been reported.
Synthesis
Overall, most reports reviewed in previous updates suggested an increased
risk of laryngeal cancer, although the individual studies often were based on small
numbers of cases and did not control for smoking. In addition, there is evidence
of an excess risk of laryngeal cancer among those who experienced chloracne—a
marker of high exposure to dioxins. The literature provides a reasonable level
of consistency regarding evidence of a moderate increase in the relative risk of
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laryngeal cancer. In larger occupational studies with good exposure characterizations that focus on the COIs, the associations are generally strong for laryngeal
cancer; however, in the extended follow-up time of the UK phenoxy herbicide
workers and sprayers, Coggon et al. (2015) found decreased risk estimates of
mortality from laryngeal cancer for all categories of exposure in workers. Studies
of Vietnam veterans have provided modest, generally not statistically significant,
associations.
Conclusion
Based on one additional study reviewed for the current update, the committee concurs with prior VAO committees and concludes that there is limited or
suggestive evidence of an association between exposure to at least one COI and
laryngeal cancer.
LUNG CANCER
Lung cancer (carcinoma of the lung or bronchus, ICD-9 162.2–162.9; ICD10 C34) is the second most common diagnosed cancer and the leading cause of
cancer death (accounting for about 26% of all cancer deaths) in the United States.
An estimated 234,030 people will receive diagnoses of lung cancer in the United
States in 2018, and 154,050 people will die from it (NCI, n.d.k). The principal
types of lung neoplasms are identified collectively as bronchogenic carcinoma
and carcinoma of the lung. Cancer of the trachea (ICD-9 162.0) is often grouped
with cancers of the lung and bronchus under ICD-9 162.2, but it is a rare cancer.
The lung is also a common site of metastatic tumors from other organ sites, but
only studies of primary cancer sites are reviewed.
The incidence of lung cancer increases with age, and the median age of diagnosis is 70 years. The age-adjusted modeled incidence rate of lung and bronchus
cancers for men 50–64 years old of all races combined was 83.3 per 100,000
in 2014 and increased to 298.6 for 65–74 year olds and 447.5 for men over 75
years. The increased incidence rate with age is similar for women, though not
as high as it is for men of the same age groups.7 The incidence of lung cancer is
consistently higher in black men than in white men, but slightly lower in black
women compared with white women. It is lowest among Hispanic men and
women (NCI, n.d.k).
Smoking is a major risk factor for lung cancer and increases the risk of all
histologic types of this disease, but the associations with squamous-cell and
small-cell carcinomas are the strongest. CDC’s 2014 Surgeon General report estimated that 82% of lung cancer deaths are attributable to cigarette smoking (CDC,
7 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using SEER
18 dataset and choosing age-adjusted rates, lung cancer, all races, age ≥ 65 years, and male sex.
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2014a). Other risk factors include exposure to asbestos, uranium, vinyl chloride,
nickel chromates, coal products, mustard gas, chloromethyl ethers, gasoline,
diesel exhaust, and inorganic arsenic. The risk posed by arsenic does not imply
that cacodylic acid, which is a metabolite of inorganic arsenic, can be assumed
to be a risk factor for lung cancer. Important environmental risk factors include
exposure to secondary tobacco smoke and radon (Lantz et al., 2013; NRC, 1999;
Samet et al., 2009).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was limited or
suggestive evidence of an association between exposure to at least one COI and
lung cancer. Additional information available to the committees responsible for
subsequent Updates did not change that conclusion.
The most compelling evidence of an association with lung cancer has come
from studies of heavily exposed occupational cohorts, including British 2-methyl4-chlorophenoxyacetic acid (MCPA) production workers (Coggon et al., 1986),
German production workers (Becher et al., 1996), a BASF cohort (Ott and Zober,
1996), a NIOSH cohort (Fingerhut et al., 1991; Steenland et al., 1999), and Danish production workers (Lynge, 1993). The methodologically sound AHS did not
show any increased risk of lung cancer. Although there was substantial 2,4-D
exposure in the AHS cohort (Blair et al., 2005b), the dioxin exposure of the
contemporary farmers was probably negligible. In large part, the environmental
studies have not been supportive of an association, although in the cancer-
incidence update from Seveso (Pesatori et al., 2009), the highest risks of lung
cancer occurredin the most exposed.
In studies of U.S. veterans, a significantly increased risk of lung-cancer risk
was found in ACC veterans who used herbicides in Vietnam (Cypel and Kang,
2010; Dalager and Kang, 1997), and an increased risk of lung cancer was associated with increased serum TCDD concentrations in AFHS Ranch Hand veterans
(Pavuk et al., 2005). The Australian cohort studies of Vietnam veterans (ADVA,
2005a,b,c), which presumably cover a large proportion of exposed soldiers,
showed higher than expected incidence of and mortality from lung cancer. The
main limitations of the Australian and American ACC studies are that there was
no assessment of exposure and that some potential confounding variables, notably
smoking, could not be accounted for. Additionally, the Korean Veterans Health
Study (Yi, 2013; Yi and Ohrr, 2014; Yi et al., 2014b) found modestly elevated, but
not statistically significant, relative risks of both lung cancer incidence and mortality compared with the general population and high- versus low-exposure groups.
The results were not adjusted for smoking, but earlier self-reported information
from a large portion of the cohort indicated that smoking behavior did not appear
related to the extent of a veteran’s exposure to herbicides.
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Despite evidence of an association with lung cancer incidence and mortality
in the male Vietnam veteran studies, data from the U.S. veteran women showed
no excess lung cancer mortality in comparison to the U.S. cohort of non-deployed
women or those from the U.S. general population. Similar results were observed
also among male Vietnam veterans in New Zealand. Despite their limitations,
these studies of Vietnam veterans are largely suggestive of modest associations
between herbicide exposure and lung cancer incidence and mortality.
Update of the Epidemiologic Literature
No new studies of Vietnam veterans (U.S. or international) and lung cancer
have been identified since Update 2014. No environmental or case-control studies
of the COIs and lung cancer have been identified since Update 2012. Reviews
of the relevant studies are presented in the earlier reports. Table 9, which can be
found at www.nap.edu/catalog/25137, summarizes the results of studies related
to lung, bronchus, or trachea cancer.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared with
the standardized U.S. population, two estimates were presented––all cancers
of the respiratory system combined (ICD-10 C30–C39) and also a subgroup of
bronchus, trachea, and lung cancers (ICD-10 C33–C34) (Collins et al., 2016). For
all cancers of the respiratory system combined, no differences in mortality were
found for the TCP workers (n = 77; SMR = 0.88, 95% CI 0.69–1.10) or the PCP
workers (n = 42; SMR = 1.05, 95% CI 0.76–1.42). Likewise, after restricting
the analysis to the subgroup of bronchus, trachea, and lung cancers, no differences in mortality was found for the TCP workers (n = 72; SMR = 0.86, 95% CI
0.67–1.08) or the PCP workers (n = 39; SMR = 1.02, 95% CI 0.73–1.40).
A recent analysis of lung cancer incidence was conducted using data collected from the U.S. AHS (Bonner et al., 2017). The sample included 57,310
pesticide applicators from Iowa and North Carolina who were enrolled in the
study between 1993 and 1997; vital status was updated through 2011. Exposure
was assessed by extensive questionnaire, allowing for estimates of intensity and
duration of exposure, and the information was updated from 1999 to 2005. In
the 43 pesticides chosen for assessment of risk, there was considerable variation
in the risk estimates associated with exposure estimates, with dicamba exposure estimated to be inversely related to lung cancer risk when modeled both
as quartiles of lifetime days of exposure and as quartiles of intensity-weighted
lifetime days of exposure and compared with the non-exposed group (p trend
= 0.007 and 0.001, respectively). Similar results were found for 5-year and 15year lagged lifetime-days of dicamba exposure presented as quartiles and again
compared with no exposure (p trend = 0.001 and < 0.001, respectively). Robust
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data collection allowed for an adjustment of confounders and common risk factors, including lag time from first exposure. However, the committee notes that
the authors did not control for multiple comparisons (although there is some disagreement in the literature concerning such methods), the number of lung cancer
cases is small, and the exposure data are based only on recall.
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et
al. (2015) reported deaths from lung cancer. Their analyses were not adjusted
for smoking status, but mortality from lung cancer was not elevated for any of
the groups of workers: all workers (n = 392; SMR = 1.01, 95% CI 0.91–1.11),
workers exposed to herbicide levels above background (n = 298; SMR = 1.07,
95% CI = 0.95–1.20), or workers exposed for more than 1 year at levels above
background (n = 138; SMR = 1.05, 95% CI 0.88–1.24).
Cappelletti et al. (2016) performed a retrospective study of 331 male electric
arc foundry workers at a single plant in Trentino, Italy, to determine if they experienced excess mortality from all causes, all cancers, and specifically respiratory
cancers or if they experienced increased risk for other morbidities. Their analysis
of the dust emissions found that the dust contained metals (including iron, aluminum, zinc, manganese, lead, chromium, nickel, cadmium, mercury, and arsenic),
PAHs, PCBs, and PCDD/Fs (reported as TEQs). Therefore, the authors could not
determine which of the agents were associated with a specific outcome or to what
extent. The men had worked at the factory for at least 1 year and, for the mortality analysis, were compared with the standardized general population of Region
Trentino-Alto Adige (where the factory was located) because there were few nonexposed foundry workers and high attrition rates. Company and medical records
were used to determine vital status; the cause of death was determined from death
certificates or other registries. The workers were followed from March 19, 1979
(or their first day of employment), through December 31, 2009, or date of death.
Compared with the general population, workers exposed for more than 1 year
were at increased risk of mortality from malignant tumors of the larynx, trachea,
bronchi, and lungs (reported as a group) (n = 8; SMR = 3.35, 95% CI 1.45–6.60,
p = 0.01). When workers were stratified by the number of years of exposure, there
were three individuals or fewer in each of the strata, resulting in large and imprecise
effect estimates, but none was statistically significant. This study is most limited
by the fact that foundry dust is a complex mixture, which results in an inability to
discern the impact of the specific contaminants of the foundry dust on the health
outcomes of those exposed workers. Estimates were only adjusted for age group
and not adjusted for other risk factors such as tobacco use, BMI, or other jobs or
activities that could result in similar exposures. Exposure to foundry dust by the
general population that was used for comparison is not discussed, although the
foundry appears to be in the local vicinity and emissions from it were reported to
be present in a 2-kilometer radius of it.
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Other Identified Studies
Two other studies of respiratory cancers were identified. The first lacked sufficient exposure specificity to be included as contributing to the evidence base of
the potential effect of the COIs (Ruder et al., 2014). The second study (Akahane
et al., 2017) examined the prevalence of self-reported long-term health effects
(including lung cancer) in people exposed to PCBs, dioxins (e.g., PCDD/Fs), and
dioxin-like chemicals through the ingestion of contaminated rice bran oil (Yusho
accident) compared with an age-, sex- and residential-area-matched group. Because no TEQs or other quantification of relevant exposures was presented, the
study was not considered further.
Biologic Plausibility
Long-term animal studies have examined the effect on tumor incidence of
exposure to each of the COIs: 2,4-D and 2,4,5-T (Charles et al., 1996), TCDD
(Walker et al., 2006), picloram (Stott et al., 1990), and DMA (Wanibuchi et
al., 1996, 2004). As noted in previous VAO reports, there is evidence of an increased incidence of squamous-cell carcinoma of the lung in male and female rats
exposed to TCDD at high concentrations (Kociba et al., 1978; Van Miller et al.,
1977). A significant increase in neoplastic and non-neoplastic lung lesions was
found in female rats exposed to TCDD for 2 years (Kociba et al., 1978; NTP,
1982a,b, 2006; Walker et al., 2006, 2007). The most common non-neoplastic
lesions were bronchiolar metaplasia and squamous metaplasia of the alveolar
epithelium. Cystic keratinizing epithelioma was the most commonly observed
neoplasm. The lung was also identified as a target organ in an NTP tumor-
promotion study, which examined the presence of tumors after 60 weeks of
exposure to TCDD in ovariectomized female Sprague Dawley rats initiated with
a single dose of diethyl-N-nitrosamine (Beebe et al., 1995; Tritscher et al., 2000).
Those studies reported increased incidences of alveolar epithelial hyperplasia
and alveolar–bronchiolar metaplasia—results that were similar to those found
in the earlier NTP studies (Tritscher et al., 2000). A study with female mice in
the lung-cancer-sensitive A/J strain background showed that estrogen exposure
increased lung tumor incidence significantly in ovariectomized mice treated with
a chemical carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK),
known to induce these tumors. However, TCDD exposure did not increase lung
tumor formation further in these ovariectomized and estrogen-treated mice (R. J.
Chen et al., 2014a). TCDD by itself had little lung tumor–promoting activity
in intact female A/J mice, but it exhibited a significant synergistic effect when
combined with a low dose of NNK. Cell-culture experiments suggested that the
TCDD effect was via the inhibition of apoptosis (R. J. Chen et al., 2014b). The
AHR has been implicated in both the chemical induction of lung tumors (Tsay et
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al., 2013) and the inhibition of their metastasis (Zhang et al., 2012) but has not
been linked specifically at this time to TCDD or the other COIs.
Cacodylic acid (DMAIII and DMAV) is carcinogenic, but results from studies
of DMA exposure and lung cancer in laboratory animals have not been consistent.
In the mouse lung, cacodylic acid (DMAV) was been shown to act as a tumor initiator (Yamanaka et al., 1996, 2009) and as a tumor promoter (Mizoi et al., 2005).
DMAV can also act as a complete carcinogen, inducing lung tumors in susceptible
strains of mice, including those with deficient DNA-repair activity (Hayashi et
al., 1998; Kinoshita et al., 2007). However, a 2-year study of F344 rats exposed
to cacodylic acid at 0–100 ppm and B6C3F1 mice exposed at 0–500 ppm failed to
detect lung neoplasms at any dose (Arnold et al., 2006). 2,4-D causes lung damage, and a recent report provided evidence that this effect occurs via disruption
of the microtubule network (Ganguli et al., 2014).
Synthesis
Epidemiologic findings for the incidence and mortality of lung, bronchus,
and trachea cancers have been suggestive of an association with exposure to the
COIs. The several toxicologic studies of mechanistic activity provide further support for the conclusion that the evidence of an association is limited or suggestive.
Since Update 2014, four occupational studies have been published. Three
of them extended the follow-up period of their respective, well-characterized
cohorts. Consistent with the prior follow-ups of the Dow Midland, Michigan,
plant workers, TCP workers had a slightly decreased risk of all respiratory
system cancers combined and also when restricted to only lung, bronchus, and
trachea cancers, but neither estimate was statistically significant. PCP workers
had slight but not statistically significant increased risks of all respiratory system
cancers combined as well as for lung, bronchus, and trachea cancers (Collins et
al., 2016). Among the UK factory workers or sprayers of phenoxy herbicides
who have been followed since 1947, Coggon et al. (2015) reported a slightly
increased, but not statistically significant, risk of lung cancer mortality for all
groups of workers; however, the analyses were not adjusted for smoking status.
Although it was a relatively small cohort of male steel workers, Cappelletti
et al. (2016) found that workers exposed for more than 1 year were at increased
risk of mortality from malignant tumors of the larynx, trachea, bronchi, and lungs
compared with the general population of the area. However, neither smoking nor
residential proximity to the plant was considered in the analysis.
An analysis of lung cancer incidence in the U.S. AHS found that dicamba
exposure, measured as both lifetime days and years of lag time, showed an inverse relationship with lung cancer (Bonner et al., 2017). However, the analysis
is limited by the small number of lung cancer cases and the fact that exposure
data are based only on recall.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the
committee concludes that there is limited or suggestive evidence of an association between exposure to at least one COI and carcinomas of the lung, bronchus,
and trachea.
BONE AND JOINT CANCERS
Primary bone and joint cancers (ICD-9 170; ICD-10 C40–C41) are relatively
rare, with an estimated 3,450 new diagnoses and 1,590 expected deaths in the
United States in 2018 (NCI, n.d.l). Primary bone and joint cancers refer to malignancies that originate in the bone joint; cancers that metastasize from another
site are excluded from the discussion. Bone and joint cancers are most commonly
diagnosed in persons less than 20 years of age, and these cancers are rare in adults,
including those in the youngest age group of Vietnam veterans (62–70 years).
Risk factors for bone and joint cancers in adults are gender, ethnicity, genetic and
familial factors, exposure to ionizing radiation in treatment for other cancers, and a
history of some non-cancer bone diseases, including Paget disease (Chung and
Van Hul, 2012; Ottaviani and Jaffe, 2009).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate
or insufficient information to determine whether there is an association between
exposure to the COIs and bone and joint cancers. Very few studies of bone and
joint cancers were conducted in veteran populations, and none found statistically
significant associations. Additional information available to the update committees, in general, did not have adequate power or detailed information concerning
exposures to the COIs to change that conclusion.
Update of the Epidemiologic Literature
Two studies that examined the prevalence of osteosarcoma (Akahane et al.,
2017) and the mortality outcomes of bone and joint cancers (Ruder et al., 2014)
have been identified since Update 2014. The first study examined the prevalence of a
variety of self-reported conditions, including osteosarcoma, in Yusho patients (known
to be exposed to PCBs, PCDD/Fs, and dioxin-like chemicals) and an age-, sex-,
and residence-matched comparison group. Because TEQs or other quantification of
relevant exposures were not presented, the study was not considered further. The
study by Ruder et al. (2014) lacked sufficient exposure specificity to be included as
contributing to the evidence base of the potential effect of the COIs. No environmental or case-control studies of exposure to the COIs and bone and joint cancers have
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been published since Update 2012. Reviews of the relevant studies are presented
in the earlier reports. Table 10, which can be found at www.nap.edu/catalog/25137,
summarizes the results of studies related to bone and joint cancers.
Biologic Plausibility
No animal studies have reported an increased incidence of bone and joint
cancers after exposure to the COIs.
Synthesis
There is a paucity of literature on bone and joint cancers to explain the biological plausibility or population-level risk from exposure to the COIs. This is
not surprising, given the low frequency of these tumors in the adult population.
The newly identified studies (Akahane et al., 2017; Ruder et al., 2014) either
lacked exposure specificity or a quantification of exposure and, therefore, were
not considered further by the committee.
Conclusion
Given the absence of new evidence for the current update, the committee
concurs with prior VAO committees and concludes that there is inadequate or
insufficient evidence to determine whether there is an association between exposure to at least one COI and bone and joint cancers.
SOFT-TISSUE SARCOMAS
Soft-tissue sarcomas (STSs) (ICD-9 164.1, 171; ICD-10 C38.0, C47, and
C49) arise within organs and in the tissue between organs, such as fat, muscle,
nerves, fibrous tissues, blood vessels, or deep skin tissues, and can be found
in any part of the body. There are more than 50 types of STSs, but the three
most common types are undifferentiated pleomorphic sarcoma (malignant fibrous
histiocytoma), leiomyosarcoma, and liposarcoma (ACS, 2018a). Because of the
diverse histological features of STS, accurate diagnosis and classification can be
difficult. The American Cancer Society estimated that 13,040 new diagnoses of
STS and 5,150 deaths were expected in the United States in 2018 (ACS, 2018a).
The incidence of STS increases with age. The age-adjusted modeled incidence rate of STS for men 65 years and older for all races combined was 15.4 per
100,000 for 2000–2014 and increases to 19.9 for men over 75 years. The increase
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in incidence rate with age is similar for women, but it is not as high as it is for
men of the same age groups.8
Among the risk factors for STS are exposure to ionizing radiation during
treatment for other cancers, some inherited genetic conditions (including neurofibromatosis and Li-Fraumeni syndrome), chronic conditions including lymphedema and immune deficiency (Kaposi sarcoma), and exposure to chemicals
such as phenoxyacetic acids (herbicides), and woods preservatives that contained
chlorophenols (Cormier and Pollock, 2004).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was sufficient epidemiologic data to support an association between exposure to the COIs and STS.
Additional information available to the committees responsible for subsequent
updates has reaffirmed that conclusion.
The available epidemiologic evidence suggests that phenoxy herbicides
rather than TCDD may be associated with developing STS. Some of the strongest evidence of an association between STS and exposure to phenoxy herbicides
comes from a series of case-control studies conducted in Sweden (Eriksson et
al., 1979, 1981, 1990; Hardell and Eriksson, 1988; Hardell and Sandström, 1979;
Wingren et al., 1990). The studies, involving a total of 506 cases, show an association between STS and exposure to phenoxy herbicides, chlorophenols, or both.
The VAO committee concluded that although those studies have been criticized,
there is insufficient justification to discount the consistent pattern of increased
risks in these well-designed and conducted studies. Furthermore, a reanalysis of
the data by Hardell (1981) to evaluate the potential influence of recall bias and
interviewer bias confirmed the original results. Other studies among male Danish
gardeners (Hansen et al., 2007) and forestry workers (Reif et al., 1989) also supported the association with STS. Case-control studies evaluating the association
between phenoxy herbicide and chlorophenol exposure and STS incidence and
mortality in New Zealand found the risk of STS to be elevated but not statistically
significant so (A. H. Smith et al., 1983, 1984; Smith and Pearce, 1986). Other
international case-control studies of STS and the COIs have been conducted in
England (Balarajan and Acheson, 1984), northern Italy (Vineis et al., 1986), and
Australia (Smith and Christophers, 1992).
Additional support for an association between exposure to the COIs and STS
comes from a NIOSH study showing increased risk for STS in those production
workers who were most highly exposed to TCDD (Fingerhut et al., 1991). Similarly, an increased risk of death 10–19 years after first exposure was seen in the
8 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the
SEER 18 dataset and choosing age-adjusted rates, soft-tissue sarcoma, all races, age ≥ 65 years, and
male sex, and using the modeled incidence rate.
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IARC cohort (Kogevinas et al., 1992; Saracci et al., 1991) according to a fairly
crude exposure classification. An updated and expanded study of the IARC cohort
by Kogevinas et al. (1997) found risk of STS was not statistically significantly
increased when follow-up was extended to 1992. The NIOSH and IARC cohorts
are among the largest and the most highly exposed occupational cohorts. Smaller
studies of workers that are included in the multinational IARC cohort—Danish
herbicide manufacturers (Lynge et al., 1985, 1993) and Dow production workers
in Midland, Michigan (Collins et al., 2009b), and in New Zealand ('t Mannetje et
al., 2005)—showed an increased risk of STS, but the results were often not statistically significant, possibly because of the small samples (related to the relative
rarity of STS in the population). Several studies have reported on STS in relation
to living near waste incinerators that release dioxin as a contaminant; each of
those studies found a statistically significant excess of STS, but none showed any
objective evidence of human exposure. No cases of STS have been reported in
zones A (highest exposure) and B (intermediate exposure) in the Seveso cohort
(Consonni et al., 2008); the incidence of STS was slightly, but not significantly,
increased in Zone R (lowest exposure) (Pesatori et al., 2009).
Case-control studies have also been conducted in various U.S. populations
looking for associations of herbicides with STS and other lymphohematopoietic
cancers (Hoar et al., 1986; Woods and Polissar, 1989; Woods et al., 1987) but no
statistically significant associations were reported for STS. Case-control studies
conducted among international populations have, for the most part, reported null
associations.
Studies of Vietnam veterans have not found significant increases in STS.
No increase was seen in Ranch Hand veterans (AFHS, 1996, 2000; Michalek
et al., 1990) or in VA studies of U.S. Vietnam veterans (Breslin et al., 1986,
1988; Bullman et al., 1990; Watanabe and Kang, 1995; Watanabe et al., 1991).
A nonstatistically significant increase in mortality from STS was seen in state
studies of veterans in Massachusetts, Michigan, and New York. A slight increase
in the incidence of STS was seen in Australian Air Force veterans compared with
the general Australian population but not in Army or Navy personnel (ADVA,
2005a), and no increase in mortality was seen in Australian veterans who served
in any of the military branches (ADVA, 2005b). No differences in incidence of or
mortality from connective and soft-tissue cancers was found in the New Zealand
veteran cohort (McBride et al., 2013), nor among the Korean veteran cohort (Yi
and Ohrr, 2014).
Update of the Epidemiologic Literature
No studies of Vietnam veterans or environmental studies of the COIs and
STS have been identified since Update 2014. Reviews of the relevant studies are
presented in the earlier reports. Table 11, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to STS.
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Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared with
the standardized U.S. population (Collins et al., 2016), few deaths from STSs
were reported (four among TCP workers and one among PCP workers), and risk
estimates for the total worker population were imprecise (SMR = 2.31, 95% CI
0.63–5.91). When examined by the specific dioxin congener and exposure level,
an increased risk for STS was found with increasing exposure level of TCDD,
but the test for trend was not statistically significant (p = 0.32). None of the
individual exposure-level risk estimates reached statistical significance, and all
estimates were imprecise. The one caveat the authors present is that they knew
that one of the four deaths at the highest exposure level of TCDD was determined
to be misclassified and, in fact, was not an STS. Because this determination was
discovered during the pathology review of an earlier study and the rest of the
cases in this study were not reviewed, this finding was ignored, and the death
was counted as an STS death. The authors concluded that any increased risk of
STS with TCDD should be interpreted with caution, given the small numbers of
cases of STS and the uncertainty of the diagnosis.
In an extension of the follow-up of UK phenoxy herbicide manufacturers and
sprayers to examine the carcinogenicity of phenoxy herbicides and their association primarily with HL, STS, and chronic lymphocytic leukemia, Coggon et al.
(2015) reported four cases of STS among all the workers. The highest risk estimate for STS was in workers with exposure above background and for more than
1 year (n = 3; SMR = 2.05, 95% CI 0.42–5.98), while the effect for all workers
regardless of the extent and duration of exposure was less than 1.0 (n = 4; SMR
= 0.92, 95% CI 0.25–2.36). Neither estimate was statistically significant, and
both were imprecise. A nested case-control analysis was performed within the
cohort that showed a protective effect for workers exposed to above background
levels for less than 1 year (OR = 0.77, 95% CI 0.17–3.50) but an increased risk
for workers exposed above background for more than 1 year (OR = 1.30, 95%
CI 0.30–5.62), but again both estimates were imprecise. Stratifying the w
 orkers
with above-background levels into low- and high-exposure groups resulted in
decreased and imprecise risk estimates (OR = 0.79, 95% CI 0.16–3.89 and
OR = 0.95, 95% CI 0.19–4.88, respectively). No clear link between phenoxy
herbicides and STS was observed in this study. The authors concluded that if
there is an association, it is very small, and it is unlikely that phenoxy herbicides
were responsible for the increased risk of STS.
Case-Control Studies
In a Finnish study, Tuomisto et al. (2017) compared the odds ratios for STS
calculated from survey data versus tissue TEQs for dioxin congeners. Previously,
the authors had performed a prospective study in which patients undergoing
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STS surgery or appendectomy (no cancer) consented to have a subcutaneous
fat sample taken at the time of surgery. Fat samples were tested for 17 PCDD/F
congeners. All participants filled out a survey regarding exposure history to wood
preservatives, fungicides and herbicides, and insecticides. The data were collected prospectively, and this analysis included 87 STS patients age-matched to
308 controls who underwent an appendectomy. When exposure information from
questionnaires was used to compute effect estimates, wood preservatives (n = 8;
OR = 6.7, 95% CI 1.4–33), fungicides and herbicides (n = 7; OR = 16.0, 95%
CI 1.9–138), and reported exposure to any of the chemical groups (n =15; OR =
7.0, 95% CI 2.2–22) were statistically significant but not precise. However, when
the exposure assessment was based on the actual levels of PCDD/Fs in the same
patients,none of the classes of chemicals were statistically significantly associated with STS. One reason for the differences between the survey results and
the objective measures in the fat samples may be that cancer patients are more
prone to recall bias than controls. A second factor for the difference in results
between questionnaires and tissue samples may be that the risk for STS is not the
contaminant dioxin, but rather the primary chemical exposure. Dioxin is poorly
absorbed and, in order to accumulate a high level, an individual is also likely to
have accumulated a high level of the primary chemical, which perhaps is more
likely to be the real carcinogen. The authors concluded that the number of cases
of STS was so low that it is unlikely that chlorophenols or phenoxy herbicides
were major risk factors for STS. While this study contradicts the earlier literature
supporting an association between exposure to the COIs and STS (Eriksson et
al., 1981, 1990; Hardell and Eriksson, 1988; Hardell and Sandström, 1979), it
has too few cases of STS to reverse the previous VAO committees’ conclusions.
This study does, however, demonstrate the strength of using tissue levels versus
questionnaires to overcome recall bias among cancer patients.
Other Identified Studies
One other study that reported on mortality of STSs was identified, but it
lacked sufficient exposure specificity to be included as contributing to the evidence base of the potential effect of the COIs (Ruder et al., 2014).
Biologic Plausibility
In a 2-year study, dermal application of TCDD to Swiss-Webster mice led
to an increase in fibrosarcomas in females but not in males (NTP, 1982b). There
is some concern that the increase in fibrosarcomas may be associated with the
treatment protocol rather than with TCDD. The NTP gavage study (NTP, 1982a)
also found an increased incidence of fibrosarcomas in male and female rats and
in female mice. No new mechanistic or biologic plausibility studies on STS have
been identified by VAO committees.
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Synthesis
Previous committees have concluded that the occupational, environmental,
and Vietnam-veteran studies showed sufficient evidence to link herbicide expo
sure to STS. Mechanistic data from animal studies continue to be sparse and not
compelling. Two new occupational studies that extended the follow-up period
of established cohorts (Coggon et al., 2015; Collins et al., 2016) reported small
numbers of STS cases and imprecise risk estimates, which do not provide enough
evidence to refute the previous conclusion that there are sufficient data to link
STS with one of the COIs. The findings from Tuomisto et al. (2017), which show
sizable differences in risk estimates when using questionnaires versus tissue
levels to determine exposure to the COIs, raise important methodological issues
for future studies.
STS is a rare tumor that is frequently misclassified. In a small study, even a
single death can have a large impact on effect estimates. The findings from the
three studies reviewed for the current update are not as supportive of an association between STS and the COIs. This may be due to flaws in design in earlier
studies, or it may reflect the possibility that the risk for this malignancy occurs
within a shorter latency period than other malignancies. Therefore, the conclusion
of sufficient evidence of an association between exposure to at least one of the
COIs and STS remains unchanged.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the
committee concludes that there is sufficient evidence of an association between
exposure to at least one of the COIs and STS.
SKIN CANCERS
Skin cancers are generally divided into two broad categories: malignant
melanoma (or simply melanoma) and non-melanoma skin cancers. The two most
common non-melanoma skin cancers are squamous-cell carcinomas, which are
derived from the squamous epithelium, and basal-cell carcinomas, which are derived from stem cells. Melanomas are derived from melanocytes. Non-melanoma
skin cancers have a far higher incidence than melanoma but are less likely to
metastasize and are more easily cured with primary resection.
The committee responsible for Update 1998 first chose to address melanoma
studies separately from those of non-melanoma skin cancers. Some researchers
report results by combining all types of skin cancers without specifying type.
Although there is a general supposition that high mortality figures refer predominantly to melanoma and high-incidence figures refer to non-melanoma skin
cancers, the committee believes that combined information is not interpretable,
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and therefore, it is interpreting data only when the results specify melanoma or
non-melanoma skin cancers.
Melanoma
Melanoma is the fifth most commonly diagnosed cancer; with an estimated
91,270 new diagnoses (ICD-9 172; ICD-10 C43) expected in the United States in
2018 accounting for 5.3% of all new cancer diagnoses. It is estimated that 9,320
people will die from melanoma in 2018 (NCI, n.d.m). Because non-melanoma
skin cancers are not required to be reported to registries, the estimated number of
cases is not as precise as those of other cancers. Although melanoma accounts for
less than 5% of skin cancer cases, it is responsible for about 75% of skin cancer
deaths (Siegel et al., 2017). The incidence of melanoma is higher in men than
in women and increases with age. The age-adjusted modeled incidence rate of
melanoma for men 50–64 years old of all races combined was 47.5 per 100,000
for 2000–2014 and increased to 118.3 for 65–74 year olds and 184.7 for men over
75 years. The increasing incidence rate with age is similar for women, though not
as high as it is for men of the same age groups.9
Melanoma occurs more frequently in fair-skinned people than in darkskinned people; the risk in whites is roughly 20 times higher than it is in blacks.
Other risk factors include the presence of large numbers of moles (> 50) or dysplastic nevi (also called atypical moles), having a suppressed immune system,
and excessive exposure to ultraviolet (UV) radiation, typically from the sun but
also from artificial sources, such as tanning beds. A family history of the disease
has been identified as a risk factor, but it is unclear whether that is attributable to
genetic factors or to similarities in skin type and sun-exposure patterns (Rastrelli
et al., 2014). There is a genetic predisposition to melanoma, known as BK Mole
syndrome (also called familial atypical multiple mole melanoma syndrome),
which is characterized by a mutation in the CDKN2A gene. In addition to the
dermal forms of melanoma, these tumors occur much more infrequently in various tissues of the eye.
Conclusions from VAO and Previous Update
The committee responsible for VAO concluded that there was inadequate
or insufficient information to determine whether there is an association between
exposure to the COIs and skin cancers. The Update 1998 committee considered
the literature on melanoma separately from that of non-melanoma skin cancers
and found that there was inadequate or insufficient information to determine
9 Modeled incidence rate as calculated on the site https://seer.cancer.gov/faststats/selections.
php?#Output using SEER 18 dataset and by choosing age-adjusted rates, melanoma of the skin, all
races, age ≥ 50 years, and male sex.
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whether there is an association between the COIs and melanoma. Additional
evidence reviewed by update committees has not changed the conclusion.
Few studies of melanoma among veteran populations have been conducted.
In a comparison of cause-specific mortality between the deployed and the nondeployed veterans who served in the U.S. ACC, a moderate but not statistically
significant increase in the risk of malignant skin cancer was observed in the
deployed cohort (Cypel and Kang, 2010). Few cases of melanoma were reported
among the AFHS participants, and when stratified by serum TCDD exposure
level, the risk estimates were elevated but imprecise and not statistically significant (Pavuk et al., 2005). An analysis using quartiles of years of service in
Southeast Asia also failed to find an association with melanoma among Ranch
Hands (Akhtar et al., 2004). Data from the final AFHS examination cycle indicate
that many more melanoma cases were diagnosed in the comparison veterans than
in the Ranch Hand subjects. Consequently, the committee responsible for Update
2006 (the report in which these studies were reviewed) recommended that a uniform TCDD-based analysis be performed on the on the most recent melanoma
data for all subjects in the AFHS (Pavuk, 2005). These data would possibly
support or contradict the suggestive findings of the Ranch Hand cohort (Akhtar,
2004). Such a comprehensive analysis of the most current melanoma data from
the AFHS has not yet been published.
In a study of 2,783 New Zealand veterans who served in Vietnam, both
melanoma mortality and incidence risk estimates were less than 1.0 but neither
was statistically significant (McBride et al., 2013). Likewise, findings from the
Korean Veterans Health Study showed that the incidence of melanoma in highexposed veterans was lower, but not to the point of statistical significance, than in
the low-exposed group, based on the calculated EOI scores (Yi and Ohrr, 2014).
No statistically significant difference was observed for melanoma mortality between high- and low-exposed groups.
Studies of mortality from melanoma related to occupational exposures have
also been reviewed. In TCP workers in New Zealand (McBride et al., 2009a) and
in the Dow cohort in Midland, Michigan (Collins et al., 2009b), no evidence of an
association between the COIs and melanoma was found. In evaluating the use of
specific pesticides and melanoma in the AHS, Dennis et al. (2010) found that only
an exposure to arsenic-based pesticides, among the COIs, was correlated with any
increase in risk, which was weak and not statistically significant. Updates of cancer
incidence in the Seveso cohort for the period 1977–1996 (Pesatori et al., 2009)
continued to provide evidence that melanoma is associated with exposure to TCDD.
Update of the Epidemiologic Literature
No new studies of Vietnam veterans (U.S. or international) and melanoma
or environmental studies of melanoma and the COIs have been identified since
Update 2014. Reviews of the relevant studies are presented in the earlier reports.
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Table 12, which can be found at www.nap.edu/catalog/25137, summarizes the
results of studies related to melanoma.
Occupational Studies Among the Dow Midland, Michigan, worker cohort that
was compared with the standardized U.S. population, Collins et al. (2016) found
only two deaths from malignant melanoma during the follow-up period. Although
the calculated estimate showed decreased risk, because of the few cases it is
unreliable and imprecise (SMR = 0.36, 95% CI 0.04–1.30), and no conclusions
should be made based on this finding.
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et
al. (2015) reported a total of seven deaths from melanoma among all the workers. Melanoma mortality was lower than expected for each of the three groups
of workers presented, but no estimates were statistically significant: all workers
(n = 7; SMR = 0.66, 95% CI 0.26–1.35), workers exposed to herbicide levels
above background (n = 6; SMR = 0.73, 95% CI 0.27–1.59), or workers exposed
for more than 1 year at levels above background (n = 2; SMR = 0.55, 95% CI
0.07–2.00). This study does not support an association between pheonxy herbicide exposure and melanoma.
Other Identified Studies Three other studies were identified that reported on
the outcomes of melanoma or skin cancer. The first was a mortality study of an
occupational cohort of capacitor manufacturers exposed to mixed PCBs as well
as several other chemicals and metals; this study lacked sufficient exposure specificity to be included as contributing to the evidence base of the potential effect
of the COIs and melanoma (Ruder et al., 2014). The second study was a welldesigned case-control study to examine the association of pesticide use and the
risk of cutaneous melanoma in Brazil (Segatto et al., 2015). Although a validated
structured questionnaire was used to collect detailed information on exposure factors (including domestic and occupational exposures to pesticides and herbicides,
frequency, types, and commercial names), only 3.5% of pesticide exposures
were to organochlorines, which were not specified further, and a small number
of participants (7 cases and 3 controls) reported exposure to herbicides, for
which an effect estimate was not provided. A third study (Akahane et al., 2017)
examined the prevalence of self-reported long-term health effects, including
skin cancer without further differentiation, in people exposed to PCBs, dioxins
(e.g., PCDD/Fs), and dioxin-like chemicals through ingestion of contaminated
rice bran oil (Yusho accident) compared with an age-, sex- and residential-areamatched group. Because no TEQs or other quantification of relevant exposures
was presented, the study was not considered further.
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Biologic Plausibility
TCDD and related herbicides have not been found to cause melanoma in
animal models. IARC considers DMA to be a Group 2B compound indicating
that it is possibly carcinogenic to humans (IARC, 2012a). In general, rodents,
which are used in most toxicology studies, are not a good model for studying
melanoma. As discussed elsewhere in this chapter, TCDD and DMA are known
tumor p romoters and could act as a promoter for skin cancer initiators, such as
UV radiation (Morikawa et al., 2005). Ikuta et al. (2009) examined the physiologic role of the AHR in human skin and theorized that over-activation can lead
to skin cancers, but they provided no evidence that melanoma incidence is
increased after TCDD exposure. Ahr has been shown to mediate UVB-induced
skin tanning in a murine model through an action on melanocytes (Jux et al.,
2011), which suggests that TCDD may affect skin pigmentation and potentiate
other pathways in the developmet of melanoma. Studies of human cells have also
confirmed a role of the AHR in the regulation of keratinocytes and melanocytes.
Kalmes et al. (2011) showed that AHR signaling in immortalized HaCaT cells
is associated with cell-cycle progression. Borland et al. (2014) found that peroxisome proliferator-activated receptor beta/delta is involved in AHR-mediated
tumorigenic activity in keratinocytes. In human melanocytes, Luecke et al. (2010)
demonstrated that TCDD exposure induced tyrosinase and tyrosinase-related
protein 2 gene expression—an indication that AHR signaling after TCDD exposure modulates melanogenesis. O’Donnell et al. (2012) further showed that the
activity of AHR was associated with the proliferation of melanoma cells. Finally,
a study of a Han Chinese population (X. W. Wang et al., 2012) has shown that
normal genetic variants of AHR are associated with the occurrence of vitiligo.
Studies reviewed here strongly suggest that AHR is associated with melanocyte
function and number in humans.
Synthesis
No association between the COIs and melanoma was observed in occupational studies that extended the follow-up period for their cohorts of interest
(Coggon et al., 2015; Collins et al., 2016). For both studies, the total number of
melanoma deaths in each cohort was less than five, leading to imprecise effect
estimates. Mechanistic data from animal studies are sparse and have not found
associations between the COIs and melanoma. As such, the committee maintains
the previous conclusion of inadequate or insufficient evidence to determine whether
there is an association between exposure to any one of the COIs and melanoma.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
melanoma (dermal or ocular).
Basal-Cell and Squamous-Cell Cancers (Non-Melanoma Skin Cancers)
Basal- and squamous-cell skin cancers are the most common type of cancer,
with an estimated 5.4 million basal and squamous cell skin cancers diagnosed
each year (occurring in about 3.3 million Americans since some people have
more than one). About 80% of these are basal-cell cancers. The incidence of these
cancers has been increasing for several years, and some possible explanations for
the increase are better skin cancer detection, people getting more sun exposure,
and people living longer (ACS, 2018b).
Excessive exposure to UV radiation is the most important risk factor for nonmelanoma skin cancers (ICD-9 173; ICD-10 C44); radiation exposure, HPV,immune suppression, and a family history of non-melanoma skin cancers have also
been identified as potential risk factors (Dubas and Ingraffea, 2013). Although
exposure to inorganic arsenic is recognized as a risk factor for non-melanoma
skin cancers (Bailey et al., 2010; Gilbert-Diamond et al., 2013), this does not
imply that exposure to cacodylic acid (DMA), which is a metabolite of inorganic
arsenic, can be assumed to be a risk factor. The relevance of aresenicals and DMA
to the committee’s charge are discussed in Chapter 4.
Conclusions from VAO and Previous Updates
Until Update 1998, all skin cancers were considered together, and the evidence of an association between the COIs and skin cancers was determined to
be inadequate or insufficient. Update 1998 and all subsequent updates through
Update 2014 concluded that there was inadequate or insufficient information,
based on new evidence of studies of veterans, occupational cohorts, and casecontrol studies, to determine whether there is an association between exposure
to the COIs and basal-cell or squamous-cell cancers.
Update of the Epidemiologic Literature
Since Update 2014, no additional environmental or case-control studies of
non-melanoma skin cancers and exposure to the COIs have been published. Reviews of the relevant studies are presented in the earlier reports. Table 13, which
can be found at www.nap.edu/catalog/25137, summarizes the results of studies
related to non-melanoma skin cancers.
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Vietnam-Veteran Studies Nosrati et al. (2014) performed a retrospective
medical chart review of 1,499 non-melanoma skin lesions from 1,024 patients
seen at a VA medical center from 2003 to 2013 in order to determine the rates
of spontaneous regression of residual tumor left behind after biopsy. In patients
with positive margins, the absence of tumor tissue in the re-resection sample
implies spontaneous regression. The authors hypothesized that Agent Orange–
induced tumors would behave more aggressively and be less likely to undergo
spontaneous regression. Agent Orange exposure was determined by participation in the Agent Orange Registry (n = 100). The overall regression rates for all
non-melanoma subtypes was 43% for the Agent Orange exposed and 41% for
unexposed; there was no difference between groups (p = 0.28).
Occupational Studies In an extension of the follow-up of UK phenoxy herbicide manufacturers and sprayers to examine the carcinogenicity of phenoxy
herbicides, Coggon et al. (2015) reported four deaths from “other skin” (not
melanoma) cancers among all the workers (SMR = 1.15, 95% CI 0.31–2.93). Two
deaths were reported among workers exposed to herbicide levels above background (SMR = 0.81, 95% CI 0.10–2.91), and no deaths were reported among
workers exposed for more than 1 year at levels above background. Because of
the small number of deaths, the effect estimates are imprecise, which limits their
interpretation. This study does not support an association between pheonxy herbicide exposure and non-melanoma/other skin cancer.
Other Identified Studies One other study that reported on the mortality of nonmelanoma skin cancers was identified, but it lacked sufficient exposure specificity
to be included as contributing to the evidence base of the potential effect of the
COIs (Ruder et al., 2014).
Biologic Plausibility
There are no new studies on animal models of skin cancers that are relevant
to this update. TCDD and DMA have been shown to produce non-melanoma
skin cancers in animal models (Morikawa et al., 2000; Wyde et al., 2004). As
discussed elsewhere in this chapter, TCDD and DMA are known tumor promoters
and each could act as a promoter for skin cancer initiators, such as UV radiation.
Synthesis
The two new studies of non-melanoma skin cancer do not support any
change in the conclusion of inadequate or insufficient evidence to determine
whether an association with exposure to at least one of the COIs exists. In the
study of veterans seen at a VA medical center, exposure was based on self-report
and participation in the Agent Orange Registry (Nosrati et al., 2014). Tumors
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among the Agent Orange–exposed participants were not more aggressive or less
likely to undergo spontaneous regression than those in the unexposed group. In a
study extending the follow-up period of UK men who worked in factories manufacturing or formulating a variety of phenoxy herbicides or who were contract
workers spraying the compounds, Coggon et al. (2015) reported small numbers
of non-melanoma skin cancer deaths (n = 4) among all workers, yielding unstable
and imprecise risk estimates that do not support an association between pheonxy
herbicide exposure and non-melanoma skin cancer. Although TCDD has been
previously shown to produce non-melanoma skin cancers in animal models
(Wyde et al., 2004), no new studies on animal models of skin cancers have been
published.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the
committee concludes that there is inadequate or insufficient evidence to determine whether there is an association between exposure to the COIs and basal-cell
or squamous-cell skin cancers.
BREAST CANCER
Breast cancer (ICD-9 174 for females, ICD-9 175 for males; ICD-10 C50
for both males and females) is the second most common type of cancer (after
non-melanoma skin cancers) in women in the United States (ACS, 2018c). For
2018, NCI estimated that in the United States, there would be 266,120 incident
cases of breast cancer and 40,920 deaths from it (NCI, n.d.n). Overall, those
numbers represent 15% of all new cancer diagnoses and 6.8% of all cancer
deaths. Breast cancer in men is much less common; the American Cancer
Society estimated that in 2018 in the United States, there would be 2,550 incident cases of and 480 deaths from breast cancer in men (ACS, 2018d).
Breast cancer incidence generally increases with age; the median age of diag
nosis is 62 years for females. In the age groups of most Vietnam veterans, the
incidence in men is higher in blacks than in whites, while in women the incidence
is generally higher in whites than blacks (NCI, n.d.n). The age-adjusted modeled
incidence rate of breast cancers for women 50–64 years old of all races combined
was 265.5 per 100,000 for 2000–2014 and increased to 448.6 for 65- to 74-yearolds and drops to 412.1 for women over 75 years.10 The roughly 5,000–8,000
female Vietnam veterans who were potentially exposed to herbicides in Vietnam
would now be menopausal. Given the high incidence of breast cancer in older and
10 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the
SEER 18 dataset, and choosing age-adjusted rates, breast cancer, female, all races, and the appropriate age range.
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postmenopausal women in general, it is expected on the basis of demographics
alone that the breast cancer burden in female Vietnam veterans will be increasing
in the near future.
The age-adjusted modeled incidence of breast cancers for men 65 years and
older for all races combined was 6.4 per 100,000 for 2000–2014.11 Breast cancer
incidence in men has increased over the past 30 years (Kamińska et al., 2015).
However, as the majority of breast cancer epidemiologic studies involve women,
although instances of male breast cancer are noted below when they have been
reported, the committee’s conclusions are based on the studies in women.
Established risk factors for women other than age include a personal or
family history of breast cancer, alcohol consumption, and some characteristics
of reproductive history, specifically early menarche, late onset of menopause,
and either no pregnancies or a first full-term pregnancy after the age of 30 years
(Kamińska et al., 2015). In a meta-analysis of studies on alcohol consumption and
female breast cancer, Corrao et al. (2004) reported that, in comparison to those
who never drank, light drinkers (≤ 1 drink/day or 12.5 g/day) had an elevated
pooled relative risk (RR = 1.25, 95% CI 1.20–1.29), and the risk was markedly
increased (RR = 1.55, 95% CI 1.44–1.67) for heavy drinkers (≥ 4 drinks/day or
50 g/day). Other post-menopausal lifestyle risk factors for breast cancer include
high BMI/obesity and physical inactivity. In addition, breast cancer risk is increased by the prolonged use of hormone-replacement therapy, particularly preparations that combine estrogen and progestins, whereas estrogen-only therapy
(only applied in women without a uterus) slightly decreased the risk (Anderson
et al., 2004; Chlebowski et al., 2003). The potential of other personal behavioral
and environmental factors (including the use of exogenous hormones) to affect
breast cancer risk is being studied extensively.
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate
or insufficient information to determine whether there is an association between
exposure to the COIs and breast cancer. The additional information available to
the committees through Update 2014 did not change that conclusion. Several
studies with positive, but mostly not statistically significant, findings in different populations and with different COI exposures have since been reviewed (for
example, updates from the Seveso Women’s Health Study, women employed at
an insecticide/herbicide plant in Hamburg, Dow’s Michigan plant cohort, the
NIOSH PCP cohort). However, due to the null findings on mortality from breast
cancer in the important cohorts of female Vietnam-era veterans (Cypel and Kang,
11 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by choosing
incidence by cancer site for the SEER 18 dataset and using age-adjusted rates, breast cancer, all races,
male sex, and selecting 65 years and older.
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2008; Dalager et al., 1995a; H. K. Kang et al., 2000b, 2014a; Thomas et al., 1991)
as well as other U.S. and foreign cohorts of male Vietnam veterans (ADVA,
2005b,c; CDVA, 1997; Yi and Ohrr, 2014) and the inconsistent findings of risk in
studies of the incidence of breast cancer in several occupational cohorts and the
Seveso study, the committees have maintained that breast cancer should remain
in the category of inadequate or insufficient evidence to determine whether there
is an association.
Update of the Epidemiologic Literature
No studies of breast cancer among Vietnam veterans or occupational cohorts
of exposure to the COIs and breast cancer have been published since Update
2014. Reviews of the relevant studies are presented in the earlier reports. Table
14, which can be found at www.nap.edu/catalog/25137, summarizes the results
of studies related to breast cancer.
Environmental Studies
Morgan et al. (2017) used 1999–2004 NHANES data to examine the asso
ciation between breast cancer and environmental exposure to PCBs, bisphenol
A (BPA), and phthalates. The study sample included women, ages 20–85 years,
who participated in NHANES by completing questionnaires and for whom data
were available on serum concentrations of PCBs and urinary phthalate and BPA.
Cases were defined as women who self-reported breast cancer, and controls were
chosen as those who had specifically responded that they did not have breast
cancer. The women were grouped by age for analysis (20–59 years, 60–74 years,
and 75 years and above). Serum levels of PCBs 74, 99, 118, 138, 153, and 180
were measured, as were the sums of dioxin-like PCBs (PCBs 74 and 118) and
non-dioxin-like PCBs for 2,007 women. Urinary BPA and seven urinary phthalate
metabolites were also analyzed (but the information is not presented, as these
chemicals are not related to the COIs). Concentrations of all individual PCBs and
sums of PCBs increased with age. When cases were compared with controls, the
age-adjusted geometric means for individual PCB concentrations were significantly higher in cases for the non-dioxin-like PCBs only. When stratified by age
groups, non-dioxin-like PCBs were significantly higher in cases versus controls
only for the 20- to 59-year age group. When examined by ethnic background,
the women with breast cancer who identified race as “other” had significantly
higher levels of all PCBs (including the dioxin-like PCBs) except PCB 180 in
comparison to non-Hispanic whites with breast cancer, with a geometric mean
(standard deviation) for PCB 74 of 27.4 (1.05) versus 13.5 (1.07), p < 0.05; and
for PCB 118 of 32.8 (1.01) versus 16.4 (1.21), p < 0.05. To further examine the
relationship of PCB concentration and breast cancer, cases and controls were
divided into two groups, PCB levels ranging from below the limits of detection
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to the 50th percentile (reference) and those above the 50th percentile (no cases
had PCB concentrations below the limits of detection). The geometric means of
the PCB concentrations were significantly higher in cases versus controls for all
PCBs, but when this model was adjusted for age, BMI, race/ethnicity, lactation,
and age of menarche, the concentrations of non-dioxin-like PCBs 138 and 180
were imprecise, but significantly associated with breast cancer. For comparisons
of the dioxin-like PCBs above the 50th percentile versus the reference, after full
adjustment in the model, neither PCB 74 (OR = 2.64, 95% CI 0.59–12.0) or PCB
118 (OR = 2.01, 95% CI 0.48–8.44) or their sum (OR = 1.58, 95% CI 0.29–8.53)
was statistically significantly associated with breast cancer. The authors then performed an analysis using the same reference group of women with PCB levels
from below the limits of detection to the 50th percentile (reference) and comparing them with two groups of higher PCB exposure: those between 50th and 75th
percentile and those above the 75th percentile. This model included adjuments for
age, BMI, and race/ethnicity, and only non-dioxin-like PCB 138 was significantly
associated with breast cancer in the 50th to 75th percentile (OR = 2.93, 95% CI
1.04–8.26) and the above 75th percentile groups (OR = 3.43, 95% CI 1.13-10.4).
For the dioxin-like PCBs, neither the 50th to 75th nor the above 75th percentiles
were statistically significant for PCB 74 (OR = 1.79, 95% CI 0.20–10.8 and OR =
1.65, 95% CI 0.24–11.4, respectively) or PCB 118 (OR = 1.27, 95% CI 0.21–7.79
and OR = 1.45, 95% CI 0.26–7.92, respectively). Likewise when the dioxin-like
PCBs were summed and entered into the fully adjusted model, no statistically
significant associations were found. Thus, in adjusted models that account for
known risk factors for breast cancer, dioxin-like PCB were not associated with
increased risk.
Danjou et al. (2015) reported findings from a prospective study of dioxin
exposure through dietary intake and risk of breast cancer using a subset of women
who participated in the French E3N study. Women in the E3N study were born
between 1925 and 1950 and, when enrollment began in 1990, were members of a
national teachers’ health insurance plan. Participants completed a dietary survey
in 1993 and were followed through 2008, with additional questionnaires on lifestyle, health status, and medical history completed every 2–3 years. The current
analysis was limited to 63,830 women who did not have a cancer diagnosis (except non-melanoma skin cancer) and for whom follow-up data were available (including height and weight). Women who had never menstruated were excluded.
The occurrence of breast cancer was ascertained by self-report from the health
questionnaires, but 92% of cases were confirmed by pathology reports. The study
team used the dietary questionnaires to calculate the amount and the frequency of
various food groups (meat, seafood, fruits and vegetables, eggs, dairy) consumed
by the individual women, and then dioxin levels in various foods were estimated
using a database from a large public health study that had measured dioxin levels
in various foods during a time period similar to that of the E3N study. During the
14.9 years of follow-up, there were 3,465 incident cases of breast cancer. The
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average daily dioxin exposure was 1.3+/− 0.4 pg TEQ/kg of bodyweight per day
(range 0.1–5.7), which is below the acceptable WHO level of 2.3 pg TEQ/kg
of bodyweight per day. Only 2.7% of the women in the study had higher levels
of exposure. Hazard ratios were calculated for pre- and post-menopausal breast
cancer risk per increased intake of 0.43 pg/kg/day (one standard deviation) and
per quartiles of estimated dietary dioxin exposure. No increased risk of breast
cancer was found. After adjusting for multiple factors, a decreased HR was found
for all types of breast cancer in postmenopausal women at the highest quartile
of exposure (HR = 0.77, 95% CI 0.54–1.06). For post-menopausal women in the
highest quartile of exposure, the HR for ER+/PR+ (estrogen and progesterone
receptor positive) tumors, corrected for multiple risk factors, was again decreased
(HR = 0.91, 95% CI 0.75–1.10). Moreover, among postmenopausal women there
was an inverse relationship between dioxin exposure and ER-/PR- breast cancer.
This finding is not unique and has been reported by others. Signaling through
AHR may have an antiproliferative effect, or the effect may depend on the timing
of exposure. The analysis by Danjou et al. was well powered, had a long length
of follow-up (which allowed for an adequate latency period), had few missing
data, and used validated questionnaires. Limitations include recall bias for dietary
history, the fact that the dioxin sampling did not include all foods consumed, and
the source of the food was not considered. Some food could have been more contaminated if grown or produced near dioxin sources. Estimates of dietary dioxin
exposure cannot be generalized to the French population as the exposure levels
are highly dependent on the food groups consumed. There was no increased risk
for breast cancer in this primarily postmenopausal group of women who were
apporoximate the age of the female Vietnam veterans. Most of the women had
low levels of exposure (below what WHO has reported as safe), and even the
women in the highest quartile of exposure (> 1.52 pg/kg of bodyweight per day)
did not have an increased risk for breast cancer.
Case-Control Studies
Arrebola et al. (2015) performed a case-control study of incident non-
metastatic female breast cancer cases in two cancer centers in Tunisia. In all,
69 cases were recruited and age matched to 56 female visitors, blood donors, or
staff from the two centers who served as the control group. Fasting serum was
obtained before any therapeutic intervention, and concentrations of multiple
chemicals including β-hexachlorocyclohexane (β-HCH), hexachlorobenzene,
heptachlor (a metabolite of dioxin), and oxychlordane were measured by gas
chromatography with micro-electron capture detection. Wet-basis models and
lipid-basis models were both performed with no reported difference in results.
Serum levels were presented in tertiles or, in the case of β-HCH, above or below
the limits of detection. Adjustments were made for age, age at menarche, reproductive history, breastfeeding history, tobacco and alcohol use, and BMI. Data
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were collected on occupational status, urban-versus-rural residence, education
levels, family history, and marital status. The cases were more likely to be less
educated, rural dwellers, and postmenopausal than the controls. Serum concentration levels of β-HCH and heptachlor were significantly higher in the cases:
β-HCH mean (standard deviation) 25.17 (57.74) ng/g lipid versus below limits
of detection in controls, p = 0.003; heptachlor, 22.49 (15.12) ng/g lipid versus
14.48 (14.86) ng/g lipid in controls, p = 0.001. In adjusted models, β-HCH (OR =
3.44, 95% CI 1.30–9.72) and the third tertile of hepatachlor (OR = 1.06, 95%
CI 1.00–1.15) were elevated, but the estimate for β-HCH was imprecise. When
heptachlor, β-HCH, and p,p’-DDE were included in a model that was adjusted
for covariates and used all three chemicals as continuous variables, only β-HCH
remained associated with elevated odds of breast cancer (OR = 1.18, 95% CI
1.05–1.34). The results suggest a potential relationship between β-HCH levels
and breast cancer, but the results should be interpreted with caution and require
verification. Heptachlor has dioxin-like properties and is the chemical in this
study most related to the COIs, but it was not associated with increased odds of
breast cancer in the most rigorous model, and therefore, this analysis does not add
sufficient data to the weight of the evidence regarding the association between
exposure to the COIs and female breast cancer.
Yang et al. (2015) conducted a hospital-based case-control study of women
in China to compare levels of organochlorine pesticides in serum and breast
adipose tissue and infiltrating ductal carcinomas. The women were recruited
over 19 months from 2005 through 2006, and the final study sample consisted
of 75 women with infiltrating ductal carcinoma, 79 women with benign conditions, and 80 healthy women (no breast conditions); the latter two groups
served as controls. Pesticide residues were measured and included 4 isomers
of 1,2,3,4,5,6-HCH (α,β,γ,δ), which exhibit dioxin-like properties, and other
organochlorine pesticides and metabolites. β-HCH was one of two residues
detected in the serum, and the concentration was statistically significantly
higher in the women with breast cancer than in the women with benign breast
disease or the healthy controls (3.42 mg/L versus 0.60 mg/L and 0.58 mg/L,
respectively, p < 0.05). β-HCH, pp’-DDE, and PCTA residues were detected
in breast adipose tissue, with the concentrations of β-HCH statistically significantly higher in the women with breast cancer than in the women with
benign breast tissue (219.34 mg/L versus 57.84 mg/L, p < 0.05). The serum
concentration of β-HCH increased with differentiation and was significantly
elevated for well-differentiated versus poorly-differentiated tumors (4.92 mg/L
and 2.32 mg/L, p < 0.05, respectively). β-HCH was significantly elevated in breast
adipose tissue in well-differentiated (303.6 mg/kg) compared with moderatelydifferentiated (214.0 mg/kg) and poorly-differentiated tumors (147.8 mg/kg)
(p < 0.05). When examined by estrogen receptor status, ER+ tumors had significantly higher levels of β-HCH in the breast adipose: 238.78 mg/k versus 141.92
mg/k (p < 0.05). The authors propose that organochlorine pesticides acting as
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endocrine disruptors upset the normal estrogen–progesterone balance contributing to breast cancer. The higher levels of organochlorine pesticide residues
in blood and breast adipose tissue imply an association with infiltrating ductal
carcinoma, but further work is needed to determine causality.
Other Identified Studies
Four other studies that reported outcomes of breast cancer were identified,
but all lacked sufficient exposure specificity to be included as contributing to the
evidence base of the potential effect of the COIs. The first study examined breast
cancer mortality in an occupational cohort of both women and men who worked
in capacitor manufacturing and who were exposed to mixed PCBs as well as
several other chemicals and metals, but no additional information was provided
regarding the specific PCBs or objective measures of exposure (Ruder et al.,
2014). Benedetti (2017) conducted an ecologic analysis to determine breast
cancer (and other cancer) incidence rates at 14 of Italy’s national priority contaminated sites and compared the rates among those sites. Although the known
exposures at these sites consisted of mixtures of PCBs, furans, benzene and other
solvents, arsenic, and cadmium, they were not measured or specified in enough
detail to indicate which of the COIs were present and to what extent. Finally, two
studies reported on breast cancer outcomes following the 1968 Yusho accident in
Japan, where people were exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxinlike chemicals through the ingestion of contaminated rice bran oil. Kashima et
al. (2015) compared mortality rates from breast cancer using an ecologic design
to define exposure (likely introducing selection bias) and did not use individual
serum samples or previously published measurements. Akahane et al. (2017)
examined the prevalence of self-reported long-term health effects, including
breast cancer, in people exposed via the Yusho accident compared with an age-,
sex- and residential-area-matched group. Because no TEQs or other quantification of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
The experimental evidence indicates that 2,4-D, 2,4,5-T, and TCDD are
weakly genotoxic at most. However, TCDD is a demonstrated carcinogen in
animals and is recognized as having carcinogenic potential in humans because
of the mechanisms discussed in Chapter 4. There is no evidence from carcinogenicity bioassays that TCDD causes breast cancer in laboratory animals (Baan
et al., 2009; IARC, 2012c). However, studies performed in laboratory animals
indicate that TCDD may modify the carcinogenic process in the mammary gland
and that the effect of TCDD may depend on the age of the animal. Toxicology
studies using different rat models have demonstrated that the fetal mammary
gland is highly sensitive to dioxin, and severe and persistent mammary-gland
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developmental abnormalities—including decreased ductal branching, delayed
epithelial migration into the fat pad, and fewer differentiated terminal end
buds—were evident after exposure to a single dose of dioxin during mammary
bud development (N. M. Brown et al., 1998; Fenton et al., 2002; Lewis et al.,
2001). For example, a single oral exposure of 50-day-old Sprague Dawley
rats to 10 μg/kg TCDD 3 days prior to a single administration of the chemical
carcinogen dimethylbenzanthracene (DMBA) was found to inhibit mammarytumor induction (Holcombe and Safe, 1994), while a single 2.5-μg/kg dose of
TCDD to 18-day-old rats slightly increased tumor induction when followed by
a single injection of the carcinogen methylnitrosourea (MNU) at 21 days of age
(Desaulniers et al., 2001).
In a 2015 review of the literature on TCDD and breast cancer, Fenton and
Birnbaum suggested a mechanism that may be related to endocrine disruption
and that might indicate a close association between the development of mammary cancers and mammary gland differentiation. Agents capable of disrupting
the ability of the normal mammary epithelial cell to enter or maintain its appropriate status (a proliferative, differentiated, apoptotic state), to maintain its
appropriate architecture, or to conduct normal hormone (estrogen) signaling are
likely to act as carcinogens, co-carcinogens, or tumor promoters for the breast
(Fenton, 2006; McGee et al., 2006). In that light, it is interesting that prenatal
exposure of rats to TCDD was found to alter the proliferation and differentiation
of cells in the mammary gland of the dams (Vorderstrasse et al., 2004) and of the
offspring (Birnbaum and Fenton, 2003). There is evidence that TCDD directly
targets mammary epithelial cells and the surrounding stromal fat cells during
pregnancy-induced mammary gland differentiation; this points to interference
with stromal–epithelial cross-talk as one of several underlying pathways (Lew
et al., 2011). Jenkins et al. (2007) used a rat carcinogen-induced mammary
cancer model to show that prenatal exposure to TCDD alters mammary gland
differentiation and increases susceptibility to mammary cancers by altering the
expression of estrogen-receptor genes and of genes involved in oxidative-stress
defense. Thus, the effect of TCDD may depend on the timing of the exposure
and on the magnitude of gene expression at the time of exposure; TCDD may
influence mammary-tumor development only if exposure to it occurs during a
specific window during breast development (Rudel et al., 2011). Susceptibility
to breast cancer appears to peak in utero and at puberty, which would not be
relevant for female Vietnam veterans, who were potentially exposed as adults.
This finding would only be relevant to the female child of a female veteran
exposed to the herbicides while pregnant, an unlikely scenario given that few
women were stationed in areas where herbicides were known to be sprayed and
that pregnant women were barred from duty in Vietnam. The breast is the only
human organ that does not fully differentiate until it becomes ready for use; nulliparous women have less-differentiated breast lobules, which are presumably
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more susceptible to carcinogenesis. Pregnancy is protective, particularly if carried to full term.
Activation of AHR by dioxin or by the non-dioxin ligand indole-3-carbinol
has also been shown to protect against experimental breast cancer by mechanisms
that disrupt migration and metastasis (Bradlow, 2008; Hsu et al., 2007). The administration of TCDD to mice that harbored highly metastatic murine breast-cancer
cells in the mammary fat pad reduced the rate of metastasis by 50% without suppressing primary tumor size—an indication that TCDD’s protective effects are
selective to the metastatic process (T. Wang et al., 2011). In addition, AHR agonists
inhibit the formation of lung metastases by ER-negative breast cancer cells (S.
Zhang et al., 2012). Hanieh (2015) and Hanieh et al. (2016) found that TCDD and
other AHR agonists suppressed pro-metastatic SOX4 in breast cancer cell lines.
However, Spink et al. (2013), using clones derived from the MCF-7 human breast
cancer cell line that express different levels of AHR, showed that in nude mice,
Ahr expression is not necessary for proliferation, migration, invasion, or tumor
growth of ER-positive MCF-7 cells and that the knock-down of Ahr in wild-type
MCF-7 cells did not affect the anti-proliferative effect of TCDD (Yoshioka et
al., 2012). Also, knock-down of AHR in triple-receptor-negative MDA-MB-231
cells inhibited their in vivo growth and metastases (Goode et al., 2013). Recently
Go et al. (2017) showed that 17b-estradiol promoted AHR-dependent CPY1A1
expression in MCF-7 clonal variant cells through an ER pathway. Collectively,
these findings suggest that there may be species differences, ER-specific mechanisms, ER-independent mechanisms, or carcinogenic process-specific effects of
AHR in breast carcinogenesis. It is possible that some protective effects may be
mediated through the known cross-talk between AHR and ERα, which has been
studied extensively at the molecular level for potential therapeutic benefit. There
is evidence to indicate that AHR controls ERα-regulated gene expression through
its effects on DNA methylation (Marques et al., 2013) or through the recruitment
of receptor-interacting protein 140 (RIP140), which can both activate and repress
ER actions (Madak-Erdogan and Katzenellenbogen, 2012). In the presence of
dioxin, AHR can repress specific estrogen-dependent genes in MCF-7 breast cancer cells (Labrecque et al., 2012) and in triple-receptor-negative MDA-MB-231
cells (Goode et al., 2014). TCDD can also activate AHR-mediated G1cell-cycle
arrest (Barhoover et al., 2010); however, in the presence of progesterone receptor,
TCDD enriches the G2/M phase and stimulates the proliferation of MCF-7 cells
(Y. J. Chen et al., 2012). Together, these results demonstrate a complicated interplay between the AHR and other nuclear transcription factors, including steroid
hormone receptors, which can either stimulate or inhibit breast cancer growth
in a manner that depends on cell context. The growth of MCF-7 cells as mammospheres appears to be negatively regulated by AHR (Zhao et al., 2012), but in
the context of an inflammatory microenvironment and HER2 overexpression, the
opposite effect has been reported (Zhao et al., 2013). Saito et al. (2017) found that
TCDD-activated AHR stimulated the estrogen-dependent progression of breast
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carcinoma by inducing aromatase expression under some conditions; although
AHR activation has also been shown to inhibit the ER pathway, the AHR-induced
aromatase activity persisted for a longer duration than the ER inhibition in three
breast carcinoma cell lines.
TCDD may affect breast carcinogenesis by silencing the Brca-1 tumor suppressor gene through promoter hypermethylation, thereby impairing DNA repair
(Papoutsis et al., 2012). TCDD has also been shown to modulate the induction
of DNA-chain breaks in human breast cancer cells by regulating the activity of
the enzymes responsible for estradiol catabolism and generating more reactive
intermediates, which might contribute to TCDD-induced carcinogenesis by alter
ing the ratio of 4-OH-estradiol to 2-OH-estradiol, a marker of breast cancer risk
(La Merrill et al., 2010; P. H. Lin et al., 2007, 2008). A similar imbalance in
metabolite ratios has been observed in pregnant Taiwanese women, in whom the
ratio of 4-OH-estradiol to 2-OH-estradiol decreased with increasing exposure to
TCDD (S. L. Wang et al., 2006). The expression of CYP1B1, the cytochrome
P450 enzyme responsible for 2-OH-estradiol formation, but not of CYP1A1, the
one responsible for 4-OH-estradiol formation, was found to be highly increased
in premalignant and malignant rat mammary tissues in which Ahr was constitutively active in the absence of ligand (X. Yang et al., 2008). On the basis of recent
mechanistic data, it has been proposed that AHR contributes to mammary-tumor
cell growth by inhibiting apoptosis while promoting the transition to an invasive,
metastatic phenotype (Marlowe et al., 2008; Schlezinger et al., 2006; Vogel et
al., 2011). There is also evidence showing that AHR activation by TCDD in
human breast and endocervical cell lines induces sustained high concentrations
of the IL-6 cytokine, which has tumor-promoting effects in numerous tissues,
including breast tissue, suggesting that TCDD might promote carcinogenesis in
these tissues (DiNatale et al., 2010; Hollingshead et al., 2008). Similarly, TCDD
induced IL-8 expression in an AHR-dependent manner and may contribute to
inflammatory breast cancer (Vogel et al., 2011). Degner et al. (2009) have shown
that AHR ligands can upregulate the expression of COX-2, which may lead to a
proinflammatory local environment that can support tumor development.
Synthesis
In the early 1990s it was suggested that exposure to some environmental
chemicals, such as organochlorine compounds, might play a role in the etiology
of breast cancer through estrogen-related pathways. The relationship between
organochlorines and breast cancer risk has been studied extensively, especially in
the past decade; TCDD and dioxin-like chemicals have been among the organo
chlorines so investigated.
Some well-designed environmental and case-control studies with good expo
sure assessment found statistically significant increased risk of breast cancer
(Bertazzi et al., 1993; Pesatori et al., 2009; Reynolds et al., 2005; Viel et al.,
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2008a; Warner et al., 2011). On the other hand, no increased risk of breast cancer
mortality was observed in the cohorts of female Vietnam-era veterans (Cypel and
Kang, 2008; Dalager et al., 1995a; Kang et al., 2014a; Thomas et al., 1991) and
Seveso residents (Consonni et al., 2008). The data on male breast cancer from
the Korean veterans study are sparse and imprecise mainly due to the very low
incidence of breast cancer in men (Yi and Ohrr, 2014). The findings of breast
cancer risk in follow-up studies of cancer incidence in Seveso were inconsistent (Pesatori et al., 2009; Warner et al., 2011). An increase in the SMR for
breast cancer was observed in the Hamburg cohort of workers exposed to dioxin
(Manuwald et al., 2012), while the study of the Dow 2,4-D production workers
had null findings (C. J. Burns et al., 2011).
The two new environmental studies do not support an association with
exposure to dioxin and breast cancer incidence (Danjou et al., 2015) or exposure
to dioxin-like PCBs and breast cancer (Morgan et al., 2017). The results of the
case-control studies were mixed. Arrebola et al. (2015) did not find an association
with dioxin-like chemicals, β-HCH and heptachlor, and breast cancer in adjusted
models. But C. Y. Yang et al. (2015) showed higher levels of β-HCH in the serum
of breast cancer patients versus controls as well as higher levels in ER+ versus
ER- tumors and well-differentiated versus poorly differentiated tumors. The authors propose a likely association between the endocrine disrupter organochlorine
pesticides in the breast adipose and serum and breast cancer. Furthermore, because several organochlorine residues, not considered relevant to this study, were
also measured and also found to have statistically significant positive associations
with ER+ and well-differentiated tumors, it is not clear which (or if all) of these
agents are responsible for the increased risk of breast cancer.
The main strength of these studies was the availability of organochlorine
pesticide levels in blood (Morgan et al., 2017; C. Y. Yang et al., 2015) and breast
adipose tissue (C. Y. Yang et al., 2015). The data from C. Y. Yang and colleagues
showing significantly elevated concentrations of β-HCH in well-differentiated
ER+ tumors aligned with the role of endocrine disrupters in breast cancer oncogenesis. However, Morgan et al. (2017) found a greater association with nondioxin-like PCBs than with dioxin-like PCBs and breast cancer. TEQ data were
not presented for the dioxin-like PCBs, and of the dioxin-like PCBs measured,
PCB 118, a mono-ortho is given low consideration as it contributes less than 10%
to total TEQs.
Biological mechanistic data from cell lines and non-primate animal models
have provided insight into a number of ways in which TCDD and related chemicals may interact with AHR, ER, aromatase enzyme, inflammatory cytokines,
DNA repair genes, and the stroma to modulate events leading to breast cancer.
Pre-clinical studies have shown that the timing of the exposure to the COIs is
critical, with in utero and pubertal breast tissue being most sensitive to carcinogenic effects. Data also suggest that AHR agonists are protective against breast
cancer via the modulation of signaling pathways involved in proliferation and

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

288

VETERANS AND AGENT ORANGE: UPDATE 11

metastases. Despite the advances in understanding the various effects of TCDD
and related chemicals on breast cell metabolism, there is no experimental evidence to support the hypothesis that TCDD by itself is a breast tissue carcinogen
or that it enhances breast carcinogenesis.
Conclusion
Having considered the new evidence and the results of studies reviewed in
previous updates, the present committee concludes that there is inadequate or
insufficient evidence to determine whether there is an association (either positive
or negative) between exposure to the COIs and breast cancer.
CANCERS OF THE FEMALE REPRODUCTIVE SYSTEM
This section addresses cancers of the cervix (ICD-9 180; ICD-10 C53),
endometrium (also referred to as the corpus uteri; ICD-9 182.0–182.1, 182.8;
ICD-10 C54), and ovary (ICD-9 183.0; ICD-10 C56). Additional cancers of the
female reproductive system that are infrequently reported separately are cancers
of the uterus not otherwise specified (ICD-9 179; ICD-10 C55), placenta (ICD-9
181; ICD-10 C58), fallopian tube and other uterine adnexa (ICD-9 183.2–183.9;
ICD-10 C57.0–C57.4), and other female genital organs (ICD-9 184; ICD-10 C57,
C58); findings on these cancers are included in this section. NCI estimates of the
numbers of new female reproductive-system cancers in the United States in 2018
are presented in Table 7-1; they represent roughly 12% of new cancer cases and
11% of cancer deaths in women (NCI, n.d.o–r).
Cervical cancer occurs more often in blacks than in whites, but endometrial
and ovarian cancers occur more often in whites. The incidence of endometrial and
ovarian cancers is higher in older women and in those who have family histories
of these cancers. The use of unopposed (without progestogen) estrogen-hormone
therapy and obesity, which increases endogenous concentrations of estrogen,
increases the risk of endometrial cancer. HPV infection, particularly infection
with HPV types 16 and 18, is the most important risk factor for cervical cancer
(McGraw and Ferrante, 2014).
The age-adjusted modeled incidence rate of female genital system cancers
(which includes the cervix uteri, corpus and uterus not otherwise specified, ovary,
vagina, and vulva) for women 50–64 years old of all races combined was 114.2
per 100,000 in 2015 and increased to 169.1 for 65–74 year olds and dropped to
147.3 for women over 75 years.12 The roughly 7,500 female Vietnam veterans
who were potentially exposed to herbicides in Vietnam would now be menopausal.
12 Modeled incidence rates as calculated on the site https://seer.cancer.gov/faststats/selections.
php?#Output by using the SEER 18 dataset and choosing age-adjusted rates, female genital system,
all races, and age groups 50–64, 65–74, and ≥ 75 years.
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TABLE 7-1 Estimates of New Cases and Deaths from Selected Cancers of the
Female Reproductive System in the United States in 2018
Site

Estimated Incidence

Estimated Deaths

Cervix
Endometrium
Ovary
Vagina and other female genital

13,240
63,230
22,240
6,190

4,170
11,350
14,070
1,200

SOURCES: NCI, n.d.o–r.

Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate
or insufficient information to determine whether there is an association between
exposure to the COIs and female reproductive cancers. Additional information
available to the committees responsible for subsequent updates through Update
2014 has not changed that conclusion.
Results from three cohorts of U.S. female veterans who were followed for
overall and specific-cause mortality from 1992 through 2010 (H. K. Kang et al.,
2014a) were reviewed in Update 2014. Among the three cohorts of U.S. women
veterans—those who served in Vietnam (n = 4,734), those who served in countries near Vietnam (n = 2,062), and those who did not deploy (n = 5,313)—very
few deaths from cervical cancer were observed: five among those who served
in Vietnam, one among those who served near Vietnam, and six among those
who were non-deployed. Compared with the general population of U.S. women,
SMRs were lower for each cohort (SMRs between 0.27 and 0.65) but the esti
mates were imprecise due to the small number of cervical cancer deaths. In
comparison with non-deployed female Vietnam-era veterans, those who served in
Vietnam had no excess cervical cancer mortality. A further analysis restricted to
female nurses, again using the non-deployed cohort as the referent, yielded virtually the same nonstatistically significant risk of mortality from cervical cancer.
Similarly, there were also very few observed uterine cancer deaths of women who
served in Vietnam, served near Vietnam, or were non-deployed, with 9, 4, and
12 deaths, respectively, and no excess risk of uterine cancer mortality was found
in any of the three cohorts when compared with the general population. In the
internal comparison to non-deployed Vietnam-era veterans, uterine cancer mortality was not associated with service in Vietnam or near Vietnam. Similar results
were observed in the analysis restricted to only nurses. There were more deaths
from ovarian cancer in the entire cohort, but no differences in the risk of ovarian
cancer mortality were found among those who served in Vietnam, served near
Vietnam, or were non-deployed in comparison with the general population of U.S.
women. In the internal comparison with the non-deployed veterans, ovarian cancer
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mortality was increased among Vietnam veterans and among women who served
near Vietnam, but neither was statistically significant. An analysis restricted to
nurses revealed similar patterns of increased (albeit not statistically significant)
ovarian cancer mortality, both for veterans who served in Vietnam and for veterans who served near Vietnam, when compared with non-deployed nurses.
Update of the Epidemiologic Literature
Relevant studies on cancers of the female reproductive system include the
cervix, uterus, ovary, and vagina. No studies of female reproductive cancers
among Vietnam veterans have been published since Update 2014. No occupational cohort, environmental, or case-control studies of exposure to the COIs and
female reproductive cancers have been published since Update 2012. Reviews
of the relevant studies are presented in the earlier reports. Tables 15, 16, and 17,
which can be found at www.nap.edu/catalog/25137, summarize the results of
studies related to female cervical, uterine, and ovarian cancer.
Other Identified Studies
Three studies that reported outcomes of uterine or ovarian cancer were identified, but all lacked sufficient exposure specificity to be included as contributing
to the evidence base of the potential effect of the COIs. The first study examined
mortality from malignant neoplasms of female genital organs in an occupational
cohort of capacitor manufacturers who were exposed to mixed PCBs as well as
to several other chemicals and metals, but no additional information was provided regarding the specific PCBs or objective measures of exposure (Ruder et
al., 2014). Two studies reported on mortality from (Kashima et al., 2015) or the
prevalence of (Akahane et al., 2017) uterine or ovarian cancer outcomes related
following the 1968 Yusho accident in Japan, where people were exposed to
PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion
of contaminated rice bran oil. Both lacked the necessary exposure specificity to
be considered further.
Biologic Plausibility
Yoshizawa et al. (2009) showed that the chronic administration of TCDD and
other AHR ligands to adult female Harlan Sprague Dawley rats results in chronic
inflammation and an increased incidence of reproductive-tissue preneoplasia
and tumors, including cystic endometrial hyperplasia and uterine squamous-cell
carcinoma. The mechanism of action might be related to endocrine disruption
and chronic inflammation. Qu et al. (2014) observed increased mRNA and protein
expression of AHR in human endometrial cancer tissue and human endometrial cancer cell lines (Ishikawa and ECC-1) compared with nonmalignant
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endometrium; increased AHR expression in human endometrial cancer tissue
compared to nonmalignant tissue has also been reported by D. Li et al. (2013).
Qu et al. (2014) showed that a polycyclic hydrocarbon known to be an AHR
ligand inhibited the proliferation of Ishikawa and ECC-1 cells mediated in part
by AHR. Wormke et al. (2000) reported that TCDD inhibited the proliferation
of Ishikawa endometrial cancer cells stimulated by estradiol and also reduced
estrogen receptor activity, but increased AHR-mediated gene expression in
these cells, suggesting that the estrogen receptor, not the AHR, mediates the antiproliferative effect of TCDD in the Ishikawa endometrial cancer cells. Y. Li et
al. (2014) showed that TCDD-AHR activation inhibited cell proliferation in
human ovarian cancer (OVCAR-3) cells. Hollingshead et al. (2008) showed
that TCDD activation of AHR in human breast and endocervical cancer cell lines
induces sustained high concentrations of the IL-6 cytokine. It is noteworthy that
the effects of TCDD treatment differed between MCF-7 breast cancer cells and
ECC-1 endometrial carcinoma cells with respect to the activation and repression
of genes; this illustrates the role of cell context and organ specificity in responses
to TCDD by cancer cells (Labrecque et al., 2012).
Synthesis
Compared with other cancer types, relatively few studies have reported on
associations between any of the COIs and female reproductive cancers. The most
relevant evidence came from a follow-up study on mortality among female U.S.
Vietnam-era veterans that was reviewed in Update 2014. For both cervical and
uterine cancers there was no evidence of increased mortality risk; however, the
small observed number of deaths for these outcomes in all three cohorts limited
the statistical power of the associations. With regard to ovarian cancer, there
was some evidence of a slightly elevated mortality in veterans who served either
in or near Vietnam, but for both risks the CIs were large and their point estimates
imprecise. However, because the rate of ovarian cancer mortality was similar
between veterans who served in Vietnam (with potential exposure to herbicides)
and those who served near Vietnam (who presumably were not so exposed), this
evidence is equivocal.
Most findings from occupational cohorts and environmental studies for
which exposure was well characterized have not found increased risks for cervical, uterine, or ovarian cancers. Follow-ups of the Seveso cohort (where residents
were exposed to TCDD following an explosion of the chemical plant) have not
found increased incidence of or mortality from uterine cancer (Bertazzi et al.,
2001; Consonni et al., 2008; Pesatori et al., 2009). No new studies with sufficient
exposure specificity were identified for the current update.
The results of mechanistic studies provide more plausibility for a reduced risk
of female reproductive cancers than for an increased risk. Therefore, the conclusion
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of inadequate or insufficient evidence of an association between the COIs and
uterine, ovarian, or cervical cancers remains unchanged.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the committee concludes that there is inadequate or insufficient evidence to determine
whether there is an association between exposure to the COIs and uterine, ovarian, or cervical cancers.
PROSTATE CANCER
The prostate gland lies just below the urinary bladder and surrounds the
urethra. It makes fluid that forms part of semen. NCI estimated that 164,690 new
cases of prostate cancer (ICD-9 185; ICD-10 C61) would be diagnosed in the
United States in 2018 and that 29,430 would die from it (NCI, n.d.s). That makes
prostate cancer the second most common cancer in men (after non-melanoma
skin cancers); it is expected to account for about 9.6% of all new cancer diag
noses and 4.4% of all cancer deaths in 2017. The incidence of and mortality from
prostate cancer varies widely with age and race. The incidence rate of prostate
cancer for all races combined more than doubles from the ages of 50–64 years
(207.3 per 100,000) to the ages of 65–74 years (579.5 per 100,000). The incidence rate of prostate cancer for men aged 75 years and older decreases slightly,
but remains high (432.7 per 100,000). As a group, African American men have
the highest recorded incidence of prostate cancer in the world (Jemal et al., 2011);
their risk is roughly 40% higher than that of whites in the United States and three
times that in “American Indians/Alaska natives” (NCI, n.d.s).
Little is known about the causes of prostate cancer. Other than race and age,
the risk factors include a family history of the disease both in first- and seconddegree relatives (Bruner et al., 2003; Zeegers et al., 2003). A review of occupational factors found heavy metals, PCBs, and PAHs to be associated with prostate
cancer but did not specify particular pesticides (Doolan et al., 2014). There is
some evidence that some elements of the Western diet, including a high consumption of red meat and saturated fats, may be a risk factor for prostate cancer,
but these have not been conclusively identified. Of note, selenium and vitamin
E supplementation did not reduce, but rather slightly increased, prostate cancer
incidence in a large clinical trial (Klein et al., 2011; Kristal et al., 2014; Lippman
et al., 2009), and soy protein supplementation did not prevent the recurrence of
prostate cancer after surgical treatment in a randomized study (Bosland et al.,
2013). The 5α-reductase inhibiting drugs finasteride and dutasteride, which are
widely used to treat benign enlargement of the prostate, were found to decrease
the prevalence of prostate cancer by about 25% in two major randomized trials
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(Andriole et al., 2010; Thompson et al., 2003); however, in the finasteride trial,
the risk of high-grade prostate cancer was increased. Finasteride acts by decreasing the formation of the potent androgen metabolite 5α-dihydrotestosterone in
the prostate.
Study of the incidence of and mortality from prostate cancer is complicated
by various approaches to screening for the disease in different countries and
populations. The widespread adoption of serum prostate-specific antigen (PSA)
screening in the 1990s led to very large increases in reported prostate cancer
incidence in the United States, which have recently subsided as exposure to the
screening has become saturated. However, PSA screening has recently come
under scrutiny and is no longer uniformly recommended or consistently applied
in the United States, following a D grade recommendation from the U.S. Preventive Services Task Force in 2012 (Moyer et al., 2012).
Prostate cancer tends not to be fatal in many cases (NCI estimates a 98%
5-year survival rate), particularly for screening-detected (i.e., localized stage/
well-differentiated grade) prostate cancer, so mortality studies may miss an
increase in the incidence of the disease and thus potentially misclassify the
outcome. In addition, findings that show an association between an exposure
and prostate cancer mortality should be examined closely to determine whether
the exposed group had poorer access to screening or treatment that would have
decreased the likelihood of survival.
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was limited or suggestive evidence of an association between exposure to the COIs and prostate
cancer, based on positive associations observed in occupational and environmental
studies. Additional information from various epidemiologic studies—including the
AFHS and ACC, veterans seen in VA medical facilities, and occupational cohorts
of phenoxy chemical factory workers and pesticide applicators from the AHS—
reviewed in subsequent updates has not changed that conclusion.
Four studies of prostate cancer and Vietnam veterans were reviewed in Update 2014, two among veterans at VA medical facilities and two international
cohort studies of male Vietnam veterans from New Zealand and Korea. A study of
U.S. Vietnam veterans who were referred to the Portland VA Medical Center with
an elevated serum PSA and who underwent an initial prostate biopsy reported
a statistically significant association between herbicide exposure (7.5% of cases
classified as herbicide-exposed) and the overall risk of prostate cancer after adjustment for age and the receipt of screening (Ansbaugh et al., 2013). Stratifying
tumors by grade and characteristics led to a stronger association between herbicide exposure and intermediate- to high-grade prostate cancer and an even stronger association with more aggressive prostate cancer. Although this study had a
relatively large sample size, it is limited by uncertainty about individual exposure
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levels and potential selection/referral bias because men who were referred for
prostate biopsy probably had an elevated PSA and could possibly have had better
access to health care in comparison with other veterans.
A small study using VA administrative databases to determine the relationship between herbicide exposure (determined by self-report and military records
confirming that Vietnam veterans had served in an area in which herbicides had
been sprayed) and a biochemical recurrence of prostate cancer during an average
of 5.3 years of follow-up after prostatectomy was conducted (Q. Li et al., 2013).
Subcutaneous adipose tissue was obtained during prostatectomy and assayed for
dioxin, and the measured TEQ levels of the 37 men with self-reported herbicide
exposure were statistically significantly higher than those of the 56 men who did
not report exposure. The proportions of men with biochemical recurrence were
not statistically significantly higher for the veterans with self-reported herbicide
exposure than for those who did not report exposure or for those with higher TEQ
levels compared with those with lower TEQ levels.
In a follow-up study of 2,783 male New Zealand veterans who had served
in Vietnam and were still alive as of 1988, McBride et al. (2013) reported that
the incidence of prostate cancer was slightly but not statistically significantly
increased among the veterans; the difference from the general male population of
New Zealand was not statistically significant, nor was the rate of prostate cancer–
specific mortality. No information on potential confounding factors was included.
Among Korean veterans who served in Vietnam, a total of 125 incident cases
and 53 deaths from prostate cancer were identified during the follow-up period in
the cohort studied by Yi and colleagues (Yi, 2013; Yi and Ohrr, 2014; Yi et al.,
2014b). When compared with the general Korean population, there was a 22%
statistically significant excess prostate cancer risk in the entire cohort (Yi, 2013),
which was mostly due to a significant 2.5-fold elevated prostate cancer incidence
among officers. In the internal comparison analysis, Yi and Ohrr (2014) reported
an inverse association between the EOI scores and prostate cancer incidence,
which was based on 53 cases in the high-exposure category. Yi and Ohrr (2014)
did not stratify incident prostate cancer cases according to tumor characteristics
(low- versus high-grade tumors) as is usually done in studies of prostate cancer
incidence. Similarly, Yi et al. (2014b) reported a similar inverse association when
examining exposure potential and prostate cancer–specific mortality.
Update of the Epidemiologic Literature
Several new studies reporting associations of prostate cancer or surrogate
measures and the COIs were identified. Reviews of the relevant studies are
presented in the earlier reports. Table 18, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to prostate cancer.
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Vietnam-Veteran Studies
Ovadia et al. (2015) conducted an analysis of the relationship between
self-reported Agent Orange exposure (veterans submit a claim of exposure that
is reviewed by VA using service records to confirm whether the veteran was
stationed in an area that was sprayed with herbicides during the service period)
and long-term outcomes among prostate cancer patients. Data for this analysis
were drawn from the Shared Equal Access Regional Cancer Hospital database
of 1,882 men undergoing radical prostatectomy for prostate cancer between
1988 and 2011 at six VA health care facilities; 333 men (17.7%) were considered Agent Orange exposed. The clinical outcomes reported included pathologic
Gleason Score, pathologic stage, and postoperative pathologic and treatment
characteristics and prostate cancer–specific death. Cox proportional hazards
regression modeling was used to assess the relationship between exposure to
Agent Orange and biochemical recurrence, secondary treatment, metastases, and
prostate cancer–specific mortality. Models were adjusted for age, race, clinical
stage, PSA level, BMI, center, and biopsy Gleason sum. Agent Orange exposure
was not found to be associated with biochemical recurrence (HR = 1.21, 95% CI
0.99–1.49), secondary treatment (HR = 1.21, 95% CI 0.97–1.5), metastases (HR =
0.93, 95% CI 0.30–2.66), or prostate cancer–specific mortality (HR = 0.89, 95%
CI 0.46–1.85). The study was generally well conducted, with excellent clinical
data and follow-up available within the VA system. Although Agent Orange expo
sure included an additional level of service location verification to self-report,
this measure is still only a proxy for actual initial and subsequent exposure levels.
However, a previous study by Q. Li et al. (2013) of 93 men showed good correlation between self-reported Agent Orange exposure and dioxin TEQ levels in
adipose tissue. The study’s negative results may be applicable to the relationship between Agent Orange and prostate cancer progression, but do not directly
address initiation and incidence.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared with
the standardized U.S. population, Collins et al. (2016) found no differences in
mortality from prostate cancer for either the TCP workers (n = 21; SMR = 1.01,
95% CI 0.62–1.54) or the PCP workers (n = 11; SMR = 1.05, 95% CI 0.53–1.87).
In a well-designed and conducted study and analysis, Christensen et al.
(2016) examined the interactions among pesticide exposure, single nucleotide
polymorphisms (SNPs) of genes in the steroid hormone synthesis, metabolism,
or regulation pathway, and the risk of prostate cancer. Interactions with 39 pesticides were examined using 776 cases and controls nested in the AHS cohort of
private and commercial pesticide applicators. A total of 1,117 SNPs (in 56 genes)
were evaluated. Cases were diagnosed from the period 1993–2004. Controls were
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pesticide applicators frequency-matched 2:1 to cases by age. Lifetime pesticide exposure information was obtained from multiple surveys. Several pesticide exposure
metrics were constructed for each pesticide based on the duration and frequency
of pesticide exposure. Estimates were adjusted for age and the study site; other
covariates of smoking, BMI, and physical activity were also included but did not
change the effect estimates. The final analysis included 39 pesticides. Only one
multiple-comparisons corrected herbicide–SNP interaction was found—between
the herbicide dicamba and a SNP in the testosterone metabolizing gene SRD5A. In
the cohort, no association for 2,4-D or 2,4,5-T was found, and it appears there are
no SNP interactions with these two herbicides. The results suggest that a genetic
variation may decrease the risk of prostate cancer with exposure to dicamba.
However, this finding requires replication and is not directly useful in drawing any
conclusions about the significance of potential positive associations of COIs and
prostate cancer.
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et al.
(2015) reported deaths from several types of cancer. Prostate cancer was slightly
elevated but was not statistically significant for any of the groups of workers: all
workers (n = 120; SMR = 1.10, 95% CI 0.91–1.32), workers exposed to herbicide
levels above background (n = 89; SMR = 1.14, 95% CI 0.92–1.14), or workers
exposed for more than 1 year at levels above background (n = 43; SMR = 1.15,
95% CI 0.83–1.55).
Environmental Studies
In a well-designed and conducted nested case-control study, Koutros et
al. (2015) used prospectively collected serum to estimate associations between
organocholorine exposures and metastatic prostate cancer in a population-based
cohort from Norway. The study sample was identified from the Janus Serum
Bank cohort, a population-based research biobank consisting of almost 317,000
individuals with an average age at enrollment of 41 years. The Janus cohort was
linked with to the Cancer Registry of Norway to identify new cases of prostate
cancer. Only metastatic prostate cancer cases were included to avoid possible
detection bias associated with PSA testing. Eligible cases consisted of incident
metastatic prostate cancer cases with no history of cancer (except non-melanoma
skin cancer) who were diagnosed from enrollment through December 31, 1999,
and were diagnosed at least 2 years after serum collection. Controls (up to six per
case) were randomly selected male members of the cohort who had no history
of cancer (except for non-melanoma skin cancer) at the time of their matched
case’s diagnosis. Cases (n = 150) and controls (n = 314) were matched on date
of blood draw (1-year strata), age at blood draw (2-year strata), and region. Sera
concentrations of 11 organochlorine pesticide metabolites and 34 PCB congeners
(including five dioxin-like congeners PCB 118, PCB 156, PCB 157, PCB 167,
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and PCB 189) were analyzed for cases and their matched controls in the same
laboratory batch. Demographic data and other covariates, including BMI, as well
as smoking habits were obtained from baseline questionnaire data at the National
Institute of Public Health, and census data were obtained from Statistics Norway.
No statistically significant pattern of association was found with regard to any of
the dioxin-like PCBs analyzed. Comparing the highest exposure quartile to the
lowest quartile, the odds ratios adjusted for country, age at collection, and date
of collection, were: PCB 118 (OR = 1.07; 95% CI 0.56–2.02), PCB 156 (OR =
0.80; 95% CI 0.42–1.52), PCB 157 (OR = 0.86; 95% CI 0.43–1.71), PCB 167
(OR = 1.23; 95% CI 0.67–2.29), and PCB 189 (OR = 0.64; 95% CI 0.30–1.37).
The power to detect more modest associations was limited in the higher exposure
level categories.
Lim et al. (2017) conducted a case-cohort study to evaluate the relationship
between serum concentrations of persistent organic pollutants and the incidence
of prostate cancer using the Korean Cancer Prevention Study-II cohort. The
case–cohort design consisted of 1,879 subjects who were randomly selected from
the full Korean Cancer Prevention Study-II cohort of 270,514 individuals who
visited 11 national health promotion centers from 1994 to 2013. After excluding
women and men with missing data, the subcohort consisted of 831 subjects from
which 256 controls and 110 incident cases of prostate cancer (identified through
the N
 ational Cancer Registry, a nationwide hospital cancer registry covering 99%
of all cases diagnosed in South Korea) were selected. Serum concentrations of
32 PCB congeners and 19 organochlorine pesticides were measured and were
included individually and in sum in the analysis. The sum of dioxin-like PCBs
(77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, and 189) and the sum of
non-dioxin-like PCBs was calculated. A TEQ was calculated based on the individual TEF of each PCB congener, and tertiles of concentrations were calculated.
Hazard ratios for the association between the chemicals and incidence of prostate
cancer were estimated using the weighted Cox regression models adjusted for
age, BMI, smoking status, physical activity, and the age difference between age at
enrollment and age at serum measurement. Elevated adjusted HRs were found for
higher serum levels (tertile 3 versus tertile 1) of PCBs that have dioxin-like activity including PCB 118 (HR = 3.44, 95% CI 1.01–11.69), PCB 156 (HR = 2.26,
95% CI 0.84–6.10), and PCB 167 (HR = 1.75, 95% CI 0.71–4.29) but the estimates were imprecise. The model that used a continuous measure of chemicals
(instead of grouping into tertiles) was statistically significant for PCB 156 (HR
= 2.17, 95% CI 1.28–3.66) and PCB 167 (HR = 2.09, 95% CI 1.26–3.47). Using
the sum of non-dioxin-like PCBs the upper tertile was statistically significantly
elevated compared with the lowest tertile (HR = 3.47, 95% CI 1.21–9.98). The
effect estimate using the sum of dioxin-like PCBs was elevated but not statistically significant (continuous HR = 1.39, 95% CI 0.89–2.19; tertile 3 versus tertile
1 HR = 1.73, 95% CI 0.70–4.27). The TEQ continuous measure was statistically
significantly elevated (HR = 1.40, 95% CI 1.21–1.62) as was the tertile 3 versus
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tertile 1 comparison (HR = 1.83, 95% CI 0.75–4.46). The study is somewhat
limited by the relatively small number of cases and by the fact that 89,169 of the
full Korean Cancer Prevention Study-II cohort participants (56% of the original
participating cohort) were excluded from selection because of insufficient serum
samples for assay.
Case-Control Studies
Pi et al. (2016) conducted a hospital-based case-control study of prostate
cancer with cases identified from a tertiary general hospital in Singapore. A total
of 240 incident cases were identified, and 268 controls with other diseases (except
cancer) were recruited and matched to cases on ethnicity and age. Sera samples
from 60 cases and 60 controls were used to assess the presence of 74 organohalogens. Other information was collected by interview. The mean concentration of
PCB 118 was significantly higher (p < 0.05) in the serum of patients than in that
of controls. Results were reported for two PCBs with dioxin-like activity. PCB
118 at the highest tertile (> 67th) (OR = 1.71, 95% CI 0.79–3.71) had a significant
trend test. For PCB 156 the trend test was significant, although the only elevated
OR estimate was in the third tertile. Given that this is a small study that did not
report information on case and control response rates, that control diagnoses were
not known, and that it is not clear whether there was adjustment for potential
confounders, this study is of limited utility.
Other Identified Studies
Several other studies of prostate cancer were identified. Among occupational cohorts, one examined mortality (Ruder et al., 2014), and one incidence
(Lemarchand et al., 2016). Both lacked sufficient exposure specificity to be
included as contributing to the evidence base of the potential effect of the COIs.
An Italian environmental study was also identified that performed an ecological analysis to determine prostate cancer (and other cancer) incidence rates at
14 of Italy’s national priority contaminated sites and compare the rates among
those sites. Although the known exposures at these sites consisted of mixtures
of PCBs, furans, benzene and other solvents, arsenic, and cadmium, they were
not measured or specified in enough detail to indicate which of the COIs were
present and to what extent. Akahane et al. (2017) examined the prevalence of selfreported long-term health effects, including prostate cancer, in people exposed to
PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion
of contaminated rice bran oil (Yusho accident) compared with an age-, sex- and
residential-area-matched group. Because no TEQs or other quantification of relevant exposures was presented, the study was not considered further.
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X. L. Sun et al. (2017) conducted a study of dioxin levels and steroid
hormone levels (including PSA, testosterone, estradiol, DHEA, DHT, and
3β-hydroxysteroid dehydrogenase and CYP17-lyase activity and 5α-reductase
activity) among rural men residing in a dioxin “hot spot” located at a former
U.S. Vietnam War–era air base and men in a non-sprayed region in the Kim
Bang district (Ha Nam Province). Although serum dioxin levels were measured
and the mean levels of most dioxins, furans, and non-ortho PCBs were significantly higher in the hot spot area group than in the non-sprayed area group, this
study was not given further consideration because it was not designed to directly
estimate the risk of prostate cancer with dioxin exposure. The small number of
participants, uncertainty about length of residence in the study areas, unknown
response rate, and uncertainty on how the blood draw 2 years apart might have
affected the results further limit this study’s utility to the committee.
Biologic Plausibility
In prostate cells and prostate cancer cell lines TCDD can lead to the induc
tion of various genes, including those involved in drug metabolism. Simanainen
et al. (2004) used different rats (TCDD-resistant Hannover/Wistar and TCDDsensitive Long Evans) and found that TCDD treatment resulted in a significant
decrease in the weight of prostate lobes; the effect did not appear to be rat
strain–specific. Different responses to TCDD in the human prostate cancer cell
lines LNCaP and PC3 have been reported, including increased proliferation
or no growth and stimulation or repression of AHR activity, which may be
a function of coactivator–corepressor concentrations in the cells (Kollara and
Brown, 2009, 2010). In addition, AHR activation has been shown to interfere
with androgen receptor binding to androgen response elements in LNCaP cells
via the upregulation of AP-1, resulting in a reduced expression of PSA (Kizu et
al., 2003). However, the number of CAG repeats in the androgen receptor gene,
which affects androgen receptor activity, did not significantly affect the induction
of CYP1A1 by TCDD in androgen receptor–negative prostate cells transfected
with androgen receptor constructs with different CAG repeat lengths (Björk and
Giwercman, 2013). In that study, TCDD altered androgen receptor activity in a
CAG repeat length–dependent manner in PC3 cells, but not in a non-tumorigenic,
immortalized epithelial prostate cell line. AHR is upregulated in androgen receptor–negative, hormone-independent prostate cancer cells compared with androgen receptor–positive, hormone-dependent LNCaP cells, and the treatment of
these cells (PC3, PC3M, and DU145) with an AHR agonist suppressed their
growth (Richmond et al., 2014). In contrast, even though AHR is upregulated
in castration-resistant C4-2 cells compared with the LNCaP cells from which
they have been derived, the silencing of AHR caused a growth inhibition of
these cells, perhaps because they retained androgen-receptor expression and
are androgen-sensitive (C. Tran et al., 2013). TCDD suppressed expression of
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genes associated with cell-cycle progression in LNCaP cells, but also suppressed
DNA-repair genes and increased Wnt5a concentrations; these effects could lead
to divergent responses in prostate cancer progression (Hruba et al., 2011). AHR
overexpression and activation reduced induction of the expression of vascular
endothelial growth factor in PC3 cells, raising the possibility of interference with
angiogenesis by AHR ligands (P. Y. Wu et al., 2013). LNCaP cells under oxidative stress have reduced viability and migration, and greater induced apoptosis;
AHR activation exacerbates those changes (Yu et al., 2017). TGF-β suppressed
AHR expression via SMAD4 and possibly also interfered with AHR signaling
in a non-tumorigenic, but immortalized, epithelial prostate cell line (BPH-1)
(Staršíchová et al., 2012); whether this also occurs in prostate cancer cells and
has a bearing on prostate carcinogenesis is not known.
In utero and lactational exposure to TCDD increases aging-associated
cribiform hyperplasia in the murine prostate, which may be a pre-cancerous lesion (Fritz et al., 2005). In a follow-up, progeny of a genetic cross between Ahrnull mice and the transgenic adenocarcinoma of the mouse-prostate (TRAMP)
strain that models prostate cancer showed that the presence of Ahr inhibited
the formation of prostate tumors that have a neuroendocrine phenotype (Fritz
et al., 2008). As with breast cancer, these studies suggest that the timing of an
exposure may be critical, with early-life exposures increasing prostate cancer
susceptibility or risk and adult Ahr activation reducing it (recently demonstrated
in TRAMP mice by Moore et al. [2016]). Because male Vietnam veterans were
exposed to herbicides after adolescence, toxicologic findings concerning earlylife exposure are not particularly relevant to this population, although their
exposure to herbicides could potentially influence risk of the prostate cancer
later in life.
Taken together, there is some in vivo and in vitro laboratory evidence in
support of a role of AHR in prostate cancer and suggesting that dioxin exposure
could affect processes involved in prostate carcinogenesis or prostate cancer
growth and progression. However, there is no substantial understanding of the
importance of these mechanisms or how they could affect prostate cancer risk.
Synthesis
This update describes several newly published studies involving prostate
cancer in Vietnam veterans being seen at VA medical centers, occupational
cohorts, and several other populations outside the United States. Most of the
effect estimates were either below 1.0 or barely above 1.0 and were not statistically significant.
One new study of U.S. veterans was identified. Ovadia et al. (2015)
examined outcomes related to prostate cancer progression (not the incidence of
prostate cancer) and found self-reported Agent Orange exposure was not associated with biochemical recurrence, secondary treatment, metastases, or prostate
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cancer–specific mortality after adjusting for age, race, clinical stage, PSA level,
BMI, health care center, and biopsy Gleason sum. However, studies among U.S.
Ranch Hands and Australian Vietnam veterans that used better exposure assessment support an association between exposure to the herbicides used in Vietnam
and prostate cancer.
Several positive associations between exposure to specific herbicides or their
contaminants and prostate cancer have been reported from previously reviewed
occupational studies. In studies extending the follow-up period of workers who
were exposed to dioxins during the manufacturing process of PCP and TCP
(Collins et al., 2016) and workers who manufactured or sprayed phenoxy herbicides (Coggon et al., 2015), no statistically significant difference in mortality for
prostate cancer was found between the workers and the corresponding standardized populations. Christiansen et al. (2016) conducted a well-designed nested
case-control study of 776 cases and controls within the AHS that examined the
interactions among exposure to 39 pesticides (including dicamba, 2,4-D, and
2,4,5-T); 1,117 SNPs from 56 genes in the steroid hormone synthesis, metabolism, or regulation pathway; and the risk of prostate cancer. Several pesticide
exposure metrics were constructed for each pesticide based on the duration and
frequency of pesticide exposure. After adjustment, the only interaction found
was for a SNP with dicamba, which resulted in lower prostate cancer risk with
dicamba exposure; no association for 2,4-D or 2,4,5-T was found, and it appears
there are no SNP interactions with these two herbicides.
Environmental and case-control studies reviewed in this update each used
sera samples to estimate TEQs for dioxins, organochlorine pesticide metabolites,
or PCB congeners. A well-designed and conducted nested case-control study
by Koutros et al. (2015) used prospectively collected serum to estimate associations between organocholorine exposures and 34 PCB congeners (including
five dioxin-like congeners) and metastatic prostate cancer in a population-based
cohort from Norway. After controlling for demographic factors, BMI, and smoking habits, no statistically significant pattern of association was found with any
of the dioxin-like PCBs analyzed. A hospital-based case-control study of prostate
cancer in Singapore (Pi et al., 2016) used sera samples to assess the presence of
74 organohalogens and found that the mean concentration of dioxin-like PCB 118
was significantly higher (p < 0.05) in the serum of patients than in that of controls. PCBs with dioxin-like activity (PCB 118 and PCB 156) showed increased,
but generally not statistically significant, risk estimates. A Korean case-cohort
analysis reported elevated hazard ratios for some dioxin-like PCBs and for the
sum of dioxin-like PCBs (Lim et al., 2017).
There is some in vivo and in vitro laboratory evidence supporting the role
of AHR in prostate cancer and suggesting that dioxin exposure could affect
processes involved in prostate carcinogenesis or in prostate cancer growth and
progression. However, there is no substantial understanding of the importance of
these mechanisms or how they could affect prostate cancer risk.
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The existing body of epidemiologic evidence, including the new studies
reviewed here, provide mixed findings on an association between exposure to
the COIs and prostate cancer. The epidemiologic evidence is robust enough and
has support through biologic mechanisms that this committee finds no justification for reversing the conclusion of prior VAO committees that there is limited or
suggestive evidence of an association.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the committee concludes that there remains limited or suggestive evidence of an association between exposure to at least one of the COIs and prostate cancer.
TESTICULAR CANCER
NCI estimated that 9,310 men would receive diagnoses of testicular cancer
(ICD-9 186; ICD-10 C62) in the United States in 2018 and that 400 men would
die from it (NCI, n.d.t). Other cancers of the male reproductive system that are
infrequently reported separately are cancers of the penis (ICD-9 187.1–187.4;
ICD-10 C60) and of other male genital organs (ICD-9 187.5–187.9; ICD-10 C63).
Testicular cancer occurs most often in men between the ages of 25 and 29.
The modeled incidence rate of testicular cancer in 2014 for all races combined
for men ages 65 years and over (which would include most Vietnam veterans) is
1.2 per 100,000.13 On a lifetime basis, the risk in white men is about five times
higher than in black men (Stevenson and Lowrance, 2015). Known risk factors
for testicular cancer include cryptorchidism (undescended testes) and having a
previous occurrence of testicular cancer, infertility, and HIV infection. Several
other hereditary, medical, and environmental risk factors have been suggested,
but the results of research are inconsistent (Michaelson and Oh, 2018; Mikuz,
2015; Stevenson and Lowrance, 2015).
Conclusions from VAO and Previous Updates
After a published study indicated a potential association between testicular
cancer in dogs and their service in Vietnam (Hayes et al., 1990), Tarone et al.
(1991) conducted a case-control study of testicular cancer in male veterans,
but the committee responsible for VAO concluded that there was inadequate or
insufficient information to determine whether there was an association between
exposure to the COIs and testicular cancer.

13 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using SEER
18 dataset and choosing age-adjusted rates, testicular cancer, all races, and age ≥ 65 years.
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Additional information available to the committees responsible for Update
1996 through Update 2012 did not change that conclusion. Update 2014 reviewed
a follow-up of the Korean Veterans Health Study through 2003 and found no
difference in the incidence of testicular cancer (n = 5 cases) compared with the
Korean general population (Yi, 2013) and maintained the conclusion of inadequate or insufficient evidence of an association between exposure to the COIs
and testicular cancer.
Update of the Epidemiologic Literature
No studies of testicular cancer in Vietnam veterans (U.S. or those of other
countries) or environmental studies of exposure to the COIs and testicular cancer
have been published since Update 2014. Reviews of the relevant studies are
presented in the earlier reports. Table 19, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to testicular cancer.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared
with the standardized U.S. population, Collins et al. (2016) presented mortality
for several cancers. For this outcome, results were presented as cancers of the
testes and other male genital (excluding prostate), but only one death of a TCP
worker was reported in this category. Therefore, given the single death from this
outcome, no conclusions can be drawn.
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et al.
(2015) found only five deaths in the cohort from testicular cancer. Mortality effect
estimates from testicular cancer were elevated but imprecise and not statistically
significant for any of the groups of workers: all workers (SMR = 2.00, 95% CI
0.65–4.67), workers exposed to herbicide levels above background (n = 4; SMR =
2.10, 95% CI 0.57–5.37), or workers exposed for more than 1 year at levels above
background (n = 3; SMR = 4.03, 95% CI 0.83–11.78).
Case-Control Studies
Paoli et al. (2015) conducted a small case-control study to examine the asso
ciation between occupational and environmental endocrine disruptor exposure
and testicular cancer. They recruited 125 testicular cancer (seminoma and nonseminoma) patients attending the Laboratory of Seminology Sperm Bank at the
University of Rome for semen cryobanking. All patients were studied about 1
month after orchiectomy and before beginning chemo- or radiotherapy. The control group consisted of 103 healthy men undergoing an andrological examination
and semen analysis in the same department as part of a nationwide preventive
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screening campaign. Cases and controls completed an in-person interview to
collect demographic information, residence prior to diagnosis and andrological
medical history, occupational history, diet history, lifestyle, and other environmental factors involving activities with suspected exposure to organochlorines.
Serum samples were assayed for nine PCB congeners (including the dioxin-like
congeners 77, 126, 169) and hexachlorobenzene. The associations between the
organochlorine exposure and testicular cancer were estimated by logistic regression with adjustment for age and educational level. In the analysis, PCB and
hexachlorobenzene values were grouped as being below or above the level of
detection (0.2 ng/ml). Analyses of potential occupational pesticide exposure and
possible maternal occupational exposure to pesticides (from interview data, but
pesticides were not specified) both found nonstatistically significant associations.
A detectable concentration of the sum of the nine PCB congeners (none of the
congeners were analyzed separately) was found in 16 testicular cancer cases and
no controls (p < 0.001). No effect measure was presented for this comparison,
making this study of limited utility for the committee.
Other Identified Studies
An Italian environmental study was identified that performed an ecological
analysis of testicular cancer incidence rates at 14 Italian priority contaminated
sites and compared the rates among those sites (Benedetti et al., 2017); however,
the study lacked sufficient exposure specificity to be included as contributing to
the evidence base of the potential effect of the COIs.
Biologic Plausibility
No animal studies of the incidence of testicular cancer after exposure to
any of the COIs have been published since Update 2012. That is undoubtedly
due to the lack of a valid animal model of testicular cancer. SNPs of uncertain
functional significance in the human AHR gene (11 SNPs) and the AHR repressor gene (18 SNPs) were studied in a case-control study of 278 Swedish men and
89 Danish men with testicular germ cell cancers (mean age 31 years) and 214
Swedish men without testicular cancer (mean age 18 years) (Brokken et al., 2013).
There was no association between the risk of testicular germ cell cancer and any
of the SNPs analyzed, but four SNPs in the AHR repressor gene were significantly
associated with the risk of metastatic cancer compared to localized cancer.
Synthesis
The evidence from epidemiologic studies is inadequate to link herbicide exposure and testicular cancer. The relative rarity of this cancer makes it difficult to
develop risk estimates with any precision. Most cases occur in men 25 to 35 years
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old, and men who have received such a diagnosis could have been excluded from
military service; this could explain the slight reduction in risk observed in some
veteran studies. In the analysis extending the follow-up period of workers who were
exposed to dioxins during the manufacturing process of PCP and TCP (Collins et
al., 2016), only one case of testicular cancer was reported. Among UK workers
who manufactured or sprayed phenoxy herbicides (Coggon et al., 2015), five cases
were reported, resulting in mortality effect estimates that, although elevated, were
imprecise and not statistically significant for any of the groups of workers.
The committee considered one other study of testicular cancer, but exposure
characterization was nonspecific, making it of limited value to the evidence base
for determining associations with testicular cancer. Paoli (2015) recruited patients
with testicular cancer who had not begun treatment and controls undergoing an
andrological examination to examine the association between occupational and
environmental endocrine disruptor exposure and testicular cancer. Serum samples
were assayed for nine PCB congeners and hexachlorobenzene; however, results
for specific congeners were not presented. Analyses of potential occupational
pesticide exposure (pesticides not specified) and possible maternal occupational
exposure to pesticides found no statistically significant associations.
No valid animal model has been identified for testicular cancer, which has
resulted in a paucity of biologic plausibility data for mechanisms relating exposure to one of the COIs with testicular cancer. Based on the findings from studies
reviewed in the current and previous updates and the lack of supporting mechanistic
data, the committee maintains the conclusion of inadequate or insufficient evidence
for an association between exposure to at least of the COIs and testicular cancer.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the committee concludes that there is inadequate or insufficient evidence to determine
whether there is an association between exposure to the COIs and testicular cancer.
BLADDER CANCER
Urinary bladder cancer (ICD-9 188; ICD-10 C67) is the most common urinary tract cancer. Cancers of the urethra, and paraurethral glands and other or
unspecified urinary cancers (ICD-9 189.3–189.9; ICD-10 C68) are infrequently
reported separately; any findings on these cancers would be reported in this
section. NCI estimated that 81,190 people would receive a diagnosis of bladder
cancer in the United States in 2018 and that 17,240 people would die from it
(NCI, n.d.u). For all races combined, the incidence of bladder cancer in males is
four times higher than in females.
Bladder cancer risk rises rapidly with age. The median age of diagnosis is
73 years. The age-adjusted modeled incidence rate of bladder cancer for men
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5 0–64 years old of all races combined was 36.1 per 100,000 in 2014 and increased
to 144.5 for 65–74-year-olds and 296.4 for men over 75 years.14 In men in the
age groups that characterize most Vietnam veterans, bladder cancer incidence is
nearly twice as high in whites as in blacks. The most important known risk factor
for bladder cancer is tobacco smoke inhalation, which accounts for about one-half
of the bladder cancers in men and one-third of them in women (Cumberbatch
et al., 2016; Ferrís et al., 2013a). Occupational exposure to hair dyes, aromatic
amines (also called arylamines), PAHs, and some other organic chemicals used
in the aluminum, rubber, leather, textile, paint-products, and printing industries is
associated with higher incidence (Ferrís et al., 2013a,b). In some parts of Africa
and Asia, infection with the parasite Schistosoma haematobium contributes to the
high incidence (Ferrís et al., 2013a).
Exposure to inorganic arsenic is also a risk factor for bladder cancer.
Although cacodylic acid is a metabolite of inorganic arsenic, as discussed in
Chapter 4, the data are insufficient to conclude that studies of inorganic-arsenic
exposure are directly relevant to exposure to cacodylic acid, so the literature on
inorganic arsenic is not considered in this section. Cacodylic acid constituted
about 30% of the approximately 4 million liters of Agent Blue mixtures sprayed
in Vietnam (see Table 2-2), as compared with approximately 44 million liters of
100% phenoxy herbicide mixtures with various degrees of TCDD contamination. Moreover, other than studies of exposure in Vietnam, there have been no
occupational or environmental epidemiologic studies investigating bladder cancer
incidence or mortality involving direct exposure to cacodylic acid.
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was limited or suggestive evidence of no association between exposure to the COIs and urinary
bladder cancer. The conclusion of no increased risk of bladder cancer was based
largely on the null results from the overarching IARC cohort study of phenoxy
herbicide production workers and sprayers (Saracci et al., 1991) and the consistently inconclusive results from studies of additional occupationally exposed
cohorts, environmentally exposed populations, and two small studies of Vietnam
veterans. Updates of the IARC cohort, augmented with 12 additional cohorts and
updated through 1992 (Kogevinas et al., 1997), led the committee responsible for
Update 1998 to move bladder cancer to the default category of inadequate or insufficient information to determine whether there is an association. The committees
responsible for subsequent updates did not change that conclusion. A total of 264
incident cases and 61 deaths from bladder cancer were reported during follow-up
of the Korean Veterans Health Study, and the internal comparison analysis of the
14 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using SEER
18 dataset and choosing age-adjusted rates, urinary bladder cancer, all races, and male sex.
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groups with high- versus low-exposure-opportunity scores (Yi and Ohrr, 2014) revealed no difference in the risk of a bladder cancer diagnosis (RR = 0.99, 95% CI
0.77–1.28). By contrast, Yi et al. (2014b) reported a statistically significant two-fold
increase in bladder cancer–specific mortality in this same cohort (RR = 2.04, 95%
CI 1.17–3.55), comparing the high- and low-exposure groups without adjustment
for smoking. On the basis of those studies and the evidence reviewed in previous
VAO reports, the Update 2014 committee concluded that there is limited or suggestive evidence of an association between exposure to the COIs and bladder cancer.
Update of the Epidemiologic Literature
No studies of U.S. or international cohorts of Vietnam veterans have been
published since Update 2014. No environmental or case-control studies of exposure to the COIs and urinary bladder cancer have been published since Update
2012. Reviews of the relevant studies are presented in the earlier reports. Table
20, which can be found at www.nap.edu/catalog/25137, summarizes the results
of studies related to urinary bladder cancer.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort, Collins et al. (2016)
combined deaths from bladder and other types of urinary cancer (ICD-10 C66–
C68). Compared with the standardized U.S. population, no difference in mortality for bladder or other urinary cancers was found for the TCP workers (n = 9;
SMR = 1.26, 95% CI 0.57–2.38) or the PCP workers (n = 4; SMR = 1.13, 95%
CI 0.31–2.90).
Koutros et al. (2016) used data collected by the AHS to report the association of general exposure to herbicides, insecticides, and pesticides with bladder
cancer. This is a prospective study of 57,310 pesticide applicators from Iowa
and North Carolina who were enrolled between 1993 and 1997, and whose
vital status was followed through 2011. Exposure was assessed by an extensive
questionnaire, allowing for estimates of intensity and duration of exposure,
and the information was updated from 1999 to 2005. A total of 321 incident
bladder cancers were reported. After adjusting for lifestyle and demographic
factors (including age, race, state of residence, and smoking status), elevated,
but not statistically significant, risks were associated with use of chlorphenoxy
herbicides 2,4,5-T (n = 91; RR = 1.15, 95% CI 0.84–1.59), 2,4,5-TP (n = 40;
RR = 1.07, 95% CI 0.74–1.56), 2,4-D (n = 245; RR = 1.46, 95% CI 0.98–2.18),
and organochlorine insecticides. There was a decreased risk for exposure to
dicamba after adjusting for the same factors as above (n = 125; RR = 0.84,
95% CI 0.62–1.14). Never smokers with the highest use of 2,4,5-T and 2,4-D
had higher risks of bladder cancer (RR = 2.64, 95% CI 1.23–5.68 and RR =
1.88, 95% CI 0.94–3.77, respectively), and for both herbicides there was a
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statistically significant trend of increasing risk with increasing exposure (p =
0.02). As in other publications from the AHS, concerns included the lack of
control for multiple comparisons, the small number of cases, and the assessment of exposure based only on recall.
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et al.
(2015) found that mortality from bladder cancer was lower than expected but not
statistically significant for any of the groups of workers: all workers (n = 44; SMR =
0.92, 95% CI 0.67–1.23), workers exposed to herbicide levels above background
(n = 30; SMR = 0.87, 95% CI 0.59–1.25), and workers exposed for more than 1
year at levels above background (n = 16; SMR = 0.98, 95% CI 0.56–1.59).
Other Identified Studies
Two other studies of bladder cancer among occupational cohorts were identified: one examined mortality in U.S. workers exposed to mixed PCBs (Ruder et
al., 2014), and the other examined risk factors among Egyptian agricultural workers (Amr et al., 2015). However, both lacked sufficient exposure specificity to be
included as contributing to the evidence base of the potential effect of the COIs. A
third study (Akahane et al., 2017) examined the prevalence of self-reported longterm health effects (including bladder cancer) in people exposed to PCBs, dioxins
(e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion of contaminated
rice bran oil (Yusho accident) compared with an age-, sex- and residential-areamatched group. Because no TEQs or other quantification of relevant exposures
was presented, the study was not considered further.
Biologic Plausibility
Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown
to induce urinary bladder cancer in F344 rats (Arnold et al., 2006; Cohen et
al., 2007b; A. Wang et al., 2009; M. Wei et al., 2002, 2005; S. Yamamoto et al.,
1995). A study by Z. Lin et al. (2015) suggests a carcinogenic process of chronic
inflammation, bladder epithelium lesions, and proliferation in rat bladder following DMAV exposures. Cao et al. (2015) exposed Wistar rats to DMAV and found
increased TGF-β immunoreactivity in bladder epithelium and increased IL-1β
secretion in urine.
No studies have reported an increased incidence of urinary bladder cancer
in TCDD- or 2,4-D-treated animals. Working with tissues from urothelial cancer
patients, Ishida et al. (2010) found that the activation of the AHR pathway by
TCDD enhanced bladder cancer cell invasion through an upregulated expression
of matrix metalloproteinases 1 and 9 and that reduced expression of AHR resulted
in the inhibition of invasive behavior of urothelial cancer cells. They also found
that the level of nuclear AHR expression in human upper urinary tract urothelial
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cancers was positively associated with cancer grade and stage and that it predicted
poor prognosis. In contrast, transgenic mice that have a deletion of Ahr exhibit
immune-cell infiltration in bladder submucosa and the loss of e-cadherin in some
epithelial cells in aged mice (Butler et al., 2012); although direct studies with
TCDD were not undertaken, these findings suggest a protective effect of AHR
signaling in bladder cancer.
Synthesis
This update describes three new published studies extending the follow-up
period of occupational cohorts. Many of the studies reviewed in previous updates
were characterized by low precision because of the small numbers of exposed
cases, low exposure specificity, and a lack of ability to control for confounding,
particularly cigarette smoking, which is a major risk factor for bladder cancer.
Studies of U.S. Vietnam veterans (including AFHS Ranch Hands, Army veterans
in the CDC Vietnam Experience Study, and state-specific studies of veterans)
have not reported statistically significant increased risks of bladder cancer. More
recent analyses of the Korean Veterans Health Study were well powered but did
not control for smoking; however, self-reported information on smoking among
surviving Korean veterans revealed that the distribution of smoking habits was
similar in high and low EOI-score groups, indicating that the results for bladder
cancer mortality are unlikely to have been majorly confounded by smoking (Yi et
al., 2013b). Although Yi and Ohrr (2014) did not observe an increased incidence
of bladder cancer, Yi et al. (2014b) reported a statistically significant difference in
mortality from bladder cancer among veterans in the high-exposure-opportunity
group relative to those in the low-exposure group.
Several positive associations between exposure to specific herbicides or
their contaminants and bladder cancer mortality have been reported from previously reviewed occupational studies (Boers et al., 2010; Manuwald et al., 2012;
Steenland et al., 1999); however, several other studies of occupational cohorts
have found minimal or no association with exposure to one of the COIs and bladder cancer (Boers et al., 2010; C. J. Burns et al., 2011; McBride et al., 2009a;
Ruder and Yiin, 2011). Collins et al. (2016) extended the follow-up period of
workers who were exposed to dioxins during the manufacturing process of PCP
and TCP in Midland, Michigan, and found slightly elevated, but not statistically
significant, differences in mortality for bladder or other urinary cancers compared
with the standardized U.S. population. In contrast, additional follow-up of the
UK workers who manufactured or sprayed phenoxy herbicides found decreased,
though not statistically significant, risks for mortality from bladder cancer for all
three groups of exposed workers (Coggon et al., 2015). An analysis of exposure
to herbicides, insecticides, and pesticides relative to bladder cancer incidence,
usingdata collected by the AHS, found that after an adjustment for lifestyle and
demographic factors, elevated risks were associated with the use of chlorphenoxy
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herbicides and organochlorine insecticides (Koutros et al., 2016). Never smokers
with the highest use of 2,4,5-T and 2,4-D had higher risks of bladder cancer, and
for both of these herbicides there was a statistically significant trend in increasing
risk with increasing exposure.
Toxicologic and mechanistic data to support an association between the COIs
and bladder cancer are limited. Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown to induce urinary bladder cancer in F344 and Wistar
rats, but no studies have reported an increased incidence of urinary bladder cancer
in TCDD- or 2,4-D-treated animals. The three new occupational cohort studies
reviewed by the committee in combination with the prior reviewed literature continue to support the conclusion of limited suggestive evidence for an association
of bladder cancer with exposure to the COIs.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the committee concludes that there is limited or suggestive evidence of an association
between exposure to the COIs and urinary bladder cancer.
RENAL CANCERS
Cancers of the kidney other than the renal pelvis (ICD-9 189.0; ICD-10
C64) and cancer of the renal pelvis (ICD-9 189.1; ICD-10 C65) are often
grouped in epidemiologic studies; cancer of the ureter (ICD-9 189.2; ICD-10
C66) is also sometimes included. Although diseases of these organs have distinct characteristics and could have different risk factors, there is some logic to
grouping them: the structures are all exposed to filterable chemicals, such as
PAHs, that appear in urine. NCI estimated that 63,990 men and women would
receive diagnoses of kidney or renal pelvis cancer in the United States in 2018
and that 14,400 men and women would die from it. The incidence of renal cancer
increases with age, and median age of diagnosis is 64 years (NCI, n.d.v). Except
for Wilms tumor, which is more likely to occur in children, renal cancers are
more common in people over 50 years old.
In the age groups that include most Vietnam veterans, the age-adjusted modeled incidence rate of kidney and renal pelvis cancers for men 50–64 years old
of all races combined was 45.3 per 100,000 in 2014 and increased to 93.1 for
65–74-year-olds and 105.1 for men over 75 years. The incidence rate for men
is about twice as high as it is for women of the same race. Among men, blacks
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have the highest incidence rate, whereas among women, both black and American
Indian/Alaska Natives have the highest incidence rates.15
Tobacco use is a well-established risk factor for renal cancers (Qayyum
et al., 2013). Obesity is also another risk factor for renal cell carcinoma, and a
recently published meta-analysis of 21 cohort studies reported an elevated risk
for renal cancers (RR = 1.77, 95% CI 1.68–1.87) when comparing obese to normal weight participants (Wang and Xu, 2014). Some rare syndromes—notably,
von Hippel–Lindau syndrome and tuberous sclerosis—are associated with an
elevated risk of renal cancer. Other potential risk factors include acetaminophen
or non-aspirin non-steroidal anti-inflammatory drug use, organic solvents, and,
in men, a history of kidney stones (Cheungpasitporn et al., 2015; Choueiri et al.,
2014; Qayyum et al., 2013). Firefighters, who are routinely exposed to numerous
pyrolysis products, have a significantly increased mortality risk after 20 or more
years of employment (Youakim, 2006).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate
or insufficient information to determine whether there is an association between
exposure to the COIs and renal cancers. Additional information available to the
committees responsible for subsequent updates from Update 1996 through U
 pdate
2012 did not change that conclusion. Update 2014 identified a single study of renal
cancer in a follow-up of the Korean Veterans Health Study. Results were reported
separately for kidney cancer (n = 186 cases) and renal pelvis cancer (n = 23 cases),
but no excess cancer risk for the kidney or renal pelvis was found when compared
with the general Korean population (Yi, 2013) or when internal comparisons of
high- versus low-exposure-opportunity scores were made (Yi and Ohrr, 2014).
An inverse association for renal cancer risk (HR = 0.74, 95% CI 0.55–1.00) was
reported, but no association for cancer of the renal pelvis (HR = 1.05, 95% CI
0.44–2.50). A non-significant increased risk of ureter cancer (ICD-10 C66) was
also reported. When kidney, renal pelvis, and ureter cancer deaths were combined
for the internal cohort comparison of high versus low exposure, no excess cancer
mortality was found (Yi et al., 2014b). Information on smoking or other lifestyle
habits was not available for this cohort during the follow-up through 2003, and
thus the modest associations could be due to confounding by smoking or obesity.

15 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the
SEER 18 dataset and choosing age-adjusted rates, kidney and renal pelvis cancers, all races, age ≥
50 years, and male sex.
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Update of the Epidemiologic Literature
Two new published studies were identified that addressed exposure to the
COIs from occupational settings and mortality from renal cancers. No studies
of renal cancers in Vietnam veterans have been identified since Update 2014.
Furthermore, no environmental studies or case-control studies of exposure to
the COIs and renal cancers have been published since Update 2010. Reviews of
the relevant studies are presented in the earlier reports. Table 21, which can be
found at www.nap.edu/catalog/25137, summarizes the results of studies related
to renal cancer.
Occupational Studies
Among the Dow Midland, Michigan, worker cohort that was compared with
the standardized U.S. population, Collins et al. (2016) found no differences in
mortality for kidney cancers (C64–C65) for the TCP workers (n = 4; SMR = 0.63,
95% CI 0.17–1.61) or the PCP workers (n = 4; SMR = 1.37, 95% CI 0.37–3.51).
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers to examine carcinogenicity of phenoxy herbicides, Coggon et al.
(2015) found that mortality from kidney cancer was not statistically significant
for any of the groups of workers: all workers (n = 23; SMR = 0.87, 95% CI
0.55–1.31), workers exposed to herbicide levels above background (n = 16;
SMR = 0.81, 95% CI 0.46–1.32), or workers exposed for more than 1 year at
levels above background (n = 11; SMR = 1.22, 95% CI 0.61–2.19).
Other Identified Studies
Two other studies that reported outcomes of renal cancer were identified, but
both lacked sufficient exposure specificity to be included as contributing to the
evidence base of the potential effect of the COIs (Akahane et al., 2017; Ruder
et al., 2014).
Biologic Plausibility
Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown to
induce renal cancer. In F344/DuCrj rats treated with a mixture of carcinogens for
4 weeks, subsequent exposure to DMA (not indicated whether this was DMAIII
or DMAV) via their drinking water for 24 weeks caused tumor promotion in the
kidney, liver, urinary bladder, and thyroid gland, but it inhibited induction of
tumors of the nasal passages (S. Yamamoto et al., 1995). More recent studies have
also found that oral exposure of adult mice to 200 ppm DMAV in addition to fetal
arsenic exposure can act as a promoter of renal and hepatocellular carcinoma,
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markedly increasing tumor incidence beyond that produced by fetal arsenic exposure alone (Tokar et al., 2012).
No animal studies with exposure to the other COIs have reported an increased
incidence of renal cancers.
Synthesis
The available analyses of an association between exposure to the COIs and
renal cancer risk have been limited by the small number of cases and a lack of
exposure specificity. Studies of Vietnam veterans have not found statistically
significant associations between deployment and presumed exposure to the herbicides and incidence or mortality of renal cancers. Similarly, no increases of risk or
mortality from renal cancers have been reported among the several occupational
cohorts, for which exposure was often better characterized. Collins et al. (2016)
extended the follow-up period of workers who were exposed to dioxins during the
manufacturing process of PCP and TCP in Midland, Michigan, and reported four
cases of renal cancer among PCP workers and four cases among TCP workers,
but in neither group were the risk estimates statistically significant. Coggon et al.
(2015) identified a total of 23 deaths from renal cancer in the additional followup of the UK workers who manufactured or sprayed phenoxy herbicides, but the
direction of the risk estimates for mortality from renal cancer was not consistent
or statistically significant for any of the three groups of exposed workers.
Cacodylic acid (DMAIII and DMAV) is carcinogenic and has been shown to
induce tumors in the kidneys of F344 rats, but no animal studies with exposure
to the other COIs have reported an increased incidence of renal cancer. Results
from two studies that extended the follow-up period of well-characterized occu
pational cohorts in combination with the prior reviewed literature continue to
support the conclusion of inadequate or insufficient evidence for an association
of renal cancers with exposure to the COIs.
Conclusion
Based on the epidemiologic evidence reviewed here and in previous VAO
reports, the committee concludes that there is inadequate or insufficient evidence
to determine whether there is an association between exposure to the COIs and
renal cancers.
BRAIN CANCER
Nervous-system cancers (ICD-9 191–192; ICD-10 C70–C72) involve the
central nervous system (CNS) and include tumors of the brain and spinal cord,
the cranial nerves, and the meninges (the outer coverings of the brain and spinal
cord). Any of the cell types in the CNS can develop into cancer. Tumors of the
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peripheral nervous system and autonomic nervous system are considered soft-tissue tumors (ICD-9 171; ICD-10 C38.0, C47, C49). Most cancers that are found in
the CNS are not primary tumors arising from nervous system tissues, but instead
represent metastases from other primaries, such as the lung or breast. This section focuses on cancers that originate in the CNS. Cancer of the eye (ICD-9 190;
ICD-10 C69) is included with the results on brain cancer because when cancer
of the eye is reported, it is often grouped with brain cancer.
About 95% of primary CNS malignancies originate in the brain, cranial
nerves, and cranial meninges. In people over 45 years old, about 90% of tumors
that originate in the brain are gliomas—astrocytoma, ependymoma, oligodendroglioma, or glioblastoma multiforme. Although the committee was tasked with
examining all health outcomes that may be associated with exposure to the COIs,
VA specified that the committee should give particular attention to glioblastoma
multiforme. Glioblastoma multiforme is the most common brain tumor and has
the worst prognosis (Muth et al., 2016). Meningiomas make up 20% to 40% of
CNS cancers; they tend to occur in middle age and are more common in women
than in men. Most meningiomas are benign and can be removed surgically.
NCI estimated that about 23,880 people would receive diagnoses of brain
and other nervous-system cancers in the United States in 2018 and that 16,830
people would die from them (NCI, n.d.w). Those numbers represent 1.4% of new
cancer diagnoses and 2.8% of cancer deaths. An estimated 12,000 new cases of
glioblastoma are diagnosed in the United States each year.16 The incidence of
brain and other CNS cancers increases with age, and the median age of diagnosis
is 58 years. The incidence rate for men is higher than for women of the same race.
By race and sex, whites have the highest incidence rate and American Indian/
Alaska Natives have the lowest incidence rates (NCI, n.d.w). In the age groups
that include most Vietnam veterans, the age-adjusted modeled incidence rate of
brain and other nervous-system cancers for men 50–64 years old of all races combined was 11.5 per 100,000 in 2014 and increased to 20.2 for 65- to 74-year-olds
and 26.2 for men over 75 years.17
In reviewing the descriptive epidemiology of these cancers, it is important
to recognize the variation with which specific cancers are included in published
reports, many of which distinguish between benign and malignant tumors. Another
variation is whether cancers derived from related tissues (such as the pituitary
or the eye) are included with CNS cancers. Several types of cancer are usually
grouped together; although this may bias results in unpredictable ways, the most
likely consequence is a dilution of risk estimates toward the null.
16 Paul Mischel, head of Laboratory of Molecular Pathology at Ludwig Institute for Cancer
ResearchSan Diego, presentation to the committee, November 30, 2017.
17 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output using the SEER
13 dataset and choosing age-adjusted rates, brain and other nervous-system cancers, all races, age ≥
50 years, and male sex.
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The only well-established environmental risk factor for brain tumors is
exposure to high doses of ionizing radiation (ACS, 2012b; Wrensch et al., 2002).
Other environmental exposures—such as to petroleum products, electromagnetic
fields, and cell-phone use—are unproven as risk factors (Gomes et al., 2011;
Ostrom et al., 2015). The causes of most cancers of the brain and other portions
of the nervous system are unknown.
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was limited or
suggestive evidence of no association between exposure to the COIs and brain
cancer. The committees responsible for Update 1996, Update 1998, Update 2000,
Update 2002, and Update 2004 did not change that conclusion.
The committee responsible for Update 2006 changed the classification for
brain cancer (formally expanding it to include cancers of the eye and orbit) to
inadequate or insufficient evidence to determine whether there is an association
between exposure to the COIs and brain cancer. That committee considered one
study that suggested a relationship between phenoxy acid herbicides and adult
gliomas (W. J. Lee et al., 2005), studies that reported slightly but not statistically significantly higher risks of brain cancer in deployed versus non-deployed
Australian Vietnam-era veterans (ADVA, 2005a,b) and in pesticide applicators in
the AHS (Alavanja et al., 2005), and several studies that had essentially neutral
findings (Carreon et al., 2005; Magnani et al., 1987; McLean et al., 2006; Ruder
et al., 2004; Torchio et al., 1994).
The committees for Update 2008, Update 2010, and Update 2012 reviewed
several new occupational, environmental (including updates of the Seveso
cohort),case-control, and Vietnam-veteran studies, but maintained that brain
cancer should remain in the inadequate or insufficient category, given the largely
null findings and that several studies did not specify the chemicals of exposure.
The Update 2014 committee reviewed two studies of Vietnam veterans.
In a retrospective study of mortality outcomes in three cohorts of U.S. military
women—4,734 who served in Vietnam, 2,062 who served in countries near
Vietnam, and 5,313 who served primarily in the United States—no association
was found between any cohort and brain or nervous-system cancers (H. K. Kang
et al., 2014a). In a sub-analysis, nurses who served in Vietnam had a statistically significantly higher risk of brain cancer death than nurses who served in
the United States (adjusted RR = 4.61, 95% CI 1.27–16.83), but nurses who
served near Vietnam did not have an elevated risk (adjusted RR = 2.12, 95% CI
0.42–10.83) although both estimates were imprecise. None of the other studies
of U.S. or international Vietnam veterans found statistically significant associations between exposure to the COIs and brain cancer. The U.S. Vietnam veterans
nurses study is limited by the issue of multiple comparisons, the possibility of
false positives, and imprecise risk estimates.
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Update of the Epidemiologic Literature
Because glioblastoma multiforme was specifically noted as an outcome of importance in the committee’s Statement of Task, a targeted literature search for this
outcome was undertaken. No date or language parameters were applied, and a total
of 153 articles were found. Each was reviewed for relevance against the COIs and
checked against the previous VAO reports. Using those criteria, only two epidemiologic studies were identified that had exposure to one of the COIs, were published
before 2014, and had not previously been reviewed. Both studies are summarized
in this section. No new published literature of Vietnam veterans that addressed
exposure to the COIs and brain cancers was identified by the committee for the
current update. Furthermore, no environmental studies of exposure to the COIs
and brain cancer have been published since Update 2012. Reviews of the relevant
studies are presented in the earlier reports. Table 22, which can be found at www.
nap.edu/catalog/25137, summarizes the results of studies related to brain tumors.
Occupational Studies
Although the results are not brain-cancer specific, but rather presented as
cancers of the CNS (C70–C72), Collins et al. (2016) reported on the causes of
mortality among the Dow Midland, Michigan, worker cohort. Few cases of CNS
cancers were identified: three among TCP workers and one among PCP workers,
again making reported risk estimates unreliable. Compared with the standardized
U.S. population, no differences in mortality for CNS cancers were found for the
TCP workers (SMR = 0.47, 95% CI 0.10–1.38).
In the Coggon et al. (2015) extension of the follow-up of UK phenoxy
herbicide manufacturers and sprayers to examine carcinogenicity of phenoxy
herbicides, no differences in mortality from brain and CNS cancers were found
for any of the groups of workers when compared with the standardized population
of Great Britian: all workers (n = 33; SMR = 1.15, 95% CI 0.79–1.62), workers
exposed to herbicide levels above background (n = 25; SMR = 1.15, 95% CI
0.74–1.70), or workers exposed for more than 1 year at levels above background
(n = 10; SMR = 1.04, 95% CI 0.50–1.92).
Case-Control Studies
Brownson et al. (1989) conducted a case-control study using data from
the Missouri Cancer Registry to examine the association between employment
in certain industries and specific occupations with brain cancer. A total of 312
cases (all white males diagnosed with histologically confirmed brain and other
CNS cancer between 1984 and 1988) were studied. Each case was frequency
matched to four controls, white males diagnosed with other cancers who were
randomly selected from each of six age strata and information on occupation
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(usual or longest held) and tobacco smoking history (never, former, current).
Odds ratios were calculated and adjusted for age and smoking status. Additional analyses were conducted for specific brain cancers, including unspecified astrocytomas, unspecified glioblastomas, anaplastic astrocytomas, and other
(oligodendrogliomas, unspecified cell types, and unspecified ependymomas).
Although specific exposures were not collected and many of the categories had
small numbers of people, a statistically significant excess of brain cancer was
associated with agricultural work (22 cases and 62 controls, OR = 1.5, 95% CI
1.0–2.4) and printing and publishing work (6 cases and 36 controls, OR = 2.8,
95% CI 1.0–8.3), although the effect estimate for the printing industry was quite
imprecise. Comparisons by occupation found an excess risk associated with
social science professionals (6 cases and 4 controls, OR = 6.1, 95% CI 1.5–26.1)
and police and fire protection professionals (12 cases and 22 controls, OR = 2.2,
95% CI 1.0–4.7), but these estimates were imprecise and limited by specific
exposure information and the small number of individuals reporting such occupations. Furthermore, no excess of brain cancer was found for farming (21 cases
and 80 controls, OR = 1.1, 95% CI 0.6–1.7), food production (3 cases and 8
controls, OR = 1.6, 95% CI 0.3–6.8), or laborers other than construction (7 cases
and 46 controls, OR = 0.6, 95% CI 0.2–1.4). Analyses by histologic type of brain
cancer found elevated, but imprecise, risks of “other” cell types for workers in the
agricultural industry (OR = 5.3, 95% CI 1.9–14.3) and for occupation of farmer
(OR = 3.7, 95% CI 1.4–9.8). When cases and controls were compared by tobacco
smoking status, no difference in risk for brain cancer was found. The study is
limited by the lack of specific exposure information; industry and occupation
information was incomplete in the registry (of the initially eligible subjects,
34% of cases and 38% of controls were excluded from the final sample due to
missing information), restricted to “usual” or “longest held” job, and obtained
from the medical record at the time of diagnosis and subject to misclassification.
Therefore, while these data are consistent with some other studies that suggest
an agricultural chemical exposure risk for brain cancer, they are very nonspecific
and must be considered exploratory.
Other Identified Studies
Three other studies of brain cancer were identified, but all lacked sufficient
exposure specificity to be included as contributing to the evidence base of the
potential effect of the COIs. One examined causes of mortality in U.S. workers
exposed to mixed PCBs (Ruder et al., 2014). Bencko et al. (2009) was an ecological study that compared the 10-year incidence of selected cancers, including brain
cancer, in known PCB/TCDD-contaminated regions of the Slovak Republic and
the Czech Republic. A third study (Akahane et al., 2017) examined the prevalence of self-reported long-term health effects, including brain tumors, in people
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the
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ingestion of contaminated rice bran oil (Yusho accident) compared with an age-,
sex- and residential-area-matched group. Because no TEQs or other quantification
of relevant exposures was presented, the study was not considered further.
Invited Presentations to the Committee
Given the dearth of new studies that examined exposure to the COIs and
brain cancer (particularly glioblastoma multiforme), and because this outcome
was specified in the committee’s Statement of Task, the committee invited presentations by VA (to hear of their specific concerns, questions, and continuing
research initiatives regarding glioblastoma multiforme), by experts on the epidemiology and molecular pathology of glioma, and by veterans and their families.
Hearing from the scientific experts ensured that the committee had information
that was as complete and current as possible regarding the science of glioblastoma, whereas hearing from the families of veterans who had been diagnosed
with glioblastoma provided a reminder of the burden of the disease. The committee appreciates the efforts of all presenters and members of the public who
attended the open session and their willingness to provide information for the
committee’s consideration.
Quinn Ostrom, Ph.D., from Case Western Reserve University, presented a
review of the epidemiology of glioma, which included population estimates of
its incidence and prevalence as well as its distribution by demographic factors.
Although a relatively small number of all new cancer cases each year originate in the brain or nervous system for both men and women (1.6% and 1.2%,
respectively), they account for 3% of deaths from cancer each year. Dr. Ostrom
reported that the overall incidence of primary brain and CNS tumors is 22.6
per 100,000 and that almost one-third of these tumors (31.5%) are malignant.
Gliomas are the most common type of malignant brain tumor, accounting for
approximately 26.6% of all primary brain tumors and nearly 80% of malignant
brain tumors. There are multiple subtypes of glioma, with glioblastoma being the
most common (56.1%). The incidence of glioblastoma increases with age and
peaks at 75–79 years for both males and females; the median age of diagnosis
is 64 years. In the United States, incidence is about 50% higher in males than
in females, highest for non-Hispanic whites, and associated with higher socioeconomic status. This review highlighted the stark fact that there has been little
change in the incidence rate of glioblastoma since the 1990s and little progress
eliciting clear risk factors. Consistent with the prior updates by VAO committees,
this committee found that while numerous environmental risk factors have been
studied, no environmental factors accounting for glioma have been identified. Of
interest, about 25% of glioma risk is estimated to be genetic, and current research
has identified 12 common genetic variants that explain approximately 27% of the
genetic risk for glioblastoma. Accepted non-genetic risk factors include exposure
to ionizing radiation and a history of respiratory allergies and atopic disease,
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specifically asthma and eczema. While associations with other exposures have
been studied, including herbicide exposure, no additional accepted risk factors
(including immune suppression arising from various exposures) have been found.
A presentation by Paul Mischel, M.D., which highlighted the fast-moving
research into the basic science of glioblastoma, concentrated on both new discoveries and their implications for understanding controversies concerning the
mechanisms responsible for the aggressive nature of this disease. Many fundamental characteristics of this tumor—one of the cancers that has been most
well characterized genetically by NCI’s Cancer Genome Atlas initiative—have
been well described, and research has identified some of the discrete pathways
involved in its development and elucidated some of the factors underlying its
mutational diversity, including copy number alterations and point mutations,
insertions and deletions, and the role of extrachromosomal DNA. These novel
mechanisms may fundamentally change how we think about the evolution of this
(and other) cancers. At the same time, this understanding of the basic biology has
so far not directly led to new treatment options.
VA representatives, who reiterated the origin of the VAO series and the current committee’s specific charge, presented data on overall brain cancer incidence
from VA administrative databases and summarized the results of selected studies of
brain cancer in different populations of veterans. All of the published studies they
presented had been reviewed by previous VAO Update committees. In the final part
of its presentation, VA representatives informed the committee of the department’s
current and planned studies of brain cancer in Vietnam veterans. The planned
studies included an update of the causes of mortality of deployed and Vietnam-era
veterans from 1979 through 2014 and an exploratory study of self-reported exposures and different types of brain cancer using information, in part, from the Agent
Orange Registry. VA has completed a new national survey on the current health of
deployed and nondeployed Vietnam-era veterans (VE-HEROeS); however, none of
the results were published in time for the committee’s consideration. The committee supports VA’s continued research efforts and urges the department to continue
to conduct rigorous and thorough epidemiologic investigations of veterans’ health
issues, but cautions that these are unlikely to yield information on the association
between exposure to the COIs and brain cancers..
Finally, the committee also heard from family members and widows of
veterans who died from brain cancer and who are working to have VA recognize
the diagnosis of brain cancer, specifically glioblastoma, as a presumptive disease
associated with exposure to the herbicides used in Vietnam. Their presentations
were compelling and heartfelt. One such effort discussed was Sierra Valley
Cancer Registry Services, which is a registry that collects self-reported information related to exposures and confirmed diagnosis of glioblastoma for Vietnam
veterans. As of 2017, the registry contains information on 372 Vietnam veterans
who have been diagnosed with glioblastoma.
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Biologic Plausibility
The committee did not identify any animal studies that have reported an
association between exposure to the COIs and brain cancer.
In a study of the role of the AHR–MYCN oncogene in neuroblastoma,
P. Y. Wu et al. (2014) reported that AHR was inversely correlated with MYCN
expression in neuroblastoma tissues, but found AHR expression to be highly
correlated with the histological grade of differentiation. This correlation was confirmed in a further study of 14 human neuroblastoma samples. Dever et al. (2012)
found that AHR promotes proliferation in medulloblastoma cells. S
 ilginer et al.
(2016) identified a signaling network comprising integrins, AHR, and TGF-β in
a human glioma cell line. AHR mediates integrin control of the TGF-β pathway;
TGF-β contributes to the malignancy of glioblastoma by “promoting invasiveness and angiogenesis, maintaining tumor cell stemness and inducing profound
immunosuppression” (p. 3260).
Recent work relevant to glioblastoma elucidates a role for AHR activation
by endogenous ligand kynurenine (Beischlag et al., 2016; Platten et al., 2012a,b).
The activation of AHR by kynurenine resulted in tumor growth, invasiveness, and
immunosuppression (Platten et al., 2012a). Genes that may mediate the promotion
of tumor growth and invasiveness include interleukins 1β, IL-6, IL-8, epiregulin
and aldehyde dehydrogenase 1 family, member A3 (Platten et al., 2012b).
Synthesis
Studies of Vietnam veterans have not found statistically significant associations between deployment and presumed exposure to the herbicides and incidence
or mortality of brain or other nervous-system cancers. Many of the studies conducted among U.S. Vietnam veteran cohorts were underpowered. Similarly, no
increases of risk or mortality from brain and CNS cancers have been reported
among the several occupational cohorts, for which exposure was often better
characterized. Collins et al. (2016) extended the follow-up period of workers
who were exposed to dioxins during the manufacturing process of PCP and TCP
in Midland, Michigan, and reported four cases total of brain and other nervoussystem cancers resulting in decreased risk estimates that were not statistically
significant. Coggon et al. (2015) identified a total of 33 brain and nervous-system
cancer deaths in the additional follow-up of the UK workers who manufactured
or sprayed phenoxy herbicides, but no increased risk was observed for any of the
three groups of e xposed workers. Brownson et al. (1989), used a case-control design and reported some small but statistically significant elevations in risk associated with several occupations. However, the study lacked exposure estimates and
was underpowered and potentially biased by missing data, and, ultimately, the
committee considered it an exploratory analysis and did not give it full weight.
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Given the limited epidemiologic data available on glioblastoma, the committee heard invited presentations from two glioblastoma experts. While the
presentations to the committee were helpful and impressive, demonstrating that
the biological understanding of glioblastoma is rapidly advancing, they reinforced
the absence of clear data suggesting that the COIs are associated with the occurrence of brain cancers.
The committee did not identify any animal studies that have reported an
association between exposure to the COIs and brain cancer. AHR was found
to be inversely correlated with MYCN expression but highly correlated with
the histological grade of differentiation in neuroblastoma tissues in a small
sample of human cases. Recent research has shown that AHR mediates integrin
control of the TGF-β pathway and that TGF-β contributes to the malignancy of
glioblastoma. The new epidemiologic and mechanistic data reviewed in this update along with the presentations to the committee from experts in the field were
not sufficient to alter the committee’s conclusion that the evidence is inadequate
or insufficient to determine whether there is an association between exposure to
the COIs and brain or other nervous-system cancers.
Conclusion
Based on the epidemiologic evidence from new and previously reported
studies of populations that had potential exposure to the COIs, the committee
concludes that there is inadequate or insufficient evidence to determine whether
there is an association between exposure to the COIs and brain cancer or other
nervous-system cancers.
The committee believes it is appropriate for VA to be mindful of the concerns
raised about the possible association between Vietnam service and glioblastoma
but observes that the outcome is so rare and the information concerning herbicide exposures so imprecise that is doubtful that any logistically and economically feasible epidemiologic study of veterans—no matter how well designed or
executed—would produce meaningful results. The committee therefore recommends that VA not seek to undertake such an epidemiologic study and
instead to focus on fostering advancements in other areas that may be used
to inform improved treatment options.
ENDOCRINE CANCERS
Cancers of the endocrine system have a disparate group of ICD codes:
thyroid cancer (ICD-9 193; ICD-10 C73) and other endocrine cancers including
the thymus (ICD-9 164.0, 194; ICD-10 C37, C74, C75). According to NCI, in the
United States in 2018 there would be an estimated 53,990 new diagnoses of and
2,060 deaths from thyroid cancer (NCI, n.d.x). NCI does not report estimates of
other endocrine cancers, but the American Cancer Society estimated that 1,210
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men and 1,170 women would receive diagnoses of other endocrine cancers in
2017 and that 520 men and 480 women would die from them (Siegel et al., 2017).
Thyroid cancer is the most prevalent endocrine cancer. The thyroid contains
two main types of cells: follicular cells, which synthesize and store thyroid
hormones and synthesize thyroglobulin, and C cells, which synthesize the hormone calcitonin, which regulates calcium metabolism. Malignancy can develop
from any cell type. The four main types of thyroid cancer are papillary cancer,
follicular cancer, anaplastic cancer, and medullary carcinoma (Wiltshire et al.,
2016). Papillary carcinoma is the most common and accounts for the majority of the increasing incidence rate (Lubitz and Sosa, 2016). It usually affects
women of childbearing age; the most common variant of papillary carcinoma is
the follicular subtype (also known as mixed papillary–follicular variant), which
metastasizes slowly and is the least aggressive type of thyroid cancer. Follicular
carcinoma (or follicular adenocarcinoma), which is associated with inadequate
dietary iodine intake, accounts for about 10% of all cases and has greater rates
of recurrence and metastasis. Medullary carcinoma, a cancer of the parafollicular
cells in the thyroid, is less common (4% of all cases) and tends to occur in families. Anaplastic carcinoma (also called giant-cell cancer and spindle-cell cancer)
is rare but is the most aggressive form of thyroid cancer; it does not respond to
radioiodine therapy and metastasizes quickly, invading such nearby structures as
the trachea and causing compression and breathing difficulties.
Thyroid cancer can occur in all age groups, but the median age of diagnosis
is 51 years (NCI, n.d.x). As radiation exposure is recognized as a risk factor for
thyroid cancer, increased incidence is being observed in people who received
radiation therapy directed at the neck (a common treatment in the 1950s for
enlargedthymus, adenoids, and tonsils and for skin disorders) or who were
exposed to iodine-125, for example, from the Chernobyl nuclear power-plant
accident. If the radiation exposure occurred in childhood, then the risk of thyroid
cancer is further increased. In the age groups that include most Vietnam veterans,
the age-adjusted modeled incidence rate of thyroid cancer for men 50–64 years
old of all races combined was 13.4 per 100,000 in 2014 and increased to 21.5
for 65- to 74-year-olds before decreasing to 16.5 for men over 75 years.18 The
incidence rate of thyroid cancer is about three times higher in women than in men
of the same race. Whites and Asian/Pacific Islanders have the highest incidence
rates for both sexes (NCI, n.d.x). Other risk factors are a family history of thyroid
cancer and chronic goiter. Adrenal and pituitary cancers are much less common
than thyroid cancers. Benign adenomas are more common than malignancies in
these endocrine glands.

18 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the
SEER 13 dataset and choosing age-adjusted rates, thyroid, all races, age, and male sex.

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

323

CANCER

Conclusions from VAO and Previous Updates
The committees responsible for VAO, Update 1996, Update 1998, Update
2000, Update 2002, and Update 2004 did not report endocrine cancers as a separate outcome and therefore reached no conclusion as to whether there was an
association between exposure to the COIs and endocrine cancers. The committees
responsible for Update 2006, Update 2008, Update 2010, and Update 2012 did
consider endocrine cancers separately and concluded that there was inadequate
or insufficient evidence to determine whether there is an association between
the COIs and endocrine cancers. Analysis of incidence and mortality of cancers
in the Korean Veterans Health Study was reviewed in Update 2014. There were
no statistically significant differences in the incidence of or death from thyroid
cancer when compared to the general Korean population; nor were there differences between the high- and low-exposure groups (Yi and Ohrr, 2014). However,
based on 11 deaths, a statistically significant association between exposure and
thyroid cancer–specific mortality was found both when analyzed in terms of log
increments in the exposure opportunity scores and when comparing high- versus
low-exposure groups (Yi et al., 2014b). The small number of cases and imprecise
estimates did not change the conclusion that there was inadequate or insufficient
evidence to determine whether there is an association between the COIs and
endocrine cancers.
Update of the Epidemiologic Literature
No environmental or case-control studies of exposure to the COIs and thyroid or other endocrine cancers have been published since Update 2012. Reviews
of the relevant studies are presented in the earlier reports. Table 23, which can be
found at www.nap.edu/catalog/25137, summarizes the results of studies related
to endocrine cancers (thyroid, thymus, and other).
Vietnam-Veteran Studies
Le et al. (2016) performed a retrospective review of the VA Corporate Data
Warehouse database from all VA sites from October 1, 1999, to December 21,
2013, to examine incident cases of thyroid cancer based on ICD-9 codes. No
pathology was available, and no clinical information on the patients was reported.
A total of 19,592 thyroid cancer cases were identified, 42% of which were among
Vietnam-era veterans. Agent Orange exposure was obtained from VA records and
was determined by self-report at first visit to the VA system. The authors found a
statistically significantly higher proportion of self-reported Agent Orange exposure
among thyroid cancer patients (10.0%) compared with the general VA health care
population (6.2%) (p < 0.0001). However, this analysis is limited by the absence
of pathology reviews of identified cases, no reporting of histological subtypes, and
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no adjustment or inclusion of additional information on comorbidities or other
risk factors. Furthermore, the exposure to Agent Orange was based on self-report.
Occupational Studies
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et
al. (2015) reported a total of 3 deaths from thyroid cancer. With limited deaths,
mortality risk estimates were imprecise and not statistically significant for any
of the groups of workers.
Other Identified Studies
Four other studies were identified that reported outcomes of thyroid cancer,
but all lacked sufficient exposure specificity to be included as contributing to the
evidence base of the potential effect of the COIs. The first examined m
 ortality
from malignant neoplasms of the thyroid gland in an occupational cohort of
capacitor manufacturers who were exposed to dioxin-like and non-dioxin-like
PCBs (Ruder et al., 2014). The second study (Benedetti et al., 2017) was an Italian environmental study that performed an ecological analysis of thyroid cancer
(and other cancer) incidence rates at 14 Italian priority contaminated sites and
compared the rates among those sites. The third study looked for clusters of thyroid cancer in an Andean town in Colombia using a spatial analysis of aggregated
data (smoothed standardized incidence ratios at census tracts) and point data
(individual case location) to determine if clusters of thyroid cancer in this region
were associated with industrial sources of air pollution, which included PCDD/
Fs (Arias-Ortiz et al., 2018). The final study (Akahane et al., 2017) examined the
prevalence of self-reported long-term health effects (including thyroid cancer)
in people exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals
through the ingestion of contaminated rice bran oil (Yusho accident) compared
with an age-, sex- and residential-area-matched group. Because no TEQs or other
quantification of relevant exposures was presented, the study was not considered
further.
Biologic Plausibility
NTP conducted carcinogenesis bioassays in Osborne-Mendel rats and
B6C3F1 mice that were exposed to TCDD by gavage (NTP, 1982a). The incidence of follicular-cell adenoma, but not of carcinoma, increased with increasing
TCDD dose in male and female rats; the increase was significant in male but
not in female rats. There was a significant increase in follicular-cell adenoma
in female but not in male mice. NTP then carried out a similar study in female
Sprague Dawley rats (NTP, 2006), and Walker et al. (2006) compared the data
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from that study and the results of the Dow Chemical assessment of TCDD
carcinogenicity (Kociba et al., 1978). In the NTP and Dow studies, the incidence
of C-cell adenoma and carcinoma decreased with an increasing dose of TCDD.
However, an increased incidence of mild thyroid follicular-cell hypertrophy was
noted in rats that were given TCDD at 22 ng/kg of body weight or more. A more
recent 2-year NTP study (Yoshizawa et al., 2010) treated female Sprague Dawley
rats with TCDD, 2,3,4,7,8-pentachlorodibenzofuran, dioxin-like PCB c ongeners
(PCB 126 or PCB 118), a non-dioxin-like PCB (PCB 153), or mixtures of these
chemicals; it did not find any increases in either thyroid adenoma or carcinoma.
Thus, although human and animal studies showed that dioxin and dioxin-like
chemicals alter thyroid hormones and increase follicular-cell hyperplasia, there is
little evidence of an increase in thyroid cancer. There are some reports of therapeutic treatment with arsenic trioxide and later development of thyroid cancer
(Au et al., 2014; Firkin, 2014), raising the possibility of an association between
arsenic and a risk of this malignancy. DMA treatment via the drinking water for
24 weeks caused increases in the incidence of thyroid hyperplasia and adenoma,
but not of adenocarcinoma, in male F344/DuCrj rats that were first exposed for
4 weeks to a mixture of five carcinogens to induce tumor initiation in a wide
range of tissues (S. Yamamoto et al., 1995). These increases were statistically
significant at DMA doses of 200 and 400 ppm, but not at 50 or 100 ppm. Animals
treated with 200 and 400 ppm DMA but not given the carcinogens did not develop thyroid lesions, which is consistent with the absence of elevated incidences
of endocrine organ tumors in other bioassays with DMA (see Chapter 4).
As indicated in Chapter 4, 2,4-D and 2,4,5-T are at most weakly mutagenic or
carcinogenic, and no studies that addressed a possible association between exposure to those herbicides and thyroid cancer in animal models have been identified.
Synthesis
The studies of Vietnam veterans and of occupational cohorts reviewed in previous updates did not provide compelling evidence to determine whether there is
an association between exposure to the COIs and cancers of the endocrine organs.
Although Le et al. (2016) found an increased incidence of thyroid cancer among
VA health care users who self-reported exposure to Agent Orange, the study had
several limitations, including self-reported, unconfirmed Agent Orange exposure
and a lack of pathology confirmation of thyroid carcinomas. The small number
of thyroid cancer deaths and the imprecise risk estimates identified among the
UK phenoxy herbicide manufacturers and sprayers limited those findings as well.
Few animal studies have been conducted examining the association between
TCDD, dioxin-like PCBs, or DMA and thyroid cancer, but the results were incon
sistent. Consequently, given the limitations of the new epidemiologic studies
and the inconsistent results of the animal studies, the committee maintains that
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the evidence is inadequate or insufficient to determine an association between
exposure to the COIs and thyroid and other endocrine cancers.
Conclusion
Based on the epidemiologic evidence reviewed here, the committee concludes
that there is inadequate or insufficient evidence to determine whether there is an
association between exposure to the COIs and thyroid or other endocrine cancers.
LYMPHOHEMATOPOIETIC CANCERS
Lymphohematopoietic cancers (LHCs) constitute a heterogeneous group
of clonal hematopoietic disorders including leukemias, lymphomas, and multiple myeloma. They are among the most common types of cancer induced by
environmental and therapeutic agents. As with other cancers that are subject to
evolving and complex grouping in reports of the results of epidemiologic studies
(notably, head and neck cancers and gastrointestinal cancers), the conclusions
that the VAO committees have drawn about associations between exposure to the
COIs and specific LHCs have been complicated by the lack of specificity and by
inconsistencies in groupings in the available evidence. For LHCs, that has been
a function not only of epidemiologists seeking to combine related cancers to produce categories that have enough cases to permit statistical analysis, but also of
a continuous evolution of the system used by the medical community to classify
these malignancies. The categorization of cancers of the lymphatic and hematopoietic systems has changed over time, guided by growing information about
somatic mutation, gene expression, and subclonal lineage of the cancer cells that
characterize each of a broad spectrum of neoplasms arising in these tissues (Jaffe,
2009). The WHO categorization presented in the WHO Classification of Tumours
of Haematopoietic and Lymphoid Tissue (WHO, 2008) bases its primary partition
on whether the cancer cells are of myeloid or lymphoid origin (see Figure 7-1).
This classification was updated in 2016 and reviewed by several academics and
clinicians (Arber et al., 2016; Swerdlow et al., 2016), but the revised “blue book”
has not yet been published.
Stem cells arising in the bone marrow generate two major lineages of leukocytes: myeloid and lymphoid. Myeloid cells include monocytes and three types
of granulocytes (neutrophils, eosinophils, and basophils). Lymphoid cells include
T and B lymphocytes and a smaller set of cells called natural killer cells. All of
these mature cells circulate in the blood and are collectively referred to as white
blood cells or leukocytes. Monocytes move out of the bloodstream into inflamed
tissues, where they differentiate into macrophages or dendritic cells. Progenitor
cells that are destined to become T lymphocytes migrate from the bone marrow
to the thymus, where they acquire antigen-specific receptors. Antigen stimulation
induces the T cells to differentiate into several subtypes involved in cell-mediated
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FIGURE 7-1 Hematopoiesis of stem cell differentiation.
SOURCE: © Winslow, 2007. U.S. government has certain rights.

immunity, immune regulation, and the facilitation of B-cell function. Progenitor or pre-B cells mature in the bone marrow into antigen-specific B cells. On
encountering their cognate antigens, B cells differentiate into antibody-secreting
plasma cells involved in humoral immunity.
LHCs originate in specific pluripotent or lineage-restricted cells at different stages in hematopoiesis and immune-cell development. The normal cells
are transformed into a malignant cell population through a multistep process
that involves genetic and epigenetic alterations. Traditionally, LHCs have been
divided into leukemias, lymphomas, myelomas, and so on, according to their cell
type and site of origin (see Figure 7-1). Additional morphologic, cytochemical,
and immunophenotypic data are used to characterize LHCs further and to further
divide them into distinct subtypes.
Leukemias occur when a myeloid stem cell residing in the bone marrow
becomes transformed, resulting in a failure of differentiation and a resistance to
normal feedback on cellular proliferation. As the leukemic cells (blasts) fill the
bone marrow, they actively secrete cytokines that prevent normal cellular proliferation, leading to reduced circulating normal blood cells. In addition, changes in
adhesion molecules allow the release of these immature cells into the peripheral
blood. Leukemias are generally classified as myeloid or lymphoid, depending
on the lineage of the malignant cell population. If the original mutated cell of
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a cancer of the blood arises in a lymphoid progenitor, then the malignancy is
termed lymphocytic leukemia; lymphocytic leukemias have been further partitioned into acute lymphoblastic leukemia (ALL) (also known as acute lymphoid
leukemia or acute lymphocytic leukemia), which is derived from precursor B
or T lymphoid stem cells, and chronic lymphocytic leukemia (CLL), which is
a “mature B-cell neoplasm” arising from a transformed B lymphocyte. Myeloid
leukemias arise from a myeloid hematopoietic stem cell and are classified into
acute (AML) and chronic (CML) forms.
Lymphoma is a general term for malignancies that arise from lymphocytes
(B, T, or natural killer cells). Lymphomas generally present as solid tumors at
lymphoid proliferative sites, such as lymph nodes and the spleen. As stem cells
mature into B or T cells, they pass through several developmental stages, each
with unique functions. The developmental stage of the malignant cell defines the
subtype of lymphoma. About 85% of lymphomas are of B-cell origin, and 15%
are of T-cell or natural killer–cell origin (Jaffe et al., 2001; Liao et al., 2012).
There are two major types of B-cell lymphomas: HL, previously referred to
as Hodgkin disease, and NHL. B cells give rise to a wide array of neoplasms,
which are characterized by the stage at which B-cell development was arrested,
as well as by the surface protein expression and the genetic characteristics of the
malignant cells. Follicular, large-cell, and immunoblastic lymphomas result when
a malignancy develops after a B cell has been exposed to antigens. CLL is a
tumor of antigen-experienced (memory) B cells (Chiorazzi et al., 2005); small
lymphocytic lymphoma involves the same cells as CLL, but presents primarily in
lymph nodes rather than in the bone marrow and blood and is therefore a variant
of the same disease (Jaffe et al., 2008).
Multiple myeloma is a lymphohematopoietic malignancy derived from
antibody-secreting plasma cells, which also have a B-cell lineage, that accumulate primarily in the bone marrow but may also infiltrate extramedullary sites. The
related condition amyloid light chain (AL) amyloidosis also arises from B cell–
derived plasma cells and reflects an abnormal deposition of antibody-derived light
chains. It occurs as a complication in 5–15% of patients with multiple myeloma,
and may also occur without evidence of frank multiple myeloma. Monoclonal
gammopathy of undetermined significance (MGUS) is a clonal proliferation of
plasma cells condition that may progress to multiple myeloma.
The ICD system partitions these malignancies into leukemias and lymphomas based primarily on whether the cancer cells circulate in the blood (disseminated) or a ppear in the lymphatic tissues, respectively, before subdividing by cell
type. The emerging WHO classification of lymphohematopoietic malignancies
(Campo et al., 2011; Jaffe, 2009) stratifies malignancies of the blood and lymph
nodes into disease categories by their cell lineages—lymphoid or myeloid—as
shown in F
 igure 7-1. It represents a substantial advance in understanding the
biologic paths by which these malignancies develop. Since the new WHO classification has not yet been definitively approved, the committee decided that it
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would not be productive to reformulate this entire section to correspond to the new
WHO categories. In practice, LHCs have routinely been reported in a variety of
groupings, so it is a continuing challenge to parse out results, noting when results
for broader groupings are presented in the supplementary tables for several more
specific diagnoses, while recognizing that the specific results may be confounded
by being“misclassified” with other entities. Most epidemiologic studies already
in the evidentiary database that specifed diseases precisely used codes from ICD-9
or earlier versions, but some recent studies have applied ICD-10. Furthermore,
the existing records that will serve as the basis of many current and even future
studies will use earlier and evolving classifications, so a confounding of classification is likely to remain, even in new literature. The nomenclature has become
more uniform in recent studies, but the possibility of ambiguity remains if earlier
researchers did not use a unique code in accordance with some established system.
On occasion, the observed number of cases is so small that researchers cannot perform useful analyses for each type of LHC and will instead provide summary statistics for the entire group of them. In updating mortality in the Hamburg
cohort in 1952–2007, Manuwald et al. (2012) found non-significant increases in
mortality from LHC in both men and women, which combined to give a significant association between TCDD and all LHC deaths in the whole cohort (SMR =
1.61, 95% CI 1.03–2.40). In a Dutch cohort of workers in two phenoxy-herbicide
plants, Boers et al. (2012) assessed plasma TCDD concentrations at the time of
the assumed last exposure and reported a modest but not statistically significant
increase in the HR for LHC in the total cohort, but there was no increase in plant
A, where workers were occupationally exposed to TCDD.
Because VAO committees aim to address disease entities as specifically as
possible with the available data, the overall results on the broader grouping of
LHCs are of little consequence for the conclusions of association that have been
drawn for the more specific entities. The committee for Update 2010 noted, however, that the common biologic origin of LHCs that have been judged to have a
substantial amount of evidence supporting association with the COIs (HL, NHL,
CLL, hairy-cell leukemia [HCL], multiple myeloma, and AL amyloidosis) means
that the WHO approach is supportive of and consistent with these decisions on
the part of VAO committees. The Update 2014 committee familiarized itself
with the classification systems that have been used for lymphoid malignancies,
including hearing a presentation from the International Lymphoma Epidemiology
Consortium (InterLymph) describing a proposed classification of these cancers
into subtypes that are particularly appropriate for epidemiologic research, including methods to harmonize data, standardized definitions of disease entities and
rigorous quality control of these subtype assessments, and attempts to understand
the implications of etiologic heterogeneity (Morton et al., 2014a,b). At the same
time, as has been recognized by others (Saberi Hosnijeh et al., 2012c), given the
type and quality of the historical data that constitute the majority of the material

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

330

VETERANS AND AGENT ORANGE: UPDATE 11

available to the committee for review and judgement, little of that impressive
effort can be applied to the committee’s assessment of association.
VA asked previous VAO committees to address CLL, AML, and HCL individually. A scrutiny of the entire body of epidemiologic results on leukemias for
findings on particular types (as had been the most common manner of grouping)
revealed several studies that showed increased risks specifically of CLL but that
did not provide support for an association of AML with exposure to the COIs.
The committee for Update 2002 advised VA that CLL is recognized as a form
of NHL, which is already recognized as a service-related condition, whereas the
committee for Update 2006 did not recognize an association between the COIs
and AML. Later, the committee responsible for Update 2008 advised VA that,
like CLL, HCL should be grouped as a mature B-cell neoplasm. For the current
update, VA has tasked the committee to specifically address myeloproliferative
neoplasms (MPNs). In light of the history and in accord with the current WHO
classification, the committee for this update has incorporated data specifically
on CLL and HCL into the section on NHL. After a brief synopsis of biologic
plausibility of the LHCs overall, the more common cancers of the lymphatic
system are described in the sections below on HL, NHL, and multiple myeloma
(with a section on the related condition, AL amyloidosis), and then evidence
on leukemias in general is discussed, with a focus on information regarding
leukemias of myeloid origin.
Biologic Plausibility
Studies in animal models have indicated that the AHR pathway plays an
integral role in B-cell maturation and that TCDD and dioxin-like chemical
exposure may alter the function of these cells and lead to critical changes in the
immune response. The suppression of the immune response by TCDD and similar chemicals in rodents and primates has been known for more than 30 years,
but the effect on human cells is less clear. Some reports indicate that TCDD and
dioxin-like chemicals elicit similar effects in humans. The activation of nontransformed human B cells results in an increase in the expression of AHR, and
additional data indicate that this pathway has a role in normal B-cell function
(Allan and Sherr, 2010; Sherr and Monti, 2013). Furthermore, treating these
cells with benzo[a]pyrene suppresses B-cell differentiation. H. Lu et al. (2010)
demonstrated that although human B cells appeared less responsive to TCDD in
terms of increasing the expression of AHR pathway genes, the ability of TCDD
to decrease immunoglobulin (Ig) M production is similar in both mouse and
human B cells. Research that modeled the mode by which TCDD suppresses the
terminal differentiation of B cells offers distinct pathways whose action can be
altered by exposure (Q. Zhang et al., 2013). Data on human hematopoietic stem
cells and from the use of knockout Ahr mouse models show that Ahr is critical
in hematopoietic stem cell maturation and differentiation (Ahrenhoerster et al.,
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2014; Fracchiolla et al., 2011; K. P. Singh et al., 2011, 2014; B. W. Smith et al.,
2013). TCDD not only alters hematopoietic stem cell maturation, but also alters
proliferation and migration in vivo and in vitro (Casado et al., 2011). Finally,
emblematic of the potential pleotropic effects of TCDD, Hughes et al. (2014)
demonstrated that AHR plays a critical role in promoting lymphocyte differentiation into mature natural killer cells. Reviews have highlighted the complex and
varied nature of the interaction of TCDD with the immune system (Gasiewicz
et al., 2014; Lindsey and Papoutsakis, 2012).
Saberi Hosnijeh et al. (2012b, 2013a) assessed both the immune profile and the
levels of soluble immune signaling proteins in TCDD-exposed workers. Consistent
with data published on U.S. ACC veterans, in 47 highly TCDD-exposed and 38 low
TCDD-exposed workers they found no effect of TCDD on major leukocyte subsets
or on white blood cell counts. They did note a non-significant decrease in most
lymphocyte subsets, which was most prominent for B cells. In these same workers,
a study of soluble CD27 and soluble CD30 in sera found no clear dose–response
relationship of TCDD with the level of these signaling proteins. However, there
was a significant negative association of the serum IL-1RA level with the TCDD
serum level among workers without chronic disease. Taken together, these data
indicate that exposure to TCDD (and the alteration of normal AHR function) may
have multiple effects on immune cell differentiation and function.
No new mechanistic or biologic plausibility studies regarding lymphohematopoietic cells have been identified by the committee since Update 2014.
Hodgkin Lymphoma
HL (ICD-9 201; ICD-10 C81), also known as Hodgkin disease, is distinguished from NHL primarily based on its neoplastic cells, mononucleated
Hodgkin cells, and multinucleated Reed–Sternberg cells, derived from germinalcenter B cells (Küppers et al., 2002). NCI estimated that 8,500 people would
receive a new diagnosis of HL in the United States in 2018 and that 1,050 men
and women would die from it; it ranks 25th in most common cancer diagnoses
(NCI, n.d.y).
The incidence of HL increases with age; the average age of diagnosis is
39 years. Although the incidence rate is slightly higher in men than in women
of the same race, it is about the same in whites and blacks (NCI, n.d.y). In
the age groups that include most Vietnam veterans, the age-adjusted modeled
incidence rate of HL for men 50–64 years old of all races combined was 3.2
per 100,000 in 2014 and increased to 4.7 for 65–74-year-olds and 5.7 for men
over 75 years.19
19 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output by using the
SEER 13 dataset and choosing age-adjusted rates, HL, all races, age ≥ 50 years, and male sex.
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The possibility that HL has an infectious etiology has been a topic of discussion since its earliest description. A higher incidence in people who have a
history of infectious mononucleosis has been observed in some studies, and a
link with Epstein–Barr virus has been proposed (Balfour et al., 2015; Murray
and Bell, 2015). In addition to the occupational associations discussed below,
higher rates of the disease have been observed in people who have suppressed or
compromised immune systems.
Conclusions from VAO and Previous Updates
Based on the 32 studies it reviewed, the committee responsible for VAO
determined that there were sufficient epidemiologic data to support an association between exposure to the COIs and HL. Additional studies available to the
committees responsible for subsequent updates have not changed that conclusion.
Two well-conducted Swedish studies with good exposure characterization reviewed in VAO provide the most comprehensive information on the
association between exposure to phenoxy herbicides (2,4-D and 2,4,5-T),
picloram, or chlorophenols and HL. Hardell et al. (1981) considered NHL and
HL together, and Hardell and Bengtsson (1983) considered HL separately; they
found statistically significant associations with exposure to phenoxy acids (after
excluding people who were exposed to chlorophenols) and with exposure to
chlorophenols. In a study of 54 HL cases, Persson et al. (1989) found a large
but imprecise and not statistically significant risk associated with exposure to
phenoxy acids. Several of the other case-control and occupational-cohort studies in U.S. and international populations reviewed in VAO showed an increased
risk of HL, but only a few of the results were statistically significant. As with
NHL, even the largest studies of production workers who were exposed to
TCDD did not indicate an increased risk. The few studies of HL in Vietnam
veterans tended to show increased risks, but only one (Holmes et al., 1986) was
statistically significant.
Among the studies of veterans reviewed throughout the VAO series, no statistically significant increased risk of HL was found. Publications from the AFHS
showed no statistically significant increases in HL or lymphopoietic cancers
(AFHS, 2000; Akhtar et al., 2004). Other populations of Vietnam-era veterans
likewise did not find an association (Anderson et al., 1986a,b; Holmes et al.,
1986; Lawrence et al., 1985; Visintainer et al., 1995). A proportionate mortality
ratio analysis that compared the experience of 33,833 U.S. Army and Marine
Corps Vietnam veterans who died during 1965–1988 with that of 36,797 deceased
non-Vietnam veterans found a statistically significant increase of deaths from
HL in Marine Corps veterans—although not Army veterans—who had served in
Vietnam (Watanabe and Kang, 1996). Cypel and Kang (2008) compared mortality
from lymphopoietic cancers in female Vietnam veterans with that of female era
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veterans and the U.S. population; deaths from lymphopoietic cancers were not
higher in those who served in Vietnam.
Studies of Australian, New Zealand, and Korean veterans who served in Vietnam have also been reviewed. The incidence of HL was found to be statistically
significantly higher than the general population when Australian veterans from all
branches were combined (ADVA, 2005a), but when veterans were stratified by
service branch, the only statistically significant association was between HL and
service in the Army. However, no statistically significantly increased mortality
from HL was found for all service branches combined, nor for any single branch
(ADVA, 2005b). A comparison of deployed and non-deployed Vietnam-era Australian conscripted Army National Service veterans found no association between
deployment and the incidence of or mortality from HL (ADVA, 2005c). Among
a cohort of male Vietnam veterans from New Zealand, McBride et al. (2013)
reported one death from and three incident cases of HL resulting in imprecise
and unstable effect estimates. Among the Korean veterans who had served in
Vietnam, Yi and Ohrr (2014) reported no statistically significant difference in
the risk of HL in the internal comparison of the high- and low-exposure groups
based on the EOI scores.
Several occupational cohorts of workers from several countries who were
exposed to phenoxy herbicides and other related chemicals have been followed
long term. Studies of the IARC phenoxy-herbicide cohort showed no excess of
HL incidence or mortality compared with national rates (Kogevinas et al., 1993).
Additional follow-up showed a non-statistically significant increase in HL in
workers who were exposed to TCDD or higher chlorinated hydrocarbons but
no association was found between phenoxy herbicides or chlorophenols and HL
(Kogevinas et al., 1997). In a multinational IARC cohort of 60,468 pulp-and-paper-industry workers, McLean et al. (2006) found that death from HL was significantly higher in those who had ever been exposed to nonvolatile organochlorine
compounds (which would include TCDD) but not in those who had never been
exposed compared with the national standardized populations.
In a retrospective cohort study of Dutch production and contract workers
who were exposed to phenoxy herbicides, chlorophenols, and contaminants
during 1950–1976, Hooiveld et al. (1998) reported a non-significant increase
in HL. Rix et al. (1998) compared mortality in a cohort of Danish paper mill
workers with mortality in the general Danish population and found a statistically significant increase in men but not women. Swaen et al. (2004) extended
the follow-up of mortality by 13 years in a cohort of Dutch herbicide appliers
and observed no additional deaths, causing the earlier mortality risk estimate of
HL in the cohort to no longer be statistically significant (Swaen et al., 1992).
Studies of German manufacturing workers found no association between exposure to TCDD and HL (Becher et al., 1996). McBride et al. (2009a) examined
mortality in TCP manufacturing workers in the Dow AgroSciences plant in New
Zealand, but a single observed HL death yielded inconclusive results. A French,
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hospital-based, case-control study of lymphoid neoplasms (Orsi et al., 2009) did
not find a statistically significant increase in the risk of HL after occupational
exposure to herbicides in general or after occupational exposure to phenoxy
herbicides in particular.
Among U.S. production workers, the low numbers of deaths from HL and
imprecise estimates limited the findings. In an update and expansion of cohorts
involved in the NIOSH study, Steenland et al. (1999) observed three deaths attributed to HL, which was not statistically different from the comparison population.
No deaths from HL were identified in Dow PCP workers in Midland, Michigan
(Collins et al., 2009c; Ramlow et al., 1996), and only two deaths from HL
occurred among the TCP workers, resulting in imprecise risk estimates (Collins
et al., 2009b). Additional updates of these occupational cohorts noted very small
numbers of additional cases of HL, which did not produce substantive changes in
prior findings. Burns et al. (2011) reported an additional case among Dow 2,4-D
production workers. Ruder and Yiin (2011) likewise reported one additional HL
death in the NIOSH cohort of PCP workers.
Studies of the Seveso cohort have found few cases and no increased incidence or mortality of HL among men or women in zones A, B, or R. These findings remained consistent at the 10-year follow-up (Bertazzi et al., 1993), 15-year
follow-up (Bertazzi et al., 1997), 20-year update (Bertazzi et al., 2001; Pesatori
et al., 2009), and 25-year update (Consonni et al., 2008).
Several studies of HL among agricultural workers have also been reviewed by the update committees. Whereas Persson et al. (1993) reported a
significant increase in the odds of HL prevalence in Swedish farmers who
were exposed to phenoxy acid herbicides, no excess of HL deaths was found
in a death certificate review of U.S. farmers from 23 states (Blair et al., 1993).
In a nonspecific analysis of exposure to “herbicides” in a Michigan farming
community, Waterhouse et al. (1996) demonstrated a statistically significant
increase in the combined incidence of lymphopoietic neoplasms in a prospective study. Two reports from the AHS found no excess risk of HL in pesticide
applicators, commercial applicators, or their spouses, but herbicide exposures
were not specific (Alavanja et al., 2005; Blair et al., 2005a). Updates of cancer
incidence (Koutros et al., 2010a) and mortality (Waggoner et al., 2011) among
participants in the AHS also did not find increases of HL in private applicators
or their spouses.
In the Cross-Canada Study of Pesticides and Health, P. Pahwa et al. (2006)
found no association of any exposure to phenoxy herbicides, 2,4-D, Mecoprop,
or MCPA and HL. Nested case-control studies of data from the Cross-Canada
study found no statistically significant associations of exposure to COIs with
HL (Karunanayake et al., 2012; P. Pahwa et al., 2003). A follow-up analysis of
the Cross-Canada study (Navaranjan et al., 2013) that examined the incidence
of STS, NHL, multiple myeloma, and HL in men ages 19 years and older found
no increased risk of HL in those exposed to one, two, or three or more phenoxy
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herbicides after adjusting for age and the province of residence. However, exposure specificity remains a major issue for this study.
Update of the Epidemiologic Literature
No new published literature of Vietnam veterans, environmental studies, or
case-control studies that addressed exposure to the COIs and HL was identified
by the committee for the current update. Reviews of the relevant studies are
presented in the earlier reports. Table 24, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to HL.
Occupational Studies Among the Dow Midland, Michigan, worker cohort
that was compared with the standardized U.S. population, Collins et al. (2016)
found only two deaths from HL were reported during the follow-up period and
both were among TCP workers, making the reported risk estimates unreliable.
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers to examine the carcinogenicity of phenoxy herbicides, Coggon et
al. (2015) reported only three deaths from HL, and all were among the workers
potentially exposed to phenoxy acids above background levels and for more than
1 year (SMR = 1.71, 95% CI 0.35–4.99).
Other Identified Studies One other study that reported outcomes of mortality
from HL was identified, but it lacked sufficient exposure specificity to be included
as contributing to the evidence base of the potential effects of the COIs (Ruder
et al., 2014).
Biologic Plausibility
HL arises from the malignant transformation of a germinal-center B cell and
is characterized by malignant cells that have a distinctive structure and phenotype; these multinucleate cells are known as Reed–Sternberg cells (Jaffe et al.,
2008). No animal studies have shown an increase in HL after exposure to the
COIs. Reed–Sternberg cells have not been demonstrated in mice or rats, so there
is no good animal model of HL. Thus, there are no specific animal data to support
the biologic plausibility of an association between the COIs and HL.
Synthesis
The relative rarity of HL complicates the evaluation of epidemiologic studies
because their statistical power is generally low. Earlier studies (Eriksson et al.,
1992; Hardell et al., 1981; Holmes et al., 1986; LaVecchia et al., 1989; Persson et
al., 1993; Rix et al., 1998; Waterhouse et al., 1996; Wiklund et al., 1988a) were
generally well conducted and included excellent characterizations of exposure,
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and they formed the basis of previous VAO committees’ conclusions. Subsequent
findings have not contradicted those conclusions, especially given that most studies
have had low statistical power, as was seen in the current extended follow-ups of
occupational cohorts that reported two (Collins et al., 2016) and three (Coggon et
al., 2015) deaths from HL. Although it has not been demonstrated in any animal
models, a positive association between the COIs and the development of HL is biologically plausible because of the common lymphoreticular origin of HL and NHL
(which has been demonstrated in animal models) and their common risk factors.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the
committee concludes that there is sufficient evidence of an association between
exposure to at least one of the COIs and HL.
Non-Hodgkin Lymphoma
NHL (ICD-9 200.0–200.8, 201, 202.0–202.2, 202.8–202.9; ICD-10 C82–85,
C96.3) is a general name for malignancies of the lymphatic system other than
HL or plasma cell dyscrasias. NHL consists of a large group of lymphomas
that can be partitioned into acute and aggressive (fast-growing) or chronic and
indolent (slow-growing) types of either B-cell or T-cell origin. B-cell NHL
includes Burkitt lymphoma, diffuse large B-cell lymphoma, follicular lymphoma,
large-cell lymphoma, precursor B-lymphoblastic lymphoma, and mantle-cell
lymphoma. T-cell NHL includes mycosis fungoides and anaplastic large-cell
lymphoma. Precursor T-lymphoblastic lymphoma is not considered a type of
NHL and is considered instead part of T-lymphoblastic lymphoma/leukemia, a
precursor lymphoid neoplasm included with the broad group of “acute lymphoid
leukemias,” which can be of either T-cell or B-cell origin.
In response to requests from VA to address CLL, HCL, and AML specifically and individually, CLL and HCL have been recognized as subtypes of NHL
(demonstrating B-cell origin and immunohistochemical properties consistent with
B-cell lymphoma). The proposed WHO classification of NHL notes that CLL
(ICD-9 204.1; ICD-10 C91.1) and its lymphomatous form, small lymphocytic
lymphoma, are both derived from mature B cells (Chiorazzi et al., 2005; IARC,
2001). The committee for Update 2012 determined that it is more appropriate to
consider those lymphatic malignancies with other forms of NHL. Therefore, the
discussion of CLL and HCL has been moved into the NHL grouping.
NCI estimated that 74,680 people would receive a new diagnosis of NHL
in the United States in 2018 and that 19,910 men and women would die from
it; it ranks as the seventh most common cancer diagnosis (NCI, n.d.z). The incidence of NHL increases with age; the average age of diagnosis is 67 years. The
incidence rate is about 50% higher in white and black men than in women of the
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same race and is highest for whites. In the age groups that include most Vietnam
veterans, the age-adjusted modeled incidence rate of NHL for men 50–64 years
old of all races combined was 36.3 per 100,000 in 2014 and increased to 91.1 for
65–74-year-olds and 147.8 for men over 75 years.20
In addition, NCI estimated that 20,940 men and women would receive a
diagnosis of CLL in the United States in 2018 and that 4,510 people would die
from it. Nearly all cases occur after the age of 50 years, and the median age of
diagnosis is 70 years. The incidence rate is about two times higher in men than
in women of the same race and is highest for whites (NCI, n.d.aa).
The causes of NHL are poorly understood. People who have suppressed or
compromised immune systems are known to be at higher risk, and some studies
show an increased incidence in people who have HIV, human T-cell leukemia
virus type I, Epstein–Barr virus, surface antigen positive hepatitis B, or gastric
Helicobacter pylori infections. The human retrovirus HTLV-1 causes adult T-cell
lymphoma, but early reports that HTLV-2 might play a role in the etiology of
HCL have not been substantiated. A broad spectrum of behavioral, occupational,
and environmental risk factors have been proposed as contributors to the occurrence of NHL, but given the diversity of malignancies included under this name
and the evolving classification of the subtypes (to date, minimal exploration of
etiologic heterogeneity has been done), it is not too surprising that—aside from
infectious agents, immune problems, and particular chemotherapies—specific
risk factors have not been definitively established (Morton et al., 2008, 2014a,b;
Wang and Nieters, 2010).
Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was sufficient
evidence to support an association between exposure to at least one of the COIs
and NHL. Additional information available to the committees responsible for
later updates has not changed that conclusion. Update 2002 was the first to discuss CLL separately from other leukemias. The epidemiologic studies indicated
that farming, especially with exposure to 2,4-D and 2,4,5-T, is associated with
significant mortality from CLL. Many more studies support the hypothesis that
herbicide exposure can contribute to NHL risk. Most cases of CLL and NHL
reflect the malignant transformation of germinal-center B cells, so these diseases
could have a common etiology.
As with HL, the epidemiologic data reviewed by previous VAO committees
suggest that it is the phenoxy herbicides (including 2,4-D) rather than TCDD
that may be associated with NHL. The original VAO committee concluded that a
20 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output using the SEER
13 dataset and by choosing age-adjusted rates, non-Hodgkin lymphoma, all races, age groups 50–64,
65–74, and ≥ 75 years, and male sex.
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positive association existed between exposure to herbicides and the development
of NHL, and studies reviewed by later committees have continued to support
that finding. A large, well-conducted case-control study in Sweden by Hardell
(1981) examined NHL and HL together and found, on the basis of 105 cases, a
statistically significantly increased risk associated with exposure to phenoxy acids
or chlorophenols. Those results were replicated in further investigations of the
validity of the exposure assessment and potential biases (Hardell, 1981). Hardell
et al. (1994) also examined the relationship between occupational exposure to
phenoxyacetic acids and chlorophenols and various characteristics related to
NHL—including histopathologic measures, stage, and anatomic location—on the
basis of the NHL cases in a previous study (Hardell et al., 1981). Similar data by
Persson et al. (1989) showed, based on a logistic regression analysis of 106 cases,
an increased risk of NHL in those exposed to phenoxy acids. Other case-control
studies of NHL conducted in Sweden found a statistically significantly elevated
risk of NHL (Eriksson et al., 2008; Hardell and Eriksson, 1999; Hardell et al.,
2001, 2002; Olsson and Brandt, 1988).
Several case-control studies of NHL incidence, risk, or mortality in other
exposed populations have also been reviewed by VAO committees, including
studies from New Zealand (Pearce et al., 1985, 1986b, 1987), Italy (Amadori et
al., 1995; Nanni et al., 1996), and Canada (Ng et al., 2010; Spinelli et al., 2007).
Various U.S. populations have also been studied for associations of herbicides
with NHL (Cantor, 1982; Cantor et al., 1992; Colt et al., 2009; Hartge et al., 2005;
Tatham et al., 1997; Zahm et al., 1993); NHL and multiple myeloma (Burmeister
et al., 1983); and STS and NHL (Woods and Polissar, 1989; Woods et al., 1987).
Studies of production workers have shown some association between TCDD
exposure and NHL. A larger study of 21,863 workers in the IARC phenoxyherbicide cohort followed from 1939 to 1992 found a non-significant increase in
NHL risk (Kogevinas et al., 1997). Other studies of Danish and Dutch phenoxy-
herbicide workers who were part of the IARC cohort have shown a non-significant increased risk of NHL (Boers et al., 2010; Bueno de Mesquita et al., 1993;
Hooiveld et al., 1998; Lynge, 1993). A cohort of 2,479 workers in four plants
in Germany with exposure to phenoxy herbicide and contaminants (dioxins
and furans) had a significantly increased risk of NHL on the basis of five cases
(Becher et al., 1996). Non-statistically significant increases in risk have also been
found in the NIOSH mortality study (Steenland et al., 1999). Risks were not significantly increased among the Dow Chemical Company Midland, Michigan, or
Plymouth, New Zealand, chemical production workers, phenoxy-herbicide sprayers, or 2,4-D production workers (Bloemen et al., 1993; Bodner et al., 2003; C. J.
Burns et al., 2001; Collins et al., 2009b,c; McBride et al., 2009a,b; Ramlow et
al., 1996; 't Mannetje et al., 2005). A multinational IARC cohort study of paperand-pulp workers found a statistically significant increase in workers who were
exposed to chlorophenols (McLean et al., 2006).
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Studies of farmers and agricultural workers have been generally positive
for an association between herbicides or TCDD and NHL; however, only a few
were statistically significant. A meta-analysis of several studies of the association
between employment as a farmer in the central United States and NHL showed
a statistically significant risk (Keller-Bryne et al., 1997). All of the studies of
U.S. agricultural workers that were reviewed showed increased risk ratios, and
two NCI studies of farmers in Kansas and Nebraska (Hoar et al., 1986; Zahm
et al., 1990) showed patterns of an increased risk linked to use of 2,4-D. A third
NCI study of NHL was conducted in four Surveillance, Epidemiology and End
Results program centers (Detroit, Iowa, Los Angeles, and Seattle) from 1998 to
2000 (Pronk et al., 2013). The researchers used residential history from 15 years
prior to diagnoses to link residence to EPA databases of dioxin-emitting facilities,
studying 969 cases and 749 controls. Proximity to any dioxin-emitting facility
was not associated with NHL. A study of a subcohort of Hispanic workers in
a larger cohort of 139,000 California members of the United Farm Workers of
America (Mills et al., 2005) and a population-based case-control study in Italy
of NHL and CLL cases (combined) identified during 1991–1993 (Miligi et al.,
2006) both showed statistically significant associations with 2,4-D. An additional
occupational exposure study using the EPI-LYMPH multicenter study (conducted
in the Czech Republic, France, German, Ireland, Italy, and Spain from 1998 to
2004) assessed pesticide use in applying a crop-exposure matrix with lymphoma
diagnoses in a case-control design (Cocco et al., 2012). No statistically significant
association was observed between any kind of pesticide or herbicide use and lymphomas or its subtypes, including between exposure to phenoxy acids and CLL.
The Cross-Canada Study of Pesticides and Health, a large, well-conducted,
population-based, case-control study, reported on pesticide use and NHL incidence in men identified from cancer registries of six Canadian provinces from
1991 to 1994. Statistically significant associations were found between exposure
to phenoxy herbicides, 2,4-D, or Mecocrop (MCPA) and NHL. A reanalysis of
the data from that study confirmed the findings on phenoxy herbicides but found
that the association with 2,4-D, although still increased, was no longer statistically significant (McDuffie et al., 2001). A study of the participants who had a
first diagnosis of STS, NHL, multiple myeloma, or HL during the original study
period were followed through mailed and telephone interviews to examine the
joint effects of asthma, allergies, or asthma and allergies and hay fever combined
with pesticide exposure in the genesis of NHL. Incident NHL cases (n = 513)
diagnosed between 1991 and 1994 were compared with the experience of 1,506
controls. Subjects with asthma, allergies, or hay fever had elevated risks that were
not statistically significant associated with the use of phenoxy herbicides, MCPA,
or 2,4-D. The results overall were not supportive of any major effect modification
by these immune conditions.
A population-based case-control study conducted in 2000–2001 of men
and women 20–74 years old living in New South Wales, Australia, found an
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increased risk of NHL associated with “substantial” exposure to phenoxy herbicides ( Fritschi et al., 2005). Spinelli et al. (2007) reported on a population-based
case-control study in Vancouver and Victoria, British Columbia, which found
strong monotonic increases in serum concentrations of two dioxin-like PCBs
(PCB 118 and PCB 156). Chiu et al. (2004) and W. J. Lee et al. (2004a) conducted a pooled analysis of two case-control studies that were carried out in three
midwestern U.S. states—Iowa and Minnesota (Cantor et al., 1992) and Nebraska
(Zahm et al., 1990)—and found that NHL risks were increased in farmers by the
use of herbicides, including 2,4-D and 2,4,5-T. In a study of NHL incidence in
people who lived near 13 French municipal waste incinerators, Viel et al. (2008b)
found a small but statistically significant increase in the risk of NHL and evidence
of a dose–response relationship with increased exposure to dioxin. A case-control
study of NHL rates in people who lived near a municipal solid-waste incinerator
in Bensaçon, France, found that the incidence of NHL was significantly increased
in the area determined to have the highest dioxin contamination, but no increases
were found in the low and intermediate categories (Floret et al., 2003). A French
hospital-based case-control study of lymphoid neoplasms (Orsi et al., 2009) did
not find the occurrence of NHL to be associated with occupational or domestic
use of pesticides or phenoxy herbicides in particular. With 25 years of follow-up
of the Seveso population and a relatively small number of observed cases, there is
no evidence of an increased incidence of NHL or mortality in any of the exposed
zones (Bertazzi et al., 1989b, 1993, 1997, 2001; Consonni et al., 2008; Pesatori
et al., 1992, 2009).
The findings of several PCB-focused studies (Bertrand et al., 2010; Engel
et al., 2007; Laden et al., 2010) are consistent with the associations with NHL
repeatedly observed in connection with the COIs in the VAO series. However, the
extent of intercorrelation of these persistent organic pollutants greatly curtails the
degree to which any effect can be specifically attributed to dioxin-like activity.
Evidence of an association between the COIs and NHL in Vietnam veterans,
the primary population of interest in the VAO updates, has been lacking. The CDC
Selected Cancers Study (CDC, 1990a,b) showed a significantly increased risk of
NHL in all Vietnam veterans; however, in an analysis that considered branch of
service, Army and Air Force personnel were found not to be at increased risk.
Marine Corps veterans had a higher mortality in the CDC Selected Cancers Study
and significantly increased risks in several other studies (Breslin et al., 1988; Burt
et al., 1987; Watanabe and Kang, 1996; Watanabe et al., 1991), but the implications of these findings are unclear. No increased risk has been found in Ranch
Hand veterans (AFHS, 2000; Akhtar et al., 2004; Michalek et al., 1990; Wolfe et
al., 1990) or in members of the ACC (Boehmer et al., 2004).
In studies of Vietnam veterans from New Zealand and Korea, no statistically
significant increased risk of NHL was found in either group. The New Zealand
study also reported on lymphoid leukemia (which would include any cases of
CLL) and found a statistically significant increase (McBride et al., 2013). Yi et
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al. (2014b) reported a modestly increased risk for NHL mortality between the
high- versus low-exposure groups of the Korean veterans and a small increased
risk with the individual log-transformed EOI scores, but neither was statistically
significant. Lymphoid leukemia showed a nonstatistically significant decreased
risk based on nine low-exposure and five high-exposure deaths.
Update of the Epidemiologic Literature
Several new studies of exposure to the COIs and NHL were identified
including two studies of Vietnam veterans and CLL. Reviews of the relevant
studies are presented in the earlier reports. Table 25, which can be found at www.
nap.edu/catalog/25137, summarizes the results of studies related to NHL.
Vietnam-Veteran Studies A retrospective study of veterans diagnosed with
CLL who attended the Minneapolis VA at least one time between 2001 and 2010
was conducted to determine whether exposure to Agent Orange alters features of
CLL disease presentation or its prognostic features, including stage at diagnosis,
lymphocyte doubling time, or cytogenetics (Baumann Kreuziger et al., 2014).
Of the 195 veterans identified as having a diagnosis of CLL, 33 (17%) were
determined to have been exposed to Agent Orange. (Veterans submit a claim of
exposure that is reviewed by VA using service records to confirm whether the veteran was stationed in an area that was sprayed with herbicides during the service
period.) Except for age at diagnosis, demographic factors and laboratory counts
were similar between the veterans determined to have been exposed and those
reported as unexposed. Compared with veterans who were reported as unexposed
to Agent Orange, the exposed patients showed a statistically significantly lower
age of presentation (61 versus 72 years; p = 0.001), and the time to first treatment
was also shorter in the exposed patients (9.6 versus 30 months, p = 0.02), but the
number of therapies and the rate of transformation were not different between exposed and unexposed patients. However, providers were not blinded to exposure
status, and, because patients were younger, these factors may have influenced the
therapy paradigm used. Overall, survival was not statistically different between
exposed and unexposed patients, and this remained the case after adjusting for
age (HR = 1.8, 95% CI 0.7–4.5, p = 0.24).
A second retrospective study among U.S. Vietnam veterans was identified
that examined CLL prognosis, treatment, and survival and their association with
exposure to Agent Orange (determined by benefits and compensation officers who
use service records to confirm if the locations and timeframes of deployment correspond to sprayed areas). Mescher et al. (2018) identified 2,052 Vietnam veterans
(20.4% determined to have been exposed to Agent Orange) who were diagnosed
with CLL between 2009 and 2013 from the National VA Tumor Registry. Information on demographics, laboratory and disease-related parameters at the time of the
initial diagnosis, and the type and number of treatments received was taken from
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medical records. Overall survival was defined as time from CLL diagnosis to death
from any cause or else to date of last follow-up. The Cox proportional hazards
model included age, Rai stage, and baseline laboratory parameters. Prognostic
factors did not differ based on exposure. Compared with the unexposed, veterans
exposed to Agent Orange were diagnosed at younger age (63.2 versus 70.5 years,
p < 0.0001) and had longer overall survival (p < 0.001). CLL prognostic factors
and cytogenetics did not differ between the groups, although more of the exposed
group had cytogenetics available. Time to initial treatment was shorter in exposed
patients. Median overall survival was longer in exposed patients—quite possibly
because they were treated more aggressively because they were young.
Occupational Studies Among the Dow Midland, Michigan, worker cohort,
Collins et al. (2016) found that compared with the standardized U.S. population,
no differences in mortality for NHL were found for the TCP workers (n = 10;
SMR = 1.08, 95% CI 0.52–1.99) or the PCP workers (n = 8; SMR = 1.92, 95%
CI 0.83–3.79).
In an extension of the follow-up of UK phenoxy herbicide manufacturers
and sprayers examining the carcinogenicity of phenoxy herbicides and their
association primarily with HL, STS, and CLL, Coggon et al. (2015) calculated
standardized mortality ratios using person-years and the general populations of
England and Wales as the comparison group. Nested case-control analyses compared men with incident or fatal NHL/CLL (n = 74) and matched controls (up to
10 per case). A total of 29 NHL/CLL deaths were reported. The risk of death from
NHL/CLL was not statistically significantly elevated among all workers (SMR
= 0.96, 95% CI 0.64–1.38) or among workers exposed to herbicide levels above
background (n = 26; SMR = 1.15, 95% CI 0.75–1.68). However, death from NHL
was statistically significantly higher for men who were exposed to phenoxy acids
above background for 1 year or longer (n = 19; SMR = 1.85, 95% CI 1.12–2.89).
No other statistically significant associations or trends were reported for mortality
from other types of cancers. Although a statistically significant excess of deaths
from NHL was reported, the authors believe that greater weight should be given
to the nested case-control analysis, which included both non-fatal and fatal cases
and men with CLL as well as solid lymphomas. That analysis found no statistically significant increased risk with exposure to phenoxy herbicides; the highest
risk estimate was for workers with high exposure (OR = 1.22, 95% CI 0.61–2.46).
The committee believes that the caveat here is that the researchers seem to use
CLL as their surrogate for NHL, which may or may not be correct. A cleaner
analysis would have been to look specifically at other lymphomas (diffuse large
B cell, follicular lymphomas, etc.). However, as the data linking exposure to phenoxy herbicides and NHL have been inconsistent, the committee agrees with the
authors that if there really is an increased risk of NHL/CLL, it is likely very small.
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Case-Control Studies Czarnota et al. (2015) conducted an analysis of 27 correlated chemicals (5 PCBs, 7 PAHs, and 15 pesticides) measured in house dust
samples and NHL risk using data collected from 1998 to 2000 as part of the
population-based case-control study of NHL in four SEER study sites (Detroit,
Iowa, Los Angeles, and Seattle). Eligible cases were 20–74 years of age, diagnosed with a first primary NHL, and uninfected with HIV. The study recruited
1,321 people with NHL who were frequency-matched to 1,057 controls by sex,
age (within 5-year groups), race, and study site. Computer-assisted personal
interviews were conducted in the home of each participant and included questions on demographics, house characteristics, pesticide use in the home and
garden, and residential and occupational histories. Dust samples were collected
and analyzed from vacuum cleaners for participants who had used their vacuum
cleaner within the past year and owned at least half of their carpets or rugs for
5 years or more. The chemicals relevant to the work of the VAO committee that
were analyzed were PCB 105, 2,4-D, and dicamba. Pairwise comparisons were
performed to obtain a weighted quantile sum for an index of 27 environmental
chemicals. The 27 chemicals were not weighted equally in the index, overall or
by site. The weighted quantile sum index was statistically significantly associated with NHL (OR = 1.30, 95% CI 1.08–1.56). Concentrations of 2,4-D and
dicamba were found to be elevated in the Iowa site. The only individual chemical
that was associated with NHL was non-dioxin-like PCB 180. However, associations with NHL were negative and statistically significant for 2,4-D (OR = 0.36,
95% CI 0.19–0.68) and dicamba (OR = 0.48, 95% CI 0.26–0.90) in the Iowa site
and 2,4-D (OR = 0.53, 95% CI 0.29–0.97) and dicamba (OR = 0.41, 95% CI
0.22–0.76) in the Seattle site.
Kelly et al. (2017) used data from the EnviroGenoMarkers study, which
is nested within two prospective cohorts in Italy and Sweden, to determine the
association between NHL and prediagnositic blood plasma concentrations of 10
environmental pollutants, including two dioxin-like PCB congeners (118 and
156). During 16 years of follow-up, 270 incident cases of B-cell NHL (including 76 cases of multiple myeloma) were diagnosed. Cases were matched to 270
healthy controls by center, age, gender, and date of blood collection. Cases were
categorized into ordered quartiles of exposure for each persistent organic pollutant based on the distribution of exposure in the control population. No difference
in median exposure levels was observed between cases and controls for any of
the chemical exposures (p > 0.05) or, specifically, for the dioxin-like PCBs: PCB
118 (p = 0.991) and PCB 156 (p = 0.186). The quartile analysis similarly did not
show an association between the dioxin-like PCBs and NHL (only the comparison of cases and controls in the third quartile was statistically significant, but
there was no significant association in the test for trend). These were not heavily
exposed individuals, so the levels may be uniformly low. Overall, this study does
not provide evidence that higher body burden of the two dioxin-like PCBs (or
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the other persistent organic pollutants measured) increases the risk of subsequent
NHL diagnosis.
Other Identified Studies Six other studies of NHL in occupational cohorts
were identified. Two examined participants of the AHS: in the first study none
of the COIs were included in the analysis of exposures (Alavanja et al., 2014),
and the second paper (Goodman et al., 2017) was an updated meta-analysis
of 2,4-D and NHL that included 10 studies of the AHS but did not contribute
original data. A third study examined cause-specific mortality, including NHL,
among U.S. workers exposed to mixed PCBs (Ruder et al., 2014), the fourth
study analyzed health outcomes among Brazilian agricultural workers exposed
to unspecified pesticides (Boccolini et al., 2017), and the fifth study was a small
case-control study designed to investigate the effects of exposure to pesticides
(determined by occupation as a farm worker) on NADPH (nicotinamide adenine
dinucleotide phosphate, a cofactor used in biochemical reactions), including its
level and relationship with the Th1/Th2 ratio, in patients diagnosed with NHL in
Algeria (Zahzeh et al., 2015). A sixth study (Aras et al. 2014) was a case-control
study conducted at a cancer center in France to determine whether patient diagnosed with NHL had reported exposure to pesticides (types of insecticides and
herbicides, if known; frequency; and duration), and other known or suspected
risk factors. However, all these studies lacked sufficient exposure specificity to be
included as contributing to the evidence base of the potential effect of the COIs.
Biologic Plausibility
The diagnosis of NHL encompasses a wide variety of lymphoma subtypes. In
humans, about 85% are of B-cell origin and 15% of T-cell origin. In commonly
used laboratory mice, the lifetime incidence of spontaneous B-cell lymphomas
is about 30% in females and about 10% in males. Although researchers seldom
note the subtypes of B-cell lymphomas observed, lymphoblastic, lymphocytic,
follicular, and plasma-cell lymphomas are seen in mice and are similar to the
types of NHL seen in humans. Laboratory rats, on the other hand, are less prone
to develop lymphomas, although Fisher 344 rats do have an increased incidence
of spontaneous mononuclear-cell leukemia of non-specific origin. The lifetime
incidence of leukemia is about 50% in male rats and about 20% in female rats.
Neither mice nor rats develop T-cell lymphomas spontaneously at a predictable incidence, but T cell–derived tumors can be induced by exposure to some
carcinogens.
Several long-term feeding studies of various strains of mice and rats have
been conducted over the past 30 years to determine the effects of TCDD on
cancer incidence. Few of them have shown effects of TCDD on lymphoma
or leukemia incidence. NTP (1982a) reported no increase in the overall incidence of lymphoma in female B6C3F1 mice exposed to TCDD at 0.04, 0.2, or
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2.0 μg/kg per week for 104 weeks, but it did find that histiocytic lymphomas
(now considered to be equivalent to large B-cell lymphomas) were more common in the high-dose group. No effects on lymphoma incidence were seen
in Osborne–Mendel rats treated with TCDD at 0.01, 0.05, or 0.5 μg/kg per
week. Sprague Dawley rats treated with TCDD at 0.003, 0.010, 0.022, 0.046,
or 0.100 μg/kg per day showed no change in the incidence of malignant lymphomas. Nor has long-term exposure to phenoxy herbicides or cacodylic acid
resulted in an increased incidence of lymphomas in laboratory animals. Thus,
few laboratory animal data support the biologic plausibility of the promotion of
NHL by TCDD or the other COIs, but it should be noted that the standard rodent
models are not particularly sensitive for the detection of chemicals that cause
lymphohematopoietic cancers.
In contrast, more recent studies at the cellular level indicate that activation
of AHR by TCDD inhibits apoptosis, a mechanism of cell death that controls the
growth of cancer cells. Vogel et al. (2007) studied human cancer cells in tissue
culture and showed that the addition of TCDD inhibited apoptosis in histiocyticlymphoma cells, Burkitt-lymphoma cells, and NHL cell lines. The reduction in
apoptosis was associated with an increase in the expression of Cox-2, C/EBP β,
and Bcl-xL mRNA in the cells. Those genes code for proteins that protect cells
from apoptosis. The effects of TCDD on apoptosis were blocked when an AHR
antagonist or a Cox-2 inhibitor was added to the culture; this demonstrated the
underlying AHR-dependent mechanism of the effects. More important, when
C57Bl/10J mice were given multiple doses of TCDD over a period of 140 days,
premalignant lymphoproliferation of B cells was induced before the appearance
of any spontaneous lymphomas in the control mice. When the B cells were
examined, they were found to manifest changes in gene expression similar to
those induced by TCDD in the human cell lines, which provided support for
this mechanism of lymphoma promotion by TCDD. Work by Phadnis-Moghe
et al. (2015) found that TCDD exposure in human B-cell culture impairs B-cell
lymphoma-6 activity, which may contribute to the development of NHL.
It is well established that AHR activation by TCDD in human breast and
endocervical cell lines induces sustained high concentrations of the IL-6 cytokine, which has tumor-promoting effects in numerous tissues (Hollingshead et
al., 2008). IL-6 plays a role in B-cell maturation and induces a transcriptional
inflammatory response. It is known to be increased in B-cell neoplasms, including
multiple myeloma and various lymphomas, and especially diffuse large B-cell
lymphomas (Hussein et al., 2002; Kato et al., 1998; Kovacs, 2006).
An alternative link that could help explain the association between TCDD
and NHL has been explored in human studies. Chromosomal rearrangements,
with the consequent dysregulation of the expression of various genes, are prevalent in B-cell lymphomas, and the t(14;18) reciprocal translocation, which juxtaposes the BCL2 with the locus of the immunoglobin heavy chain, is found
in tumor cells in most cases of follicular lymphoma. Roulland et al. (2004)
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investigated the prevalence of the t(14;18) translocation, which is characteristic
of most cases of follicular lymphoma, in 53 never-smoking and pesticide-using
men in a cohort of French farmers whose pesticide exposures and confounding
information had previously been well characterized; blood samples had been
gathered from 21 of them during periods of high pesticide use, and samples from
the other 32 had been collected during a period of low pesticide use. The authors
found a higher prevalence of cells carrying the translocation in the farmers whose
blood had been drawn during a period of high pesticide use than in those whose
blood had been drawn during a low-use period. Baccarelli et al. (2006) reported
an increase in t(14;18) chromosomal translocation in lymphocytes from humans
who were exposed to TCDD in the Seveso accident. In most cases of follicular
lymphoma, tumor cells carry the t(14;18) chromosomal translocation, and there
is evidence that an increased frequency of lymphocytes from the peripheral blood
carrying this tumor marker may be a necessary but not sufficient step toward the
development of follicular lymphoma (Roulland et al., 2006).
More recently, Saberi Hosnijeh et al. (2011, 2012a,b, 2013a,b) have published a series of papers examining factors associated with immune regulation
and possibly related to B-cell neoplasms and serum TCDD levels in Dutch production workers from a subcohort of the IARC study sample. The mortality status
of the entire subcohort was updated, and blood samples were gathered in 2007–
2008 from a small number of survivors—45 who had TCDD exposure in factory
A, 39 whose jobs in factory A did not expose them to TCDD, and 69 in factory
B that produced phenoxy herbicides not subject to TCDD contamination (Boers et
al., 2010). Boers et al. (2012) modeled the resulting contemporary TCDD serum
levels to back-extrapolated TCDD concentrations at the end of employment for
each worker. When examining immunoglobulin (IgG, IgA, IgM, IgD, and IgE)
and complement (C3 and C4) concentrations measures of humoral immunity,
Saberi Hosnijeh et al. (2011) found a consistent pattern only for C4, which was
negatively associated with both measured current and estimated maximum TCDD
serum concentrations. Limiting the analyses to workers from factory A and examining serum concentrations of 16 cytokines, 10 chemokines, and 6 growth
factors, Saberi Hosnijeh et al. (2012a) found that most analytes were negatively
associated with the current and estimated past maximum TCDD levels. Saberi
Hosnijeh et al. (2012b) found that for both cell counts and lymphocytes, the results were similar between high- and low-exposed workers from factory A, except
for a non-dose-dependent increase in the CD4/CD8 ratio among the high-exposed
workers. Most lymphocyte subsets, in particular the B-cell compartment, showed
decreases with higher levels of both current and estimated maximum levels of
TCDD. Saberi Hosnijeh et al. (2013a) addressed plasma levels of CD27, CD30,
and IL-1RA, which are proteins that regulate immune function and are thought to
be involved in lymphopoeitic neoplasms, and they found a tendency toward decreased levels with increasing TCDD concentrations, which would be consistent
with immune suppression. Similarly, Saberi Hosnijeh et al. (2013b) investigated
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the possibility of a relationship between TCDD levels and serum metabolites, but
they found no notable patterns. Overall, this set of findings in a group of workers
with an elevated incidence of NHL at its most recent mortality update provides
some insight into the biological processes, particularly immunological ones, that
TCDD might stimulate on the path to this malignancy.
Synthesis
The first VAO committee concluded that there was sufficient evidence of an
association between exposure to at least one of the COIs and NHL. The evidence
was drawn from occupational and other studies in which subjects were exposed
to a variety of herbicides and herbicide components. Although the new studies of
NHL incidence and mortality that were reviewed in this update (Coggon et al.,
2015; Collins et al., 2016; Czarnota et al., 2015) mostly found increased, but not
statistically significant, risks of NHL after exposure to at least one of the COIs,
based on the results of studies previously reviewed, the committee maintains the
conclusion of sufficient evidence of an association.
Individual findings on CLL are fairly few compared with the considerable
number of studies supporting an association between exposure to the COIs
and NHL. Two new studies of CLL in U.S. Vietnam veterans were reviewed.
Baumann Kreuziger et al. (2014) found that veterans who reported having been
exposed to Agent Orange had a statistically significantly lower age of presentation and time to first treatment, but the number of therapies and the rate of transformation were not different between exposed and unexposed patients. In the
second study, Mescher et al. (2018) used data from the National VA Tumor Registry to identify cases of CLL. Similar to the findings of Baumann Kreuziger et
al., veterans presumed to have been exposed to Agent Orange were diagnosed at
a younger age and had shorter time to initial treatment, but in this analysis those
exposed had significantly longer overall survival. Results of some high-quality
studies show that exposure to 2,4-D and 2,4,5-T appears to be associated with
CLL; these studies include the incidence study of Australian veterans (ADVA,
2005a), the case-control study by Hertzman et al. (1997) of British Columbia
sawmill workers who were exposed to chlorophenates, the Danish-gardener study
(Hansen et al., 1992), and the population-based case-control study in two U.S.
states by Brown et al. (1990) that showed increased risks to be associated with
any herbicide use and, specifically, with the use of 2,4,5-T for at least 20 years
before the interview. Other studies that showed positive associations have lacked
exposure-specificity in the the populations studied.
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Conclusion
Based on the evidence reviewed here and in previous VAO reports, the
committee concludes that there is sufficient evidence of an association between
exposure to at least one of the COIs and NHL.
Plasma Cell Dyscrasias
Plasma cell dyscrasias are a heterogeneous group of disorders characterized
by the presence of monoclonal immunoglobulins in the serum, which reflects a
monoclonal proliferation of lymphoplasmacytic cells in the bone marrow (Wahed
and Dasgupta, 2015). Plasma cell neoplasms are lymphoid neoplasms of terminally differentiated B cells, all of which exhibit the expansion of a single clone of
Ig-secreting plasma cells. Included in this group are MGUS, multiple myeloma,
Waldenstrom’s macroglobulinemia, immunoglobulin deposition diseases (such
as AL amyloidosis and primary amyloidosis), plasmacytoma, and plasma cell
leukemia.
Monocolonal Gammopathy of Undetermined Significance
MGUS is a precursor condition of multiple myeloma. However, only an
estimated 1% of MGUS cases progress to multiple myeloma each year (Kyle et
al., 2018; Mateos and Landgren, 2016). It is a clinically silent condition, meaning that there are no apparent signs or symptoms or other clinical manifestations, although MGUS has been associated with osteoporosis, hip fractures, and
peripheral neuropathy (Bida et al., 2009). MGUS is defined by the presence of a
monoclonal antibody, antibody heavy chain, or antibody light chain in the blood
or urine of a person lacking the symptoms or signs of a more serious plasma cell
dyscrasia. MGUS is categorized into subtypes based on the identity and levels of
the myeloma proteins detected as well as the prognosis for progressive disease.
IgG and IgA MGUS are precursor conditions of multiple myeloma, whereas IgM
MGUS is a precursor of Waldenstrom’s macroglobulinemia and other lympho
proliferative disorders (van de Donk et al., 2014). The condition is typically discovered as an incidental finding when a protein electrophoresis test is performed
for reasons unrelated to plasma cell dyscrasias.
A prospective longitudinal study of 1,384 (predominantly white) patients
who were residing in southeastern Minnesota and who were diagnosed with
MGUS at the Mayo Clinic from 1960 through 1994 were followed for progression to multiple myeloma or another plasma-cell or lymphoid disorder. The
patients were stratified into IgM and non-IgM MGUS to determine their risk
factors for progression. The presence of one of two factors (an abnormal serum
free light-chain ratio and a high serum M protein level [≥ 1.5 g per deciliter]) was
associated with a higher risk of progression in both groups; IgM MGUS patients

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

CANCER

349

had an even higher risk than the non-IgM MGUS patients. After an adjustment
for competing causes of death, the risk of progression was 10% at 10 years, 18%
at 20 years, 28% at 30 years, 36% at 35 years, and 36% at 40 years (Kyle et al.,
2018). Using the same population in another analysis, the prevalence of MGUS
in people 50 years and older was found to be 3.2% and 5.5% in people over
70 years (Kyle et al., 2007).
A systematic review and meta-analysis of MGUS conducted in 2010 found
that the prevalence of MGUS ranged from 0.05% to 6.1% in 11 different studies. The prevalence of MGUS increases with age and is affected by race (higher
among blacks than whites and Japanese), sex (higher in men than women), family
history, immunosuppression, and pesticide exposure (Wadhera and Rajkumar,
2010).
The risk factors for the progression of clinical MGUS to multiple myeloma
that have been reported are the size and type of serum M protein and the presence of an abnormal serum free light chain ratio (Rajkumar et al., 2005), immune
status (with higher prevalence among immunosuppressed and immunocompromised patients), hereditary or familial factors (Landgren et al., 2006; Vachon et
al., 2009), and some occupational and environmental factors such as exposure
to certain pesticides and fertilizers in the AHS (Landgren et al., 2009), but those
associations have been inconsistent. Heavy tobacco smoking has also been asso
ciated with the prevalence of MGUS (Pasqualetti et al., 1997).
Update of the Epidemiologic Literature MGUS was not considered as a
separate outcome in any of the prior VAO updates primarily because most relevant studies focused on multiple myeloma and did not include MGUS. The
present committee determined that because it is a precursor condition of multiple
myeloma, it would be considered as a separate outcome with respect to exposure to the COIs. It was felt that an increased incidence of MGUS, while itself
clinically silent, could be a harbinger of an increase in the incidence of multiple
myeloma; however, there are not yet any data to support this inference. One published study that specifically examined the prevalence of MGUS in Vietnam veterans who were responsible for spraying herbicides was identified and reviewed;
no other studies of MGUS and the COIs were identified. Table 27, which can be
found at www.nap.edu/catalog/25137, summarizes the results of studies related
to plasma cell dyscrasias and includes the studies of MGUS.
In a new analysis using data and biospecimens collected from the AFHS,
Landgren et al. (2015) examined the association between serum TCDD levels
and the presence of MGUS. Data and biospecimens were collected prospectively
from individuals to whom structured questionnaires and physical exams were
given at set times over 20 years, with the final exam conducted in 2002. The
study included 479 Ranch Hand veterans (who conducted aerial spray missions
of the herbicides from 1962 to 1971) and 479 controls (comparison veterans
who were also in the Air Force and had similar job duties and were deployed to
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Southeast Asia during the same period) who participated in the 2002 follow-up
examination and had given a serum specimen and were at least 50 years old at
the 2002 follow-up. Individuals with a history of multiple myeloma, Waldenstrom
macroglobulinemia, solitary plasmacytoma, or amyloidosis were excluded. All
serum specimens were tested without knowledge of the exposure status. TCDD
concentrations were either measured in the 1987 exam or reconstructed from the
measurement in the nearest subsequent follow-up (1992, 1997, 2002 follow-ups).
Logistic regression was used for analyses, and models were adjusted for age,
race, BMI at the 2002 examination, and changes in BMI between 2002 and the
time of blood draw for the TCDD measurement; additional variables of military
occupation, smoking history, drinking history, and history of radiation therapy
or chemotherapy for cancer treatments were also considered. The Ranch Hand
veterans and comparison veterans had similar demographic and lifestyle characteristics and medical histories. The crude prevalence of overall MGUS was 7.1%
in Ranch Hand veterans and 3.1% in comparison veterans, which is equivalent
to a 2.4-fold increased risk for MGUS in Ranch Hand veterans versus the comparison veterans, after adjustment (OR = 2.37, 95% CI 1.27–4.44, p = 0.007).
The risk of MGUS was significantly increased in veterans younger than 70 years
(OR = 3.4, 95% CI 1.46–8.13, p = 0.004), whereas no significant increase in the
risk was seen in those 70 years or older (OR = 1.4, 95% CI 0.55–3.63, p = 0.63),
although both estimates were imprecise. When compared with the veterans in
the lowest TCDD level (≤ 3.65 ppt), the crude ORs for having MGUS were statistically significant for veterans with TCDD levels of 5.81–10.92 ppt and more
than 10.92 ppt, but an adjustment eliminated the significant effect of TCDD at
the highest level. In both Ranch Hand veterans and comparison veterans, the
prevalence of MGUS increased with age. This study is the first to correlate
objective measurement of levels of TCDD exposure with MGUS. This study was
well designed and is strengthened by its use of objective measurements of serum
TCDD levels in both exposure groups, long-term follow-up with prospective
data and biospecimen collection, and the use of standard laboratory analyses.
Although the serum samples taken to measure TCDD levels were collected at
least 15 years after military exposure and it was not possible to measure exposure
to 2,4-D or 2,4,5-T, TCDD levels may be used as a surrogate of exposure for the
Ranch Hands and comparison veterans. However, the findings strongly support
an association between TCDD exposure and MGUS, and therefore, multiple
myeloma.
Multiple Myeloma
Multiple myeloma (ICD-9 203.0; ICD-10 C90.0) is characterized by a proliferation of bone marrow cells that results in an excess of neoplastic plasma cells
and in the production of excess immunoglobulin protein. Multiple myeloma is
sometimes grouped with other immunoproliferative neoplasms (ICD-9 203.8;
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ICD-10 C90.2). The American Cancer Society estimated that 16,400 men and
14,370 women would receive diagnoses of multiple myeloma in the United States
in 2018 and that 6,830 men and 5,940 women would die from it (ACS, 2018e).
The incidence of multiple myeloma is highly age-dependent and is relatively
low in people under 40 years old. The incidence is slightly higher in men than in
women; for all races the incidence rate for 2009–2013 was 8.0 per 100,000, and
for women it was 5.2 per 100,000. The difference becomes more pronounced with
age. In the age groups that include most Vietnam veterans, the age-adjusted modeled incidence rate of myeloma for men 50–64 years old of all races combined
was 13.1 per 100,000 in 2014, increasing to 39.0 for 65- to 74-year-olds and 61.1
for men over 75 years.21
An increased incidence of multiple myeloma has been observed in several
occupational groups, including farmers and other agricultural workers and those
with workplace exposure to paint strippers, petroleum, and certain metals, minerals, and chemical substances (Sergentanis et al., 2015). People who have high
exposure to ionizing radiation and those who have other plasma-cell diseases,
such as MGUS or solitary plasmacytoma, are also at greater risk (Sergentanis
et al., 2015).
Conclusions from VAO and Previous Updates The committee responsible for
VAO concluded that there was limited or suggestive evidence of an association
between exposure to the COIs and multiple myeloma. Few studies of multiple
myeloma have been conducted among Vietnam veterans, and most of them have
reported no cases of or decreased risks of multiple myeloma (Akhtar et al., 2004;
Boyle et al., 1987; Breslin et al., 1988; Cypel and Kang, 2008; Goun and Kuller,
1986; Wolfe et al., 1990). Follow-up analyses of the New Zealand cohort of veterans who served in Vietnam found no statistically significant increase in the risk of
deaths from or incidence of multiple myeloma when compared to the standardized
general New Zealand population (McBride et al., 2013). Likewise, in the Korean
cohort of veterans who served in Vietnam, there was no statistically significant
increase in multiple myeloma in the internal comparison of the high- and lowexposure groups based on EOI scores (Yi and Ohrr, 2014). Similarly for multiple
myeloma mortality, Yi et al. (2014b) reported a decreased risk for the high- versus
low-exposure groups and with the individual log-transformed EOI scores.
However, several occupational cohort studies with well-characterized exposures to one or more of the COIs found a statistically significant increased
incidence or mortality of myeloma among agricultural workers and farm workers
(Blair et al., 1993; Boffetta et al., 1989; Brown et al., 1993; Burmeister et al.,
1983; Eriksson and Karlsson, 1992; La Vecchia et al., 1989; Morris et al., 1986).
21 As calculated on the site https://seer.cancer.gov/faststats/selections.php?#Output using the SEER
13 dataset and by choosing age-adjusted rates, myeloma, all races, age groups 50–64, 65–74, and ≥
75 years, and male sex.
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Additional studies reviewed since VAO have reported increased risks of incidence
or mortality, but in general the findings have not been statistically significant.
Most recently, a follow-up analysis of the Cross-Canada Study of Pesticides and
Health was reviewed by the Update 2014 committee. The association between
lifetime use of multiple pesticides and multiple myeloma risk was examined
among men 19 years and older who worked in agriculture and had a first diagnosis of STS, NHL, multiple myeloma, or HL during the original study period
of 1991–1994 (Kachuri et al., 2013). Pesticides were grouped by type, chemical
class, and their carcinogenic potential. The investigators recruited 342 cases
and 1,357 controls. Odds ratios were calculated and adjusted for age, residence,
medical history, and smoking. A statistically significant increased risk of multiple
myeloma was observed with exposure to Mecoprop but not with exposure to
2,4-D. An evaluation of days per year of mixing or applying phenoxy herbicides
was not statistically significant for any category (≤ 2 days per year, 2–5 days,
and > 5 days).
Update of the Epidemiologic Literature No new studies of multiple myeloma
in Vietnam veterans or environmental or case-control studies of exposure to the
COIs and multiple myeloma have been published since Update 2014. Reviews of
the relevant studies are presented in the earlier reports. Tables 26 and 27, which
can be found at www.nap.edu/catalog/25137, summarize the results of studies
related to CLL and plasma cell dyscrasias and include the studies of multiple
myeloma.
Occupational Studies In an extension of the follow-up of UK phenoxy herbicide
manufacturers and sprayers to examine the carcinogenicity of phenoxy herbicides
and their association primarily with HL, STS, and CLL, Coggon et al. (2015) also
reported mortality from other types of cancer, including multiple myeloma. A total
of 18 deaths from multiple myeloma were reported, but although risk estimates
were slightly elevated, none were statistically significant for any of the groups of
workers: all workers (n = 18; SMR = 1.04, 95% CI 0.62–1.64), workers exposed
to herbicide levels above background (n = 15; SMR = 1.18, 95% CI 0.66–1.94),
or workers exposed for more than 1 year at levels above background (n = 6; SMR
= 1.01, 95% CI 0.37–1.86).
Other Identified Studies One other study that reported mortality outcomes from
multiple myeloma was identified, but it lacked sufficient exposure specificity to
be included as contributing to the evidence base of the potential effect of the
COIs (Ruder et al., 2014).
Biologic Plausibility No animal studies have reported an association between
exposure to the COIs and multiple myeloma. AHR activation by TCDD in human
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breast and endocervical cell lines induces sustained high concentrations of IL-6,
which has tumor-promoting effects in numerous tissues (Hollingshead et al.,
2008). IL-6 plays a role in B-cell maturation and induces a transcriptional inflammatory response. It is known to be increased in B-cell neoplasms, including
multiple myeloma and various lymphomas (Hussein et al., 2002; Kovacs, 2006).
In comparing the frequency of specific variants of several metabolic genes
between multiple myeloma cases and controls, Gold et al. (2009) found some
indication of differences, particularly in CYP1B1 and AHR alleles, that might reflect an increased susceptibility to multiple myeloma after exposure to particular
chemicals. A biochemical link to the COIs, however, is far from being established.
Synthesis Previous VAO reports found limited or suggestive evidence of an
association between exposure to at least one of the COIs and multiple myeloma.
The evidence of an association between the COIs and lymphomas (NHL, HL, and
CLL/HCL) has been classified as sufficient. Most of these cancers also arise from
B cells, so the committee hypothesized that it would be etiologically plausible
for the association with multiple myeloma to belong with the lymphomas in the
sufficient category. Although many studies of exposure to pesticides in general
and multiple myeloma found strong or at least positive associations, a review of
studies that addressed an association between exposure to the specific COIs and
multiple myeloma found that the results were considerably weaker than those
for the other B-cell neoplasms; in particular, the results did not justify advancing multiple myeloma out of the limited or suggestive category. No animal
studies have reported an association between exposure to the COIs and multiple
myeloma. However, given the close relationship between myeloma and other
lymphoproliferative neoplasms, biologic and mechanistic studies implying a
connection between the COIs and NHL likely link to similar pathways in plasma
cell dyscrasias. Two well-designed studies of well-characterized cohorts were
reviewed in the current update. In an analysis using data and preserved serum
samples from the AFHS, Landgren et al. (2015) found a 2.4-fold increased risk
of MGUS in Ranch Hand veterans compared with a matched group of veterans
who did not participate in aerial herbicide spraying missions. In both Ranch Hand
veterans and comparison veterans, the prevalence of MGUS increased with age.
This study is the first to provide objective evidence of an association between
higher levels of TCDD exposure and MGUS, and therefore, possibly multiple
myeloma. In the extended follow-up of UK men who worked manufacturing or
spraying phenoxy acids in the United Kingdom, Coggon et al. (2015) reported
slightly increased, but not statistically significant, risks of multiple myeloma, and
the increased risk was lowest in the most highly exposed group. No toxicologic
studies on exposure to the COIs and MGUS or multiple myeloma have been
identified.
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Amyloid Light Chain Amyloidosis
AL amyloidosis is a rare condition that is a complication of multiple
 yeloma. The committee responsible for Update 2006 moved the discussion
m
ofAL a myloidosis from the chapter on miscellaneous non-neoplastic health
conditions to the cancer chapter to put it closer to related neoplastic conditions, such as multiple myeloma and some types of B-cell lymphomas. The
conditions share several biologic features, notably the clonal hyperproliferation of B cell–derived plasma cells and the production of abnormal amounts
of immunoglobulins.
The primary feature of amyloidosis (ICD-9 277.3; ICD-10 E85) is the accu
mulation and deposition in various tissues of insoluble proteins, or amyloids.
Amyloid protein accumulates in the extracellular spaces of various tissues.
The pattern of organ involvement depends on the nature of the protein; some
amyloid proteins are more fibrillogenic than others. Amyloidosis is classified
according to the biochemical properties of the fibril-forming protein. Excessive amyloid protein can have modest clinical consequences, or it can produce
severe, r apidly progressive multiple-organ-system dysfunction. The Amyloidosis
Foundation estimates that approximately 4,500 new cases are diagnosed each
year (Amyloidosis Foundation, 2018). It usually affects people from ages 50 to
80 years and occurs more often in males than in females.
AL amyloidosis is the most common form of systemic amyloidosis; the A
stands for amyloid, and the L indicates that the amyloid protein is derived from
immunoglobin light chains. AL amyloidosis results from the overproduction of
immunoglobulin light-chain protein from a monoclonal population of plasma
cells; some of these light chains can form a beta-pleated sheet, engendering
protein deposition in tissue. Clinical findings can include excessive AL protein
or immunoglobulin fragments in the urine or serum, renal failure with nephrotic
syndrome, liver failure with hepatomegaly, heart failure with cardiomegaly,
marcroglossia, carpal tunnel syndrome, and peripheral neuropathy. Bone marrow
biopsies commonly show an increased density of plasma cells, which suggests
a premalignant state. Historically, bone marrow biopsies emphasized routine
histochemical analysis, but modern immunocytochemistry and flow cytometry
now commonly identify monoclonal populations of plasma cells with molecular
techniques. AL amyloidosis can progress rapidly and is often far advanced by the
time it is diagnosed (Buxbaum, 2004).
Conclusions from VAO and Previous Updates The committees responsible
for Update 2000, Update 2002, and Update 2004 concluded that there was
inadequate or insufficient evidence to determine whether there is an association between exposure to the COIs and AL amyloidosis. Although there are few
epidemiologic data specifically on AL amyloidosis, the committee responsible
for Update 2006 changed the categorization to limited or suggestive evidence
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of an association on the basis of commonalities in its cellular lineage with multiple myeloma and B-cell lymphomas. Later committees have not changed that
categorization.
Epidemiologic results for amyloidosis were reported for the first time in
Vietnam veterans in the publication from the Korean Veterans Health Study (Yi
et al., 2014a) on the prevalence of diseases as confirmed by insurance records.
From the internal comparison of veterans in the category with high EOI scores
(nine cases) to those in the low-potential-exposure group (six cases) with adjustments for age, rank, smoking, drinking, physical activity, domestic herbicide use,
education, income, and BMI, a statistically significantly elevated, but imprecise,
risk of amyloidosis (OR = 3.02, 95% CI 1.02–8.93) was found. When regression
with the same adjustments was performed on the logarithms of the individual
EOI scores for the entire set of veterans, a statistically significant increased risk
was again found but it was lower in magnitude (OR = 1.32, 95% CI 1.02–1.71).
Update of the Epidemiologic Literature No new studies of exposure to the
COIs and AL amyloidosis (human or animal) have been identified since those
reviewed in Update 2014. Reviews of the relevant studies are presented in the
earlier reports. Table 27—contained in the supplementary tables available at
www.nap.edu/catalog/25137—summarizes the results of studies related to plasma
cell dyscrasias and includes the studies of amyloidosis.
Biologic Plausibility A 1979 study reported the dose-dependent development
of a “generalized lethal amyloidosis” in Swiss mice that were treated with TCDD
for 1 year (Toth et al., 1979). That finding has not been validated in 2-year carcinogenicity studies of TCDD in mice or rats, but the use of different strains may
explain the discrepancies. Thus, few animal data support an association between
TCDD exposure and AL amyloidosis in humans, and no animal data support an
association between the other COIs and AL amyloidosis.
It is known, however, that AL amyloidosis is associated with B-cell diseases,
and 15–20% of cases of AL amyloidosis occur with multiple myeloma. Other
diagnoses associated with AL amyloidosis include B-cell lymphomas (Cohen et
al., 2004), MGUS, and agammaglobulinemia (Rajkumar et al., 2006).
Synthesis AL amyloidosis is very rare, and previous VAO committees have
thought that it was unlikely that population-based epidemiology will ever provide substantial direct evidence regarding its causation. The assignment of this
condition to the “limited or suggestive” category of association has been based
on the biologic and pathophysiologic features linking AL amyloidosis, multiple
myeloma, and some types of B-cell lymphomas—especially the clonal hyperproliferation of plasma cells and abnormal immunoglobulin production—thus indi
cating that AL amyloidosis is pathophysiologically related to these conditions.
No new epidemiologic or mechanistic studies of exposure to the COIs and AL
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amyloidosis have been identified since Update 2014, and therefore the committee maintains the conclusion of limited or suggestive evidence of an association.
Conclusion on Plasma Cell Dyscrasia
Based on new information from an analysis of the AFHS that examined
MGUS and used objective measures of dioxin exposure in a well-characterized
exposed group of Vietnam veterans, the committee concludes that there is sufficient evidence of an association between exposure to at least one of the COIs and
MGUS. However, the committee notes that the clinical and health implications
of a diagnosis of MGUS are minimal and that only a small percentage of people
with MGUS progress to multiple myeloma. Although an increase in MGUS may
be inferred to predict an increased incidence of multiple myeloma, there is no
scientific evidence at this time to confirm that the elevated rates of MGUS seen
in the exposed population will translate to higher rates of multiple myeloma.
Therefore, based on the evidence reviewed here and in previous VAO reports,
the committee concludes that there remains limited or suggestive evidence of an
association between exposure to at least one of the COIs and multiple myeloma
and AL amyloidosis. The close association of these diagnoses to a previous
diagnosis of MGUS strengthens this association; however, further study would
be needed to establish definitively that the increased prevalence of MGUS will
translate to higher levels of these clinically significant plasma cell neoplasms.
Leukemias
Leukemias (ICD-9 202.4, 203.1, 204.0–204.9, 205.0–205.9, 206.0–206.9,
207.0–207.2, 207.8, 208.0–208.9; ICD-10 C90.1–C95.9) have traditionally been
divided into four primary types: acute and chronic lymphocytic leukemias and
acute and chronic myeloid leukemias. There are numerous subtypes of acute
myeloidleukemia (ICD-9 205; ICD-10 C92), which is also called acute myelogenous
leukemia, granulocytic leukemia, or acute non-lymphocytic leukemia.
NCI estimated that in the United States in 2018, 60,300 people would receive
a new diagnosis of and 24,370 men and women would die from some form of
leukemia. Collectively, leukemias were expected to account for 3.7% of all new
diagnoses of malignancies and 4.1% of deaths from malignancy in 2017 (NCI,
n.d.bb). Grouping all different forms of leukemias into a single group is not
informative because the different forms have different patterns of incidence and
different risk factors.
Myeloid Leukemias
In adults, the majority of acute leukemias are AML (ICD-9 205.0, 207.0,
207.2; ICD-10 C92.0, 92.4–92.5, 94.0, 94.2). NCI estimated that 19,520 people
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would receive a new diagnosis of AML in the United States in 2018 and that
10,670 men and women would die from it. Overall, AML is slightly more common in men than in women of the same race and incidence is highest in whites
and lowest in American Indians/Alaska Natives (NCI, n.d.cc). Risk factors associated with AML include high doses of ionizing radiation, occupational exposure
to benzene, and exposure to some medications used in cancer chemotherapy (such
as melphalan) (Deschler and Lubbert, 2006; IARC, 2016). Several bone marrow
failure syndromes (severe congenital neutropenia, Fanconi anemia, SchwachmanDiamond syndrome, and dyskeratosis congenital) and Down syndrome are asso
ciated with an increased risk of AML, and tobacco use is thought to account for
about 20% of AML cases.
Vietnam veterans have expressed concern about whether myelodysplastic
syndromes, which can transform to AML, are associated with Agent Orange
exposure. However, no results on those conditions in conjunction with the COIs
have been found in VAO literature searches. Epidemiologic research on those
hematologic disorders has been undertaken fairly recently; for instance, the
LATIN case-control study (Maluf et al., 2009) has undertaken an investigation
of aplastic anemia in South America, but the reported exposures have been only
as specific as “herbicides” and “agricultural pesticides.”
The incidence of CML increases steadily with age in people older than 30
years. NCI estimated that 8,430 people would receive a new diagnosis of CML in
the United States in 2018 and that 1,090 men and women would die from it. Its
lifetime incidence is roughly equal in whites and blacks and is slightly higher in
men than in women of the same race and ethnicity (NCI, n.d.dd). CML accounts
for about one-third of cases of leukemias in people in the age groups that include
most Vietnam veterans (60–80 years). It is associated with an acquired chromosomal translocation known as the Philadelphia chromosome, for which exposure
to high doses of ionizing radiation is a known risk factor.
Lymphoid Leukemias
ALL is a disease of young children (peak incidence at the age of 2–5 years)
and of people over 70 years old. NCI estimated that 5,960 people would receive
a new diagnosis of ALL in the United States in 2018 and that 1,470 men and
women would die from it (NCI, n.d.ee). The lifetime incidence of ALL is slightly
higher in whites than in blacks and about the same for men and women. Exposure
to high doses of ionizing radiation is a known risk factor for ALL, but there is
little consistent evidence on other factors.
CLL is more appropriately classified as a form of B-cell NHL given its
immunohistochemistry, B-cell origin, and progression to an acute, aggressive
form of NHL. Therefore, the committee considers it in the section above on NHL,
as classified in the WHO system.
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Conclusions from VAO and Previous Updates
The committee responsible for VAO concluded that there was inadequate
or insufficient information to determine whether there is an association between
exposure to the COIs and all types of leukemias. Additional information available to the committees responsible for Update 1996 through Update 2010 did not
change that conclusion. The committee responsible for Update 2002, however,
considered CLL separately and judged that there was sufficient evidence of an
association with the herbicides used in Vietnam and CLL alone, and Update 2008
noted that HCL is closely related to CLL.
The committee responsible for Update 2006 considered AML individually but did not find evidence to suggest that its occurrence is associated with
exposure to the COIs, and there is still not sufficient evidence to support such
an association, so AML has been retained with other non-CLL leukemias in the
category of inadequate or insufficient evidence.
The Update 2014 committee assessed two cohorts of veterans who served
in Vietnam. In the New Zealand cohort, McBride et al. (2013) reported four
leukemia deaths, which was not statistically different from the general standardized population. They also reported the incidence of 21 leukemias overall, which
resulted in a statistically significantly elevated standaridized incidence ratio.
Results were stratified by incident non-lymphoid and lymphoid leukemias, but
only the lymphoid leukemia standardized incidence ratio was statistically significant. From the Korean Health Study, Yi et al. (2014b) reported 107 leukemia
deaths, but neither the low-exposure nor the or high-exposure hazard ratios were
statistically significant. That included 5 ALL, 46 AML, and 15 CML deaths. The
small number of low-exposure deaths makes the reported estimates quite u nstable.
When examined using EOI scores, the adjusted hazard ratios for myeloid leukemia in the low-exposure and high-exposure groups were not statistically significant (Yi and Ohrr, 2014).
Update of the Epidemiologic Literature
No studies of leukemia of any type in Vietnam veterans have been published since Update 2014. Likewise, no environmental or case-control studies
of the COIs and leukemia were identified. Reviews of the relevant studies are
presented in the earlier reports. Table 28, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to leukemia.
Occupational Studies Among the Dow Midland, Michigan, worker cohort,
Collins et al. (2016) reported categories of leukemia and leukemia (C91–C95),
total lymphoid leukemia (C91–C95), total myeloid leukemia (C92), acute nonlymphatic leukemia (92.0, 93.0, 94.0), and all other leukemia (C93–C95). Compared with the standardized U.S. population, an increased risk of mortality for
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all leukemias was found for the TCP workers (n = 17; SMR = 1.78, 95% CI
1.04–2.85) but not for the PCP workers (n = 3; SMR = 0.67, 95% CI 0.14–1.96).
Likewise, an increased risk of death was seen among TCP workers for total
myeloid leukemia (C92) (n = 10; SMR = 2.42, 95% CI 1.16–4.46) and acute
non-lymphatic leukemia (C92.0, 93.0, 94.0) (n = 9; SMR = 2.88, 95% CI 1.32–
5.47), but no difference was found for PCP workers, for which there were only
two reported deaths from each of those leukemias. No differences in mortality
for total lymphoid leukemia was found for either the TCP workers (n = 5; SMR
= 1.99, 95% CI 0.64–4.64) or the PCP workers, for which there was only one
death. Only two deaths among TCP workers and none among the PCP workers
were found for all other leukemias.
Coggon et al. (2015) extended the follow-up period of a large IARC-sponsored study and examined the carcinogenicity of phenoxy herbicides and their
association primarily with HL, STS, and CLL, but deaths from other types of
cancer were also reported. A total of 40 leukemia deaths were reported. Although
risk-of-death estimates from leukemia were slightly elevated for all three groups
of workers, none reached statistical significance: all workers (SMR = 1.27, 95%
CI 0.91–1.73), workers exposed to herbicide levels above background (n = 30;
SMR = 1.29, 95% CI 0.87–1.84), and workers exposed to phenoxy acids above
background for 1 year or longer (n = 11; SMR = 1.04, 95% CI 0.52–1.86).
Mortality from myeloid leukemia specifically (n = 22) was also not statistically
significant for any of the groups of workers: all workers (SMR = 1.21, 95%
CI 0.76–1.84), workers exposed to herbicide levels above background (n = 15;
SMR = 1.11, 95% CI 0.62–1.83), or workers exposed for more than 1 year at
levels above background (n = 6; SMR = 0.98, 95% CI 0.36–2.13).
Other Identified Studies Several other studies (occupational, environmental,
and case-control designs)were identified that examined leukemia outcomes, but
all lacked sufficient exposure specificity (e.g., mixtures to several chemicals with
no concentrations measured, general herbicide exposure, or exposure determination based on broad categories of occupation with no further details collected) to
be included further as contributing to the evidence base of the potential effect of
the COIs (Akahane et al., 2017; Levine et al., 2016; Maryam et al., 2015; Poynter
et al., 2017; Punjindasup et al., 2015; Ruder et al., 2014).
Biologic Plausibility
Leukemia is a relatively rare spontaneous neoplasm in mice, but it is less rare
in some strains of rats. A small study reported that 5 of 10 male rats fed TCDD at
1 ng/kg per week for 78 weeks showed an increased incidence of various cancers,
one of which was lymphocytic leukemia (Van Miller et al., 1977). Later studies of
TCDD’s carcinogenicity have not shown an increased incidence of lymphocytic
leukemia in mice or rats.
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Two studies that used cells in tissue culture suggested that TCDD exposure
does not promote leukemia. The proliferation of cultured human bone marrow
stem cells (the source of leukemic cells) was not influenced by the addition
of TCDD to the culture medium (van Grevenynghe et al., 2005). Likewise,
Mulero-Navarro et al. (2006) reported that the AHR promoter is silenced in
ALL—an effect that could lead to a reduced expression of the receptor, which
binds TCDD and mediates its toxicity. No reports of animal studies have noted
an increased incidence of leukemia after exposure to the phenoxy herbicides or
other COIs. AHR plays a role in hematopoetic stem cell expansion as well as in
erythroid and megakaryocytic differentiation (B. W. Smith et al., 2013). In this
context, information in a letter to the editor of the American Journal of Hematology from Nguyen-Khac et al. (2014) is interesting. The researchers described
a chromosomal translocation found in a human acute leukemia that r ecombines
the TEL gene with the ARNT (Arylhydrocarbon Receptor Nuclear Translocator)
gene, producing a fusion gene product. This recent functional work strongly
suggests that the translocation impairs the normal functions of ARNT, potentially
contributing to leukemogenesis.
Synthesis
Several studies of the incidence of or mortality from leukemia have been
reviewed in the VAO series. Among U.S. Vietnam veterans, findings have been
null, and risk estimates have been less than 1.0; among international cohorts of
Vietnam veterans (Australia, New Zealand, and Korea), risk estimates have been
mixed in direction, but most continue not to be statistically significant. No new
studies of leukemia in Vietnam veterans were identified for the current update.
Two mortality updates of occupational cohorts were reviewed that examined all
leukemia and subtypes. Collins et al. (2016) extended the follow-up period of
workers who were exposed to dioxins during the manufacturing process of PCP
and TCP in Midland, Michigan, and found a statistically significant elevated risk
of mortality from all leukemias for the TCP workers, but not for PCP workers
compared with the standardized U.S. population. Likewise, a statistically significant increased risk of death compared with the standardized U.S. population was
seen among TCP workers for total myeloid leukemia and acute non-lymphatic
leukemia, but no difference was found for PCP workers for which there were only
two reported deaths from each of those leukemias. A small number of deaths from
total lymphoid leukemias and all other leukaemia were reported for both TCP and
PCP workers, and neither estimate was statistically significant. In the follow-up
study of UK workers who manufactured or sprayed phenoxy herbicides, SMR
estimates from all leukemia and myeloid leukemia specifically were slightly
elevated for all three groups of workers, but none reached statistical significance
(Coggon et al., 2015). Given the new mixed findings from the well-characterized
occupational cohorts and the lack of reported findings of increased incidence
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of leukemia after exposure to the phenoxy herbicides or other COIs in animal
models, the committee maintains the conclusion of inadequate or insufficient evidence of an association between exposure to the COIs and leukemias in general.
Conclusion
Based on the evidence reviewed here and in previous VAO reports, the committee concludes that there is inadequate or insufficient evidence to determine
whether there is an association between exposure to the COIs and leukemias in
general. An exception is the specific leukemia subtypes of chronic B-cell hemato
proliferative diseases, including CLL and HCL, which are more appropriately
grouped with lymphomas.
Other Myeloid Diseases
Myelodysplastic syndromes (MDSs) are a collection of clonal diseases
(ICD-9 238.7; ICD-10 D46) that involve dysplastic maturation and cytopenias.
The malignant potential of MDS is variable, but with time, many patients will
progress to AML. MDS was not required to be reported to cancer registries
until 2001. U.S. incidence was estimated at 4.9 per 100,000 people per year for
2007–2011, but this is thought to be an underestimate due to underreporting and
underdiagnosis (Cogle, 2015). NCI has estimated the incidence rate of MDS to be
even higher in older age groups: 13.5 per 100,000 in those aged 65–69 years to
63.6 per 100,000 in those aged 85 years and older. The median age of diagnosis
is 70 years (Montalban-Bravo et al., 2016). In addition to increasing incidence
with older age, MDS is most prevalent in individuals who are white and male.
It has been conservatively estimated that 10,000 new cases of MDS occur in the
United States annually and that more than 60,000 individuals in the United States
are currently living with MDS (Ma, 2012).
Various factors determine the prognosis for MDS, and several scoring systems are used. Most involve the number of cytopenias, dependence on transfusion, cytogenetic abnormalities, and the number of blasts in the marrow. For
low-risk disease, the median survival is about 7 years; for high risk, it is less than
1 year. MDS does not always progress to AML, and the incidence of progression varies with the risk category. Of cases with high-risk MDS, around 25–35%
progress to AML. More people die from complications of infection or bleeding
related to cytopenias than through transformation to AML.
Myeloproliferative neoplasms (MPNs) (ICD-9 205.1, 238.4, 289.89, 289.9;
ICD-10 D47.1) are clonal diseases of the myeloid lineage associated with hyper
proliferation and elevated blood counts, usually associated with constitutive
tyrosine kinase activation. These syndromes include polycythemia vera, essential
thrombocytosis, myelofibrosis, and CML. The non-CML MPNs have a closelyrelated pathogenesis. Nearly all of patients with polycythemia vera have a point
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mutation in the JAK2 gene (JAK2V617F), which is also present in about half
of patients with essential thrombocytosis and myelofibrosis. The majority of
JAK2-negative essential thrombocytosis and myelofibrosis are associated with
mutations in the calreticulin gene.
The non-CML myeloproliferative neoplasms are characterized by abnormal
peripheral blood counts with increased reticulin fibrosis in the bone marrow;
the degree to which the abnormalities relate to red cells (polycythemia vera),
platelets (essential thrombocytosis), and fibrosis (myelofibrosis) determines the
phenotype. All of these closely related illnesses are associated with increased
clotting and bleeding risk, and all have the potential to progress to marrow failure
(secondary to myelofibrosis) and AML.
Aplastic anemia (ICD-9 284; ICD-10 D60–D61) is a bone marrow failure
syndrome associated with the primary loss of stem cells or the immunologic
suppression of stem-cell proliferation and maturation leading to pancytopenia.
Exposures to radiation, a number of drugs, and some industrial chemicals (such
as benzene) are recognized as risk factors for this condition, but it may also arise
from an autoimmune disease.
Conclusions from VAO and Previous Updates
MDS was not reviewed as a separate category until Update 2014, which
reviewed only one paper that included MDS as an outcome. Yi and Ohrr (2014)
assessed cancer incidence among Korean veterans who had served in Vietnam
between 1964 and 1973 and reported a non-significant increased risk of MDS
in the internal comparison of the high- and low-exposure groups, based on the
EOI scores.
Update of the Epidemiologic Literature
Although VA charged the committee with specifically considering and
reviewing the evidence of exposure to the COIs and MPNs, no published studies were identified (in humans or in animals or cell lines). There have been no
published data on the relationship between the COIs and MPNs; therefore no
evaluation of the literature could be performed.
Biologic Plausibility
K. P. Singh et al. (2014) explored the relationship of the absence of the AHR
locus and changes in hematopoetic stem cells associated with aging. They followed Ahr-null mice, showing that they have diminished survival, splenomegaly,
leukocytosis, and anemia. The hematopoetic stem cells showed diminished selfrenewal capacity, with somatic changes compatible with a profile of accelerated
aging and hematopoetic stem cell exhaustion.
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Synthesis
There are minimal data to assess the role that specific COIs may play in the
occurrence of the various nonmalignant bone marrow–derived diseases. Based on
the one null study of Korean veterans who served in Vietnam that was reviewed
in Update 2014 and the paucity of new studies, the committee maintains the
conclusion of inadequate or insufficient evidence of exposure to any of the COIs
and other myeloid diseases including MPNs.
Conclusion
Based on the available information, the committee concludes that there is
inadequate or insufficient evidence to determine whether there is an association
between exposure to the COIs and other myeloid diseases including myelo
proliferative neoplasms.
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Reproductive Health Effects and
Effects on Descendants

Chapter Overview
Based on new evidence and a review of prior studies, the current committee did
not find any new associations between outcomes related to the reproductive health
of veterans or effects on their descendants and exposure to the chemicals of interest (COIs; 2,4-dichlorophenoxyacetic acid [2,4-D], 2,4,5-trichlorophenoxyacetic
acid [2,4,5-T], picloram, dimethylarsinic acid [DMA or cacodylic acid], 2,3,7,8tetrachlorodibenzo-p-dioxin [TCDD]).
Thus, the findings on these outcomes can be summarized as follows:
• None of the outcomes met the committee’s criteria for determining that
there was sufficient evidence of an association with exposure to the COIs.
• None of the outcomes met the committee’s criteria for determining that
there was limited or suggestive evidence of an association with exposure
to the COIs.
• There is inadequate or insufficient evidence to determine whether there
is an association between exposure to the COIs and endometriosis;
decreased sperm counts or sperm quality, subfertility, or infertility; spontaneous abortion, stillbirth, neonatal death, or infant death; and low birth
weight or preterm delivery, birth defects, childhood cancers, or other
disease in their children as they mature or in later generations.
• There is limited or suggestive evidence of no association between paternal
exposure to TCDD and spontaneous abortion.
365
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This chapter summarizes the scientific literature published since Veterans
and Agent Orange: Update 2014, hereafter referred to as Update 2014 (NASEM,
2016a), on the association between exposure to herbicides and adverse effects
on the reproductive health of male and female Vietnam veterans and the health
of their children and later generations. The literature considered in this chapter
includes studies of a broad spectrum of reproduction-related effects in veterans
and in other populations exposed occupationally or environmentally to the herbicides sprayed in Vietnam or to TCDD. Because some polychlorinated biphenyls
(PCBs), some polychlorinated dibenzofurans (PCDFs or furans), and some polychlorinated dibenzodioxins (PCDDs) other than TCDD have dioxin-like biologic
activity, studies of populations exposed to these chemicals were reviewed if their
results were presented in terms of TCDD toxic equivalents (TEQs). As noted in
Chapter 3, studies that report TEQs based only on mono-ortho PCBs (which are
PCBs 105, 114, 118, 123, 156, 157, 167, and 189) are considered even though
their TEQs are several orders of magnitude lower than those of the non-ortho
PCBs (77, 81, 126, and 169), based on the revised World Health Organization
(WHO) toxicity equivalency factor (TEF) scheme of 2005 (La Rocca et al., 2008;
van den Berg et al., 2006). This is because the lower TEQs of the mono-ortho
PCBs may be counterbalanced by their abundance, which is generally many
orders of magnitude higher than the abundance of the non-ortho PCBs (H.-Y.
Park et al., 2010).
The adverse outcomes evaluated in this chapter are male reproductive health
effects such as alterations in sperm quality, semen, sex ratio, or hormonal levels;
female reproductive health effects, including endometriosis and outcomes related
to alterations in hormonal levels such as polycystic ovary syndrome and gestational diabetes; increased fetal loss (spontaneous abortion and stillbirth); neonatal and infant mortality; adverse gestational outcomes of low birth weight and
preterm delivery; and the possibility of adverse health outcomes (birth defects,
cancer; and changes in growth and physical parameters and in immune, allergic,
motor development, cognitive, behavioral and socio-emotional outcomes) at any
time during the lives of all progeny of Vietnam veterans. The committee responsible for Updates 2012 and 2014 separated those outcomes most directly related
to reproductive health and to the health of progeny into separate chapters. This
report combines them because the committee believes that reproduction-related
effects are best understood as a continuum.
Because the vast majority of Vietnam veterans are men, the primary focus
of the Veterans and Agent Orange (VAO) series has been on potential adverse
effects of herbicide exposure on men, and the etiologic importance of the
exposed party’s sex does not play the same dominant role in non-reproductive
outcomes that it does in reproductive outcomes. However, an estimated 7,500
women are thought to have served in Vietnam (VA, 2017a), so findings relevant
to female reproductive health, such as those concerning endometriosis, are also
included in the chapter. Whenever the information was available, an attempt has
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been made to evaluate the effects of exposure on males and females separately.
It should be kept in mind, though, that the amount of research providing reliable
information on the consequences of paternal exposure is extremely sparse for
the COIs in the VAO report series and also for the full array of environmental
agents that may pose threats to the health of future generations.
In addition, for published epidemiologic or experimental results to be fully
relevant to the evaluation of the plausibility of reproductive effects in Vietnam
veterans, whether female or male, the veteran’s exposure needs to have occurred
before the conception of the child. With the exception of female veterans who
became pregnant while serving in Vietnam, pregnancies that might have been
affected occurred after deployment, when primary exposure had ceased but fetal
exposure via dioxin stored in maternal tissue was possible. In the case of pregnancies of women who have previously been substantially exposed to the lipophilic
dioxins, the direct exposure of the fetus throughout gestation is possible through
the mobilization of toxicants from the mother’s adipose tissue. In contrast, adverse
effects on offspring mediated by male veterans would be via alterations in the
sperm genome and associated ribonucleic acids (RNAs) or semen that would have
been transmitted after exposure and deployment.
The categories of association and the approach to categorizing the health
outcomes are discussed in Chapter 3. To reduce repetition throughout the report,
Chapter 5 characterized study populations and presents design information related
to new publications that report findings or that revisit study populations considered in earlier updates.
BIOLOGIC PLAUSIBILITY OF REPRODUCTIVE HEALTH EFFECTS
There have been few studies of the effects on reproductive outcomes of
exposure to the four herbicides in question, particularly picloram and cacodylic
acid, and the available studies generally have shown toxicity only at very high
doses. Much of the following discussion thus concerns TCDD, which, other than
in controlled experimental circumstances, usually occurs in a mixture of dioxins
(dioxin congeners in addition to TCDD).
TCDD is stored in fat tissue and has a long biologic half-life, so internal
exposure at generally constant concentrations may continue after an episodic,
high-level exposure to an external source is discontinued. If a person had a high
exposure, then high amounts of dioxins may still be stored in fat tissue and be
mobilized, particularly at times of weight loss. That would not be expected to be
the case for nonlipophilic chemicals, such as cacodylic acid.
Dioxin exposure has the potential to disrupt male reproductive function by
altering the expression of genes that are pertinent to spermatogenesis and by
altering steroidogenesis (Wong and Cheng, 2011); it has the potential to disrupt
female reproductive function by altering the expression of genes relevant to
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ovarian follicle growth and maturation, uterine function, placental development,
and fetal morphogenesis and growth (Bruner-Tran et al., 2017).
A father’s direct contribution to a pregnancy is limited to the contents of the
sperm that fertilizes an egg; those contents had long been thought to consist of
greatly condensed, transcriptionally inert deoxyribonucleic acid (DNA) constituting half the paternal genome (a haploid set of chromosomes). Consequently,
it was once believed that paternally derived damage to the embryo or offspring
could only result from changes in sperm DNA, and dioxins have not been shown
to mutate the DNA sequence. However, as discussed in greater detail below,
TCDD can have epigenetic effects that modify the expression of a cell’s genetic
material, and those modifications persist in the daughter cells following cell
division, whether the division involves an individual’s own somatic tissues or
the production of his (or her) gametes. This provides an alternative pathway to
creating permanent (heritable) changes in gene expression—a pathway that does
not involve altering the DNA sequence. Epigenetic changes include chemical
modifications made to DNA (usually involving methylation) or to other cellular
components such as histones and RNAs (Jirtle and Skinner, 2007). As a sperm
matures, most of its histones are replaced by protamines, which renders it transcriptionally quiescent and permits extensive DNA compaction. The core histones
that are retained in human sperm carry epigenetic modifications to maintain open
nucleosomes, which permits the transcription of genes that are important during
embryo development (Casas and Vavouri, 2014). Sperm also carry a considerable
collection of RNA fragments (Kramer and Krawetz, 1997; Krawetz et al., 2011),
including ribosomal RNAs, messenger RNAs, and small noncoding RNAs (Casas
and Vavouri, 2014; Lane et al., 2014). Small RNAs have been found to play
critical roles in fertilization (Amanai et al., 2006), early embryonic development
(Hamatani, 2012; Suh and Blelloch, 2011), and epigenetic modifications (Gapp
et al., 2014; Kawano et al., 2012). Therefore, male infertility or fetal loss associated with exposure to the COIs might be mediated by epigenetic modifications to
components of sperm other than the DNA (Krawetz, 2005; Vecoli et al., 2016).
A mother’s contribution to a pregnancy is obviously more extensive, and
damage to an embryo or offspring can result from epigenetic changes in the egg
DNA or from the direct effects of exposure on placenta formation and on the fetus
during gestation. The mobilization of dioxin during pregnancy may be increased
because the body is drawing on fat stores to supply nutrients to the developing fetus. TCDD has been measured in human circulating maternal blood, cord
blood, and placenta. Thus, dioxin in the mother’s bloodstream could cross the
placenta and expose the developing embryo and fetus. Data indicate that dioxin
can accumulate in placental tissue and that dioxin can transfer from the placenta
to the developing fetus (Mose et al., 2012).
On the basis of laboratory animal studies, it is known that TCDD can affect
reproduction, so a connection between TCDD exposure and human reproductive and gestational effects is biologically plausible. However, making definitive
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conclusions based on animal studies about the potential for TCDD to cause
reproductive and gestational toxicity in humans is complicated by differences in
sensitivity and susceptibility among different species, including strain-specific
differences; by differences in the route, dose, duration, and timing of exposure
between experimental protocols and real-world exposure; and by substantial differences between laboratory animals and humans in the toxicokinetics of TCDD.
Experiments with 2,4-D and 2,4,5-T indicate that these chemicals have subcellular effects that could constitute a biologically plausible mechanism for reproductive and gestational effects. However, the preponderance of evidence from animal
studies indicates that these chemicals do not have reproductive effects. There is
insufficient information on picloram and cacodylic acid to assess the biologic
plausibility of their potential reproductive or gestational effects.
The sections on the biologic plausibility of the specific outcomes considered
in this chapter present more detailed toxicologic findings that are of particular
relevance to the outcomes discussed.
MALE REPRODUCTIVE HEALTH
Male reproductive function is under the control of a variety of components whose proper coordination is important for normal fertility. Several of
these components and some health outcomes related to male fertility, including
reproductive hormones and sperm characteristics, can be studied as indicators
of fertility. The reproductive neuroendocrine axis involves the hypothalamus,
the anterior pituitary gland, and the testis. Gonadotropin-releasing hormone is
secreted from the hypothalamus in a pulsatile fashion and acts on the anterior
pituitary gland, leading to the release of both follicle-stimulating hormone and
luteinizing hormone. Both are secreted into the circulatory system in episodic
bursts by the anterior pituitary gland and are necessary for normal spermatogenesis. In the testis, luteinizing hormone interacts with receptors on Leydig
cells, where it stimulates increased testosterone synthesis. Follicle-stimulating
hormone and the testosterone from the Leydig cells interact with Sertoli cells in
the seminiferous tubule epithelium to regulate spermatogenesis. A more detailed
review of the male reproductive hormones can be found elsewhere (Strauss and
Barbieri, 2013). Several agents, such as lead and dibromochloropropane, affect
the neuroendocrine system and spermatogenesis (for reviews, see Schrader and
Marlow, 2014; Sengupta, 2013). Reviews on the effects of various environmental
toxicants, including TCDD, on testicular steroidogenesis and spermatogenesis
provide insights into the potential underlying mechanisms, including reducing
testosterone production in Leydig cells and inhibiting the formation of cyclic
adenosine monophosphate (Mathur and D’Cruz, 2011; Svechnikov et al., 2010).
The committee responsible for the original VAO report (IOM, 1994) concluded that there was inadequate or insufficient evidence of an association
between exposure to 2,4-D, 2,4,5-T, picloram, cacodylic acid, or dioxin and
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alterations in sperm characteristics or other male reproductive health parameters,
finding, generally, that existing studies reported inconsistent or non-significant
results. Additional information available to the committees responsible for subsequent updates did not change these conclusions. Reviews of the relevant studies
are presented in the earlier reports. Table 29, which can be found at www.nap.edu/
catalog/25137, summarizes the results of studies related to male reproductive
health outcomes.
Update of the Epidemiologic Literature
Environmental Studies
Mumford et al. (2015) examined the relationship between exposure to a number of persistent organic pollutants (POPs) and semen quality as part of the Longitudinal Investigation of Fertility and the Environment (LIFE) Study of environmental
influences on human fecundity and fertility. Participants were 501 male partners
of couples discontinuing contraception for the purposes of becoming pregnant,
who were recruited in Michigan and Texas during 2005–2009. Upon enrollment,
in-person interviews were conducted with each male partner to ascertain health,
demographic, and reproductive histories. All data and biospecimens were collected
in the home, and baseline interviews were followed by a standardized anthropometric assessment for the determination of BMI conducted by research nurses, and the
research nurse also obtained non-fasting blood (10 mL) for quantification of serum
chemicals and lipids. The quantification of POPs in serum included 1 polybrominated biphenyl (PBB 153); 9 organochlorine pesticides, and 10 polybrominated
diphenyl ethers. PCBs with TEFs include 105, 114, 118, 156, 157, 167, and 189.
PCDFs and the dioxin-like PCBs 77, 81, 123, 126, and 169 were not measured,
leading to an underestimation of the TEQ. A baseline semen sample was obtained,
followed by a second sample approximately 1 month afterwards, irrespective of
the couples’ pregnancy status. A total of 35 semen parameters were measured,
including five reflecting general characteristics (volume, straw distance [a motility
marker], sperm concentration, total sperm count, and percent hypo-osmotic swollen
[a marker of sperm quality]), 8 motility measures, 12 morphometry measures, 8
morphology measures, and 2 sperm chromatin stability assay measures. The m
 odels
were a djusted for age, BMI, cotinine (a marker of tobacco smoke exposure), research site, total serum lipids, fish consumption, abstinence time, and sample age.
A total of 468 men had measured chemical concentrations and semen quality and
were included in the analysis. The levels of PBBs and some other chemicals were
lower in this cohort than those observed in the U.S. National Health and Nutrition
Examination Survey (NHANES) although the exposures were comparable. When
males with chemical concentrations in the fourth quartile were compared with those
in the first quartile, significant associations (at the 0.05 level) were found for several
individual POPs and semen quality parameters. Although the majority of the comparisons were null, the researchers did observe associations between each chemical
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class and each type of semen quality parameter, with results indicating both positive and negative associations with semen quality. At the 0.05 level of significance,
among the PCBs with a TEF, only the 4th quartile of PCB 156 showed a positive
association with a sperm morphology marker indicative of reduced semen quality.
At the 0.01 level of statistical significance, PCBs 157 and 189 were associated with
markers of improved semen quality. This report was based on a relatively large
study cohort, and the results were adjusted for BMI and other potential confounders. Without a direct measurement of TCDD, though, the report is of modest utility.
Den Hond et al. (2015) measured biomarkers of exposure in 163 men recruited through academic fertility clinics in Belgium. All were under 50 years
of age, with a body mass index (BMI) ≤ 35 and no known congenital, genetic,
or acquired cause of infertility. Blood, urine, and two serially collected semen
samples were obtained along with patient-provided information on smoking,
food intake, physical activity, socioeconomic status, health status, and living
conditions. Exposure characterization consisted of an evaluation of the serum
for levels of endocrine-disrupting chemicals, including dioxins and dioxin-like
PCBs. Men who had total motility counts of less than 20 million were classified
as subfertile. The investigators found that elevated levels of PCDDs and PCDFs
were associated with a non-significant increase in the risk of subfertility (1.59;
95% CI 0.96–2.65; p = 0.07), and elevated levels of dioxin-like PCBs were
associated with a non-significant decrease in that risk (0.45; 95% CI 0.17–1.22;
p = 0.12) after adjustment for confounders. This study was limited by its very
small sample size and by a failure to use all of the semen quality markers available. It also had a confusing sampling frame with cases and controls sampled first
based on an unsuccessful conception within 12 months status, and then further
divided by total motile count. The generalizability of results from fertility clinic
patients to Vietnam veterans is also uncertain. The report is thus of limited utility
for the committee.
Galimova et al. (2015) measured PCDD/F levels in the semen of 168 infertile and 49 fertile men in Ufa, Russia, a city close to a manufacturing plant that
produced, among other herbicides, 2,4,5-T during the 1960s through the 1980s.
All subjects were patients of reproductive health clinics. Testing found PCDD/F
TEQ levels to be 2.2–2.3 times higher in the ejaculate of infertile men than in
that of fertile men. The highest concentration of the 2,3,7,8-TCDD congener was
found in the ejaculate of men with abnormal sperm. 2,3,7,8-TCDD did not make
a material contribution to the total level of dioxin load—its share was 12% of the
equivalent dose, whereas the major part of toxicity as measured by the TEQ was
determined by the presence of PCDFs. Other congeners also showed consistently
higher levels among the men in the infertile groups. The paper lacked many details on the recruitment of the men, the number of men was small, and no analysis
of the impact of adjustment for other factors was presented.
Mínguez-Alarcón et al. (2017) examined a group of young Russian men
to determine whether peripubertal serum organochlorine concentrations affect
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semen parameters. The analysis was based on the Russian Children’s Study,
which is an ongoing prospective study of 516 males. Boys were enrolled at age
8–9 years and underwent a physical exam, blood sampling and, together with
the mother or guardian, completed a questionnaire. Annual follow-ups were
conducted. Because of loss to follow-up and other reasons, the analysis is based
on 133 males (18–19 years) who had serum organochlorine concentration data
collected and who provided one or two semen samples. One hundred twenty-three
men provided two semen samples a week apart, and 10 provided one sample. Semen analysis included sperm motility, semen volume, and sperm concentration.
Sera samples were used to measure 7 PCDDs, 10 PCDFs, 4 coplanar PCBs, 6
mono-ortho-substituted PCBs, and 31 other PCBs (non-dioxin-like PCBs). The
measured TCDD concentrations (pg TEQ/g lipid) were: minimum, 0.35; 25th
percentile, 1.77; 50th percentile, 2.9; 75th percentile, 4.2; and maximum, 12.1. A
general pattern of decreased semen quality (concentration, count, motile sperm)
with increasing TCDD was found. In adjusted models, men in the highest quartile
of serum TCDD TEQs had, on average, a lower sperm concentration, lower sperm
count, and lower total motile sperm count than those in the lowest quartile. There
were no significant associations for the summed concentration of PCDD, PCDFs,
coplanar PCBs or ∑CBs. This report is based on a well-designed study, including
a prospective follow-up and adjustment for multiple potential confounders. The
study was not able to isolate possible in utero exposure and postnatal exposure.
Moreover, its utility is limited by the fact that subjects were exposed to dioxins
in a different period of their life (infancy, childhood, and adolescence) than the
Vietnam veterans, and the generalizability of the results is open to question.
Case-Control Studies
Paul and colleagues (2017) conducted a case-control study of the association
between serum and semen levels of dioxin-like PCBs and post-testicular sperm
maturation. The study group comprised 56 adult (aged 30–55 years) males from
subfertile couples who were being evaluated for infertility at an in vitro fertilization clinic in Alicante, Spain, from May 2012 to June 2014. Cases (n = 24) were
men whose semen quality was considered low based on having at least an alteration in at least one semen quality parameter as compared with baseline values.
Controls (n = 26) were men with normal semen quality (all parameters above
WHO 2010 cutpoints). Participants underwent a complete clinical examination;
completed a questionnaire soliciting socioeconomic information, medical history, tobacco and alcohol consumption, and likely exposure to environmental
chemicals; and gave blood and semen samples. The semen parameters that were
measured included sperm concentration, volume, percentage of motile sperm,
and percentage of sperm that were morphologically normal. The levels of 12
non-ortho (77, 81, 126, 169) and mono-ortho (105, 114, 118, 123, 156, 157,
167, 189) dioxin-like PCBs were measured in the serum samples. The authors
also examined total TEQs as the sum of the TEQs obtained from the dioxin-like

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

REPRODUCTIVE HEALTH EFFECTS AND EFFECTS ON DESCENDANTS

373

PCBs. The mean levels (expressed at WHO-TEQ/g lipid) of the total dioxin-like
PCBs and the non-ortho PCBs were higher in the low-semen-quality case group
(22.32 ± 21.33 pg WHO-TEQ/g lipid and 22.52 ± 21.2 pg WHO-TEQ/g lipid,
respectively) than in the control group (14.00 ± 10.82 pg WHO-TEQ/g lipid and
13.85 ± 10.69 pg WHO-TEQ/g lipid, respectively), although the differences were
not statistically significant. The levels of mono-ortho PCBs were statistically significantly higher in low-semen-quality cases than in controls. When levels were
expressed as pg/g lipid, all comparisons showed higher levels in the case group,
which were statistically significant. Several specific PCBs had higher levels
among cases than among controls, including PCB 126, but for only one (PCB
105) was the difference statistically significant (p = 0.031). Significant decreased
correlations were found between PCB 126 and viability (r = −0.645; p = 0.013)
and between PCB 77 (r = 0.671; p = 0.009) and PCB 81 (r = 0.552; p = 0.041) and
sperm morphology among the cases. Other PCBs showed a positive correlation
with specific sperm parameters, while parameters such as sperm count and concentration showed no correlation with total PCB levels. The study results suggest
an association between exposure to dioxin-like PCBs and semen quality, but it is
limited by the small number of participants, and its generalizability is uncertain.
Other Identified Studies
Cremonese and colleagues (2017) conducted a cross-sectional study of 99
rural and 36 urban men aged 18–23 years living in southern Brazil. Occupational
exposure to herbicides (not otherwise specified) and other agricultural chemicals
was assessed via a structured questionnaire. Information was also gathered on
demographics, occupation, and other factors. Whole blood and semen samples
were collected. The investigators found a statistically significant dose–response
relationship between higher reported herbicide use and both poorer sperm morphology (p < 0.001) and reduced levels of luteinizing hormone (p = 0.002). The
study’s strengths include the use of trained researchers to collect data on randomly sampled subjects who were selected to be representative of the underlying
population, while its primary weakness is the small size of that cohort and the
lack of specificity of the exposures.
Among the newly reviewed studies, Tan et al. (2016) found that the introduction of 2,4-D to in vitro samples of ejaculated human sperm did not affect their
viability, capacitation, or spontaneous acrosome reactions, but it inhibited total
motility, progressive motility, the ability to penetrate viscous media, and progesterone-induced capacitation and acrosome reaction rates in a dose-dependent
manner. Sun and colleagues (2016) measured levels of prostate-specific antigen,
dioxins, and steroid hormones in the serum of 97 men who had resided in a dioxin
“hot spot” in Vietnam near a former U.S. airbase. Eighty-five men from a nonsprayed region in the north of the country served as controls. The investigators
collected information on the subjects’ health status, residence history, smoking
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habit, alcohol consumption, and occupation via a questionnaire. While dioxins,
furans, and non-ortho PCBs levels were significantly higher in men in the hot
spot region, prostate-specific antigen concentrations did not differ significantly
between the groups. Levels of testosterone (p = 0.003) and estradiol (p = 0.024)
were significantly higher in hot spot subjects and those of dehydroepiandrosterone
(p = 0.047) significantly lower, but there were no significant differences for the
other steroid hormones (androstenedione, cortisol, cortisone, dihydrotestosterone,
estrone, and progesterone) measured. The study’s primary weaknesses are its
cross-sectional design, and its lack of control for possible confounders, and the
fact that prostate-specific antigen level is not a health outcome.
Biological Plausibility
Although a study reported that doses of 2,4-D greater than 50 mg/kg/day
produce acute testicular toxicity in male rats (Joshi et al., 2012), there is little
evidence that lower doses of either 2,4-D or 2,4,5-T (when free of TCDD contamination) given chronically have substantial effects on either the reproductive
organs or fertility (Charles et al., 2001; Munro et al., 1992). The no-observedadverse-effect level for 2,4-D is recognized as 15 mg/kg/day (Gervais et al.,
2008). In contrast, many diverse laboratory studies have provided evidence that
TCDD can affect reproductive-organ function and reduce fertility in both
males and females.
The administration of TCDD to male animals elicits reproductive toxicity by
affecting testicular, epididymal, prostate, and seminal vesicle weight and function
and by decreasing the rate of sperm production (Foster et al., 2010; Rider et al.,
2010; Schneider et al., 2014). The mechanisms underlying those effects are not
known, but the primary hypotheses are that the changes are mediated through
the dysregulation of testicular steroidogenesis, altered Sertoli cell function, and
increased oxidative stress. The exposure of cultured testicular Leydig cells to
25 nM TCDD markedly alters gene expression (Naville et al., 2011), and the
exposure of cultured Sertoli cells to 5 nM TCDD decreases viability and increases
markers of oxidative stress (Aly and Khafagy, 2011). The exposure of adult
rats or mice to TCDD (2–7 μg/kg/week for 45–60 days) reduces testicular and
reproductive function, and these effects can be attenuated by co-treatment with
various antioxidants (Beytur et al., 2012; Ciftci et al., 2012; Sönmez et al., 2011;
H. P. Yin et al., 2012). The results of those studies are supported by the transgenic
mouse model that harbors a constitutively active aryl hydrocarbon receptor (Ahr)
in which testicular and ventral prostate weights and sperm number are reduced
(Brunnberg et al., 2011).
The discussion of the influence of paternal exposures on outcomes in offspring later in the chapter contains additional information on the biologic plausibility of COI exposure affecting male reproductive health.
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Synthesis
Reproduction is a sensitive toxic endpoint of TCDD and dioxin-like chemicals in rodents, and there are several species and strains of animals for which the
fetus is more sensitive than the adult rodent to the adverse effects of TCDD. The
sensitivity of these endpoints in humans, however, is less apparent. Although
AHR plays an important role in normal sperm development (D. A. Hansen et
al., 2014), there remains little evidence that exposure to dioxin is associated
with a reduction in sperm quality or a reduction in fertility. Some of the studies
reviewed in this update found an association between dioxin or dioxin-like PCB
exposure and one or more parameters associated with male reproductive health,
primarily poor sperm morphology (Mínguez-Alarcón et al., 2017; Paul et al.,
2017). However, others reported only non-significant associations or none at all.
The various weaknesses in these studies’ methodologies that were noted by the
committee, including small sample sizes and difficulty in generalizing the results
to the exposure experience of Vietnam veterans, greatly limits their usefulness.
Conclusion
On the basis of its evaluation of the evidence reviewed here and in previous
VAO reports, the committee concludes that there is inadequate or insufficient
evidence of an association between exposure to the COIs and alterations in semen quality or other male reproductive health markers.
FEMALE REPRODUCTIVE HEALTH
Studies of the relationship between chemicals and fertility are less common
in women than in men. Some chemicals may disrupt the female hormonal balance necessary for proper functioning. Normal menstrual-cycle functioning is
also important in the risk of hormonally related diseases, such as osteopenia,
breast cancer, and cardiovascular disease. Generally speaking, chemicals can
have multiple effects on the female system, including the modulation of hormone concentrations that results in uterine-cycle or ovarian-cycle irregularities,
changes in menarche and menopause, and the impairment of fertility (Bretveld
et al., 2006a,b). Past and current literature reviews have found studies relevant
to the committee’s Statement of Task addressing endometriosis, hormonal levels,
polycystic ovary syndrome, and gestational diabetes.
The committee responsible for the original VAO report (IOM, 1994) concluded that there was inadequate or insufficient evidence of an association between
exposure to 2,4-D, 2,4,5-T, TCDD, picloram, or cacodylic acid and alterations in
female reproductive health outcomes. Additional information available to the
committees responsible for subsequent updates did not change the conclusion that
exposure to the COIs had not been found to be associated with these outcomes.
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Reviews of the relevant studies are presented in the earlier reports. Tables 30 and
31, which can be found at www.nap.edu/catalog/25137, summarize the results of
studies related to endometriosis and other female reproductive health outcomes
reviewed in the VAO series.
Endometriosis
Endometriosis (International Classification of Diseases, 9th revision [ICD-9]
617; ICD-10 N80.8) affects more than 5 million women in the United States and
Canada at any given time (NICHD, 2017). The endometrium, the tissue that lines
the inside of the uterus, is built up and shed each month during menstruation. In
endometriosis, endometrial cells are found outside the uterus—usually in other
parts of the reproductive system, in the abdomen or pelvis, or on surfaces near the
reproductive organs. The ectopic tissue develops into growths or lesions that continue
to respond to hormonal changes in the body and break down and bleed each month
in concert with the menstrual cycle. Unlike blood released during normal shedding
of the endometrium, blood released from degenerating ectopic endometrium has no
way to leave the body. The blood sets up an inflammatory reaction causing pain,
adhesions (scars), infertility, intestinal problems, or hematuria (blood in urine).
There are several theories of the etiology of endometriosis, including one that
posits a genetic contribution, but the cause remains unknown. Estrogen depend
ence and immune modulation are established features of endometriosis, but they
do not adequately explain its cause. It has been proposed that endometrium is
distributed through the body via blood or the lymphatic system; that menstrual
tissue backs up into the fallopian tubes, implants in the abdomen, and grows; and
that all women experience some form of tissue backup during menstruation but
only those who have immune-system or hormonal problems experience the tissue growth associated with endometriosis. Despite numerous symptoms that can
indicate endometriosis, definitive diagnosis is possible only through laparoscopy
or a more invasive surgical technique. Several treatments for endometriosis are
available, but there is no cure.
Endometriosis was first reviewed in Update 2002, which identified two
relevant environmental studies. Additional studies considered in later updates
did not change the conclusion that the evidence is inadequate or insufficient to
support an association with herbicide or dioxin exposure. Table 30, which can be
found at www.nap.edu/catalog/25137, summarizes the results of studies related
to endometriosis.
Update of the Epidemiologic Literature
No Vietnam-veteran, occupational, or environmental studies of exposure to
the COIs and endometriosis have been published since Update 2014. The new
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case-control studies regarding this outcome that met the committee’s criteria for
review are summarized below.
Case-Control Studies Martínez-Zamora et al. (2015) used a case-control design
to evaluate levels of dioxin-like chemicals in the adipose tissue in 30 women
diagnosed with deep infiltrating endometriosis versus women in a control group
who were undergoing laparoscopic surgery due to benign adnexal gynecological
diseases other than endometriosis. All subjects were recruited from a university hospital located in Catalonia, Spain. Seventeen dioxins (7 PCDDs and 10
PCDFs) and 12 PCBs were analyzed. The investigators found that the TEQs and
concentrations of both dioxins and PCBs were significantly higher in patients
with deep infiltrating endometriosis than in the control group (p = 0.05), due
primarily to significantly higher values of TCDD (odds ratio [OR] = 1.41, 95%
confidence interval [CI] 1.12–2.10; p < 0.01) and 1,2,3,7,8-PeCDD (OR = 1.82,
95% CI 1.36–7.14, p < 0.01), which the authors observed was suggestive of a
potential role for dioxin-like chemicals in the pathogenesis of deep infiltrating
endometriosis. A strength of the study was the measurement of dioxins and PCBs
in adipose tissue and the calculation of TEQs; its limitations included the small
sample size (30 cases; 30 controls) and the selection bias induced by the recruitment of hospital surgery patients as subjects, which limits the generalizability of
the results to other populations like female Vietnam veterans.
Ploteau et al. (2017) examined whether deep infiltrating endometriosis with
or without concurrent ovarian endometrioma was associated with levels of POPs
measured in the adipose tissue of cases and controls undergoing surgery in a clinic
in the Pays de la Loire region of France during 2013–2015. Cases (n = 55) were
18 to 45 years old with a surgical diagnosis of deep infiltrating endometriosis;
controls (n = 44) were women of similar age and BMI who had presented for other
benign gynecological conditions. All subjects were interviewed for information on
their health, physical state, and other factors thought to be associated with POP
exposure. Serum was collected the day before the surgical procedure that led to
their participation in the study; parietal and omental fat samples were obtained
during the procedure. Biospecimens were tested for a number of POPs, including dioxins and dioxin-like PCBs. The investigators found statistically significant
associations between deep infiltrating endometriosis and adipose tissue levels of
four mono-ortho dioxin-like PCBs: 105 (adjusted odds ratio [aOR] = 2.09, 95%
CI 1.24–3.77), 114 (aOR = 1.89, 95% CI 1.04–3.69]), 118 (aOR = 2.30, 95% CI
1.31–4.36), and 123 (aOR = 2.47, 95% CI 1.42–4.66) versus controls. The statistical significance held up when subjects with deep infiltrating endometriosis with
ovarian endometrioma were examined. No such association was observed for the
dioxin-like PCB 169. The authors noted that the associations were stronger for the
subjects with deep infiltrating endometriosis with ovarian endometrioma but that
the small number of such cases complicated the interpretation of the results. They
did not calculate a TEQ, limiting the usefulness of their findings.
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Other Identified Studies A 2017 review article by Parazzini et al. concluded
that there were few studies on endometriosis and exposure to dioxin and that the
available literature had inconsistent findings. Soave and colleague’s 2015 review
contains information on several endometrial studies referenced in Update 2014,
plus the Martínez-Zamora paper reviewed above.
Biological Plausibility
As observed in Update 2014, laboratory studies that used animal models
and examined gene-expression changes associated with human endometriosis
provide evidence of the biologic plausibility of a link between TCDD exposure
and endometriosis. Genetic polymorphisms in the AHR signaling complex have
been associated with a susceptibility to advanced endometriosis in humans (D. Li
et al., 2013; C. H. Wu et al., 2012), although another study found no association
in Japanese women (Matsuzaka et al., 2012). The first suggestion that TCDD
exposure may be linked to endometriosis came as a secondary finding of a study
that exposed female rhesus monkeys (Macaca mulatta) chronically to low concentrations of dietary TCDD for 4 years (Bowman et al., 1989). Ten and 13 years
after the exposure ended, the investigators documented an increased incidence of
endometriosis in the monkeys that correlated with the TCDD exposure concentration (Rier et al., 1993, 2001). The sample was too small to yield a definitive
conclusion that TCDD was a causal agent of endometriosis, but this study led to
additional studies of the ability of TCDD to promote the growth of pre-existing
endometriotic lesions (Bruner-Tran et al., 1999; Johnson et al. 1997; J. Z. Yang
et al., 2000).
There are a number of mechanisms by which TCDD may promote endometrial lesions, which provide additional support for the biologic plausibility of a
link between TCDD and endometriosis. Human endometrial tissue and cultured
human endometrial epithelial cells both express AHR; its dimerization partner,
the aryl hydrocarbon nuclear translocator (Khorram et al., 2002); and three
AHR target genes—CYP1A1, 1A2, and 1B1 (Bulun et al., 2000; Willing et al.,
2011). These findings suggest that endometrial tissue is responsive to TCDD.
M. N. Singh et al. (2008) showed that CYP1A1 expression is greater in ectopic
endometrial tissue than in eutopic uterine tissue in the absence of TCDD exposure, which suggests that CYP1A1 may play a role in the etiology of the disease
or that AHR and its signaling pathway have been activated by an endogenous
ligand other than TCDD. Other mechanisms by which TCDD may promote
endometriosis include altering the ratio of progesterone receptor A to progesterone receptor B and blocking the ability of progesterone to suppress matrix
metalloproteinase expression—actions that promote endometrial-tissue invasion
and that are observed in women who have endometriosis (Igarashi et al., 2005).
TCDD also induces changes in gene expression that mirror those observed
in endometrial lesions. In addition to the induction of CYP1A1 noted above,
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TCDD can induce expression of histamine-releasing factor, which is increased
in endometrial lesions and accelerates their growth (Oikawa et al., 2002, 2003).
TCDD disrupts cannabinoid signaling in endometrial stromal cells by inhibiting
the progesterone-induced expression of cannabinoid receptor type 1, which is
also observed in women with endometriosis (Resuehr et al., 2012). TCDD also
stimulates the expression of RANTES (regulated on activation, normal T-cell–
expressed, and secreted protein) in endometrial stromal cells, and RANTES concentration and bioactivity are increased in women who have endometriosis (Zhao et
al., 2002). The two CC-motif chemokines (chemotactic cytokines), RANTESand
macrophage-inflammatory protein-1α (MIP-1α), have been identified as potential
contributors to the pathogenesis and progression of endometriosis. Previous studies
have shown that the combination of 17β-estradiol and TCDD increases the secretion of RANTES and MIP-1α in endometrial stromal cells (Yu et al., 2008), and a
more recent study showed that the same combination suppresses the expression of
tetraspanin CD82, a tumor-metastasis suppressor, and thus promotes the invasion
of endometrial stromal cells (M. Q. Li, 2011). Those results support the idea that
TCDD in combination with estradiol may contribute to the development of endometriosis by increasing the invasiveness of endometrial cells. Despite that evidence,
chronic exposure of rats to TCDD, non-dioxin-like PCB 153, dioxin-like PCB 118
or PCB 126, or 2,3,4,7,8-PeCDF (the furan congener with the highest TEF), either
individually or in various combinations, fails to alter endometrial histology in a
consistent manner (Yoshizawa et al., 2009). The differences between rodent and
human endometrium could account for the lack of observed effects in rats.
In summary, experimental studies, particularly ones that used human eutopic
and ectopic endometrial tissue, provide evidence of the biologic plausibility of a
link between TCDD exposure and endometriosis.
Synthesis
The human studies linking dioxin exposure with endometriosis are few and
inconsistent; information related to exposures to 2,4-D, 2,4,5-T, TCDD, picloram, or cacodylic acid is lacking. Although animal studies support the biologic
plausibility of an association, contemporary human exposures may be too low to
show an association should one exist.
Conclusion
On the basis of the evidence reviewed here, in VAO, and in the previous
VAO updates, the committee concludes that there is inadequate or insufficient
evidence to determine whether there is an association between exposure to the
COIs and endometriosis.
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Other Female Reproductive Health Outcomes
Update of the Epidemiologic Literature
Polycystic Ovary Syndrome (PCOS) PCOS is a hormonal disorder characterized by overproduction of the androgen testosterone. Three potentially relevant
studies published since Update 2014 addressed this condition. Vagi et al. (2014)
used a case-control pilot study design with Cedars Sinai Medical Center, Los
Angeles, California, patients. Serum PCBs—including the dioxin-like PCBs 105,
118, and 156—organochlorine pesticides, and other compounds were measured
in the urine of 52 cases and 50 controls. None of the dioxin-like PCBs was significantly elevated in cases compared to controls.
Q. Yang et al. (2015) used a case control design to evaluate serum PCBs,
pesticides, and polycyclic aromatic hydrocarbons in 50 cases and 30 control ethnic Han females recruited from the Peking University Third Hospital in northern
China. Exposure to dioxin-like PCBs was associated with an OR of 4.89 (95% CI
1.81–13.2), which remained significant after adjusting for confounders including
education and occupation (aOR = 5.52; 95% CI 1.51–20.2). Study limitations
include a small sample size and metabolic differences between the cases and
control that could affect the absorption, distribution, metabolism, and excretion
of COIs.
J. Zhang et al. (2014) used a cross sectional stratified case control design to
examine PCOS in females aged 12–44 years in Chengdu, China; 169 cases and
338 controls were analyzed. Questionnaire responses were used to characterize
exposure. No exposures to COIs were measured, although they can be inferred for
two categories characterizing a history of contact with polybrominated biphenyls:
“pesticide,” which yielded an odds ratio of 1.76 (95% CI 1.09–2.87) and “eating
fruit with pericarp” 5.00 (95% CI 2.67–9.48). However, the considerable uncertainty associated with this inference greatly limits the usefulness of the study
results to the committee.
Gestational Diabetes Mellitus Vafeiadi et al. (2017) used a cross-sectional/
semi-prospective design to evaluate PCBs and other compounds in first-trimester
maternal serum (dioxin-like PCBs 118 and 156 summed) with relation to gestational diabetes mellitus measured at 24–28 weeks in 939 mother–infant pairs
from the Rhea pregnancy cohort in Crete, Greece. Sixty-eight (7%) mothers presented with gestational diabetes mellitus. The adjusted odds ratio of gestational
diabetes mellitus in women in the “medium” (middle) tertile of dioxin-like PCBs
was 5.63 (95% CI 1.81–17.51) and for the high tertile 4.71 (95% CI 1.38–16-01).
The study controlled for maternal fish consumption, but the authors could not rule
out undiagnosed type 1 or type 2 diabetes or other unmeasured lifestyle factors
as confounders, limiting the usefulness of the results.
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Alteration in Hormonal Levels Anh et al. (2017) examined the relationship
between adrenal hormone disruption in lactating mothers and their children in
two locations of Vietnam, one of which was known to be contaminated with
dioxin. Thirty-seven mother–child pairs were recruited from the area near the
former U.S. air base at Bien Hoa, which stored tactical herbicides during the
Vietnam War and where at least four accidental releases of Agent Orange took
place; 47 control pairs from a rural community in northern Vietnam—where no
U.S. spraying took place—were also examined. Breast milk and blood samples
were collected from all mothers 4–16 weeks after the birth of their first child.
Data on subjects’ social characteristics, diseases (including hormonal therapy),
and body measurements were obtained via questionnaire. The researchers found
a statistically significant difference (p < 0.001) between serum androstenedione1
levels in mothers who resided in the dioxin contaminated region (n = 37; 1.91
ng/mol ± 1.00) versus the non-contaminated region (n = 47; 0.61 ng/mol ± 0.27).
They also noted an association between maternal levels of several dioxin congeners and subsequent salivary dehydroepiandrosterone levels in children (total
TEQ β = 0.42; p < 0.001). These results suggested to them that dioxin disrupts
adrenal androgens in mothers and breastfeeding children through the same mechanism. However, since the children were exposed both before and after birth, this
study is of limited relevance to the committee.
A cross-sectional study by Lignell and colleagues (2016) evaluated PBDE,
PCB, and dioxin exposures in relation to thyroid hormone status early in pregnancy in randomly selected first-time mothers (1996–1999) from Uppsala County,
Sweden. Maternal body burden of PCDD/Fs was inversely associated with firsttrimester T3 thyroid hormone levels. In fully adjusted models, no PCBs were
associated with first-trimester thyroid hormone levels; however, in crude analysis
di-ortho and mon-ortho PCB TEQ concentrations were negatively associated with
serum lipids in the third trimester and T3 in the first trimester. This result was
deemed noteworthy because maternal thyroid hormone status influences fetal
development in early pregnancy. However, reverse causality cannot be discounted
in this study as maternal T3 could influence the absorption, distribution, metabolism, and excretion of toxicants.
Biological Plausibility
Many studies have examined the effects of TCDD on the female reproductive
system. The two primary mechanisms that are believed to contribute to abnormal
follicle development and decreased numbers of ova after TCDD exposure are
the “cross-talk” of the AHR with the estrogen receptor and the dysregulation of
the hypothalamic–pituitary–gonadal axis (Pocar et al., 2005; Safe and Wormke,
1 Androstenedione and dehydroepiandrosterone are so-called “pro-hormones” that are precursors in
the production of testosterone and estrogen.
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2003). Oocytes are directly responsive to TCDD, so TCDD’s effects on hormone
concentrations, hormone-receptor signaling, and ovarian responsiveness to hormones all probably contribute to TCDD-induced female reproductive toxicity.
The data of Jung et al. (2010) in rats show that a single high-dose gavage treatment of 32 μg/kg TCDD reduces the proliferation of granulosa cells and thus
attenuates cell-cycle progression and potentially contributes to the reduction in
ovulation rates observed in other studies. In contrast, Karman et al. (2012) found
that 1 nM TCDD exposure in vitro did not reduce the rates of growth of murine
antral follicles, but did reduce the secretion of progesterone and estradiol by the
follicles. The concentrations of those hormones could be restored by the addition
of the precursor pregnenolone, which suggests that TCDD acts upstream of pregnenolone formation. Baldridge et al. (2015) have also shown that rat granulosa
cells are highly sensitive to low-level (femtomolar) TCDD, resulting in disrupted
steroid hormone secretion. A similar result was demonstrated by Jablonska et al.
(2014) in porcine granulosa cells. This would be consistent with previous observations in zebrafish that 10, 40, and 100 parts per billion TCDD in food depressed
estradiol biosynthesis (Heiden et al., 2008).
Dioxin’s effects on early embryo development and on placenta formation
are well documented (S. C. Chen et al., 2010; Ishimura et al., 2009; Tsang et al.,
2012). Petroff et al. (2011) used a rat in vitro fertilization model to demonstrate
that 100 nM TCDD perturbs chromatin and cytoskeletal remodeling at the earliest
stages of embryo development, but these changes failed to result in any apparent
morphologic changes at later stages of development. The long-term potential
effects of these early changes on pregnancy outcome are unknown. It has previously been shown that TCDD may have direct effects on human trophoblast
formation at 0.2–2.0 nM in vitro and thus may have the capacity to influence
the developing fetus (S. C. Chen et al., 2010). That idea is supported by a study
showing the ability of 5 nM TCDD to activate the AHR signaling pathway in
both rat and human placental trophoblasts (Stejskalova et al., 2011). Finally, a
study has demonstrated that TCDD at 0.1, 1.0, and 10.0 nM reduces in a dosedependent fashion the ability of trophoblastic spheroids (which constitute an
embryo surrogate) to attach to endometrial epithelial cells (Tsang et al., 2012).
The more recent literature continues to support the biologic plausibility of TCDD
having effects on male and female reproduction.
Synthesis
Eskenazi et al. (2010)—reviewed in Update 2010—published the only study
to date that has examined dioxin exposure in women with respect to time-to-
pregnancy (number of contraceptive-free months before pregnancy) and infertility (more than 12 contraceptive-free months to pregnancy). Dose–response
relationships between TCDD serum levels in women who were less than 40
years of age at the time of the Seveso accident and both time-to-pregnancy and
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infertility were observed, which is consistent with published observations in the
rat model. Epidemiologic studies have not provided sufficient data to interpret the
effects of dioxin specifically on menstrual-cycle function in humans.
The studies reviewed for this update yielded inconsistent results regarding
any association between exposure to the COIs and the outcomes studied, and they
exhibited weaknesses such as the failure to measure dioxin levels or calculate
TEQs that limit their applicability to the evaluation of outcomes for Vietnam
veterans.
Conclusion
On the basis of its evaluation of the evidence reviewed here and in previous VAO reports, the committee concludes that there is inadequate or insufficient evidence of an association between exposure to the COIs and disturbances
in hormonal levels in females and diseases that may be associated with such
disturbances.
GESTATION AND NEONATAL EFFECTS IN OFFSPRING
The gestation and neonatal periods are uniquely vulnerable times in life.
Data on health outcomes either occurring or first identified during these periods
have been collected on the offspring of those exposed to the COIs. Information
concerning spontaneous abortion, stillbirth, neonatal death, and infant death; sex
ratio; birth weight and preterm delivery; and birth defects are discussed below.
General Biologic Plausibility
Influence of Paternal Exposure
James (2006) has interpreted the perturbation of sex ratios by dioxins and
other agents as being an indicator of parental endocrine disruption and, indeed, a
population-level finding of a paternally mediated effect would be a strong indicator that dioxin exposure can interfere with the male reproductive process. If this
observation were demonstrated to be true, then it would be concordant with a
reduction in testosterone in exposed men (Egeland et al., 1994). Another pathway
to an altered sex ratio might involve male embryos experiencing more lethality
from the induction of mutations due to their unmatched X chromosome. TCDD
has not been thought to have genotoxic effects, but sex-specific adverse consequences of the modified imprinting of gametes might be a possible mechanism
leading to the observation of altered sex ratios at birth. To date, however, the
proportion of sons among the children of fathers exposed to dioxin-like chemicals
does not present a clear pattern of reduction.
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The idea that the exposure of either parent to a toxicant before conception
could result in an adverse outcome in offspring is not new and remains a topic of
much interest (Schmidt, 2013). Epidemiologic studies have reported occasional
findings of paternally transmitted adverse outcomes associated with paternal
exposures to certain agents, but none has been replicated convincingly. Even in
instances in which an agent is recognized as mutagenic or potentially carcinogenic for exposed men, adverse consequences have not been demonstrated in
their children. For example, the hypothesis was extensively investigated in the
early 1990s in relation to fathers’ exposure to ionizing radiation before conception and an increase in leukemias in their offspring. The initial study (Gardner et
al., 1990) was conducted in men who worked at the Sellafield nuclear facility in
West Cumbria, United Kingdom. It was presumed that the men were exposed to
radiation as a result of working at Sellafield. An association was found between
radiation exposures to fathers before their children’s conception and an increase
in leukemias among those children. However, later studies failed to confirm that
finding (Draper et al., 1997; Kinlen, 1993; Kinlen et al., 1993; Parker et al., 1993;
Urquhart et al., 1991). Similarly, a rigorous follow-up of children of atomicbomb survivors has not demonstrated increased risks of cancer or birth defects
(Fujiwara et al., 2008; Izumi et al., 2003; Schull, 2003), and other studies of birth
defects and cancer in the children of male cancer survivors after chemotherapy or
radiation treatment have found little support for paternal transmission (Chow et
al., 2009; Dohle, 2010; Howell and Shalet, 2005; Madanat-Harjuoja et al., 2010),
although sperm and fertility clearly are adversely effected (Green et al., 2010).
An additional problem when trying to determine whether adult male expo
sure of any type (including to the COIs) can lead to pathological effects in
descendants is that almost all experimental exposure studies designed to identify
male transmission have been limited to developmental exposures in rodents
(Guerrero-Bosagna and Skinner, 2014; Paoloni-Giacobino, 2014). An early
experiment examining male mice treated with simulated Agent Orange mixtures
prior to breeding with unexposed females failed to find an increase in a variety of
different birth defects in progeny compared with the progeny of untreated males
(Lamb et al., 1981).
Prior VAO committees have been unable to identify epidemiologic evidence
that convincingly demonstrated paternal exposure to any particular chemical before conception that resulting in cancers or birth defects in offspring. However,
few data exist to address the hypothesis of paternal exposure and adverseeffects
in human offspring in which the exposure occurred before conception only to the
father, and what little information exists comes from the radiation effects literature. Thus, it is difficult to assert conclusively that the available epidemiologic
evidence either supports or does not support paternal transmission; considerable
uncertainty remains on many fronts and would presumably vary by agent and
mode of exposure. Several systematic reviews of the topic have been conducted
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(Chia and Shi, 2002; Weselak et al., 2007, 2008; Wigle et al., 2007, 2008), and
none have established firm relationships between specific agents and particular
effects in offspring. Paternal occupation (characterized by exposure to chemicals via job title or job–exposure matrices) has been linked to an increased risk
of selected birth defects (Desrosiers et al., 2012; Fear et al., 2007; Shaw et al.,
2002) and neuroblastoma (De Roos et al., 2001a,b). Moreover, increased risks
of childhood brain cancer have been reported in relation to paternal exposure to
selected pesticides, particularly herbicides and fungicides (van Wijngaarden et
al., 2003), although the authors noted considerable uncertainty in the robustness
of the findings. Therefore, the hypothesis that paternal preconception exposure
to toxic agents may result in harm to a man’s children remains unresolved in significant part because of the sparseness of epidemiologic research on the subject.
Paternal Preconceptual Exposure There is no evidence that dioxins can mutate DNA sequences (see Chapter 4). Genetic changes in sperm genes due to
preconception exposures to TCDD—as has been shown, for example, in connection with irradiation or the anticancer drug cyclophosphamide (Codrington
et al., 2004)—are thus unlikely. The potential does exist, however, for TCDD to
alter the sperm cells of adults before fertilization through epigenetic pathways.
The sperm epigenome is distinctive from that of the egg (oocyte) or somatic cells
(all other non-gamete cells in the body). The mature sperm cell has less global
methylation than somatic cells, particularly at gene promoters, and has unique
DNA methylation marks (particularly on paternally imprinted genes) that put the
sperm genomes in a pluripotent-like state before fertilization (Hales et al., 2011).
However, rapid demethylation of most of the remainder of the paternal genome
occurs shortly after fertilization (Dean, 2014), suggesting that additional changes
are required for the nascent embryo to become truly pluripotent. Chemical alterations of DNA methylation foci of adult sperm have the potential to contribute
to permanent effects in offspring, as has been suggested for male transmittance
in fetal alcohol syndrome (Jenkins and Carrell, 2012a). During spermatogenesis
in the adult, most sperm histones are replaced by protamines, which render the
sperm transcriptionally quiescent and permit extensive DNA compaction. However, some core histones are retained in human sperm with appropriate epigenetic
modifications in order to maintain open nucleosomes at sites that are important
during embryo development (Casas and Vavouri, 2014), so their perturbation by
exogenous chemicals remains a possibility. This is particularly important because
although genome-wide DNA demethylation occurs in paternal DNA after fertilization (Dean, 2014) and should erase most sites that have been reprogrammed
by chemicals, histone modification patterns are retained and thus may transmit
chemical-induced alterations across generations (Puri et al., 2010).
Despite the exclusion of almost all cytoplasm, mature sperm, as noted above,
have been found to carry a diverse spectrum of RNAs, including messenger RNAs,
ribosomal RNAs, and small noncoding RNAs, which may affect the developing
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embryo (Casas and Vavouri, 2014; Hamatani, 2012; Kawano et al., 2012; Krawetz,
2005; Krawetz et al., 2011; Lane et al., 2014; Suh and Blelloch, 2011). For example, small RNAs of paternal origin may direct epigenetic modifications during
embryo development and lead to changes in phenotype later in life (Hales et al.,
2011). When newborn male mice were stressed by unpredictable separation from
their mothers, messenger RNAs in their sperm have been shown to transmit the
effects of this early trauma for two generations (Gapp et al., 2014). Heavy metals
interact with sperm’s nuclear proteins, and this mechanism is suspected to be a
basis of the paternally mediated effects of lead (Quintanilla-Vega et al., 2000).
Disturbances in the establishment of the epigenetic marks in mature sperm may
change cell fate in the early embryo and have effects throughout development and
postnatal life (Jenkins and Carrell, 2012b).
Direct evidence of dioxin-mediated changes in the epigenome of mature
sperm is not available. However, dioxins have been shown to modify DNA methylation in somatic cells (Hou et al., 2012), so an epigenetic pathway is plausible.
Paternal Postconceptual Exposure Contaminants such as TCDD that are
present in the tissues and blood of exposed males can be transported as parent
compounds or as metabolites into seminal fluid, the noncellular component of
the ejaculate. Typically, the concentrations of contaminants in seminal fluid are
lower than those in serum, but no direct assessments of the ratios of serum to
seminal fluid in TCDD have yet been reported. Seminal-fluid contaminants can
be transmitted to a female during sexual intercourse and be absorbed through
the vaginal wall; if the concentrations are high, then they could potentially affect a current pregnancy (Chapin et al., 2004; Klemmt and Scialli, 2005). TCDD
and other POPs have been identified and quantified in the seminal plasma of
exposed men, including Vietnam veterans (Schecter et al., 1996; Schlebusch
et al., 1989; Stachel et al., 1989); thus, this transmission route is theoretically
possible. In the Schecter et al. (1996) study, serum TCDD was measured in
50 Vietnam veterans from Michigan who had a confirmed or self-reported potential for herbicide exposure and had blood drawn an average of 26 years
after the possible exposure. Of those, six had TCDD levels greater than 20 parts
per trillion (ppt) on a lipid-adjusted basis, which supports the idea that some
veterans had high initial exposures. A subgroup of 17 men contributed semen at
the time of blood draw, and dioxin congeners were analyzed in three randomly
pooled samples—a process necessary to provide sufficient volume for chemical analysis. Although the measured concentrations were very low, the results
documented the existence of dioxins and dibenzofurans in the seminal plasma of
the veterans long after the possible herbicide exposure to TCDD-contaminated
herbicides. Because the results on serum and semen concentrations could not
be linked to individual veterans and because it is unknown whether any of the
individuals who had high serum dioxin concentrations after 26 years contributed s emen for the seminal-fluid measurements, the value of this information is
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minimal. Seminal-fluid concentrations of TCDD and related chemicals closer to
the period of exposure in Vietnam have not been determined, so it is not possible
to assess the clinical consequences of this exposure route for female partners and
gestating offspring. Banked Ranch Hand specimens, however, might provide a
valuable resource for comparing TCDD concentrations in serum and seminal
fluid. A 2015 Institute of Medicine report describes the available data and biospecimens from the Air Force Health Study (AFHS) and the potential for future
analyses (IOM, 2015).
Despite the potential for a seminal fluid route of exposure, the critical question of dose sufficiency remains unanswered. That is, could absorbed TCDD
concentrations be high enough to transmit adverse effects to the fetus? To answer
that question, one must take into account several factors. First, the volume of
seminal plasma is relatively low (1–5 mL) and, because of leakage, only a fraction of seminal constituents is absorbed across the vaginal wall. Moreover, the
dilution of absorbed chemicals in the female bloodstream before transmission
across the placenta is estimated at 3 orders of magnitude or more (Klemmt and
Scialli, 2005), which reduces a serum concentration of 20 ppt to a scale of parts
per quadrillion (10–15). Although no studies have been undertaken to address
the issue directly, the dilution factor makes it extremely unlikely that adverse
fetal and offspring outcomes would occur as a consequence of seminal plasma
exposures to TCDD during pregnancy. One caveat to this conclusion, however,
is that seminal fluid is now known to play an important role in the metabolic
phenotype of offspring because it stimulates embryotrophic factors (Bromfield,
2014; Bromfield et al., 2014). Whether TCDD contamination of the seminal fluid
can affect this function is not known and should be tested.
Influence of Maternal Exposure
Maternal exposures can affect a pregnancy and the resulting offspring far
more extensively than can paternal exposures. Because of the long half-life of
TCDD and its bioaccumulation in adipose tissues, women exposed to herbicides
in Vietnam would have the potential to expose their offspring to TCDD directly
during later pregnancies. Thus, damage to the resulting offspring or future generations could result from epigenetic changes in an egg before conception or from
the direct effects of exposure on the fetus during gestation and on the neonate
during lactation. Dioxin in the mother’s bloodstream can cross the placenta and
expose the developing embryo and fetus.
Furthermore, the mobilization of dioxin during pregnancy or lactation may
be increased because the body is drawing on fat stores to supply nutrients to the
developing fetus or nursing infant. TCDD has been measured in circulating human
maternal blood, cord blood, placenta, and breast milk (G. Suzuki et al., 2005), and
it is estimated that an infant breastfed for 1 year accumulates a dose of TCDD that
is six times as high as an infant who is not breastfed (Lorber and Phillips, 2002).
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The offspring effects of maternal exposures may not be manifested immediately
and could be a result of a dioxin-mediated reprogramming of developing organs
and lead to a disease onset later in life. As noted elsewhere, placental structure and
function are believed to play a major role in fetal growth, and TCDD has been
shown to alter placental vascular remodeling (Y. Wu et al., 2013, 2014).
As mentioned in conjunction with the role of the placenta in fetal development, the developmental basis of adult disease (Barker et al., 2012) is being
actively researched through the investigation of maternal nutritional exposures,
stress, and alcohol exposure, and more recent studies have examined exposures to
TCDD and other environmental toxicants. The molecular basis of the later-life effects is believed to be primarily epigenetic. Maladies that may be manifested later
in life include neurologic and reproductive disorders, thyroid changes, diabetes,
obesity, and adult-onset cancers. Furthermore, germ cells (eggs and spermatogonia) in offspring pass through critical developmental stages during fetal life (D.
A. Hansen et al., 2014), and emerging evidence demonstrates that fetal exposures
are capable of altering the germ cells epigenetically, resulting in a transmission
of adverse effects to future generations (intergenerational and transgenerational
inheritance) (D. A. Hansen et al., 2014).
Spontaneous Abortion, Stillbirth, Neonatal Death, and Infant Death
Spontaneous abortion is the expulsion of a nonviable fetus—generally before
20 weeks of gestation—that is not induced by physical or pharmacologic means.
The background risk of recognized spontaneous abortion is generally 11–22%
(Avalos et al., 2012), but it is established that many more pregnancies terminate
before women become aware of them (Wilcox, 2010). Such terminations are
known as subclinical pregnancy losses and generally are not included in studies of
spontaneous abortion. The estimates of the risk of recognized spontaneous abortion vary with the design and method of analysis. Studies have included cohorts
of women asked retrospectively about pregnancy history, cohorts of pregnant
women (usually those receiving prenatal care), and cohorts of women who are
monitored for future pregnancies. The value of retrospective reports can be limited by the differential recall of details (exposure history, for example) specific
to pregnancies that occurred long before the interview. Studies that enroll women
who present for prenatal care require the use of life tables and specialized statistical techniques to account for differences in the times at which women seek medical care during pregnancy. The enrollment of women before pregnancy provides
the theoretically most valid estimate of risk, but it can attract non-representative
study groups because the study protocols are demanding for the women.
Countries and U.S. states have different legal definitions of the age of fetal
viability and apply these terms differently. The American College of Obstetricians
and Gynecologists defines “stillbirth” as the delivery of a fetus that shows no signs
of life (that is, an absence of breathing and heartbeat; pulsations in umbilical cord
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are absent; no voluntary movement of muscle) at 20 weeks or greater of gestation
(if the gestational age is known) or at a weight greater than or equal to 350 g if
the gestational age is not known (Da Silva et al., 2016). “Neonatal death” refers to
the death of a live-born infant within 28 days of birth (WHO, 2006) and “postnatal
death” refers to a death that occurs before the first birthday (Andrews et al., 2008).
The causes of stillbirth and early neonatal death overlap considerably, so
they are commonly analyzed together in a category referred to as “perinatal
mortality” (Andrews et al., 2008). Stillbirths make up less than 1% of all births
(CDC, 2000). The most common causes of mortality during the neonatal period
are low birth weight (< 2.5 kg at birth), preterm delivery, congenital malformations, pregnancy or delivery complications, and placenta or cord conditions. The
most common causes of postnatal death in infants is SIDS (sudden infant death
syndrome) (Andrews et al., 2008).
The committee responsible for the original VAO report concluded that there
was inadequate or insufficient evidence of an association between exposure to
2,4-D, 2,4,5-T, TCDD, picloram, or cacodylic acid and spontaneous abortion or
perinatal death. Additional information available to the committees responsible
for Update 1996, Update 1998, and Update 2000 did not change that conclusion.
The committee responsible for Update 2002, however, found that there was
enough evidence available to conclude that there was “limited or suggestive evidence of no association” between paternal exposure to TCDD and the risk of spontaneous abortion. That conclusion was based primarily on a National Institute for
Occupational Safety and Health study (Schnorr et al., 2001) that investigated a large
number of pregnancies fathered by workers whose serum TCDD concentrations
were extrapolated back to the time of conception; no association was observed up
to the highest-exposure group (1,120 ppt or higher). Indications of a positive association were seen in studies of Vietnam veterans (CDC, 1989c; Field and Kerr,
1988; S. D. Stellman et al., 1988b), but the committee responsible for Update
2002 asserted that they might be due to an exposure to phenoxy herbicides rather
than to TCDD and concluded that there was insufficient information to determine
whether there is an association between maternal exposure to TCDD and the risk of
spontaneous abortion or between maternal or paternal exposure to 2,4-D, 2,4,5-T,
picloram, or cacodylic acid and the risk of spontaneous abortion.
The additional information (none of which concerned paternal exposure)
reviewed by the committees responsible for the Update 2004 through Update
2014 reports did not change these conclusions.
The relevant studies concerning perinatal death are reviewed in the earlier
reports. Table 32, which can be found at www.nap.edu/catalog/25137, summarizes the results of studies related to spontaneous abortion.
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Update of the Epidemiologic Literature
No Vietnam-veteran, occupational, environmental or case-control studies of
exposure to the COIs and spontaneous abortion or perinatal death have been published since Update 2014.
Biological Plausibility
Laboratory animal studies have demonstrated that TCDD exposure during
pregnancy can alter the concentrations of circulating steroid hormones and disrupt placental development and function and thus contribute to a reduction in the
survival of implanted embryos and to fetal death (L. Huang et al., 2011; Ishimura
et al., 2009; J. Wang et al., 2011; Y. Wu et al., 2013, 2014). There is no evidence
of a relationship between paternal or maternal exposure to TCDD and spontaneous abortion. Exposure to 2,4-D or 2,4,5-T causes fetal toxicity and death after
maternal exposure in experimental animals. However, that effect occurs only at
high doses and in the presence of maternal toxicity. No fetal toxicity or death has
been reported to occur after paternal exposure to 2,4-D.
Animal studies of maternal TCDD exposure during pregnancy have demonstrated the induction of fetal death; neonatal death, however, is only rarely
observed and is usually the result of TCDD-induced cleft palate, which leads to an
inability to nurse. A single study by Y. Wu et al. (2016) suggests that AHR may be
involved in unexplained recurrent spontaneous abortion without consideration of
TCDD or other ligands. Further study in this area is warranted. Studies addressing the potential for perinatal death as a result of paternal exposure to TCDD or
herbicides are at this point inadequate to support drawing any conclusions.
Synthesis
No studies concerning the COIs and spontaneous abortion, stillbirth, neonatal death, or infant death have been published since Update 2014, and available
toxicologic studies do not provide clear evidence for the biologic plausibility of
an association with paternal exposures.
Conclusion
On the basis of the evidence reviewed to date, the committee concludes that
there is limited or suggestive evidence that paternal exposure to TCDD is not
associated with risk of spontaneous abortion and that insufficient information is
available to determine whether there is an association between maternal exposure
to TCDD or either maternal or paternal exposure to 2,4-D, 2,4,5-T, picloram, or
cacodylic acid and the risk of spontaneous abortion. The committee concludes
that there is inadequate or insufficient evidence to determine whether there is an
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association between exposure to the COIs and stillbirth, neonatal death, or infant
death.
Sex Ratio
Although it would not constitute an adverse health outcome in an individual
veteran, perturbations in the sex ratio of children born to an exposed population
would suggest that the exposure had an impact on the reproductive process. Previous reports in the VAO series have reviewed the literature on this topic. U
 pdate
2014 contains a summary of this work, which is also cataloged in Table 33, which
may be found in the supplementary tables available at www.nap.edu/catalog/
25137. In brief, studies have found an alteration—most often, a reduction—in
the expected proportion of male infants at birth, but results are inconsistent and
only some reach statistical significance.
Update of the Epidemiologic Literature
One occupational cohort study on TCDD exposure and sex ratio has been
published since Update 2014 was released. 't Mannetje et al. (2017) conducted a
retrospective study of workers employed for at least 1 month between 1969 and
1984 at a phenoxy herbicide production plant in New Zealand. In 2007–2008,
a sample of 430 workers out of 631 known to be alive under the age of 80 years
and living in New Zealand was randomly selected. Of these, 244 responded,
and 212 had a biological child. Blood samples were collected and a survey was
conducted regarding biological children, their birthdates, sex, and medical conditions. Logistic regression was conducted with the outcome of male versus female
sex, with adjustment for the parent’s age at the time of birth, BMI at the time of
blood draw, and smoking status. Both female and male employees were included,
and analyses were conducted separately; however, the number of female employees was small. Exposures were estimated for the time of the child’s birth by backcalculation using first-order toxicokinetics and a half-life of 7.6 years. Results
showed reduced odds of a male birth when comparing high- versus low-TCDD
exposure. For a father’s exposure in 2007–2008, reduced odds of a male birth
(OR = 0.46, 95% CI 0.29–0.73) were observed for TCDD serum concentration ≥
4 versus < 4 pg/g lipid (OR = 0.49, 95% CI 0.30–0.79). Similarly, for a father’s
exposure at time of the child’s birth, reduced odds of a male birth were observed,
comparing TCDD concentration ≥ 20 versus < 20 pg/g lipid (OR = 0.49, 95% CI
0.30–0.79). Additionally, a significant dose–response was observed, both for the
TCDD as measured in 2007–2008 (p trend = 0.01) and for exposure estimated
at time of the child’s birth (p trend = 0.007). In both of these analyses, the upper
two exposure categories showed significant ORs of approximately half the probability of a male child compared with fathers whose exposure to TCDD was in
the low-dose group. The study found that paternal serum TCDD concentrations in
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excess of an estimated 20 pg/g lipid at time of conception were associated with a
reduced sex ratio. No significant association was observed for the mother’s exposure to TCDD, although the ORs were elevated, not reduced. These findings are
consistent with a male-mediated reduction in sex ratio, which had been observed
in some prior studies (del Rio Gomez et al., 2002; Hertz-Picciotto et al., 2008;
Mocarelli et al., 1996, 2000). The lack of an association for maternal exposure is
consistent with an endocrine-mediated outcome.
Biological Plausibility
In a previously unreviewed paper, Ishihara et al. (2007) found that male ICR
mice administered TCDD orally with an initial loading dose of 2,000 ng TCDD/kg
followed by a weekly maintenance dose of 400 ng/kg (T2,000/400) prior to mating produced a significantly lower proportion of male offspring than controls
(controls: 53.1% ± 1.7; T2000/400: 46.2% ± 2.1) while there was no alteration
in litter size. The authors speculated that TCDD might selectively reduce the
fertility potential of Y-bearing gametes before conception but stipulated that no
mechanism could be identified.
An investigation by You et al. (2018) treated mouse spermatozoa with different concentrations of TCDD in vitro (0.25, 25, 2,500 ng/mol) and then performed in vitro fertilization. The sex ratio of two-cell embryos was significantly
decreased at all TCDD treatment groups compared with the control (p < 0.05). In
addition, the sex ratio of blastocysts decreased significantly for the 25 and 2,500
ng/ml of TCDD treatment groups (p < 0.01), and embryo sex ratios were negatively correlated with live X sperm proportion (two-cell embryos, r = –0.697;
blastocyst, –0.856; p < 0.05). The researchers concluded that TCDD may affect
the fertility of Y spermatozoa more than X spermatozoa but asserted that further
studies are needed to evaluate the source of the difference of fertilizing capability
between X and Y spermatozoa exposed to TCDD.
Synthesis
Prior to this update, committees had not identified any experimental animal
studies that specifically examined the effects of the COI on the sex ratios of offspring, nor had any alterations in sex ratio been reported in animal studies that
examined the developmental effects of the COIs on offspring. However, the recent
publication of You and colleagues’ (2018) study and the previously unreviewed
Ishihara et al. (2007) paper yielded information for their consideration. The committee finds that the papers’ results are consistent with those observed in human
studies but that the lack of an identified mechanism underlying the observations
limits their usefulness. These data, along with the new 't Mannetje et al. (2017)
retrospective study add incrementally to the body of knowledge on the topic but
do not change any of the conclusions.
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Conclusion
On the basis of its evaluation of the evidence reviewed here and in previous
VAO reports, the committee concludes that there is inadequate or insufficient evidence of an association between exposure to the COIs and altered sex ratio.
Birth Weight and Preterm Delivery
Birth weight and the length of the gestation period can have important effects
on neonatal morbidity and mortality and on health over the life span. Typically,
low birth weight (LBW) is defined as a birth weight under 2,500 g (~5.5 lbs.)
(UNICEF, 2004). In the absence of congenital malformations or chromosomal
anomalies, LBW is the consequence of either preterm delivery or an intrauterine
growth restriction. Preterm delivery is delivery at less than 259 days or 37 weeks
of gestation from the date of the first day of the last menstrual period (Jones and
Lopez, 2013). Intrauterine growth restriction is functionally defined in terms of
LBW relative to gestational age when compared to local or national fetal-growth
graphs (Romo et al., 2009). LBW occurs in about 7% of live births. When no
distinction is made between intrauterine growth restriction and preterm delivery,
the factors most strongly associated with LBW are maternal tobacco use during
pregnancy, multiple births, and race or ethnicity. Other potential risk factors are
low socioeconomic status, malnutrition, maternal weight, birth order, maternal
complications during pregnancy (such as severe pre-eclampsia or intrauterine
infection), obstetric history, job stress, and cocaine or caffeine use during pregnancy (Alexander and Slay, 2002; Alexander et al., 2003; Ergaz et al., 2005; Jones
and Lopez, 2013; Peltier, 2003). Established risk factors for preterm delivery
include race (black), extremes of maternal age, low socioeconomic status, previous LBW or preterm delivery, multiple gestations, tobacco use, and low maternal
pre-pregnancy weight or poor pregnancy weight gain (Rubens et al., 2014).
The importance and interpretation of risk factors for associations with birth
weight are often unclear and a subject of controversy among researchers (Barker
et al., 2012; Wilcox, 2010). Across populations, the frequency distribution of birth
weight is Gaussian, with an extended lower tail, or “residual distribution,” that
includes preterm and LBW infants. The predominant, normal distribution corresponds largely to term births. In general, shifts in the predominant distribution
do not tend to correspond to notable shifts in infant mortality (Wilcox, 2001). A
number of factors may result in shifts in the predominant distribution; altitude,
race or ethnicity, and maternal smoking are among the better studied, and these
factors can produce either a larger or, sometimes, smaller percentage of LBW
babies. However, populations that have a larger percentage of LBW infants do
not always have higher infant mortality (Wilcox, 2001, 2010). While birth weight
is tracked internationally as a public health indicator to identify opportunities for
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intervention and to understand country-specific infant mortality (UNICEF, 2004),
strategies to increase birth weight have not been effective in reducing mortality.
The committee responsible for VAO concluded that there was inadequate
or insufficient evidence to determine whether there is an association between
exposure to the COIs and LBW or preterm delivery, and additional information
available to the committees responsible for the subsequent updates did not change
that conclusion. Reviews of the relevant studies are presented in the earlier reports.
Tables 34 and 35, which can be found at www.nap.edu/catalog/25137, summarize
the results of studies related to birth weight after paternal and maternal exposure
to the COIs.
Update of the Epidemiologic Literature
No Vietnam-veteran, occupational, or case-control studies of exposure to the
COIs and LBW or preterm delivery have been published since Update 2014. Four
new environmental studies are summarized below.
A study of 234 couples by Robledo et al. (2015) examined how birth size
varied with maternal and paternal exposures to 63 POPs from five major classes,
including 36 PCBs, seven of which were dioxin-like (PCBs 105, 114, 118, 156,
157, 167, and 189). Exposure was measured in parental serum collected before
conception. Differences in birth weight and other growth-related parameters were
estimated using multiple linear regression per 1 standard deviation increase in
natural log-transformed (ln-transformed) chemicals. The subjects were participants in the LIFE prospective cohort study,2 which was conducted in Michigan
and Texas between 2005 and 2009. Models were estimated separately for each
parent and adjusted for maternal age, maternal prepregnancy BMI, and other
confounders, and all models included an interaction term between infant sex and
each chemical. The authors found that for every 1 standard deviation increase in
ln-transformed concentration of paternal serum levels of PCB 167, the mean birth
weight among female newborns (n = 117) was 97.49 g lower (95% CI [–187.45,
–7.54]), and mean length (β = −0.57 cm; 95% CI [–1.12, −0.02]) and head circumference (β = −0.45 cm; 95% CI [−0.86, −0.03]) were smaller. No statistically
significant outcomes were observed for paternal exposures and male newborns
(n = 113). For maternal serum PCB 167 levels, male newborn birth weight was
significantly lower (−129.24 g, 95% CI [−228.16, −30.31]) and head circumference smaller (−0.47 cm, 95% CI [–0.95, 0.00]), and there were no statistically
significant outcomes for female newborns.
A birth cohort study of 484 children in Hokkaido, Japan, by Kobayashi et al.
(2017)—the Hokkaido Study on Environment and Children’s Health—measured
total dioxin levels as the sum of 29 congeners in maternal blood samples taken
2 Cited earlier in this chapter in the review of a paper by Mumford et al. (2015) in the section on
male reproductive health outcomes.
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either during the third trimester or within 1 week after delivery. (In Japan, the
largest source of dioxin exposure is dietary, and of the total dioxin intake in this
population, the main source is seafood.) This new study expanded results from a
previous study conducted in the same birth cohort (Konishi et al., 2009; r eviewed
in Update 2010) that reported a significant adverse effect on birth weight for
total PCDDs TEQ levels (adjusted β = −231.5 g, 95% CI [−417.4, −45.6]) and
total PCDFs TEQ levels (adjusted β = −258.8 g, 95% CI [−445.7, −71.8]).
Sex-stratified analyses suggested that these reductions in birth weights were
stronger in boys. Here, the investigators assessed polymorphisms in the women’s
genes encoding the aryl hydrocarbon receptor (AHR [G > A, Arg554Lys]), cytochrome P450 (CYP1A1) (T6235C), and glutathione S-transferase mu 1 (GSTM1;
non-null/null), genes that code for three metabolizing enzymes that had previously been related to dioxin or birth weight.3 Linear regression analyses that were
adjusted for confounding factors found that pregnant women with a GSTM1 null
genotype—a genotype previously established to be associated with a high inducibility of cytochrome P450 1A1 gene transcription—gave birth to infants with a
345 g (95% CI [−584, −105]) reduction in birth weight for each 10-fold increase
in total dioxin TEQ. They also noted birth weight reductions for the children of
GSTM1-null mothers for some of the individual congeners. These results suggest
that PCDDs and PCDFs may accumulate in the placenta and, through interference
with placental function, affect birth weight.
Miyashita and colleagues (2015b) investigated 70 PCB congeners, including dioxin-like PCBs, in the blood of a smaller subgroup of 367 woman–child
pairs from the Hokkaido Study cohort cited above. Mothers completed self-administered questionnaires on demographic characteristics, socioeconomic status,
personal habits, and food consumption; medical records were used to extract
details for the delivery and characteristics of the infants. The authors found no
associations between the concentrations of dioxin-like PCBs (or non-dioxin-like
PCBs) and newborn anthropometric measurements of birth weight (small for
gestational age), length, chest circumference, and head circumference in analyses
with multiple linear regression models with or without adjustment for confounding factors. A reduction in birth weight and other measures of size was observed
for dioxin-like PCBs, but these results were not statistically significant.
A study by Van Tung et al. (2016) of residents of a dioxin hot spot area in
Vietnam4 reported on 58 mother–infant pairs who were compared with 62 pairs
from a region thought to be uncontaminated. Breast milk from lactating mothers with infants ages 7 and 16 weeks at the time of sampling was analyzed for
3 Research indicates that dioxins bind AHR and induce CYP1A1 expression (Harper et al., 2002)
and absence of human glutathione S-transferase mu 1 (GSTM1; null genotype) is associated with
increased induction of CYP1A1 expression (Vaury et al., 1995).
4 Males in this study cohort were reported on by Sun et al. (2016) in a paper addressed in the male
reproductive outcomes discussion earlier in this chapter.
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dioxin congener levels. Samples from mothers living in the hot spot had fivefold
higher levels of dioxin than breast milk from controls. Birth weight was inversely
correlated with both 2,3,7,8-TCDD and 2,3,4,7,8-PeCDF congener levels. The
rate of newborns with a birth weight less than 2,500 g was threefold higher in
the hot spot (12%) than in the control region (4%). However, at 8–9 or 12–14
weeks of age, no significant associations were observed between infant size and
dioxin isomer levels.
Biological Plausibility
The available evidence from experimental animal studies indicates that
TCDD exposure during pregnancy can reduce body weight at birth, but only at
high doses. A study in human placental explants suggests that TCDD exposure
may enhance placental inflammation and may increase the risk of preterm births
associated with infection (Peltier et al., 2013). Laboratory studies of the potential
male-mediated developmental toxicity of TCDD and herbicides resulting from
the prior exposure of the fathers are inadequate to support conclusions. TCDD
and herbicides are known to cross the placenta, which leads to the direct exposure of the fetus. Data from studies of experimental animals also suggest that the
pre-implantation embryo and developing fetus are sensitive to the toxic effects
of 2,4-D and TCDD after maternal exposure.
Synthesis
Studies reviewed in this update continue the pattern observed in earlier
research of identifying either no or small decrements in birth weight and size
parameters for children born to parents with the highest levels of dioxin exposure.
As has been noted by previous committees, there are a number of challenges
in conducting these types of epidemiologic studies in a rigorous way. First, the
prenatal and immediate postpartum period is not a stable pharmacokinetic state;
there are substantial changes in body volume and fat mobilization during that
time. Biomarker measures during pregnancy may be substantially affected by
weight change during pregnancy. Moreover, the extrapolation of a more recent
biomarker measure back many years to a more relevant period is complicated
by intervening pregnancy and breastfeeding events, which result in a substantial
uncertainty in the index exposure level. Overall, although the committee notes
that the animal literature does support an effect of TCDD exposure at high doses
on birth weight, the epidemiologic literature is insufficiently robust to allow a
final determination.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
LBW or preterm delivery.
Birth Defects
A birth defect is an abnormality of structure, function, or metabolism,
whether genetically determined or resulting from an environmental influence
during embryonic or fetal life (Christianson et al., 2006). Other terms for birth
defect, often used interchangeably, are “congenital anomaly” and “congenital
malformation.” Major birth defects, which occur in 2–3% of live births, are
abnormalities present at birth that are severe enough to interfere with viability or
physical well-being. Birth defects are detected in another 5% of babies through
the first year of life. Genetic factors, exposure to some medications, exposure to
environmental contaminants, occupational exposures, maternal infections, and
lifestyle factors have been implicated in the etiology of birth defects (Christianson et al., 2006), although the causes of the vast majority of birth defects are
unknown. Most etiologic research has focused on the effects of maternal and fetal
exposures, but, as discussed in the beginning of this chapter, it is theoretically
possible that epigenetic alterations in the paternal gamete caused by preconception exposures could result in paternally mediated effects. It should be noted that
a substantial amount of epidemiologic research on suspect toxic agents has been
conducted, but none of it has definitively established paternal preconception
exposures as a contributing factor to the occurrence of birth defects (Chow et al.,
2009; Desrosiers et al., 2012; Dohle, 2010; Schull, 2003).
The committee responsible for VAO concluded that there was inadequate or
insufficient evidence to determine whether there is an association between exposure to 2,4-D, 2,4,5-T or its contaminant TCDD, picloram, or cacodylic acid and
birth defects in offspring. Additional information from the AFHS available to the
committee responsible for Update 1996 led it to conclude that there was limited
or suggestive evidence of an association between at least one of the COIs and
spina bifida in the children of veterans; there was no change in the conclusions
regarding other birth defects.
The Update 2002 committee, which reviewed a study of female Vietnam veterans that reported significant increases in birth defects in their offspring (Kang
et al., 2000a), did not find those results sufficient to modify prior conclusions.
Nonetheless, Congress mandated that a number of birth defects in the children of
female Vietnam veterans be assigned service-related status. Later committees have
not encountered data that would merit changing the conclusion that the evidence
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is inadequate to support an association between exposure to the COIs and birth
defects (aside from spina bifida) in the offspring of either male or female veterans.
The Update 2014 committee concluded that the new evidence it identified
concerning the occurrence of birth defects in association with exposure to the
COIs, in combination with existing evidence, was inadequate or insufficient to
support an association for birth defects overall in the children of Vietnam veterans. In light of the fact that evidence anticipated by the committee responsible
for Update 1996 that would support an association between paternal exposure to
the COIs and spina bifida had not materialized, that committee concluded that
spina bifida should be moved from the category of limited or suggestive evidence
of an association to the default category of inadequate or insufficient evidence
of an association. An increased scrutiny of mechanisms by which paternal exposure might contribute to adverse effects in offspring has not definitively established the biologic plausibility of this phenomenon, whereas the understanding of
how maternal exposures may disrupt fetal development has grown substantially.
There were, however, no epidemiologic results supporting an association between
maternal exposure to the COIs and spina bifida specifically, so spina bifida in
association with exposure of either parent was moved to the inadequate or insufficient category of association. Chapter 10 of Update 2014 contains a detailed
discussion of the evidence and reasoning underlying this determination.
Tables 36 and 37, which can be found at www.nap.edu/catalog/25137, summarize the results of studies related to birth defects and specifically of neural-tube
defects such as spina bifida.
Update of the Epidemiologic Literature
No Vietnam-veteran studies of exposure to the COIs and birth defects have
been published since Update 2014. New occupational, environmental, and casecontrol studies addressing neural-tube defects, cryptorchidism or hypospadias,
gastrointestinal tract defects, cardiovascular defects, and general or multiple
congenital anomalies are addressed below. All are classified as “Other Identified Studies” (as delineated in Chapter 3) because the exposures they addressed
were not described in sufficient detail to allow the committee to determine their
relevance to the experience of Vietnam veterans.
Other Identified Studies–Occupational Studies Makelarski et al. (2014)
report results from a case-control analysis of maternal periconceptional occupational exposure to pesticides and association with neural-tube defects in offspring.
Cases and controls were derived from the U.S. National Birth Defects Prevention Study (NBDPS), a large national case-control study of risk factors for birth
defects. For any insecticide and herbicide use the odds ratio for spina bifida was
2.1 (95% CI 1.0–4.1), based on 14 exposed. There was no dose–response gradient
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for cumulative exposure to insecticide and herbicide and spina bifida. The study’s
strengths include the national context of the study with a relatively large, welldefined case group and extensive covariate information. The limitations include
a lack of specific herbicide exposure information, the use of the general jobexposure matrix for exposure assessment, and the fact that small sample sizes
precluded analyses of exposure to herbicides only.
Using cases and controls from the NBDPS, Pettigrew and colleagues (2016)
examined the joint effect of parental occupational exposure to pesticides on the
risk of spina bifida in offspring (291 cases). The analysis included joint parental
exposure to insecticides and herbicides and fungicides, which yielded an odds
ratio of 0.8 (95% CI 0.4–1.5). There was only one case with joint parent herbicideonly exposure (the odds ratio was not estimated). Herbicide exposure adjusted for
other pesticides had decreased odds of spina bifida (OR = 0.6, 95% CI 0.3–125.0).
The study’s strengths include the national context of the study with a well-defined
case group and extensive covariate information. Its limitations include the lack of
specific herbicide exposure information, the lack of paternal self-reported occupational history (it was reported by the mother), the use of the general job-exposure
matrix for exposure assessment, and the very small sample sizes for herbicide
exposure.
Rocheleau et al. (2015) examined the association between maternal occu
pational exposure to fungicides, insecticides, and herbicides and the risk of
congenital heart defects among offspring. Cases and controls were drawn from
the NBDPS, a multisite case-control study. Maternal occupational exposure to
pesticides was analyzed for 3,318 cases and 2,979 controls using data for births
in 1997–2002. Only 3 case mothers and 3 control mothers were determined to
have had exposure to only herbicides. Analyses of estimated high exposure to
herbicides and insecticides found associations with any simple, isolated congenital heart defects (OR = 1.90, 95% CI 1.05–3.44), pulmonary valve stenosis
(OR = 3.64, 95% CI 1.31–10.15), right ventricular outflow tract obstruction (OR
= 3.40, 95% CI = 1.41–8.16), and hypoplastic left heart syndrome without ventricular septal defect or anomalous pulmonary venous return (OR = 5.11; 95%
CI 1.70–15.35). The study’s strengths include its use of a large population-based
case-control design with careful ascertainment and classification of congenital
heart defects, adjustment for multiple potential confounders, and an expert-based
assessment of potential pesticide exposure. The major study limitation was the
lack of information on exposure to specific pesticides.
Jorgensen and colleagues (2014) used the national Danish registries to determine parental employment in farming or horticulture and to identify their
male offspring born between 1980 and 2007. Boys were followed for a hospital
diagnosis of cryptorchidism recorded in the Danish National Patient Registry.
Hazard ratios (HRs) and 95% CIs were calculated using Cox regression to compare the occurrence of cryptorchidism among the male children of mothers and
fathers working as horticultural workers and farmers with the male children of
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parents in other occupations. Adjustment was made for birth year, parental age,
parity, and geographic region. A total of 618,081 boys born to actively employed
mothers during 1980–2007 were identified, including 2,105 and 4,520 born to
maternal horticultural workers and farmers, respectively. The adjusted HR for
cryptorchidism showed an elevated risk among boys of maternal horticultural
workers (HR = 1.20, 95% CI 0.95–1.52) and an increased risk among boys of
maternal farmers (HR = 1.31, 95% CI 1.12–1.53) compared with boys of mothers
in all other occupations. For fathers, a total of 708,283 boys were identified, and
18,648 were diagnosed with cryptorchidism during follow-up. Fathers working
in horticulture or farming had 2,157 and 24,348 sons, respectively, of whom
72 (3.3 %) and 742 (3.0%), respectively, were diagnosed with cryptorchidism.
The HRs for cryptorchidism were 1.20 (95% CI 0.96–1.51) for boys of paternal
horticultural workers and 1.04 (95% CI 0.96–1.12) for boys of paternal farmers.
The study’s strengths included a large national registry-based cohort of parental
occupational information and outcome information for offspring. However, data
on specific chemical exposures for the parents were not available, limiting the
usefulness of the study for the evaluation of risks from the COIs.
Other Identified Studies–Environmental Studies Markel and colleagues
(2015) conducted an ecologic study of hypertrophic pyloric stenosis identified
by the Indiana Birth Defects Registry from 2005–2009. Birth defect cases were
linked with their birth certificate record to obtain demographic and other infor
mation. County-level pesticide use data from available from the U.S. Geological
Survey annual agricultural pesticide use database. The county-level pesticide
data were categorized into high, moderate, and low level of use. Data were also
subdivided into fungicides, fumigants, insecticides, and herbicides. Herbicides
comprised 91% of all pesticides used. Total pesticide levels in the county of residence correlated significantly with the incidence of hypertrophic pyloric stenosis
(r = 0.029, p = 0.004), as did herbicide use (r = 0.029, p = 0.005). This analysis
is limited by the ecologic nature of the exposure data and outcome data. Although
statistically significant, the correlation values were rather small and while logistic
regression was used, the report only presents p-values and no effect estimates.
There was no information on specific herbicides, other than to note that glyphosate and atrazine, which are not COIs, were the most heavily used.
A study on the island of Guam by Noel and colleagues (2015) examined the
relationship between village-level estimates of alleged Agent Orange exposure
and infant mortality due to congenital anomalies. Total births by village (n = 19)
and infant mortality due to congenital anomalies for each year from 1970 to
1989 were obtained from the Office of Vital Statistics in the Guam Department
of Public Health and Public Services. Each birth and death was assigned to a
village based on the usual residence of the mother. The 1980 U.S. Census was
used to obtain data on the median age of the village females, village fertility
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ratio, population density, persons per household, single-mother households, and
the number of married females. Agent Orange exposure data were obtained from
a U.S. Air Force veteran who conducted ground-level Agent Orange spraying for
vegetation control. The veteran provided village-level spray estimates based on
his recollection; however, there was no reported independent verification of this
information. Eleven villages were classified as high risk (cause-specific death
rate was 2.96 per 1,000 live births) and eight as low risk (1.31 per 1,000 live
births). Twelve villages were considered to have Agent Orange spraying (10 high
risk and 2 low risk, p = 0.006). In the multivariable linear regression model,
which included an adjustment for the median age of village females, the association between Agent Orange spraying area and infant mortality due to congenital
anomalies was statistically significant (standardized regression coefficient β =
2.02; 95% CI 0.08–3.96; p = 0.042) with the model explaining approximately
51% of the variance. Models adjusting for other Census-based covariates yielded
similar results. The study had several limitations, prominently the highly subjective nature of the exposure characterization. The assignment of potential village
exposure to Agent Orange spraying was obtained from a single source and was
not independently confirmed by records or biomarker data. Lacking congenital
anomaly prevalence data, the study relied instead on mortality data, which may
be affected by village-specific differences in infant survival due to differences in
medical care and other factors.
Other Identified Studies–Case-Control Studies Shaw et al. (2014) examined
cases and controls ascertained in the San Joaquin Valley in California. Cases
were born from 1997 to 2006 with gastroschisis confirmed by clinical g eneticists;
those with single-gene conditions or chromosomal abnormalities or with identifiable syndromes were ineligible. Controls were non-malformed live-born infants
randomly selected from birth hospitals in the study area. Data were collected
from maternal telephone interviews using a standardized, computer-based questionnaire. Interviews were conducted with mothers of 72% of eligible cases (n
= 193) and 69% of controls (n = 974). Mothers with pregestational diabetes
were excluded from the analyses. Exposure assessment was performed for 461
individual chemicals and 62 physicochemical groupings that were applied at >
100 lb. in any of eight San Joaquin Valley counties in any year during the study
period. An exposure-time window of 1 month before to 2 months after the maternal reported date of conception was assigned for each case or control mother.
Exposure assignments were made for 156 cases and 785 controls whose mothers
lived in the geocoded addresses more than 68 days during the window. To estimate pesticide applications, statewide pesticide use reporting records from the
California Department of Pesticide Regulation describing agricultural pesticide
applications occurring in the study period were obtained. Pesticide exposure was
based on pounds of pesticides used during the relevant time window within a
500-meter radius of a case or control’s geocoded address. Logistic regression was
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used to estimate odds ratios for pesticide exposure (yes/no), with adjustments for
race/ethnicity, prepregnancy BMI, any use of folic acid–containing supplements,
and smoking during the month before and the first 2 months of pregnancy. 2,4-D
dimethylamine salt exposure had an adjusted odds ratio of 1.7 (95% CI 0.7–4.1)
based on 8 exposed cases. The study’s strengths include the population-based
design, comprehensive case ascertainment and classification, and extensive covariate data. The exposure assessment was performed using pesticide application data, although misclassification is expected because of the lack of data on
individual factors that may influence exposure. Random error cannot be excluded
when considering the result for 2,4-D dimethylamine salt.
Using the same study design as Shaw et al. (2014) above, Carmichaeland
colleagues (2016) examined the association between pesticide exposure and the
risk of five different types of birth defects ascertained in the San Joaquin Valley
of California. The analysis included 367 cases with one of five types of birth
defects and 785 controls without any identified malformations born in 1997–2006.
The case groups (with at least 50 cases) included anotia/microtia, anorectal
atresia/stenosis, transverse limb deficiency, craniosynostosis, and diaphragmatic
hernia. Among the published results (the criteria for presentation were an odds
ratio > 2.0 or < 0.5 or confidence intervals that excluded 1.0), the authors reported
associations between dichlorophenoxy acid or ester exposure and transverse
limb deficiency (7 exposed cases; OR = 2.5; CI 1.1–6.0) and anotia/microtia (12
exposed cases; OR = 3.4; CI 1.6–7.6). The study’s strengths and limitations are
similar to those of the Shaw et al. (2014) study, although the sample sizes for the
defects in this study were relatively small and the estimate imprecise.
Rappazzo et al. (2016) conducted a case-control study using subjects drawn
from a cohort of geocoded singleton live births (n = 335,729) in North Carolina
between 2003 and 2005. Birth records were linked to the North Carolina Birth
Defects Monitoring Program, an active birth defects surveillance system. Crop
maps and pesticide application data were combined to estimate the quantities and
types of pesticides applied during the time window of interest (1 month before
pregnancy through the third trimester). Women who either had no crops within
the buffer or who had no exposure during the relevant window of pregnancy were
considered unexposed. The analysis included 6,358 cases and 298,548 controls. A
total of 42 birth defects were ascertained, and 4,634 cases had a single (isolated)
congenital anomaly. Logistic regression was used to estimate the odds ratio for
exposure (yes/no) and each birth defect with adjustments made for race, education, marital status, maternal age, and maternal smoking. Elevated adjusted odds
ratios were observed for atrial septal defects (OR = 1.70, 95% CI 1.34–2.14)
and for patent ductus arteriosus (OR = 1.50, 95% CI 1.22–1.85) for the highest
(≥ 90th percentile) exposure subjects. The study used a population-based design
with birth defects surveillance and linked crop and pesticide records. Its limitations include the lack of individual-level pesticide exposure data for specific
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pesticides, potential residual confounding due to the use of birth certificate data
and unmeasured factors, and the small number of cases for some comparisons.
Koskenniemi and colleagues (2015) based their case-control study of 44
cases of cryptorchidism and 38 controls on subjects who were operated on for
inguinal or umbilical hernia or hydrocele at two hospitals: one in Turku, Finland
(2002–2006), and the other in Copenhagen, Denmark (2004–2005). Twelve of
the Finnish cases and two of the Danish were referred for surgical procedures
from a prospective cohort study. A subcutaneous adipose tissue biopsy was taken
during the operation, and samples were analyzed for 37 PCBs, 17 PCDD/Fs and
14 PBDEs. Covariate data were obtained through parental interview and from
medical records. Associations between adjusted and unadjusted chemical concentrations and the risk of cryptorchidism were calculated using logistic regression.
The analysis included an adjustment of the chemical concentrations by factors
influencing postnatal exposure (age at operation and duration of breastfeeding)
by linear regression, but no adjustment was made for factors related to chemical
concentrations in the mother (e.g., BMI, maternal age, parity). In a sensitivity
analysis, cases and controls were excluded if the mother had gestational diabetes. After adjustment for the country of origin, age at operation, and the duration
of breastfeeding, total TEQ (OR = 3.2, 95% CI 1.3–9.1) and sum of PCDD/Fs
(OR = 3.7, 95% CI 1.5–10.9) were associated with an increased risk of cryptorchidism. The sum of PCBs had an elevated, but non-significant, odds ratio (OR
= 1.9, 95% CI 0.9–4.0). The sum of PBDEs was not associated with an elevated
odds ratio of cryptorchidism (OR = 0.86, 95% CI 0.47–1.54). The effect estimates
were not materially different after restricting to boys who were born full term,
biopsied at less than 5 years of age, and whose mothers did not have gestational
diabetes. The study provides some evidence of an association with dioxin-like
chemicals (TCDD-specific results were not reported). However, the study was
very small and some potential confounders were not adjusted. The study is of
limited value to the committee’s assessment.
Kalfa et al.’s (2015) case-control study examined 408 boys with isolated
hypospadias and 302 controls identified at multiple institutions in the south of
France between 2009 and 2014. Control boys were matched by ethnic origin
and had no congenital malformation; no urological, genital, or nephrological
condition; and no inguinal hernia or endocrine disease. The reasons for hospitalization for the controls included acute appendicitis, idiopathic intussusception, minor abdominal trauma, and pyloric stenosis. Information about maternal
and paternal occupational and professional exposure to endocrine-disrupting
chemicals was obtained using a standardized questionnaire and a job-exposure
matrix. Environmental exposure was estimated by geocoding the residence postal
code at the time of pregnancy and factoring in the types of surrounding hazards
and their distance from that residence. The odds ratio for maternal exposure to
herbicides (otherwise unspecified) was 1.00 (95% CI 0.007–13.97); the paper
did not specify whether this imprecise estimate was adjusted. Environmental
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exposure to intensive agriculture (residence within a 3-km radius) was statistically significantly different between cases and controls, as was residence in an
industrial area or proximity to an incinerator or a waste area. The committee did
not consider this study to be informative because results for specific COIs were
not presented and there are concerns that the analysis and exposure information
is based on questionnaire and a determination by simple distance to source for
the environmental exposures.
A paper by Ueker and colleagues (2016) describes the results of a hospitalbased case-control study conducted in Cuiabá, Mato Grosso, Brazil in 2011. The
cases were children aged less than 5 years with a diagnosis of a congenital malformation in medical records who were identified at four referral institutions. The
controls were children of those ages diagnosed with other conditions (respiratory
diseases, infectious diseases, disorders of the perinatal period, and endocrine
and metabolic diseases) at the same institutions. Controls were pair-matched
with cases on sex. Information on parental exposure to pesticides (unspecified,
except to note that glyphosate is the most commonly used) and other factors was
collected by a maternal interview. The analysis group consisted of 137 cases and
274 controls. In the unadjusted analysis, several maternal pesticide exposure
variables had an elevated odds ratio for birth defects, including living close to
crop spraying with pesticides (OR = 1.61, 95% CI 0.88–3.03) and pesticide use
at work (OR = 1.52, 95% CI 0.65–3.53). Paternal application of pesticides was
also associated with an elevated odds ratio for birth defects (OR = 2.75, 95% CI
1.05–7.19). This study has several important limitations, including the lumping of
all different birth defects into a single case group, a small sample, self-reported
pesticide exposure (including maternal report of paternal exposures), no information on specific pesticides, and no information on case and control response rates.
Biological Plausibility
As was noted in Update 2014, 2,4-D has been previously shown to be a
teratogen, although at exposure levels that exceed maternal renal clearance and
thus are not relevant to herbicide exposure in Vietnam. A 2011 study showed
that late in utero and early postnatal 2,4-D exposure can result in nephrotoxicity
in offspring at one-sixth of the LD505 (Troudi et al., 2011). Other herbicides of
interest can induce fetal malformations but typically only at high doses that are
toxic to pregnant women. TCDD is a potent teratogen in all laboratory species
that have been studied, although the patterns of birth defects that are produced are
often species-specific. However, specific mechanisms that link TCDD exposure
to specific birth defects have not been fully elucidated.

5 Lethal dose 50%: the dose required to kill half of the test population, usually expressed as a function of body weight.
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A variety of animal model studies, including in utero exposures, work with
cultured cells, and studies with zebrafish embryos, have investigated the mechanisms underlying various TCDD-induced birth defects, including hydronephrosis,
cleft palate, reproductive organ anomalies, neurogenesis, and perturbed heart,
kidney, and lung development (Dong et al., 2010; Falahatpisheh et al., 2011;
Jacobs et al., 2011; Lanham et al., 2012; Latchney et al., 2011; Neri et al., 2011;
Tait et al., 2011; Yamada et al., 2014; Yoshioka et al., 2012; Yuan et al., 2012). Interestingly, AHR is required for TCDD-induced birth defects. In contrast, the induction of cytochrome P450 1A1 is not required (Dragin et al., 2006; Jang et al.,
2007; Mimura et al., 1997). When pregnant Ahr-null mice are exposed to TCDD,
the fetuses do not exhibit any of the typical developmental malformations associated with TCDD exposure, but fetuses of TCDD-exposed pregnant CYP1A1-null
mice do. In addition, an Ahr antagonist can attenuate TCDD-induced birth defects
in mice. Thus, the activation of Ahr by TCDD during development appears to be
a key first step in mediating TCDD’s developmental toxicity, but this step does
not depend on CYP1A1 activity. Although structural differences in AHR have
been identified among species, it functions similarly in animals and humans.
Therefore, a common mechanism mediated by AHR in which tissue growth and
differentiation processes are affected probably underlies the developmental toxicity of TCDD in humans and animals.
Antioxidant treatment provides protection against some TCDD-induced teratogenicity, which suggests that reactive oxygen species might be involved in the
pathways that lead to these structural changes (Jang et al., 2008). A few studies indicate that the stem cells and organ-specific progenitor cells may be direct targets and
that maternal TCDD exposures interfere with proliferation and cell differentiation
through AHR and result in defects in organ morphogenesis (Latchney et al., 2011;
Neri et al., 2011). Few laboratory studies of potential male-mediated developmental toxicity (and specifically birth defects) attributable to exposure to TCDD and
herbicides have been conducted. As noted, the feeding of simulated Agent Orange
mixtures to male mice produced no adverse effects in offspring (Lamb et al., 1981).
In sum, studies with maternal exposure in animal models suggest that a role
for TCDD and related chemicals in causing birth defects is plausible and also that
AHR plays a causal role. However, translating these results to human populations
has been difficult.
Synthesis
Given the long-standing concern of Vietnam veterans about the potential of
the COIs to adversely affect the health of their children, birth defects have been
among the outcomes considered by VAO committees since the first comprehensive review was published in 1994. Embryonic and fetal development in some
species including rodents are sensitive to the toxic effects of exposure to TCDD
and dioxin-like chemicals, and there are several species and strains of animals for
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which the fetus is more sensitive than the adult to the adverse effects of TCDD.
Human data are generally lacking, however, and the sensitivity to developmental
disruption in humans is less apparent, in part because contemporary studies of
environmental dioxin exposure and birth defects have involved extremely low
exposures. As noted, recent human population-based studies attempting to link
TCDD or the other COI exposures to birth defects have provided mixed results.
Moreover, the study of birth defects in any population is complicated by the
relatively rarity of specific birth defects. Attributing any one defect to a specific
exposure is often difficult, and it is extremely difficult to conduct rigorous epidemiology studies assessing risks to children arising from their parents’ exposure, particularly when a distinction between maternal and paternal contributions is sought.
These challenges are highlighted in the studies considered by the committee, which
exhibit sometimes significant weaknesses that limit their usefulness—particularly in
assessing the effects resulting from the exposures experienced by Vietnam veterans.
The new epidemiologic studies considered by the committee were mostly not informative because of a small sample or the absence of exposure data on COIs, or both.
There were two relatively rigorous epidemiologic studies that suggested an association between two different COIs (2,4-D dimethylamine salt; dichlorophenoxy acid)
and an increased risk of two unrelated birth defects. However, the recent studies
did not change the previous conclusion of inadequate or insufficient evidence to
support an association for birth defects overall in the children of Vietnam veterans.
Conclusion
The committee’s review of newly published studies in combination with
existing information leads it conclude that evidence remains inadequate or insufficient to determine whether there is an association between exposure to the COIs
and birth defects in the children of Vietnam veterans.
EFFECTS OCCURRING LATER IN OFFSPRING’S LIVES
Information is available concerning parental exposure to the COIs and several outcomes occurring later in the lives of their offspring. Studies investigating cancers; growth and physical parameters; motor development, cognitive,
behavioral, and socio-emotional outcomes; immune and allergic outcomes; and
reproductive health are reviewed below.
Cancer in Offspring
The American Cancer Society estimates that 10,590 children under 15 years
old will receive a new diagnosis of cancer in the United States in 2018 (ACS,
2018f). The treatment and supportive care of children who have cancer continue
to improve. The 5-year survival rate for children who receive a cancer diagnosis
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has increased from less than 60% in the 1970s to more than 80% in 2013, the
most recent year for which data are available. Despite advances, cancers remain
the second leading cause of death in children under 15 years old (after accidents);
1,180 deaths are projected for 2018 (ACS, 2018f).
Leukemias are the most common cancer in children, accounting for about
29% of all childhood cancer cases. The second-most common group of cancers
in children is cancer of the brain and tumors of other parts of the central nervous
system (CNS) (26%), followed by neuroblastomas (6%) and Wilms tumor (also
called nephroblastoma; 5%) (ACS, 2018f). Other cancers in children include
lymphomas, bone cancers, soft-tissue sarcomas, renal cancers, eye cancers, and
adrenal cancers. In contrast with adult cancers, relatively little is known about
the etiology of most childhood cancers, especially about potential environmental
risk factors and the effects of parental exposures.
The committee responsible for VAO concluded that there was inadequate
or insufficient evidence to determine whether there is an association between
exposure to 2,4-D, 2,4,5-T, TCDD, picloram, or cacodylic acid and childhood
cancers. The additional information available to the committees responsible for
Update 1996 and Update 1998 did not change that conclusion. The committee
responsible for Update 2000 reviewed the material in earlier VAO reports and in
newly available published literature and concluded that there was limited or suggestive evidence of an association between exposure to at least one of the COIs
and acute myeloid leukemia (AML).6 However, after the release of Update 2000,
investigators involved in one study discovered an error in their published data.
The Update 2000 committee reconvened to evaluate the previously reviewed and
new literature regarding AML, and it produced Acute Myelogenous Leukemia
(IOM, 2002). It reclassified AML from “limited/suggestive evidence of an asso
ciation” to “inadequate evidence to determine whether an association exists.”
The committees responsible for Update 2002, Update 2004, Update 2006,
Update 2008, Update 2010, Update 2012, and Update 2014 reviewed the material
in earlier VAO reports and in newly available published literature and agreed that
there remained inadequate or insufficient evidence to determine whether there is
an association between exposure to the COIs and childhood cancers.
Table 38, which can be found at www.nap.edu/catalog/25137, summarizes
the results of studies related to cancers in children.

6 AML (ICD-9 205; ICD-10 C92.A0) is also referred to as acute myelogenous leukemia, acute
myeloblastic leukemia, and acute nonlymphocytic leukemia. For consistency, this report uses “acute
myeloid leukemia,” or AML, regardless of the usage in the source materials.
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Update of Epidemiologic Literature
New Vietnam-veteran, occupational, environmental, and case-control studies
addressing childhood leukemias, central nervous system tumors, rhabdomyosarcoma, and retinoblastoma are addressed below.
Vietnam-Veteran Studies Grufferman and colleagues (2014) evaluated the
role of parental military service in Vietnam and service-related exposures in the
risk of rhabdomyosarcoma7 occurring in offspring. Cases of rhabdomyosarcoma
diagnosed underthe age of 20 years were identified from the Intergroup Rhabdomyosarcoma Study Group clinical trial, which included hospitals in 46 U.S. states
and the District of Columbia from 1982 to 1988. Controls were identified by
telephone random-digit dialing and were matched to cases on race, sex, and age.
Case and control families were interviewed by telephone. The interview i ncluded
questions about childhood environmental exposures, parental occupational expo
sures, family demographic characteristics, parental lifestyle and behavioral characteristics, and medical history. Questions related to military service focused
on the Vietnam War period. Each parent was asked if he or she had ever served
in the armed forces before the date of the index child’s diagnosis and, if so, in
which years the service occurred. The parent was also asked if he or she was
in contact with nuclear, chemical, and biological weaponry, radiation, radar
or microwaves, or Agent Orange. Among the 440 cases that were eligible, 351
completed interviews, and, of those, 319 eligible cases had available information on parental occupation. Subjects were matched on age, sex, and race, and
analyses were adjusted for family income, maternal education and recreational
drug use, length of pregnancy, and maternal spotting/bleeding/cramping during
pregnancy. The study reported that 3.4% of case mothers and 1.4% of control
mothers reported a history of military service. Maternal history of military service was associated with an elevated adjusted odds for rhabdomyosarcoma (OR
= 2.75, 95% CI 0.71–10.62). There were too few cases to refine this analysis
by time period of service. A history of paternal military service was not associated with rhabdomyosarcoma (OR = 0.85, 95% CI 0.58–1.25); restricting
the time of paternal military service to 1962–1970 yielded an adjusted odds
ratio of 0.78 (95% CI 0.50–1.21), based on 53 cases (18.5%) and 64 controls
(22.3%). Only 9 cases (1.7%) and 5 controls (3.1%) reported potential Agent
Orange exposure during Vietnam War service. The adjusted odds ratio was elevated for this exposure, but the estimate was not statistically significant (OR =
1.72, 95% CI 0.55–5.41). This report was based on a nationally ascertained case
groups and included a parental interview asking questions about a wide array
of potential risk factors and confounders, with specific questions on military
7 Rhabdomyosarcoma is a cancer of the muscle tissue. It is the most common form of soft-tissuesarcoma in children. See https://www.cancer.gov/types/soft-tissue-sarcoma/patient/rhabdomyosarcomatreatment-pdq (accessed October 28, 2018).
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service and Agent Orange exposure. Concerns include the use of a control group
based on telephone random-digit dialing and the recall of potential Agent Orange
exposure. The analysis of paternal Agent Orange exposure was based on a very
small number of exposed cases, and the confidence intervals associated with the
odds ratios were correspondingly broad. This report found no association between
paternal military service in Vietnam or Agent Orange exposure and an increased
risk of rhabdomyosarcoma in offspring.
Other Identified Studies–Occupational Study Febvey et al. (2016) pooled
three population-based case-control studies of childhood CNS tumors conducted
from France, Germany, and the United Kingdom. Cases were children less than
15 years of age with CNS tumors; controls were matched by gender and age.
Interview data (telephone or in-person) on parental occupational histories were
collected. Parental occupational data were harmonized, and an existing general
population job-exposure matrix was used to assign pesticide exposure into no-,
low-, or high-exposure categories for insecticides, herbicides, fungicides, and
all pesticides combined. The analysis included 1,361 cases and 5,498 controls.
Only 0.9% of mothers and 4.2% of fathers were found to have occupational exposure to pesticides during the studied pregnancy. No association was observed
between CNS tumors and maternal pesticide exposure (pooled OR = 0.76, 95%
CI 0.41–1.41) and statistically significantly decreased odds were seen with paternal occupational pesticide exposure (OR = 0.71, 95% CI 0.53–0.95). The study
included a relatively large number of subjects and used a common job-exposure
matrix to assign potential pesticide exposure across studies. However, the analysis
was limited by the low prevalence of parental exposure, precluding examination
of dose categories and a breakdown of pesticide categories. No information was
available on specific pesticides.
Other Identified Studies–Environmental Study Bailey and colleagues
(2015) used pooled individual-level data from 12 studies that participated in the
Childhood Leukemia International Consortium to examine the association between home pesticide exposure and the risk of childhood leukemia. The analysis
included data from 12 consortium studies conducted in North America, Europe,
and Australasia over a 30-year period. Self-reported home pesticide exposure
data were harmonized across studies. The time periods of potential exposure
included the period prior to conception, during pregnancy, and after the child’s
birth. Exposure could be to the mother, father, or child. A variety of factors were
examined as potential confounders. The analyses were stratified by leukemia
subgroups, including acute lymphoblastic leukemia (ALL) and AML, and cytogenetic data. Weakly elevated odds ratios for ALL were found for home herbicide
use (otherwise unspecified) during the three time periods of interest: for example,
the odds ratio for reported use within 1–3 months before conception was 1.23
(95% CI 1.04–1.45), based on 5 studies. Home herbicide use during pregnancy
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was associated with decreased odds of AML (OR = 0.84; 95% CI 0.56–1.26).
These were the only two analyses with reported results for the herbicide exposure group. The study’s strengths include a large pooled resource from multiple
international studies. Limitations include self-reported home pesticide exposure
and the inability to isolate effects of specific herbicides.
Other Identified Studies–Case-Control Studies Gunier et al. (2017) analyzed
data from the California Childhood Leukemia Study, a population-based case
control study conducted in 35 counties from 1995 to 2008. Cases were ascertained within 72 hours after diagnosis at Northern and Central California hospitals. Controls were randomly selected from California birth certificate files and
individually matched to cases on the child’s age, sex, race, and Latino ethnicity,
and on maternal race. In-person interviews collected information on occupational
history for each parent. The interview also collected information on whether the
parent worked regularly with pesticides, insecticides, fungicides, or herbicides,
otherwise unspecified, and whether the parent worked in agricultural occupations.
Detailed occupational information was collected using specific job module interview questions for occupations with potential pesticide exposure, including farm
or ranch worker; gardener, landscaper, nursery worker, or groundskeeper; agricultural packer; and pesticide applicator. The analysis was based on 669 children
diagnosed with ALL and 1,021 controls. After adjustment for child’s sex, age,
ethnicity, mother’s race, and household income an increased odds ratio of ALL
was found for paternal occupational exposure to any pesticides (OR = 1.7, 95%
CI 1.2–2.5). A statistically significant odds ratio was found for paternal pesticide
exposure and ALL in children diagnosed before 5 years of age (OR = 2.3, 95%
CI 1.3–4.1). Maternal pesticide exposure had a weakly elevated odds ratio for
ALL (OR = 1.3, 95% CI 0.8–2.4). The study strengths include a population-based
design and a comprehensive in-person interview-based collection and assessment
of parental occupational exposures, including occupations associated with pesticide use. However, the study was not large enough to assess the effect of specific
pesticides including the COIs.
Omidakhsh and colleagues (2017) conducted research based on data from a
multi-center case-control study of retinoblastoma.8 Cases included patients with
sporadic retinoblastoma who were diagnosed or treated at the Children’s Oncology Group institution or at the Wills Eye Institute in Philadelphia, Pennsylvania,
between 2006 and 2011. A total of 282 cases (186 unilateral and 96 bilateral)
were recruited. Controls were selected based on friends or non-biological relatives nominated by case families and with a child in the same age range as the
index case child. Phone interviews were used to collect information on residential
8 “Retinoblastoma is a rare childhood cancer in which malignant (cancer) cells form in the tissues
of the retina. The retina is a thin layer of nerve tissue that lines the inside of the back of the eye and
is sensitive to light.” See https://www.cancer.gov/types/retinoblastoma (accessed October 28, 2018).
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pesticide use before conception and during pregnancy, including the use of professional lawn or landscape services; the use of pest control professionals or exterminators for their home; in-home use of insect or rodent killers; use of indoor
foggers; home or garden use of herbicides, mold removal products, antifungals,
or weed killers; insect repellant; head lice treatment on the children; and, for
pets, the use of flea collars or flea or tick shampoos. When parents indicated that
they had applied a product themselves in the home or garden, they were asked to
identify the name of the product. The investigators’ analysis was based parents
of 99 unilateral and 56 bilateral case-control pairs. Odds ratios were adjusted
for mother’s race, mother’s age, mother’s work status, and whether the father
was living at home at the start of the pregnancy. Parental home use of a weed
killer (OR = 2.3; 95% CI 0.9–5.4) was associated with an elevated odds ratio
for unilateral retinoblastoma. The use of weed control products on the garden or
lawn had an adjusted odds ratio of 2.3 (95% CI 0.9–5.4). Associations between
maternal residential pesticide exposure in the month before or during pregnancy
and bilateral retinoblastoma were very imprecise. For example, the use of professional lawn or landscape services had an odds ratio of 3.4 (95% CI 0.6–18.0),
while the use of weed control products on a garden or lawn had an adjusted odds
ratio of 1.0 (95% CI 0.3–3.3). The patterns of association were similar for different exposure factors, including the types of products, locations, timing, and
frequency of pesticide use. When asked about the specific pesticide product used,
about half of participants responded with a product name for which ingredients
could be identified. Reported products used for weed control included 2,4-D,
dicamba, glyphosate, and 2-methyl-4-chlorophenoxyacetic acid (MCPA). The
study was based on national case and control groups and a detailed interview
regarding residential pesticide use and other factors. In addition, cases could be
divided into unilateral and bilateral subgroups. Limitations included the use of
friend controls that may introduce selection bias based on shared geography and
other factors, the relatively small number of cases, and the inability to analyze by
specific herbicides that may have been used, including those of particular interest
(2,4-D and dicamba).
Biologic Plausibility
Laboratory animal studies have established that TCDD can affect development, so a connection between TCDD exposure and effects on offspring,
including developmental disruption and disease onset in later life, is biologically plausible. It has been established in several animal studies that TCDD
at high doses is a potent teratogen. Studies with rodent models have demonstrated male, female, and sex-independent effects in the immediate offspring of
females exposed during pregnancy. These include epigenetic modification of
imprinted genes (Somm et al., 2013), increased DNA methylation of the BRCA1
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tumor suppressor gene in mammary tissue (Papoutsis et al., 2013), altered uterine response to estradiol (K. A. Burns et al., 2013), the dysregulation of lipid
metabolism in the presence of a high-caloric diet (Sugai et al., 2014), aberrant
emotional behaviors (A. T. Nguyen et al., 2013), a reduced capacity for lymphocyte differentiation (Ahrenhoerster et al., 2014), testicular inflammation (BrunerTran et al., 2014), and a variety of adult diseases, including kidney, prostate,
ovarian primordial follicle loss, and polycystic ovarian disease (Manikkam et al.,
2012a). Transgenerational inheritance to the F3 generation was shown for the last
two studies. However, definitive conclusions based on animal studies about the
potential for TCDD to cause later-life effects in human offspring are complicated
by differences in sensitivity and susceptibility among individual animals, strains,
and species; by differences in the route, dose, duration, and timing of exposure
in experimental protocols and real-world exposure; and by differences in the
toxicokinetics of TCDD between laboratory animals and humans. Experiments
with 2,4-D and 2,4,5-T indicate that they have subcellular effects that could constitute a biologically plausible mechanism for developmental effects, but only
at very high doses. There is insufficient information on picloram and cacodylic
acid to assess the biologic plausibility of their developmental or delayed effects
in offspring.
Paternal or maternal exposure to xenobiotics potentially could increase the
susceptibility of offspring to cancer through multiple mechanisms. Susceptibility could be increased by causing a tumor-promoting mutation in germ cells that
would be present in all of the somatic cells of the child. This de novo mutation
could then be passed on to subsequent generations via Mendelian inheritance,
assuming that the child survived to reproduce. However, as discussed earlier
in this chapter and in earlier chapters, TCDD and other COIs are not genotoxic
(i.e., they do not cause mutations), which makes the mutation-induction and
inheritance scenario unlikely. Alternatively, a maternally mediated increase in
susceptibility to childhood cancers could result from the direct exposure of a fetus
in utero or of the newborn via lactation to a xenobiotic that induces epigenetic
alterations that increase cancer susceptibility.
As noted elsewhere in this chapter, there are several pre- and post-conception
scenarios for how toxicant exposures could cause disease in first-generation
offspring and perhaps in later generations based on epigenetic mechanisms
(Vaiserman, 2014). Perhaps the most straightforward scenario is in utero exposure affecting the developing epigenome, predisposing the child to cancer. The
best example of this happening is when otherwise very rare vaginal cancers arose
in the daughters of women who took the estrogenic agent diethylstilbestrol to
prevent miscarriage (Herbst et al., 1971). Thus, this scenario is plausible for humans. Although TCDD can have antiestrogenic effects, its toxicity via AHR likely
involves transcriptional changes that could induce epigenetic mechanisms. With
regard to cancers, if the affected gene or genes are involved in cancer pathways
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and epigenetic modifications stabilize the gene-expression changes, then the
susceptibility to cancer could increase.
Prenatal TCDD exposure of rats is associated with altered mammary gland
differentiation and an increase in the number of mammary adenocarcinomas
(Brown et al., 1998). Perhaps related, prenatal TCDD exposure led to increased
DNA methylation at the BRCA1 (breast cancer) gene promoter in the female
offspring of exposed pregnant rats (Papoutsis et al., 2013). The demonstration
that early postnatal TCDD exposure does not increase mammary-cancer risk
(Desaulniers et al., 2004) does not contradict the finding that TCDD-induced
changes in utero mediate the increase in cancer susceptibility (Fenton et al.,
2000, 2002), and it is consistent with the ultimate carcinogenic effect being
greatest when epigenomic changes are the most dynamic. Thus, developmental
epigenetic alterations may be involved in the prenatal effects. TCDD has been
shown to suppress the expression of two tumor-suppressor genes, p16Ink4a and
p53, via an epigenetic mechanism that appears to involve DNA methylation (Ray
and Swanson, 2004). Similarly, it was reported that prenatal TCDD exposure
increases the DNA methylation of two growth-related imprinted genes, H19 and
Ig f2, in the developing fetus (Q. Wu et al., 2004).
No direct evidence from animal models shows that TCDD increases the risk
of childhood cancers, such as acute leukemia and germ-cell tumors; although a
2014 study showed a reduced capacity of hematopoietic stem cells to undergo differentiation in offspring (Ahrenhoerster et al., 2014). Emerging research suggests
that prenatal TCDD exposure can disrupt epigenetic imprinting patterns and alter
organ differentiation and thus could contribute to an increased susceptibility to
cancer later in life. Smith et al. (2005) showed that chromosomal rearrangements
associated with childhood ALL are evident in the neonatal blood spots, which
suggests that childhood leukemias begin before birth, perhaps due to maternal
exposures to carcinogenic xenobiotics.
Synthesis
Newly identified studies of cancer in children of parents potentially exposed
to the COIs included a case-control study in which parents were asked about military service and potential Agent Orange exposure. The study was small, and while
an elevated odds ratio was found, the estimate was very imprecise and random
error could not be ruled out. Other identified occupational and environmental
studies had methodologic challenges and did not report results for specific COIs.
In sum, the evidence is sparse and inconclusive.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
childhood cancers.
Growth and Physical Parameters
Since Update 2014, seven studies identified as relevant by the committee
have examined exposure to the COIs and the subsequent growth and development of children.
A case control study by Hsieh et al. (2017) explored whether polymorphisms
and haplotypes of arsenic methyltransferase (AS3MT), glutathione-S-transferase
omegas (GSTOs), and purine nucleoside phosphorylase (PNP) affect arsenic
methylation capacity and developmental delay. From 2010 to 2014, 179 children with developmental delay and 88 children without delay were recruited
from the Shin Kong Wu Ho-Su Memorial Teaching Hospital in Taiwan. Urinary
arsenic species, including arsenite (AsIII), arsenate (AsV), monomethylarsonic
acid (MMAV), and DMAV were measured using a high-performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. The
polymorphisms of AS3MT, GSTO, and PNP were analyzed using the Sequenom
MassARRAY platform with iPLEX Gold chemistry. Polymorphisms of AS3MT
genes were found to affect susceptibility to developmental delay in children,
but GSTO and PNP polymorphisms were not. Participants with the AS3MT
rs3740392 A/G+G/G genotype, when compared with those with the AS3MT
rs3740392 A/A genotype, had a significantly lower secondary methylation index.
This may result in an increased odds ratio for developmental delay. Participants
with the AS3MT high-risk haplotype had a significantly higher OR than those
with AS3MT low-risk haplotypes (OR = 1.59; 95% CI 1.08–2.34). This study
shows a joint dose–response effect of an AS3MT high-risk haplotype with inefficient arsenic methylation capacity on developmental delay, but it does not
constitute persuasive evidence that the AS3MT genotype causes developmental
delay by affecting arsenic methylation.
Three European birth cohorts (Belgian, Norwegian, Slovak) that assessed
dioxinexposures in cord blood or breast milk were pooled by Iszatt et al. (2016)
to investigate the influence of perinatal exposure to dioxins and dioxin-like
chemicals on infant growth and BMI in childhood. The exposure was highest
in the Belgian and lowest in the Norwegian cohort (the median and interquartile range of the pooled sample were 13 and 12.3 pg CALUX9 TEQ/g lipid
9 CALUX (Chemical-Activated LUciferase gene eXpression bioassay) is a test that may used to
determine dioxin-like activity.
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respectively). Infant growth was defined as the cohort- and sex-specific change in
weight-for-age z-score between birth and 24 months (n = 367). The investigators
also calculated BMI at ~7 years of age in 251 children. Overweight was defined
according to international standards for children equivalent to an adult BMI > 25
kg/m2. In multivariate models based on generalized estimating equations, perinatal exposure to dioxins and dioxin-like chemicals appeared to be associated with
increased growth between birth and 24 months (adjusted estimate for change in
z-score: β = 0.07, 95% CI −0.01–0.14) and at age 7 years, and dioxin exposure
was associated with a statistically significant increase in BMI in girls (adjusted
estimate for BMI units β = 0.49, 95% CI 0.07–0.91) but not in boys (β = −0.03,
95% CI −0.55–0.49) (p-interaction = 0.044). Furthermore, only girls had an
increased risk of being overweight at age 7 (54%, 95% CI −6% –151%). While
these studies suggest that perinatal exposure to dioxin and dioxin-like chemicals
may increase early infant growth and contribute to increased BMI in school age
girls, the studies were still quite small in size, and additional studies of larger
sizes are needed to re-examine these associations.
Mayhoub and colleagues (2014) used data from the MecoExpo study to
investigate the relationship between parental exposures to pesticides (as reported
by the mother) and neonatal parameters. The study included 993 mother–newborn
pairs from the Picardy region of northern France. In this cohort, each mother
completed a questionnaire that probed potential occupational, domestic, environmental, and dietary sources of parental exposure to pesticides during her
pregnancy. Multivariate regression analyses found that maternal occupational
exposure was associated with an elevated risk of low birth weight (OR = 4.2,
95% CI 1.2–15.4). Paternal occupational exposure to pesticides was associated
with a lower-than-average gestational age at birth (−0.7 weeks, p = 0.0002) and
an elevated risk of prematurity (OR = 3.7, 95% CI 1.4–9.7).
A study of 234 couples by Robledo et al. (2015)—also reviewed above in
the section regarding low birth weight and preterm delivery—examined how
birth size varied with maternal and paternal exposures to 63 POPs from five
major classes, including 36 PCBs, seven of which were dioxin-like (PCBs 105,
114, 118, 156, 157, 167, and 189). Exposure was measured in parental serum collected before conception. Differences in length, head circumference,
and ponderal index were estimated using multiple linear regression per 1 standard deviation increase in natural log-transformed (ln-transformed) chemicals.
The subjects were participants in the LIFE prospective cohort study, which
was conducted in Michigan and Texas between 2005 and 2009. Models were
estimated separately for each parent and adjusted for maternal age, maternal
pre-pregnancy BMI, and other confounders, and all models included an interaction term between infant sex and each chemical. Among girls (n = 117),
mean length (β = −0.57 cm; 95% CI [−1.12, −0.02]) and head circumference
(β = −0.45 cm; 95% CI [−0.86, −0.03]) were smaller in association, with a 1
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standard deviation increase in ln-transformed maternal serum concentrations
of the dioxin-like PCB 167. No statistically significant differences in length,
head circumference, and ponderal index were noted among boys (n = 113)
relative to maternal or paternal exposure to the COIs.
Tai et al. (2016) enrolled 217 mother–infant pairs living in a dioxin-
contaminated area in Vietnam and collected data on the birth cohort’s physical
growth during the first 3 years of life. Perinatal dioxin exposure of infants was
estimated by the measurement of dioxin levels in the breast milk of the nursing
mothers. Growth parameters—including weight, height, and head and abdominal
circumferences—were measured at birth, 1 and 4 months, and 1 and 3 years of
age. Multivariate mixed models were applied for analyzing repeated measures.
All body size measures in boys were decreased in the high-exposure groups of
TCDD (for example, head circumference age-adjusted z-score high-exposure:
−0.87, 95% CI [−1.28, −0.46], versus low-exposure: −0.18, 95% CI [−0.29,
−0.06]; p < 0.01). In girls, high TCDD exposure was associated with increased
head circumference (age-adjusted z-score high-exposure: 0.18, 95% CI [−0.08,
0.44], versus low-exposure: −0.28, 95% CI [−0.42, −0.15]; p < 0.01). This study
suggests that perinatal dioxin exposure affects the physical growth of infants and
children in the first 3 years of life in a sex-specific manner.
S. Thomas and colleagues (2015) measured arsenic and chemical levels in
blood or urine samples from the first and third trimesters in 1,835 pregnant
women from across Canada to study the association with fetal growth. The investigators adjusted for maternal age, parity, pre-pregnancy BMI, and smoking
and examined potential effect modification by single nucleotide polymorphisms
(SNPs) in GSTP1 and GSTO1 genes. No association was found for arsenic and
small-for-gestational-age as an outcome, but the researchers found an increased
risk for small-for-gestational-age for the highest compared to the lowest tertile
of exposure for the organic arsenic species arsenobetaine (> 2.25 μg/L, RR =
1.65, 95% CI 1.10–2.47) after adjusting for parity and smoking. A statistically
significant interaction was observed in the relationship between DMA levels in
urinary arsenic and small-for-gestational-age between strata of GSTO1 A104A (p
for interaction = 0.02). This study was deemed to be of limited usefulness to the
committee because the relevance of the exposures to those experienced by Vietnam
veterans is debatable.
Motor Development, Cognitive, Behavioral, and Socio-Emotional Outcomes
Since Update 2014, a number of studies identified as relevant by the committee have examined exposure to the COIs and cognitive or motor development outcomes in children.
Berghuis and colleagues (2014) reported on the results of a birth cohort study
conducted in the Netherlands, with recruitment from 1998–2000. Maternal blood
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samples were collected in the second or third trimester and analyzed for 10 PCB
congeners and 6 hydroxylated metabolites. Three mono-ortho PCBs (105, 118,
and 156), but no coplanar PCBs were measured; the hydroxylated metabolite for
PCBs 105 and 118 was measured. These prenatal exposures were analyzed in
association with scores on the Touwen neurological examination administered at
3 months of age. Many empirical analyses were conducted, with results showing,
in general, that prenatal PCB exposures were associated with more optimal devel
opment, both before and after adjustment for confounders of birth weight and
child’s age at assessment. None of the results assessing the association b etween
prenatal exposure to mono-ortho PCBs and non-optimal development were statistically significant: PCB 105 (0.833 per 1 ng/g lipid weight, CI 0.550–1.262),
118 (0.932, CI 0.728–1.191), or 156 (0.910, CI 0.831–1.019) (both genders; after
adjustment).
Braun and colleagues (2014) conducted an analysis of the effects of gestational exposure to endocrine-disrupting chemicals on 4- to 5-year-old children
enrolled in the Health Outcomes and Measures of the Environment Study conducted in the Cincinnati, Ohio, metropolitan area. The study examined a total of
25 PCBs—including the dioxin-like PCBs 105, 118, 156, 157, 167, and 170—
along with many phthalates, PBDEs, pesticides, and polyfluorinated compounds
in relation to scores on the Social Responsiveness Scale (SRS). No dioxin-like
PCB was found to be associated with SRS scores (data were presented in graphs
with no accompanying numbers). The authors cautioned, though, that their modest sample size (n = 175) precluded them from dismissing possible effects from
chemicals with null associations.
Caspersen et al. (2016) used data from the Norwegian Mother and Child
CohortStudy, also known as MoBa, to estimate maternal dietary exposure to
dioxins and PCBs using a validated food frequency questionnaire administered midpregnancy and a database of dioxin and PCB concentrations in foods. Exposure to
dioxins and dioxin-like PCBs was characterized in terms of TEQs. Children’s language skills at age 3 were assessed by parental report, including a grammar rating
scale and questions about communication skills from the Ages and Stages Questionnaire (ASQ). The total sample analyzed was 44,092 children, and a thorough
control for confounders included maternal age, education, parity, pre-pregnancy
BMI, household income, bilingualism, maternal smoking, alcohol, and folate
supplement use, dietary fatty acids intake, and dietary exposure to methylmercury
during pregnancy. Statistically significant results included associations of either
high maternal TEQ exposure from the diet or high intake (above the 97.5th percentile) of the non-dioxin-like PCB 153, with higher odds of incomplete grammar
in boys and girls (aORs 1.1 to 1.3) and severe language delay (aOR = 1.6, 95%
CI 1.1–2.4 for dioxin-like chemicals, and aOR = 1.9, 95% CI 1.1–3.4 for PCB
153). Higher exposure to dioxin-like chemicals was also associated with lower
ASQ communication scores in girls (aOR = 1.4, 95% CI 1.1–1.9).
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Hui et al. (2016) recruited 161 mothers and their 11-year-old children living
in Hong Kong to participate in a study of prenatal dioxin exposure and neurocognitive development that was a follow-up to earlier work. Neuropsychological
assessments were performed by clinical psychology trainees or senior research
assistants with graduate training in psychology who were blinded to the participating children’s dioxin exposure. A registered clinical psychologist was responsible for ensuring assessment quality and interpreting the assessment results. All
children first completed the cognitive assessments, which took approximately
3 hours, before other health assessments were performed. Most assessments were
done in the research unit, but 15 were performed at home. Testing venues were
required to be quiet and distraction free. No associations were found between any
of the neurocognitive or behavioral tests administered with the TEQ levels from
maternal breast milk obtained from their mothers 2 to 6 weeks postpartum, with
p values for interaction ranging from 0.34 to 0.99 for children who were breastfed
exclusively during infancy.
Kono and colleagues (2015) used a general population sample from an ongoing breast milk survey that has been conducted in several prefectures and cities
in Japan since 1997, from which TEQs are calculated based on PCDD/Fs and
coplanar PCBs. When the children were 6 to 13 years of age, parents were asked
to complete the extended Japanese version of the Strengths and Difficulties Questionnaire (SDQ), which consists of 25 items on specific strengths and difficulties, with an overall rating of whether the child had behavioral or psychological
problems. Four SDQ subscales were obtained—emotional symptoms, conduct
problems, hyperactive/inattention, and peer problems—as well as a total difficulties score (TDS) based on the four subscale scores. Analyses were conducted
stratified by age and sex of the child. Few covariates were considered in the multivariate analysis—maternal age, birth weight, any history of maternal cigarette
smoking, and age at SDQ assessment—raising concerns about lack of control for
the socioeconomic status of the family. None of several different metrics estimating the dioxin exposure showed any association with the TDS score in any of
the analyses of boys, girls, or different age groups: in linear regression analyses,
breast milk TEQ level was not significantly related to the TDS in boys (partial
regression coefficient = 2.29; 95% CI [−7.60, 12.18]), or in girls, (partial regression coefficient = −1.04; 95% CI [−9.24, 7.15]) after adjustment for covariates.
According to the authors, levels of dioxins in this population were comparable
to other studies from the same time period that estimated dioxin exposures from
breast milk in Japan, the United Kingdom, and Eastern Europe.
Nakajima et al. (2017) examined sex-specific differences in the effect of
prenatal exposure to dioxin-like chemicals on neurodevelopment in children who
were participants in the Sapporo cohort of the Hokkaido Study on Environment
and Children’s Health. Data included a blood draw from the mother in the second trimester of the pregnancy; a self-administered questionnaire that collected
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information on the mother’s dietary habits, exposure to chemicals during daily
life and at work site, home environment, smoking habit, and medical histories as
well as the medical histories of the mother’s partners; maternal and child medical records information; and a neurodevelopmental test (Bayley Scales of Infant
Development, 2nd Edition) administered to the child at either 6 or 18 months.
The exposure assessment included levels of a number of dioxin-like chemicals
and TEQ values. One hundred ninety mother–infant pairs in the 6-month-old
group and 122 mother-child pairs in the 18-month-old group were studied. The
investigators reported that levels of 10 dioxin-like chemicals in male children
were significantly negatively associated with the Psychomotor Developmental
Index (PDI) scores at 6 months of age after adjustment for potential confounding
variables (−0.21 point change in developmental score per dioxin level [common
logarithm], adjusted; p < 0.05) but that the associations disappeared at 18 months
of age. For female children, the level of only one mono-ortho PCB isomer (PCB
123) was significantly negatively associated with PDI at 6 months of age. However, in contrast to the males, levels of four dioxin-like chemicals (PCBs 114,
156, 157, and 189) in 18-month-old female children were significantly positively
associated (p < 0.05) with Mental Developmental Index scores.
An English-language abstract of a paper published in Chinese by Ni et al.
(2016) reports the results of a study involving 3,771 children whose mothers
were recruited during pregnancy. Maternal occupational and life exposures were
assessed in the period 6 months prior to pregnancy, and the BRIEF (Behavior
Rating Inventory of Executive Function–Preschool version) was used to assess
the preschool children’s executive function. The investigators’ findings included
that maternal exposure to pesticides in the 6 months before the pregnancy were
associated with Inhibitory Self-Control Index dysplasia (OR = 3.60, 95% CI
1.45–8.95), Flexibility Index dysplasia (OR = 6.72, 95% CI 2.50–18.07), and
Global Executive Composite dysplasia (OR = 2.39, 95% CI 1.02–5.58) in the
preschool children. No statistically significant associations between paternal
pesticide exposures and adverse outcomes were reported. It is unclear from the
abstract, however, whether any COI exposures were involved.
In a companion study to Pham et al. (2015), reviewed later in this section,
Nishijo et al. (2014) examined 153 mother–infant pairs residing in a dioxincontaminated area near a former U.S. base in Vietnam to evaluate potential associations between perinatal dioxin exposure and autism spectrum disorders in the
children. Parents completed a full-length Autism Spectrum Rating Scale (ASRS)
survey—which has not been validated in a Vietnam population but for which no
comparable test was available—and researchers calculated several outcome and
treatment scale scores from the results. These data were analyzed in conjunction with the Bayley-III neurodevelopmental battery test results described by
Pham et al. The investigators found that high-TCDD-exposed (≥ 3.5 pg per g fat
in mother’s breast milk sampled 1 month after birth) male and female children
showed significantly higher ASRS scores than less-TCDD-exposed children,
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without concomitant differences in their mental and psychomotor scores. In
contrast, high TEQ level boys (≥ 17.9 pg-TEQ per g fat), had significantly lower
neurodevelopmental scores than lesser-exposed boys without a comparable difference in their ASRS scores. These results suggest that perinatal TCDD exposure
has an effect on autistic traits in childhood that is separate from neurotoxic effects
of dioxin exposure in general.
A second follow-up to Pham et al. (2015) conducted by Nishijo et al. (2015)
focused on urinary metabolite levels in 26 children who were part of their study
cohort. The investigators found that urinary histidine is associated with dioxin
exposure–induced neurodevelopmental deficits, suggesting that it might be a useful marker of dioxin-induced neurodevelopmental deficits. However, given the
very small number of subjects and the very wide natural variability of urinary
histidine (along with that of other urinary metabolites such as glycine and tryptophan), the results are not likely to be reliable and do not present data bearing on
any direct evidence of a link between TCDD and clinical outcomes in descendants.
The Duisburg (Germany) birth cohort study by Nowack and colleagues
(2015) recruited pregnant women from September 2000 to October 2002.
Maternal blood samples were collected primarily in the third trimester (a few
in the immediate postnatal period) and used for the quantitation of PCDD/Fs
and dioxin-like PCBs in order to obtain a final TEQ for PCDD/Fs, PCBs, and
PCDD/Fs+PCBs. These TEQ values were then examined in relation to child
scores on the SRS, a standardized instrument suitable for administration to
the general population that collects data from the parent on symptoms related to autism spectrum disorders. Parents rated the children on 65 items that
were grouped into five subscales. In this study, the children were 9–12 years
of age when the SRS was completed. Results showed that SRS Social Communication scores were significantly lower in male and female children exposed
to higher TEQs from PCDD/Fs or from PCBs (p < 0.05). Autistic Mannerisms
scores also correlated significantly with TEQs from PCDD/Fs or from PCDD/
Fs+PCBs (p < 0.05). In sex-stratified analysis, the only significant association
in boys was between TEQ from PCDD/Fs and the Social Motivation subscale
(p < 0.05). In girls, however, significant associations were found for PCDD/Fs
alone or combined with PCBs in relation to the total SRS score (p < 0.05) and
the Social Communication subscale score (p < 0.05); and for all three TEQs
(PCDD/Fs, PCBs, and PCDD/Fs+PCBs) in relation to the Social Cognition (p
< 0.05) and Autistic Mannerisms (p < 0.01) subscales. The study’s limitations
were that postnatal exposures were not accounted for in the analysis of prenatal
exposures and that the sample size for this follow-up was small (n = 100 for
boys and girls combined). Also, other risk factors for autism spectrum disorder
that have emerged were not measured: air pollution, maternal nutrition, maternal
diabetes, and inter-pregnancy interval. However, the study’s major strengths were
the measurement of TEQs from the prenatal period and its control for potential
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confounders, such as maternal age, education, the presence of older siblings, the
age of the child, alcohol and smoking during pregnancy, and nationality. Some
factors were also associated with attrition, thereby reducing selection bias.
In a paper related to the Nowack et al. (2015) research described above,
Neugebauer et al. (2015) examined attention performance and attention-related
behavior among 117 school-aged children who were part of the Duisburg cohort.
Increased prenatal PCDD/F and PCB concentrations were significantly (p < 0.05)
associated with a higher number of omission errors in the subtest Divided Attention (47% and 42%; 95% CI 1.08–2.00 and 1.07–1.89, respectively). Orenstein
and colleagues (2014) evaluated verbal memory, visual memory, and learning
in 393 children born to mothers residing in New Bedford, Massachusetts, near
a Superfund Site. They calculated TEQs based on measurements of the dioxinlike mono-ortho substituted PCBs 105, 118, 156, 167, and 189 in cord serum.
Verbal memory, visual memory, and a learning index from the Wide-Range
Assessment of Memory and Learning at 8 years of age were evaluated, with
adjustments made for a broad array of confounders, including examiner, child’s
age at examination, sex, birth year, school grade, parental education, maternal
age at birth, maternal birth place, household income, prenatal tobacco smoke
exposure, prenatal alcohol exposure, prenatal omega-3 exposure, and maternal
IQ. No significant associations were found.
A birth cohort studied by Pham et al. (2015) was established in Da Nang,
Vietnam, in 2008–2009, at the site of a former U.S. air base, which is an area of
documented high exposures to TCDD and other PCDD/Fs (Hatfield Consultants,
2009a,b). The study includes two districts in a surrounding area of 10 kilometers
from the former air base. Exposure measurements were made in breast milk
collected at approximately 1 month after delivery, and the chemical measured
included 17 PCDD/Fs, including 2,3,7,8-TCDD. The Bayley Scales of Infant
Development, 3rd edition (Bayley-III), was administered at age 12 months by
an examiner who was supervised by a pediatric psychologist experienced with
the Bayley-III. Adjustments were made for the gender, parity, gestational week,
age (in days), and birth weight of the infants; the age, education, and drinking
habit during pregnancy and residential location of the mothers; and the family
income and smoking status of family members. Analyses found that the TEQs
for three different metrics of exposure (all PCDD/Fs, TCDD, and the daily dioxin
intake) showed virtually no associations with the overall cognitive score; the
language composite, receptive language and expressive language subscales; and
the motor composite, fine motor and gross motor subscales. The one exception
was the daily dioxin intake (in pg TEQ/kg/day), which was significantly associated with improved overall cognitive scores in each of the three upper levels
of exposure—mild (102.8; p = 0.033), moderate (102.1; p = 0.042), and high
(102.4; p = 0.041), as compared with low exposures (97.7). No adaptive behavior
skills showed any association with the exposures examined. However, based on
parent report (not observation), scores on a social–emotional scale that assesses
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functional emotional skills and self-regulation were lower in the children with
the highest category of prenatal overall TEQ and the highest category of the
TCDD TEQ, as compared with the corresponding lowest-exposure categories
(p = 0.09).
Tai et al. (2016)—whose results regarding physical growth in offspring
are reviewed earlier in this chapter—enrolled 217 mother–infant pairs living
in a dioxin-contaminated area in Vietnam and followed the neurodevelopment
of the birth cohort longitudinally during the first 3 years of life. The perinatal
dioxin exposure of infants was estimated by the measurement of dioxin levels in
breast milk of the nursing mothers. The neurodevelopment of infants and children, including cognitive, language, and motor development, was determined at
4 months, 1 year, and 3 years of age. Multivariate mixed models were applied for
analyzing repeated measures. In boys, composite motor (94.9, 95% CI 89.9–100,
p = 0.49) and gross motor scores (9.1, 95% CI 7.9–10.2, p = 0.36) were significantly decreased with increasing exposure of 2,3,7,8-TCDD. The high PCDDs/
PCDFs-TEQ group showed a significant decrease in expressive communication
score compared with the low-exposure group, as measured by Bayley-III (8.4,
95% CI 7.8–8.8, p = 0.30). In girls, there was no decreased score in any neurodevelopment aspects in high-exposure groups. This study suggests that perinatal
dioxin exposure a ffects the neurodevelopment of infants and children in the first
3 years of life in a sex-specific manner.
Tran et al. (2016) investigated the effects of early life exposure to dioxins
in children living around Da Nang City, Vietnam, a location known to be contaminated with dioxin. Exposure was assessed via a breast milk sample from the
nursing mother taken 1 month after birth. Demographic and confounding factors
data were collected from the mother; physical measurements of the subjects—176
children—were taken at birth and 5 years of age. In boys, the total test (7.7 versus 9.7; p = 0.018) and balance (7.3 versus 9.3; p = 0.013) scores of the Movement Assessment Battery for Children-2 (Movement ABC-2) were significantly
lower in the high-TEQ-PCDDs/Fs group compared with the moderate- and lowexposure groups. Nonverbal Index scores (77.0 versus 98.1; p = 0.034) and the
pattern reasoning subscale of the Kaufman Assessment Battery for Children, 2nd
Edition (KABC-II) (5.3 versus 7.1; p = 0.041), which measures planning ability,
were also significantly lower in the high-TCDD-exposure group compared with
the low-exposure group of boys. However, in girls no significant differences in
Movement ABC-2 or KABC-II scores were found among the different TEQPCDDs/Fs and TCDD exposure groups. The five boys and one girl who were
highly exposed to TEQ-PCDDs/Fs and TCDD were found to be at increased risk
for difficulties in both motor coordination and cognitive function. Overall, these
results suggest differing impacts of TEQ-PCDDs/Fs and TCDD exposure on
motorcoordination and higher cognitive ability, respectively. Moreover, high-TEQ-
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PCDDs/Fs exposure combined with high-TCDD exposure may increase autistic
traits combined with developmental coordination disorder.
Immune and Allergic Outcomes
Since Update 2014, five studies identified as relevant by the committee have
examined exposure to the COIs and immune or allergic outcomes in children.
P. H. Su et al. (2015) conducted a study of 56 8-year-old children from
Taiwan. The subjects were stratified into high- and low-exposure groups based
on maternal PCB and PCDD/F serum levels. No changes were found, although
there were differences (t-test) in thyroid hormones, thyroxine binding globulin,
IGFBP-3, and growth hormone.
El Majidi and colleagues (2014) used a procedure previously developed
to standardize PCB biological concentration data between published studies to
perform a systematic analysis of associations between PCB exposure and thyroid
hormones (THs) (total and free T3 and T4) or thyroid-stimulating hormone (TSH)
in pregnant women and newborns. The weight of evidence of a significant impact
of PCB exposure on TSH and TH levels at the described biological levels in
pregnant women and newborns (mean < 1,000 μg PCBΣEQ kg−1 lipids) appeared
low, according to this analysis.
S. Hansen et al. (2014) examined the association between maternal serum
concentrations of the dioxin-like PCB 118 and the risk of asthma in their offspring. Compared with subjects in the first tertile of maternal PCB 118 concentration, those in the third tertile had an adjusted HR of 1.90 (95% CI 1.12–3.23).
Offspring were exposed in utero, and this is thus evidence of a developmental
exposure leading to a later-life health impact.
A second study by S. Hansen et al. (2016) examined a cohort of 965 (421 in
the follow-up) pregnant women and measured POPs, including PCBs. Exposures
were separated into tertiles for the analysis, based on week-30 POP levels. A clinical evaluation of offspring took place at age 20. No association with asthma was
found, but dioxin-like PCB exposure in the mother was associated with offspring
airway obstruction (FEV1/FVC < 75%; OR = 2.96, 95% CI 1.14–7.70), with 9
cases versus 20 cases. This is an interesting finding in that this condition may
be associated with chronic obstructive pulmonary disease (COPD) later in life.
Nicolle-Mir (2014)—in a paper published in French—examined the association between prenatal exposure to PCBs, hexachlorobenzene, and p-p′-DDE and
the risk of asthma in children born to women included in a cohort of Danish births
in 1988–1989 (the Danish Fetal Origins Cohort). The concentrations of POPs
(congeners 118, 138, 153, 156, 170, and 180 for PCBs) were determined in a
maternal serum sample taken at 30 weeks of pregnancy. Nine hundred sixty-five
children in the cohort were contacted in 2008 to complete an online questionnaire
covering their health status, lifestyle, and diet; 872 (90%) returned data that could
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be included in the analysis. Their government personal identification numbers
were cross-referenced with the national prescriptions file, and subjects who had
been treated for asthma between the ages of 6 and 20 years were classified as
asthmatics. Those who had received a single prescription of beta-2 mimetics or
inhaled corticosteroids were excluded. Three secondary criteria were also used:
the diagnosis of asthma made by a doctor, the use of asthma treatments during the
past 12 months (questions asked in the follow-up questionnaire), and a hospital
diagnoses of asthma (outpatient or emergency, based on a central admissions
registry). The cross-tabulation of these different sources showed a good match
between the data from the national prescription file and the responses to the questionnaire. The prevalence of asthma was equal to 12.7% according to the file and
to 13.6% according the questionnaire; 76% of subjects classified as asthmatics
on the basis of the file report had an asthma diagnosis, and 72% of those who
reported having been diagnosed with asthma were identified in the file. Serum
concentrations of POPs were divided into tertiles, and the HR of asthma was
calculated for the second and third tertiles with reference to the first. Analyses
included those carried out with each individual congener and the sum of the dioxinlike congeners (PCBs 118 and 156). Models were adjusted to the child’s sex and
birth weight as well as to several maternal parameters: age at birth, pre-pregnancy
BMI, parity, smoking, alcohol consumption, education level, plasma concentrations of triglycerides, and total cholesterol. The main analysis (asthma defined
according to the national prescriptions file) showed an increase in the risk of
asthma in the third tertile concentration of dioxin-like PCBs with reference to
the first tertile (HR = 1.75, 95% CI 1.02–2.98), with significant dose–response
trends. The association between dioxin-like PCBs and asthma is mainly due to
the 118 congener (HR = 1.9, 95% CI 1.12–3.23). For PCB 156, PCBs with no
dioxin activity, and the sum of the PCBs, the increases were not significant. The
results of the secondary analyses were consistent: the strongest associations were
observed with PCB 118 when the criterion “treatment of the asthma during the
last 12 months” was used (HR in the last tertile respectively equal to 2.49 [95%
CI 1.03–5.99] and 4.18 [95% CI 1.57–11.15]). The authors indicate, however,
that the plasma levels of the dioxin-like PCBs and hexachlorobenzene were
highly correlated (Spearman’s R-value 0.53–0.99), with the mutual adjustments
weakening the associations observed in the main analysis to HR = 1.47 (95%
CI 0.75–2.86) for PCB 118. In addition, in the absence of information about
breastfeeding, it is unclear whether these associations are attributable to prenatal
or postnatal exposures or a combination of both.
Other Outcomes
No studies identified as relevant by the committee have examined exposure
to the COIs and reproductive function in offspring since the publication of U
 pdate
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2014. However, since this category was included in the Update 2014 report, it is
noted here for completeness.
Li and colleagues (2015) conducted a study of the so-called “Yucheng
children,” descendants of mothers exposed to PCBs/PCDFS via a contaminated
cooking oil incident in 1978–1979 in Taiwan, to evaluate the effect of this insult
on their auditory function later in life. Exposed children were born June 1978–
December 1998; control children were matched by age, sex, neighborhood, mother’s age, and parents’ educational level and occupation. Demographic data were
collected via questionnaire, and pure-tone audiograms were obtained. Eighty-six
Yucheng children and 97 controls participated in the study. Serum taken from the
mothers during other studies had previously been screened for dioxins and PCBs.
The study found that gestational exposure to 2,3,4,7,8-PeCDF was associated
with an increase in hearing loss (increase in the pure tonal frequency threshold),
although the frequency deficits were not the same in the right and left ears. Exposures to 1,2,3,4,7,8-HxCDF were associated with hearing loss in the left ear
at 4,000 Hz. There was no effect of PCB exposure on hearing, although the PCB
levels as measured by TEQ were rather low.
Biologic Plausibility
As noted in Update 2014, the results of studies in rodent models provide
support for the idea that prenatal exposure to TCDD can result in adverse effects
in offspring later in life, including immune disorders, behavioral disturbances, repro
ductive impairment, kidney disease, and cancers (Foster et al., 2010; Prescott,
2011; Puga, 2011; Takeda et al., 2012). Using two mouse models, investigators
showed that prenatal TCDD (2.5–5.0 mg/kg) modified multiple immune signatures in the adult offspring that were indicative of adult-onset autoimmunity
(Holladay et al., 2011). Adult-onset inflammatory disease and lupus-like autoimmunity were also observed in mice at 36 weeks of age after high-dose prenatal
TCDD exposures (Mustafa et al., 2011). A single prenatal exposure of rats to
TCDD (0.7 μg/kg of body weight) reduced brain developmental myelination and
compromised remyelination potential in adults (Fernández et al., 2010), and in
utero TCDD in mice altered neural progenitor differentiation (Mitsuhashi et al.,
2010). However, another study suggested that, in contrast to wild-type murine
neural progenitor cells (mNPCs), “human NPCs and AhR-deficient mNPCs were
insensitive to AhR agonism or antagonism” (Gassmann et al., 2010, p. 1571).
Maternal exposure to TCDD (0.2–0.4 μg/kg of body weight) in pregnant rats
perturbed neuroendocrine function as measured by thyrotropin and growth hormone concentrations in exposed offspring through peripubertal postnatal day
30, which supports the idea of continued later-life thyroid hormone disturbances
(Ahmed, 2011, 2014). These disturbances include the epigenetic modification of
imprinted genes (Somm et al., 2013), increased DNA methylation of the BRCA1
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tumor suppressor gene in mammary tissue (Papoutsis et al., 2013), altered uterine
response to estradiol (Burns et al., 2013), dysregulation of lipid metabolism in the
presence of a high-caloric diet (Sugai et al., 2014), aberrant emotional behaviors
(A. T. Nguyen et al., 2013), a reduced capacity for lymphocyte differentiation
(Ahrenhoerster et al., 2014), testicular inflammation (Bruner-Tran et al., 2014),
and a variety of adult diseases including kidney disease, prostate disease, ovarian
primordial follicle loss, and polycystic ovarian disease (Manikkam et al., 2012a).
Other studies have focused on neurobehavioral outcomes following perinatal
exposure, which is of relevance in understanding the possible consequences in
the offspring of Vietnam veterans, particularly the offspring of female veterans.
Haijima et al. (2010) found that gavage treatment of pregnant mice with 3 μg /kg
TCDD on gestation day 12.5 (resulting in in-utero and lactational exposure of the
offspring) impaired memory in the male offspring. Mitsui et al. (2006) reported
that hippocampus-dependent learning could be impaired in male rats exposed to
TCDD in utero and that the impairment could affect fear conditioning. Curran et
al. (2011) assessed the effect of CYP1A2 and Ahr genotypes on altered learning
and memory in mice exposed to an environmentally relevant mixture of dioxin
like (coplanar) and non-dioxin-like PCBs in utero and during lactation. They
observed the most significant deficits in response to PCB treatment in Ahrb1
CYP1A2(–/–) mice, including impaired novelobject recognition and increased
failure rate in the Morris water maze test. Studies in week-old rodents have also
detected molecular effects of TCDD in cerebellar granule cells and neuroblasts,
which may be relevant to motor function and cognitive processes (Kim and
Yang, 2005; Williamson et al., 2005). Stürtz et al. (2008) found alterations in
how female rats that had been fed on postpartum days 1–7 with diets containing
15, 25, or 50 mg/kg 2,4-D interacted with their pups. The specific relevance of
these findings to neurobehavioral effects in humans exposed as adults is unclear.
Another mode of epigenetic change is the modification of the spatial arrange
ment of chromosomes, which can influence gene expression and cell differentiation. Oikawa et al. (2008), for example, found that TCDD—through the
AHR—modifies the positions of chromosomes in the interphase nuclei of human
preadipocytes.
The studies discussed above suggest that TCDD has the potential to influence the epigenome and therefore could promote changes in offspring that lead to
disease later in life, although the research addressing this issue in model systems
is still at an early stage.
Synthesis
Epidemiologic studies designed to examine the effects of the COIs in more
mature offspring have evaluated a variety of growth and development, neurologic,
immunologic, reproductive, and endocrine system health outcomes. More studies
are required before conclusions can be reached as to whether such outcomes in
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the offspring of exposed parents are replicable. In particular, it would be of interest to obtain information on neuropsychiatric conditions, such as attention-deficit
hyperactivity disorder and other clinically defined neurodevelopmental outcomes
in children who were exposed in utero.
Conclusion
There is inadequate or insufficient evidence to determine whether there is an
association between the exposure of men and women to 2,4-D, 2,4,5-T, TCDD,
picloram, or cacodylic acid before conception or during pregnancy and the adverse health outcomes in their children addressed in this section. Although the
results of laboratory research support the plausibility of such clinical conditions,
there are not yet sufficient human data to support an association between the COIs
and such adverse outcomes in human offspring.
BIOLOGIC PLAUSIBILITY OF POSSIBLE EFFECTS
IN SUBSEQUENT GENERATIONS
In response to a special request from the Department of Veterans Affairs, continuing inquiries from veterans and their families, and increasing attention in research efforts, the committee responsible for Update 2010 explored the possibility
of intergenerational or transgenerational effects resulting from exposure-related
epigenetic changes in the parents or exposed fetuses that would lead to adverse
health effects in later generations, such as grandchildren. Effects in persons exposed in utero are not considered transgenerational because the fetus was likely
exposed directly. This exception includes the children of women exposed in Vietnam even if they are conceived after their tour of duty was over because TCDD
remains in the body for a long time and is mobilized during pregnancy. Likewise,
the children of men exposed to TCDD in Vietnam and born after the soldiers’ tour
of duty was over could possibly have health outcomes due in part to TCDD’s effect
on the sperm epigenome. In contrast, any adverse health effects in grandchildren
associated with exposure would be considered to be transgenerational. Figure 8-1
illustrates the partitioning between intergenerational and transgenerational effects
due to the exposure of a parent, delineating between those exposures that biologically persistent (like dioxin) and therefore dwell in the body long after exposure
versus those that do not.
The Update 2010 committee did not identify any relevant scientific studies to
review and concluded that there was inadequate or insufficient evidence to determine whether there is an association between exposure to the COI and diseases in
grandchildren or later descendants of Vietnam veterans. Committees responsible
for Updates 2012 and 2014 likewise failed to find any relevant human studies and
affirmed the conclusion of inadequate or insufficient evidence.
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Congress put forward and passed the Jeff Miller and Richard Blumenthal
Veterans Health Care and Benefits Improvement Act in 2016, and it became Public Law 114-315. Among the law’s provisions is Section 632, which called on the
Secretary of Veterans Affairs to enter into a contract with the N
 ational Academies
of Sciences, Engineering, and Medicine to conduct an assessment on scientific
research relating to the descendants of individuals with toxic exposure. As part
of its response to this directive, VA tasked this committee to “assess the current
research available on possible generational health effects that may be the result
of exposures to [the COIs]—including the biologic plausibility or potential for an
exposure to lead to an increased risk of birth defects or other adverse conditions
in the descendants of male Veterans.”10
Epidemiological Studies
No relevant studies of potential transgenerational effects of exposure to the
COIs in humans have been reported to date. The only transgenerational effect
shown in humans has been from a comparison of food supplies in Sweden during the 1800s and health outcomes in the children and grandchildren of men
who were prepubescent when food supplies were relatively high or low. These
studies found an association between high food supply levels in grandfathers
and decreased longevity and increased risk of cardiovascular disease and diabetes in grandsons that was paternally transmitted, although no mechanistic
information was obtained (Kaati et al., 2002, 2007). Whether transgenerational
effects can occur in humans from chemical exposures is unknown at this time.
Biologic Plausibility
Research on the biologic mechanisms that might underlie the potential
effectsof exposure to the COIs experienced by grandchildren and later generations is still sparse, although it has greatly expanded in the past few years.
Epigenetic effects have been shown for male gametes in adult mice exposed to
an endocrine-disrupting pesticide (methoxychlor) and fungicide (vinclozolin)
(Paoloni-Giacobino, 2014). However, the chemically induced DNA methylation
changes in sperm DNA were not transmitted from one mouse generation to the
next for imprinted genes; they were, presumably, lost during the period of active
demethylation that occurs shortly after fertilization. This observation suggests
that transgenerational effects on imprinted genes in mice that might be paternally
transmitted may not necessarily involve DNA methylation (Iqbal et al., 2015).
Nonetheless, a 2013 study showed that odor fear-conditioning in the father could
be paternally transmitted to the F2 generation (as well as the F1) and implicated
10 Gulf War and Health, Volume 11 (NASEM, 2018) addresses this mandate as it applies to exposures experienced during the conflicts in the Southwest Asia theater of military operations.
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reducedDNA methylation in the responsible odor receptor gene (Dias and Ressler,
2013). Thus, more research is required to understand better how transgenerational
effects can be transmitted paternally once they have been demonstrated (Dias and
Ressler, 2014).
A few animal studies have provided evidence of transmission of adverse
effects to later generations. The mechanisms that could underlie later-life effects
in offspring and effects in later generations (transgenerational inheritance) could
involve epigenetic processes, as described earlier in this chapter. Research into
dioxin’s potential as an epigenetic agent is in its early stages, but a few studies
have suggested that dioxin has such properties that are, in significant part, linked
to the AHR. Direct evidence, however, is limited to maternal exposures of the
developing embryo or fetus during in utero growth, and no reports exist showing
paternal TCDD exposure and later-life effects in offspring or paternally mediated
transgenerational effects in humans. Q. Wu et al. (2004) demonstrated that TCDD
exposure of mouse embryos before implantation in unexposed females resulted in
epigenetic changes, including increased DNA methylation and a reduced expression of imprinted genes, which implied that early embryonic exposure alone was
sufficient to alter gene expression in the resulting offspring. The transmission of
effects to later generations would involve epigenetic alterations in the developing germ cells of a fetus that was directly exposed to maternal TCDD in utero.
Results of a few studies support a transgenerational inheritance due to in
utero exposure to TCDD. Exposing pregnant mice to TCDD (at 10 μg/kg) reduced fertility and increased premature birth in three later generations (BrunerTran and Osteen, 2011); effects were transmitted through both male and female
offspring (Ding et al., 2011; McConaha et al., 2011). Exposing gestating female
rats (F0) to dioxin (TCDD) at 100 ng/kg was shown to result in an earlier
puberty in the offspring (F1) and in two later generations (F2 and F3) and to
reduce ovarian follicle numbers in the females of the F3 generation; this implies
transgenerational inheritance (Manikkam et al., 2012a). The F3 effects appear to
be transmitted through the sperm that were initially exposed to maternal dioxin
in utero. In a second paper by the same research team, additional diseases appeared later in life in the first generation (directly exposed offspring), including
prostate disease in males and ovarian follicle loss and polycystic ovarian disease
in females (Manikkam et al., 2012b). Further third-generation effects were noted,
including kidney disease in males and polycystic ovarian disease in females,
which imply transgenerational inheritance. The latter appear to be transmitted
through the sperm originally exposed to maternal dioxin in utero inasmuch as
sperm DNA methylation changes were observed at 50 chromosomal sites in
generations F1–F3. Testicular inflammation from TCDD exposure has also been
reported to manifest in multiple generations (Bruner-Tran et al., 2014).
The zebrafish has been used as a model to examine transgenerational effects
from dioxin exposure, although different groups have reported different aspects
of these effects since Update 2012. One group reported that exposing zebrafish at
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3 and 7 weeks old (during sexual development) to TCDD in water for 1 hour at
50 pg/ml increased female-to-male ratios and skeletal abnormalities and reduced
fertility in the F1 and F2 descendants (equivalent to F2 and F3 in mammals)
(Baker et al., 2014a,b). Another group studying DNA methylation changes in the
offspring of mothers fed 20 µg/kg TCDD in their food reported no changes in
global methylation in offspring when looking at the total levels of DNA methylation in the genome. However, gene-specific increases or decreases in promoter
DNA methylation were observed with a tiling array assay for a limited number of
genes in the F1 generation. CYP1A1 transcription, a marker of TCDD exposure,
was elevated in F1 offspring. Unfortunately, no F2 fish were generated from the
TCDD exposure because the F1 fish died 1 to 2 weeks post hatching (Olsvik et
al., 2014). Further work with this model will be helpful for providing targets for
mammalian biologists as they continue to probe for transgenerational effects from
TCDD and the other COIs.
Synthesis
No epidemiological information exists to evaluate whether paternal or maternal exposure to the COIs results in health effects in grandchildren or subsequent
generations of descendants of Vietnam veterans. The animal literature contains
evidence that environmental agents mediated by maternal exposure affect later
generations through fetal and germline modifications, but in the case of adult
male exposures before the conception of the next generation, there is insufficient
evidence on which to draw a conclusion regarding transgenerational effects.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the
committee concludes that there is inadequate or insufficient evidence to deter
mine whether there is an association between paternal or maternal exposure to
the COIs and health effects in grandchildren or later generations of descendants
of Vietnam veterans.
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9
Neurologic Disorders

Chapter Overview
Based on new evidence and a review of prior studies, the current committee did
not find any new associations between the relevant exposures and neurologic
disorders. Current evidence supports the findings of earlier updates that:
• There is limited or suggestive evidence of an association between the
chemicals of interest (COIs) and Parkinson disease and diseases that
present with Parkinson-like symptoms.
• There is inadequate or insufficient evidence to determine whether there is
an association between the COIs and any of the other adverse neurologic
outcomes.
This chapter considers the possible effects of toxic exposure to the her
bicides used during the Vietnam War and specific clinical conditions associated
with the central nervous system (CNS) and the peripheral nervous system (PNS),
primarily brain dysfunctions. The COIs are 2,4-dichlorophenoxyacetic acid
(2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T), picloram (4-amino-3,5,6trichloropicolinic acid), cacodylic acid (dimethyl arsenic acid [DMA]), and
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a contaminant of 2,4,5-T. As described in Chapter 3, studies of the effects of exposure to polychlorinated biphenyls (PCBs) and other dioxin-like chemicals were also considered informative if
their results were reported in terms of TCDD toxic equivalents (TEQs) or concentrations of specific congeners of dioxin-like chemicals. Studies that report TEQs
433
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based only on mono-ortho PCBs (which are PCBs 105, 114, 118, 123, 156, 157,
167, and 189) are considered even though their TEQs are several orders of magnitude lower than those of the non-ortho PCBs (77, 81, 126, and 169), based on
the revised World Health Organization (WHO) toxicity equivalency factor (TEF)
scheme of 2005 (La Rocca et al., 2008; van den Berg et al., 2006). The lower TEQs
of the mono-ortho PCBs, however, may be counterbalanced by their abundance,
which is generally many orders of magnitude higher than the non-ortho PCBs
(H.-Y. Park et al., 2010).
Examples of the diseases that result from the degeneration of specific brain
areas are Parkinson disease (PD), Alzheimer disease (AD), spinocerebellar degeneration, and amyotrophic lateral sclerosis (ALS). These diseases may occur in
the absence of any toxicant exposure, but all may be triggered by environmental
factors, including toxicant exposure (Bronstein et al., 2009; Chin-Chan et al.,
2015; de la Monte and Ming, 2014; H. Kang et al., 2014b; Tanner et al., 2014;
M. D. Wang et al., 2014).
Disorders of the PNS are generally referred to as neuropathies. Neuropathies
can be purely motor, presenting as deficits in strength, but most often they present
with the involvement of both motor and sensory fibers. Neuropathies are often
symmetric and start with symptoms related to dysfunction of fibers that travel
the greatest distance to their target organ. For that reason, the symptoms of neuropathy often start in the digits and travel toward the torso. Many neuropathies
also affect autonomic fibers and thus can result in changes in blood pressure and
heart rate and in symptoms related to the control of digestion. Toxicant exposure
can induce immediate (i.e., acute) damage to peripheral nerves, and previous
updates found limited or suggestive evidence that dioxin exposure can cause
such short-term effects. However, the overall focus of this chapter is on delayed
adverse effects on both the PNS and the CNS.
The immediate effects of toxicants may involve all regions of the nervous
system, whereas delayed effects are likely to be related to focal deficits. Diffuse
damage to the CNS may cause alterations in thinking, consciousness, or attention, sometimes in combination with abnormalities of movement, while focal
dysfunction can cause myriad syndromes, depending on which area of the brain
is involved and the extent and severity of damage. For the purposes of this review, neurologic deficits associated with Vietnam service are distinguished from
psychiatric and psychologic conditions—such as posttraumatic stress disorder
(PTSD), depression, and anxiety—and from chronic fatigue syndrome.
In the original Veterans and Agent Orange (VAO) report (IOM, 1994), attention was focused on persistent neurobehavioral disorders. That focus was
maintained through Update 2002 (IOM, 2003c). A slight change in emphasis
toward chronic neurodegenerative disorders was reflected in the name change of
this chapter to “Neurologic Disorders” in Update 2004 (IOM, 2005), which was
carried forward in all subsequent updates. In this update, the chapter covers data
pertinent to persistent neurologic disorders of all types.
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Many studies have addressed the possible contribution of various chemical
exposures to neurologic disorders. However, for the purposes of the VAO committees, several of these studies have been limited by the use of nonspecific or
mixed exposures and by a lack of adequate lag times between the exposure and
the neurologic outcome of interest. Case identification of neurologic disorders
is also an important consideration and is often difficult because there are few
disorders for which there are specific diagnostic tests. Because the nervous system is not readily accessible for biopsy, pathologic confirmation is usually not
feasible. However, identifiable neurologic disorders always result in objective
abnormalities that are reflected in anatomic or functional tests or discovered via
clinical examination.
This chapter reviews the association between exposure to the COIs and neurobehavioral disorders, neurodegenerative disorders, and chronic PNS disorders.
The scientific evidence supporting the biologic plausibility of each category of
disorders is also reviewed here. More complete discussions of the categories of
association and of this committee’s approach to categorizing health outcomes are
presented in Chapter 3. For citations new to this update that revisit previously
studied populations, the relevant details on the experimental design can be found
in Chapter 5.
BIOLOGIC PLAUSIBILITY
Experimental data regarding the biologic plausibility of a connection between exposure to the COIs and various neurologic disorders continue to accrue.
This section summarizes in a general way some of the information reviewed in
the current update and, for completeness, includes pertinent information from
prior updates.
Several studies have dealt with mechanisms of neurotoxicity that might be
ascribed to the COIs, notably 2,4-D and TCDD. The molecular effects of the COIs
are described in detail in Chapter 4. Some aspects of the biochemical activity of
the COIs suggest pathways by which there could be effects on the neural systems.
A number of studies suggest that the COIs, primarily 2,4-D, have neurologic effects, both neurochemical and behavioral, in animal models if exposure occurs
during development or in cultured nerve cells (Konjuh et al., 2008; Pasandi et
al., 2017; Rosso et al., 2000a,b; Stürtz et al., 2008); older references described
the behavioral effects of a developmental exposure of rodents to a 2,4-D–2,4,5-T
mixture (Mohammad and St. Omer, 1986; St. Omer and Mohammad, 1987). The
exposure of zebrafish during development to the dioxin-like chemical PCB 126
leads to behavioral deficits in adults and substantial gene expression changes in
the adult brain (Aluru et al., 2017). Juvenile TCDD exposure in zebrafish has
been shown to lead to lesions in the olfactory neuroepithelium and to dramatic
changes in the expression of genes important for neurological function (Q. Liu
et al., 2014). Perinatal exposures to TCDD and to coplanar, dioxin-like PCBs
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have reportedly caused deficits in learning behavior in rats (Curran et al., 2011;
Haijima et al., 2010; Hojo et al., 2008; Kakeyama et al. 2014). However, those
studies should be interpreted with caution because the developing nervous system
is different from the mature nervous system and may not be an appropriate model
for the possible consequences of exposure to the COIs by adults, as was the case
for Vietnam veterans.
Some studies further support suggestions that the concentration of reactive
oxygen species could alter the functions of specific signaling cascades and be
involved in neurodegeneration (Drechsel and Patel, 2008). Such studies do not
specifically concern the COIs but they are potentially relevant to these chemicals inasmuch as TCDD and herbicides have been reported to elicit oxidative
stress (Byers et al., 2006; Celik et al., 2006; J. Kumar et al., 2014c; D. Shen et
al., 2005; Wan et al., 2014). TCDD has been shown to affect phosphokinase C
biochemistry in nerve cells and so could affect the integrity and physiology of
nerve cells (S. Y. Kim et al., 2007; H. G. Lee et al., 2007). TCDD has also been
shown to affect signaling pathways that regulate nitric oxide synthesis in neural
and glial cells, leading to neurotoxicity, senescence, and cell death (Duan et al.,
2014; Jiang et al., 2014; Y. Li et al., 2013; Nie et al., 2015; Wan et al., 2014).
Pellacani et al. (2014) found that PCB 126 reduced neuroblastoma cell viability.
Zhao et al. (2016) exposed C6 glioma cell culture to TCDD and found dose- and
time-dependent down-regulation of glutamate transporter-1 expression, which
could contribute to neurotoxicity. Cytochrome P450 1A1, the aryl hydrocarbon
receptor (AHR), and the AHR nuclear transporter occur in the brain, so TCDD
may exert effects in the brain (P. Huang et al., 2000). In addition, earlier studies in
hepatocytes indicated that 2,4-D affects aspects of mitochondrial energetics and
mitochondrial calcium flux (Palmeira et al., 1994a,b, 1995a,b); if these effects
occur in mitochondria of nervous-system cells, the energy balance and energy
pathways of cells in the nervous system could be affected and disrupt nervous
system function. This is supported by the work of Morales-Hernández et al.
(2012), which showed that TCDD in cultured neuronal cells induces cell death
by the disruption of intracellular calcium levels.
Laboratory-based studies have emphasized the importance of alterations in
neurotransmitter systems as potential mechanisms underlying TCDD-induced
neurobehavioral disorders (Jiang et al., 2014; H. Q. Xie et al., 2013). Neuronal
cultures treated with 2,4-D exhibited decreased neurite extension associated with
intracellular changes, including a decrease in microtubules, the inhibition of the
polymerization of tubulin, disorganization of the Golgi apparatus, and the inhibition of ganglioside synthesis (Rosso et al., 2000a,b). Those mechanisms are important for maintaining the connections among nerve cells, which are necessary
for neuronal function and are involved in axon regeneration and recovery from
peripheral neuropathy. Early animal experiments have demonstrated that TCDD
treatments affect the fundamental molecular events that underlie the neurotransmission initiated by calcium uptake (Hong et al., 1998). Mechanistic studies
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have demonstrated that 2,4,5-T can alter cellular metabolism and the cholinergic
transmission necessary for neuromuscular transmission (Sastry et al., 1997).
TCDD treatment of rats at doses that do not cause general systemic illness or
wasting produces electric changes in peripheral nerves that are associated with altered functions and pathologic findings that are characteristic of toxicant-induced
axonal peripheral neuropathy (Grahmann et al., 1993; Grehl et al., 1993). In cultured cells, Jung et al. (2009) explored the mechanism by which TCDD inhibits
neurite outgrowth and found it to be associated with a reduction in glutaminase.
As discussed in Chapter 4, extrapolating observations of cells in culture or
in animal models to humans is complicated by differences in sensitivity and susceptibility among animals, strains, and species; by the lack of strong evidence of
organ-specific effects occurring consistently across species; and by differences in
the route, dose, duration, and timing of chemical exposures. Thus, although the
toxicologic observations themselves cannot establish a conclusion that the COIs
produced neurotoxic effects in humans, they establish biologic plausibility and
point to potential mechanisms that might have come into play.
NERVOUS SYSTEM DISORDERS REPORTED OVERALL
The literature search for this update identified publications on populations
with relevant exposures that examined overall mortality from any nervous system
disorder (Collins et al., 2016) or hospitalization, again with all nervous system
disorders combined, except epilepsy which was presented separately (Cox et
al., 2015). However, while the results of grouping all nervous system disorders
together are presented, they are not considered informative for assessing whether
specific nervous system disorders may be due to an exposure to the COIs. Therefore, such results were not considered by the committee when weighing the
evidence for specific conclusions.
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to report
the prevalent health conditions among a cohort of 2,783 male New Zealand Vietnam veterans, who served during 1964 to 1972 and were presumed to be exposed
to dioxin. For participants 30 years of age or older, person-years of follow-up were
calculated by 5-year age categories. Age-specific hospitalization rates were calculated using the total number of annual hospitalizations published by the Ministry
of Health and the average annual resident population. Standardized hospitalization
rates were calculated for both the veteran cohort and the general population, and
from these estimates a standardized hospitalization ratio (SHR) was calculated
with 99% confidence limits as a means to address multiple tests performed for
various outcomes. Results were presented for eight categories of mental and neurologic disorders and a ninth category for “other nervous disorders.” Statistically
significant increases in the hospitalization rates were observed for alcohol-related
disorders (n = 89; SHR = 1.91, 99% confidence interval [CI] 1.39–2.43), which
the authors note was often associated with PTSD, and other nervous disorders
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(n = 135; SHR = 1.32, 99% CI 1.02–1.61). “Other nervous disorder” was the
largest single category among mental and neurologic disorders, but it was unclear
which disorders were included in that category with the exception of those disorders listed under the general category of mental and neurological disorders; by a
process of elimination, this category also likely included PD and ALS. However,
hospitalization rates are not a good measure of PD and several other neurologic
disorders because people with those conditions are not necessarily hospitalized
for the symptoms. No difference in the hospitalization rates was seen for the
category of “senility or organic mental illness” (n = 28; SHR = 0.95, 99% CI =
0.49–1.41); the authors do not list specific neurologic disorders of interest, and
senility may have included both vascular and non-vascular or Alzheimer-like dementia. Overall, the results of this study for hospital admissions due to all causes
combined showed a small increase in rates for Vietnam veterans compared with
the population of New Zealand. However, exposure to the COIs was not validated
through serum measurements, and the study did not control for smoking or ethnicity or other potentially important risk factors.
Collins et al. (2016) provides additional follow-up time to a retrospective
analysis of a cohort of 2,192 workers (only 5 of whom were female) exposed to
dioxins during trichlorophenol (TCP) and pentachlorophenol (PCP) production at
a chemical manufacturing plant in Michigan. The U.S. population was used as the
comparator to generate standardized mortality ratios. Work history records were
used to determine the length of exposure. Serum samples to measure the levels of
six types of dioxins were collected for 431 workers who had been exposed to TCP
or PCP. Historic concentrations for each dioxin congener were calculated from
the median concentrations of serum samples and the known half-lives associated
with each congener. A job-exposure matrix was created for both the TCP and the
PCP production facilities based on measured concentrations for workers in different jobs. A pharmacokinetic model was applied to job-specific concentrations
and with the work history of each member of the study group to estimate each
worker’s time-dependent serum concentration profiles for each dioxin congener
(i.e., TCDD as well as Hexa-CDD, Hepta-CDD, and Octa-CDD). Complete
vital status follow-up through December 2011 was achieved for the cohort, and
there were 1,198 decedents through the entire study period (1979–2011); 1,615
deaths were among TCP workers and 773 deaths occurred among PCP workers
(196 workers were exposed to both TCP and PCP and are counted in each of
those groups). Compared with the U.S. population, no difference in mortality
from all diseases of the nervous system was found for all workers (n = 21; SMR
= 0.74, 95% CI 0.46–1.13), and the SMRs were identical for TCP workers (n =
17; SMR = 0.79, 95% CI 0.46–1.26) and PCP workers (n = 7; SMR = 0.79, 95%
CI 0.32–1.63).
A second occupational study reported on pesticide applicators from Argentina
who completed a questionnaire to document self-reported use of pesticides
and general symptoms or consultations (signs of irritation, fatigue/tiredness,
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headache, nervousness or depression, medical consultation, and hospitalization)
(Butinof et al., 2015). Included among the pesticides were the herbicides 2,4-D,
dicamba, and picloram—three of the COIs for Vietnam veterans. The percentage
of completed questionnaires indicating the use of 2,4-D was 93.5%, with lower
percentages for dicamba (69.4%) and picloram (46.0%). However, the survey
respondents reported the use of 11 different pesticides on average, and effect
estimates were based on grouped exposures or did not report any of the COIs
separately, making this analysis of little utility for the purposes of the committee.
NEUROBEHAVIORAL, COGNITIVE, AND
NEUROPSYCHIATRIC DISORDERS
This section summarizes the findings of VAO and previous updates on neuro
behavioral disorders and incorporates information published since Update 2014
into the evidence database.
Conclusions from VAO and Previous Updates
On the basis of the data available at the time, the committees responsible
for VAO and all subsequent updates through Update 2014 concluded that there
was inadequate or insufficient evidence to determine whether there is an association between exposure to the COIs and neurobehavioral disorders. The data that
informed that conclusion were mostly from the Air Force Health Study (AFHS,
1991a,b, 1995, 2000; Barrett et al., 2001, 2003). Urban et al. (2007) confirmed
that acute neurologic symptoms experienced shortly after an acute exposure to
TCDD could be sustained more than 30 years after the exposure, but this study
did not address delayed effects. In general, many of the studies reviewed by
previous VAO Updates were found to be methodologically flawed (Dahlgren
et al., 2003; Pazderova-Vejlupkova et al., 1981; Pelclová et al., 2001, 2002) or
uninformative (ADVA, 2005c; Decoufle et al., 1992; Kamel et al., 2007a; R. M.
Park et al., 2005; Sapbamrer and Nata, 2014; Solomon et al., 2007; Visintainer
et al., 1995). Difficulties in case identification and diagnosis, misclassification of
exposures because of a lack of quantitative measures, subject ascertainment and
selection bias, and uncontrolled confounding from many comorbid conditions are
common weaknesses in the studies reviewed. The variability of the test results
over time, the weak and inconsistent associations, and a lack of consistent dose–
response relationships, also prevent those studies from supporting an association
between the exposures of interest and neurobehavioral disorders.
More recent analyses using National Health and Nutrition Examination Survey (NHANES) data found no overall association between serum concentrations
of PCBs with dioxin-like activity (mono-ortho PCBs 118 and 156 and non-ortho
PCBs 126 and 169) and cognitive function scores in 708 adults aged 60–84 years,
but a subgroup analysis demonstrated lower cognition with increasing serum
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concentrations of dioxin-like PCBs (mono-ortho and non-ortho substituted PCBs)
(Bouchard et al., 2014). Also using NHANES data, Krieg (2013) performed a
limited assessment of cognition in 700 adults, aged 20–59 years, and associated
scores with 12 pesticide metabolites measured in the urine of subjects, including
two chemicals found in the urine after 2,4-D exposure: unmetabolized 2,4-D and
2,4-dichlorophenol. No urinary marker of 2,4-D was associated with any deficit
in any of the domains of neurobehavior that were tested. In contrast, increased
urine levels of the trace metabolite 2,4-dichlorophenol were associated with an
improved performance on the serial digit learning test (p = 0.0002).
Update of the Epidemiologic Literature
Since Update 2014, no new studies of Vietnam veterans or case-control
studies that examined neurobehavioral, cognitive, or neuropsychiatric outcomes
in relation to exposure to the COIs have been published.
Occupational Studies
In a study of workers exposed to PCBs from the Dortmund transformer
and capacitor recycling plant in Germany, Fimm et al. (2017) examined a broad
range of cognitive functions covering attention, executive processing, reasoning,
memory, and motor performance. The cohort consisted of 237 individuals, half
of whom were workers, and the other half were family members of the workers,
employees of surrounding companies, and area residents. The mean age was 44
years, and 17% had completed high school, that is, 12–13 years of education, with
the vast majority having completed 8–10 years and a few having completed less
than 8 years of education. Subjects were excluded primarily for lack of German
fluency, leading to 187 individuals with complete data on the neuropsychological
battery. Blood plasma PCB levels were determined and analyzed as three mutually exclusive classes: low chlorinated (PCB 28, 52, 101), high chlorinated (PCB
138, 153, 180), and dioxin-like PCBs, which included mono- and non-ortho
PCBs. However, fewer than 10% of the participants had detectable levels (limit
of detection = 0.01 ug/L blood plasma) of the non-ortho (coplanar) PCBs (77,
81, 126, and 169), and hence these PCBs were excluded from the analysis, leaving the mono-ortho PCBs 105, 114, 118, 123, 156, 157, 167, and 189. Exposure
was dichotomized into high and low, with the 95th percentile for each congener
serving as the cutpoint. For each class (low, high, and dioxin-like), an individual
was placed in the high category if his or her level of at least one congener in
that class was elevated. With this definition, 72% of the original 237 people
were classified as having high dioxin-like PCB exposure, though many of them
also had high exposures to low- or high-chlorinated PCBs, or both. Forty of
the participants had elevated levels for all of the dioxin-like PCB congeners. A
structural equations model was fit to identify correlations among the various tests
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and PCB burdens. In multiple linear regression models, adjusting for education,
dioxin-like PCBs showed no associations with any of the cognitive (vocabulary
and other achievement, non-verbal reasoning), visuo-spatial processing, word fluency, flexibility, verbal and visual memory, nonverbal (geometric) learning, and
several tests of attention and alertness. However, in the four sensorimotor tasks
designed to assess fine motor coordination and the precision of arm/hand movement, dioxin-like PCBs were associated with poorer line tracking; specifically,
a significant decrease (β = –0.206, p = 0.002) in performance on this test of fine
motor control was associated with a 10-fold increase in the sum of 8 dioxin-like
PCBs. The high-chlorinated PCBs were associated with poorer aiming, another
fine motor task; in contrast, the low-chlorinated PCBs were associated with reduced scores on verbal tests.
Environmental Studies
Przybyla et al. (2017) conducted an analysis of the associations of wholeblood concentrations of four dioxin-like PCBs (118, 126, 156, and 169), six nondioxin-like PCBs, and two metals (lead and cadmium) with cognitive impairment
in adults aged 60–84 years as measured by the Digit Symbol Coding Test of the
Wechsler Adult Intelligence Scale. The study sample consisted of 498 men and
women who participated in the 1999–2000 and 2001–2002 cycles of NHANES
and had not had a stroke. The final model included only those five neurotoxins
(including PCB 118) that were significantly (p ≤ 0.05) associated with cognitive
functioning. Estimates were adjusted for poverty–income ratio, education, race,
age, sex, and smoking status. Lower cognitive scores were found for older adults
who had higher concentrations of PCB 146 (β = −0.16, 95% CI −0.29− –0.02;
p = 0.02), whereas higher scores were observed for increased concentrations of
PCB 153, both of these being non-dioxin-like PCBs. Lower cognitive scores
were also found for older adults who had higher concentrations of PCB 118, but
the association was not statistically significant (β = −0.06, 95% CI −0.20–0.08;
p = 0.41). The results are difficult to interpret because PCBs are generally
strongly correlated with one another (the substantial change in the beta coefficient
comparing the fully adjusted model with the model with only the single PCB 153
provides evidence of such correlations in these data). Adjusting the model for
highly correlated variables can introduce a large bias in a non-predictable direction. Thus, it is difficult to interpret the findings of this study, although it should
be noted that the cross-sectional nature is not a weakness, given that the half-lives
of these compounds are generally a decade or longer.
Ames et al. (2018) reported on neurocognitive and physical functioning in
the Seveso Women’s Health Study, which enrolled women who were between
newborn and 40 years of age at the time of the explosion of the Seveso chemical
plant in 1976 and who lived in the two closer exposure zones (A and B). The
women were evaluated for their physical function in 1996 (n = 154) and with
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neurocognitive tests in 2008 (n = 459). All the women assessed for physical function were post-menarche at the time of the explosion and post-menopausal at the
time of testing. Archived serum samples collected in 1976 that were stored at
−20° C were used for an analysis of TCDD. Serum TCDD levels were reported in
pg/g lipid or parts per trillion. The physical function tests were a 10-foot walking
test of functional mobility, a coin-flipping test of manual dexterity, a grip strength
test, and a reach down test of lower-body mobility. Working memory was assessed on the Wechsler Adult Intelligence Scale digit span and spatial span tests,
each with both backward and forward tests. Multiple linear regression models
were used to assess the dose–response relationship between TCDD concentration
and the outcomes of interest, with a squared term to assess consistency with a
linear relationship; they also conducted further sensitivity analyses using semiparametric methods to make fewer assumptions about functional forms. The potential confounding variables included educational attainment, smoking, alcohol
consumption, age at interview, age at explosion, menarche status at explosion,
menopause status (pre versus post) at interview (> 12 months without a menstrual
cycle or surgical menopause), body mass index (BMI) category (referent: BMI
< 25 kg/m2, overweight: BMI ≥ 25 kg/m2 and < 30 kg/m2, and obese: BM ≥ 30
kg/m2), and marital status. Directed acyclic graphs were used to inform covariate selection into the initial adjusted model, which was pared down following
a change-in-estimate approach, retaining variables if their exclusion caused >
10% change in the TCDD coefficient. Results showed that serum TCDD was
not associated with walking speed, upper-body mobility, or manual dexterity
(p > 0.05 for these outcomes). An inverted U-shaped association was observed
for grip strength, with poorer strength at both lowest and highest TCDD exposure levels, with significance for both the linear and quadratic terms in the non-
dominant arm, and borderline significance in the dominant arm.1 There was no
association between TCDD and the Wechsler digit and spatial span tests (p > 0.05).
Neither menopause status at assessment nor age at exposure modified the associations between TCDD and working memory, that is, the lack of association
was observed in both the pre- and post-menopausal women and at all ages of
exposure following the Seveso explosion.

1 p = 0.01 for both linear (positive) and quadratic (negative) beta coefficients in the non-dominant
arm; in the dominant arm, p-values were reported as < 0.05 for both the linear and quadratic terms
in the table of the paper, but 0.07 and 0.08, respectively, in the figure; this discrepancy was due to
use of the robust variance estimates for the figure but not the table (personal communication with the
first author, Jennifer Ames).
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Other Identified Studies
One additional study in this area was identified by the committee, but it
examined biologic markers of effect of neurotransmission pathways that do not
relate to a diagnosable health outcome, and therefore it was given limited consideration. Putschogl et al. (2015) used health information and blood and urine
samples collected from people who either worked at a transformer and capacitor
recycling plant in Dortmund, Germany, or else who lived in the immediate area
and might have been exposed to dioxin-like (PCBs 105, 114, 118, 156, 157, 167,
and 189) and non-dioxin-like PCBs as a result of contamination of the area by
the facility. The focus of the study was on determining associations with neurotransmitter metabolites for dopamine (homovanillin acid) and norepinephrine
(vanillylmandelic acid) in urine as markers of targeted effects on these specific
neurotransmission pathways. All 13 dioxin-like and non-dioxin-like PCB congeners examined were significantly associated with lower urinary metabolite levels
of homovanillin acid after adjustment for creatinine. Moreover, highly chlorinated congeners were more strongly associated with increased concentration of
homovanillin acid but significantly reduced concentration of vanillylmandelic
acid, after adjustment for creatinine. These metabolites, however, are not specific
to neuronal sources, as the dietary consumption of foods with high monoamine
content (e.g., cheese, orange juice, and bananas) can also contribute to homovanillin. Only 12% of peripheral homovanillin acid derives from the brain, and
vanillylmandelic acid is heavily influenced by hepatic function. Neither information on diet nor diagnoses of hypertension were collected, which may confound
the association. Nevertheless, these measured metabolites are a poor indicator of
CNS neurotransmission, and the problems with the overall design and analysis of
the study (detailed in Chapter 5) seriously limit its contribution to the scientific
evidence on effects of exposure to the COIs.
Biologic Plausibility
Some toxicologic studies have suggested a possible involvement of the COIs
in the occurrence of neurobehavioral effects. Akahoshi et al. (2009) produced a
mouse neuroblastoma cell line that overexpressed the Ahr, a TCDD-induced protein hypothesized to be important in the synthesis of dopamine, whose perturbation has been implicated in a number of neurobehavioral syndromes. An elevated
expression of Ahr in these cells was associated with an increased production
of neurotransmitters and augmented dopamine expression, but the implication
of that finding is not clear. In vitro exposure of human CD34+ cells to TCDD
has been associated with a modulation of gene expression of the GABAergic
pathway, which may be associated with altered synaptic transmission, visual
perception, and other neurologic conditions (Fracchiolla et al., 2011). Lensu
et al. (2006) treated rats with 50 μg/kg TCDD or with leptin, a chemical with
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well-recognized effects on food consumption. When certain brain areas of the
two treated animal groups were compared 24 hours later, the results were not
consistent with a primary role for the hypothalamus brain region in TCDDinduced wasting syndrome.
Synthesis
There is not consistent epidemiologic evidence of an association between
exposure to the COIs and neurobehavioral or cognitive disorders. One occupational study (Fimm et al., 2017) and two environmental studies (Ames et al.,
2018; Przybyla et al., 2017) examined an array of neurocognitive tests, and none
showed evidence of deficits in cognitive function or attention or alertness. An
analysis of the Seveso Women’s Health Study cohort found reductions in grip
strength, one of four measures of motor function (Ames et al., 2018). More research on the COIs and these endpoints may be warranted, especially for adverse
effects of the COIs on motor function.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
neurobehavioral (cognitive or neuropsychiatric) disorders.
NEURODEGENERATIVE DISEASES
This section summarizes the findings on neurodegenerative diseases—
specifically PD, ALS, and AD—discussed in previous VAO reports. While multiple sclerosis would also be considered in this section, until Update 2014 no
published epidemiologic studies for it in relation to exposure to the COIs were
identified. A publication by H. K. Kang et al. (2014a) found an elevated risk of
death from multiple sclerosis among female Vietnam-era veterans; however, the
estimate was imprecise due to the small number of cases. Among Korean veterans, Yi et al. (2014a) found no association between prevalent multiple sclerosis
and herbicide exposure, but this very large study with substantial statistical power
did identify associations for a number of neurological conditions (paroxysmal
disorders, nerve/plexus disorders, and paralytic syndromes), which are also considerably more specific than the outcomes evaluated in previous VAO updates.
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Parkinson Disease and Parkinsonism
PD is a progressive neurodegenerative disorder that affects an estimated
6.3 million people worldwide (EBC, 2018), and it is the second-most common
neurodegenerative disease (after AD). Its primary clinical manifestations are bradykinesia, resting tremor, cogwheel rigidity, and gait instability. These signs were
first described as a single entity in 1817 by James Parkinson. Many non-motor
manifestations of PD have been described, and they can precede the motor symptoms or present together with the motor symptoms of the disease. These include
cognitive dysfunction that often progresses to frank dementia, sleep disturbances,
hallucinations, psychosis, mood disorders, fatigue, and autonomic dysfunction
affecting gastrointestinal, urinary, and heart function (Langston, 2006).
In the nearly two centuries since its initial description, much has been learned
about some genetic predispositions and the pathophysiology of PD, but its etiology in most patients remains largely unknown, with environmental risk factors
being largely understudied. The diagnosis of PD is based primarily on a clinical
examination, although in recent years magnetic resonance imaging and functional
brain imaging have become increasingly useful. Idiopathic PD at its onset may be
difficult to distinguish from a variety of Parkinsonian syndromes, including druginduced Parkinsonism, and neurodegenerative diseases, such as multiple systems
atrophy, that present with Parkinsonian features but also develop additional brain
abnormalities. Ultimately, a diagnosis of idiopathic PD can be confirmed with
a postmortem pathology examination of brain tissue showing the characteristic
loss of neurons from the substantia nigra and telltale protein aggregates known
as Lewy body intracellular inclusions. Pathology findings in other forms of
Parkinsonism show different patterns of brain injury and protein aggregation.
Mortality and hospitalization records are systems with poor diagnostic standards
for PD, and tend to under-report it. For example, on death records, PD is usually
mentioned as a contributing cause instead of an underlying cause of death, and
as such, leads to under-reporting. For PD, studies have shown that at best 60%
of PD patients have PD mentioned on their death certificates (Benito-León et al.,
2014; Désesquelles et al., 2014; Moscovich et al., 2017). Hospitalizations for PD
do not occur until very late in the disease process, if at all, and thus even though
the accuracy of hospital records in terms of diagnosis might be better than death
certificates, they may miss the less severe cases. However, unless the exposure
also contributes to differential under-reporting of PD on death certificates or admission to hospitals (and there is no obvious reason why this would be the case,
unless exposed subjects are followed for disease more carefully by their health
care system) one would expect disease misclassification to be non-differential.
Therefore, as long as the specificity of the diagnosis is close to perfect (those who
are listed as PD truly have the disease, which is what would be expected from
death certificates and hospital records) the effect estimate would not be biased.
Although the gold standard of diagnosis is pathology of the protein aggregates
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in the brain (Lewy-bodies), this standard is rarely, if ever, achieved in an epidemiologic investigation due to the low rate of autopsies or brain collection. On the
other hand, the longer the disease durations, the more likely it is that the diagnosis
is accurate (Adler et al., 2014; Wermuth et al., 2012, 2015). Diagnosis is more
accurate for patients who develop PD when they are younger than 80 years, and
the youngest onset patients are likely the most accurately diagnosed. Clinical accuracy also is much higher if patients are diagnosed in specialty clinics of tertiary
care facilities (by movement disorder specialists).
Several studies have attempted to estimate the incidence and prevalence of
PD, but methodological differences among the studies make direct comparisons
of such estimates difficult. Overall prevalence estimates of PD range from 100
to 200 per 100,000 people (von Campenhausen et al., 2005), but a recent metaanalysis of 47 studies published between 1985 and 2014 estimated an overall
PD prevalence of 315 (95% CI 113–873) per 100,000 people (Pringsheim et
al., 2014). Restricting the analysis to the highest-quality studies, the estimated
prevalence was 571 (95% CI 243–1,339) per 100,000 people, and the authors
suggested that higher-quality studies may provide a more precise estimate of
disease prevalence. Stratifying on age, the prevalence estimates clearly increase
with increasing age: 41 per 100,000 in individuals 40–49 years; 107 per 100,000
in individuals 50–59 years; 428 per 100,000 in individuals 60–69 years; 1,087 per
100,000 in individuals 70–79 years; and 1,903 per 100,000 in individuals over
age 80 years (Pringsheim et al., 2014). Meta-analyses and other data summaries
suggest a slight male preponderance in the incidence and prevalence of PD, with
PD starting earlier in men (Georgiev et al., 2017).
Similarly, the estimates of PD incidence in published studies vary considerably, possibly because of methodological differences in case ascertainment and
in which diagnostic criteria were applied. In a 2017 review, Tysnes and Storstein
(2017) estimated that the annual incidence of PD per 100,000 inhabitants ranges
from less than 10 to more than 20. A meta-analysis by age group and sex found
that males had a higher incidence of PD in all age groups and that the overall incidence rate of PD for people 40 years and older was 37.55 per 100,000 person-years
(95% CI 26.20–53.83) for females compared with 61.21 (95% CI 43.57–85.99)
in males (Hirsch et al., 2016). The incidence rate for both males and females
increases with age. For females the incidence rates by age group were calculated
as: 3.26 per 100,000 in individuals 40–49 years, 8.43 per 100,000 in individuals
50–59 years, 30.32 per 100,000 in individuals 60–69 years, 93.32 per 100,000 in
individuals 70–79 years, and 103.48 per 100,000 in individuals over age 80 years.
For males, the incidence rates by age group were: 3.57 per 100,000 in individuals
40–49 years, 14.67 per 100,000 in individuals 50–59 years, 58.22 per 100,000
in individuals 60–69 years, 162.58 per 100,000 in individuals 70–79 years, and
258.47 per 100,000 in individuals over age 80 years.
Research on the genetic, epigenetic, and environmental causes of PD suggests multiple risk factors, including aging, environmental exposure, and genetic
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predisposition (Gao and Hong, 2011; Kwok, 2010). The peak incidence and prevalence of PD are consistently found in people 60–80 years of age. A consensus statement from a 2007 meeting of PD experts (Bronstein et al., 2009) concluded that, in
addition to firm evidence that the toxicant 1-methyl-4-phenyl-1,2,4,6-tetrahydropyridine (MPTP) can induce PD, there is substantial evidence that men are at greater risk
than women, while smoking and coffee consumption are associated with a reduced
risk. Of note, it has been proposed that the latter factors—especially smoking—may
not be protective but rather a case of reverse causation (Ritz et al., 2014). Specifically, the
higher rate of quitting smoking and reduction in caffeine intake observed among
PD patients may be prodromal behavior changes in the long premotor phase of PD
when many non-motor symptoms occur, such as the loss of smell, digestive problems, and sleep disturbances. Further evidence of environmental exposures playing
a role in the development of PD has continued to accrue (Chin-Chan et al., 2015;
Mostafalou and Abdollahi, 2017; Ritz et al., 2016; Tanner et al., 2014).
Heredity has long been suspected as an important risk factor for PD. Although
risk estimates of PD for first-degree relatives of a person with PD vary from study
to study and from country to country, among large studies in the United States
first-degree relatives of an affected individual are 2.7–3.5 times more likely to
develop PD than an individual without a family history of it. For these first-degree
relatives, the cumulative lifetime risk of developing PD is between 3% and 7%
(Farlow et al., 2014). An estimated 5–10% of people with PD have monogenic
forms of it, which exhibit a classical Mendelian type of inheritance, but the majority of PD cases are sporadic (Kalinderi et al., 2016). All known monogenic
forms of PD combined explain only about 30% of familial and 3–5% of sporadic
cases (K. R. Kumar et al. 2011). At least 13 gene mutations have been identified
in autosomal dominant PD, including mutations in parkin and α-synuclein (Klein
and Lohmann-Hedrich, 2007). Mutations associated with an autosomal recessive
inheritance pattern have also been described; however, these disease genes are
found in only a handful of familial cases worldwide. More complex genetics that
act to increase susceptibility to PD in conjunction with environmental risk factors
may play a much more important role, and this has been the focus of much study
in the recent decade (Ritz et al., 2016, 2017).
Conclusions from VAO and Previous Updates
The committees responsible for VAO, Update 1996, Update 1998, Update
2000, Update 2002, Update 2004, and Update 2006 all concluded that there was
inadequate or insufficient information to determine whether there is an association between exposure to the COIs and PD. Five case-control studies reviewed by
those committees had investigated the association between PD and “herbicide”
exposure without providing further specificity and had reported mixed findings.
Two studies reviewed in Update 2008 examined the association specifically
with chlorophenoxy acid and ester herbicides and found increased odds ratios
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(Brighina et al., 2008; Hancock et al., 2008). The doubling in risk observed by
Hancock et al. (2008), however, did not achieve formal statistical significance.
Increases in the PD risk for the chemical class of chlorophenoxy acids or ester
herbicides were reported by Brighina et al. (2008) in that patients with PD were
52% more likely than control subjects to have used these pesticides. In the Agricultural Health Study (AHS), incident PD was related in a dose–response manner
to increasing days of pesticide use in general (Kamel et al., 2007b). In analyses of
single pesticide exposures, 2,4-D did not increase PD incidence risk, but 2,4,5-T
exposures did increase risk by 80% in adjusted hierarchical logistic regression
models. On the basis of that evidence, the committee for Update 2008 concluded
that there was limited or suggestive evidence associating exposure to the COIs
with PD. Additional studies considered by the committees responsible for Update
2010 and Update 2012 led them to affirm this conclusion.
The committee responsible for Update 2014 was charged specifically with
determining whether various diagnoses with Parkinsonian symptoms should be
included in the presumptive service-related category for PD. Because diagnostic
specificity is improbable in both the studies on which the conclusion of limited
or suggestive association with exposure to military herbicides was based and in
the documentation for the claims submitted to the Department of Veterans Affairs
(VA) by Vietnam veterans, the committee clarified that the finding for PD should
be interpreted by VA to include all diseases with Parkinson-like symptoms unless
those symptoms can be definitively shown to be secondary to an external agent
other than the herbicides sprayed in Vietnam.
Update 2014 included three studies of Vietnam veterans: one U.S. and two
from the Korean Veterans Health Study. Among three cohorts of U.S. Vietnamera military women—4,734 deployed to the theater of the war, 2,062 who served
in countries near Vietnam, and 5,313 who were not deployed and served primarily
in the United States—PD mortality, adjusted for age, race, duration of military
service, officer status, and nursing status, was not different in those deployed
to Vietnam from the non-deployed cohort, and there was no suggestion of an
increase when this comparison was made for the subsets of only nurses (H.
K. Kang et al., 2014a). In the Korean Veterans Health Study, 180,639 Korean
veterans were followed for vital status and cause of death (Yi et al., 2014b). An
exposure opportunity index (EOI) score was assigned to each veteran based on
the proximity of his unit to the herbicide-sprayed areas. No association was found
between PD mortality and the individual EOI scores or when the high-exposure
group was compared with the low-exposure group. A second analysis compared
the high- and low-exposure groups with respect to the prevalence of primary
PD (International Classification of Diseases, 10th Revision [ICD-10] G20) and
secondary Parkinsonism (ICD-10 G21). Effect estimates that were adjusted for
age, rank, smoking, drinking, physical activity, the domestic use of herbicides,
education, income, and BMI were less suggestive of an association with herbicide
exposure than were the unadjusted results (Yi et al., 2014a).
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Environmental (Weisskopf et al., 2012) and occupational (van der Mark et
al., 2014) exposure studies reviewed in Update 2014 did not support a statistically
significant association between exposure to the COIs and PD.
Update of the Epidemiologic Literature
One new study of Parkinson disease or Parkinsonism among Korean veterans who served in Vietnam was identified. No other studies of populations that
specifically assessed exposure to the COIs have been published since Update
2014. Table 39, which can be found at www.nap.edu/catalog/25137, summarizes
the results of studies related to Parkinson disease and Parkinson-like conditions.
Vietnam-Veteran Studies Y. S. Yang (2016) conducted an analysis of the effect of exposure to Agent Orange on Korean veterans who served in Vietnam
and had been diagnosed with PD. The study consisted of 143 PD patients with
exposure and 500 PD patients without exposure to Agent Orange, as determined
by self-report and a military record–verified “perceived exposure index.” Comparing these patients’ clinical characteristics and their radiolabeled 18F-FP-CIT
PET uptake, this study found differences in clinical profile (p < 0.05) using motor
subscales from the Unified Parkinson’s Disease Rating Scale III: tremor at rest,
rigidity, finger taps, and rapid alternating movement. Findings from the use of
FP-CIT PET showed lower uptake in basal ganglia and higher asymmetry in exposed (p < 0.05) versus unexposed patients. The authors suggested the possibility
that the PD in patients exposed to Agent Orange has a different pathophysiology
from idiopathic PD.
Other Identified Studies The committee identified several additional studies
that examined PD mortality or prevalence among occupational cohorts or in different populations with environmental exposures. However, each of them lacked
the necessary exposure specificity to be considered further as contributing to the
evidence base of the potential effect of the COIs. For example, although Ruder
et al. (2014) examined U.S. workers exposed to mixed PCBs, the specific dioxinlike PCBs were not investigated separately, and no TEQs or other quantification
of relevant exposures was presented. Likewise, a case-control study of clinically
confirmed PD among French male farmers assessed occupational pesticide and
herbicide use, duration, intensity, and cumulative exposure but did not report the
specific chemicals or classes (Moisan et al., 2015). Two environmental studies
were also identified—one among the residents of rural central California (Narayan
et al., 2015) and the other conducted in the Netherlands (Brouwer et al., 2015),
but neither specified the herbicides used in enough detail or used objective measures of exposure, such as serum concentrations, to contribute to the evidence
base of exposure to the COIs and PD.
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Biologic Plausibility
McDowell and Chesselet (2012) reviewed the literature on the ability of both
toxicant-induced (6-hydroxydopamine, MPTP, rotenone, cycad) and genetically
based animal models to reproduce the non-motor symptoms of PD. The very clear
PD-like toxicity resulting from human exposure to MPTP indicates that select
chemicals can produce the same type of damage to dopaminergic neurons as occurs in classical PD, and MPTP has become an important toxicant in studies that
use animal and in vitro models. It is notable that MPTP’s bioactive metabolite,
MPP+, is similar in chemical structure to paraquat (a commonly used herbicide,
but not one that was used in Vietnam), but structurally unrelated to any of this
report’s COIs. Pesticides shown to produce PD-like toxicity in animal models include paraquat, rotenone, maneb, and dieldrin. Substantial research has gone into
understanding the molecular mechanisms responsible for the toxicity, especially
in connection with paraquat and rotenone (Blandini and Armentero, 2012; Di
Monte et al., 2002; Drechsel and Patel, 2008; Duty and Jenner, 2011; Hatcher et
al., 2008; Moretto and Colosio, 2013; Nunomura et al., 2007; Sherer et al., 2002;
Yadav et al., 2012). The damage done to dopaminergic neurons in PD is probably
caused by oxidative stress and inflammation and may well also involve damage
to the mitochondria in the target cells (Anderson and Maes, 2014: Janda et al.,
2012; Liang et al., 2007; Littleljohn et al., 2011; Sarnico et al., 2008).
The COIs are known to be distributed to the CNS. Cholanians et al. (2016)
showed that arsenic exposure leads to an accumulation of α-synuclein in both
cultured cells and adult rats. The accumulation of α-synuclein plays a key role
in the pathogenesis of PD, suggesting that exposure to arsenical herbicides may
have an influence on PD progression. Bongiovanni et al. (2007) found that rat
cerebellar granule cells in culture (an in vitro model using cells not involved in
PD pathology) produce increased concentrations of reactive oxygen species when
exposed to 2,4-D. González-Barbosa et al. (2017) showed that TCDD exposure
causes dysregulation of the UbcH7–parkin complex in the ventral midbrain of
the mouse, but further studies are needed to characterize the consequences for
dopaminergic cells. The COIs have not been investigated in experimental systems
such as those that have shown that paraquat and other compounds cause inflammation and oxidative stress, so it is not known whether any of the COIs could
produce these responses.
Research on the neurotoxicity of 2,4-D has been going on for a number of
years, but most of it has focused on its effects on the developing rodent nervous
system. The studies have often used high doses of 2,4-D that have resulted in
adverse changes in the developing nervous system—both neurochemical (such as
changes in D2 receptors, tyrosine hydroxylase, and dopamine beta-hydroxylase)
and behavioral (for example, Bortolozzi et al., 1999, 2002, 2003, 2004; Duffard
et al., 1996; Evangelista de Duffard et al., 1990, 1995; Garcia et al., 2004, 2006;
Rosso et al., 2000a,b). The injection of 2,4-D directly into the rat brain results in
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toxicity in the basal ganglia (Bortolozzi et al., 2001), but this route of administration is highly artificial. The postpartum dietary exposure of females to 2,4-D
results in adverse alterations in maternal behavior and neurochemical changes,
including increases in dopamine and its metabolites 3,4-dihydroxyphenylacetic
acid and homovanillic acid (Stürtz et al., 2008). Such an increase in dopamine
is the reverse of what is seen in PD, in which a degradation of the dopaminergic
system occurs. In addition, a study of mice and 2,4-D yielded no evidence of
neurochemical damage to the dopaminergic system (Thiffault et al., 2001). Because most of the studies were on the developing nervous system, not the mature
nervous system, and some studies yielded evidence of a lack of a role of 2,4-D
in the development of PD, the existing studies do not support a role for the COIs
in the etiology of PD.
Synthesis
Previously reviewed studies of PD in Vietnam veterans have not shown
increased mortality or incidence of PD in U.S. or Korean Vietnam veterans. One
new epidemiologic study of PD in Korean veterans who served in Vietnam was
identified. Findings from the study suggested the possibility of a different pathophysiology for PD in patients exposed to Agent Orange than for idiopathic PD in
terms of its clinical characteristics and brain ligand measures (fluororidopa PET).
A biologic mechanism by which the COIs may cause PD has not been demonstrated. Nevertheless, the overall epidemiologic evidence continues to support
an association between herbicide exposure and PD and to be consistent with an
association with exposure to the phenoxy herbicides specifically.
Conclusion
On the basis of the lack of new evidence reviewed here supporting or refuting an association with PD, and given the evidence presented in previous VAO
reports, the committee maintains the conclusion that there is limited or suggestive evidence of an association between exposure to the COIs and PD, including Parkinson-like conditions such as Parkinsonism, in the setting of dementia,
multiple system atrophy, and progressive supranuclear palsy.
Amyotrophic Lateral Sclerosis
ALS is a progressive, adult-onset, motor neuron disease that presents with
muscle atrophy, weakness, and fasciculations and with signs that indicate the involvement of motor neuron pathways in the CNS. The incidence of sporadic ALS
is 1–2 per 100,000 person-years, and it peaks at the ages of 55–75 years (Brooks,
1996). The incidence of ALS in European populations is 2–3 people per 100,000
person-years (Johnston et al., 2006). The diagnosis of ALS is made through
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clinical examination and electrodiagnostic testing and has a high degree of accu
racy when performed by experienced neurologists (Rowland, 1998; Rowlandand
Shneider, 2001). ALS is generally more common in men than in women by a
factor ranging from 1.2 to 1.5, depending on the age group (Manjaly et al., 2010).
Established risk factors to date are older age, male gender, and a family history
of ALS (Couratier et al., 2016).
In most cases the cause of ALS is unknown, but about 5–10% of cases are
recognized as resulting from the inheritance of autosomal dominant or recessive
genes (Wood, 2014); 20% of familial-ALS patients have mutations in the gene
that encodes for superoxide dismutase-1 (Rosen et al., 1993). Many other possible etiologic factors have been investigated (Breland and Currier, 1967; Gallagher
and Sander, 1987; Hanisch et al., 1976; H. Kang et al., 2014b; Kurtzke and
Beebe, 1980; Mitchell and Borasio, 2007; Roelofs-Iverson et al., 1984; Sutedja
et al., 2009a,b; M. D. Wang et al., 2014), including military service (Weisskopf et
al., 2005), but no conclusive evidence has been found of an association with any
of the environmental exposures addressed. Pesticides have also been suggested as
a risk factor for ALS, but the results of individual studies and meta-analyses have
been mixed depending how exposure was defined, and herbicides were seldom
specified and not reported as a separate category (Kamel et al., 2012; H. Kang
et al., 2014b; Malek et al., 2012). H. Kang et al. (2014b) expanded inclusion
criteria for their meta-analysis of pesticide exposures to include the occupation
of “farmer” and a rural residence. Although some of the pesticide exposures included herbicides, they were not reported as separate estimates, and thus although
an increased risk of ALS was associated with pesticide exposure and with having
an occupation of farmer, these results are of limited usefulness.
Conclusions of VAO and Previous Updates
ALS was first evaluated as a disease that might be associated with the COIs
by the committee for Update 2002. Pesticide or herbicide exposure has been
associated with an increased risk of ALS, including a doubling of the risk after
long-term occupational exposure to pesticides (Deapen and Henderson, 1986)
and a tripling after exposure to agricultural chemical products (Savettieri et al.,
1991) and herbicides (McGuire et al., 1997), but none of the risk estimates was
statistically significant. A population-based case-control study demonstrated associations between an exposure to agricultural chemical products and ALS in
men, with an OR of 2.4 and a trend with duration of exposure that were both
statistically significant (McGuire et al., 1997). A mortality study of Dow Chemical Company employees exposed to 2,4-D found three deaths from ALS, which
resulted in a statistically significant—but imprecise—positive association (C. J.
Burns et al., 2001). Weisskopf et al. (2005) followed the vital status of subjects
in the American Cancer Society’s cohort for the Cancer Prevention Study II and
found an increased risk of ALS in those who served in any of the armed services
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during times of conflict. They adjusted for a variety of confounding variables in
their model, including exposure to herbicides, and found that none of them significantly altered their conclusions; thus, this large study indirectly suggests the
lack of a strong effect of herbicide exposure on ALS risk. A latter analysis of the
American Cancer Society’s Cancer Prevention Study II also found no association between self-reported pesticide or herbicide exposure and ALS, but the lack
of exposure specificity and the possibility of exposure estimation error limit the
weight of this evidence (Weisskopf et al., 2009). Malek et al. (2014) compared
66 ALS patients to 66 controls, administering a questionnaire on occupational,
vocational, and avocational exposures, and found self-reported pesticide exposure
to be associated with ALS. The association was even stronger after controlling for
smoking and education in a multivariate model but quite imprecise. Additional
analyses conducted on occupational exposure to insecticides, to herbicides, or to
fungicides and fumigants, individually, found no associations with ALS, but the
sample sizes were very small. None of the results is based on sufficiently specific
exposure metrics to be fully informative for VAO purposes.
Studies of veterans who served in Vietnam have reported weak and generally
not statistically significant associations with the risk of ALS. A case-control study
of Australian Vietnam veterans reported an association between deployment in
Vietnam and ALS (ADVA, 2005c) but did not specifically study exposure to
pesticides or herbicides. In the Korean Veterans Health Study, Yi et al. (2014b)
calculated individual EOI scores based on the proximity of the veteran’s unit to
given areas when herbicides were sprayed and partitioned the veterans into highand low-exposure groups. No association was found between spinal muscular
atrophy and the EOI scores or when the high-exposure group was compared with
the low-exposure group. However, in the analysis of disease prevalence among
the same Korean Vietnam veteran cohort, after adjusting for age, rank, smoking,
drinking, physical activity, domestic use of herbicides, education, income, and
BMI, Yi et al. (2014a) found the risk for spinal muscular atrophy to be slightly
elevated in both the analysis of the scores comparing high- and low-exposure
group and as a continuous variable. The more specific diagnosis of motor neuron
disease (ICD-10 G12.2), which includes ALS, had nearly the same risk estimate,
but because these cases represented only about one-third of those in the entire
spinal muscular atrophy grouping, estimates were more imprecise.
Update of the Epidemiologic Literature
Two studies of ALS in Vietnam veterans and one case-control study of occupational exposures and environmental toxicants on the odds of developing ALS
have been identified since Update 2014. Table 40, which can be found at www.
nap.edu/catalog/25137, summarizes the results of studies related to ALS.
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Vietnam-Veteran Studies Beard et al. (2016) used the National Registry of
Veterans with ALS to identify medical record–confirmed ALS cases from 2005
to 2010 for veterans who consented at the time of enrollment in the registry to
participate in further studies. Controls were selected from the Veterans Benefits
Administration’s Beneficiary Identification and Records Locator System database. A total of 958 controls who were located, screened, and found to be eligible
to participate were frequency-matched to 621 cases based on diagnosis age within
5 years and on socioeconomic status, as roughly estimated by the veteran’s use
of the VA health care system before the date of diagnosis. All participants were
followed until 2013. Clinical characteristics were extracted from medical records,
and standardized telephone interviews were used to collect self-reported information on military service (branch of the longest service, number of branches,
rank, the total service time, and the end of the most recent service), deployments
(number; locations; time in theater; ever received imminent danger pay, hardship
duty, or combat zone tax exclusion benefits for deployment to 17 foreign countries or five sea regions [plus fill-in options]), and exposures that occurred before
the diagnosis date (cases) or the interview date (controls) as well as on potential
confounders. Self-reported information on 39 specific military exposures was
also collected, some of which were conflict-specific (e.g., Agent Orange exposure during the Vietnam War). For 31 of 32 war-specific exposures, participants
were asked whether they had ever been exposed, days exposed (not exposed,
≤ 5, 6–30, > 30), and whether they felt ill after exposure (not exposed, no, yes).
Inverse probability weighting was used to adjust for potential bias from confounding, missing covariate data, and selection arising from a case group that
disproportionately included long-term survivors and a control group that may
or may not have differed from U.S. military veterans at large. The study population consisted of 302 cases and 3,793 veterans who were aged 18–25 years during the Vietnam War. War-specific exposures for these veterans were analyzed
separately, although the authors did not present all such results independently
from the analysis that included all veterans and not all veterans served in that
war. For those results presented, 58 cases and 77 controls reported exposure to
Agent Orange in the field (OR = 2.80, 95% CI 1.44–5.44), and 8 cases and 13
controls reported mixing and application of Agent Orange (OR = 1.15, 95% CI
0.38–3.44). Vietnam veterans diagnosed with ALS reported greater exposure to
pesticides on clothing or bedding (OR = 1.83; 95% CI 0.99–3.40). Overall, ALS
was positively associated with an exposure to herbicides for military purposes,
nasopharyngeal radium, personal pesticides, exhaust from heaters or generators,
high-intensity radar waves, contaminated food, explosions within 1 mile, herbicides in the field, mixing and application of burning agents, burning agents in the
field, and Agent Orange in the field.
In a second study using the same registry population of ALS veteran cases,
Beard et al. (2017) examined associations between military-related factors and
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ALS survival. A total of 616 medical record–confirmed cases were followed from
enrollment in the registry (2005–2010) until death or July 25, 2013, whichever
came first. Vital status information was obtained from several sources within VA,
and information regarding military service, deployments, and 39 related exposures was collected from self-report via a standardized telephone interview (see
details above in Beard et al. [2016]). Inverse probability weights were used to
adjust for potential confounding and missing covariate data biases as well as to
adjust for potential selection bias among a case group that included a disproportionate number of long-term survivors at enrollment. In the study population, 137
veterans diagnosed with ALS had reported service in Vietnam. The war-specific
exposures for these veterans were analyzed separately, although the authors did
not present all such results independently from the analysis that included all
veterans. A total of 446 deaths occurred during 24,267 person-months of followup (median follow-up: 28 months). For exposures constrained to deployment in
Vietnam, longer survival was associated with exposure to Agent Orange in the
field (n = 39 deaths; hazard ratio [HR] = 0.66, 95% CI 0.42–1.05) and mixing
and application of Agent Orange (n = 6 deaths; HR = 0.62, 95% CI 0.32–1.20);
however neither exposure estimate is statistically significant.
Case-Control Studies F. C. Su et al. (2016) conducted a case-control study to
evaluate the association of occupational exposures and environmental toxicants
with the odds of developing ALS in Michigan. ALS cases (n = 156) with a diagnosis of definitive, probable, probable with laboratory support, or possible ALS by
revised El Escorial criteria were recruited from a tertiary referral center for ALS.
Controls (n = 128) were recruited from postings and the University of Michigan
clinical research volunteer database and were excluded if they were diagnosed
as having ALS or another neurodegenerative condition or if they had a family
history of ALS in a first- or second-degree blood relative. Participants completed
a self-administered written survey that collected information on demographics,
occupational and residential exposures, military service, and smoking history. Specifically, there were 58 identified exposure risk factors, 20 occupational groups,
and 20 industrial groups queried for each job. Blood samples were collected from
129 cases and 119 controls and measured for concentrations of 122 persistent
environmental pollutants, including organochlorine pesticides, PCBs (and dioxinlike PCB 118, specifically), and brominated flame retardants. Odds ratios and 95%
CIs were calculated using standardized chemical concentrations from the imputed
sample (n = 284, 10 imputations) and adjusted for age, sex, and educational levels.
An effect estimate for PCB 118 was calculated only for the model that used individual compounds as covariates, which showed exposure to be associated with a
decreased risk of ALS (OR = 0.69, 95% CI 0.48–1.01).
Other Identified Studies One additional study of an occupationally exposed
cohort and ALS was identified (Ruder et al., 2014), but it lacked the necessary
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exposure specificity or quantification to be considered further as contributing to
the evidence base of the potential effect of exposure to the COIs on ALS.
Biologic Plausibility
Several studies have addressed the mechanisms of neurotoxicity that might
be ascribed to COIs, notably 2,4-D and TCDD. Some of those effects suggest
possible pathways by which the COIs could disrupt neuronal systems. A number
of the studies suggest that the COIs have had neurologic effects in animal models
when exposure occurred during development. There also are studies that suggest
reactive oxygen species could alter specific signaling cascades and be involved
in neurodegeneration. Although they do not specifically concern the COIs, such
studies are potentially relevant inasmuch as TCDD and herbicides have been
reported to elicit oxidative stress (Celik et al., 2006; Shen et al., 2005). The
mechanistic studies suggest avenues that might be pursued to determine linkages between the COIs and the neurologic outcomes that could result in adult
humans. No toxicology studies concerning exposure to the COIs and ALS have
been published since Update 2006.
Synthesis
There is overall inadequate or insufficient evidence of an association between pesticides and ALS in broad terms, but the studies published to date have
had low power to detect associations, which has resulted in numerous studies
with wide CIs and non-significant ORs for exposure to the COIs. Three studies
have been published since Update 2014. Two analyses of Vietnam veterans used
data from the National Registry of Veterans with ALS (Beard et al., 2016, 2017).
Exposure to Agent Orange in the field was statistically significantly associated
with increased odds of ALS, but mixing and application of Agent Orange was
not associated with ALS. Overall, ALS was positively associated with exposure
to herbicides for military purposes, contaminated food, explosions within 1 mile,
herbicides in the field, mixing and application of burning agents, burning agents
in the field, and Agent Orange in the field. The second analysis of this population
examined associations between military-related factors and ALS survival; longer
survival was associated with exposure to Agent Orange in the field and mixing
and application of Agent Orange, but neither of these exposure estimates was
statistically significant. The third study examined occupational exposures and
122 environmental toxicants, including organochlorine pesticides and PCB 118 as
measured in serum, on the odds of developing ALS. Exposure to PCB 118 was associated with a decreased risk of ALS in this population. The many epidemiologic
studies reviewed in the series do not indicate a consistent association between
ALS and herbicides as a class or, specifically 2,4-D or 2,4,5-T or dioxin-like
PCBs, and the toxicology studies do not support an ALS mechanism specifically.
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Conclusion
On the basis of the evidence reviewed here and in previous VAO reports, the
committee concludes that the evidence of an association between exposure to the
COIs and ALS remains inadequate or insufficient.
Alzheimer Disease
AD is a progressive, neurodegenerative form of dementia that is characterized by memory loss, confusion, mood changes, social withdrawal, and
deteriorating judgment. The course of the disease is divided into four stages—
pre-dementia, early, moderate, and advanced—depending on the level of cognitive
and functional impairment. Diagnosis typically occurs in people over 60 years old
as the symptoms develop, although pre-dementia and early AD are occasionally
seen in people as young as 30 years old. AD is the sixth leading cause of death in
the United States and the fifth leading cause of death in people over 65 years old
(S. Singh et al., 2012). In 2017 an estimated 5.5 million Americans were living
with the diagnosis. Mean life expectancy is 7 years after an AD diagnosis; about
3% of people who receive the diagnosis live 14 years or more (Alzheimer’s Asso
ciation, 2018). Although the etiology of the disease remains elusive, suspected
risk factors for AD include diet, exposure to aluminum or solvents, and genetics
(Chin-Chan et al., 2015; de la Monte and Tong, 2014; Tanner et al., 2014).
Similar to PD diagnosis, mortality and hospitalization records are poor instruments for identifying AD cases (Désesquelles et al., 2014; Romero et al.,
2014). AD is usually mentioned as contributing cause instead of the underlying
cause of death, and therefore, is more prone to under-reporting. Death certificates for AD are further limited for diagnostic and research purposes because
many times the type of dementia (vascular, AD, other) is not specified on death
certificates. Like PD, hospitalizations for AD do not occur until very late in the
disease process, if at all, and thus even though the accuracy of hospital records
in terms of diagnosis might be better than death certificates, they may miss most
of the less severe cases or those institutionalized in long-term care facilities who
might avoid hospitalizations (Wilson and Truman, 2004). However, as long as
the specificity of the AD diagnosis is close to perfect, the effect estimate would
not be biased. The gold standard of AD diagnosis is pathology of the protein aggregates in the brain (amyloid beta and tau aggregates) and this standard is rarely,
if ever, achieved in an epidemiologic project due to the low rate of autopsies or
brain collection. However, one can assume that the longer the disease duration
the more accurate the AD diagnosis. Also it is known that patients are diagnosed
more accurately when they develop the diseases before the age of 80 years and
the youngest onset patients are likely the most accurately diagnosed. Clinical
accuracy also is much higher if patients are diagnosed in specialty clinics of
tertiary care facilities (by dementia specialists), which are not common outside
of urban areas.
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Conclusions from VAO and Previous Updates
AD was first addressed directly in Update 2012. Until that time, literature
searches had not identified epidemiologic studies that assessed the possible association of AD with exposure to the specific COIs. However, an association
with exposure to the broad classification of “pesticides” had been investigated.
Because AD is a condition of considerable interest to aging Vietnam veterans,
studies with peripherally related available information (including those with
nonspecific exposure assessment) on this outcome were included. On the basis
of two studies of nonspecific herbicide exposure or mixed exposure to herbicides
and other pesticides and AD (Baldi et al., 2003; Gauthier et al., 2001) that found
inconsistent associations, the Update 2012 committee concluded that there was
inadequate or insufficient evidence to determine whether there is an association
between exposure to the COIs and AD.
Two studies of Vietnam veterans and one environmental study of AD were
reviewed in Update 2014. The analyses of mortality in the Korean Veterans
Health Study found no association between AD (ICD-10 G30) and the EOI scores
analyzed as a continuous variable or between the high- and low-exposure groups
(Yi et al., 2014b). However, a separate investigation of disease prevalence among
the Korean Vietnam veterans found the risk for AD to be elevated in both the
analysis of the scores as a continuous variable and the high- versus low-exposure
comparison after adjusting for age, rank, smoking, drinking, physical activity,
domestic use of herbicides, education, income, and BMI (Yi et al., 2014a). A
subanalysis using the Canadian Study of Health and Aging examined 2,023
subjects for whom blood was available and who had a firm diagnosis of having
dementia (n = 574, of which 399 were specifically diagnosed with AD) or not
(n = 1,449) (Medehouenou et al., 2014). Among the 10 PCB congeners measured
in the serum analyses were the mono-ortho PCBs 105, 118, and 156, which exhibit
dioxin-like activity only to a modest extent. Two adjusted models were applied to
the data, and of the 10 PCBs analyzed, only PCBs 105 and 118 showed an inverse
association with dementia overall in the first model, but adjustment for additional
confounders in the second model eliminated that negative association. Thus,
no relationship with AD specifically was seen for any of the PCBs using either
model. The Update 2014 committee reiterated that the evidence for an association
between exposure to at least one of the COIs and AD is inadequate or insufficient.
Update of the Epidemiologic Literature
No studies of AD among Vietnam veterans or other populations that specifically assessed exposure to the COIs have been published since Update 2014.
Environmental Studies D. H. Lee et al. (2016) measured PCBs and organochlorine pesticides in the participants of the PIVUS (Prospective Investigation
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of the Vasculature in Uppsala Seniors) cohort of residents 70 years and older in
Uppsala, Sweden, to examine cognitive impairment. Of 2,025 eligible subjects,
only half (n = 1,016) agreed to participate and completed a questionnaire to
assess medical history, smoking history, and medication use. In a subcohort of
989 men and women, the investigators determined whether PCB or organochlorine exposures were associated with cognitive impairment during 10 years of
follow-up, relying on medical record review and death certificate information
to ascertain disease status. General exposure to 16 PCBs and 3 organochlorine
pesticides (p,p′-DDE, trans-nonachlor, and hexachlorobenzene) was quantified
using high-resolution gas chromatography/mass spectrometry from stored serum
samples collected at the time of entry into the PIVUS study, and these measure
were normalized using individual lipid levels. The authors analyzed exposures
using a compound summary score for the three organochlorine pesticides and the
PCBs, grouping them according to the < 25th, 25th–75th, and > 75th percentile
of exposure. Adjusted hazard ratios for the higher summary score PCB exposures
compared with exposure < 25th percentile showed no associations with cognitive
impairment, but the study did not distinguish between dioxin-like and non-dioxinlike PCBs. For the highest exposure (> 75th percentile) of hexachlorobenzene,
a chemical with dioxin-like activity, the weight-loss-adjusted HR was 2.4 (95%
CI 1.0–5.8) in those who developed cognitive impairment after age 75, and the
p-trend was statistically significant. These results suggest that exposure to hexachlorobenzene may predispose to the development of cognitive impairment or
AD.
Other Identified Studies Two additional studies of occupational exposures
and mortality from AD and dementia (Ruder et al., 2014) or mortality from nonvascular dementia (Koeman et al., 2015) were identified. However, both studies
lacked the necessary exposure specificity or quantification to be considered further as contributing to the evidence base of the potential effect of exposure to the
COIs on AD or dementia.
Biologic Plausibility
There has been little toxicologic investigation of adult exposure to the COIs
and endpoints relevant to AD.
Synthesis
The findings in the Korean Veterans Health Study (Yi et al., 2014a,b) remain
the first in which the risk of AD has been investigated in association with a fully
relevant exposure, but the findings were not consistent. Except for the analysis of
the PIVUS cohort (D. H. Lee et al., 2016), which only suggested an association
with cognitive impairment for hexachlorobenzene and only in subgroup analyses,
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there are no new relevant epidemiologic studies on AD to add to the evidence base
since the last update, and the toxicologic data remains sparse.
Conclusion
On the basis of the lack of new evidence reviewed here and that reviewed in
previous VAO reports, the committee concludes that there is inadequate or insufficient evidence to determine whether there is an association between exposure
to the COIs and AD.
CHRONIC PERIPHERAL NERVOUS SYSTEM DISORDERS
Peripheral neuropathies are an array of disorders caused by damage to nerve
fibers (axonal neuropathies) or to the myelin sheath that surrounds many fibers
(demyelinating neuropathies). The manifestations of neuropathy can include a
combination of sensory changes, weakness, and autonomic instability. Clinically,
various forms of peripheral neuropathy can be characterized by the distribution
of nerve abnormalities and their patterns of progression.
Peripheral neuropathy resulting from toxic exposure usually affects nerve fibers
in a symmetric pattern, beginning distally in the longest fibers (in the toes) and moving proximally (toward the spine). This kind of neuropathy is called symmetric axonal sensorimotor polyneuropathy. Sensory deficits begin at the toes, progress above
the ankles, and only later affect the hands. Motor symptoms show the same general
pattern. Physiologically, various forms of peripheral neuropathy can be characterized by the results of electrodiagnostic testing to indicate which neural structures
are affected. Most toxicant-induced neuropathies involve injury to the nerve-cell
bodies or the axons, giving rise to changes in the amplitude of a nerve’s response to
an electric stimulus. The clinical manifestations of most symmetric axonal neuropathies are similar except for variations in the rates of progression and in whether pain
is prominent. No specific signature distinguishes a toxicant-related neuropathy from
one induced by other causes. As many as 30% of neuropathies are “idiopathic,” that
is, no etiology is determined despite exhaustive clinical evaluation.
The most common toxicant-induced neuropathy occurs as a result of chronic
alcohol exposure. Peripheral neuropathy also occurs commonly as a complication
of diabetes; its reported prevalence in people who have chronic diabetes is up to
50%. Thus, it is important to include an assessment of alcohol use and diabetes
as covariates in epidemiologic studies because the neuropathies that are related
to these conditions are clinically and physiologically indistinguishable from other
toxicant-induced neuropathies.
Toxicant exposure can result in early onset (immediate) peripheral neuropathy or delayed-onset peripheral neuropathy, which occurs years after the external
exposure has ended. For classification purposes, the committee considers a neuropathy early onset if abnormalities appear within 1 year after external exposure
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ends and delayed-onset if abnormalities appear more than 1 year after external
exposure ends. Because the exposures of interest for Vietnam veterans are long
past (more than 40 years ago), the immediate effects of the COIs are no longer
pertinent for this cohort. Such outcomes would include early onset peripheral
neuropathy and porphyria cutanea tarda. Because early onset peripheral neuropathy is not necessarily a transient condition, it may become a chronic condition
that should be distinguished from delayed-onset peripheral neuropathy. The focus
of this section is on data related to delayed-onset peripheral neuropathy.
Conclusions from VAO and Previous Updates
Several studies of Vietnam veterans have examined peripheral neuropathy. A
study by the Centers for Disease Control and Prevention (CDC, 1988b) reported a
slight excess in the signs or symptoms of peripheral neuropathy among deployed
versus non-deployed Vietnam-era veterans. Decoufle et al. (1992) reported no
association between self-reported exposure to herbicides in Vietnam and peripheral neuropathy. There was no indication of an increased incidence of peripheral
neuropathy in the first examination of the Air Force Health Study (AFHS), which
established the baseline for Ranch Hand veterans (AFHS, 1984a). Michalek et
al. (2001c) described peripheral neuropathy in the AFHS cohort. In a primary
analysis, the investigators had included diabetes as a potential confounder in the
statistical model. In a secondary analysis, the subjects who had conditions that
were known to be associated with neuropathy were excluded, and the subjects
who had diabetes were enumerated. In both analyses, there were strong and significant associations between serum dioxin concentrations and possible and probable neuropathy, and significant trends were found with increasing concentrations
of dioxin. However, there were too few nondiabetic subjects to produce useful
estimates of risk in the absence of the contribution of diabetes. Thus, questions
remained about the specific association between an exposure to the COIs and
peripheral neuropathy in the absence of any effect of diabetes. The large veteran
studies are limited by the confounding nature of concurrent diabetes and alcohol
exposure, both of which are also related to neuropathy.
In the study of disease prevalence among the Korean Vietnam veterans, after
adjusting for age, rank, smoking, drinking, physical activity, the domestic use of
herbicides, education, income, and BMI, Yi et al. (2014a) found that the risk for
polyneuropathies of the PNS (ICD-10 G60–G64) was slightly elevated in both
the analysis of the EOI scores as a continuous variable and in the high- versus
low-exposure comparison.
D. H. Lee et al. (2008) evaluated the association of exposure to a variety of
toxicants to the presence of neuropathy in subjects who had either frank diabetes or
impaired glucose tolerance. No evidence of an increased incidence of neuropathy
or of a dose–response relationship was found for either group when stratified by
high- versus low-hemoglobin A1c level that suggested a concentration-dependent
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risk of neuropathy. However, this study was limited by the small sample size and
a lack of information regarding the duration of diabetes.
Update of the Epidemiologic Literature
No studies of exposure to the COIs and chronic peripheral system disorders
were identified for the current update.
Biologic Plausibility
No new toxicity studies directly pertinent to the COIs and peripheral neuropathy were identified for the present update. However, it is worth reiterating
findings from earlier updates. Neuronal cell cultures treated with 2,4-D showed
decreased neurite extension associated with intracellular changes, including a
decrease in microtubules, an inhibition of the polymerization of tubulin, disorganization of the Golgi apparatus, and an inhibition of ganglioside synthesis
(Rosso et al., 2000a,b). The normal activity of those target processes is important
for maintaining synaptic connections between nerve cells and for supporting
the mechanisms involved in axon regeneration during recovery from peripheral
neuropathy. Grahmann et al. (1993) and Grehl et al. (1993) reported observation
of, respectively, electrophysiologic and pathologic abnormalities in the peripheral
nerves of rats treated with TCDD. When the animals were sacrificed 8 months
after exposure, there was pathologic evidence of persistent axonal nerve damage
and histologic findings typical of toxicant-induced injury. These results constitute
evidence of biologic plausibility for an association between exposure to the COIs
and peripheral neuropathy.
Synthesis
The epidemiologic studies relating industrial or individual exposure to acute
neuropathy were judged by the committee for Update 1996 and later updates to
provide limited or suggestive evidence of an association between exposure to the
COIs and early onset transient peripheral neuropathy. Beginning with Update
2010, these acute outcomes were removed from this section to keep the focus on
chronic and delayed-onset conditions. That committee concluded that no data suggest that exposure to COIs can lead to the development of delayed-onset chronic
neuropathy many years after the termination of exposure of those who did not
originally complain of early onset neuropathy and concluded the evidence to be
inadequate or insufficient. Since Update 2010, only one relevant study was identified and reviewed, and that study was reviewed in Update 2014. Among Korean
Vietnam veterans, the prevalence of polyneuropathies was slightly elevated in
high- versus low-exposure comparisons. Given the lack of new epidemiologic
studies and toxicologic information, the committee agrees with the prior two
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committees and concludes that the evidence does not support an association
between exposure to the COIs and the development of delayed-onset chronic
neuropathy.
Conclusion
On the basis of the lack of new evidence to date, the committee concludes
that there is inadequate or insufficient evidence to determine whether there is an
association between exposure to the COIs and delayed-onset chronic neuropathy.
HEARING LOSS
Hearing loss increases markedly with age, from approximately 3% among
adults aged 20–29 years to an estimated 49% among people 60–69 years of age and
more than 80% among people 85 years and older (NASEM, 2016b). These estimates
are based on NHANES data and are likely to underestimate the true population
prevalence of hearing loss because the NHANES sampling frame does not include
people living in assisted care facilities, group homes, or nursing homes or those
unable to come to the mobile examination center. Hearing loss is somewhat higher
in men than in women (NASEM, 2016b). The most common forms of hearing impairment in adults are presbycusis and tinnitus. Heritable factors may influence the
susceptibility to hearing loss, but external agents can also contribute. Aspirin at high
doses can cause reversible tinnitus, and permanent hearing loss may be induced
by certain pharmaceuticals (particularly antibiotics and antineoplastic drugs) and
by some environmental and industrial chemicals (primarily solvents and metals)
(Cannizzaro et al., 2014). In occupational medicine, hearing loss is most often regarded as noise induced. Farmers and migrant or seasonal agricultural workers have
also been found to have high rates of hearing loss compared with those who had the
lowest levels of pesticide exposure (Crawford et al., 2008; Rabinowitz et al., 2005).
Conclusions from VAO and Previous Updates
Epidemiologic results on hearing loss in relation to service in Vietnam or to
herbicide exposure more generally were first discussed in Update 2010, when
two citations that addressed this health outcome were identified. O’Toole et al.
(2009) re-examined the health status of a cohort of Australian Vietnam veterans;
as for almost every health endpoint surveyed in that group, the incidences of
self-reported complete or partial deafness and of tinnitus showed statistically significant increases compared to the general population, but these results are likely
compromised by methodologic problems with the study. Excesses in self-reported
hearing loss were also found among licensed pesticide applicators in the AHS at
the time of the 5-year follow-up interview (Crawford et al., 2008), but this effect
was associated with insecticide exposure, not with herbicide use.
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Update of the Epidemiologic Literature
No epidemiologic studies addressing exposure to the COIs and hearing loss
have been published since Update 2014.
Biologic Plausibility
Although no studies of hearing loss in adult animals directly exposed to
the COIs were found, Crofton and Rice (1999) reported that perinatal maternal
exposure to PCB 126 (a dioxin-like PCB) resulted in low-frequency hearing
deficits in the offspring of exposed maternal rats. Increased auditory thresholds
occurred in the group treated at 1.0 μg/kg/day for 0.5- and 1-kHz tones, but
higher frequencies were not significantly affected. The frequency-specific deficit
was hypothesized to be secondary to a postnatal hypothyroxinemia that occurred
during a sensitive period for the development of the low-frequency regions of
the cochlea, which was consistent with the finding that the pups had decreased
T4 concentrations in their sera on postnatal day 21.
Synthesis
Two prior studies observed an increased prevalence of hearing loss in Vietnam
veterans and pesticide applicators, but neither was able to examine exposure
specifically to the COIs or to confirm hearing loss clinically. Furthermore, the
report from the AHS (Crawford et al., 2008) observed an association only in
insecticide applicators, not in herbicide applicators. Hearing loss among Australian Vietnam veterans was compared with the general Australian population, not
veterans from the same era who were not deployed to Vietnam, so it could not
distinguish between hearing loss that may be associated with noise that was related to military service and hearing loss potentially associated with exposures to
toxic chemicals. In the absence of new studies, the conclusion remains unchanged
since Update 2010.
Conclusion
On the basis of the evidence reviewed here, the committee concludes that
there is inadequate or insufficient evidence to determine whether there is an association between exposure to the COIs and hearing loss.
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Metabolic and Cardiovascular Disorders

Chapter Overview
Based on new evidence and a review of prior studies, the current committee found
that new scientific evidence combined with previously reviewed studies has led to
changes in the categorizations of association for two metabolic and cardiovascular outcomes outcomes: type 2 diabetes and hypertension.
• After extensive deliberation concerning the new evidence and the results
of studies reviewed in previous updates, the committee was unable to
reach consensus as to whether the evidence of an association between
exposure to the chemicals of interest (COIs) and diabetes met the criteria
for being considered sufficient or whether concerns about chance, bias,
and confounding lead to the conclusion that the evidence regarding diabetes is limited or suggestive.
• There is sufficient evidence of an association of hypertension with the COIs.
The committee found that the current evidence supports the conclusions reached
by committees responsible for earlier updates concerning the other metabolic and
cardiovascular outcomes reviewed in the Veterans and Agent Orange (VAO) series
of reports:
• There is limited or suggestive evidence of an association between the
COIs and ischemic heart disease and stroke.
• There is inadequate or insufficient evidence to determine whether there
is an association between the COIs and any other adverse metabolic or
cardiovascular outcome examined.
465
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This chapter summarizes and presents conclusions about the strength of the
evidence from epidemiologic studies regarding an association between exposure
to the COIs—2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) and its contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), picloram, and cacodylic acid—and metabolic and cardiovascular disorders. The committee also considers studies of exposure to polychlorinated biphenyls (PCBs) and other dioxin-like chemicals to be informative if their results were
reported in terms of TCDD toxic equivalents (TEQs) or concentrations of specific
congeners. Studies that report TEQs based only on mono-ortho PCBs (which are
PCBs 105, 114, 118, 123, 156, 157, 167, and 189) are considered even though
their TEQs are several orders of magnitude lower than those of the non-ortho
PCBs (77, 81, 126, and 169), based on the revised World Health Organization
(WHO) toxicity equivalency factor (TEF) scheme of 2005 (La Rocca et al., 2008;
van den Berg et al., 2006). The lower TEQs of the mono-ortho PCBs, however,
may be counterbalanced by their abundance, which is generally many orders of
magnitude higher than that of the non-ortho PCBs (H. Y. Park et al., 2010).
The first part of the chapter covers the metabolic disorder type 2 diabetes and
the second part reviews a variety of cardiovascular and blood disorders. Cardiovascular conditions explored in this chapter are based on the categories in the 9th
and 10th revisions of the International Classification of Diseases (ICD; ICD-9
390–459 and ICD-10 I00–I99, respectively) and include hypertension (ICD-9
401–404; ICD-10 I10–I13), ischemic heart disease (ICD-9 410–414; ICD-10
I20–I25), heart failure (ICD-9 428; ICD-10 I50), and cerebrovascular disease
(ICD-9 430–438; ICD-10 I60–I69).
TYPE 2 DIABETES
Diabetes mellitus is a group of heterogeneous metabolic disorders characterized by hyperglycemia and a quantitative or qualitative deficiency in insulin
action (Orchard et al., 1992) and classified as E08–E13 by ICD-10. Although all
forms of diabetes share hyperglycemia, the pathogenic processes involved in the
development of the various types of diabetes differ. Most cases of diabetes mellitus are classified as being in one of two categories: type 1 diabetes or type 2
diabetes. The long-term complications of both types can include cardiovascular
disease (CVD), nephropathy, retinopathy, neuropathy, and increased vulnerability
to infections.
When referring to diabetes, most research will not distinguish between type 1
and type 2 because type 2 diabetes accounts for 90% to 95% of all cases. Type 1
diabetes (ICD-10 E10) is characterized by a lack of insulin caused by the immunologically mediated destruction of insulin-producing cells in the pancreas
(β cells), which often occurs during childhood but can occur at any age. As with
many autoimmune diseases, genetic and environmental factors both influence its
pathogenesis. Some viral infections are believed to be important environmental
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triggers for the autoimmunity associated with type 1 diabetes. Type 1 diabetes
most often occurs in children, which is only of relevance in offspring of adults
exposed to the COIs.
Type 2 diabetes exhibits both resistance to the actions of insulin and inadequate secretion of insulin (called relative insulin deficiency). The prevalence of
diabetes in the United States has been increasing among nearly all races and ethnic groups. In 2015 there were approximately 30.3 million people ages 18 years
and older who had diabetes in the United States, or 9.4% of the U.S. population.
Of these, 23.1 million had officially been diagnosed, whereas 7.2 million (23.8%)
were considered to be prediabetic (CDC, 2017c). Although the modern ICD-10
classification system recognizes that type 2 diabetes can occur in children and can
require insulin treatment, most cases of type 2 diabetes occur in adults.
Onset can occur before 30 years of age, and the incidence increases with age.
The main risk factors for type 2 diabetes are age, obesity, abdominal fat deposition, a history of gestational diabetes (in women), physical inactivity, ethnicity,
and family history, but the relative contributions of each of those risks to the
overall prevalence are not known. Type 2 diabetes affects women and men nearly
equally (11.7 million versus 11.3 million, respectively); however, the Centers for
Disease Control and Prevention (CDC) estimates that there are more undiagnosed
diabetes cases among men than among women (4.0 million versus 3.1 million,
respectively). Table 10-1 shows the estimated prevalence of diagnosed and undiagnosed diabetes among adults over 18 years by age and sex. The prevalence of
type 2 diabetes among U.S. adults aged 18 years and older is greatest in American Indians/Alaska Natives (15.1%), followed by non-Hispanic blacks (12.7%)
and Hispanics (12.1%). The lowest prevalence rates are for non-Hispanic whites
(7.4%) and Asians (8.0%). As of 2015, an estimated 1.5 million new cases of
diabetes are diagnosed annually, for an incidence rate of approximately 6.7 per
1,000 persons. In non-Hispanic blacks the incidence was 9.0 per 1,000 persons
and 8.4 per 1,000 persons among people of Hispanic origin (CDC, 2017c).
TABLE 10-1 Estimated Number and Percentage of Diagnosed and
Undiagnosed Diabetes Among Adults, Aged ≥ 18 years, United States, 2015
Characteristic

Diagnosed Diabetes
# in Millions (95% CI)

Undiagnosed Diabetes
# in Millions (95% CI)

Total Diabetes

Age in years
18–44
45–64
≥65
Sex
Women
Men

3.0 (2.6–3.6)
10.7 (9.3–12.2)
9.9 (9.0–11.0)

1.6 (1.1–2.3)
3.6 (2.8–4.6)
2.1 (1.4–3.0)

4.6 (3.8–5.5)
14.3 (12.7–16.1)
12.0 (10.7–13.4)

11.7 (10.5–13.1)
11.3 (10.2–12.4)

3.1 (2.4–4.1)
4.0 (3.0–5.5)

14.9 (13.5–16.4)
15.3 (13.8–17.0)

Total

23.0 (21.1–25.1)

7.2 (6.0–8.6)

30.2 (27.9–32.7)

SOURCE: CDC, 2017c.
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The etiology of type 2 diabetes is unknown, but three major components have
been identified: peripheral insulin resistance in target tissues (muscle, adipose
tissue, and liver), a defect in β-cell secretion of insulin, and the overproduction
of glucose by the liver. When a person enters a state of insulin resistance, insulin
secretion is initially higher for each concentration of glucose than in people who
are not insulin resistant. This hyperinsulinemic state compensates for peripheral
resistance and in many cases keeps glucose concentrations normal for years.
Eventually, however, β-cell compensation becomes inadequate, and there is a
progression to overt diabetes with concomitant hyperglycemia. Why the β cells
cease to produce sufficient insulin is not known.
Pathogenic diversity and diagnostic uncertainty are some important problems
in conducting epidemiologic studies of diabetes mellitus. There are multiple
pathogenic mechanisms that are likely to play a role in the development of diabetes mellitus, including various genetic susceptibilities (as varied as autoimmunity
and obesity) and a variety of potential environmental and behavioral factors (such
as viruses, nutrition, and physical activity). Because in some populations up to
half of all cases of diabetes remain undiagnosed for an extended period of time,
the potential for ascertainment bias in population-based surveys is high, and
groups that are more intensively followed for signs and symptoms of diabetes
or those with more frequent health care contact, in general, are more likely to
be diagnosed in time to receive appropriate treatment; this points to the need for
formal standardized testing to detect cases in epidemiologic studies.
Metabolic syndrome is a cluster of at least three of the following—increased blood pressure or hypertension, insulin resistance, excess body fat
around the waist, and abnormal serum cholesterol or triglyceride levels—that
occur together, increasing the risk of heart disease, stroke, and diabetes. Although it is not a disease entity itself, metabolic syndrome is associated with a
five-fold increased risk of developing type 2 diabetes and a doubling of the risk
of developing CVD (Alberti et al., 2009). Swaminathan et al. (2015) found that
pesticide exposure was a contributing factor to hyperglycemia and type 2 diabetes
even after adjusting for body mass index (BMI). There is a growing literature on
the association between the COIs and metabolic syndrome and its components.
Given its strong linkage with type 2 diabetes, studies on metabolic syndrome will
be discussed in this section.
Conclusions from VAO and Previous Updates
The committee responsible for the first report in the VAO series (IOM, 1994)
concluded that there was inadequate or insufficient information to determine
whether there is an association between exposure to the COIs and diabetes mellitus. Additional information available to the committees responsible for Update
1996 (IOM, 1996) and Update 1998 (IOM, 1999) did not change that conclusion.
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In 1999, in response to a request from the Department of Veterans Affairs,
the Institute of Medicine convened a committee to conduct an interim review of
the scientific evidence regarding exposure to the COIs and type 2 diabetes. That
review focused on information published after the deliberations of the Update
1998 committee and resulted in the report Veterans and Agent Orange: Herbicide/
Dioxin Exposure and Type 2 Diabetes (IOM, 2000b). The committee responsible
for that report determined that there was limited or suggestive evidence of an
association between exposure to at least one COI and type 2 diabetes, based on
positive associations reported in several mortality studies (Pesatori et al., 1998;
Steenland et al., 1992, 1999; Vena et al., 1998), which may underestimate the
incidence of diabetes, and positive associations reported in most of the morbidity
studies (AFHS, 2000; Calvert et al., 1999; CDVA, 1998a,b; Cranmer et al., 2000;
Longnecker and Michalek, 2000; Michalek and Tripathi, 1999) reviewed by that
committee. However, that committee also noted that the studies indicate that the
increased risk, if any, from herbicide or dioxin exposure appeared to be small and
that the known predictors of diabetes risk—family history, physical inactivity,
and obesity—continued to greatly outweigh any suggested increased risk from
wartime exposure to herbicides. The committees responsible for updates since
that report have upheld that finding. Reviews of the considered studies are found
in the earlier reports.
Several epidemiologic studies have been published that examined type 2
diabetes in different populations of Vietnam veterans: Air Force Health Study
(AFHS), female U.S. Vietnam-era veterans, and Korean Vietnam veterans. Publications from the AFHS have found a statistically significant increased risk of
diabetes among the Ranch Hands (Henriksen et al., 1997; Kern et al., 2004;
Longnecker and Michalek, 2000; Michalek and Pavuk, 2008). Most analyses of
the Army Chemical Corps (ACC) veterans did not find increased risk of diabetes.
Using mortality data on U.S. women veterans, Kang et al. (2014a) found that
the adjusted relative risk of diabetes mortality was non-significantly lower for the
female veterans deployed to Vietnam than for their non-deployed counterparts,
and when the analysis was restricted to nurses only, the adjusted relative risk of
diabetes mortality was effectively the same for deployed and non-deployed nurses.
No statistically significantly increased risk of diabetes was found in several
studies of Australian Vietnam veterans. In an exceptionally large epidemiologic
study of Korean veterans who served in the Vietnam War, using data from the
Korea National Health Insurance Service, the risk of type 2 diabetes mellitus
was found to be nominally higher for those with a high potential for herbicide
exposure than for those with low–exposure opportunity index scores, and there
was a small, but statistically significant association for veterans with non-insulindependent diabetes mellitus (Yi et al., 2014a). In the mortality study of 180,639
Korean Vietnam veterans, Yi et al. (2014b) found that after adjustment, high
exposure (compared with low exposure) was not associated with mortality from
all forms of diabetes (ICD-10 E10–E14).
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Occupational studies of diabetes have found slightly elevated but generally not statistically significant associations between exposure to the phenoxy
herbicides or TCDD and a risk of diabetes. Results from the Agricultural Health
Study (AHS) found an increased risk of developing diabetes in the wives of pesticide applicators who themseleves had reported personally mixing or applying
pesticides or the ever use of 2,4,5-T or 2(2,4,5-trichlorophenoxy) propionic acid
(2,4,5-TP). Ever use of 2,4-D was much more prevelant, but it was not associated
with a risk of diabetes (Starling et al., 2014). No difference or decreased risk of
diabetes was found among the AHS pesticide applicators in both morbidity and
mortality studies.
Several studies of environmental exposures to the COIs and diabetes have
been reviewed in the VAO series. The findings are mixed, and the studies have
used different designs and methods for adjusting effect estimates for confounding.
Update of the Epidemiologic Literature
Two new studies of Vietnam veterans and diabetes have been identified since
Update 2014. Several occupational, environmental, and case-control studies of
diabetes and exposure to the COIs were also identified for this update. Table 41,
which can be found at www.nap.edu/catalog/25137, summarizes the results of
studies related to diabetes and related health outcomes.
Vietnam-Veteran Studies
Using data from the AFHS, Mazur et al. (2014) studied 991 Ranch Hands
and comparison veterans who completed all six medical examinations over the
20 years of data collection (1982, 1985, 1987, 1992, 1997, 2002) to see if low
testosterone is a risk factor for high fasting glucose and for a type 2 diabetes diagnosis. Subjects ranged from 32 to 68 years of age at the onset of the study. Fasting
glucose was tested in the morning for all men at each exam. Hemoglobin A1c
(HbA1c), which is indicative of blood glucose levels over the preceding 120 days,
was measured for all men in cycles 4 and 5. Among the men, gradual increases
in obesity, fasting glucose, and type 2 diabetes and a decline in mean testosterone levels occurred over the 20 years of study. The authors noted that men who
would not be diagnosed with type 2 diabetes until cycles 5 or 6 already showed
by cycle 1 that their mean fasting glucose was significantly higher than normal.
A statistically significant (p < 0.001) correlation was found between fasting glucose in all six cycles and both HbA1c in the fourth and fifth cycles and a diagnosis
of type 2 diabetes in any of the six cycles. Men who had high testosterone levels
and low BMI had a mean fasting glucose level of 100 mg/dl, whereas men with
a high BMI and low testosterone levels had a fasting glucose level of 116 mg/dl.
The multivariate analyses showed that testosterone was inversely related to
glucose, independently of BMI and age, but its effect on glucose was small. The
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study showed that levels of low testosterone were related to high fasting glucose,
independent of the participant’s age or obesity. Results also indicated that low
testosterone is a relatively poor predictor of a type 2 diabetes diagnosis. However,
this study is of limited value to this update because the results were not stratified
by exposure status (Ranch Hand versus comparison) and because serum concentrations of dioxin were not included in the analysis.
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to
identify prevalent health conditions in 2,783 male New Zealand veterans who
served in Vietnam. Age-specific hospitalization rates were calculated using the
total number of annual hospitalizations published by the Ministry of Health and
the average annual resident population. Standardized hospitalization rates and
99% confidence intervals (CIs) were calculated for the veteran cohort and the
general population and reported for diabetes and other outcomes. Although the
risk estimate was slightly elevated for diabetes (standardized hospitalization ratio
[SHR] = 1.14, 99% CI 0.90–1.38), it was not statistically significant compared
with the general population. However, diabetes is not usually a condition that
requires hospitalization, thus likely only those with the most severe disease were
identified, and the number of cases available for study would be expected to be
low, limiting the statistical power for this type of analysis considerably. Exposure
to the COIs was not validated through serum measurements, and the study did
not control for smoking or ethnicity or other potentially important risk factors.
Occupational Studies
Collins et al. (2016) added follow-up time for a retrospective cohort of 2,192
workers exposed to dioxins during trichlorophenol (TCP) and pentachlorophenol (PCP) production at a chemical manufacturing plant in Midland, Michigan.
Workers were compared to the U.S. population in order to calculate standardized
mortality ratios (SMRs), and work history records provided information about
the length of exposure. Serum samples used to measure levels of six types of
dioxins were collected from 431 TCP and PCP workers. Concentrations for each
dioxin congener were calculated based on the median concentration in the serum
samples and the known half-lives associated with each congener. Complete vital
status follow-up was achieved for the cohort, and there were 1,198 deaths during the entire study period (1979–2011). Compared with the standardized U.S.
population, no statistically significant difference in mortality for diabetes was
found for the TCP workers (n = 19; SMR = 0.92, 95% CI 0.55–1.43) or the PCP
workers (n = 9; SMR = 0.97, 95% CI 0.44–1.84). Among the combined 1,198
TCP and PCP workers, there were 28 deaths from diabetes (SMR = 0.97, 95%
CI 0.64–1.42). Additionally, there are other concerns with the diabetes outcome
in this analysis. First, mortality data for diabetes likely under-reports disease
prevalence because diabetes is often a contributing factor to but not the actual
cause of a death. Second, using the general U.S. population as the comparison
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is problematic because of the “healthy worker effect,” that is, some of the comparison subjects are not in the workforce and will typically have, on average,
poorer general health than individuals in the workforce. In this case, it would
imply a control group with rates of diabetes greater than those in the workforce.
In contrast, an internal comparison of workers with high- versus low-dioxin
concentrations, which was not presented by the authors, would have avoided this
type of selection bias.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of
workers who were employed at the New Plymouth, New Zealand, phenoxy herbicide production plant for at least 1 month between 1969 and 1984. The plant
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, intermediates of TCP and other chlorophenols, and TCDD. Workers had previously been
recruited and examined as part of the international cohort of producers of phenoxy herbicides led by the International Agency for Research on Cancer (IARC)
(Kogevinas et al., 1997); see Chapter 5 for more details on the IARC cohort and
the New Zealand phenoxy producers. This study extended the follow-up period of
these workers to approximately 30 years from the last 2,4,5-T production exposure. From the original cohort of 1,025 workers, 631 were living, had a current
address in New Zealand, and were below 80 years of age on January 1, 2006.
For the current follow-up, 430 of the 631 workers were randomly selected and
invited to participate in the morbidity survey, of which 245 (57%) participated.
The survey was administered in 2007–2008 by face-to-face interview, and it
collected information on demographic factors and health information, including
doctor-diagnosed conditions and the year of diagnosis. A blood sample was also
collected at that time and analyzed for TCDD, lipids, thyroid hormones, and other
parameters. For 111 participants, a neurological examination was conducted.
Associations between exposure and health outcomes were assessed using logistic
regression models that controlled for age, gender, smoking, BMI, and ethnicity
using two methods: working in a TCDD-exposed job (based on occupational
records) and serum TCDD concentration ≥ 10 pg/g lipid (18%). Mean TCDD
concentrations were 19 pg/g lipid in the 60 men directly involved in phenoxy/
TCP production and 6 pg/g lipid in the 141 men and 43 women who worked in
other parts of the plant. Compared with the people in the non-highly exposed
jobs, the people who had ever worked in a highly exposed job at the plant had an
elevated risk of doctor-diagnosed diabetes (n = 13; odds ratio [OR] = 3.98, 95%
CI 1.03–15.4), although the estimate was imprecise. When compared by serum
TCDD concentration, no difference in risk of diabetes was found for workers in
the high- versus low-exposure groups (n = 7; OR = 3.05, 95% CI 0.87–10.67),
although the estimate was again imprecise.
Cappelletti et al. (2016) performed a retrospective study of 331 male electric arc foundry workers at a single plant in Trentino, Italy, to determine if they
experienced excess mortality from all causes or were at increased risk for several
other diseases due to occupational exposures to foundry dust. An analysis of the
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dust emissions found that it contained metals (including iron, aluminum, zinc,
manganese, lead, chromium, nickel, cadmium, mercury, and arsenic), polycyclic
aromatic hydrocarbons (PAHs), PCBs, and polychlorinated dibenzo-p-dioxin/
dibenzofurans (PCDD/Fs) (reported as TEQs). Therefore, the authors could not
determine which of the agents were associated with a specific outcome or to what
extent. The men had worked at the factory for at least 1 year and, for the diabetes
analysis, were compared with 32 presumed non-exposed workers (clerks, managers, and watchmen) or the general population of Region Trentino-Alto Adige
(where the factory was located) because there were few non-exposed foundry
workers and high attrition rates. Company and medical records were used to
determine vital status; the cause of death was determined from death certificates
or other registries. Requests for exemption health care fees were used as a surrogate measure to identify the most prevalent morbid conditions in the general
population, which were then applied to the cohort to compute relative risks for
each of the conditions, which included diabetes. The workers were followed
from March 19, 1979 (or their first day of employment), through December 31,
2009, or date of death. The analysis for diabetes was limited to the 235 living
workers, and effect estimates (prevalence ratios) were calculated using MantelHaenszel estimator adjusted for age group (20–64, 65–74, ≥ 75 years). Compared
with the age-adjusted provincial population, a statistically significant increased
risk of diabetes was found among electric arc furnace workers (n = 25; relative
risk [RR] = 2.39, 95% CI 1.67–3.41). This study is most limited by the fact that
foundry dust is a complex mixture, resulting in an inability to discern the impact
of the specific contaminants of the foundry dust on the health outcomes of those
exposed workers. Estimates were adjusted only for age group and not for other
risk factors, such as tobacco use, BMI, or other jobs or activities that could result
in similar exposures. Possible exposure to foundry dust by the general population
that was used for comparison is not discussed, although the foundry appears to
be in the local vicinity, and emissions from it were reported to be present within
a 2-kilometer radius of it.
Yamamoto et al. (2015) performed a cross-sectional study to investigate the
health outcomes that 698 male workers sustained while employed at 36 municipal and private waste incineration plants in Japan; serum dioxin measurements
were obtained for 678 of the workers. These workers were employed from 2000
to 2007. First, a questionnaire was distributed to the participants to determine
their medical history. Blood samples were taken from each subject to evaluate
serum dioxin and PCB levels. Both clinical and physiological examinations were
also performed. Participants were then categorized into four groups: workers
whose jobs did not involve working directly in an incineration facility, workers
whose jobs did involve work inside the incineration facility (but only handling
solidified fly ash and slag or residues that were nonflammable), workers whose
jobs involved helping with incineration-related work inside an incineration facility, and workers whose jobs mainly involved operation and maintenance of an
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incinerator including a furnace, electric dust collector, and wet scrubber inside
an incineration facility. Subjects were tested for diabetes, hypertension, hyperlipidemia, and liver dysfunction. The total serum dioxin concentration level for
incinerator workers was 13.7 (median) or 17.2 (arithmetic mean) pg TEQ/g lipid,
while the (arithmetic mean) average total dioxin concentration was 19.4 pg TEQ/g
lipid for the general population in Japan, indicating no real difference between
the two groups. However, in the exposed workers, the duration of employment
was positively associated with TEQ levels (9.8 and 21.7 pg TEQ/g lipid for those
employed 9 years and 15.5 years, respectively). Coplanar PCBs were significantly
correlated (p < 0.05) with 14 parameters of laboratory and physiological tests.
Diabetes was statistically significantly associated with PCDDs, PCDFs, coplanar
PCBs, and total dioxins based on adjusted odds ratios between the first and fourth
quartile, and tests for trend were also significant for each of these COIs. Positive
associations were found between serum levels of total dioxins and the prevalence
of diabetes in the incinerator workers even though, as the healthy worker effect
would predict, the overall diabetes prevalence in the workers was not as high as
in the general Japanese population (6.6% versus 9.0%, p = 0.07).
Environmental Studies
Everett and Thompson (2016) measured three chlorinated dibenzo-p-dioxins,
one chlorinated dibenzofuran, and four dioxin-like PCBs in human blood and
assessed their cross-sectional associations with nephropathy, specifically diabetes-related nephropathy using data collected between 1999 and 2004 from the
National Health and Nutrition Examination Survey (NHANES). Two groups of
people were included: the teen and young adult sample (12–30 years old) and
the all-adult sample (≥ 20 years old). Nephropathy was defined as a urinary
albumin-to-creatinine ratio > 30 mg/g, representing both microalbuminuria and
macroalbuminuria. Diagnoses of diabetes were determined by individual, selfreported answers to the NHANES question: “Other than during pregnancy, have
you ever been told by a doctor or health professional that you have diabetes or
sugar diabetes?” Those who answered “borderline” were considered to not have
diabetes. Having undiagnosed diabetes was defined as participants who had A1c
levels ≥ 6.5% but had not been diagnosed as having diabetes. Total diabetes was
defined as either diagnosed or undiagnosed diabetes. Several differences were
noted between the teen/young adult and the all-adult samples. One or more of
the eight dioxin-like chemicals were elevated among 9.9% of the teen/young
adult sample (at-risk population) and among 53.5% of the all-adult sample. The
proportions for nephropathy and pre-diabetes were, respectively, 7.8% and 1.8%
in the teen/young adult sample versus 5.5% and 9.7% in the all-adult sample.
The unweighted number of people with nephropathy in the teen/young adult
sample was 87 females and 35 males. Only three people had pre-diabetes with
nephropathy in the teen/young adult sample, which was too few for analyses.
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None of the eight dioxin-like chemicals were associated with pre-diabetes, but in
most instances there were no cases of pre-diabetes in the elevated concentration
range. In the highest TEQ8 category, which included 2.6% of the sample, there
was a strong but very imprecisely estimated association with pre-diabetes among
females (OR = 11.9, 95% CI 1.6–87.2), but no associations with pre-diabetes at
any level of elevated TEQ8 in the entire sample.
Two reports from a study conducted by Aminov et al. (2016a,b) examined
diabetes among 601 people of the Mohawk Nation between the ages of 18 and
84 years living at Akwesasne, which spans New York, Ontario, and Québec. The
most detailed reporting of this data is found in Aminov et al. (2016a). Serum
samples were taken from the subjects to test for PCB and pesticide concentrations
as well as to determine each individual’s fasting glucose levels. A subject in this
study was considered to have diabetes if he or she had a fasting glucose concentration of > 125 mg/dL or if it was reported that a physician had made a diabetes
diagnosis. Several models were used to estimate risks. Model 1 adjusted for sex,
age, BMI, and serum lipid concentrations. In model 2, the total concentrations
of PCBs were adjusted for the variables in model 1 and also for total pesticides
(the sum of the concentrations of 101 PCB congeners, DDE, hexachlorobenzene
[HCB], and mirex). Multiple analyses were undertaken, and in the minimally
adjusted model 1, both total PCBs (highest quartile OR = 3.45, 95% CI 1.4–8.5)
and total pesticides (highest quartile OR = 3.12, 95% CI 1.12–8.65) showed
statistically significant associations with diabetes. These associations were attenuated in model 2, which adjusted for total pesticides, with total dioxin-like
PCBs estimates having an odds ratio that was elevated but did not reach statistical
significance (highest quartile OR = 1.82, 95% CI 0.61–5.40), while the total pesticides estimate (highest quartile OR = 5.01, 95% CI 1.76–14.24) was statistically
significantly elevated but quite imprecise. In model 3, PCB concentrations were
divided into three groups by numbers of chlorines (3–4, 5–6, and ≥ 7) and by
numbers of ortho-substitute chlorines and each pesticide was considered alone.
In addition to adjustment for sex, age, BMI, and total lipids, each result was
also adjusted for the concentrations of all other groups of contaminants. Results
using model 3 suggested a low-dose effect. In general, there was an association
between PCB exposure and diabetes, but this was reported to be mainly due to
low-chlorinated, non-dioxin-like congeners.
Grice et al. (2017) assessed the association of type 2 diabetes with persistent
organic pollutants (POPs), including dioxin-like PCBs (PCB 105, 118, 156, 157,
and 167) and HCB, using a nested case-control design from a relatively small
prospective study conducted in American Indians in Arizona. A sample of 100
men and 200 women who were at high risk of diabetes were enrolled between
1965 and 1974. Participants underwent a baseline examination that included a
blood draw and took an oral glucose tolerance test. The oral glucose test was
repeated at each follow-up. Levels of PCBs and pesticides in the serum samples
were assessed by CDC. Over 8 years of follow-up, 149 people developed diabetes
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(cases), and 151 remained non-diabetic (controls). Cases were followed from diabetes onset to end stage renal failure, death, or 2013. When models were adjusted
for age, sex, BMI, 2-hour postload plasma glucose concentration, sample water
loss, sample storage time, cholesterol, and triglycerides, the odds of diabetes
were statistically significantly decreased for HCB exposure (OR = 0.64, 95%
CI 0.41–0.99). In fully adjusted models, most dioxin-like PCBs were positively
associated with incident diabetes, but none was statistically significant: PCB 105
(OR = 1.14, 95% CI 0.81–1.60), PCB 118 (OR = 1.16, 95% CI 0.82–1.65), PCB
156 (OR = 1.06, 95% CI 0.73–1.53), PCB 157 (OR = 1.06, 95% CI 0.75–1.49),
and PCB 167 (OR = 1.11, 95% CI 0.80–1.55). This study is limited by the small
sample size and the fact that serum concentrations of COIs were measured only
once, yet the participants were followed for diabetes incidence for 8 years.
During 2007–2008, Singh and Chan (2017) conducted a cross-sectional
survey study of 33 Canadian Inuit coastal communities and three inland communities. The survey included questions about health status, chronic diseases, and
such behaviors as alcohol consumption, smoking, and exercise habits. Clinical
tests such as fasting glucose and blood levels of PCBs and organochlorine pesticides supplemented the survey. In total, 2,172 Inuit people aged 18 years or older
participated and provided blood samples. Of the PCB congeners measured in the
blood, the dioxin-like mono-ortho PCBs 105, 118, and 156 are of interest for the
committee’s charge. Associations of diabetes with individual PCB congeners,
the sum of dioxin-like PCBs, the sum of non-dioxin-like PCBs, and total PCBs
were determined. Of the 2,172 respondents, 147 (5.7%) self-reported diabetes,
with nearly the same proportions among males and females (5.5% and 5.8%,
respectively). As expected, the percentage of people with diabetes increased as
age increased (2.9% in the 31- to 50-year-old category and 22.1% in the 71- to
90-year-old category), and diabetes was clustered within families (either parent
having diabetes: 19.7% in diabetics versus 10.4% in non-diabetics; or having
a sibling with diabetes: 20.4% in diabetics versus 4.5% in non-diabetics). All
contaminant concentrations were higher in respondents with diabetes. The concentrations of congeners were divided into quartiles, and odds ratios—adjusted
for age, sex, BMI, high density lipoprotein-C, omega-3/omega-6 ratio, and education—were calculated for quartile 4 versus quartile 1 of self-reported diabetes.
Statistically significant (p < 0.05) positive ORs were found for PCB 105, PCB
118, and PCB 156 as well as for some of the non-dioxin-like PCBs. With lipid
adjustment, statistically significant positive ORs were found for dioxin-like PCB
118 and PCB 156 (information taken from graph; exact numbers not reported).
The study also reported fasting glucose β coefficients for PCB congeners that
were statistically significant based on lipid standardization or lipid adjustment;
the congeners included PCB 105 and PCB 118. These models were adjusted for
age, sex, BMI, high density lipoprotein-C, triglycerides, alcohol intake, smoking,
omega-3/omega-6 ratio, selenium, and education. The β coefficients for wetweight analyses were positive and were statistically significantly associated with
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an increase in fasting glucose for PCB 105 (6%, 95% CI 3%–9%) and PCB 118
(7%, 95% CI 4%–10%). The primary limitation of this study is its cross-sectional
design, but the half-lives of these two congeners are estimated at 4.5–5.5 years
(Grandjean et al., 2008), and the results of this study agree with other similar
studies that found positive associations between PCBs and diabetes in different
exposed populations.
Using data collected as part of cross-sectional health study of Taiwan residents living near a closed PCP-producing factory, C. Y. Huang et al. (2015)
conducted an analysis of exposure to PCDD/Fs in order to evaluate the association between such exposures and type 2 diabetes. More details on the factory, exposure, recruitment, and collection of health information are provided
in Chapter 5, but, briefly, the environmental contamination took place 25–40
years prior to the study. Of the 2,898 participants included in this analysis, 1,143
had a serum dioxin level between 20 and 63 pg WHO98-TEQDF/g lipid, which
was considered a “high dioxin level”; and 284 subjects had a dioxin level of
64 pg WHO98-TEQDF/g lipid or higher. Of the 2,898 participants included in this
analysis, 425 had diabetes, defined as having a fasting plasma glucose level above
126 mg/dL or an existing diagnosis. Subjects who had diabetes were compared
with those who did not have diabetes; these two groups were comparable with
regard to sex and reported family history of diabetes, but differed in age and BMI
(high BMI was defined as ≥ 24 kg/m2), factors that were controlled in analyses.
Serum dioxin levels of 20–63 pg WHO98-TEQDF/g were associated with statistically significantly increased odds of diabetes (OR = 4.4, 95% CI 3.4–5.7),
and the association was even stronger for serum dioxin levels above 64 pg
WHO98-TEQDF/g lipid (OR = 7.8, 95% CI 5.6–10.9). After adjusting for age
and BMI in multiple logistic regression models, high dioxin levels of 20–63 pg
WHO98-TEQDF/g lipid (OR = 2.1, 95% CI 1.5–2.8) and ≥ 64 pg WHO98TEQDF/g lipid (OR = 2.7, 95% CI 1.9–4.0) were found to increase the risk for
diabetes. When the dioxin level was included as quartiles in the model, adjusted
ORs remained elevated and statistically significant, with a statistically significant
and steep upward trend (p < 0.001). Additional analyses replaced age with the
duration of residency in the endemic area in the model, and after adjustment for
the duration of residency and BMI, a high dioxin level of 20–63 pg WHO98TEQDF/g lipid (OR = 2.2, 95% CI 1.6–3.0) and ≥ 64 pg WHO98-TEQDF/g lipid
(OR = 3.6, 95% CI 2.4–5.4) remained strongly associated with risk of diabetes.
The duration of residency in the endemic area was also an independent risk factor
for diabetes, with a positive trend (p = 0.01). The strengths of this study include
its large population (including a substantial proportion with diabetes, n = 425,
the largest number of cases in studies newly reviewed in this volume); serum
measurements of dioxin concentration; adjustments for age, BMI and residency;
and a clear definition of diabetes and control groups. General limitations for this
study and all studies that used the cross-sectional data collected from this population include an unknown age at first exposure to PCDDs and PCDFs, unknown
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cumulative exposure dose, the cross-sectional design, and the lack of additional
data on other potentional confounders, such as waist circumference, dietary
intake, and socioeconomic status.
Van Larebeke et al. (2015) describes how dioxin-like activity and serum
HCB affected the risk of diabetes in both men and women (n = 1,583; 775 men
and 808 women) enrolled by biomonitoring programs organized by the Flemish
Centre for Environment and Health. Associations were based on self-reported
health outcomes obtained in questionnaires administered in 2011. Blood and
urine samples provided measures of internal exposure to organochlorine pollutants, PCB 118, and cadmium; samples had been collected from these subjects
between September 2004 and June 2005. The researchers also assessed dioxinlike activity in pg TEQ/g fat. Among the participants, 30 men reported having
diabetes (6.4%), and 62 men (13.2%) reported having either diabetes or a related
condition; while 29 (5.8%) women reported having diabetes, and 55 (10.9%)
women reported having diabetes or a related condition. A significant association
(p ≤ 0.05) was found between internal exposure to the above mentioned pollutants
and diabetes or a related condition when both men and women were combined;
however, when the estimates were adjusted for additional covariates and stratified
by sex, serum dioxin-like activity showed a significantly positive association with
diabetes and with diabetes or a related condition for men and women separately.
Results from this study suggest that exposure to dioxin-like chemicals increases
the risk of diabetes or a related condition.
Other Identified Studies
Two other studies of diabetes were identified but either lacked exposure
specificity (Swaminathan and Thangavel, 2015) or examined the association of
diet in diabetics on serum levels of persistent organic pollutants (Kahleova et al.,
2016), which is not considered relevant to the committee’s charge.
Biologic Plausibility
Data from cell culture and animal models support the potential diabetogenic
effects of TCDD in humans. TCDD is known to modify the expression of genes
related to insulin transport and signaling and to inflammation (Ambolet-Camoit et
al., 2015; M. J. Kim et al., 2012), which play a pivortal role in diabetes progression. In previous VAO updates, several studies have been reviewed that support
the postulate that TCDD is mechanistically implicated in an increased risk of
insulin resistance and in the development of diabetes. C. Wang et al. (2011) found
that mice that lacked the aryl hydrocarbon receptor (Ahr) had enhanced insulin
sensitivity and enhanced glucose tolerance, suggesting that Ahr has a physiologic
function in glucose metabolism. This is supported by studies that found that
sustained activation of Ahr by dioxin-like chemicals could contribute to diabetes,
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including a study by Kurita et al. (2009), who found that exposing mice to dioxin
significantly reduced insulin secretion after a glucose challenge. Recent data also
demonstrate the importance of Ahr in glucose and fat metabolism, showing that
the chemical inhibition of Ahr leads to decreased obesity and fatty livers in both
male and female mice (Moyer et al., 2017). In an in vitro study of differentiated
adipocytes, TCDD was found to significantly reduce insulin-stimulated glucose
uptake (Hsu et al., 2010). Furthermore, P. Lu et al. (2015) found that activation
of the AHR leads to dysregulation of the link between fatty liver and insulin resistance, suggesting a mechanism involving fibroblast growth factor 21. A recent
study used a transcriptomic approach to identify potential molecular mechanisms
of TCDD-induced changes in the insulin secretion of pancreatic islets and β cells
(Lai et al., 2017). Taken together, these data provide potential mechanims for the
metabolic-modulating effects of AHR and dioxins that are critical for the progreassion of metabolic diseases, including diabetes.
Among the studies included in the current literature review, K. S. Kim et
al. (2014) explored the relationships of diabetes and insulin resistance with 14
organochlorine insecticides and 22 PCBs in visceral adipose tissue and subcutaneous adipose tissue in 50 patients with or without type 2 diabetes who underwent
surgery for either cancer or benign liver or gallbladder lesions. The researchers
reported that persistent organic pollutants in visceral or subcutaneous fat were
significantly associated with both diabetes and insulin resistance. These findings
are consistent with experimental animal studies that have reported that exposure
to persistent organic pollutan mixtures through contaminated fish oil induces a
severe impairment of whole-body insulin action (e.g., Ibrahim et al., 2011). Thus,
on balance, there is biological plausibility for the COIs being causally implicated
in the development of insulin resistance and diabetes. No new content has been
identified since Update 2014.
Synthesis
The considerable amount of new evidence regarding type 2 diabetes reviewed
and considered by the committee in forming its judgment included studies on
male Vietnam veterans from the United States and New Zealand and studies of
occupational cohorts and residential population-based studies of exposure. The
analysis of AFHS data on testosterone levels and incident diabetes was considered to be of limited value to the committee’s charge because the results were not
stratified by exposure status and because serum concentrations of dioxin were not
included in the analysis (Mazur et al., 2014). Cox et al. (2015) calculated annual
rates of hospital discharge records for New Zealand Vietnam veterans (presumed
to be exposed to herbicides based on deployment to Vietnam) compared with
the general residential population of New Zealand. Although slightly elevated
among the veterans, the standardized hospitalization ratio for diabetes was not
statistically significant. However, because diabetes is not usually a condition that
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requires hospitalization, it is likely that only those with the most severe form
of the disease were identified, and the prevalence of diabetes is expected to be
higher. Moreover, this analysis is limited because exposure was not confirmed
through serum measurements, and hospitalization estimates were adjusted only
for age and not for other important risk factors, such as BMI or ethnicity.
The four occupational studies that were examined presented mixed results
concerning an association between exposure to the COIs and diabetes mortality
or prevalence. Among U.S. workers who were exposed to dioxins through the
manufacturing of TCP or PCP, no difference in the rate of death from diabetes
was found between either group of workers and the general U.S. population
(Collins et al., 2016). Although serum dioxin measurements were collected,
no results based on those measurements were presented for diabetes; instead
the authors used employment records to categorize exposure, which may have
introduced exposure misclassification, and use of the general U.S. population
as a comparison likely introduced selection bias. Moreover, mortality is a poor
measure of diabetes prevalence since while diabetes is often a contributing factor,
it is not the actual cause of death and so may not be listed on the death certificate. Three international cohorts of workers examined the prevalence of diabetes.
New Zealand workers who were employed in a phenoxy herbicide production
plant that produced 2,4,5-T were also potentially exposed to the intermediates
of TCP and other chlorophenols, and TCDD. 't Mannetje et al. (2018) extended
the follow-up period of the 245 men and women in this cohort to approximately
30 years from their last 2,4,5-T production exposure. Comparisons of workers
by job title (high- versus low-exposure jobs) found that workers with highly
exposed jobs had an elevated risk of doctor-diagnosed diabetes after controlling for age, gender, smoking, BMI, and ethnicity, but when the comparison of
diabetes prevalence was based on serum TCDD concentration, no difference
in the risk of diabetes was found for workers in the high- versus low-exposure
groups, although both of the estimates were imprecise. A cross-sectional study
of Japanese incinerator plant workers that included serum dioxin measurements
found that the duration of employment was positively associated with TEQ levels
(Yamamoto et al., 2015). Diabetes was statistically significantly associated with
PCDDs, PCDFs, coplanar PCBs, and total dioxins based on adjusted odds ratios
between the first and fourth quartile, and tests for trend were also significant
for each of these COIs. Finally, among 235 Italian electric arc furnace workers
exposed to multiple agents including metals and PCDD/Fs, PAHs, and PCBs,
as sampled in the foundry dust, the prevalence of diabetes among the workers
was statistically significantly increased compared with the general population;
however, this study is quite limited because foundry dust is a complex mixture,
and the authors were unable to discern the impact of the specific contaminants
of the foundry dust on the health outcomes of those exposed workers. Estimates
were adjusted only for age group and were not adjusted for other risk factors or
activities that could affect the association (similar to Cox et al., 2015). It is likely
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that many of the occupationally exposed study populations received co-exposures
to metals and chemicals other than those that the committee was charged with
specifically reviewing. Co-exposure to metals is a possible confounder that may
affect the estimates and associations reported in those studies but none of them
attempted to adjust for this factor.
Several studies that examined environmental exposures to the COIs or related
chemicals were also reviewed. Four of the studies used U.S. populations. An
analysis of NHANES data that examined serum concentrations of three chlorinated dibenzo-p-dioxins, one chlorinated dibenzofuran, and four dioxin-like PCBs
and diabetes-related nephropathy found that none of the eight dioxin-like chemicals were associated with pre-diabetes (Everett and Thompson, 2016). Two other
studies, both of U.S. American Indian populations, were examined for diabetes
prevalence (Aminov et al., 2016a,b) and incidence (Grice et al. 2017) with exposure to the COIs. Aminov et al. (2016a,b) found an association between pesticide
(including HCB, a dioxin-like chemical) and PCB exposures and diabetes among
a sample of people from the Mohowk Nation; however, analyses of individual
dioxin-like chemcials or congeners were not presented. In a study of American
Indian men and women in Arizona, Grice et al. (2017) examined incident type 2
diabetes with a one-time baseline measurement of serum concentrations of POPs,
including dioxin-like PCBs and HCB, and found that the adjusted odds of diabetes
were statistically significantly decreased for HCB exposure and that none of the
measured dioxin-like PCBs were statistically significantly associated with incident
diabetes.
Three international studies of environmental exposures to the COIs and
diabetes were reviewed for the current volume. The largest study of diabetes
reviewed in this volume was a population-based study of diabetes using residents living in close proximity to a closed PCP-producing factory in Taiwan that
had contributed to a high dioxin (PCDD/Fs) contamination of the environment
between 1965 and 1979 (C. Y. Huang et al., 2015). Blood samples and health
information were collected on 2,898 residents in 2005–2007; 1,143 participants
had dioxin levels between 20 and 63 pg WHO98-TEQDF/g, and 284 subjects
had a dioxin level of 64 pg WHO98-TEQDF/g lipid or higher (considered to be
the high-exposure groups). Serum dioxin levels of 20–63pg WHO98-TEQDF/g
were associated with statistically significantly increased odds of diabetes in both
crude and adjusted models (adjusted for age, BMI, and years of residence in
the contaminated area), and the association was even stronger for serum dioxin
levels above 64 pg WHO98-TEQDF/g lipid. When the dioxin level was analyzed
in terms of quartiles in the model, the adjusted estimates remained elevated and
statistically significant, with a statistically significant and steep upward trend
(p < 0.001). In a cross-sectional survey of health outcomes that included a
blood draw to measure the serum concentrations of PCBs (including dioxin-like
mono-ortho congeners 105, 118, and 156) and organochlorine pesticides in 2,172
Canadian Inuits aged 18 years and older, 147 respondents self-reported diabetes
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(Singh et al., 2017). All contaminant concentrations were higher in respondents
with diabetes. The concentrations of congeners were divided into quartiles, and
the adjusted odds ratios for diabetes were found to be statistically significant for
quartile 4 versus quartile 1 for PCB 105, PCB 118, and PCB 156. In the third
international environmental study, Van Larebeke et al. (2015) conducted a general
population study in Beligium and described how dioxin-like activity and serum
HCB affected the risk of diabetes in both men and women. They assessed dioxinlike activity in pg TEQ/g fat and found a statistically significant association for
both sexes between internal exposure to the COIs as well as dioxin-like activity
in pg TEQ/g fat and diabetes or a related condition.
Several lines of toxicologic evidence support mechanisms by which dioxins
and dioxin-like chemicals could increase risk for diabetes. First, these chemicals
modify the expression of genes related to insulin transport and signaling and
to inflammation (Ambolet-Camoit et al., 2015; Kim et al., 2012). Studies in
Ahr knockout mice demonstrate increased insulin resistance and glucose tolerance (J. Wang et al., 2011), findings that are consistent with an experiment that
found dioxin-exposed mice to have significantly reduced insulin secretion after
a glucose challenge (Kurita et al., 2009). More recently, Lai et al. (2017) used
a transcriptomic approach to identify the potential molecular mechanisms of
TCDD-induced changes in the insulin secretion of pancreatic islets and β cells.
In the aggregate, the epidemiologic studies provide new evidence supporting
the previously observed associations between dioxins or dioxin-like PCBs and increased risk for type 2 diabetes. Although some studies had substantial limitations
or weaknesses, the Taiwanese study was large and demonstrated that even after
adjustment for the factors associated with diabetes in their study, the odds ratios
for dioxin-like chemicals equivalents had a strong monotonic trend for higher
risk. The committee was divided on whether the newly reviewed studies were
adequate to move the level of evidence of association of the COIs and diabetes
to sufficient versus leaving the conclusion as limited or suggestive.
Conclusion
Following extensive deliberations regarding the strengths and weaknesses of
the new evidence and evidence from studies reviewed in previous VAO reports,
the current committee could not reach a consensus on whether the body of literature continues to constitute limited or suggestive evidence of an association
between exposure to the COIs and diabetes or whether it now meets the criteria,
shown below, for sufficient evidence of an association:
Epidemiologic evidence is sufficient to conclude that there is a positive association. That is, a positive association has been observed between exposure to herbicides and the outcome in studies in which chance, bias, and confounding could
be ruled out with reasonable confidence. For example, if several small studies
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that are free of bias and confounding show an association that is consistent in
magnitude and direction, then there could be sufficient evidence of an association.

Studies quite consistently show a relationship between exposure to dioxin
and dioxin-like chemicals, characterized via serum levels, occupation, or subject
self-report, and measures of diabetes health outcomes. These studies include
multiple, independent studies of Vietnam veteran populations as well as studies
of diverse cohorts of men and women with occupational or environmental exposure to the COIs. Much is known about the risk factors for diabetes, such as age,
obesity, and family history, and these have by and large been controlled for in the
analyses of most studies reviewed. The studies of Ranch Hand veterans reviewed
by previous committees and the Taiwan study examined by this committee demonstrate strong dose–response trends and excellent control for confounding. The
disease is, unfortunately, common enough that it has been feasible for a number
of investigators to conduct epidemiological investigations in worker or general
populations with sufficient statistical power to allow for conclusions to be drawn
from the results. Importantly, there is a separate scientific literature that has
identified candidate biologic mechanisms that would account for the observed
health outcomes in humans.
However, the human evidence base also has its weaknesses. Although positive associations have been observed, some of the relative risks reported are low.
A number of studies examined cohorts exposed to mixtures of both dioxin and
dioxin-like chemicals and, importantly, a number of other chemicals that could
plausibly influence diabetes outcomes. This lack of exposure specificity complicates any attribution of the outcome to the COIs. While most studies adjusted
for the primary risk factors for diabetes, several investigations relied on selfreported information that might affect the development of the disease, rendering
any adjustment for confounders possibly less effective. The studies of diabetes
mortality are of limited utility because death from diabetes, either as a primary
or a contributing cause, is underdiagnosed, which could introduce bias. Finally,
some committee members felt that it is not yet possible to dismiss the notion that
an as yet unidentified systematic bias, including confounding, may be influencing
the observed results.
Given these observations, it was not clear to all committee members that a
category change was appropriate. Thus, the committee was unable to reach consensus as to whether the evidence regarding exposure to the COIs and diabetes
should be classified as “limited or suggestive” or “sufficient.”
CIRCULATORY DISORDERS
Circulatory diseases are a group of diverse conditions, of which hypertension, coronary heart disease, and stroke are the most prevalent. CDC reports that
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the number one cause of death for people 65 years of age and older is diseases of
the heart. In the United States, 28.4 million adults (11.7% of the population) have
a physician-diagnosed heart disease. American Indian and Alaska Natives have
the highest incidence of heart disease, estimated at 13.7%, followed by whites
with 11.3% and blacks with 9.5% (CDC, n.d.).
In 2016 more than 630,000 people died as a result of diseases of the heart,
and more than 140,000 people died as a result of cerebrovascular disease and
stroke (CDC, 2016). In addition to family history, the major risk factors for circulatory diseases include age, male gender, smoking, hyperlipidemia, diabetes,
and hypertension (World Heart Federation, 2018). Ideally, epidemiologic investigations of circulatory diseases would consider the conditions in this category
separately rather than as a group because they all have different patterns of
occurrence, and many have different etiologies. However, many mortality studies
follow the ICD-9 rubric and report deaths from circulatory diseases together as
a single category. Deaths from coronary or ischemic heart disease (IHD), heart
failure, and, to a lesser extent, stroke predominate. Many of the reports also
break out subcategories such as cerebrovascular disease and hypertension. The
American Heart Association reports mortality related to coronary heart disease,
not to its symptoms, which include angina and myocardial infarction. The relative
importance of heart failure is determined by the age of the cohort. In younger age
groups, most of the deaths in this category are expected to be from IHD. In most
cases, cerebrovascular deaths are deaths from strokes, which can be classified
as either ischemic or hemorrhagic. In the U.S. population, the great majority of
strokes are of the ischemic type.
The methods used in morbidity studies of circulatory diseases may involve
a direct assessment of the circulatory system, including an analysis of symptoms
or history, a physical examination of the heart and peripheral arteries, ultrasound measurements of the heart and arteries, electrocardiography (ECG), chest
radiography, cardiac computed tomography (CT), and, more recently, cardiac
magnetic resonance imaging (MRI). Carotid ultrasound, echocardiogram, CT,
MRI, and nuclear medicine studies can be used to visualize the heart and related
vasculature directly as well as to assess function. ECG can be used to detect heart
conditions and abnormalities, such as arrhythmias (abnormal heart rhythms),
heart enlargement, and ischemia (acute or past myocardial infarctions). Chest
radiography can be used to assess the consequences of IHD and hypertension,
such as the enlargement of the heart often seen in heart failure. It is sometimes
difficult to determine the time of onset of clinical findings, making the temporal
relationship between exposure and disease occurrence uncertain. Although the
ideal way to study cardiovascular outcomes would be to prospectively following a well-characterized cohort and monitor for the incidence of discrete clinical
events, researchers often must rely instead on medical records (which may or
may not have all CVD-related information and outcomes) or death certificates
(which may list nonspecific causes of death [e.g., respiratory arrest] and may not
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contain all comorbid or contributing factors of death). New-onset angina or the
performance of a revascularization procedure in a person who has no history of
disease is also used as evidence of incident disease.
The committee responsible for Update 2006 began evaluating hypertension
separately from other circulatory diseases, and the committee responsible for
Update 2008 began the practice of evaluating IHD separately from other cardiovascular outcomes. Beginning in Update 2012, stroke and cerebrovascular
disease were also considered separately from discussions of “other circulatory
diseases.” The current committee has continued the practice of evaluating the
literature related to these outcomes as independent subsections.
A number of studies of different populations that received potentially relevant exposures were identified in the literature search, but the studies did not
characterize exposure with sufficient specificity for their results to meet the committee’s criteria for inclusion in the evidentiary database (see Chapter 3), and they
are only briefly mentioned under the heading of “Other Identified Studies.” For
instance, this rubric would apply to the occupational study conducted by Ruder et
al. (2014) in which 24,865 eligible workers from capacitor manufacturing, repair,
and maintenance sites in the United States were exposed to arochlor 1254, 1242,
and 1016, among others (mixed PCBs), and the authors sought to examine the
relationship between PCB exposure and different causes of mortality. However,
the study did not name specific dioxin-like PCBs, and no TEQs or other quantification of relevant exposures was presented. Likewise, Ljunggren et al. (2014)
assessed serum concentrations of dioxin-like chemicals in patients diagnosed
with CVD but did not define how this determination was made, and therefore the
work is of little utility to the commmittee.
Table 42, which can be found at www.nap.edu/catalog/25137, summarizes
the results of studies related to circulatory disorders.
Biologic Plausibility
Studies have demonstrated that both the vasculature and the adipose tissue
are targets of TCDD toxicity, and these studies have provided a mechanistic
understanding of how TCDD exposure increases the risk of circulatory diseases,
such as hypertension, IHD, and stroke. Exposing cultured endothelial cells or
cultured adipocytes to TCDD induces major changes in gene expression and leads
to substantial increases in oxidative stress and inflammatory markers (Andersson
et al., 2011; S. G. Han et al., 2012; Ishimura et al., 2009; Kerley-Hamilton et al.,
2012a; M. J. Kim et al., 2012; Kopf and Walker, 2010; Majkova et al., 2009;
Puga et al., 2004; Qin et al., 2015; Zhou et al., 2017). Studies also indicate that
the exposure of cultured endothelial cells to TCDD results in the down-regulation
of genes involved in blood pressure regulation and the up-regulation of genes involved in the myocardial infarction pathways (Qin et al., 2015) and can promote
endothelial cell apoptosis (Q. Liu et al., 2017). In animal models, developmental
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exposure to TCDD has been shown to cause structural, molecular and functional
cardiac abnormalities, and altered heart physiology in mouse embryos and to
predispose adults to cardiac disease (Carreira et al., 2015). Furthermore, the
loss of AHR, as happens in Ahr knockout mice, is associated with decreases
in blood pressure (modeling hypotension), while sustained activation of AHR
resulting from dioxin exposure leads to increases in blood pressure (Agbor et
al., 2011). N. Zhang et al. (2010) showed that the genetic loss of AHR from all
tissues or solely from endothelial cells results in hypotension. In contrast, Kopf
et al. (2010) demonstrated that the chronic exposure of mice to TCDD induces
hypertension that is associated with significant increases in vascular oxidative
stress and decreases in vascular relaxation. Those changes in vascular function
and blood pressure could be mediated in part by increases in the metabolism of
arachidonic acid to vasoconstrictive and inflammatory eicosanoids (Bui et al.,
2012; Diani-Moore et al., 2014). Studies have also demonstrated that exposure
to AHR agonists, including TCDD and benzo[a]pyrene, increases the incidence,
severity, and progression of atherosclerosis, a primary cause of IHD and stroke
(Dalton et al., 2001; Kerley-Hamilton et al., 2012a; D. Wu et al., 2011). Furthermore, D. Wu et al. (2011) demonstrated that TCDD mediates those effects in part
by increasing vascular inflammation, a finding that is suppored by a recent study
in chick embryos showing that TCDD-cardiotoxicity is eliminated with exposure
to a COX-2 inhibitor (Fujisawa et al., 2014). Another study in human coronary
artery smooth muscle cells indicates that the AHR pathway can cooperate with
the Tcf21 pathway to initiate the expression of pro-inflammatory genes (J. B. Kim
et al., 2017). In addition to the vasculature, studies also suggest that the heart is
a target of TCDD. TCDD exposure increases the hypertrophy of rat cardiac cells
in culture (Zordoky and El-Kadi, 2010) and impairs the differentiation of mouse
embryonic stem cells into cardiomyocytes (Neri et al., 2011).
In addition to the direct effects of TCDD on the vasculature and heart, there
is evidence that TCDD influences other CVD risk factors, for example, by promoting obesity (Brulport et al., 2017; Kerley-Hamilton et al., 2012b), accumulating macrophage lipid, inducing lipid mobilization, and altering lipid metabolism.
Thus, on the basis of animal models, there appear to be several overlapping and
potentially contributing pathways that link TCDD exposure and increased CVD
risk.
Arsenic exposure has also been linked to heart effects in a study examining
the relationship between the expression of AHR and CYP1A1 in humans exposed
to arsenic in drinking water. Data from this study indicate that arsenic exposure
was associated with an increased expression of AHR and CYP1A1 in the blood
and that increased CYP1A1 was associated with a prolonged corrected QT interval following long-term exposure to arsenic (Cui et al., 2016).
Long-term exposure to oxidative stress is suspected to be etiologic to many
chronic diseases, including CVDs. A variety of data, some discussed above,
demonstrates a link between TCDD exposure and oxidative stress (reviewed in
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Mohsenzadeh et al., 2018). A recent small study by Lerro et al. (2017) indicates
a link between 2,4-D and biologic markers of oxidative stress in 30 farmers
who participated in the AHS and who applied pesticides occupationally and in
10 non-farming controls who did not apply pesticicides; all were non-smoking
men ages 40–60 years. Multivariate linear mixed-effect models for repeated
measures were used for each pesticide–oxidative stress marker combination,
and all estimates were adjusted for age, farmer or control subject, study time
point, and creatinine to account for pesticide metabolites and oxidative stress
markers in urine. Other confounders included were BMI, smoking history
and duration, alcohol use, regular physical activity, multivitamin or vitamin C
supplementation, infection or symptoms at sample collection, allergy symptoms
at sample collection, and history of cancer. Farmers had significantly higher
urinary 2,4-D levels compared with controls, and this was associated with
elevated levels of 8-OHdG, a marker of oxidative stress (β = 0.066, 95% CI
0.008–0.124), and 8-isoPGF, a product of lipoprotein peroxidation (β = 0.088,
95% CI 0.004–0.172). Thus, this study provides one route to plausibility for
the 2,4-D association with cardiovascular outcomes, although studies will need
to be specifically conducted in individuals with known clinical endpoints (e.g.,
hypertension) in order to implicate this mechanism directly.
Hypertension
Hypertension, typically defined as blood pressure above 140/90 mmHg,
affects more than 70 million adult Americans and is a major risk factor for coronary
heart disease, myocardial infarction, stroke, and heart and renal failure. The major
quantifiable risk factors for hypertension are well established and include family
history, age, sex, race, obesity, reduced nephron number, high dietary salt intake,
tobacco use, excessive alcohol intake, and physical inactivity (CDC, 2014b). The
strongest conclusions regarding a potential increase in the incidence of hypertension come from studies that have controlled for these risk factors. CDC estimates
that in the United States, 64% of men and 69% of women ages 65–74 years have
hypertension. When stratified by race/ethnicity and sex, the prevalence of diagnosed hypertension is highest among African American men and women (43.0%
and 45.7%, respectively), followed by white men and women (33.9% and 31.3%,
respectively). For the groups reported, hypertension is lowest among Mexican
Americans (27.8% for men and 28.9% for women) (CDC, 2018).
Conclusions from VAO and Previous Updates
The committee responsible for Update 2006 first concluded that the available evidence placed hypertension in the limited or suggestive category, based
primarily on consistent evidence from several studies of Vietnam veterans that
used measured serum concentration of dioxin. Additional evidence reviewed
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in Update 2008, Update 2010, Update 2012, and Update 2014 reaffirmed this
conclusion.
Several studies of hypertension among Vietnam veterans have been reviewed
in the VAO series. These have included well-designed studies of incidence, prevalence, or mortality in the U.S. ACC (Cypel and Kang, 2010; Kang et al., 2006)
and the AFHS (AFHS, 1995, 2000, 2005) cohorts that have consistently reported
increased hypertension with increasing levels of serum dioxin. Other studies of
U.S. Vietnam veterans that did not use serum dioxin concentrations as markers of
exposure also reported an increased prevalence of hypertension associated with
presumed exposure to herbicides.
Among international cohorts of Vietnam veterans, the prevalence of and
mortality due to hypertension have been assessed among Australians and South
Koreans. A statistically significant increased prevalence was found among the
Australian veterans compared with standardized population controls. Two prevalence studies of hypertension among the Korean Vietnam veteran cohort did not
find an increased prevalence of hypertension (Yi, 2013; Yi et al., 2014a), but the
studies were limited because they do not include veterans who died or relocated
between their Vietnam service and the start of the investigation. Thus, the validity
of the calculated exposure–outcome relationship is based on the strong assumption that the observed relationships in those included are similar to those who
were not included, which is doubtful. In some cases, 40% of the relevant data for
the population are missing. In addition, the determination of hypertension was
either by self-report or through health insurance claims. It cannot be certain that
all participants with hypertension were detected because no standardized blood
pressure assessment was done.
Mortality studies that report hypertension are rarely informative because
hypertension is so prevalent in the adult population and many more people die
with hypertension than from hypertension. For those with hypertension listed
as the cause or a contributing cause of death, it is uncertain how representative
those who died from hypertension are of all people who may have developed it.
Several mortality studies that included hypertension have been reviewed by VAO
committees, but they have shown inconsistent findings, likely because they suffer
from the limitations listed above as well as from a lack of adjustment for many
important confounding factors. A decreased, but not statistically significant, risk
of mortality from hypertension was found in the study of U.S. women veterans
as well as when the population was limited to nurses only (Kang et al., 2014a),
whereas a slight, but again, not statistically significant, increase was reported
among Korean veterans (Yi et al., 2014b).
The studies of occupational cohorts reviewed by previous VAO update committees rarely reported hypertension as a discrete outcome; among those that
did, the results were mixed, with reports of both increased and decreased risk,
but none of the risk estimates were statistically significant. Several studies did
not define hypertension, therefore making it difficult to draw conclusions on its
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association with the COIs. Similar mixed and not statistically significant findings
were reported for the environmental studies that have been reviewed.
Update of the Epidemiologic Literature
Six new studies of exposure to the COIs and hypertension have been published since Update 2014.
Vietnam-Veteran Studies Cypel et al. (2016) analyzed the results of a 2013
survey of 3,086 (80.3% response rate) ACC veterans that compared outcomes
in both Vietnam-deployed (n = 1,477) and non-Vietnam-deployed (n = 1,609)
herbicide sprayers and non-sprayers. Eligibility for the ACC cohort was restricted
to men who had a minimum of 18 months of active U.S. Army service from July
4, 1965, to March 28, 1973, and who were alive in October 2011 and whose
health allowed them to participate. ACC veterans were specifically involved in
chemical operations in Vietnam and were directly exposed to herbicides and other
chemicals, including tear gas and napalm (see description of the ACC veterans
in Chapter 5). Participants self-reported physician-diagnosed hypertension, but
the diagnosis was evaluated and confirmed by blood pressure measurements
taken by trained medical technicians and by medical record reviews for a subset of 468 individuals. Overall agreement between the medical records review
and self-reported hypertension was 89%. Additionally, individual exposure to
herbicides was collected by self-report to questions of mixing, handling, and
spraying herbicides while in the military and was verified by using measured
serum TCDD levels for a subset of 636 individuals who had participated in an
earlier health survey of the cohort (1999–2000) and who had had blood drawn
and serum TCDD (ppt or pg/g lipid) measurements made at that time. A history
of herbicide spraying was much higher among the Vietnam-deployed (62.0%)
than non-Vietnam-deployed veterans (28.0%) (p < 0.0001). A greater percentage
of Vietnam-deployed veterans were current or former smokers (72.3%) than nonVietnam-deployed veterans (64.0%) (p < 0.0001). Hypertension was highest in
Vietnam-deployed sprayers (81.6%), followed by non-Vietnam-deployed sprayers
(77.4%), Vietnam-deployed non-sprayers (72.2%), and non-Vietnam-deployed
non-sprayers (64.6%). Overall, self-reported hypertension was found in 78.0% of
all participants who served in Vietnam and in 68.2% of all participants who did
not deploy to Vietnam, indicating a possible effect of Vietnam tour of duty over
and above exposure to herbicides. To demonstrate a dose–response relationship,
the authors showed that the mean serum TCDD levels were significantly higher
among Vietnam herbicide sprayers (mean = 3.5 ppt, range: 0.5–30.6) than among
Vietnam non-sprayers (mean = 2.5 ppt, range: 0.7–17.7) (p < 0.0001), but no
differences in mean TCDD level were observed between non-Vietnam-deployed
sprayers (mean = 2.4 ppt, range: 0.7–9.6) and non-sprayers (mean = 2.2 ppt,
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range: 0.4–12.5) (p = 0.69). Using logistic regression and adjusting for Vietnam
service status, rank, age at the time of the survey, tobacco use, alcohol use, race,
and BMI, having sprayed herbicides (OR = 1.74, 95% CI 1.44–2.11) and having
deployed to Vietnam (OR = 1.26, 95% CI 1.05–1.53) were both strongly associated with self-reported hypertension. The association was strongest when
comparing Vietnam-deployed sprayers to non-Vietnam-deployed non-sprayers
(OR = 2.21, 95% CI 1.76–2.77). Finally, among Vietnam-deployed veterans, a
significantly elevated association between the odds of hypertension for sprayers
and non-sprayers remained after an adjustment was made for potential confounders (OR = 1.77, 95% CI 1.35–2.30). Similarly, for those veterans who did not
deploy to Vietnam, self-reported hypertension was significantly elevated when
sprayers were compared with non-sprayers (OR = 1.72, 95% CI 1.31–2.26).
This was a well-designed study with a large sample size and conducted
among the most relevant population (Vietnam veterans with known herbicide
exposure) which included several levels of exposure (herbicide sprayers and
non-sprayers and Vietnam-deployed and non-Vietnam-deployed) and an attempt
to quantify it in the participants. Although serum TCDD concentrations were not
available for all participants and were collected at least 25 years after Vietnamera service, for those with serum TCDD levels available, self-reported herbide
spray status had high agreement with the measured levels. The highest mean
serum TCDD level was observed among sprayers deployed to Vietnam, and the
lowest mean TCDD level was found for non-Vietnam non-sprayers, as would
be expected, with a significant dose–response association. Likewise, there was
high agreement (89%) between self-reported hypertension and in-person blood
pressure measurements and medical records review for a subsample of study
participants. The analyses controlled for important risk factors for hypertension,
including age, race (white versus others), BMI, tobacco smoking status, rank,
Vietnam service status, and alcohol intake, but did not collect information on
(and therefore did not control for) other risk factors such as diabetes, a family
history of hypertension, and dietary intake of sodium and fat. A major strength of
this analysis was using the non-Vietnam-deployed ACC veterans as a comparison
group because they were similar to members of the study group with respect to
branch, length and time period of service, military occupation, and duties except
for deployment in Vietnam, which has the effect of minimizing unmeasured exposures and confounders of concern and bias. Additionally, because all of the men
who served in ACC units were stationed at Fort McClellan for at least some time,
and Fort McClellan is in close proximity to Anniston, Alabama, where Monsanto
operated a plant that produced PCBs, all ACC veterans were likely exposed to
at least low levels of these and other chemicals. Therefore, comparisons using
deployed and non-deployed ACC men are likely to be biased toward the null
due to this baseline of increased exposure, but despite that, the adjusted effect
estimate when Vietnam-deployed sprayers were compared with non-Vietnamdeployed non-sprayers was still more than twice as high, precise, and statistically
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significant. Although the exact types and quantities of the various chemicals these
ACC veterans were possibly exposed to during the Vietnam War are unknown
and may include chemicals other than the herbicides (such as insecticides, diesel
and jet fuels, cleaning solvents, tear gas, napalm, and antimalarial medications),
there is statistically significant support for an association between herbicide
exposure and self-reported, physician-diagnosed hypertension.
Occupational Studies Cappelletti et al. (2016) performed a retrospective study
of 331 male electric arc foundry workers at a single plant in Trentino, Italy, to
determine if they experienced excess mortality from all causes or were at an
increased risk for several other disases including complicated (with end organ
damage) and uncomplicated (no end organ damage) hypertension, diabetes, and
CVD due to their occupational exposure to foundry dust. An analysis of the dust
emissions found that the dust contained metals (including iron, aluminum, zinc,
manganese, lead, chromium, nickel, cadmium, mercury, and arsenic), PAHs,
PCBs, and PCDD/Fs (reported as TEQs). Because foundry dust is a mixture, it
is not known which of the agents were associated with a specific outcome or to
what extent. The men included in the study had worked at the factory for at least
1 year. For the hypertension analysis, 235 living workers, were compared with the
standardized general population of Region Trentino-Alto Adige (where the factory was located) because there were few non-exposed foundry workers and high
attrition rates. Company and medical records were used to determine vital status.
Requests for exemption health care fees were used as a surrogate measure to identify the most prevalent morbid conditions in the general population, which were
then applied to the cohort to compute relative risks for each of the conditions. The
workers were followed from March 19, 1979 (or their first day of employment),
through December 31, 2009 or date of death. Effect estimates (prevalence ratios)
were calculated using Mantel-Haenszel estimator adjusted for age group (20–64,
65–74, ≥ 75 years). Compared with the age-adjusted provincial population, statistically significantly elevated risks of both non-complicated hypertension (n =
30; RR = 2.44, 95% CI 1.75–3.40) and complicated hypertension (n = 14; RR =
2.22, 95% CI 1.35–3.65) were found among the electric arc furnace workers. The
strengths of the study include its long-term follow-up of the workers. This study
is most limited by the fact that foundry dust is a complex mixture, which made it
impossible to discern the impacts of the specific contaminants of the foundry dust
on the health outcomes of the exposed workers. Estimates were adjusted only for
age group and were not adjusted for other risk factors such as tobacco use, BMI,
or other jobs or activities that could result in similar exposures. The possible
exposure to foundry dust by the general population that was used for comparison
is not discussed, although the foundry appears to be in the local vicinity and
emissions from it were reported to be present within a 2-kilometer radius of it.
Yamamoto et al. (2015) performed a cross-sectional study to investigate the
health outcomes that 698 male workers sustained while employed at 36 municipal
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and private waste incineration plants in Japan; serum dioxin measurements were
obtained for 678 of the workers. These workers were employed from 2000
to 2007. First, a questionnaire was completed by participants on lifestyle and
medical history. Blood samples were taken from each subject to evaluate serum
dioxin, PCDD, PCDF, and coplanar PCB levels (77, 81, 126, 169, 105, 114,
118, 123, 156, 157, 167, and 189). Serum concentrations of dioxin isomers were
expressed as pg/g lipid, converted to TEQ, and expressed as TEQ/g lipid. Both
clinical and physiological examinations were also performed. Participants were
then categorized into four groups: workers whose jobs did not involve working
directly in an incineration facility, workers whose jobs did involve work inside
the incineration facility (but only handling solidified fly ash and slag or residues
that were nonflammable), workers whose jobs involved helping with incineration-
related work inside an incineration facility, and workers whose jobs mainly
involved the operation and maintenance of an incinerator including a furnace,
electric dust collector, and wet scrubber inside an incineration facility. Subjects
were tested for diabetes, hypertension, hyperlipidemia, and liver dysfunction. The
total serum dioxin concentration level for incinerator workers was 13.7 (median)
or 17.2 (arithmetic mean) pg TEQ/g lipid, while the (arithmetic mean) average
total dioxin concentration was 19.4 pg TEQ/g lipid for the general population
in Japan, indicating no real difference between the two groups. However, in the
exposed workers, the duration of employment was positively associated with
TEQ levels (9.8 and 21.7 pg TEQ/g lipid for those employed 9 years and 15.5
years, respectively). Coplanar PCBs were significantly correlated (p < 0.05)
with 14 parameters of laboratory and physiological tests. Serum concentrations
of total dioxins were higher in workers whose jobs involved operation, maintenance, and other incinerator work inside the facilities regardless of the duration
of their employment as compared with workers without these job duties. Serum
concentrations of dioxin congeners (PCDDs, PCDFs, coplanar PCBs, and total
dioxins) were used to divide the participants into quartiles, and odds ratios for
hypertension were computed for each category of dioxin congener by comparing
each quartile to the lowest quartile (referent) and adjusting for age, survey year,
BMI, smoking, and alcohol consumption. Although the adjusted associations
between quartiles 2 and 3 and the referent were not consistently significantly
elevated, the comparisons of quartile 4 with the referent group for PCDDs (OR =
1.66, 95% CI 1.00–2.78, p < 0.05), PCDFs (OR = 1.90, 95% CI 1.12–3.25, p < 0.05),
coplanar PCBs (OR = 2.31, 95% CI 1.33–4.02, p < 0.01), and total dioxins (OR
= 1.92, 95% CI 1.12–3.28, p < 0.05) showed elevated, statistically significant
associations between the serum levels of PCDD/Fs and total dioxins with the
prevalence of hypertension. The test for trend was also significant (p < 0.05)
for each of these COIs. Overall, there was no difference in the prevalence of
hypertension among the workers of all ages and the Japanese population (44.8%
versus 46.2%, respectively). However, when stratified by age groups and compared with the general Japanese population, the prevalence of hypertension was
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statistically significantly increased in in workers between the ages of 29 to
49 years. Nonetheless, there were no statistically significant differences in any of
the age groups in the total dioxin concentrations between the incinerator workers
and the general population, suggesting that something other than dioxin may be
contributing to the increased risk for hypertension among this younger population. The strengths of this study include a large sample size, the homogeneity
of study subjects with respect to ethnicity and workplace, the measurement of
exposure for individuals, significance for each congener, and the adjustments of
multiple confounders in the analysis.
Environmental Studies Shiue et al. (2014) used the U.S. population-based
NHANES study data from 2011–2012 to examine whether different sets of environmental chemical concentrations were risk factors of high blood pressure. The
study used previously collected demographics and blood pressure readings along
with the concentrations of various environmental chemicals (14 heavy metals and
20 industrial chemicals, including arsenic compounds and 2,4-D) measured in
urine. The urine samples were available for only a subsample of the study population (20–30%). High blood pressure was defined as a systolic blood pressure ≥
140 mmHg or a diastolic blood pressure ≥ 90 mmHg. The analysis used a total
sample size of 9,756 participants who were 20 years of age or older, of whom
3,035 (31.1%) had high blood pressure. This sample is quite young, with 63% of
participants being under age 39 years, a group in whom hypertension would be
uncommon. The associations of the environmental contaminents with high blood
pressure were adjusted for urinary creatinine, age, sex, ethnicity, and BMI and
were weighted for the survey design using logistic regression. After full adjustment, even though a number of heavy metals and chemicals were associated with
high blood pressure, none of them were the COIs. Of note, however, although
total arsenic was marginally associated with high blood pressure in the weighted
model (OR = 1.13, 95% CI 0.99–1.29, p = 0.066), trimethylarsine oxide (OR =
2.47, 95% CI 1.27–4.81, p = 0.011) and dimethylarsonic acid concentrations (OR
= 1.42, 95% CI 1.12–1.79, p = 0.006) were associated with high blood pressure.
Thus, in the general U.S. population, arsenic and its related compounds were
found to elevate the risk for hypertension, even in this low at-risk NHANES
sample, and the correlation was likely detected because of the large sample size
and accurate determinations of exposure concentrations.
Van Larebeke et al. (2015) prospectively studied the associations of exposure
to organochlorine pollutants, HCB, dioxin-like (PCB 118) and non-dioxin PCBs,
and cadmium with a variety of self-reported health conditions, including diabetes
and hypertension, as part of a Flemmish biomonitoring program. In 2004–2005,
height, weight, urine, and serum were collected from the participants. Dioxin-like
activity in pg TEQ/g fat was also assessed. Subjects filled out a survey collecting
demographic data and information on education and tobacco and alcohol use. In
2011, participants in the program were mailed a second survey to collect updated
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information on general health, smoking and alcohol consumption behaviors,
medical conditions, and current medications. There were 973 respondents, 504
women and 469 men (response rate 65.6%), whose information was used for the
current analysis. Serum was assayed for HCB, dioxin-like PCB 118, and other
chemicals. Medical diagnoses were all self-reported and not confirmed. For the
diagnosis of hypertension, subjects were asked, “Do you suffer or have you suffered from arterial hypertension in the past 10 years?” Although 162 (34.5%) men
and 172 (34.1%) women reported hypertension, it is likely underreported in this
population of adults aged 50–65 years when recruited in 2002–2006. Overall,
there were no differences in the levels of dioxin-like activity (pg/TEQ/g fat) or
PCB 118 (ng/g fat) between participants and non-participants of the follow-up
survey, emphasizing the representativeness of the sample. However there was
a difference for HCB (p = 0.051). In the combined sample, after adjusting for
BMI, exercise in minutes per week, level of education, and glasses of alcoholic
beverages per week, dioxin-like activity was positively associated with a risk of
hypertension (OR = 1.61, p = 0.014), as were HCBs (OR = 1.99, p = 0.0005);
PCB 118 was not reported. PCBs with dioxin-like activity approached statistical significance in men only (p = 0.066), while HCBs were significant for both
men and women in at least one model. In a crude model, the serum concentration of PCB 118 was not associatied with hypertension. In a model accounting
for confounders and with additional adjustments made for correlated exposures
(HCB, p,p′-DDE, cadmium, and non-dioxin PCBs), there was a significant association between serum PCB 118 levels and hypertension in men, but not women.
The odds ratio for men for the 90th percentile vs. 10th percentile was 3.27 (p
= 0.0011). In a model with additional adjustments for covariates and correlated
exposures (HCB, p,p′-DDE, cadmium, and non-dioxin PCBs), the association
with hypertension was marginally significant for men: the OR for 90th percentile
versus 10th percentile was 1.95 (p = 0.09). The strengths of the study included its
prospective design, its large sample size, the representativeness of the older adult
general population, and the use of objective measures of exposure. However, the
findings are limited by the absence of validated medical diagnoses. Although
HCB was associated with hypertension in several models, mono-ortho dioxin-like
PCB 118 was not associated with hypertension.
P. M. Lind et al. (2014) examined hypertension in participants of the PIVUS
(Prospective Investigation of the Vasculature in Uppsala Seniors) cohort, who
were men and women aged 70 years or older and residents of Uppsala, Sweden.
Of 2,025 eligible subjects, only half (n = 1,016) agreed to participate. Participants completed a questionnaire to assess their medical history, smoking history,
and medication use. A clinical exam including blood pressure measurement was
performed, and fasting blood work was obtained for lipid and glucose analysis.
Hypertension was defined as having a systolic blood pressure > 140 mmHg,
a diastolic blood pressure > 90 mmHg, or using antihypertensive medication.
General exposure to 23 persistent organic pollutants (POPs) was quantified from
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stored serum samples collected at the time of entry into the PIVUS study using
high-resolution gas chromatography/mass spectrometry. Normalized POPs were
estimated using individualized lipid levels and TEQs measured for dioxin-like
PCBs and OCDD combined and separately for the dioxin-like coplanar nonortho PCBs (PCB 126 and PCB 169) and the dioxin-like mono-ortho PCBs (105,
118, 156, 157, and 189). As the participation rate in this cohort was only 50%,
an evaluation of cardiovascular disorders and medications in 100 consecutive
non-PIVUS participants was also performed to serve as a control. Although both
PIVUS participants and non-participants were broadly similar, the prevalence of
diabetes, congestive heart failure, and stroke was higher among non-participants.
Overall, 72% of the participants in this study had hypertension. When exposures
were adjusted for gender, BMI, smoking status, exercise habits, and education
levels, none of the dioxin-like PCBs were associated with prevalent hypertension: PCB 105 (OR = 1.23, 95% CI 0.96–1.60; p = 0.11), PCB 118 (OR = 1.26,
95% CI 0.95–1.67; p = 0.11), PCB 156 (OR = 0.9, 95% CI 0.63–1.3; p = 0.58),
PCB 157 (OR = 0.9, 95% CI 0.65–1.26; p = 0.55), PCB 189 (OR = 0.87, 95%
CI 0.69–1.09; p = 0.22), PCB 126 (OR = 1.1, 95% CI 0.94–1.3; p = 0.24), and
PCB 169 (OR = 0.86, 95% CI 0.61–1.2; p = 0.36). When exposure was classified
by individual POPs, PCB 105 (OR = 1.5, 95% CI 1.19–1.89) and PCB 118 (OR
= 1.56, 95% CI 1.2–2.01) were significant when adjusted for gender only. This
was a large and well-designed and analyzed study of elderly adults that when
adjusted for gender, BMI, smoking staus, exercise habits, and education showed
no associations between hypertension and dioxin-like PCBs.
Other Identified Studies One other occupational study was identified that reported deaths from hypertension with underlying heart disease, but it was limited
by a lack of exposure specificity (Ruder et al., 2014). An environmental study
was also identified (Akahane et al., 2017) that examined the prevalence of selfreported long-term health outcomes (including high blood pressure) in people
exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the
ingestion of contaminated rice bran oil (Yusho accident) compared with an age-,
sex- and residential-area-matched group. Because no TEQs or other quantification of relevant exposures was presented, the study was not considered further.
Biologic Plausibility
The biological mechanism for dioxin’s impact on hypertension is being
investigated in animal models and human cell cultures, and it has shown clear
effects on gene expression, vascular function, and lipid glucose metabolism.
The exposure of human endothelial cells to TCDD causes the down-regulation
of genes involved in blood pressure regulation (Qin et al., 2015), suggesting a
potential molecular mechanism for TCDD’s impact on hypertension. Recent data
also indicate that the increase in hypertension following AHR activation is linked
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to the inactivation of endothelial nitric oxide synthases, which is expressed in endothelial cells and functions to modulate vascular blood pressure (C. C. Chang et
al., 2017). Data also demonstrate a link to the Ahr pathway using mouse models,
demonstrating that sustained Ahr activation by dioxins results in increased blood
pressure, which is associated with significant increases in vascular oxidative
stress and decreases in vascular relaxation (Kopf et al., 2010). Conversely, hypotension is associated with Ahr loss in knockout models, either knocked out in the
whole animal or specifically in endothelial cells, (Agbor et al., 2011; N. Zhang et
al. 2010). Those changes in vascular function and blood pressure could be mediated in part by increases in the metabolism of arachidonic acid to vasoconstrictive
and inflammatory eicosanoids (Bui et al., 2012; Diani-Moore et al., 2014).
A recent study on genetic polymorphisms of the AHR signaling pathway
genes in a human cohort recruited from central Russian (Kursk) cardiology and
neurology clinics also suggests a plausible link between exposure to TCDD
and dioxin-like chemicals and essential hypertension (Polonikov et al., 2017).
Seven common polymorphisms in the AHR pathway genes AHR, ARNT, AHRR,
CYP1A1, CYP1A2, CYP1B1, and NQO1 were genotyped from venous blood
samples of 1,341 cases and 819 controls. A polymorphism in ARNT was shown to
be associated with increased essential hypertension, whereas a single nucleotide
polymorphism in CYP1A2 showed a decreased risk of essential hypertension in
a recessive genetic model. Additional log-likelihood ratio tests showed epistatic
interactions on essential hypertension susceptibility for all single nucleotide polymorphisms. These results are generally consistent with the suggestion that the
AHR pathway is involved in hypertension and that TCDD activation of this pathway can influence hypertension in the human population.
Synthesis
Hypertension, defined as a systoloic/diastolic blood pressure exceeding
140/90 mmHg, affects approximately 75 million Americans, or one in every
three adults. This trait remains one of the main contributing risk factors to cardiovascular, peripheral vascular, and cerebrovascular disease. Risk factors include
family history, age, sex, race, obesity, reduced nephron number, high dietary salt
intake, tobacco use, excessive alcohol intake, and physical inactivity. Owing to
its frequency, assessing whether there is increased risk with exposure to the COIs
has been challenging. However, the committee for the current update believes
that there are enough new data to move the category of association to sufficient
evidence.
Cypel et al. (2016) offers the most compelling evidence for the change. The
well-designed study was conducted in the population of interest, U.S. Vietnam
veterans, had a large sample size, appropriate controls (non-Vietnam-deployed
sprayers, Vietnam non-sprayers, and non-Vietnam-deployed non-sprayers), and
validated endpoints (self-reported physician-diagnosed hypertension that was
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confirmed with measurements and medical record reviews). The study also quantified exposures using serum TCDD measurements that were validated in a subset
of participants. Finally, the statistical analyses conducted are robust, used stateof-the art methods, and adjusted for appropriate confounders. This study clearly
demonstrated that self-reported physician-diagnosed hypertension rates were the
highest among Vietnam-deployed sprayers (81.6%) compared with non-Vietnamdeployed sprayers (77.4%), Vietnam-deployed non-sprayers (72.2%), and nonVietnam-deployed non-sprayers (64.6%), representing a significant association
with exposure.
The five additional studies reviewed were occupational (Cappeletti et al.,
2016; Yamamoto et al., 2015) and environmental (Lind et al., 2014; Shiue et al.,
2014; Van Larebeke et al., 2015) exposure investigations. Each of these has one
or more significant study design deficiencies as compared to Cypel et al. (2016)
and would not be considered adequate to change the level of association individually. However, at least a portion of the effect model results corroborate the
positive, elevated risk between exposure to the COIs and hypertension using a
variety of study designs, populations, and measurements of exposure.
Briefly, among the occupational cohorts, Yamamoto et al. (2015) found
hypertension to be statistically significantly associated with serum concentrations of PCDDs, PCDFs, dioxin-like PCBs, and total dioxins based on adjusted
odds ratios between the first and fourth quartile of each of those COIs among
incinerator workers, and tests for trend were also significant for each of these
COIs. Among 235 Italian electric arc furnace workers exposed to multiple agents,
including metals and PCDD/Fs, PAHs, and PCBs, as sampled in the foundry dust,
the prevalence of both complicated and non-complicated hypertension among
the workers compared with the general regional population showed statistically
significant increased risks; however, this study is quite limited because foundry
dust is a complex mixture, and the authors were unable to discern the impact of
the specific contaminants of the foundry dust on the health outcomes of those
exposed workers (Cappelletti et al., 2016). Estimates were only adjusted for age
group, and were not adjusted for other risk factors or activities that could affect
the association. It is likely that workers of both of these occupationally exposed
study populations received co-exposures to metals and chemicals other than those
that the committee was charged with specifically reviewing that may be possible
confounders that may affect the true estimate of association.
The results of the three environmental exposure studies had mixed findings.
In their analysis of 2011–2012 NHANES data, Shiue and colleagues (2014) found
an increased risk of hypertension with urinary levels of a number of heavy metals
and other chemicals, including trimethylarsine oxide and dimethylarsonic acid,
after adjusting for several risk factors of hypertension. Among the participants of
a Flemish biomonitoring program, Van Larebeke et al. (2015) found an elevated
risk of self-reported (and unconfirmed) hypertension for dioxin-like activity and
HCB after adjusting for BMI, exercise in minutes per week, level of education,
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and glasses of alcoholic beverages per week that was significant for men and
women combined. However, when stratified by sex, the risk of hypertension was
only marginally significant for men exposed to PCBs with dioxin-like activity,
while HCBs were significant for both men and women in at least one model. In
the third environmental exposure study of elderly residents of Upsala, Sweden,
significant positive associations between hypertension and dioxin-like PCBs were
found only for PCB 105 and PCB 118 when analyses were adjusted for gender
only. When models were fully adjusted for the risk factors of hypertension, no
association between dioxin-like PCBs and hypertension was found (Lind et al.,
2014).
In addition to the new studies, the committee re-examined the studies
reviewed from the previous VAO reports, specifically those among Vietnam
veterans (AFHS, 1995, 2000, 2005; CDC, 1988a; Cypel and Kang, 2010; Kang
et al., 2006, 2014; J. S. Kim et al., 2003; O’Toole et al., 2009; Yi et al., 2014a,b)
when making its decision of the strength of the evidence of exposure to the COIs
and hypertension. Furthermore, data from animal and human cell-culture models
support the hypothesis that TCDD activation of AHR increases the development
of hypertension, and suggest plausible molecular mechanisms for hypertension.
Conclusion
After an examination of the literature that had been previously reviewed with
the additional new evidence, the committee determined that there is sufficient
evidence of an association between at least one of the COIs and hypertension.
Ischemic Heart Disease
IHD refers to a loss of blood flow and lack of oxygen to the heart muscle.
It is also referred to as cornonary heart disease or myocardial ischemia and
includes the conditions of stable angina, unstable angina, myocardial infarction,
and sudden cardiac death. It is often the result of an atherosclerotic narrowing
of the blood vessels that supply the heart muscle. Risk factors include smoking,
hypertension, hyperlipidemia, obesity, family history, age, and male sex. It is one
of the leading causes of death in the United States, at a rate of 97.2 per 100,000
deaths (Healthypeople.gov, 2018a). IHD was first addressed as a separate oucome
in Update 2008.
Conclusions from VAO and Previous Updates
The committee responsible for Update 2008 revisited the entire body of
evidence on TCDD exposure and heart disease and concluded that the evidence
supported moving IHD to the limited or suggestive category. That conclusion was
based on evidence of a dose–response relationship in the occupational cohorts,
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evidence of an increased risk of myocardial infarction in Vietnam veterans, supporting cross-sectional survey data, and a strong biologic rationale. Evidence
reviewed for Update 2010 and Update 2012 continued to support that classification. A number of studies of potential relevance were reviewed for Update 2014,
including several studies of Vietnam veterans. The studies of New Zealand, Korean, and female U.S. veterans did not find an increase in IHD mortality (Kang
et al. 2014a; McBride et al. 2013; Yi et al. 2013a, 2014a,b). However, because
IHD is not a uniformly fatal disease, mortality rates may not be the most accurate marker of prevalence. Information on IHD gleaned from death certificates
represents not only disease occurrence but also disease severity—the validity of
which depends on those dying of the disease being a fair representation of all
persons developing IHD. For example, in the Korean Veterans Health Study of
veterans who served in Vietnam, the mortality analysis included 843 deaths from
IHD, but analyses of disease prevalence in the same population identified more
than 20,000 persons with this condition.
Studies comparing mortality among veteran populations to that among the
general population may also be biased by the so called “healthy warrior effect,”
in which veterans have a health advantage over the general population across a
range of health outcomes. Furthermore, only the study of Korean veterans quantified possible herbicide exposure, whereas the New Zealand and U.S. veteran
studies assumed deployment to be synonymous with herbicide exposure. Each
of the Vietnam veteran cohort studies was limited by not adjusting the estimates
for various relevant confounding variables. Additional studies of CVD, which
includes IHD, in well-conducted and nationally representative samples, such as
NHANES (Lin et al., 2012), found an increase in the risk of CVD death in those
with higher levels of dioxin TEQs, but other studies of CVD did not demonstrate
such relationships; thus IHD has remained in the limited or suggestive category.
Update of the Epidemiologic Literature
Results of new studies of IHD and exposures to the COIs are summarized
below. No case-control studies of exposure to the COIs and IHD have been published since Update 2014.
Vietnam-Veteran Studies Cox et al. (2015) used hospital discharge records
from 1988 to 2009 to identify prevalent health conditions in 2,783 male New
Zealand veterans who served in Vietnam. Age-specific hospitalization rates
were calculated using the total number of annual hospitalizations published
by the Ministry of Health and the average annual resident population. Standardized hospitalization rates and 99% CIs were calculated for the veteran cohort and the general population and reported for CVD overall as well as for
acute myocardial infarction, coronary atherosclerosis, chest pain, cardiac arrest, dysrhythmia, and congestive heart failure. CVD was broken down into
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acute myocardial infarction (SHR = 1.16, 99% CI 1.00–1.33), coronary atherosclerosis (SHR = 1.27, 99% CI 1.14–1.39), chest pain (SHR = 1.35, 99%
CI 1.16–1.53), cardiac arrest (SHR = 1.54, 99% CI 0.22–2.86), dysrhythmia (SHR
= 1.27, 99% CI 1.06–1.48), and congestive heart failure (SHR = 1.02, 99% CI
0.78–1.26). Acute myocardial infarction, coronary atherosclerosis, and chest pain
were further examined by 4-year periods of time. In each case, the time period
2006–2009 had the highest SHR, which was also statistically significant. The
authors concluded that there was a small but significant increase in the number
of hospitalizations for New Zealand Vietnam veterans, with modest increases in
hospitalization for common conditions such as CVD. Exposure to the COIs was
not validated through serum measurements, and the study did not control for
smoking or ethnicity or other potentially important risk factors.
Occupational Studies Collins et al. (2016) offers additional follow-up time to
a retrospective analysis of a cohort of 2,192 workers exposed to dioxins during
TCP and PCP production at a chemical manufacturing plant in Michigan. The
U.S. population was used as the comparator for standardized mortality ratios.
Work history records were used to determine the length of exposure. Serum
samples to measure levels of six types of dioxins, which were collected from
431 TCP and PCP workers. The historical concentrations for each dioxin congener were calculated from the median concentrations from the serum samples
and the known half-lives associated with each congener. Complete vital status
follow-up was achieved for the cohort, and there were 1,198 decedents through
the entire study period (1979–2011). For IHD, there were 371 deaths among all
workers combined (SMR = 1.10, 95% CI 0.99–1.22). No difference in mortality
from IHD was found among the TCP workers (n = 256; SMR = 1.07, 95% CI
0.95–1.21), but there was a slight increase of death from IHD among the PCP
workers (n = 150; SMR = 1.20, 95% CI 1.01–1.41). When the SMRs for IHD
were evaluated by exposure levels of each constituent congener, only the middle
estimates for HpCDD and OCDD were statistically significantly elevated, but
the trend was not.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of
workers who were employed at the New Plymouth, New Zealand, phenoxy herbicide production plant for at least 1 month between 1969 and 1984. The plant
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, intermediates of TCP and other chlorophenols, and TCDD. Workers had previously been
recruited and examined as part of the international cohort of producers of phenoxy herbicides led by IARC (Kogevinas et al., 1997); see Chapter 5 for more
details on the IARC cohort and the New Zealand phenoxy producers. This study
extended the follow-up period of these workers to approximately 30 years from
the final 2,4,5-T production exposure. From the original cohort of 1,025 workers,
631 were living, had a current address in New Zealand, and were below 80 years
of age on January 1, 2006. For the current 't Mannetje et al. follow-up, 430 or the
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631 workers were randomly selected and invited to participate in a morbidity survey, of whom 245 (57%) participated. The survey was administered in 2007–2008
by face-to-face interviews and collected information on demographic factors and
health information, including doctor-diagnosed conditions and the year of diagnosis. A blood sample was also collected at that time and analyzed for TCDD,
lipids, thyroid hormones, and other parameters. A neurological examination was
conducted for 111 of the participants. Associations between exposure and health
outcomes were assessed using logistic regression models that controlled for age,
gender, smoking, BMI, and ethnicity using two methods: working in a TCDDexposed job (based on occupational records) and serum TCDD concentration
≥10 pg/g lipid (18%). Mean TCDD concentrations were 19 pg/g lipid in the 60
men directly involved in phenoxy/TCP production and 6 pg/g lipid in the 141
men and 43 women who worked in other parts of the plant. Compared with the
people in the not highly exposed jobs, the people who had ever worked in a highly
exposed job at the plant did not have any difference in risk of doctor-diagnosed
heart disease (n = 10; OR = 2.71; 95% CI 0.65–11.4), although the estimate
was imprecise. When compared by serum TCDD concentration, again there was
no difference in the risk of heart disease for workers in the high- versus lowexposure groups (n = 5; OR = 1.64; 95% CI 0.41–6.57), although the estimate
was again imprecise.
Cappelletti et al. (2016) performed a retrospective study of 331 male electric
arc foundry workers at a single plant in Trentino, Italy, to determine if they experienced excess mortality from all causes or were at an increased risk for several
other disases including CVD, due to an occupational exposure to foundry dust.
An analysis of the dust emissions found that the dust contained metals (including
iron, aluminum, zinc, manganese, lead, chromium, nickel, cadmium, mercury,
and arsenic), PAHs, PCBs, and PCDD/Fs (reported as TEQs). Because foundry
dust is a mixture, it is not known which of the agents were associated with a
specific outcome or to what extent. The men included in the study had worked
at the factory for at least 1 year. Company and medical records were used to
determine vital status. Requests for exemption health care fees were used as a
surrogate measure to identify the most prevalent morbid conditions in the general
population, which were then applied to the cohort to compute relative risks for
each of the conditions. The workers were followed from March 19, 1979 (or their
first day of employment), through December 31, 2009, or date of death. Effect
estimates (prevalence ratios) were calculated using Mantel-Haenszel estimator
adjusted for age group (20–64, 65–74, ≥ 75 years). Compared with the ageadjusted provincial population, no difference in death from IHD (n = 4; SMR
= 1.27, 95% CI 0.35–3.26) was found among the electric arc furnace workers.
However, a statistically significantly elevated risk of CVD (n = 5; RR = 1.74,
95% CI 1.07–2.82) was found. This study is most limited by the fact that foundry
dust is a complex mixture, which makes it impossible to discern the impact of
the specific contaminants of the foundry dust on the health outcomes of those
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exposed workers. Estimates were adjusted only for age group and were not adjusted for other risk factors such as tobacco use, BMI, or other jobs or activities
that could have resulted in similar exposures. Exposure to foundry dust by the
general population that was used for comparison is not discussed, although the
foundry appears to be in the local vicinity and emissions from it were reported
to be present within a 2-kilometer radius of it.
Environmental Studies Van Larebeke et al. (2015) carried out a prospective
study of the associations of exposure to organochlorine pollutants, HCB, dioxin-like
(PCB 118) and non-dioxin-like PCBs, and cadmium with a variety of self-reported
health conditions, including diabetes, hypertension, and atheromata (the results for
diabetes and hypertension were described earlier) as part of a Flemmish biomonitoring program. In 2004–2005, height, weight, urine, and serum were collected
from the participants. Dioxin-like activity in pg TEQ/g fat was also assessed.
Subjects filled out a survey that collected demographic data and information on
education, tobacco use, and alcohol consumption. In 2011, participants in the program were mailed a second survey to collect updated information general health,
smoking and alcohol consumption behaviors, medical conditions, and current
medications. There were 973 respondents, 504 women and 469 men (response
rate 65.6%), whose information was used for the current analysis. The serum was
assayed for HCB, dioxin-like PCB 118, and other chemicals. Medical diagnoses
were all self-reported and not confirmed. For the diagnosis of atheromata, subjects
were asked, “Did you have a problem with the blood circulation in the brain (cerebrovascular incident, ischemic episode)?” “Have you ever experienced a heart
infarction?” and “Do you sometimes suffer from pain in the thorax during physical
effort?” A positive response to at least one of these questions was considered a
diagnosis. A total of 71 men (15.1%) and 62 women (12.3%) reported atheromata,
and 27 men (5.8%) and 10 women (2%) reported myocardial infarction. Overall,
there were no differences in the levels of dioxin-like activity (pg/TEQ/g fat) or
PCB 118 (ng/g fat) in participants versus non-participants of the follow-up survey,
but there was a difference for HCB (p = 0.051). In the combined sample, after
adjusting for BMI, the level of education, and cholesterol concentration in blood,
the researchers found that dioxin-like activity was not associated with the risk of
atheromata (OR = 1.60, p = 0.083); estimates for HCBs and PCB 118 were not provided. In a model accounting for confounders and making additional adjustments
for correlated exposures (HCB, p,p’-DDE, cadmium, and non-dioxin PCBs), the
odds of atheromata in the 90th versus the 10th percentiles were increased in men
only (OR = 1.83, p = 0.031). No individual analyses were performed for myocardial infarction. The strengths of the study include its prospecitive design, its large
sample size, the representativeness of the older adult population of Flanders, and
the use of objective measures of exposure. However, the findings are limited by
the study’s lack of validated medical diagnoses, and the data were collected based
on self-report from a survey that was not validated.
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Bergkvist et al. (2015) performed a prospective population-based cohort study
of 33,446 women who participated in the Swedish Mammography Cohort and who
were free of CVD, diabetes, and cancer at baseline. The women were followed
for 12 years to determine the association between dietary PCB exposure and the
risk of myocardial infarction. Fish fatty acid consumption was also measured to
determine any protective effects of the consumption of eiconsapentaenoic acid
and docosahexaenoic acid. The food frequency questionnaire-based dietary PCB
estimates have been extensively validated against serum PCBs in women from
this cohort. During the follow-up period, 1,386 myocardial infarctions occurred,
276 of which were fatal. Cases were ascertained through a computerized linkage to the National Hospital Discharge and Cause of Death Registers in Sweden
using personal identification numbers. PCB exposure was grouped into quartiles,
and women in the highest quartile of dietary PCB exposure were found to be
more likely to report high cholesterol levels, to use fish oil supplements, to have
a slightly higher consumption of alcohol and red and processed meat, and to have
up to a six-times-higher consumption of fish than those in the lowest quartile.
Multivariate-adjusted analysis was used to determine the association between risk
of myocardial infarction and PCB exposure. Models were adjusted for several
factors, including postsecondary education, a family history of myocardial infarction before the age of 60 years, ever use of postmenopausal hormones, the use
of aspirin, the use of fish oil supplements, and a weight loss of ≥ 5 kg within
1 year, which were treated as dichotomous variables (yes/no). Additional variables
were also included in Cox proportional hazards regression models: smoking status (never, past, or current); waist circumference (< 80, 80–87, ≥ 88 cm); parity
(0, ≥ 1 children); total physical activity (quartiles, MET-h); alcohol consumption
(0, > 0–4.9, 5.0–14.9, > 15.0 g/day); energy intake (continuous, kcal/day); consumption of fruit and vegetables (quartiles, servings/week), dairy products (quartiles,
servings/day), and red and processed meat (quartiles, servings/week); dietary intake
of saturated fatty acids (quartiles, g/day); and dietary methyl mercury exposure (quartiles,
μg/day). In additional adjustments, the dietary sum of both eiconsapentaenoic acid
and docosahexaenoic acid (quartiles, g/day) was also included. Models were not
adjusted for hypertension or high cholesterol levels because the authors reasoned
that these intermediate risk factors may be in the causal pathway between PCB
exposure and CVD. Dietary PCB exposure was associated with total myocardial
infarction in the multivariable-adjusted model (RR = 1.21, 95% CI 1.01–1.45; p for
trend = 0.012), and this estimate increased after adjusting the model for the sum
intake of eiconsapentaenoic acid and docosahexaenoic acid (RR = 1.58, 95% CI
1.10–2.24; p for trend = 0.007). There are several limitations to the study. Although
the survey was validated with a serum PCB analysis in this population, recall bias is
of concern, as is the fact that this information was collected only at baseline, yet the
cohort was followed for 12 years. Using a prospective design eliminates concerns
of temporal ambiguity. Methyl mercury is a potentially confounding factor. Though
adjustments were made for dietary intake, it is not possible to ascertain the role of
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mercury in risk of CVD. Most importantly, because exposure to PCBs is grouped,
it is not possible to know if any of the increased risk is due to dioxin-like PCBs
and which specifically those might be.
Other Identified Studies One other study that reported deaths from IHD was
identified, but it was limited by its lack of exposure specificity (Ruder et al.,
2014).
Biologic Plausibility
Experimental studies demonstrate that exposure to AHR agonists, including
TCDD and benzo[a]pyrene, increase the incidence, severity, and progression of
atherosclerosis, a primary cause of IHD (Dalton et al., 2001; Kerley-Hamilton et
al., 2012a; D. Wu et al., 2011). There is also evidence that TCDD influences other
IHD risk factors by promoting obesity (Brulport et al., 2017; Kerley-Hamilton
et al., 2012b), accumulating macrophage lipid, inducing lipid mobilization, and
altering lipid metabolism. Thus, on the basis of animal models there appear to
be several overlapping and potentially contributing pathways that link TCDD
exposure and increased IHD risk.
Synthesis
This committee considered six new studies in addition to the multiple studies reviewed by prior VAO committees when determining its conclusion of the
level of association. Among New Zealand veterans who had served in Vietnam, Cox et al. (2015) calculated hospitalization ratios for CVD and found elevated rates for the outcomes of acute myocardial infarction, chest pain, and
coronary atherosclerosis among the veterans. The two occupational studies of
heart disease mortality—one among U.S. workers producing TCP and PCP
(Collins et al., 2016) and the other among Italian electric arc foundry workers
exposed to dioxins (Cappelletti et al., 2016)—both found no difference in mortality
from heart disease compared with their resepective general populations; however
the use of general populations as a comparator likely introduced selection bias. A
third occupational study of morbidity among people who had worked in a New Zealand plant that produced phenoxy herbicides also found no increased risk of heart
disease based on high versus low exposure ('t Mannetje et al., 2018). Two studies
of populations with environmental exposures were also examined. Bergkvist et al.
(2015) followed a cohort of women for 12 years who were free of CVD at baseline
and who were exposed to PCBs via dietary exposure. Even though adjustments
were made for dietary intake, PCBs were grouped together, making it difficult to
determine the role of individual dioxin-like PCBs in the CVD risk. Regardless,
these data are not immediately generalizable, given that very few women were
exposed to the herbicides. The occupational studies are further limited because
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these populations of workers likely received c o-exposures to metals and chemicals
other than those that the committee was charged with specifically reviewing that
may be possible confounders that may affect the true estimate of association. Van
Larebecke et al. (2015) studied the association of exposure to organochlorine pollutants, HCB, and dioxin-like and non-dioxin-like PCBs with a self-reported history
of atheromata and myocardial infarction. While there was a significant association
for men reporting atheromata, this association lost significance when the analysis
corrected for other risk factors known to cause atheromata. Furthermore, based on
a review of available experimental data, there appear to be several overlapping and
potentially contributing pathways that link TCDD exposure and an increased risk
of IHD.
The above studies were limited by relatively small numbers of cases, a lack
of consistent case definitions for the various types of CVD (IHD versus angina
versus chest pain versus atheromata), the use of non-validated surveys for diagnosis, and the presence of mixtures of chemicals in addition to the COIs. Most of
the new studies used mortality or hospitalization data, which, as discussed above,
may not be the best endpoint for determining an increased risk for a particular
condition. Given these considerations, the committee reaffirmed the decision of
previous VAO committees to keep IHD in the limited or suggestive category.
Conclusion
After reviewing the new evidence, the present committee concurred with
those for previous updates that there is limited or suggestive evidence that IHD
is associated with exposure to the COIs.
Cerebrovascular Disease and Stroke
Cerebrovascular disease refers to a disorder that affects the circulation in
the brain. The most common conditons are ischemic stroke, hemorrhagic stroke,
and transient ischemic attack. This disease is one of the top 10 causes of death in
the United States and was responsible for 5.2% of deaths overall in 2015 (CDC,
2017b). Presented by race, in 2015 whites had the greatest number of deaths from
cerebrovascular disease (~117,000) followed by blacks (~18,000), Asian and
Pacific Islanders (~5,000), and American Indians/Alaska Natives (~700) (CDC,
2017b). Mortality rates from cerebrovascular disease and stroke were declining,
but have remained stagnant in recent years (CDC, 2017d).
Conclusions from VAO and Previous Updates
Among U.S. Vietnam veterans, stroke and cerebrovascular disease have not
been found to be elevated in the AFHS, ACC, or female veteran cohorts (Cypel
and Kang, 2010; Kang et al., 2014; Ketchum and Michalek, 2005). Similar to
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the analysis of deployed and non-deployed U.S. female veteans, analyses of
Australian Vietnam veterans compared with the general Australian population
have found a decreased risk of stroke and cerebral hemorrhage. Among Korean
Vietnam-era veterans, after adjustment for multiple behavioral, demographic, and
service-related factors, stroke prevelance was statistically significantly elevated
among the more highly exposed cohort members (Yi et al., 2014a). The association was seen for both major stroke types: cerebral infarction (ICD-10 I63) and
cerebral hemorrhage (ICD-10 I60–I62). In the mortality study in the same cohort,
after adjusting for only age and rank, no differences were found in mortality from
cerebrovascular disease (ICD-10 I60–I69) between the groups with high and low
potential for herbicide exposure or when individual exposure potential was used
as a continuous variable (Yi et al., 2014b).
Few occupational cohorts have examined stroke and cerebrovascular diseases,
but those that have, have reported very few cases and very few differences in
mortality rates. Such studies have included Dutch herbicide production workers
(Boers et al., 2010), the U.S. National Institute for Occupational Safety and Health
mortality cohort (Steenland et al., 1999), PCP production workers in Midland,
Michigan (Collins et al., 2009a), and Italian licensed pesticide users (Gambini et
al., 1997). One study of AHS applicators and their wives (Waggoner et al., 2011)
found a statistically significantly decreased risk of cerebrovascular disease.
Only two environmental studies have reported on stroke or cerebrovascular
disease. Y. S. Lin et al. (2012) reported a positive, but not significant association
between dioxin-like compounds in the blood and mortality from cerebrovascular
disease (defined as a stroke) in an analysis of NHANES data. In the 25-year
follow-up of the Seveso cohort, Consonni et al. (2008) found no difference in
cerebrovascular disease between people exposed in Zone A and nonexposed
residents of 11 surrounding municipalities, but slight statistically significant
increases in cerebrovascular disease were found for people residing in Zones B
and R compared with the nonexposed residents of 11 surrounding municipalities.
Therefore, based on these studies the evidence to determine an association
between exposure to the COIs and cerebrovascular disease and stroke remains
limited or suggestive.
Update of the Epidemiologic Literature
Four new studies of exposure to at least one COI and cerebrovascular disease
and stroke outcomes have been identified since Update 2014.
Vietnam-Veteran Studies Cox et al. (2015) used hospital discharge records
from 1988 to 2009 to identify prevalent health conditions in 2,783 male New
Zealand veterans who served in Vietnam. Age-specific hospitalization rates were
calculated using the total number of annual hospitalizations published by the
Ministry of Health and the average annual resident population. Standardized
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hospitalization rates and 99% CIs were calculated for the veteran cohort and the
general population and reported for several noncancerous conditions. A total of
170 cases of acute cerebrovascular disease were found in the veteran population,
which was statistically significantly elevated compared with the standardized
hospitalization rate of New Zealand (SHR = 1.31, 99% CI 1.05–1.56). In addition, a total of 45 cases of aneurysm within the veteran population were identified
(SHR = 1.47, 99% CI 0.91–2.04). The study was limited by its assumption that
deployment to Vietnam was synonomous with herbicide exposure, which was not
validated through serum measurements, and by a lack of adjustment for smoking
or ethnicity or other potentially important risk factors.
Han et al. (2016) conducted a small hospital-based study of Korean Vietnam
veterans in Seoul who had presumed Agent Orange exposure (determined by
deployment to Vietnam) to examine whether exposure resulted in differences
in the vascular features of acute ischemic stroke. A total of 91 veterans with
preseumed exposure were compared with 288 male patients from other area
general hospitals (and presumed to be unexposed to Agent Orange). Both groups
of patients were compared on lifestyle factors, clinical history, and the clinical
manifestations of stroke at admission and discharge. Vascularity was examined
within 7 days of acute ischemic stroke onset, and stroke was confirmed by MRI
within 1 week after onset. The subtype of the stroke was assessed using the acute
stroke treatment protocol and the modified Rankin Scale at discharge and at
3 months after onset. The two groups were comparable for many demographic and
lifestyle factors except that veterans (exposed) had higher rates of smoking and
comorbid diabetes and the unexposed males had higher hyperlipidemia and history of stroke. Stroke subtypes were statistically significantly different (p = 0.014)
between the two groups, and characterized by small vessel occlusion in exposed
subjects and large artery atherosclerosis in unexposed subjects. These features
may have led to a somewhat better short-term prognosis of exposed than unexposed members. The exposed veterans had lower scores on the stroke scale at
admission than the control group (p = 0.003), but there was no significant difference between the two groups at discharge. This study was small and exposure
was assumed based on deployment to Vietnam and not otherwise objectively
measured or validated. Only simple comparison testing was used, but the study
does indicate that studying stroke as a single category may lose statistical power
especially when attempting to study the effects of potential exposure to the COIs.
Occupational Studies Collins et al. (2016) offered additional follow-up time
to a retrospective analysis of a cohort of 2,192 workers exposed to dioxins during TCP and PCP production at chemical manufacturing plant in Michigan. The
U.S. population was used as the comparator for standardized mortality ratios.
Work history records were used to determine the length of exposure. Serum
samples were collected from 431 TCP and PCP workers to measure the levels
of six types of dioxins. The historical concentrations for each dioxin congener
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were calculated from the median concentrations from the serum samples and
the known half-lives associated with each congener. Complete vital status follow-up was achieved for the cohort, and there were 1,198 deaths through the
entire study period (1979–2011). For cerebrovascular disease, there were 68
deaths among all workers combined and no difference in the mortality rate
compared with the general population (SMR = 1.03, 95% CI 0.80–1.30). No
difference in mortality from cerebrovascular disease was found among the
TCP workers (n = 49; SMR = 1.07, 95% CI 0.79–1.41) or the PCP workers
(n = 27; SMR = 1.07, 95% CI 0.701–1.55). Although serum dioxin measurements
were collected, no results based on those measurements were presented for cerebrovascular disease; instead the authors used employment records to categorize
exposure, which may have introduced exposure misclassification, and use of the
general U.S. population as a comparison likely introduced selection bias.
Environmental Studies Van Larebeke et al. (2015) carried out a prospective study of the associations of exposure to organochlorine pollutants, HCB,
dioxin-like (PCB 118) and non-dioxin-like PCBs, and cadmium with a variety
of self-reported health conditions, including atheromata, as part of a Flemmish
biomonitoring program. Because a diagnosis of atheromata was assessed based
on three questions, one of which was “Did you have a problem with the blood
circulation in the brain (cerebrovascular incident, ischemic episode)?” the results
for atheromata were described in the section on IHD.
Other Identified Studies One other study that reported deaths from cerebrovascular disease was identified, but it was limited by a lack of exposure specificity
(Ruder et al., 2014).
Biologic Plausibility
Although no papers were identified that specifically addressed cerebrovascular disease and stroke following exposure to the COIs, many of the mechanisms
that influence stroke and cerebrovascular disease incidence and progression have
been shown to be targets of TCDD and the AHR pathway, as noted in the introduction of the biologic plausibility section under the circulatory diseases heading.
These mechanisms include impacts on endothelial cell function and proliferation,
inflammation, and blood vessel blockage.
Synthesis
Four new studies on cerebrovascular disease or stroke were reviewed for
the current update. Two studies followed Vietnam veterans. Cox et al. (2015)
used hospital discharge records from 1988 to 2009 to identify the health conditions that had affected the veterans. Among New Zealand veterans, 170 cases
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of cerebrovascular disease or stroke were observed, resulting in a significant
increase in the standardized hospitalization rate for acute cerebrovascular disease
compared with the general population. Han et al. (2016) published a hospitalbased case-control study of 91 Korean veterans presumed to have been exposed
to Agent Orange during their deployment to Vietnam who presented for medical
attention within 7 days of the onset of an acute ischemic stroke. The key finding
was a statistically different type of stroke between the presumed exposed and
unexposed groups, with small vessel occlusion more common in the exposed
subjects and large artery atherosclerosis more common in the unexposed subjects,
resulting in a somewhat better short-term prognosis for the exposed versus the
unexposed patients. While this study is small and requires replication as well as
exposure validation, it raises an important issue about including all stroke subtypes in future studies of stroke and exposure to the COIs. Among a long-term
follow-up of U.S. workers exposed to dioxins during TCP and PCP production,
Collins et al. (2016) found no difference in the mortality rate from cerebrovascular disease between the workers and the standardized general population, but
the study is limited by likely exposure misclassification and selection bias. In a
prospective study of environmental exposure to organochlorine pollutants, HCB,
and dioxin-like and non-dioxin-like PCBs in Belgium, Van Larebeke et al. (2015)
assessed levels of exposure with a variety of self-reported health conditions,
including atheromata. A small but statistically significant increase was found
between the 90th versus the 10th percentile of exposure, but this was found for
men only. The strengths of the study include its prospecitive design and large
sample size, the representativeness of the older adult population of Flanders, and
the use of objective measures of exposure. However, the findings are limited by
the study’s lack of validated medical diagnoses and by the fact that the data were
collected based on self-report from a survey that was not validated. No new data
specifically addressing the biological plausibity of the impact of exposure to the
COIs on cerebrovascular disease and stroke were identified. Therefore, on the
basis of the new studies, the committee maintained the previous conclusion of
limited or suggestive evidence between exposure to the COIs and cerebrovascular
disease or stroke.
Conclusion
After carefully reviewing the previous evidence as well as the new evidence
related to exposure to the COIs and cerebrovascular disease and stroke, the
committee maintains the prior conclusion of limited or suggestive evidence of
association that cerebrovascular disease and stroke are associated with exposure
to the COIs.
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Other Cardiovascular Outcomes
The previous sections in this chapter cover hypertension, IHD, and cerebrovascular disease and stroke. This section covers additional cardiovascular and
blood disorders that have been examined in studies that have measured exposure
to the COIs.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to
identify health conditions in 2,783 male New Zealand veterans who served in
Vietnam. Age-specific hospitalization rates were calculated using the total number of annual hospitalizations published by the Ministry of Health and the average annual resident population. Standardized hospitalization rates and 99% CIs
were calculated for the veteran cohort and the general population and reported
for cardiovascular and other outcomes. Syncope (n = 100; SHR = 1.47, 99%
CI 1.18–1.76) and phlebitis (n = 51; SHR =1.67, 99% CI 1.07–2.28) were
both elevated among the veterans compared with the standardized New Zealand
population. No difference in the hospitalization rate for peripheral atherosclerosis
(n = 70; SHR = 1.17, 99% CI 0.81–1.53) was found. Asymptomatic peripheral
arterial vascular disease is more common than symptomatic disease and does not
often result in death or hospitalization. This study was limited by its assumption
that deployment to Vietnam was synonomous with herbicide exposure, which was
not validated through serum measurements, and by the fact that important risk
factors, such as smoking and ethnicity, were not controlled for in the analysis.
Occupational Studies
Laverda et al. (2015) assessed the association between weight gain (using
BMI) and pesticide use using data on 8,365 male pesticide applicators from the
AHS. The goal was to assess the effect of common factors beyond high-calorie
diet and physical activity on BMI; pesticides were studied because many include
endocrine disruptors and thus have a biological rationale for why they might affect
BMI. Details of the AHS study design, exposure measurement, and data collection
are presented in Chapter 5. Multivariate linear regression was used to estimate the
unit change in BMI (kg/m2/d) associated with a unit change in exposure to a pesticide class/individual pesticide. To assess validity and the strength and direction
of the associations, partial Spearman correlation coefficients controlling for all
covariates were calculated for BMI at follow-up in relation to cumulative exposure
days to each pesticide class/individual pesticide. Ordinal logistic regression was
used to evaluate the exposure–response associations between BMI and pesticide
exposures. Models were adjusted for BMI at age 20 years (from enrollment data),
age, smoking, energy input, and energy output (from follow-up data). Results
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were also adjusted for the state of residence and used multiple test corrections. In
this analysis, 1,262 (15.1%) applicators reported exposure to phenoxy herbicides
(2,4,5-T and 2,4,5-TP), and 1,214 (14.9%) applicators reported exposure to 2,4-D.
The adjusted parameter estimate for unit change in BMI (kg/m2/d) was statistically significant for both phenoxy herbicides and 2,4-D in the entire sample (p =
0.02 for both), but when stratified by state, the two parameter estimates remained
statistically significant for Iowan applicators only.
Environmental Studies
S. A. Kim et al. (2015) used serum concentrations of persistent organic
pollutants, including dioxin-like and non-dioxin-like PCBs and organochlorine
pesticides collected within the 1999–2004 NHANES and adjusted for fat mass
in order to make associations with overall mortality, mortality from all cancers
combined, and mortality from CVDs in people 70 years and older. Among the 633
people for whom there was information on PCBs, 50 had died of cardiovascular
disease during the follow-up, while 56 had died among the 675 people for whom
there was information on organochlorine pesticides. Models were adjusted for
age, sex, race, BMI, cigarette smoking, and physical activity. When fat mass was
excluded from the analysis of PCB exposure by tertiles, the adjusted hazard ratio
for death from CVD in the second tertiles compared with the lowest exposure
(tertile 1) was not different (HR = 1.06, 95% CI 0.47–2.40), but it was elevated
for the third versus first tertile (HR = 2.37, 95% CI 1.10–5.09), and the trend for
increasing exposure was statistically significant (p = 0.02). For organochlorine
pesticides there was no difference in cardiovascular deaths between the second and third tertiles and the referent (p trend = 0.17). When individuals were
stratified by body fat mass (< 25%, 25%–75%, and > 75%) and estimates were
adjusted for the factors listed above, there were statistically significantly more
deaths from CVD with exposure to PCBs only for the comparison of the third
tertile with the first in the intermediate fat mass group (25– < 75%) (HR = 3.42,
95% CI 1.02–11.4), but this estimated is imprecise. This study was limited by the
relatively low numbers of deaths, especially when stratified by exposure levels.
This study measured death, not the incidence of disease, and it is possible that
the POPs affect development of disease differently than they affect survival once
the disease has been acquired.
Penell et al. (2014) investigated whether baseline circulating levels of POPs
can predict future changes in circulating lipid levels. They measured lipid levels
and the levels of 23 different POPs in 598 individuals in the PIVUS study at ages
70 and 75 years. No subjects were on lipid-lowering medications. POPs included
non-dioxin-like PCBs, organochlorine pesticides, one dioxin (OCDD), and one
brominated flame retardant compound. There were no significant difference related to the level of dioxin. The authors propose that the increase in low-density
lipoproteins could strengthen the link between POP exposure and CVD.
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Other Identified Studies
Zong et al. (2015) conducted a methodological study to assess the relationship between POPs and the fat mass percentage in the trunk, leg, and whole body,
so the study does not have direct relevance to a health outcome. Their rationale
was that since fat biopsies are used for assessing long-term lipophilic pollutant
exposure, the anatomical location of the biopsy may affect the estimated body burden of these chemicals. The analysis included 2,358 men and women 20 years of
age and older who had participated in NHANES 1999–2004 and who had stored
serum samples. Serum measurements of 49 to 68 POPs were measured using gas
chromatography/isotope dilution mass spectrometry. X-ray bone densitometry
was used for dual-energy X-ray absorptiometry scans and fat mass percentage
measurement. Demographics and information on lifestyle, medical history, and
the history of lactation and parity for women were collected using questionnaires.
Ethnicity, educational attainment, smoking and alcohol use, and physical activity
were used as covariates. β-hexachlorocyclohexane, heptachlorodibenzo-p-dioxin,
octachlorodibenzo-p-dioxin, and PCB 126 showed stronger positive correlations
with trunk fat mass percentage than with leg fat mass percentage, suggesting a
more important or greater role of trunk fat in the action and pharmacokinetics
of persistent organic pollutants as endocrine disrupters. This study highlights
one explanation for why studies may provide varying results on a metabolic or
cardiovascular effect of COI exposure depending on which anatomical site was
used for measurement.
Biologic Plausibility
Stea et al. (2016) suggest that the inconsistent associations of chronic lowdose exposure to arsenic on CVD may be due to high inter-individual variability in susceptibility to arsenic’s toxicity, a part of which is genetic. To assess
this relationship, 214 healthy Italian volunteers between the ages of 20 and
46 years were studied for arsenic and related compounds in first voided urine,
intima-media thickness, and genotypes for arsenic-metabolizing genes (ASIIIMT
Met287Thr, GSTT1+/−, and GSTM1+/−). The samples were tested for inorganic
arsenics (including trivalent and pentavalent), for methylated metabolites (i.e.,
mono-methylarsinic [MMA] and dimethylarsinic acid [DMA]), and for total
arsenic using high-performance liquid chromatography and mass spectrometry.
Intima-media thickness was measured on the common carotid artery on both sides
using carotid ultrasound by a trained cardiologist. All genotypes were obtained
by PCR and RFLP analysis. The main finding was that in both men and women
with chronic low dose exposure to arsenic, intima-media thickness increases significantly faster with age than in the healthy population. The findings also suggest
that GSTT1 and hOGG1 gene polymorphisms might play an important role in the
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individual risk of arsenic-induced carotid atherosclerosis, with the same exposure
providing differential outcomes.
Synthesis
In addition to outcomes related to hypertension, IHD, and cerebrovascular
disease, several studies presented other cardiovascular and circulatory outcomes.
However, most of these findings were of limited use because they examined different outcomes and different measures, and some of the outcomes were more
methodologic or surrogates in the pathway of disease. For example, Penell et
al. (2014) examined whether POPs can predict changes in lipid levels because
higher blood lipid levels are a risk factor for CVD; however, no association was
found for dioxin-like chemicals. S. A. Kim et al. (2015) conducted an analysis
using NHANES data to look for an association between the concentrations of
POPs (both dioxin-like and non-dioxin-like) and organochlorine pesticides and
mortality from CVD. While there were statistically significant trends in death
from cardiovascular disease among several subgroups classified by body fat, the
estimates were imprecise. Stea et al. (2016) examined how exposure to arsenic
may be a possible contributing factor to the individual risk of arsenic-induced
carotid atherosclerosis, but a genetic component appears to play a part. The study
of hospitalization risk among New Zealand Vietnam veterans used deployment
to Vietnam as an indicator of presumed exposure to herbicides, and in analyses
that did not control for smoking or other important risk factors of CVDs they
found elevated rates of syncope and phlebitis but not peripheral atherosclerosis.
Although there is similarity in the mechanisms by which atherosclerosis develops regardless of where it occurs (e.g., the heart, central nervous system, or
periphery), asymptomatic peripheral arterial vascular disease is more common
than symptomatic disease. The peripheral vascular disease literature is limited by
high rates of asymptomatic disease, the requirement for specific and often costly
testing to document clinically silent disease, death due to myocardial infarction
and stroke before diagnosis, and infrequency of death or hospitalization from
peripheral vascular disease alone.
In an assessment of weight gain (using BMI) and pesticide use from the
AHS, Laverda et al. (2015) found that the parameter estimate for unit change
in BMI (kg/m2/d) was statistically significant for both phenoxy herbicides and
2,4-D in the entire sample. However, based on the myriad studies and outcomes
examined, no conclusion can be made concerning an association of exposure to
the COIs and other cardiovascular disorders.
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Conclusion
After carefully reviewing the previous evidence as well as the new evidence
related to exposure to the COIs, the committee maintains the prior conclution
that there is inadequate or insufficient evidence that blood disorders and other
cardiovascular disorders are associated with exposure to the COIs.
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Other Chronic Health Outcomes

Chapter Overview
Based on new evidence and a review of prior studies, the current committee
did not find any new associations between exposure to the chemicals of interest
(COIs; 2,4-dichlorophenoxyacetic acid [2,4-D], 2,4,5-trichlorophenoxyacetic
acid [2,4,5-T], picloram, dimethylarsinic acid [DMA or cacodylic acid], and
2,3,7,8-tetrachlorodibenzo-p-dioxin [TCDD]) and other chronic, non-malignant
outcomes including respiratory disorders, gastrointestinal and digestive diseases,
adverse effects on thyroid homeostasis, kidney and urinary disorders, chronic
skin conditions, eye problems, and bone conditions. Current evidence supports
the results of earlier updates that:
• There is sufficient evidence of an association between the COIs and
chloracne.
• There is limited or suggestive evidence of an association between exposure to the COIs and hypothyroidism, early onset peripheral neuropathy,
and porphyria cutanea tarda.
• There is inadequate or insufficient evidence to determine whether there is
an association between exposure to the COIs and respiratory disorders,
gastrointestinal and digestive disease (including liver toxicity), kidney and
urinary disorders, adverse effects on endocrine function (other than hypothyroidism), chronic skin conditions, eye problems, or bone conditions.
This chapter discusses data on the possible association between exposure to
the COIs and several non-cancer health outcomes: respiratory disorders, gastrointestinal and digestive disease (including liver toxicity), adverse effects on thyroid
515
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homeostasis, kidney and urinary disorders, chronic skin conditions, eye problems,
and bone conditions. The committee also considers the results of studies of exposure to polychlorinated biphenyls (PCBs) and other dioxin-like chemicals to be
informative if they were reported in terms of TCDD toxic equivalents (TEQs) or
as concentrations of dioxin-like specific congeners. Although all studies reporting TEQs based on PCBs were reviewed, TEQs based only on mono-ortho PCBs
(which are PCBs 105, 114, 118, 123, 156, 157, 167, and 189) are several orders
of magnitude lower than those of the non-ortho PCBs (77, 81, 126, and 169),
based on the revised World Health Organization (WHO) toxicity equivalency
factor (TEF) scheme of 2005 (La Rocca et al., 2008; van den Berg et al., 2006).
The lower TEQs of the mono-ortho PCBs, however, may be counterbalanced by
their abundance, which is generally many orders of magnitude higher than that
of the non-ortho PCBs (Park et al., 2010).
In previous updates, chloracne and porphyria cutanea tarda were considered with the chronic non-cancer conditions. They are accepted as being asso
ciated with dioxin exposure, but they are considered acute outcomes and are
no longer considered specifically in this chapter. For each type of health outcome, background information is followed by a brief summary of the findings
described in earlier Veterans and Agent Orange (VAO) reports. In the discussion of the most recent scientific literature, the studies are grouped by exposure type (Vietnam veteran, occupational, or environmental). For articles that
report on the health outcomes of a previously studied population, the detailed
design information is summarized in Chapter 5. A synopsis of toxicologic and
clinical information related to the biologic plausibility of the COIs influencing the occurrence of a health outcome is presented next and is followed by
a synthesis of all the material reviewed. Each health-outcome section ends
with the committee’s conclusions regarding the strength of the evidence that
supports an association with the COIs. The categories of association and the
committee’s approach to categorizing the health outcomes are discussed in
Chapter 3.
NON-CANCEROUS RESPIRATORY DISORDERS
For the purposes of this report, “non-cancerous respiratory disorders” are
defined as all acute and chronic lung diseases other than cancers; the variety of
conditions are described by the International Classification of Diseases (ICD),
9th Revision (ICD-9 460–519) or 10th Revision (ICD-10 J00–J99). Acute noncancerous respiratory disorders include pneumonia and other respiratory infections; they can increase in frequency and severity when the normal defense
mechanisms of the lower respiratory tract are compromised.
Chronic non-cancerous respiratory disorders generally take two forms: airways diseases and parenchymal diseases. Airway diseases are disorders characterized by an obstruction of the flow of air out of the lungs; common examples
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are asthma and chronic obstructive pulmonary disease (COPD). COPD includes
such disorders as emphysema and chronic bronchitis. Parenchymal disease, or
interstitial disease, generally includes disorders that cause inflammation and
scarring of the deep lung tissue, including the air sacs and supporting structures.
Parenchymal disease is less common than airway diseases and is characterized
by a reduction in lung capacity, although it can also include a component of airway obstruction. Some severe chronic lung disorders, such as cystic fibrosis, are
hereditary. Because Vietnam veterans received health screenings before entering
military service, few severe hereditary chronic lung disorders are expected in
that population.
More than 25 million people in the United States are thought to be living
with asthma. As of 2015, the mortality rate for asthma among children and adults
in the United States was highest among African Americans with 13.2 deaths per
100,000 in people less than 35 years old. Non-Hispanic whites had the second
highest mortality rate, with 4.3 deaths per 100,000 in people less than 35 years
old. There are nearly 14.8 million people who have physician-diagnosed COPD,
but 12 million people are estimated to have undiagnosed COPD. The mortality
rate for COPD was highest among non-Hispanic whites, with 127.8 deaths per
100,000 people. Native Americans had a death rate of 81.1 per 100,000 in individuals 45 years and older. African Americans ranked third, with a rate of 78.4
deaths per 100,000 people 45 years and older. Mortality rates were lowest among
Asian or Pacific Islanders with 30.3 per 100,000 (healthypeople.gov, 2018b).
The most important risk factor for many non-cancerous respiratory disorders
is the inhalation of cigarette smoke. Although exposure to cigarette smoke is not
associated with every disease of the lungs, it is the major cause of many airway
disorders, especially COPD; it also contributes to some interstitial disease, and it
compromises host defenses in such a way that people who smoke are generally
more susceptible to some types of pneumonia. Cigarette smoking also makes
almost every respiratory disorder more severe and symptomatic than it would
otherwise be. The incidence rates of habitual cigarette smoking vary with occupation, socioeconomic status, and generation. For those reasons, cigarette smoking
can be a major confounding factor in interpreting the literature on risk factors for
respiratory disease. Vietnam veterans are reported to smoke more heavily than
non-Vietnam veterans (Kang et al., 2006; McKinney et al., 1997).
The causes of death from respiratory diseases, especially chronic diseases,
are often misclassified on death certificates (Mieno et al. 2016). Grouping various respiratory diseases for analysis, unless they all are associated with a given
exposure, will lead to an attenuation of the estimates of relative risk and to a
diminution of statistical power. Moreover, the diagnosis of the primary cause of
death from respiratory and cardiovascular diseases is often inconsistent. In particular, when a person had both conditions concurrently and both contributed to
the death, there may be some uncertainty about which cause should be selected
as the primary underlying cause. In other instances, errors may arise in selecting
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one underlying cause in a complex chain of health events (for example, if COPD
leads to congestive heart failure and then to respiratory failure).
Many study populations are small, so investigators often group deaths from
all non-cancerous respiratory diseases into one category that combines pneumonia, influenza, and other diseases with COPD and asthma. The committee notes
that an association between the group of all non-cancerous respiratory diseases
with any of the COIs would be too nonspecific to be clinically meaningful; at
most, such a pattern would be an indication that within this broad classification,
the incidence of some particular disease entity might be affected by an exposure
to a COI.
Conclusions from VAO and Previous Updates
The committee responsible for the initial VAO report (IOM, 1994) concluded
that there was inadequate or insufficient information to determine whether there
is an association between exposure to the COIs and respiratory disorders. Additional information available to the committees responsible for Update 1996
(IOM, 1996), Update 1998 (IOM, 1999), Update 2000 (IOM, 2001), Update
2002 (IOM, 2003c), and Update 2004 (IOM, 2005) also maintained the original
conclusion of an inadequate or insufficient level of association.
A number of studies of non-malignant respiratory diseases in Vietnam veterans have since been reviewed. However, the majority of these studies were not
able to control for major risk factors, such as smoking or tobacco use. Mortality
from respiratory diseases was not found to be higher than expected in the Centers
for Disease Control and Prevention’s Vietnam Experience Study (Boehmer et al.,
2004), in the Air Force Health Study (AFHS) (Ketchum and Michalek, 2005), or
in two Australian studies of Vietnam veterans (ADVA, 2005b,c), but it is possible
that the use of death certificates may have introduced some misclassification of
respiratory deaths (Drummond et al., 2010). In contrast, in the Army Chemical
Corps (ACC) cohort of Vietnam veterans, the prevalence of self-reported noncancerous respiratory problems diagnosed by a doctor was significantly increased
by about 40–60%, although no differences in the prevalence of respiratory problems were found in the subset of veterans whose serum TCDD was above 2.5
parts per trillion (Kang et al., 2006). Further study of cause-specific mortality in
the ACC cohort by Cypel and Kang (2010) found a statistically significant excess of mortality from COPD when comparing the deployedand non-deployed
groups. In a later analysis, Cypel and Kang were able to control for self-reported
herbicide exposure, body mass index (BMI), and smoking status but found no
statistically significant differences in respiratory diseases between sprayers and
nonsprayers. Deaths due to COPD were lower in non-deployed ACC veterans
than in males in the U.S. population; this is noteworthy because the prevalence
of smoking in the non-deployed ACC veterans was about twice that in men in
the U.S. population (Kang et al., 2006). Kang et al. (2014a) found lower risks
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of respiratory system disease deaths and COPD deaths in women veterans who
were deployed to Vietnam compared with non-deployed women veterans, but
these associations were not statistically significant.
Comparing New Zealand veterans who served in Vietnam with the standardized general male population of New Zealand, the risk of death from all nonmalignant respiratory diseases (excluding COPD) was statistically significantly
lower, but for COPD specifically no difference was found (McBride et al., 2013).
Researchers of the Korean Veterans Health Study applied the Stellman exposure
model and found no statistically significant difference for deaths from respiratory
disease (Yi et al., 2014a,b). A comparison of deaths in the low-exposure category
with the deaths in the high-exposure category found a statistically significant risk
for non-malignant respiratory diseases that was statistically significantly elevated
for COPD but not for pneumonia or asthma. A separate analysis of disease prevalence in the Korean Veterans Health Study used insurance claim data and found
no difference in the risk of diseases of the respiratory system overall between the
high-exposure and the low-exposure groups, but it did report statistically significant differences in the risks for COPD, pneumonia not due to influenza, chronic
bronchitis, bronchiectasis, and asthma (Yi et al., 2014a).
Several studies of occupational cohorts have also been reviewed by the many
VAO Update committees. Update 2000 (IOM, 2001) drew attention to findings
in the Seveso cohort that suggested a higher mortality from non-cancerous respiratory disorders in study subjects, particularly males, who were more heavily
exposed to TCDD. Additional follow-up of mortality in the Seveso cohort found
some increase in mortality from COPD at the 15- and 20-year points (Bertazzi
et al., 1998, 2001) as well as at the 25-year follow-up (Consonni et al., 2008).
Occupational and industrial cohorts in the United States, the United Kingdom,
New Zealand, and Australia did not find increased mortality from non-cancerous
respiratory diseases overall (Boers et al., 2010; Collins et al., 2009a,c; McBride
et al., 2009a), though they were unable to control for smoking. An update of the
National Institute for Occupational Safety and Health (NIOSH) cohort of pentochlorophenol (PCP) workers (Ruder and Yin, 2011) did not find an association
between exposure to the COIs and deaths from all non-malignant respiratory
diseases; no association with COPD deaths was found for the subgroup exposed
to both TCDD and PCP. Updated mortality data on workers in two chlorphenoxy
herbicide plants in the Netherlands were reanalyzed by Boers et al. (2012) using
serum measurements, but no association of TCDD exposure with respiratory diseases was observed. An updated mortality study of workers in a pesticide factory
with TCDD contamination (Manuwald et al., 2012) showed no association of
non-malignant respiratory disease with exposure.
No associations were observed with respiratory mortality in a small subcohort of New Zealand phenoxy herbicide sprayers ('t Mannetje et al., 2005) or
with mortality from COPD in private applicators or their spouses in the Agricultural Health Study (AHS) (Blair et al., 2005a). Several other studies using the
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AHS cohort that examined morbidity from particular self-reported respiratory
health problems, including wheeze, asthma, “farmer’s lung” or hypersensitivity
pneumonitis, and chronic bronchitis were examined by update committees, but
most findings were not statistically significant.
Based on the many studies considered in various cohorts that applied different designs, measures of exposure, and definitions of non-malignant respiratory
outcomes, the conclusion of inadequate or insufficient evidence of an association
between exposure to the COIs and mortality from all non-cancerous respiratory
diseases or from COPD specifically, has remained unchanged. There also remains
inadequate or insufficient evidence of an association between exposure to the
COIs and the prevalence of respiratory diseases, such as wheeze or asthma,
COPD, and farmer’s lung.
Update of the Epidemiologic Literature
This section summarizes the results of the relevant studies on respiratory
disorders and exposures to the COIs. One new study of Vietnam veterans and
respiratory disorders, one occupational study, and three other relevant studies
of respiratory disorders and the COIs have been identified since Update 2014.
Tables 43 and 44, which can be found at www.nap.edu/catalog/25137, summarize
the results of studies related to non-cancer respiratory disease and COPD and
pulmonary function, respectively.
Vietnam-Veteran Studies
Since Update 2014, one follow-up study of 2,783 male New Zealand Vietnam veterans, who served during 1964 to 1972 was identified and reviewed. Cox
et al. (2015) used hospital discharge records from 1988 to 2009 to report the
prevalent health conditions among this population. Age-specific hospitalization
rates were calculated using the total number of annual hospitalizations published
by the Ministry of Health and the average annual resident population. Standardized hospitalization rates and 99% confidence intervals (CIs) were calculated
for both the veteran cohort and the general population, and a standardized hospitalization ratio (SHR) was calculated using the two rates. Results showed a
statistically significant increase in the hospitalization risk for COPD (n = 300;
SHR = 1.68, 99% CI 1.43–1.93) and pneumonia (n = 174; SHR = 1.36, 99%
CI 1.09–1.63). No difference in the ratio was found for asthma, although the
estimate was decreased (n = 33; SHR = 0.84, 99% CI 0.46–1.21). Overall, the
results of this study showed a small increase in hospital admissions of Vietnam
veterans for COPD and pneumonia compared with the standardized population
of New Zealand. Because smoking is a major risk factor for respiratory conditions, the lack of smoking-adjusted ratios raises concerns about the validity of
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the estimates. Moreover, exposure to the COIs was not validated and was simply
assumed based on deployment to Vietnam.
Occupational Studies
Collins et al. (2016) added follow-up time for a retrospective cohort of 2,192
workers exposed to dioxins during trichlorophenol (TCP) and PCP production
at chemical manufacturing plant in Michigan. Workers were compared with the
U.S. population in order to calculate standardized mortality ratios, and work
history records provided information about the length of the exposure. Serum
samples used to measure levels of six types of dioxins were collected from 431
TCP and PCP workers. The historical concentrations for each dioxin congener
were calculated based on the median concentration in the serum samples and the
known half-lives associated with each congener. Complete vital status follow-up
was achieved for the cohort, and there were 1,198 deaths during the entire study
period (1979–2011). For the 1,198 TCP and PCP workers, there were 110 deaths
from respiratory system disorders, with an SMR of 0.94 (95% CI 0.77–1.13).
Henneberger et al. (2014) examined the exacerbation of asthma among
pesticide applicators with asthma who were enrolled in the AHS; details of the
AHS study design, data collection, and cohort are found in Chapter 5. In this
analysis, participants were selected for inclusion based on completing both the
baseline and an additional take-home questionnaire and having reported a doctor diagnosis of asthma and also having reported active asthma based on having
had at least one episode of wheezing or whistling in the previous 12 months and
having had breathing problems in the same time period. The final study sample
included 926 adult pesticide applicators with active asthma. Exacerbation was
defined as having visited a hospital emergency room or doctor for an episode
of wheezing or whistling in the previous 12 months. AHS participants were
asked about their use of individual pesticides, and this analysis focused on the
36 pesticides used in the 12 months before enrollment (current exposure) by at
least 10 applicators with at least two exacerbation cases. Logistic regression was
used to estimate odds ratios for pesticide exposure, controlling for age, state,
type of pesticide applicator (private or commercial), cigarette smoking status,
allergy status based on self-reports of doctor-diagnosed hay fever or eczema, and
adult onset of asthma based on onset at >20 years of age. No association with
an elevated odds of asthma exacerbation was found for either 2,4-D (OR = 0.8;
95% CI 0.5–1.3) or dicamba (OR = 1.0; 95% CI 0.6–1.6). Interaction models for
pesticide exposure and allergic status were not significant for 2,4-D and dicamba.
The authors interpreted the inverse associations as related to the possibility that
asthmatic farmers avoided certain activities and exposures. The AHS includes a
well-characterized cohort with self-reported pesticide exposure data that has been
shown to be reliable and the asthma and exacerbation outcomes were carefully
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defined. However, the data are cross-sectional, and the sequence of exposure and
events cannot be determined.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of
workers who were employed at the New Plymouth, New Zealand, phenoxy
herbicide production plant for at least 1 month between 1969 and 1984. The
plant produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, the
intermediates of TCP and other chlorophenols, and TCDD. Workers had previously been recruited and examined as part of the international cohort of producers of phenoxy herbicides led by the International Agency for Research on
Cancer (IARC) (Kogevinas et al., 1997); see Chapter 5 for more details on the
IARC cohort and the New Zealand phenoxy producers. This study extends the
follow-up period of these workers to approximately 30 years from their last
2,4,5-T production exposure. From the original cohort of 1,025 workers, 631
were living, had a current address in New Zealand, and were below 80 years of
age on January 1, 2006. For the current follow-up, 430 of the 631 workers were
randomly selected and invited to participate in the morbidity survey, of which
245 (57%) participated. The survey was administered in 2007–2008 by face-toface interview, and information was collected on demographic factors and health
information, including doctor-diagnosed conditions and the year of diagnosis.
A blood sample was also collected at that time and analyzed for TCDD, lipids,
thyroid hormones, and other substances. For 111 participants, a neurological
examination was conducted. Associations between exposure and health outcomes
were assessed using logistic regression models that controlled for age, gender,
smoking, BMI, and ethnicity using two different methods of exposure: having
worked in a TCDD-exposed job (based on occupational records) and having
serum TCDD concentration ≥10 pg/g lipid (18%). Mean TCDD concentrations
were 19 pg/g lipid in the 60 men directly involved in phenoxy/TCP production,
and 6 pg/g lipid in the 141 men and 43 women who worked in other parts of the
plant. Compared with the 124 people in the non-highly-exposed jobs, the 121
people who had ever worked in a highly exposed job were no more likely to
have doctor-diagnosed asthma (n = 8; OR = 1.13; 95% CI 0.40–3.22) or chronic
bronchitis (n = 3; OR = 2.39; 95% CI 0.17–34.0). When compared by serum
TCDD concentration ≥10 pg/g lipid, there were few cases of asthma or chronic
bronchitis, and no difference in risk was found. Diagnoses of tuberculosis, pleurisy, or pneumonia were also examined, but there were too few cases to present
valid estimates.
Cappelletti et al. (2016) performed a retrospective study of 331 male electric arc foundry workers at a single plant in Trentino, Italy, to determine if
they experienced excess mortality from all causes or were at an increased risk
for several other diseases, including asthma, due to occupational exposures to
foundry dust. Analysis of the dust emissions found that the dust contained metals
(including iron, aluminum, zinc, manganese, lead, chromium, nickel, cadmium,
mercury, and arsenic), polycyclic aromatic hydrocarbons (PAHs), PCBs, and
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polychlorinated dibenzo-p-dioxin/dibenzofurans (PCDD/Fs) (reported as TEQs).
Therefore, the authors could not determine which of the agents were associated
with a specific outcome or to what extent. The men had worked at the factory for
at least 1 year and, for the asthma analysis, were compared with 32 presumed
non-exposed workers (clerks, managers, and watchmen) or with the standardized general population of Region Trentino-Alto Adige (where the factory was
located) because there were few non-exposed foundry workers and high attrition
rates. Company and medical records were used to determine vital status; the cause
of death was determined from death certificates or other registries. Requests for
exemption health care fees were used as a surrogate measure to identify the most
common morbid conditions in the general population, which were then applied
to the cohort to compute the relative risks for each of the conditions. The workers
were followed from March 19, 1979 (or their first day of employment), through
December 31, 2009, or date of death. The analysis for asthma was limited to 235
workers, and effect estimates were calculated using Mantel-Haenszel tests. Only
two cases of asthma were found among the workers, and there was no difference
in risk compared with the age-adjusted provincial population, although the effect
estimate was imprecise (RR = 1.08, 95% CI = 0.27–4.31). This study is most
limited by the fact that foundry dust is a complex mixture, which made it impossible to discern the impact of the specific contaminants of the foundry dust on
the health outcomes of those exposed workers. Estimates were adjusted for only
the age group and were not adjusted for other risk factors such as tobacco use,
BMI, or other jobs or activities that could result in similar exposures. Exposure
to foundry dust by the general population that was used for comparison was not
discussed, although the foundry appears to be in the local vicinity, and emissions
from it were reported to be present within a 2-kilometer radius.
Other Identified Studies
Five other studies of non-malignant respiratory diseases were identified,
but all lacked sufficient exposure specificity to be included as contributing to
the evidence base of the potential effect of the COIs. One study of U.S. capacitor manufacturer workers exposed to mixed PCBs that reported on deaths from
respiratory diseases was identified, but it was limited by its lack of exposure
specificity (Ruder et al., 2014). An analysis of data from the AGRICAN French
cohort study examined the prevalence of respiratory diseases in adult men and
women who were active or retired farm workers or owners, but all exposures
and outcomes, which included asthma, were self-reported, and exposures to
specific pesticides were not ascertained (Baldi et al., 2014). Butinof et al. (2015)
conducted a cross-sectional study of male pesticide applicators who were licensed in Argentina and who were directly exposed to pesticides (n = 880). All
participants completed a self-administered questionnaire that was adapted from
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the U.S. AHS, which collected information about herbicides, insecticides, and
fungicides used, but no pesticide-specific exposure assessment was conducted,
which limited the study’s utility. A study of occupational exposure to pesticides
in Ethiopian farmers and farm workers and respiratory health effects was conducted by Negatu et al. (2016) but was not considered further since data on
specific pesticides were not collected. Finally, Akahane et al. (2017) examined
the prevalence of self-reported long-term health effects (including respiratory
disorders) in people exposed to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like
chemicals through the ingestion of contaminated rice bran oil (Yusho accident)
compared with an age-, sex- and residential-area-matched group. Because no
TEQs or other quantification of relevant exposures were presented, the study
was not considered further.
Biologic Plausibility
Several recent studies explored the pro- and anti-inflammatory activity of
TCDD exposure and of aryl hydrocarbon receptor (Ahr) in lungs in mice and in
mouse and human lung cells. These studies addressed such health effects as lung
response to viral infections, asthma, COPD, and allergen-induced lung inflammation. Cho et al. (2015) found that nuclear coactivator 7 (NCOA7) showed
differential activity in a cell-culture study of TCDD exposure in normal lung
epithelial and lung cancer cells with NCOA7 increasing CYP1A1 activity and
the levels of inflammatory cytokines in the diseased cells but not in normal cells.
S. M. Lee et al. (2017) found that AHR activation by the endogenous ligand
kynurenine plays a role in immune regulation in inflammatory responses in a
mouse model of lung injury.
Q. Liu et al. (2014) exposed juvenile zebrafish to TCDD in diet and reported
a novel finding of lesions in nasal epithelium. Boule et al. (2015) exposed mice
to TCDD during development and investigated their response to viral infection
as adults. Treated mice had increased bronchopulmonary inflammation with an
enhanced CD4+ T-cell response.
X. M. Li et al. (2016) found that TCDD-Ahr activation prevented inflammation and airway hyper-responsiveness in a non-eosinophilic asthma model
in mice. The lungs of treated mice showed reduced eosinophil and neutrophil
infiltration, and Th17 cytokine IL-17 was reduced in serum and bronchio-alveolar
lavage fluid (with Th2 cytokine IL-4 also reduced). In a study comparing Ahr
knockout and wild-type mice, T. Xu et al. (2015) found that TCDD treatment
enhanced mesenchymal stem cell recruitment, thereby suppressing allergen-induced
lung inflammation.
Sarill et al. (2015) explored the role of AHR and suggested that AHR has
a role regulating anti-oxidant defenses in lung structural cells. In Ahr knockout
mouse lung fibroblasts and human lung adenoma cells that were deficient in
AHR expression and exposed to cigarette smoke extract, they found increased
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oxidative stress compared to wild-type cells. They also showed that anti-oxidant
gene induction was significantly less in the Ahr knockout mouse lung fibroblasts.
In lung fibroblasts from mice with an Ahr mutation (incapable of DNA binding),
they showed that anti-oxidant sulfiredoxin 1 induction after cigarette smokeextract exposure was independent of dioxin-response element binding (i.e., a
role for AHR independent of exogenous ligand). In sum, the findings of Sarill
et al. (2015) suggest that low AHR expression may facilitate the development
or progression of COPD. Zago et al. (2017) studied the role of AHR and Cox-2
protein suppression and also concluded that low AHR contributes to increased
inflammation, based on their study in human lung fibroblasts.
Synthesis
Update 2014 included new data that did not add any compelling evidence
of an association of exposure to the COIs and respiratory disorders. The current update still does not display a coherent body of epidemiologic evidence to
support conclusions concerning whether the risks of other particular respiratory
problems are associated with exposure to the COIs. Cox et al. (2015) showed an
increase in hospitalization risk rates for COPD and pneumonia, but not asthma,
in New Zealand Vietnam veterans. However, smoking was not controlled for in
the analysis and exposure to the COIs was not verified. In a 30-year follow-up of
workers who produced 2,4,5-T in New Zealand, highly exposed workers did not
have an elevated risk of doctor-diagnosed asthma, chronic bronchitis, tuberculosis, pleurisy, or pneumonia compared with lower-exposed workers based on job
duties or serum TCDD concentration. The study of electric arc foundry workers
in Italy (Cappelletti et al., 2016) reported no difference in the risk of asthma, but
this was based on two cases. Moreover, the primary exposure, foundry dust, is a
complex mixture, and it is not possible to isolate any potential COI exposure. In a
follow-up of TCP and PCP workers at the Dow Midland, Michigan, plant, Collins
et al. (2016) did not find elevated mortality for respiratory system disorders.
Henneburger et al. (2014) found no association of asthma exacerbation with exposure to the COIs in the AHS. Therefore, the prior assessment cannot be altered
since the new findings are mixed, and the study designs have limitations.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence of an
association between exposure to the COIs and mortality from all non-cancerous
respiratory diseases or from COPD specifically. There is also inadequate or
insufficient evidence of an association between exposure to the COIs and the
prevalence of respiratory disorders.
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GASTROINTESTINAL AND DIGESTIVE DESEASES,
INCLUDING LIVER TOXICITY
This section discusses a variety of conditions specified by ICD-9 520–579 or
ICD-10 K00–K95: diseases of the esophagus, stomach, intestines, rectum, liver,
and pancreas. Details on peptic ulcer and liver disease, the two conditions most
often discussed in the literature reviewed, are provided below. The symptoms
and signs of gastrointestinal disease and liver toxicity are highly varied and often
vague.
The essential functions of the gastrointestinal tract are to absorb nutrients and
to eliminate waste. Those complex tasks involve numerous chemical and molecular interactions on the mucosal surface and complex local and distant neural and
endocrine activity. One common condition of the gastrointestinal tract is motility disorder, which is present in about 15% of adults. The most convenient way
to categorize diseases that affect the gastrointestinal system is according to the
affected anatomic segment. Esophageal disorders predominantly affect swallowing, gastric disorders are related to acid secretion, and conditions that affect the
small and large intestines are reflected in alterations in nutrition, mucosal integrity, and motility. Some systemic disorders (inflammatory, vascular, infectious,
and neoplastic conditions) also affect the gastrointestinal system.
Peptic-Ulcer Disease
Peptic-ulcer disease refers to ulcerative disorders of the gastrointestinal tract
that are caused by the action of acid and pepsin on the stomach or duodenal mucosa.
Peptic-ulcer disease is characterized as gastric or duodenal ulcer, depending on
the site of origin. Peptic-ulcer disease occurs when the corrosive action of gastric
acid and pepsin overcomes the normal mucosal defense mechanisms that protect
against ulceration. About 10% of the population has clinical evidence of having
had a duodenal ulcer at some time in their lives; a similar percentage is affected
by gastric ulcer. The incidence of duodenal ulcer peaks in the fifth decade, and
the incidence of gastric ulcer about 10 years later.
Evidence increasingly indicates that the bacterium Helicobacter pylori is
linked to peptic-ulcer disease (both duodenal and gastric). H. pylori colonizes
the gastric mucosa in 95–100% of patients who have a duodenal ulcer and in
75–80% of patients who have a gastric ulcer. Healthy people in the United States
under 30 years old have gastric colonization rates of about 10%. Over the age
of 60 years, colonization rates exceed 60%. Colonization alone, however, is not
sufficient for the development of ulcer disease; only 15–20% of subjects who
have H. pylori colonization will develop ulcers in their lifetime. Other risk factors include genetic predisposition (such as some blood and human leukocyte
antigen types), cigarette smoking, and psychologic factors (chronic anxiety and
stress).
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Liver Disease
Blood tests of liver function are the mainstay of diagnosing liver disease.
Increases in serum bilirubin and in the serum concentrations of some hepatic
enzymes—aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and γ-glutamyltransferase (GGT)—are commonly noted in liver disorders. The relative sensitivity and specificity of those enzymes for diagnosing
liver disease vary, and a diagnosis can require several tests. The only regularly
reported abnormality in liver function associated with TCDD exposure in humans
is an increase in GGT. The estimated serum activity of that enzyme is a sensitive
indicator of a variety of conditions, including alcohol and drug hepatotoxicity,
infiltrative lesions of the liver, parenchymal liver disease, and biliary tract
obstruction. Increases are noted after many chemical and drug exposures that
are not followed by evidence of liver injury. The confounding effects of alcohol
use (often associated with increased GGT) make it difficult to interpret changes
in GGT in exposed people (Calvert et al., 1992). An increase in GGT can be
considered a normal biologic adaptation to chemical, drug, or hormone exposure.
Cirrhosis is the most commonly reported liver disease in epidemiologic studies of herbicide or TCDD exposure. Cirrhosis is an irreversible chronic injury
of the liver with extensive scarring and a resulting loss of function. Clinical
symptoms and signs include jaundice, edema, abnormalities in blood clotting, and
metabolic disturbances. Cirrhosis can lead to portal hypertension with associated
gastroesophageal varices, an enlarged spleen, abdominal swelling attributable
to ascites, and, ultimately, hepatic encephalopathy that can progress to coma.
It is generally impossible to distinguish the various causes of cirrhosis through
the clinical signs and symptoms or pathologic characteristics. The most common cause of cirrhosis in North America and many parts of western Europe and
South America is excessive alcohol consumption. Other causes are chronic viral
infection (hepatitis B or hepatitis C), the poorly understood condition primary
biliary cirrhosis, chronic right-sided heart failure, and a variety of less common
metabolic and drug-related conditions.
Conclusions from VAO and Previous Updates
Several studies reviewed by previous VAO committees have reported on
several non-cancerous digestive system outcomes, and for that reason this section
and the update of new epidemiologic literature presents all results for digestive
and hepatobiliary outcomes by publication. Some studies that have been reviewed
focused on liver enzymes, while others reported on specific liver diseases. An
evaluation of the effects of herbicide and TCDD exposure on non-cancerous
gastrointestinal ailments is challenging in that clinical experience suggests that
medical history and physical examination are undependable diagnostic tools
for some ailments, so incidence data are sometimes problematic. The strong
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interdependence among the characteristics of a given person (such as weight and
the laboratory indexes of hepatic function and health) and TCDD body burden
complicates the already difficult task of assessing association.
Studies of Vietnam veterans have generally examined different laboratory
endpoints and clinical conditions, making comparisons and overall conclusions
difficult. An analysis of the AFHS found that a significantly higher percentage of
Ranch Hand veterans in the high-dioxin category had excesses of transaminase
and other nonspecific laboratory measures of liver function than their comparison
subjects. The data were consistent with an interpretation of a dose–response relationship, but other explanations were also plausible (AFHS, 2000). Later analyses
also reported some abnormalities in liver enzymes among the Ranch Hands,
including decreasing levels of C4 complement as dioxin increased and abnormal triglyceride concentrations that increased as the 1987 dioxin concentration
increased (AFHS, 2005). However, mortality studies of the Ranch Hand cohort
have not found an increased mortality related to gastrointestinal or liver disease
(Ketchum and Michalek, 2005). Among ACC veterans, an increased rate of
hepatitis was associated with Vietnam service but not with a history of spraying
herbicide (Kang et al., 2006), and an 80% excess of digestive system or cirrhosis
deaths was observed in veterans who handled or sprayed herbicides in Vietnam
compared with their non-Vietnam-veteran peers (Cypel and Kang, 2010).
Studies of digestive and liver disease among other Vietnam veterans cohorts
have not found associations with presumed herbicide exposure. The Australian
Vietnam-veterans study (ADVA, 2005b) did not find an increase in liver disease
in military personnel who served in Vietnam compared with the general population of Australia. The relationship between possible herbicide exposure and liver
and gastric-ulcer disease was described in a sample of Korean Vietnam-era veterans in three publications by Yi et al. (2013, 2014a,b). Based on health insurance
claims data, the adjusted prevalence of peptic-ulcer disease was found to be 3%
higher in those with high exposure than in those with low exposure after adjusting for several behavioral, demographic, and service-related factors. For liver
cirrhosis, there was likewise a small elevation in the prevalence and a significant
log-linear relationship between an exposure opportunity score and the odds of
having cirrhosis. In the mortality study in the same cohort of Korean Vietnam
veterans, there was no association between putative log-transformed exposure
and mortality from peptic ulcers (Yi et al., 2014b). However, highly exposed veterans were 17% more likely to die from cirrhosis than those with low exposure.
Deaths from alcoholic liver disease were also statistically significantly elevated
in the more highly exposed veterans.
Most of the analyses of occupational or environmental cohorts have had
insufficient numbers of cases to support confident conclusions. Gastric ulcer was
not associated with serum levels of dioxin-like PCDD/Fs or dioxin-like PCBs or
with total TEQs after adjusting for possible confounders in a general population
sample of 2,264 Japanese adults (Nakamoto et al., 2013). An analysis of National
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Health and Nutrition Examination Survey (NHANES) data on blood levels of 37
environmental pollutants and alanine aminotransferase levels in 1,345 persons
aged 12 years and older found that, in general, blood levels of dioxin-like chemicals were not significantly correlated with alanine aminotransferase levels. The
exception was 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin, which was associated
with only a slight elevation (< 1%) (Yorita Christensen et al., 2013).
A study of the IARC cohort of phenoxy-herbicide and chlorophenol production workers and sprayers (Vena et al., 1998), the only study that had a relatively
large number of observations, found less digestive system disease and cirrhosis
mortality in exposed workers than in non-exposed controls. The mortality results
through 2001 for the Seveso, Italy, cohort (Consonni et al., 2008) found no excess of deaths related to digestive diseases or specifically to cirrhosis. Several
mortality studies of various occupational cohorts exposed to the COIs have been
inconsistent but generally found no statistically significant increases in deaths
from either ulcers or cirrhosis (Boers et al., 2010, 2012; Collins et al., 2010a,b;
Manuwald et al., 2012; McBride et al., 2009a,b; Ruder and Yiin, 2011).
Thus, the reports have been inconsistent, and interpreting individual studies
is difficult because of a lack of information on alcohol consumption and other
risk factors. In the studies that showed the strongest association between potential
exposure and gastrointestinal disease (specifically cirrhosis), there was strong
evidence that excess alcohol consumption was the cause of the cirrhosis. The
committee responsible for VAO concluded that there was inadequate or insufficient information to determine whether there is an association between exposure
to the COIs and gastrointestinal and digestive disease, including liver toxicity.
Additional information available to the committees responsible for subsequent
updates has not changed that conclusion.
Update of the Epidemiologic Literature
One new study of gastrointestinal diseases among Vietnam veterans and two
occupational studies of workers in herbicide-producing plants have been identified since Update 2014.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to
identify health conditions that affected 2,783 male New Zealand veterans who
had served in Vietnam during 1964–1972. Age-specific hospitalization rates
were calculated using the total number of annual hospitalizations published by
the Ministry of Health and the average annual resident population. Standardized
hospitalization rates and 99% CIs were calculated for the veteran cohort and
the general population and reported for 14 conditions related to gastrointestinal and hepatobiliary outcomes. Those conditions were: esophageal disorders,
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gastroduodenal ulcer, gastritis, appendicitis, abdominal hernia, intestinal obstruction, diverticulosis, anal/rectal disorders, biliary disorders, alcoholic liver disease, other liver disease, pancreatic disease, abdominal pain, and gastrointestinal
hemorrhage. The risk of hospitalization for gastroduodenal ulcer was elevated
for veterans (n = 44; SHR = 1.80, 99% CI 1.10–2.50). Few cases of alcoholic
liver disease were found, but the risk of hospitalization was not different between
veterans and the general population (n = 11; SHR = 1.07, 99% CI 0.24–1.90).
The risk of hospitalization from other liver disease (not further defined) was
higher in veterans (n = 48; SHR = 1.86, 99% CI 1.17–2.55). No other increased
or decreased risks of gastrointestinal and hepatobiliary outcomes were found.
Exposure to the COIs was not validated and was assumed based on deployment
to Vietnam. Moreover, the analysis did not control for smoking or ethnicity or
other potentially important risk factors.
Occupational Studies
Collins et al. (2016) included additional follow-up time in a retrospective
analysis of a cohort of 2,192 workers exposed to dioxins during TCP and PCP
production at chemical manufacturing plant in Michigan. The U.S. population
was used as the comparator for estimating standardized mortality ratios. Work
history records were used to determine the length of the exposure. Serum samples
for measuring the levels of six types of dioxins were collected for 431 TCP and
PCP workers. The historical concentrations for each dioxin congener were calculated from the median concentrations from the serum samples and the known
half-lives associated with each congener. Complete vital status follow-up was
achieved for the cohort, and there were 1,198 deaths through the entire study
period (1979–2011). Deaths from ulcer of the stomach and duodenum (K25–K27)
and cirrhosis of the liver (K70–K74) were also included. No difference in the
mortality of ulcer of the stomach and duodenum was found for the TCP workers
(n = 2; SMR = 0.78, 95% CI 0.10–2.82), but an increased risk was found for the
PCP workers (n = 5; SMR = 3.38, 95% CI 1.10–7.89). However, the interpretation of this finding is limited because the number of deaths from ulcers was small
and the resulting risk estimates were imprecise. There were 16 total reported
deaths from liver cirrhosis, but no difference in mortality was found for the TCP
workers (n = 8; SMR = 0.44, 95% CI 0.19–87.2) or the PCP workers (n = 8; SMR
= 0.97, 95% CI 0.42–1.91) compared with the standardized U.S. population.
The committee notes that there is a possible mistake in the confidence interval
reported for the TCP risk estimate, but there is no compelling data to indicate that
cirrhosis of the liver is associated with exposure to dioxin. The committee also
notes that no new deaths from stomach or duodenum ulcer have been reported
since the last update of this cohort in 2003 (Collins et al., 2009a,b) at which time
a statistically significant increase in stomach and duodenal ulcer deaths was found
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for PCP workers but not TCP workers. Since 2003, two additional deaths from
liver cirrhosis among TCP workers were reported.
't Mannetje et al. (2018) conducted a morbidity survey among a subset of
workers who were employed at the New Plymouth, New Zealand, phenoxy herbicide production plant for at least 1 month between 1969 and 1984. The plant
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, the intermediates of TCP and other chlorophenols, and TCDD. Workers had previously
been recruited and examined as part of the international cohort of producers of
phenoxy herbicides led by IARC (Kogevinas et al., 1997); see Chapter 5 for more
details on the IARC cohort and the New Zealand phenoxy producers. This study
extends the follow-up period of these workers to approximately 30 years from
their last 2,4,5-T production exposure. From the original cohort of 1,025 workers, 631 were living, had a current address in New Zealand, and were below 80
years of age on January 1, 2006. For the current follow-up, 430 of the 631 workers were randomly selected and invited to participate in the morbidity survey,
of which 245 (57%) participated. The survey was administered in 2007–2008
by face-to-face interview, and information was collected on demographic factors and health information, including doctor-diagnosed conditions and the year
of diagnosis. A blood sample was also collected at that time and analyzed for
TCDD, lipids, thyroid hormones, and other substances. For 111 participants, a
neurological examination was conducted. Associations between exposure and
health outcomes were assessed using logistic regression models that controlled
for age, gender, smoking, BMI, and ethnicity using two different methods of
exposure: having worked in a TCDD-exposed job (based on occupational records)
and having serum TCDD concentration ≥10 pg/g lipid (18%). Mean TCDD concentrations were 19 pg/g lipid in the 60 men directly involved in phenoxy/TCP
production and 6 pg/g lipid in the 141 men and 43 women who worked in other
parts of the plant. Compared with the 124 people in the non-highly-exposed jobs,
the 121 people who had ever worked in a highly exposed job were no more likely
to have a doctor-diagnosed liver function problem (n = 10; OR = 0.84; 95% CI
0.30–2.34). When compared by serum TCDD concentration ≥10 pg/g lipid, there
were few cases of liver function problem, leading to imprecise effect estimates (n
= 3; OR = 0.54; 95% CI 0.12–2.36).
Other Identified Studies
Ruder et al. (2014) assessed cause-specific mortality including grouped diseases of the digestive system among 24,865 workers exposed to dioxin-like and
non-dioxin-like PCBs from three U.S. electrical capacitor manufacturing plants who
were employed 3 months or more from as early as 1939 through 1977. However, a
lack of exposure specificity precluded further consideration. Akahane et al. (2017)
examined the prevalence of self-reported long-term health effects in people exposed
to PCBs, dioxins (e.g., PCDD/Fs), and dioxin-like chemicals through the ingestion
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of contaminated rice bran oil (Yusho accident) compared with an age-, sex- and
residential-area-matched group. Because no TEQs or other quantification of the
relevant exposures was presented, the study was not considered further.
Yamamoto et al. (2015) studied 678 male workers at a waste incineration
plant in Japan. Blood samples were measured to determine the amounts of TCDD
and PCBs in the blood, and several markers of hematology and blood chemistry
profiles were also measured. Although some of these tests may be able to detect
liver dysfunction, it was not linked to a health outcome, and the study was not
considered further.
Biologic Plausibility
The liver is the first organ that encounters chemicals absorbed from the
gastrointestinal tract, and it is responsible for metabolizing them to water-soluble
chemicals that can be excreted in the urine. Because the liver has many detoxifying enzymes that efficiently metabolize many chemicals, liver toxicity is
usually associated only with high-dose acute exposure or lower-dose chronic
exposure. The liver can be damaged if the metabolism of a chemical results
in the production of a reactive intermediate that is more toxic than the parent
chemical. Changes in the serum concentrations of liver enzymes are biomarkers of liver toxicity, and their magnitudes correlate with the degree of liver
damage. The exposure of laboratory animals to high doses of 2,4-D, 2,4,5-T,
and TCDD is known to cause liver damage. The mechanisms by which the phenoxy herbicides damage the liver are based on the inhibition of mitochondrial
function by the blocking of oxidative phosphorylation; this leads to a loss of
generation of adenosine triphosphate, the death of cells, and hepatic necrosis
and fibrosis. TCDD-induced hepatotoxicity is mediated by the activation of the
AHR, which leads to changes in gene transcription and associated changes in
cell function. Changes in gene expression are associated with several physiologic processes, oxidative stress, and apoptosis (Boverhof et al., 2005, 2006).
TCDD-mediated hepatic steatosis is characterized by the accumulation of triglycerides caused by the combined up-regulation of CD36/fatty acid translocase
and fatty acid transport proteins, the suppression of fatty acid oxidation, the
inhibition of the hepatic export of triglycerides, an increase in peripheral fat
mobilization, and an increase in hepatic oxidative stress (J. H. Lee et al., 2010).
Recent evidence suggests that hepatic steatosis produced by TCDD might be
mediated by the mitochondria (He et al., 2013). The exposure of rats to TCDD
over a 2-year period (NTP, 2004) also produced several changes in the liver,
including hepatocyte hypertrophy, multinucleated hepatocytes, inflammation,
pigmentation, diffuse fatty change, necrosis, bile duct hyperplasia, bile duct cyst,
nodular hyperplasia, portal fibrosis, and cholangiofibrosis. Lamb et al. (2016)
studied a mouse model of liver injury and found that TCDD exposure increased
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liver damage and inflammation, suggesting that TCDD-activated AHR enhanced
hepatic stellate cell activity.
AHR displays species differences; for example, amino acid sequences in the
C-terminal region of human and mouse AHR are only 58% identical. Compared
with the mouse Ahr, the human AHR has about a 10-fold lower relative affinity
for TCDD; the difference has been attributed to the amino acid residue valine 381
in the ligand-binding domain of the human AHR (Flaveny et al., 2009; Ramadoss
and Perdew, 2004). The existence of species differences associated with AHR
activation is supported by the divergence in the transcriptomic and metabolomic
responses to TCDD in mouse, rat, and human liver (Boutros et al., 2008, 2009;
Carlson et al., 2009; Forgacs et al., 2012, 2013; Kim et al., 2009; Nault et al.,
2013; Watson et al., 2017). In a recent study, gene-expression changes were compared in adult female primary human and rat hepatocytes that had been exposed
to TCDD in vitro (Black et al., 2012). Whole-genome microarrays found that
TCDD produced divergent gene-expression profiles in rat and human hepatocytes,
both on an ortholog basis (conserved genes in different species) and on a pathway basis. For commonly affected orthologs or signaling pathways, the human
hepatocytes were about 15-fold less sensitive than rat hepatocytes. Another microarray study examining species-specific transcriptomic differences in primary
hepatocytes from humans, mice, and rats identified 16 orthologous genes that were
dysregulated by TCDD in all three species (Forgacs et al., 2013). Such findings are
consistent with epidemiologic studies that have shown humans to be less sensitive
to TCDD-induced hepatotoxicity. However, it should be noted that in vitro human
hepatocyte studies may not reflect the in vivo response of human liver to TCDD.
There have been few reports of health-relevant effects of phenoxy herbicides or TCDD on the gastrointestinal tract, even after high exposure. A series of
recent papers demonstrated the influence of TCDD and the Ahr pathway on the
development of the gut microbiome in mice (Stedtfeld et al., 2017a,b,c), which is
thought to influence immune response that may affect gastrointestinal disorders.
However, the available animal data do not support a plausible link between herbicide exposure and gastrointestinal toxicity in Vietnam veterans.
Synthesis
Previous updates indicated that there have been inconsistent findings for the
COIs and gastrointestinal and liver disease and that interpreting individual studies
is difficult because of a lack of information on alcohol consumption (especially
for liver cirrhosis) and other risk factors. The recent studies of Vietnam veterans
from New Zealand (Cox et al., 2015) and occupational cohorts of phenoxy herbicide producers (Collins et al., 2016; 't Mannetje et al., 2018) have not provided
informative evidence for an association with the COIs. Although a few animal
studies have shown an influence of TCDD and the Ahr pathway on the development of the gut microbiome in mice (Stedtfeld et al., 2017a,b,c), which may
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modify the immune response in gastrointestinal disorders. The available animal
data do not support a plausible link between herbicide exposure and gastrointestinal toxicity in Vietnam veterans.
Conclusion
On the basis of the evidence reviewed here and in previous VAO reports,
the committee concludes that there is inadequate or insufficient evidence to
determine whether there is an association between exposure to the COIs and
gastrointestinal and digestive diseases.
KIDNEY AND URINARY DISORDERS
Update 2014 was the first update for which the literature search identified
studies reporting results concerning a possible association between exposure to
the COIs and kidney diseases (ICD-9 580–589; ICD-10 N00–N29). The kidneys
are located in the lower back region; their main function is to filter wastes and
excess water out of the blood, which results in the production of urine. The
kidneys are also responsible for helping maintain the body’s chemical balance,
helping control blood pressure, and synthesizing hormones. When problems arise
with kidney function, it is often the result of damaged nephrons, which may leave
the kidneys unable to filter blood and, thus, unable to remove wastes, which can
then accumulate in the body. Chronic kidney disease is characterized by a gradual
and usually permanent loss of kidney function that often results in renal failure.
Diabetes, hypertension, and glomerulonephritis (acute inflammation) can all
increase the risk of kidney disease.
Conclusions from VAO and Previous Updates
Publications from the Korean Veterans Health Study included findings for
non-malignant kidney disease. Yi et al. (2013a) examined the prevalence of selfreported exposure based on six questions and self-reported kidney failure using a
postal survey of 114,562 Korean veterans who had served in the Vietnam War. The
incidence of kidney failure was compared by defining high and low categories of
exposure based on the six exposure questions and also by exposure opportunity
index (EOI) scores that were calculated. Self-reported kidney failure was statistically significantly increased when the analysis was based on perceived exposures,
but it was not significant when the analysis was based on the EOI scores. In a study
of cause-specific mortality through 2005 for 180,639 Korean veterans who were
alive in 1992, Yi et al. (2014b) found that after adjustment for age in 1992 and
rank, no differences in the hazard ratios were observed for acute renal failure or
for chronic renal failure when the analyses were based on the EOI scores.
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Two environmental studies of non-U.S. populations were also considered.
In a cross-sectional study of 2,264 Japanese men and women who had not been
occupationally exposed to dioxins, self-reported kidney disease (not otherwise
specified) was not associated with serum levels of dioxin-like PCDD/Fs or
dioxin-like PCBs or with total TEQs after adjusting for possible confounders
(Nakamoto et al., 2013). The second study sought to determine the factors contributing to a form of kidney disease not related to diabetes, hypertension, or
any other recognized cause in adults in Sri Lanka (Jayatilake et al., 2013). Urine
samples were taken from 57 cases and from 39 controls who were from nonendemic areas, and the samples were analyzed for 11 biomarkers of pesticides,
including the COIs 2,4-D, 2,4,5-T, and 2,4,5-TCP. Of these, only 2,4-D was
among the seven biomarkers found at concentrations above the limit of detection; 3.5% of the cases had 2,4-D concentrations above the reference limit of
0.3 μg/L. Since the urinary pesticide results were presented for only the cases,
no inference can be made about the relative risk for this kidney condition in
association with 2,4-D.
Based on these four studies, the committee for Update 2014 concluded that
there was inadequate or insufficient evidence of exposure to the COIs and nonmalignant kidney diseases.
Update of the Epidemiologic Literature
One new study of Vietnam veterans and kidney and urinary disorders has
been identified since Update 2014, as well as supporting occupational, environmental, and case-control studies of kidney and urinary disorders and exposure
to the COIs.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to
identify health conditions that affected 2,783 male New Zealand veterans who
had served in Vietnam during 1964–1972. Age-specific hospitalization rates
were calculated using the total number of annual hospitalizations published by
the Ministry of Health and the average annual resident population. Standardized
hospitalization rates and 99% CIs were calculated for the veteran cohort and the
general population and the two rates were used to calculate an SHR for several
conditions including kidney and urinary outcomes. An elevation in chronic renal
failure risk was identified (SHR = 1.21, 95% CI 1.07–1.36), with an acceleration
in the risk for later time periods. No significant associations were identified with
urinary tract infections (OR = 1.06, 95% CI 0.66–1.46), benign prostatic hypertrophy (OR = 1.11, 95% CI 0.79–1.42), or urinary stones (OR = 1.06, 95% CI
0.81–1.31). The exposures were not validated through serum measurements and
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were assumed based on deployment to Vietnam, and the study did not control for
smoking status, ethnicity, or other potentially important risk factors.
Occupational Studies
Two studies using data from the AHS were reviewed. Using a prospective
cohort design with an average of 16 years of follow-up, Lebov et al. (2016) evaluated the association between use of 41 specific pesticides and end-stage renal
disease in 55,580 male pesticide applicators. Significant associations were found
with several non-COIs (p for trend < 0.05), but there were no statistically significant associations with the phenoxy herbicides (2,4-D p for trend = 0.32; 2,4,5,T
p for trend = 0.55). An education level greater than high school and obesity at
enrollment were also associated with end-stage renal disease, as were diabetes,
high blood pressure, and kidney disease.
Lebov et al. (2015) evaluated the use of 50 pesticides and factors of use and
exposure, including frequency and duration, duration of residence on a farm,
specific farm tasks performed, household practices of pesticides, and end-stage
renal disease in the wives of pesticide applicators (n = 31,142). End-stage renal
disease was higher in women who were obese, who used nonsteroidal antiinflammatory drugs, or who had diabetes and hypertension. There was a protective effect associated with the personal use of any pesticide (hazard ratio [HR]
= 0.42, 95% CI 0.28–0.64), but among women who personally mixed or applied
pesticides, positive associations were observed only for the highest category of
lifetime exposure days (HR = 4.22, 95% CI 1.26–14.20), although the estimate
was imprecise. Wives with end-stage renal disease who reported having direct
exposure to phenoxy herbicides (n = 9; HR = 1.10, 95% CI 0.50–2.39) or 2,4-D
(n = 9; HR = 1.11, 95% CI 0.51–2.41) were found not to be at an elevated risk
of the disease. Among wives who reported no direct use of pesticides but whose
husbands used phenoxy herbicides (n = 47; HR = 0.86, 95% CI 0.49–1.51), 2,4-D
(n = 45; HR = 0.82, 95% CI 0.47–1.43), 2,4,5-T (n = 12; HR = 0.69, 95% CI
0.36–1.32), or 2,4,5-TP (n = 5; HR = 0.88, 95% CI 0.36–2.15), the risks of endstage renal disease were all decreased.
A third occupational exposure study was identified. 't Mannetje et al. (2018)
conducted a morbidity survey among a subset of workers who were employed
at the New Plymouth, New Zealand, phenoxy herbicide production plant for
at least 1 month between 1969 and 1984. The plant produced 2,4,5-T, and the
workers were potentially exposed to 2,4,5-T, the intermediates of TCP and other
chlorophenols, as well as to TCDD. Workers had previously been recruited and
examined as part of the international cohort of producers of phenoxy herbicides
led by IARC (Kogevinas et al., 1997); see Chapter 5 for more details on the
IARC cohort and the New Zealand phenoxy producers. This study extends the
follow-up period of these workers to approximately 30 years from their last
2,4,5-T production exposure. From the original cohort of 1,025 workers, 631
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were living, had a current address in New Zealand, and were below 80 years of
age on January 1, 2006. For the current follow-up, 430 of the 631 workers were
randomly selected and invited to participate in the morbidity survey, of whom
245 (57%) participated. The survey was administered in 2007–2008 by face-toface interview, and information was collected on demographic factors and health
information, including doctor-diagnosed conditions and the year of diagnosis. A
blood sample was also collected at that time and was analyzed for TCDD, lipids,
thyroid hormones, and other substances. For 111 participants, a neurological examination was conducted. Associations between exposure and health outcomes
were assessed using logistic regression models that controlled for age, gender,
smoking, BMI, and ethnicity using two different methods of exposure: having
worked in a TCDD-exposed job (based on occupational records) and having
serum TCDD concentration ≥10 pg/g lipid (18%). Mean TCDD concentrations
were 19 pg/g lipid in the 60 men directly involved in phenoxy/TCP production
and 6 pg/g lipid in the 141 men and 43 women who worked in other parts of
the plant. Compared with the people in the non-highly exposed jobs, the people
who had ever worked in a highly exposed job at the plant were no more likely
to have a doctor-diagnosed kidney function problem (n = 13; OR = 0.82, 95%
CI 0.34–1.99). When compared by serum TCDD concentration, no difference in
the risk of kidney function problems was found for workers in the high- versus
low-exposure groups (n = 5; OR = 1.03, 95% CI 0.32–3.33).
Environmental Studies
Using data from the 1999–2004 cycles of NHANES, Everett and Thompson
(2016) evaluated the association of blood levels of three chlorinated dibenzop-dioxins, one chlorinated dibenzofuran, and four dioxin-like PCBs with nephro
pathy (microalbuminuria or macroalbuminuria) among 1,505 adolescents and
young adults (12–30 years of age) with normal glycohemoglobin (A1c < 5.7%).
In logistic regression models 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin (OR = 51.1,
95% CI 4.1–641.6), PCB 126 (OR = 8.9, 95% CI 2.0–39.7), PCB 169 (OR = 9.4,
95% CI 1.02–87.6), and PCB 156 (OR = 17.9, 95% CI 2.1–152.6) were associated with nephropathy (OR = 7.1, 95% CI 1.8–28.1) when one or more of these
four dioxin-like chemicals was elevated; however, the effect estimates are quite
imprecise. The effect was driven by females (OR = 17.4, 95% CI 3.4–88.6),
as among males there were no cases of nephropathy when one or more of
the four dioxin-like chemicals were elevated. These results were verified by
TEQs; TEQ8 ≥ 50.12 fg/g was associated with nephropathy among females
(OR = 11.9, 95% CI 1.6–87.2) but not males. Thus, in a cross-sectional study,
dioxin-like chemicals were associated with nephropathy among young females,
but not males, though reverse causality cannot be excluded, and the effect estimates were very imprecise.
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Two analyses using data from the cross-sectional, community-based study
in the Annan District of Tainan City, Taiwan, where a former PCP factory had
operated, and had released PCDD/Fs into the surrounding area, were identified
that examined outcomes related to kidney disease (J. W. Chang et al., 2013; C. Y.
Huang et al., 2016). As described in Chapter 5, people who were 18 years of age
and older and who were residents of the exposure area were asked to participate
in the study. Health examinations were performed on each participating individual, and serum samples had been previously collected and measured for levels of
dioxins by the Tainan City Bureau of Health. A self-administered questionnaire,
which was administered at the same time as the examination, was used to collect
demographic information and medical history. C. Y. Huang et al. (2016) examined
chronic kidney disease, defined as having an estimated glomerular filtration rate
≤ 60 mL/min/1.73m2 or having been diagnosed by a physician. People diagnosed
with congenital kidney disease, IgA nephropathy, post-infectious kidney disease, or medicine-induced kidney disease were excluded from the study. Of the
2,828 participating individuals, 1,427 had high dioxin levels (defined as > 20 pg
WHO98-TEQDF/g lipid in the serum), and 156 had chronic kidney disease. High
dioxin levels were associated with an increased prevalence of chronic kidney
disease compared with low dioxin levels (10.9% versus 1.6%, respectively, p <
0.001). After adjustment for PCDD/Fs, gender, mercury, metabolic syndrome,
age, fasting glucose, insulin, and uric acid, a high dioxin level was found to
be significantly associated with chronic kidney disease (OR = 1.74, 95% CI
1.02–2.97). The strengths of this study include a large population, adjustments
for age, fasting glucose, insulin, and uric acid, as well as serum measurements of
exposure and a clear definition of chronic kidney disease. However, this study is
limited by having had no follow-up of renal function measurements, the fact that
the serum PCDD/Fs levels were collected over an extended period of time that
ended about 3 years before the interview and health examination, unknown age at
first exposure to PCDD/Fs, unknown duration of exposure, unknown cumulative
exposure dose, the cross-sectional design, and a lack of additional data collection.
Data on other potential confounders, such as waist circumference, dietary intake,
and socioeconomic status, were not available.
Case-Control Studies
Raines et al. (2014) examined agricultural behaviors and health outcomes
via questionnaire in a Nicaraguan community. Of the 424 total participants, 151
reported an occupational history of agriculture. The pesticides that were reported
by participants as commonly used included 2,4-D. Decreased glomerular filtration
rate was found in 9.8% of the women and 41.9% of the men. Glomerular filtration
rate was associated with cutting sugarcane during dry season (OR = 5.86, 95%
CI 2.45–14.01) and sugarcane chewing (OR = 3.24, 95% CI 1.39–7.58). Glomerular filtration rate was also associated with non-deliberate pesticide inhalation
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(OR = 3.31, 95% CI 1.32–8.31). This study is limited by its lack of exposure
validation through serum or other measures.
Other Identified Studies
Two other studies of kidney and urinary disorders were identified, but both
were limited by a lack of exposure specificity (Orantes et al., 2015; Ruder et al.,
2014). In a study of women in agricultural communities in El Salvador (Orantes
et al., 2015), the authors examined exposures to various agrochemicals, which
may have included organophosphate insecticides as well as phenoxy herbicides
(2,4,-D, hedonal), but the results were not stratified by chemical exposures, and
thus the study was not considered further.
A third study was also identified, but instead of being limited by exposure
specificity, it was limited by the fact that the outcomes examined were not
diagnosed health outcomes but rather indicators of biologic effects. In a separate
analysis of people residing near the former PCP factory in Taiwan, J. W. Chang et
al. (2013) evaluated associations between PCDD/Fs and the risk of hyperuricemia
(too much uric acid in the blood) in a subset of healthy subjects from the community health study (n = 1,531). Serum levels of 17 2,3,7,8-substituted PCDD/Fs
were measured, and associations were tested between the serum TEQDF-2005
(total PCDD/Fs 2005 WHO TEQ) and various factors, including uric acid, glomerular filtration rates, and hyperuricemia risk. Hyperuricemia is a measure of
disturbed metabolism, not a health outcome, and therefore this study was not
considered relevant to the committee’s task.
Biologic Plausibility
Studies of mice, rats, goldfish, and zebrafish have documented kidney toxicity from TCDD exposure. Studies of 2,4-D in goldfish and TCDD in rats report
oxidative stress in kidneys (Matviishyn et al., 2014; Palaniswamy et al., 2014).
Q. Liu et al. (2014) investigated the effects of developmental exposure to TCDD
in zebrafish and found kidney lesions and the dysregulation of the genes involved in renal necrosis and cell death as well as decreased hematopoietic cells
in the kidney marrow. Aida-Yasuoka et al. (2014) reported a chance finding that
C57BL/6J mouse pups are more susceptible to TCDD-induced hydronephrosis
than BALB/cA mice; in pups exposed to TCDD on postnatal days 1–7, the prevalence of hydronephrosis was 64% in the C57BL/6J pups and 0% in BALB/cA
pups. In both strains of mice, the Ahr receptors are highly responsive to TCDD;
however, genetic differences were found in expression of renal m-Prostaglandin
E synthase-1 and early growth response 1 (Egr-1). In a study of mice, Bu et
al. (2017) found that Ahr activation up-regulates glucose transporter 9 (Glut9),
which plays a role in maintaining uric acid homeostasis.
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Synthesis
Since Update 2014, seven studies have been reviewed for kidney disease
and urinary disorder outcomes related to exposure to the COIs. A hospitalization study of New Zealand Vietnam veterans found that chronic renal failure
risk was statistically significantly increased among the veterans compared with
the standardized general population of New Zealand, but there was no difference in the prevalence of other kidney or urinary outcomes (Cox et al.,
2015); however, there was no exposure validation, some of the conditions
(such as urinary tract infections) do not typically require hospitalization, and
potentially important risk factors were not adjusted for in the analysis. In a
30-year follow-up study of New Zealand workers in a plant that produced
2,4,5-T, having a doctor-diagnosed kidney function problem was not different
for workers in high- versus low-exposure groups, based on reported job and
duties in the plant or on serum TCDD levels. Two analyses of end-stage renal
disease in the AHS (Lebov et al., 2015, 2016) found no statistically significant
associations with the phenoxy herbicides 2,4-D or 2,4,5-T among the male
pesticide applicators or their wives. In an analysis of NHANES, Everett and
Thompson (2016) evaluated the association of the blood levels of three chlorinated dibenzo-p-dioxins, one chlorinated dibenzofuran, and four dioxin-like
PCBs with nephropathy among 1,505 adolescents and young adults and found
that dioxin-like chemicals were associated with nephropathy among young
females, but not males, although the effect estimates were very imprecise. An
environmental exposure study of Taiwanese residents living in close proximity to a former PCP-producing factory found that those who had high serum
dioxin levels had a statistically significantly elevated risk of chronic kidney
disease (Huang et al., 2016). A second analysis of this population was identified (Chang et al., 2013), but because it examined hyperuricemia, which is
a measure of disturbed metabolism and not a recognized health outcome, it
was not considered as part of the evidence base of chronic kidney conditions
related to exposure to the COIs. A cross-sectional study of agricultural behaviors, including the use of 2,4-D, and health outcomes in a Nicaraguan community (Raines et al., 2014) found a decreased glomerular filtration rate to
be associated with cutting sugarcane, sugarcane chewing, and non-deliberate
pesticide inhalation, but no serum or other objective measure of exposure
were collected. Studies of mice, rats, goldfish, and zebrafish document kidney
toxicity from TCDD exposure, but such outcomes do not present a consistent
mechanism for the kidney dysfunction diseases in humans. Epidemiology studies concerning exposure to the COIs and kidney diseases were not reported
prior to Update 2014. However, the new epidemiologic findings reviewed do
not present a coherent pattern of an association between exposure to the COIs
and kidney or urinary disorders.
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Conclusion
After reviewing the new evidence of exposure to the COIs and non-malignant kidney and urinary outcomes, the committee concludes that there remains
inadequate or insufficient evidence of an association between exposure to the
COIs and non-malignant kidney or urinary disorders.
THYROID HOMEOSTASIS AND OTHER ENDOCRINE FUNCTIONS
This section discusses a variety of conditions related to endocrine function,
excluding diabetes and other pancreatic disorders, which were discussed in Chapter 10: Cardiovascular and Metabolic Outcomes. In particular, clinical disruptions of thyroid function are grouped as ICD-9 240–246 or as ICD-10 E00–E07,
E20–21, while the remaining endocrine disorders are grouped as ICD-9 252–259
or as ICD-10 E22–E35. Thyroid homeostasis in humans was first addressed with
respect to the COIs by the committee for Update 2002.
The thyroid secretes the hormones thyroxine (T4) and triiodothyronine (T3),
which stimulate and help to regulate metabolism throughout the body. The thyroid also secretes calcitonin, a hormone that controls calcium concentration in the
blood and the storage of calcium in bones. Secretion of T4 and T3 is under the
control of thyroid-stimulating hormone (TSH), which is secreted by the anterior
pituitary. Iodine operates in thyroid physiology both as a constituent of thyroid
hormones and as a regulator of glandular function. Concentrations of those circulating hormones are regulated primarily by a negative-feedback pathway that
involves three organs: the thyroid, the pituitary, and the hypothalamus. In the
hypothalamus–pituitary–thyroid feedback scheme, the hypothalamus releases
thyrotropin-releasing hormone (TRH), which stimulates the pituitary to produce TSH, which in turn triggers the thyroid to produce T4 and T3. Cells in the
hypothalamus and pituitary respond to concentrations of circulating T4 and T3.
When T4 and T3 are low, the pituitary is stimulated to deliver more TSH to the
thyroid, which increases T4 and T3 output. When circulating T4 and T3 are high,
it triggers a reduction in the output of TRH and TSH. The negative-feedback loop
maintains hormone homeostasis.
A disruption of thyroid homeostasis can be stimulatory (hyperthyroidism)
or suppressive (hypothyroidism). Both conditions are diagnosed on the basis of
blood concentrations of thyroid hormones, TSH, and other proteins (antithyroid
antibodies). The prevalence of thyroid dysfunction in adults in the general population ranges from 1% to 10%, depending on the group, the testing setting, sex,
age, the method of assessment, and the presence of conditions that affect thyroid
function. People who have subclinical (biochemical) conditions may or may not
show other signs or symptoms of thyroid dysfunction.
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It is important to distinguish between potential effects on adults and effects
that may occur during development. In adults, the thyroid is able to compensate,
within reasonable limits, for mild or moderate disruption (such as that caused by
hyperplasia or goiter). In contrast, the fetus is highly sensitive to alterations in
thyroid hormones, and alterations in thyroid homeostasis can hamper the development of many organ systems, including the nervous and reproductive systems;
such findings are discussed in Chapter 8, which addresses the potential effects of
Vietnam veterans’ exposure to herbicides on their offspring. Only observations
on adults are considered here.
Conclusions from VAO and Previous Updates
Thyroid homeostasis in humans was first addressed with respect to the COIs
by the committee for Update 2002. After consideration of several new studies and
because of the consistent observations of exposures to the COIs being related to
perturbations of thyroid function—and to clinical hypothyroidism in particular—
the committee for Update 2014 considered the body of epidemiologic data, in
combination with strong biologic plausibility, to represent limited or suggestive
evidence of an association between exposure to the COIs and hypothyroidism.
Additional endocrine effects have been observed in conjunction with exposure
to the COIs in both humans and animals, but the evidence is inadequate or insufficient to establish an association with herbicide exposure for them.
An extensive assessment of endocrine function in clinical examinations,
including a series of thyroid-function tests, failed to show systematic differences
in thyroid function between Ranch Hands and comparison veterans (AFHS,
1991a). In analyzing individual TCDD readings obtained for subjects in the
AFHS, however, Pavuk et al. (2003) found statistically significantly increased
TSH measures from the 1985 and 1987 examinations in the high-exposure category and a significant increasing trend across the three TCDD categories during
the 1982, 1985, 1987, and 1992 examinations. No increased risk of disorders of
the thyroid was found among a study of Australian Vietnam veterans (O’Toole et
al., 2009). Among Korean Vietnam veterans, two publications considered thyroid
outcomes (Yi et al., 2014a,b). The first (Yi et al., 2014a) used claims data to report
on the prevalence of disorders of the thyroid gland in 111,726 veterans and found
an increased risk of thyroid conditions overall (ICD-10 E00–E07) with herbicide
exposure, after adjustment for several factors. The pattern was very similar for
both non-iodine-deficiency hypothyroidism (ICD-10 E03) and for other nontoxic goiter (ICD-10 E04). The risk of thyroiditis (ICD-10 E06) overall was not
found to be significantly associated with herbicide exposure, but the strongest
endocrine-related results were for autoimmune thyroiditis (ICD-10 E06.3), a
subcategory of thyroiditis. No difference in the risk of hyperthyroidism (ICD-10
E05) was found between high- and low-exposure groups. Comparing the highexposure group with the low-exposure group based on EOI scores, an elevated
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risk was observed for pituitary hypofunction (p = 0.011), while the risk of pituitary
hyperfunction was not different between high- and low-exposure groups. The risk
of hyperaldosteronism was also not elevated. A mortality analysis of the Korean
Vietnam veteran cohort of 180,639 male veterans did not find any association
between herbicide exposure and deaths from endocrine diseases when the cohort
was analyzed as a group (Yi et al., 2014b).
Few studies of thyroid function have been conducted among occupational
cohorts exposed to the COIs. Calvert et al. (1999) provided evidence of higher
adjusted mean free-T4 concentrations in TCDD-exposed workers in the NIOSH
Cross-Sectional Medical Study, but there was no dose–response relationship
with serum TCDD. Bloom et al. (2006) found indications of an inverse relationship between the sum of dioxin-like chemicals and the concentration of free T4
in anglers in New York State, but no association between the sum of dioxinlike chemicals and TSH or T3. An analysis of the AHS that was restricted to
male private pesticide applicators examined self-reported physician-diagnosed
hyperthyroidism, hypothyroidism, and other thyroid conditions and the use of 50
specific agents, including 2,4-D, 2,4,5-T, and 2-(2,4,5-triphenoxy) proprionic acid
(2,4,5-TP) (Goldner et al., 2013). After adjusting for age, education, and BMI, the
odds of hypothyroidism for ever-use versus never-use were significantly elevated
for 2,4-D, for 2,4,5-T, and for 2,4,5-TP. In comparison with those who had never
used 2,4-D, an increased risk of hypothyroidism was seen in both those who had
used 2,4-D for more than the median number of days and those whose days of
2,4-D use were fewer than the median (p-trend = 0.025). The use of 2,4,5-TP
was found to be associated with a decreased risk of hyperthyroidism. None of the
phenoxy herbicides were found to be related to having histories of other thyroid
diseases. In an Italian study that compared urban and rural workers, Ciarrocca et
al. (2012) found that the workers’ urinary arsenic levels differed by a factor of
between 2 and 4, and urinary arsenic was positively correlated with serum TSH
and thyroglobulin and negatively with free T3 and T4.
The results from several environmental studies have also been reviewed by
update committees, and no evidence was found of effects on thyroid function
or disease in women exposed to pesticides (Chevrier et al., 2008) or, among
women in the AHS, exposed to phenoxy herbicides (Goldner et al., 2010). Using data from NHANES III (1988–1994), Schreinemachers (2010) did not find
associations between recent exposure to 2,4-D and T4 or TSH concentrations. An
analysis of 1999–2002 NHANES data (Turyk et al., 2007) found total T4 to have
a weak inverse relationship with serum TEQs; the effect was somewhat stronger
in people over 60 years old and in women.
Among women exposed in the Seveso incident, a significant inverse asso
ciation was found between serum concentrations of TCDD over a 20-year period (1976–1996) with serum total T4, but not with TSH or free T3, which
were measured in 1996. This association was stronger for women who were
exposed before menarche than for women exposed after menarche. When thyroid
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hormones were measured again in 2008 and compared with TCDD levels in
1976 and 1996, the association was no longer present (Chevrier et al., 2014).
In a cross-sectional study of 2,264 Japanese men and women who had not
been occupationally exposed to dioxins, self-reported thyroid disease (not otherwise specified) was not associated with serum levels of dioxin-like PCDD/Fs
or dioxin-like PCBs or with total TEQs after adjusting for possible confounders
(Nakamoto et al., 2013). Abdelouahab et al. (2008) described thyroid function in
adult freshwater-fish consumers in Canada; dioxin-like congeners were associated with an increase in TSH and a decrease in T4 but below the threshold at
which clinical symptoms would be present. Clear effects of dioxin-like chemicals
on thyroid function were not apparent in Inuit adults (Dallaire et al., 2009) or in
a cross-sectional study of a Chinese community exposed to an electronic-waste
recycling plant (J. Zhang et al., 2010). Manh et al. (2013) and Kido et al. (2014)
studied steroid hormone levels in the serum and saliva and dioxin concentrations
in the breast milk of lactating Vietnamese women living in an “Agent Orange
hot spot” (n = 51) or in an area with no suspected exposure (n = 58). Levels of
cortisol and corticosterone in serum and saliva were higher in those women living in the hot spot area and were positively correlated with breast-milk dioxin
concentrations. Trnovec et al. (2013) measured thyroid gland volume and free
T4 in 320 adults from an organochlorine-contaminated area in Slovakia. Blood
samples from these subjects produced readings above the limits of detection for
all 7 dioxins, 8 of 10 furans, and all but 1 of the 12 PCBs on the 2005 WHO list
of dioxin-like chemicals.
Update of the Epidemiologic Literature
One new epidemiological study of occupational exposures to the COIs and
thyroid or endocrine effects has been identified for this update. Table 45, which
can be found at www.nap.edu/catalog/25137, summarizes the results of studies
related to thyroid homeostasis that have been reviewed in the VAO series.
Occupational Studies
't Mannetje et al. (2018) conducted a morbidity survey among a subset of
workers who were employed at the New Plymouth, New Zealand, phenoxy herbicide production plant for at least 1 month between 1969 and 1984. The plant
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, the intermediates of TCP and other chlorophenols, and TCDD. Workers had previously
been recruited and examined as part of the international cohort of producers of
phenoxy herbicides led by IARC (Kogevinas et al., 1997); see Chapter 5 for more
details on the IARC cohort and the New Zealand phenoxy producers. This study
extends the follow-up period of these workers to approximately 30 years from
their last 2,4,5-T production exposure. From the original cohort of 1,025 workers,
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631 were living, had a current address in New Zealand, and were below 80 years
of age on January 1, 2006. For the current follow-up, 430 of the 631 workers were
randomly selected and invited to participate in the morbidity survey, of which
245 (57%) participated. The survey was administered in 2007–2008 by face-toface interview and information was collected on demographic factors and health
information, including doctor-diagnosed conditions and the year of diagnosis.
A blood sample was also collected at that time and analyzed for TCDD, lipids,
thyroid hormones, and other substances. Associations between exposure and
health outcomes were assessed using logistic regression models that controlled
for age, gender, smoking, BMI, and ethnicity using two different methods of exposure: having worked in a TCDD-exposed job (based on occupational records)
and having serum TCDD concentration ≥10 pg/g lipid (18%). Mean TCDD concentrations were 19 pg/g lipid in the 60 men directly involved in phenoxy/TCP
production and 6 pg/g lipid in the 141 men and 43 women who worked in other
parts of the plant. Compared with the people in the non-highly exposed jobs, the
people who had ever worked in a highly exposed job at the plant were no more
likely to have a doctor-diagnosed thyroid disorder (n = 6; OR = 0.95, 95% CI
0.19–4.67). When compared by serum TCDD concentration, no difference in the
risk of thyroid disorder was found for workers in the high- versus low-exposure
groups (n = 5; OR = 4.00, 95% CI 0.76–21.0), but the estimate is very imprecise
owing to the small number of cases.
Other Identified Studies
Three additional epidemiologic studies were identified that presented outcomes on endocrine and metabolic effects. A cross-sectional study of endocrine effects from the use of pesticides was conducted using a random sample
of agricultural workers aged 18–69 years old in Brazil (Piccoli et al., 2016).
Although questionnaires that collected detailed information on exposures were
administered by trained interviewers to the participants and blood samples
were collected from all participants to test cholinesterase activity, serum residues of organochlorine pesticides, and levels of free T4, total T3, and TSH, the
researchers did not offer results for specific herbicides and organochlorine pesticides, thereby limiting the usefulness of this study to provide evidentiary weight
regarding a potential association between exposure to the COIs and thyroid
functioning. The second study was a cross-sectional study that examined whether
the presence of metabolic syndrome altered serum concentrations of dioxin-like
and non-dioxin-like PCBs under conditions of weight loss (Dirinck et al., 2016).
Given the cross-sectional nature of the work, it is of limited usefulness in assessing the association of metabolic syndrome with dioxin-like chemicals.
A study by X. Sun et al. (2014) collected blood samples to determine the
dioxin concentration and levels of nine steroid hormones from 48 men in an
herbicide-sprayed hot spot and 36 men from a non-sprayed area. Participants
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also completed a questionnaire about their health status. The levels of the steroid
hormones, including testosterone, dehydroepiandrosterone, and estradiol, were
measured and compared by exposure group. However, the differences in hormone
levels are not surrogate measures of a health outcome, and, therefore, this study
was not considered relevant to the committee’s charge.
Biologic Plausibility
The influence of TCDD on thyroid-hormone homeostasis has been measured in numerous animal studies, and TCDD exposure has been associated with
changes in serum concentrations of T4, T3, and TSH. In most studies, TCDD
exposure is associated with a hypothyroid state, including reduced circulating T3
and T4 and increased TSH, especially after chronic exposure. The reduction in
circulating T4 concentrations is robust and has recently been proposed as a biomarker of the effect of dioxin-like chemicals (J. M. Yang et al., 2010). Female rats
exposed chronically to TCDD showed follicular-cell hyperplasia and hypertrophy
of thyroid follicles, which were consistent with an overstimulation of the thyroid
by TSH (TSH increases as a homeostatic response to low T4 levels) (Yoshizawa
et al., 2010). TCDD enhances the metabolism of thyroid hormones primarily
through an AHR-dependent induction of glucuronyl transferase activity (Gessner
et al., 2012; Y. Kato et al., 2010; Martin et al., 2012; Nishimura et al., 2005). An
enhanced accumulation of T4 in hepatic tissue of TCDD-treated mice may also
contribute to the reduction in circulating T4 (Y. Kato et al., 2010).
The possibility that arsenic could act as an endocrine disruptor on thyroid
hormone–mediated processes has been proposed on the basis of cell-culture studies
and experiments with the ex vivo amphibian tail metamorphosis a ssay (Davey et
al., 2008). In guinea pigs that were fed diets containing 50 ppm arsenic as sodium
arsenite or arsenic trioxide for 11 weeks, serum (total) T3 and T4 were reduced
compared to controls by about 20–25% and 33%, respectively (Mohanta et al.,
2014). Recent data in zebrafish show that arsenite exposure increases thyroxine
levels and alters the expression of genes in the hypothalamic–pituitary–thyroid
axis, including thyroid receptors α and β, TSH, and corticotropin-releasing hormone (H. J. Sun et al., 2015). These data raise the possibility that cacodylic acid
may also disrupt thyroid homeostasis, but there are no published epidemiologic
studies that have addressed this.
Synthesis
Numerous animal experiments and several epidemiologic studies have shown
that TCDD and dioxin-like chemicals exert some influence on thyroid homeostasis, with the findings being most consistently indicative of hypothyroidism (Boas
et al., 2006, 2012; Chevrier et al., 2014). The underlying molecular mechanisms
resulting in these effects on thyroid hormone and TSH concentrations in humans,
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however, are not yet fully characterized. In addition, there are some data to suggest the possibility that arsenic-based herbicides may also affect thyroid function.
Several previous studies of populations environmentally exposed to PCBs
found some combination of elevated TSH concentrations and depressed T4 and
T3 levels (Bloom et al., 2006; Hagmar et al., 2001a; Persky et al., 2001; Schell
et al., 2004), although some (Hagmar et al., 2001b; Sala et al., 2001) found no
significant effect. For example, Pavuk et al. (2003) reported a trend of higher
TCDD serum concentrations being associated with increasing concentrations of
TSH that was not accompanied by changes in circulating T4 or T3 (which would
be interpreted as subclinical hypothyroidism) in participants in the AFHS. This
finding in U.S. Vietnam veterans is complemented by the results from the Korean
Veterans Health Study (Yi et al., 2014a), which found evidence of an increased
occurrence of clinical hypothyroid disease, possibly associated with autoimmune hypothyroidism, in association with higher estimated potential herbicide
exposure. In addition, the report from the AHS of increased physician-diagnosed
hypothyroidism in herbicide applicators with phenoxy herbicide exposure (Goldner et al., 2013) supports the notion that this association is real. Results from the
Korean Veterans Health Study suggest that adrenal and possibly pituitary function
may also be affected by exposure to dioxin-like chemicals.
For the current update, in vitro and animal data continue to support previous
findings that the COIs can alter thyroid homeostasis. There is additional new data
(Sun et al., 2015) that raise the possibility that cacodylic acid might similarly
disrupt the normal action of the thyroid. There is little additional epidemiologic
data available regarding the association of the COIs with thyroid disease or other
endocrine function. A follow-up of phenoxy herbicide producers in New Zealand
did not find any difference in thyroid disorders between high- and low-exposure
groups ('t Mannetje et al., 2018).
Conclusion
On the basis of the new evidence and that reviewed in previous VAO reports,
the committee concludes that there is limited or suggestive evidence of an association between exposure to at least one of the COIs and hypothyroidism. There
is inadequate or insufficient evidence for disruption of thyroid homeostasis or
other endocrine disorders.
CHRONIC SKIN DISORDERS
In previous VAO reports, skin disorders such as chloracne were mentioned,
but they were not consistently included as independent outcomes. However, due to
the nature of new published epidemiologic literature, the committee has reviewed
several studies of exposure to the COIs that have included skin conditions, and thus
the committee has decided to include them as a distinct outcome in this chapter.
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Chloracne is a skin disease that is characteristic of high levels of exposure
to TCDD and other diaromatic organochlorine chemicals. It is one of the few
outcomes in humans that are consistently associated with such exposure, and it
is a well-validated indicator of high-dose exposure to TCDD and related chemicals (Sweeney et al., 1997/1998). Chloracne shares some pathologic processes
(such as the occlusion of the orifice of the sebaceous follicle) with more common
forms of acne (such as acne vulgaris), but it can be differentiated by the presence
of epidermoid inclusion cysts, which are caused by the proliferation and hyperkeratinization (horn-like cornification) of the epidermis and sebaceous gland
epithelium. Although chloracne is typically distributed over the eyes, ears, and
neck, it can also occur on the trunk, genitalia, and buttocks of chemical-industry
workers exposed to TCDD (Neuberger et al., 1998).
If chloracne occurs, it appears within a few months after the chemical expo
sure, not after a long latent period; therefore, new cases of chloracne among
Vietnam veterans would not be the result of exposure during the Vietnam War.
Although it is resistant to acne treatments, it usually regresses.
The chronic skin conditions considered include skin infections, nuclear buds,
karyolysis or karyorrhexis, comedones, scar formation, and skin pigmentation.
Conclusions from VAO and Previous Updates
The committee responsible for VAO (IOM, 1994) determined that there
was sufficient evidence of an association between exposure to at least one COI
(TCDD) and chloracne. Additional information available to the committees
responsible for Update 1996 (IOM, 1996), Update 1998 (IOM, 1999), Update
2000 (IOM, 2001), Update 2002 (IOM, 2003c), Update 2004 (IOM, 2005),
and Update 2006 (IOM, 2007) maintained that conclusion. Even in the absence
of a full understanding of the cellular and molecular mechanisms that lead to
the disease, several notable reviews (Panteleyev and Bickers, 2006; Sweeney
and Mocarelli, 2000) have deemed the clinical and epidemiologic evidence of
dioxin-induced chloracne to be strong. The occupational epidemiologic literature
has many examples of chloracne in workers after reported industrial exposures
(Beck et al., 1989; Bond et al., 1987, 1989a,b; Cook et al., 1980; Goldman, 1972;
May, 1973, 1982; Oliver, 1975; Pazderova-Vejlupkova et al., 1981; Poland et al.,
1971; Suskind and Hertzberg, 1984; Suskind et al., 1953; Zober et al., 1990).
With relative risk estimates as high as 5.5 in exposed workers compared with
referent non-exposed workers, Bond et al. (1989a) identified a dose–response
relationship between probable exposure to TCDD and chloracne. Not everyone
who is exposed to relatively high doses develops chloracne, and some with lower
exposure may demonstrate the condition (Beck et al., 1989).
Almost 200 cases of chloracne were recorded among those residing in the
vicinity of the accidental industrial release of dioxin in Seveso, Italy; most cases
were in children and in those who lived in the highest-exposure zone, and most
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had resolved within 7 years (Assennato et al., 1989a,b; Caramaschi et al., 1981;
Mocarelli et al., 1991).
Exposures of Vietnam veterans were substantially lower than those observed
in occupational studies and in environmental disasters, such as in Seveso. The
long period since the putative exposure has imposed methodologic limitations on
the studies of Vietnam cohorts for chloracne. Nonetheless, the Vietnam Experience Study (CDC, 1988a) found that chloracne-like lesions were self-reported
more often by Vietnam veterans than by Vietnam-era veterans (OR = 1.4; 95%
CI 0.7–2.9). No excess risk was found in Vietnam versus era veterans among
subjects who had dermatologic examinations (OR = 0.9, 95% CI 0.7–1.2 for
comedones and acne from lesions; OR = 1.2, 95% CI 0.9–1.7 for hyperpigmentation). Compared with matched, non-exposed controls, Ranch Hand personnel
reported a significant excess of acne (OR = 1.6, 95% CI 1.1–2.1) (Wolfe et al.,
1990), but no cases of chloracne or post-inflammatory scars were found on physical examination 20 years after the potential herbicide exposure (AFHS, 1991b).
Update of Epidemiologic Literature
Three new studies of exposure to the COIs and chronic skin conditions have
been identified since Update 2014. However, each study examined different outcomes, making comparisons among the studies difficult.
Vietnam-Veteran Studies
Cox et al. (2015) used hospital discharge records from 1988 to 2009 to
identify health conditions that affected 2,783 male New Zealand veterans who
had served in Vietnam during 1964–1972. Age-specific hospitalization rates were
calculated using the total number of annual hospitalizations published by the
Ministry of Health and the average annual resident population. Standardized
hospitalization rates and 99% CIs were calculated for the veteran cohort and for
the general population for several noncancerous conditions, and an SHR was
calculated using the two rates. This analysis found that hospitalization for skin
infections (n = 140; SHR = 1.22, 99% CI 1.15–1.21) was greater in Vietnam
veterans than what would be expected based on same-age New Zealand males.
However, there was no difference in hospitalizations for other skin diseases (n =
60; SHR = 1.17, 99% CI 0.87–1.46). This analysis was restricted to the first hospitalization for each cause in order to account for chronic disease. This analysis
did not include information on or control for lifestyle factors or ethnicity. Exposure was not validated through serum measurements and was assumed based on
deployment to Vietnam.
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Occupational Studies
't Mannetje et al. (2018) conducted a morbidity survey among a subset of
workers who were employed at the New Plymouth, New Zealand, phenoxy herbicide production plant for at least 1 month between 1969 and 1984. The plant
produced 2,4,5-T, and workers were potentially exposed to 2,4,5-T, the intermediates of TCP and other chlorophenols, and TCDD. Workers had previously
been recruited and examined as part of the international cohort of producers of
phenoxy herbicides led by IARC (Kogevinas et al., 1997); see Chapter 5 for more
details on the IARC cohort and the New Zealand phenoxy producers. This study
extends the follow-up period of these workers to approximately 30 years from
their last 2,4,5-T production exposure. From the original cohort of 1,025 workers, 631 were living, had a current address in New Zealand, and were below 80
years of age on January 1, 2006. For the current follow-up, 430 of the 631 workers were randomly selected and invited to participate in the morbidity survey,
of which 245 (57%) participated. The survey was administered in 2007–2008
by face-to-face interview, and information was collected on demographic factors and health information, including doctor-diagnosed conditions and the year
of diagnosis. A blood sample was also collected at that time and analyzed for
TCDD, lipids, thyroid hormones, and other substances. For 111 participants, a
neurological examination was conducted. Associations between exposure and
health outcomes were assessed using logistic regression models that controlled
for age, gender, smoking, BMI, and ethnicity using two different methods of
exposure: having worked in a TCDD-exposed job (based on occupational records)
and having serum TCDD concentration ≥10 pg/g lipid (18%). The mean TCDD
concentrations were 19 pg/g lipid in the 60 men directly involved in phenoxy/
TCP production and 6 pg/g lipid in the 141 men and 43 women who worked in
other parts of the plant. Compared with the 124 people in the non-highly exposed
jobs, the 121 people who had ever worked in a highly exposed job were no more
likely to have doctor-diagnosed eczema (n = 17; OR = 0.57, 95% CI 0.27–1.21)
or acne (n = 2; OR = 0.73, 95% CI 0.10–5.47). When compared by serum TCDD
concentration ≥10 pg/g lipid, no difference in eczema (n = 8; OR = 1.31, 95% CI
0.47–3.61) or acne (based on 1 case) was found.
Environmental Studies
In 1968, bran rice oil was accidentally contaminated with high concentrations of PCBs, dioxins, and dioxin-like chemicals in Western Japan (the Yusho
accident). People who were poisoned were recruited into a cohort (i.e., the Yusho
Group) and received regular medical follow-up. Mitoma et al. (2015) examined
skin symptoms in the Yusho Group (n = 352) who underwent dermatological
check-ups in 2012. PCB and dioxin serum concentrations were still elevated in
the Yusho Group compared to the general Japanese population, and skin diseases
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were still very common. Furthermore, black comedones and scar formation were
significantly correlated with blood 2,3,4,7,8-PeCDF level, and black comedones
(n = 115; 32.7% of all patients), scar formation (n = 111; 31.5% of all patients),
and skin pigmentation (n = 57; 16.2% of all patients) were significantly positively
associated with the total serum PCB concentration. These results show that the
prevalence of skin conditions such as black comedones, scar formation, and skin
pigmentation are correlated with exposure to PCBs, dioxins, and dioxin-like
chemicals, and that chloracne was persistent in this population 44 years after the
acute ingestion of dioxins and dioxin-like chemicals.
Other Identified Studies
Four additional studies that reported skin conditions were identified, but
each lacked the necessary exposure specificity to be considered further. A second
study of long-term health effects from the Yusho accident (Akahane et al., 2017)
examined the prevalence of self-reported conditions including diseases of the skin
compared with an age-, sex-, and residential area–matched group. Because no
TEQs or other quantification of relevant exposures was presented, the study was
not considered further. Butinof et al. (2015) conducted a cross-sectional study of
male pesticide applicators (n = 880) who were issued applicator licenses by the
Agriculture, Livestock, and Food Ministry of Argentina between 2007 and 2010.
All participants completed a self-administered questionnaire that was adapted
from the U.S. AHS. The average worker was exposed to 11 different chemicals,
and no pesticide-specific exposure assessment was conducted. Ruder et al. (2014)
examined skin conditions such as chloracne and hyperpigmentation in a U.S.
cohort of capacitor manufacturers exposed to dioxin-like and non-dioxin-like
PCBs, but it was limited by a lack of exposure specificity. C.Y. Yang et al. (2015)
evaluated 240 Yucheng, Taiwan, subjects aged 9–65 years who were exposed to
PCB-contaminated rice oil in 1979 and who completed a health-related qualityof-life questionnaire about 30 years following the exposure. Exposure was not
verified by serum measurements or other means.
A fifth study (Carbajal-Lopez et al., 2016) involved a cross-sectional study
that examined biomarkers of DNA damage in buccal cells in male agricultural
workers in Mexico who were exposed to pesticides that likely included 2,4-D
and dicamba (n = 111) and compared them with males who had no occupational history of pesticide exposure (n = 60). Although significantly (p < 0.0001)
more evidence of DNA damage, as measured by comet tail length, micronuclei,
binucleated cells, pycnosis, and condensed chromatin, was found among the
agricultural workers who were exposed to pesticides than among the non-exposed
workers, these differences are not tied to an observable health outcome, and the
study was not considered further.
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Biologic Plausibility
Previous updates have reported that chloracne-like skin lesions have been
observed in several animal species in response to exposure to TCDD but not to
purified phenoxy herbicides. Data accruing over the past several decades demonstrated that TCDD alters the differentiation of human keratinocytes, and more
recent studies have illuminated how. TCDD accelerates the events associated with
early differentiation and also obstructs the completion of differentiation (Bock,
2017a,b; Fontao et al., 2017; Geusau et al., 2005; Mandavia, 2015). Panteleyev
and Bickers (2006) proposed that the major mechanism of TCDD induction of
chloracne is activation of the stem cells in the basal layer of the skin to differentiate and then an inhibition of their ability to commit fully to a differentiated status.
De Abrew et al. (2014) elucidated the role of matrix metalloproteinase-10 in the
histopathological changes that typify chloracne. Work by Tauchi et al. (2005) and
K. J. Smith et al. (2017) implicated additional inflammation-related mechanisms
by which TCDD exposure may lead to chloracne. The data provide biologically
plausible mechanisms for the induction of chloracne by TCDD.
Synthesis
No epidemiologic data in the past decade have refuted the conclusion of
prior VAO committees that the evidence of an association between exposure
to dioxin and chloracne is sufficient. Because TCDD-associated chloracne
becomes evident within a few months after exposure, there is no risk of new
cases long after service in Vietnam. Given the established relationship of an
association between TCDD and chloracne and the long period that has elapsed
since service in Vietnam, the present committee concludes that the emergence
of persistent additional biologic or epidemiologic evidence that would merit
review and deliberation by later VAO committees is unlikely. The formation
of chloracne lesions and other skin disorders after the administration of TCDD
has been observed in some species of laboratory animals. The newly identified
epidemiologic studies (Cox et al., 2015; Mitoma et al., 2015; 't Mannetje et
al., 2018) examined different outcomes and had varying exposure specificity,
thereby limiting the comparisons that could be made. Although some differences between exposed and unexposed populations were noted, each study
had several limitations that did not change the evidence of association with
exposure to the COIs and chronic skin conditions.
Conclusion
On the basis of numerous epidemiologic studies of occupationally and environmentally exposed populations and supportive toxicologic information, previous VAO committees have consistently concluded that there is sufficient evidence
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of an association between exposure to at least one COI and chloracne. After
review of new literature, the committee concludes that there is inadequate or
insufficient evidence of an association between exposure to the COIs and other
chronic skin conditions.
EYE PROBLEMS
This section discusses eye problems (ICD-9 360–379; ICD-10 H00–H59).
The loss of vision is increasingly common with advanced age, and about one-sixth
of people over 70 years old have substantial impairment, with men and women
being similarly affected (NCHS, 2010). The most prevalent ocular problems in
the current age range of Vietnam veterans are age-related macular degeneration,
cataracts, glaucoma, and diabetic retinopathy. Ocular problems involving chemical agents most often arise from acute, direct contact with caustic or corrosive
substances that may have permanent consequences. Ocular impairment arising
from systemic exposure to toxic agents may be mediated by nerve damage. Cataracts can be induced by a chronic internal exposure of the lens to such chemicals
as 2,4-dinitrophenol, corticosteroids, and thallium; glaucoma may be secondary
to a toxic inflammation or may result from topical or systemic treatment with
anti-inflammatory corticosteroids (Casarett and Doull, 1995).
Conclusions from VAO and Previous Updates
Update 2010 considered one study of Australian Vietnam veterans that found
that the veterans had a higher prevalence of all the eye conditions assessed—
cataracts, presbyopia, color blindness, and other diseases of the eye—than the
Australian population (O’Toole et al., 2009). However, the committee noted a
lack of information on exposure to the COIs and a lack of clinical confirmation
of the eye conditions, and it had serious concerns about the possibility that recall
bias had played a role in the findings. On the basis of that one study, the committee for Update 2010 concluded that there was inadequate or insufficient evidence
to determine whether there is an association between exposure to the COIs and
eye conditions. No new epidemiologic studies of exposure to the COIs and eye
problems had been published for review in Update 2012 and Update 2014.
Update of Epidemiologic Literature
Only one new study of eye conditions was identified. Cox et al. (2015) used
hospital discharge records from 1988 to 2009 to identify prevalent health conditions in 2,783 male New Zealand veterans who had served in Vietnam during
1964–1972. Age-specific hospitalization rates were calculated using the total
number of annual hospitalizations published by the Ministry of Health and the
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average annual resident population. Standardized hospitalization rates and 99%
CIs were calculated for the veteran cohort and the general population, and an
SHR was calculated using the two rates for two conditions related to the eyes.
Neither the risk of hospitalization for cataracts (n = 99; SHR = 1.11, 99% CI
0.82–1.40) nor retinal disease (n = 31; SHR = 1.35, 99% CI 0.73–1.98) was
different between the veterans and general New Zealand population. Cataract
and retinal disease are not generally conditions that require hospitalization, and
therefore, the estimated prevalence may be higher. Exposure was not validated
through serum measurements and was assumed based on deployment to Vietnam.
Biologic Plausibility
There have been several recent reports of ocular activity associated with
Ahr activation or TCDD exposure of rats (Sugamo et al., 2009), mice (Takeuchi
et al., 2009), and human non-pigmented ciliary epithelial cells (Volotinen et al.,
2009). Hu et al. (2013) reported that mice harboring the null allele at the Ahr
locus developed macular age-related degeneration-like pathology.
Woeller et al. (2016) investigated whether AHR activation had therapeutic
potential for thyroid eye disease, which includes myofibroblast accumulation and
orbital scarring. TGF-β induces myofibroblast formation, and AHR influences
TGF-β signaling. Using orbital fibroblasts cultured from thyroid eye disease
patients, Woeller et al. found that exposure to AHR ligands 6-formylindolo(3,2b)carbazole2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester
(FICZ and ITE) prevented TGF-β-induced myofibroblast formation.
Synthesis
Hospital discharge data from New Zealand Vietnam veterans (Cox et al.,
2015) do not suggest any association between exposure to the COIs and retinal
disease or cataracts. The data generated in vitro or in vivo in animal models
reveal a quite modest possibility of ocular activity for the COIs; these are limited data that do not assist the committee in determining an association between
exposure to the COIs and eye conditions.
Conclusion
Given the lack of additional evidence, the committee concludes that there is
inadequate or insufficient evidence to determine whether there is an association
between exposure to the COIs and eye conditions.
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BONE CONDITIONS
This section discusses osteoporosis, or decreased bone density (ICD-9
733.0–733.1; ICD-10 M80–M81), and other joint and connective tissue disease,
excluding arthritis, which is discussed in Chapter 6: Immune System Disorders.
Osteoporosis is a skeletal disorder characterized by a decrease in bone mineral
density and a loss of the structural and biomechanical properties of the skeleton,
which leads to an increased risk of fractures. Although there are no practical
methods for assessing overall bone strength, bone mineral density correlates
closely with skeletal load-bearing capacity and fracture risk (Lash et al., 2009).
WHO has defined osteoporosis based on bone mineral density measurements. The
diagnostic T-score derived by dual energy X-ray absorptiometry is the number of
standard deviations from the mean bone mineral density for healthy women. In
women, readings greater than −1.0 are normal, whereas osteopenia is defined by
a T-score between −1.0 and −2.5, osteoporosis is defined by a T-score between
−2.5 and −5.0, and severe osteoporosis corresponds to a T-score of −5.0 or lower.
Diagnostic criteria have not been standardized for osteoporosis in men. Although
men have much higher baseline bone mineral density than women, they seem to
have a similar fracture risk for a given bone mineral density (Lash et al., 2009),
so most authorities apply the same WHO ranges for T-scores calculated relative
to normal young women.
Sex is an important risk factor for osteoporosis; about 56% of postmenopausal women have decreased bone mineral density, and 6% have osteoporosis
(CDC, 2002). The effects of aging on bone loss in women are well known, but
many health care providers and patients are less familiar with the prevalence and
effects of bone changes in older men (Orwoll et al., 2010). Individual patients
have genetic and acquired risks of osteoporosis, and the osteoporosis disease
process can be without symptoms for decades. It is well known that hormones,
vitamins, and pharmaceuticals can have adverse effects on bone and that druginduced osteoporosis occurs primarily in postmenopausal women, but premenopausal women and men are also significantly affected. Glucocorticoids are the
most common cause of drug-induced osteoporosis (Mazziotti et al., 2010). Other
risk factors for the loss of bone mineral density include the use of long-acting
benzodiazepine or anticonvulsant drugs, previous hyperthyroidism, excessive
caffeine intake, and routinely standing for less than 4 hours per day (Lash et al.,
2009).
Several studies have described a link between organochlorine exposure and
effects on bone growth, most notably reports of infants exposed in utero to high
concentration of PCBs and PCDFs who developed irregular calcifications of
their skulls (Miller, 1985) and reports of accidental organochlorine poisoning
that resulted in osteoporosis (Cripps et al., 1984; Gocmen et al., 1989). However, epidemiologic studies of the association between environmental exposures
to organochlorine compounds and bone disorders have had inconsistent results.
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Conclusions from VAO and Previous Updates
Update 2010 was the first report in the VAO series to review studies of
the association between exposures to the COIs and a decrease in bone mineral
density. Few studies have reported results in this category with enough exposure
specificity to be fully informative. Hodgson et al. (2008) studied the relationship between environmental exposures and bone mineral density in a set of 325
members of the Osteoporosis Cadmium as a Risk Factor (OSCAR) cohort who
were at least 60 years old. Forearm bone mineral density was measured, blood
samples were analyzed for the five dioxin-like mono-ortho PCB congeners (PCB
105, 118, 156, 157, and 167), and TEQs were calculated. In men, PCB 118 was
significantly negatively associated with bone mineral density, but there was no
association between the TEQ for any of the five dioxin-like mono-ortho PCBs
and bone mineral density. In women, PCB 118 and the TEQs for all five dioxinlike mono-ortho PCBs were positively associated with bone mineral density.
When the risk of low bone mineral density was treated as a binary variable in
an adjusted logistic model, there was a significant association with PCB 118 in
men, but none of the measured compounds was predictive in women. A study of
350 women who were exposed to TCDD as a result of the chemical explosion
in Seveso, Italy, examined the relationship of DEXA-assessed bone mineral density and TCDD serum levels (Eskenazi et al., 2014). The results suggested that
TCDD levels were associated with some evidence of better bone structure in the
48 women for whom exposure occurred after peak bone mass, which is estimated
to happen 2 years after menarche, but the findings did not support the hypothesis
that postnatal TCDD exposure adversely affects adult bone health. Two crosssectional studies that examined the association of exposure to dioxin-like chemicals and bone quality in residents of Canada’s northern regions, who are known
to be exposed to these chemicals as a result of their diet of marine mammals and
predatory fish (Paunescu et al., 2013a,b), found an increase in dioxin-like PCBs
105 and 108 to be negatively associated with a “stiffness index,” and neither total
plasma dioxin-like chemicals levels nor any specific dioxin-like PCB level was
associated with ultrasonography-assessed bone strength in Inuit women.
Update of the Epidemiologic Literature
Only one new study of bone conditions was identified. Cox et al. (2015)
used hospital discharge records from 1988 to 2009 to identify health conditions
that had affected 2,783 male New Zealand veterans who had served in Vietnam
during 1964 to 1972. Age-specific hospitalization rates were calculated using the
total number of annual hospitalizations published by the Ministry of Health and
the average annual resident population. Standardized hospitalization rates and
99% CIs were calculated for the veteran cohort and the general population,
and an SHR was calculated using the two rates for conditions related to other joint
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diseases and other connective tissue diseases. An elevated risk of hospitalization
for other joint diseases (n = 77; SHR = 1.34, 99% CI 1.04–1.64) and other connective tissue disease (n = 169; SHR = 1.25, 99% CI 1.06–1.44), neither of which
is further defined, was found for veterans when compared with the standardized
New Zealand population. Since these disease categories were not clearly defined,
it is difficult to interpret the findings. The study is also limited because the exposures were not validated through serum measurements and were assumed based
on deployment to Vietnam.
Biologic Plausibility
Animal studies suggest that TCDD may have some influence on bone formation and maintenance. Recent work from Herlin et al. (2013) showed that the
exposure of adult mice to TCDD resulted in harder bone matrix, thinner cortical
bone, mechanically weaker bones, and, most notably, increased trabecular bone
volume fraction in Ahr knockout mice. It is known that TCDD can induce chondrocyte apoptosis in culture, which could be an initial event leading to the sort of
cartilage degradation observed in arthritis (Yang and Lee, 2010). Lee and Yang
(2012) recently demonstrated that this is mediated by reactive oxygen species. In
addition, TCDD exposure via the dam’s milk impaired bone mineralization during postnatal development in mice because of a reduction in osteoblastic activity
as a result of TCDD-induced up-regulation in the active form of vitamin D in
serum (Nishimura et al., 2009). TCDD altered osteogenesis (bone formation) in
an in vitro osteoblast model and led to alterations in the proteins associated with
cytoskeleton organization and biogenesis, a decrease in the expression of calcium-binding proteins, and a decrease in osteoblast calcium deposition (Carpi et
al., 2009). In adult rats, TCDD exposure reduced trabecular bone cross-sectional
area, but it significantly increased total bone mineral density; it was further noted
that TCDD decreased the expression of the bone-formation marker procollagen
type I N-terminal propeptide and increased the expression of the bone-resorption
marker carboxy-terminal collagen cross-link, suggesting a net loss of bone tissue
(Lind et al., 2009). It is also known that exposure to polyaromatic hydrocarbons
(such as those in tobacco smoke) can affect bone health, and some of these alterations have been shown to be mediated, at least in part, by the AHR. That implies
that TCDD may alter or modify the effects of osteoblast formation and function
as well as inhibit osteoclast formation and function (Kung et al., 2012; Yan et
al., 2011). Iqbal et al. (2013) recently addressed this, studying genetically altered
mice in order to understand the contributions of tobacco carcinogens and TCDD.
In their work, mice in which the Ahr or CYP1A1, CYP1A2, and CYP1B1 genes
were deleted displayed reduced resorption and high bone mass. In contrast, Ahr
activation by administering benzo[a]pyrene to wild-type mice increased osteoclastogenesis and bone resorption.
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Synthesis
The small amount of available epidemiologic information on the possible
adverse effects of exposure to the COIs on bone structure has previously been
based entirely on dioxin-like mono-ortho PCBs, which contribute a small percentage to total TEQs based on all dioxin-like PCBs. The recent data from New
Zealand Vietnam veterans, while suggesting a slightly statistically elevated risk
of “other” bone and joint conditions, has poorly described outcomes (with essentially no data on the exact bone conditions considered) and is further limited by
the use of hospitalization rates for such outcomes, which are difficult to interpret.
Biological data confirm that TCDD is active in bone metabolism, but the pattern
of association of exposure to the COIs and subsequent disease is not consistent
in the current literature.
Conclusion
There is inadequate or insufficient evidence of an association between expo
sure to the COIs and clinical or overt adverse effects of osteoporosis, loss of bone
mineral density, or other bone conditions.
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Chapter Overview
This final chapter presents a synopsis of the conclusions drawn by the committee
regarding statistical associations between diseases and possible exposure to dioxin
and other chemical compounds in herbicides used in Vietnam. It also presents the
committee’s recommendations regarding future research on Vietnam veterans’ health.
SYNOPSIS OF COMMITTEE CONCLUSIONS
Under the aegis of Public Law (PL) 102-4, the current committee reviewed
and evaluated the available scientific evidence regarding the associations between
diseases and exposure to dioxin and other chemical compounds in herbicides used
during the Vietnam War.1 In reaching its conclusions, it weighed the strengths and
limitations of the epidemiologic evidence reviewed in its report and in previous
Veterans and Agent Orange (VAO) reports. Although the studies published since
Update 2014 are the subject of a detailed evaluation here, the committee drew
its conclusions in the context of the entire body of literature. The contribution of
recent publications to the scientific evidence base is emphasized in this report,
but the weight of the evidence in its totality was the primary consideration guiding the evaluation of health outcomes. Although the study subjects in much of
the new literature reviewed here were not the male U.S. Vietnam veterans who
1 These chemicals—2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5-trichlorophenoxyacetic acid
(2,4,5-T), picloram, and cacodylic acid—and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD or dioxin)
are collectively referred to as the “chemicals of interest” (COIs) in the report.

559

Copyright National Academy of Sciences. All rights reserved.

Veterans and Agent Orange: Update 11 (2018)

560

VETERANS AND AGENT ORANGE: UPDATE 11

constitute most of the population affected by the VAO reports, the new studies
from U.S. and other Vietnam veteran populations provided pertinent information.
Epidemiologic methods and analytic capabilities have continued to improve
over the period in which the previous VAO updates have been conducted. As
has been the case for recent updates, a considerable number of the new studies
presented their results in terms of serum TCDD concentrations or total toxic
equivalents (TEQs), which are particularly useful for the committee’s purpose because they provide a cumulative measure of exposure to all dioxin-like chemicals.
The committee also notes that considerable experimental data related to the
biologic plausibility of the health conditions statistically associated with exposure to the components of the herbicides sprayed in Vietnam have emerged since
the beginning of the VAO report series. These findings help to inform decisions
about how to categorize the degree of association for individual conditions. On
the basis of its evaluation of epidemiology studies of Vietnam-veteran populations and of occupationally and environmentally exposed populations, and aided
by experimental studies on biologic plausibility, the committee assigned each
health outcome to one of four categories of relative certainty of association
with exposure to the herbicides used in Vietnam or to any of their components
or contaminants.
Principal Changes from Previous Updates
The application of the committee’s evaluation methodology led to three
principal changes in the conclusions regarding exposure to the chemicals of
interest (COIs) and adverse health outcomes reported in Update 2014. They are
explicated in the preceding chapters and summarized below.
First, the current committee concluded that the information now assembled
constitutes sufficient evidence of an association between exposure to at least one
of the COIs and hypertension. As detailed in Chapter 10, the decision to change
the classification from limited or suggestive evidence of an association was
motivated in large part by the work of Cypel and colleagues (2016). These investigators conducted a study on the population of interest, U.S. Vietnam veterans
(specifically, the Army Chemical Corps), that was characterized by a large sample
size, appropriate controls (non-Vietnam-deployed sprayers, Vietnam-deployed
non-sprayers, and non-Vietnam-deployed non-sprayers), and validated endpoints
(self-reported physician-diagnosed hypertension that was confirmed by medical
record reviews and serum TCDD measurements in a subset of participants). The
statistical analyses conducted were robust, used state-of-the art methods, and
adjusted for relevant confounders. The study clearly showed that self-reported
hypertension rates were the highest among Vietnam-deployed sprayers (81.6%)
followed by non-Vietnam-deployed sprayers (77.4%), Vietnam-deployed nonsprayers (72.2%), and non-Vietnam-deployed non-sprayers (64.6%), providing a
significant association with exposure. Among Vietnam-deployed veterans, there
was a significantly elevated association between the odds of hypertension for
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sprayers versus non-sprayers that remained after adjustment for potential confounders (odds ratio [OR] = 1.77, 95% confidence interval [CI] 1.35–2.30).
Similarly, for those veterans who did not deploy to Vietnam, self-reported hypertension was significantly elevated when sprayers were compared with non-sprayers (OR = 1.72, 95% CI 1.31–2.26). When considered in light of other new
research and earlier papers that demonstrated a consistency in the direction and
magnitude of this effect—notably Kang et al. (2006), Cypel and Kang (2010),
and multiple publications from the Air Force Health Study (AFHS; AFHS, 1995,
2000, 2005)—the committee found that this body of literature constituted sufficient evidence of an association.
The committee also concluded (as detailed in Chapter 7) that there was sufficient evidence of an association between exposure to at least one of the COIs
and a previously unclassified health condition, monoclonal gammopathy of undetermined significance (MGUS). MGUS is a precursor to multiple myeloma,
although only an estimated 1% of cases of it progress to multiple myeloma each
year. It is a clinically silent condition defined by the presence of a monoclonal
antibody, antibody heavy chain, or antibody light chain in the blood or urine of
a person lacking symptoms or signs of a more serious plasma cell dyscrasia. The
foundation of this finding was a well-conducted study by Landgren et al. (2015)
that examined data and biospecimens from a population of veterans that included
participants with known exposure to herbicides in Vietnam: the AFHS cohort.
Landgren and colleagues used previously measured serum levels of TCDD and
performed a new assay of 958 serum samples to detect MGUS. Known confounders, including age, race, body mass index, smoking and drinking history, and a
history of radiation therapy or chemotherapy, were considered. The investigators found that the prevalence of MGUS in veterans involved in herbicide spray
operations (7.1%) was higher than in comparison veterans (3.1%) (adjusted OR
= 2.37, 95% CI 1.27–4.44; p = 0.007). The direct relevance of the exposure and
exposed population, combined with the high quality of the study and underlying
database, were persuasive in convincing the committee that there was sufficient
evidence of an association.
Finally, the committee—after extensive deliberations regarding the strengths
and weaknesses of the new evidence and evidence from studies reviewed in
previous VAO reports—could not come to a consensus on whether the available
scientific information regarding exposure to the COIs and type 2 diabetes should
continue to be categorized as limited or suggestive or whether it meets the criteria
for sufficient evidence of an association (see Chapter 10). Newly and previously
reviewed studies consistently show a relationship between well-characterized
exposure to dioxin and dioxin-like chemicals and measures of diabetes health
outcomes in diverse cohorts, including Vietnam veteran populations. However,
the lack of exposure specificity and the potential for uncontrolled confounding
that characterized many of these studies complicates any attribution of the outcome to the COIs. It was therefore not clear to the committee as a whole whether
a category change was appropriate.
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Health Outcomes Identified by the Department
of Veterans Affairs for Specific Focus
The Department of Veterans Affairs (VA) also asked the committee to specifically focus on three health outcomes: possible generational health effects that
may be the result of herbicide exposure among male Vietnam veterans, myeloproliferative neoplasms, and glioblastoma multiforme.
Chapter 8 summarizes the available literature on the effects of exposure to
the COIs on the reproductive health of Vietnam veterans and on the health of
their descendants. This is a burgeoning area of research, and there were several new studies for the committee to consider. Few of them address Vietnam
veterans specifically, however, and almost all of those that were conducted on
other populations have weaknesses—prominently, different exposures than those
experienced by veterans and also poor exposure characterization—that limit
their usefulness in assessing risks for veterans. Some find associations between
exposures and various outcomes, but there are no circumstances for which there
is a consistent and compelling body of evidence that would lead the committee
to conclude that there might be limited or suggestive or sufficient evidence of an
association between an exposure to a COI and a particular outcome. Transgenerational effects—those that might occur in veterans’ grandchildren and subsequent
generations in which gestational exposure did not take place—are of great interest
to veterans, but no epidemiological literature exists to evaluate whether exposure
to the COIs might lead to such outcomes.
As further delineated below, the committee strongly believes that more work
in this area is warranted. It concurs with the Update 2014 committee that it is
critical that such research include animal studies in order to elucidate whether
and which mechanisms for intergenerational and transgenerational effects might
exist. It is, in principle, possible to do studies on the health of children and grandchildren of veterans, but it must be understood up front that such complex studies
will need to be carefully planned and conducted if they are to yield meaningful
results. Voluntary participation surveys and registries relying on self-reported
information will not be helpful. The 2018 National Academies of Sciences,
Engineering, and Medicine report Gulf War and Health, Volume 11: Generational
Health Effects of Serving in the Gulf War (NASEM, 2018) addresses how studies
of health outcomes in the progeny of veterans might be conducted.
Myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes,
addressed in Chapter 7, are diseases of the blood cells and bone marrow. VA asked
that MPNs be explicitly examined as part of the consideration of the literature
concerning leukemias and related diseases. However, after conducting a targeted
search of scientific and medical databases (delineated in Box 3-1), the committee
was unable to identify any papers that addressed the outcome with the exception of
Yi and Ohrr (2014) (reviewed in Update 2014), which assessed cancer incidence
among Korean veterans who had served in Vietnam between 1964 and 1973.
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Those authors reported non-significant and imprecise increased risks of myeloproliferative disease and myelodisplastic syndrome in internal comparisons of
high- and low-exposure groups, based on so-called exposure opportunity scores.2
The organization MPN Advocacy and Education International presented anecdotal
information on MPNs in Vietnam veterans for the committee’s consideration, but
this was not usable for drawing conclusions.
The committee observes that, in general, those studies that looked at exposure to the COIs and hematological outcomes have generated much more compelling results—including results on abnormalities of lymphoid development and
immune function such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, multiple myeloma, and MGUS—than have those that examined whether
myeloid neoplasms or MPNs have some relation with the COIs.
Given the absence of new studies, the paucity of epidemiologic studies in
general, and the lack of information on the biologic plausibility of a connection
between exposures to the COIs and abnormalities of hematopoietic cells associated with nonmalignant bone marrow–derived diseases, the committee concluded
that there was inadequate or insufficient evidence of an association between
exposure to the COIs and MPNs. Because the outcome has not been subject to
previous research attention and is of interest to veterans, the committee recommends that investigators examine existing databases on myeloid diseases to
determine whether there are data available that would allow for an evaluation of MPNs in Vietnam veterans and others who have been exposed to
dioxin and the other COIs.
The scientific literature regarding exposure to the COIs and brain and other
nervous system cancers, including glioblastoma multiforme (often abbreviated as
glioblastoma), has been examined since the first VAO report. The body of evidence that has been developed, which is summarized in Chapter 7, has not found
statistically significant associations between exposure and any relevant outcome
in studies performed on Vietnam-veteran, occupational, or environmental cohorts.
These studies have by and large been underpowered because of the relative rarity of
these cancers. Given the limited epidemiologic data available on glioblastoma, the
committee heard invited presentations from two experts on the disease. While their
presentations to the committee were helpful and impressive, demonstrating that the
biological understanding of glioblastoma in particular is rapidly advancing, they
reinforced the absence of clear data suggesting that the COIs are associated with
the occurrence of brain cancers. Information on glioblastomas in Vietnam veterans
submitted for the committee’s consideration by the Sierra Valley Cancer Registry
Services, Inc., was, in part, anecdotal and without documented levels of exposure
and was therefore of limited usefulness for the purpose of drawing conclusions.
2 In brief, an exposure opportunity score is a means of quantifying exposure that accounts for the
quantity of herbicide sprayed and the distance in time and space from the spraying (S. D. Stellman
and J. M. Stellman, 2004).
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Furthermore, the committee did not identify any animal studies that have reported
an association between exposure to the COIs and any brain cancer. While some
studies have put forward mechanisms that might explain why dioxin exposure would
be associated with glioblastoma, the information reviewed by the committee along
with the presentations it received from experts in the field were not sufficient to alter
the conclusion of previous reports that the evidence is inadequate or insufficient to
determine whether there is an association between exposure to the COIs and brain or
other nervous system cancers. The committee believes it is appropriate for VA to be
mindful of the concerns raised about the possible association between Vietnam service and glioblastoma, but it observes that the outcome is so rare and the information
concerning herbicide exposures so imprecise that it is doubtful that any logistically
and economically feasible epidemiologic study of veterans—no matter how well
designed or executed—would produce meaningful results. The committee therefore
recommends that epidemiologic studies of glioblastoma in Vietnam veterans
should not be pursued and that VA should instead focus on fostering advancements in other areas that may be used to inform improved treatment options.
Other Health Outcomes
Table 12-1 summarizes the conclusions regarding exposure to the COIs and
health outcomes, with changes to the categorizations determined by the committee for Update 2014 noted in boldface. As mandated by PL 102-4, the distinctions
among categories are based on statistical association and not on strict causality.
The committee was directed to review the scientific data, not to recommend VA
policy, and, therefore, the conclusions presented in Table 12-1 are not intended to
imply or suggest policy decisions. Instead, the conclusions are based on observed
associations between exposure and health outcomes in human populations. These
categorizations do not address the likelihood that the health problems of any one
individual are associated with or caused by the chemicals in question.
OTHER COMMITTEE RECOMMENDATIONS
As part of their charge, all VAO committees have been asked to offer recommendations concerning the need for additional scientific studies and research to
resolve areas of continuing scientific uncertainty concerning the health effects of
exposure to the COIs. The previous update of the VAO series (the tenth update;
Update 2014) was originally understood to be the last of the reports mandated
by the Agent Orange Act (PL 102-4, renewed in PL 107-103, and subsequently
extended). The committee responsible for that report thus considered it appropriate
to compile the recommendations made by prior VAO committees and to consider,
in light of the lessons learned in this process, what would be the most important
activities to undertake in the future. They produced two tables as part of this effort:
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TABLE 12-1 Summary of the Eleventh Biennial Update Findings on
Vietnam-Veteran, Occupational, and Environmental Studies Regarding
Scientifically Relevant Associations Between Exposure to Herbicides and
Specific Health Outcomesа
Sufficient Evidence of an Association
Epidemiologic evidence is sufficient to conclude that there is a positive association. That is,
a positive association has been observed between exposure to herbicides and the outcome in
studies in which chance, bias, and confounding could be ruled out with reasonable confidence.b
For example, if several small studies that are free of bias and confounding show an association
that is consistent in magnitude and direction, there could be sufficient evidence of an association.
There is sufficient evidence of an association between exposure to the chemicals of interest and the
following health outcomes:
Soft-tissue sarcoma (including heart)
* Non-Hodgkin lymphoma
*	Chronic lymphocytic leukemia (including hairy cell leukemia and other chronic B-cell
  leukemias)
* Hodgkin lymphoma
Chloracne
Hypertension (category change from Limited or Suggestive in Update 2014)
	
Monoclonal gammopathy of undetermined significance (MGUS) (newly considered
  condition)
The committee did not reach consensus on whether the evidence regarding type 2 diabetes
(mellitus) was more properly classified as Sufficient or Limited or Suggestive.
Limited or Suggestive Evidence of an Association
Epidemiologic evidence suggests an association between exposure to herbicides and the
outcome, but a firm conclusion is limited because chance, bias, and confounding could not be
ruled out with confidence.b For example, a well-conducted study with strong findings in accord
with less compelling results from studies of populations with similar exposures could constitute
such evidence. There is limited or suggestive evidence of an association between exposure to the
chemicals of interest and the following health outcomes:
Laryngeal cancer
Cancer of the lung, bronchus, or trachea
Prostate cancer
Cancer of the urinary bladder
* Multiple myeloma
* AL amyloidosis
Early-onset peripheral neuropathy
Parkinson disease (including Parkinsonism and Parkinson-like syndromes)
Porphyria cutanea tarda
Ischemic heart disease
Stroke
Hypothyroidism
The committee did not reach consensus on whether the evidence regarding type 2 diabetes
(mellitus) was more properly classified as Sufficient or Limited or Suggestive.
continued
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TABLE 12-1 Continued
Inadequate or Insufficient Evidence to Determine an Association
The available epidemiologic studies are of insufficient quality, consistency, or statistical power to
permit a conclusion regarding the presence or absence of an association. For example, studies fail
to control for confounding, have inadequate exposure assessment, or fail to address latency. There
is inadequate or insufficient evidence to determine association between exposure to the chemicals
of interest and the following health outcomes that were explicitly reviewed:
Cancers of the oral cavity (including lips and tongue), pharynx (including tonsils), or nasal
cavity (including ears and sinuses)
Cancers of the pleura, mediastinum, and other unspecified sites in the respiratory system
and intrathoracic organs
Esophageal cancer
Stomach cancer
Colorectal cancer (including small intestine and anus)
Hepatobiliary cancers (liver, gallbladder, and bile ducts)
Pancreatic cancer
Bone and joint cancers
Melanoma
Non-melanoma skin cancer (basal-cell and squamous-cell)
Breast cancer
Cancers of reproductive organs (cervix, uterus, ovary, testes, and penis; excluding prostate)
Renal cancer (kidney and renal pelvis)
Cancers of brain and nervous system (including eye)
Endocrine cancers (thyroid, thymus, and other endocrine organs)
Leukemia (other than chronic lymphocytic leukemia, including hairy-cell leukemia and
other chronic B-cell leukemias)
    Other myeloid diseases (including myeloproliferative neoplasms)
Cancers at other and unspecified sites
Infertility
Spontaneous abortion (other than after paternal exposure to TCDD, which appears not to be
associated)
Neonatal or infant death and stillbirth in offspring of exposed people
Low birth weight in offspring of exposed people
Birth defects in offspring of exposed people, including spina bifida
Childhood cancer (including acute myeloid leukemia) or other adverse health outcomes in
offspring of exposed people
Neurobehavioral disorders (cognitive and neuropsychiatric)
Neurodegenerative diseases, excluding Parkinson disease
Chronic peripheral nervous system disorders
Hearing loss
Respiratory disorders (wheeze or asthma, chronic obstructive pulmonary disease, and
farmer’s lung)
Gastrointestinal, metabolic, and digestive disorders (changes in hepatic enzymes, liver
disorders including cirrhosis, lipid abnormalities, and ulcers)
Immune system disorders (immune suppression, allergy, and autoimmunity)
Circulatory disorders (other than hypertension, ischemic heart disease, and stroke)
Endometriosis
continued
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TABLE 12-1 Continued
Disruption of thyroid homeostasis (other than hypothyroidism)
Eye problems
Bone conditions
    Kidney and urinary disorders (including chronic kidney disorder, differences in kidney
    function, nephropathy, and end stage renal disorder)
    Chronic skin disorders (including skin infections and changes in skin pigmentation)
The committee used a classification that spans the full array of cancers. However, reviews for
non-malignant conditions were conducted only if they were found to have been the subjects of
epidemiologic investigation or at the request of the Department of Veterans Affairs. By default, any
health outcome on which no epidemiologic information has been found falls into this category.
Limited or Suggestive Evidence of No Association
Several adequate studies, which cover the full range of human exposure, are consistent in
not showing a positive association between any magnitude of exposure to a component of the
herbicides of interest and the outcome. A conclusion of “no association” is inevitably limited to the
conditions, exposures, and length of observation covered by the available studies. In addition, the
possibility of a very small increase in risk at the exposure studied can never be excluded. There is
limited or suggestive evidence of no association between exposure to the herbicide components of
interest and the following health outcome:
Spontaneous abortion after paternal exposure to TCDD
aHerbicides indicates the following chemicals of interest: 2,4-dichlorophenoxyacetic acid (2,4-D),
2,4,5-trichlorophenoxyacetic acid (2,4,5-T) and its contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD or dioxin), cacodylic acid, and picloram. The evidence regarding association was drawn
from veteran, occupational, and environmental cohort studies in which people were exposed to the
herbicides used in Vietnam, to their components, or to their contaminants.
bEvidence of an association is strengthened by experimental data supporting biologic plausibility,
but its absence would not detract from the epidemiologic evidence.
*The committee notes the consistency of these findings with the biologic understanding of the
clonal derivation of lymphohematopoietic cancers that is the basis of the World Health Organization classification system (Campo et al., 2011; see table here: www.ncbi.nlm.nih.gov/pmc/articles/
PMC3109529/table/T1, accessed May 17, 2018).

• a compendium of the recommendations of prior committees condensed
and sorted into topic areas, with comments on what response these recommendations received from VA, the Department of Defense, and other
parties (Update 2014, Table 14-2, pp. 910–917), and
• a summary of the future activities the committee considered most important for monitoring and evaluating the health issues of Vietnam veterans
and other veterans who might experience service-related health problems
long after discharge (Update 2014, Table 14-3, pp. 918–919).
Generally speaking, the recommendations of previous VAO committees
fell into four primary areas: better management of veterans’ health information;
additional epidemiologic studies; the improvement of exposure estimation; and
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priority areas for toxicologic research. Suggested future activities included initiatives in these areas plus other initiatives related to the collection and analysis
of additional information on Vietnam veterans’ service, exposures, and health.
Complete details may be found in Chapter 14 of the Update 2014 report.
While there have been a few laudable exceptions—notably, the initiation
of additional epidemiologic studies on Vietnam veterans, the development of a
herbicide exposure assessment model for use in studies of Vietnam veterans, and
the fostering of additional research on the data and biospecimens collected in the
course of the AFHS3—there has been no known follow-up to the vast majority of
recommendations that have been offered. The current committee did not choose
to revisit this issue in general, concluding that the Update 2014 committee had
effectively covered it.
It does observe, though, that the very first VAO (1994) indicated that “carefully conducted epidemiologic studies—with adequate sample size to detect elevated associations—of the reproductive history of individuals with occupational
or environmental exposure to herbicides and dioxin are . . . needed” (p. 731).
Several subsequent volumes (Updates 2006, 2008, 2010, 2012, and 2014; summarized in Table 12-2) have echoed and expanded on this. The current committee is in agreement with these sentiments and therefore recommends further
specific study of the health of offspring of male Vietnam veterans.
The Update 2014 committee also offered suggestions for research activities
that should follow the end of the VAO report series. Several of these, summarized in Table 12-3, addressed reproductive outcomes. As that committee noted,
although progress has been made in understanding the health effects of exposure
to the COIs and the mechanisms underlying these effects, significant gaps in our
knowledge remain. Many additional opportunities for progress via continuing
and new toxicologic, mechanistic, and epidemiologic research exist. Such work
should include efforts to gain new knowledge through the integration of existing
Department of Defense and VA databases. While such research opportunities
were mentioned in previous VAO updates, the Update 2014 committee restated
them to emphasize its conviction that more progress should be made in the fields
noted. This committee concurs in this assessment and endorses the recommendations offered in Table 12-3, noting that research in the rapidly advancing field
of epigenetics appears to hold particular promise. Furthermore, the committee
observes that VA’s Vietnam Era Health Retrospective Observational Study (VEHEROeS)—a study of the health and well-being of U.S. Vietnam and Vietnamera veterans—was under way at the time this report was completed and that it,
along with other ongoing Vietnam veteran research efforts, holds the promise of
adding to the body of knowledge.

3 The Institute of Medicine publications Disposition of the Air Force Health Study (IOM, 2006)
and The Air Force Health Study Assets Research Program (IOM, 2015) provide details of this work.
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International Agency for Research on Cancer (IARC)
Carefully conducted epidemiologic studies—with adequate sample size
to detect elevated associations—of the reproductive history of individuals
with occupational or environmental exposure to herbicides and dioxin are
recommended.

National Institute for Occupational Safety and Health (NIOSH)
Conduct epidemiologic studies—with adequate sample size to detect elevated
associations—of the reproductive history of individuals with occupational or
environmental exposure to herbicides and dioxin.

VAO

No known follow-up

continued

As noted in Chapter 5, NIOSH has, at its own
instigation, collected data on and followed
several groups of U.S. workers exposed to the
committee’s COIs since the early 1990s.

No known follow-up

Update 2008

VAO

No known follow-up

No known follow-up

Follow-Up?

Update 2006

Update 2006

EPIDEMIOLOGIC STUDIES
Army Chemical Corps (ACC)
Study paternally mediated effects on health outcomes in offspring.

Air Force Health Study (AFHS)
Study the potential for paternally mediated effects on health outcomes in
offspring.
Comprehensive longitudinal analysis of the AFHS data collected in the six
intensive medical-cycle examinations particularly concerning birth defects in
veterans’ offspring, making use of the available exposure data.

Volume Initially
Recommended

Recommendation Focus Area

TABLE 12-2 Compendium of Research Recommendations from Previous Veterans and Agent Orange Series Reports
Related to Effects on Veterans’ Descendants (excerpted, adapted, and updated from Update 2014, Table 14-2)
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Update 2006

Update 2010

Update 2010

Conduct studies of defined clinical health conditions in mature offspring
following exposure of either parent, rather than more investigations of
physiological biomarkers that may merely be predictive of disease development
later in life.

Develop epidemiologic protocols to address whether adverse effects are being
manifested in later generations as a result of paternal exposure (in the absence
of maternal exposure, focusing on those organ systems that have shown the
greatest impact following maternal exposure, including neurologic, immune, and
endocrine effects). Consideration must be given to the minimum sample size
needed to detect changes, if present, and to which outcome measures would be
most sensitive and reliable.

Update 2006

Volume Initially
Recommended

Investigate possible effects in offspring of Vietnam veterans (especially for birth
defects or developmental disease, including cognitive and developmental effects
in children and possibly grandchildren), especially those associated with paternal
exposures.

Other Recommended Epidemiologic Studies and Analyses:
An ad hoc group should conduct a meta-analysis of the current epidemiologic
studies of male populations exposed to COIs and the risk of birth defects in
offspring.

Recommendation Focus Area

TABLE 12-2 Continued

No known follow-up

No known follow-up

No known follow-up

No known follow-up (Given the paucity of
studies of only paternal transmission and the
extremely heterogeneous study designs and
exposures, meta-analyses no longer seems a
plausible approach to evaluating birth defects
[or any other health outcome].)

Follow-Up?
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Update 2010

Update 2012

Update 2014

Animal studies of the mechanisms of inhibition of fetal growth, particularly in
male offspring, after maternal exposure could help to elucidate findings seen in
some epidemiologic studies that examined maternal exposure and birth weight.

Given the current concern among male veterans about the transmission of
adverse effects to their descendants, focused use of animal models to investigate
the possibility of paternal exposure contributing to the development of disease in
offspring would be very informative.

Update 2006

Update 2010

Toxicological investigations of the potential for the COIs (particularly TCDD)
to induce epigenetic modifications, with special attention to the capacity for
paternal transmission of such effects, should be conducted.

TOXICOLOGIC STUDIES
Animal models are needed to elucidate disease mechanisms and progression,
including transgenerational or paternally mediated effects.

Case-control study should be used to explore whether information about
Vietnam exposure or specific herbicide exposure could be ascertained in any of
the many birth cohorts that have been established in the past several decades
(especially for very uncommon health outcomes). To home in on a paternal
effect, however, it will be necessary to establish that the mothers did not have
the opportunity for other than background exposure to the chemicals of interest.

No known follow-up

No known follow-up

No known follow-up

No known specific follow-up of the committee’s
recommendation, although numerous animal
studies have been conducted since the report was
published.

No known follow-up
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TABLE 12-3 Suggested Activities to Follow the Completion of the Veterans
and Agent Orange Report Series Mandated by the Agent Orange Act Related to
Effects on Veterans’ Descendants (excerpted from Update 2014, Table 14-3)
OVERSIGHT OF LONG-TERM HEALTH STATUS OF DEPLOYED SERVICE MEMBERS
Very careful review of evidence concerning whether paternal exposure to any toxicant has
definitively been demonstrated to result in abnormalities in even the first generation of offspring.
Careful assessment of the risks to offspring that may arise from maternal exposure is also
merited, given the greatly increased number of women now serving in the military.
EPIDEMIOLOGIC STUDIES
Air Force Health Study (AFHS)
Comprehensive longitudinal analysis of the AFHS data collected in the six intensive medicalcycle examinations (including birth defects in veterans’ offspring), making use of the available
exposure data.
Use AFHS samples for study of epigenetic changes and definition of biomarkers of exposure
and effect.*
Other Epidemiology Goals
Pursue development of protocols that could feasibly and efficiently investigate paternal
transmission of adverse effects to offspring at birth or manifesting with maturation that have
sufficient power for convincing findings. The logistics of attempting to detect adverse effects in
the grandchildren of Vietnam veterans would be considerably more challenging.
TOXICOLOGIC RESEARCH
Foster investigation of epigenetic changes in both somatic tissues and germ cells and during
gestation.
Without sophisticated and specific markers of environmentally induced epigenetic activity,
epidemiologic investigations will not be able to distinguish the mechanisms inducing any
observed adverse health effects in exposed people or their offspring.
Fully investigate whether paternally transmitted adverse effects occur in animal models.
*A pilot study by Boekelheide and colleagues—described in IOM (2005)—proposed to use a
“new epigenome-wide molecular approach to detect dioxin exposure-related alterations in DNA
methylation in biospecimens from the Air Force Health Study” (p. 112). Proof-of-concept work was
conducted, but the project was not carried forward due to lack of funding.

FINAL OBSERVATIONS
In the course of carrying out its Statement of Task, the committee has offered
myriad criticisms of the conduct of studies of Vietnam veterans’ health, pointing
out specific weaknesses and shortcomings in particular papers along with widespread (although not universal) issues such as poor exposure characterization,
failure to fully control for confounding influences on outcomes, and sample sizes
that are inadequate for drawing statistically meaningful results. The committee
wishes to make clear, though, that the difficulty in conducting research on Vietnam veteran health issues should not act as a barrier to carrying out such work.
There are many questions regarding veterans’ health that cannot be adequately
answered by examining superficially analogous exposures and outcomes in other
populations. It is only through research on veterans themselves that the totality of
the military service experience can be properly accounted for.
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Appendix A
Public Meeting Agendas

FIRST PUBLIC MEETING
March 2, 2017
Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001
Open Session
1:00–1:10 p.m.

Welcome and introductions; conduct of the open session
Irva Hertz-Picciotto, Ph.D. – Committee Chair

1:10–2:00 p.m.

Charge to the committee and discussion
Peter R. Rumm, M.D., M.P.H. – Director, Pre-9/11 Era
Environmental Health Program, Department of Veterans
Affairs (VA), with Dr. R. Loren Erickson, Chief Consultant,
Post-Deployment Health Services

2:00–2:45 p.m.

Overview of VA’s Vietnam Era Health Retrospective
Observational Study (VE-HEROeS)
Victoria Davey, Ph.D., M.P.H., R.N. – Principal Investigator,
VA
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2:45–3:30 p.m.

VA Health Care Utilization for Vietnam Veterans
Aaron I. Schneiderman, Ph.D., M.P.H., R.N. – Director,
Epidemiology Program Post-Deployment Health Services,
VA

3:30–4:30 p.m.

Public comments
Thomas Berger, Ph.D., Vietnam Veterans of America
Ann Brazeau, MPN Advocacy and Education International
Carla L. Dean, Bladder Cancer Foundation of Florida
Cindy Fabbri
MSgt LeRoy G. Foster
	Raajit K. Rampal, M.D., Ph.D., Memorial Sloan Kettering
Cancer Center
Rick Weidman, Vietnam Veterans of America
4:30 p.m.

Open session adjourns
SECOND PUBLIC MEETING
September 7, 2017
Courtyard Marriott Bloomington by Mall of America
7800 Bloomington Avenue S.
Lake Hiawatha Room
Bloomington, MN 55425
Open Session

1:00–1:10 p.m.

Welcome | Notes on the conduct of the open session |
Introduction of participants
Irva Hertz-Picciotto, Ph.D. – Committee Chair

1:10–2:30 p.m.

Presentations and comments by participants and questions
from the committee
Ronald R. Bach, Ph.D.
Robert Behrens
Richard Bergling
Linda O. Bergum, M.D.
Jeremy Eberley and parents
Maynard Kaderlick
Lee McClary
Mokie Porter

2:30 p.m.

Wrap-up and thanks to participants
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THIRD PUBLIC MEETING
November 30, 2017
Keck Center of the National Academies
500 Fifth Street, NW
Washington, DC 20001
Open Session
10:15–10:30 a.m. Welcome | Notes on the conduct of the open session |
Introduction of participants
Irva Hertz-Picciotto, Ph.D. – Committee Chair
10:30–11:15 a.m. Exposures and Heritable Effects
Thaddeus (Thad) Schug, Ph.D. – Health Scientist
Administrator, Population Health Branch, National Institute
of Environmental Health Sciences and the National
Toxicology Program
11:15 a.m.–
12:00 p.m.

Russian Children’s Study: Dioxins and Semen Quality
Russ Hauser, Sc.D. – Frederick Lee Hisaw Professor
of Reproductive Physiology. Chair, Department of
Environmental Health, Harvard T.H. Chan School of Public
Health

12:45–1:30 p.m. Multiple Myeloma and its Precursor Disease (MGUS)
C. Ola Landgren, M.D., Ph.D. – Professor of Medicine
and Chief Attending Physician of the Myeloma Service,
Memorial Sloan Kettering Cancer Center
1:30–2:15 p.m.

Epidemiology of Glioma
Quinn T. Ostrom, Ph.D., M.P.H. – Research Coordinator,
Case Comprehensive Cancer Center, Case Western Reserve
University School of Medicine; Research Manager and
Primary Analyst, Central Brain Tumor Registry of the
United States

2:15–3:00 p.m.

Glioblastoma – State of the Science
Paul S. Mischel, M.D. – Member and Head, Laboratory of
Molecular Pathology, Ludwig Institute for Cancer Research
San Diego and Professor, Department of Pathology,
University of California, San Diego
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3:00–3:30 p.m.

U.S. Department of Veterans Affairs: Vietnam Veterans and
Brain Cancer
Ralph L. Erickson, M.D., Dr.P.H., Chief Consultant, PostDeployment Health Services
Peter D. Rumm, M.D., M.P.H., Director, Pre-9/11 Era
Environmental Health Program

3:30–4:00 p.m.

Public comments (spoken comments may not exceed 3
minutes per person; written submissions of any length are
welcome)
Kathy-Lynn Carroll Josenhans
Robert M. (Bob) Hunter, Ph.D.
Pegi Scarlett
Laurel Smith Holt

4:00 p.m.

Open session adjourns
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Committee and Staff Biographies

COMMITTEE BIOGRAPHIES
Irva Hertz-Picciotto, Ph.D., M.P.H., M.A. (Chair), is a professor in the Department of Public Health Sciences in the School of Medicine and also at the Medical
Investigations of Neurodevelopmental Disorders (MIND) Institute, University of
California, Davis (UC Davis), and she is the chief of the Division of Environmental and Occupational Health. She is also the deputy director of the Center for
Children’s Environmental Health at UC Davis and the director of the Northern
California Center for the National Children’s Study. She has published widely on
environmental exposures, including metals, pesticides, polychlorinated biphenyls,
and air pollution and on their effects on pregnancy, the neonate, and early child
development as well as on methods in epidemiologic research. She has also led
several cohort studies of toxic chemicals and both pregnancy outcomes and early
child development in Chile, eastern Europe, and Mexico. Recently she co-founded
Project TENDR (Targeting Environment and Neuro-Developmental Risks), a collaborative effort of scientists, clinicians, policy makers, and advocates that aims
to decrease the incidence of neurodevelopmental disorders by reducing the neurotoxicant exposures that contribute to them. Dr. Hertz-Picciotto has served on
scientific advisory panels for the Environmental Protection Agency, the National
Institutes of Health’s (NIH’s) National Toxicology Program, the National Institute
for Occupational Safety and Health, the NIH Interagency Coordinating Committee on Autism Research, and the California Governor’s Proposition 65 committee. She has served or currently sits on the editorial boards for the American
Journal of Epidemiology, Environmental Health Perspectives, Epidemiology, and
Autism Research. She served as the president of the Society for Epidemiologic
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